<SEC-DOCUMENT>0001185185-23-000693.txt : 20230707
<SEC-HEADER>0001185185-23-000693.hdr.sgml : 20230707
<ACCEPTANCE-DATETIME>20230707161534
ACCESSION NUMBER:		0001185185-23-000693
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		98
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230707
DATE AS OF CHANGE:		20230707

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IGC Pharma, Inc.
		CENTRAL INDEX KEY:			0001326205
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				202760393
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32830
		FILM NUMBER:		231076949

	BUSINESS ADDRESS:	
		STREET 1:		10224 FALLS ROAD
		CITY:			POTOMAC
		STATE:			MD
		ZIP:			20854
		BUSINESS PHONE:		301-983-0998

	MAIL ADDRESS:	
		STREET 1:		10224 FALLS ROAD
		CITY:			POTOMAC
		STATE:			MD
		ZIP:			20854

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	India Globalization Capital, Inc.
		DATE OF NAME CHANGE:	20050505
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>igcpharma20230331_10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Jul 07 17:41:03 UTC 2023 -->
<html xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:igc="http://www.indiaglobalcap.com/20230331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml"><head>
	<title>igcpharma20230331_10k.htm</title>

	<!-- Generated by ThunderDome Portal - 7/7/2023 4:45:11 PM -->

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font-size: 10pt; font-family: &#34;Times New Roman&#34;; padding: 0in 0.1in; cursor: auto;"><div>
</div><hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/><div>
</div><hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/><div>
</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>UNITED STATES</b></p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt auto;"/><div>
</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">10-K</ix:nonNumeric></b></p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p><div>

</div><hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt auto;"/><div>
</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:0.9%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:20.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Annual report pursuant to Section</b>&#160;<b>13 or 15(d) of the Securities Exchange Act of 1934</b></p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:0.9%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:top;width:20.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>For Fiscal</b>&#160;<b>Year Ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate">March 31</ix:nonNumeric>, 2023</ix:nonNumeric>.</b></p>	</td>	</tr>
</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:0.9%;">	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:top;width:20.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Transition report pursuant to Section</b>&#160;<b>13 or 15(d) of the Securities Exchange Act of 1934</b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>For the transition period from <span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;to <span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></b></p>	</td>	</tr>
</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Commission file number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-32830</ix:nonNumeric></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div style="text-align: center;">
<div><img alt="igcpharma_logo1.jpg" src="igcpharma_logo1.jpg"/></div>
</div><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b><span style="text-decoration:underline">IGC PHARMA, INC.</span></b></ix:nonNumeric></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in Its Charter)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:4.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b><span style="text-decoration:underline">Maryland</span></b></ix:nonNumeric></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or other jurisdiction of</p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">incorporation or organization)</p>	</td>	<td style="vertical-align:bottom;width:1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:top;width:4.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber"><b><span style="text-decoration:underline">20-2760393</span></b></ix:nonNumeric></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer</p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Identification No.)</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:4.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:top;width:4.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:4.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">10224 Falls Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Potomac</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Maryland</ix:nonNumeric></span></b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of Principal Executive Offices)</p>	</td>	<td style="vertical-align:bottom;width:1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:top;width:4.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode"><b><span style="text-decoration:underline">20854</span></b></ix:nonNumeric></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Zip Code)</p>	</td>	</tr>
</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline">(<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">301</ix:nonNumeric>) <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">983-0998</ix:nonNumeric></span></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:bottom;width:18.5%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle">Common Stock</ix:nonNumeric> </span></b></p>	</td>	<td style="vertical-align:bottom;width:9.3%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><b><span style="text-decoration:underline">IGC</span></b></ix:nonNumeric></p>	</td>	<td style="vertical-align:bottom;width:18.5%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric> American LLC</span></b></p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:18.5%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Title of each class)</p>	</td>	<td style="vertical-align:bottom;width:9.3%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Trading Symbol)</p>	</td>	<td style="vertical-align:top;width:18.5%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of each exchange on which registered)</p>	</td>	</tr>
</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Securities registered pursuant to Section 12(g) of the Act: None.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;">&#160;</div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9744; Yes &#9745; <ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9744; Yes &#9745; <ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9745; <ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric> &#9744; No</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9745; <ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric> &#9744; No</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:bottom;width:2.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Large accelerated filer &#9744;</p>	</td>	<td style="vertical-align:top;width:4.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:3.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Accelerated filer &#9744;</p>	</td>	</tr>	<tr>	<td style="vertical-align:bottom;width:2.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric> &#9745;</p>	</td>	<td style="vertical-align:bottom;width:4.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:3.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Smaller reporting company <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness">&#9745;</ix:nonNumeric></p>	</td>	</tr>	<tr>	<td style="vertical-align:bottom;width:2.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></p>	</td>	<td style="vertical-align:bottom;width:4.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:3.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>	</td>	</tr>
</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant has filed a report on and attestation to its management assessment of the effectiveness of its Internal Control Over Financial Reporting under section 404 (b) of the Sarbanes-Oxley by the registered public accounting firm that prepared or issued its annual report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentFinStmtRestatementRecoveryAnalysisFlag">&#9744;</ix:nonNumeric></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9744; Yes &#9745; <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany">No</ix:nonNumeric></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The aggregate market value of the voting and non-voting stock held by non-affiliates of the Registrant, as of September 30, 2022, the last business day of the Registrant&#8217;s most recently completed second fiscal quarter, was approximately $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="dei:EntityPublicFloat" scale="0" unitRef="usd">20,812,750</ix:nonFraction>. Solely for purposes of this disclosure, shares of common stock held by executive officers and directors of the Registrant as of such date have been excluded because such persons may be deemed to be affiliates. This determination of executive officers and directors as affiliates is not necessarily a conclusive determination for any other purposes.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">53,077,436</ix:nonFraction> shares of our common stock were outstanding as of July 6, 2023.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DOCUMENTS INCORPORATED BY REFERENCE</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">None</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">&#160;</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IGC PHARMA, INC.</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM 10-K</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FOR THE FISCAL YEAR ENDED MARCH 31, 2023</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="toc" title="toc"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline">TABLE OF CONTENTS</span></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Page</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PART I</b></p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 1.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i1" style="-sec-extract:exhibit;">Business</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 1A.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i1a" style="-sec-extract:exhibit;">Risk Factors</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">22</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 1B.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i1b" style="-sec-extract:exhibit;">Unresolved Staff Comments</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 2.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i2" style="-sec-extract:exhibit;">Properties</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 3.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i3" style="-sec-extract:exhibit;">Legal Proceedings</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 4.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i4" style="-sec-extract:exhibit;">Mine Safety Disclosures</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PART II</b></p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 5.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i5" style="-sec-extract:exhibit;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 6.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i6" style="-sec-extract:exhibit;">[Reserved]</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 7.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i7" style="-sec-extract:exhibit;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 7A.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i7a" style="-sec-extract:exhibit;">Quantitative and Qualitative Disclosures About Market Risk</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">48</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 8.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i8" style="-sec-extract:exhibit;">Financial Statements and Supplementary Data</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">49</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 9.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i9" style="-sec-extract:exhibit;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">74</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 9A.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i9a" style="-sec-extract:exhibit;">Controls and Procedures</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">74</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 9B.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i9b" style="-sec-extract:exhibit;">Other Information</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">74</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 9C.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i9c" style="-sec-extract:exhibit;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">74</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:17.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PART III</b></p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 10.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i10" style="-sec-extract:exhibit;">Directors, Executive Officers, and Corporate Governance</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">75</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 11.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i11" style="-sec-extract:exhibit;">Executive Compensation</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">79</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 12.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i12" style="-sec-extract:exhibit;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">82</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 13.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i13" style="-sec-extract:exhibit;">Certain Relationships and Related Transactions, and Director Independence</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">83</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 14.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i14" style="-sec-extract:exhibit;">Principal Accountant Fees and Services</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">83</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PART IV</b></p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 15.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i15" style="-sec-extract:exhibit;">Exhibits and Financial Statement Schedules</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">86</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Item 16.</p>
			</td>
			<td style="vertical-align:top;width:18.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#i16" style="-sec-extract:exhibit;">Form 10-K Summary</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">86</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align:top;width:20.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#sig" style="-sec-extract:exhibit;">Signatures</a></p>
			</td>
			<td style="vertical-align:top;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">87</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;">&#160;</div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORWARD-LOOKING STATEMENTS AND IMPORTANT FACTORS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Annual Report on Form 10-K and the documents incorporated in this report by reference contain &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Additionally, we or our representatives may, from time to time, make other written or verbal forward-looking statements. In this report and the documents incorporated by reference, we discuss plans, expectations, and objectives regarding our business, financial condition, and results of operations. Without limiting the foregoing, statements that are in the future tense, and all statements accompanied by terms such as &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;expect,&#8221; &#8220;trend,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;assume,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;target,&#8221; &#8220;anticipate,&#8221; &#8220;outlook,&#8221; &#8220;preliminary,&#8221; &#8220;will likely result,&#8221; &#8220;will continue,&#8221; and variations of them and similar terms are intended to be &#8220;forward-looking statements&#8221; as defined by federal securities laws. We caution you not to place undue reliance on forward-looking statements, which are based upon assumptions, expectations, plans, and projections. In addition, our goals and objectives are aspirational and are not guarantees or promises that such goals and objectives will be met. Forward-looking statements are subject to risks and uncertainties, including those identified in the &#8220;Risk Factors&#8221; included in this report and in the documents incorporated by reference that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements speak only as of the date when they are made. Except as required by law, we assume no obligation to update forward-looking statements to reflect events, circumstances, changes in expectations, or the occurrence of unanticipated events after the date of those statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Forward-looking statements are based upon, among other things, our assumptions with respect to:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">the sufficiency of our existing cash and cash equivalents and marketable securities to fund our future operating and capital expenses;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to successfully register trademarks and patents, create and market new products and services, including trading in Hong Kong and other parts of South Asia, contract for infrastructure projects and rental of equipment in India, and achieve customer acceptance in the industries we serve;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">current and future economic and political conditions, including in Hong Kong, North America, Colombia, and India;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to accurately predict the future demand for our products and services;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to successfully market our hemp-based products in countries and states where hemp and hemp products are legal;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to maintain a stock listing on a national securities exchange;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to obtain and maintain regulatory approval of our existing product candidates and any other product candidates we may develop, and the labeling under any approval we may obtain;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to timely complete regulatory filings;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to obtain the U.S. Food and Drug Administration (FDA) approval for an Investigational New Drug Application (INDA) and to successfully run medical trials, including a Phase 2 trial for IGC-AD1;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our reliance on third parties to conduct clinical trials, and for the manufacture of IGC-AD1 for non-clinical studies and clinical trials;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">the impact of the COVID-19 pandemic on our results of operations, including the delay in our ability to launch certain projects;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our financial performance;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">the outcome of medical trials that are conducted on our Investigational Drug Candidates and products;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to fund the costs of clinical trials and other related expenses;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to maintain our intellectual property position and our ability to maintain and protect our intellectual property rights;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">competition and general acceptance of phytocannabinoids for alternative, pharmaceutical, and nutraceutical therapies;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to effectively compete and our dependence on market acceptance of our brands and products within and outside the United States;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">federal and state legislation, and administrative policy regulating phytocannabinoids;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability (based in part on regulatory concerns) to license our products to processors that can produce pharmaceutical grade phytocannabinoids;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to obtain and protect patents for the use of phytocannabinoids in our formulations;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to obtain and install equipment for processing and manufacturing hemp and hemp products;</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 2.1%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 44.2%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;">our ability to successfully navigate disruptions of information technology systems or data security breaches that could adversely affect our business.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">You should consider the limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of predictions contained in such forward-looking statements. As noted above, these forward-looking statements speak only as of the date when they are made. Moreover, in the future, we may make forward-looking statements through our senior management that involve the risk factors and other matters described in this report, as well as other risk factors subsequently identified, including, among others, those identified in our filings with the SEC in our quarterly reports on Form 10-Q and our current reports on Form 8-K.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This document contains statements and claims that are not approved by the FDA, including statements on hemp and hemp extracts, including cannabidiol and other cannabinoids. These statements and claims are intended to be in compliance with state laws, specifically in states where medical cannabis has been legalized, and the diseases which we anticipate our products will target are approved conditions for treatment or usage with cannabis or cannabinoids.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;">&#160;</div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PART I</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>In this report, unless the context requires otherwise, all references in this report to </i>&#8220;<i>IGC,</i>&#8221;<i> </i>&#8220;<i>the Company,</i>&#8221;<i> </i>&#8220;<i>we,</i>&#8221;<i> </i>&#8220;<i>our,</i>&#8221;<i> and </i>&#8220;<i>us</i>&#8221;<i> refer to IGC Pharma, Inc., together with the subsidiaries </i>identified<i> in Exhibit 21.1 of this Annual Report on Form 10-K. We exclude our investments and minority non-controlling interests, and any information provided by them is not incorporated by reference in this report. They should not be considered part of this report.</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i1" title="i1"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 1. BUSINESS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Overview</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IGC Pharma, Inc., formerly known as India Globalization Capital Inc., is a clinical-stage pharmaceutical company with a diversified revenue model that develops both prescription drugs and over-the-counter (OTC) products. IGC is a Maryland corporation established in 2005 with a fiscal year that is a 52- or 53-week period that ends on March 31. IGC has two business segments: Life Sciences and Infrastructure.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our focus is on developing innovative therapies for neurological disorders such as Alzheimer&#8217;s disease, epilepsy, Tourette syndrome, and sleep disorders. We also focus on formulations for eating disorders, chronic pain, premenstrual syndrome (PMS), and dysmenorrhea, in addition to health and wellness OTC formulations. The Company is developing its lead candidate, IGC-AD1, an investigational oral therapy for the treatment of agitation associated with Alzheimer&#8217;s disease. IGC-AD1 is currently in Phase 2 (Phase 2B) clinical trials after completing nearly a decade of research and realizing positive results from pre-clinical and a Phase 1 trial. This previous research into IGC-AD1 has demonstrated efficacy in reducing plaques and tangles, which are two important hallmarks of Alzheimer&#8217;s, as well as reducing neuropsychiatric symptoms associated with dementia in Alzheimer&#8217;s disease, such as agitation.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Alzheimer&#8217;s is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. As the most common cause of dementia, it affects over 50 million people worldwide. The disease is associated with the accumulation of plaques and tangles in the brain, leading to brain cell deterioration and impaired cognitive functions. Currently, there is no cure for Alzheimer&#8217;s, and the projected cost of Alzheimer&#8217;s and associated dementia is expected to be around $1 trillion just in the U.S., placing a significant financial strain on individuals, families, and the healthcare system.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The progress we are making in clinical trials gives us confidence in the potential of IGC-AD1 to be a groundbreaking therapy, with the potential to treat Alzheimer&#8217;s and also to manage devastating symptoms that separate families, increase admissions to nursing homes, and drive the cost of Alzheimer&#8217;s care. We have filed forty-one (41) patent applications in different countries and secured nine patents, including control of four in the Alzheimer&#8217;s space. We have built a facility for a potential Phase 3 trial and have strategic relations for the procurement of Active Pharmaceutical Ingredients (APIs). In addition, we have acquired and initiated work on TGR-63, a pre-clinical molecule that exhibits an impressive affinity for reducing neurotoxicity in Alzheimer&#8217;s cell lines. The advancement of IGC-AD1 into Phase 2 trials represents a significant milestone for the Company and positions us for multiple pathways to future success. We anticipate that the positive outcomes from these and other trials will drive further growth, valuation, and market potential for IGC-AD1, although there can be no assurance thereof.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At IGC Pharma, we recognize the significance of operational excellence and cost management in clinical trials. We have established an internal capability to manage trials, including proprietary software, rather than working with an external Contract Research Organization (CRO). We believe this empowers us to substantially reduce the costs associated with clinical trials compared to relying on external CROs. Our proprietary software allows us to streamline the trial processes, enabling seamless coordination and data management. Additionally, we are integrating machine learning technologies into our software framework. We believe this overlay of Artificial Intelligence (AI) will help us simulate trial scenarios, generate new insights to facilitate improved decision-making, efficiently design our Phase 3 trial, provide advanced data analysis, and ultimately enhancing the effectiveness and efficiency of our clinical trials, although there can be no assurance thereof.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Life Sciences Segment </i></b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IGC develops advanced formulations for treating diseases and conditions, including Alzheimer&#8217;s disease (AD), menstrual cramps (dysmenorrhea), premenstrual syndrome (PMS), and chronic pain. The Company&#8217;s leading drug candidate, IGC-AD1, has demonstrated in Alzheimer&#8217;s cell lines the potential to be effective in suppressing or ameliorating two key hallmarks of Alzheimer&#8217;s: plaques and tangles. IGC-AD1 is currently in a Phase 2B safety and efficacy clinical trial for agitation in dementia from Alzheimer&#8217;s (clinicaltrials.gov, NCT05543681). The Company also has a line of consumer product such as Holief<sup style="vertical-align:top;line-height:120%;">TM</sup>, which includes gummies and pain relief creams for women experiencing PMS and menstrual cramps, all currently available for purchase.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">5</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i><span style="text-decoration:underline">Pharmaceutical</span></i>: Since 2014, the Company has focused primarily on the potential uses of phytocannabinoids, including Tetrahydrocannabinol (THC) and Cannabidiol (CBD), in combination with other compounds to treat multiple diseases, including Alzheimer&#8217;s. As a company engaged in the clinical-stage pharmaceutical industry, we focus our research and development efforts, subject to results of future clinical trials, on seeking pharmaceutical solutions that may a) alleviate neuropsychiatric symptoms such as agitation, anxiety, and depression associated with dementia in Alzheimer&#8217;s disease; and b) halt the onset, progression, or cure Alzheimer&#8217;s disease.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><span style="text-decoration:underline">The Company currently has two main investigational small molecules in various stages of development:</span></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:36pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IGC-AD1</b>, our lead therapeutic candidate, is a THC based formulation that has demonstrated in AD cell lines, in vitro, the potential in reducing a key peptide responsible for A&#946;&#160;plaques and the potential to decrease or inhibit the phosphorylation of tau, a protein that is responsible for the formation of neurofibrillary tangles, both important hallmarks of AD. In addition, Phase 1 human trial results demonstrated IGC-AD1&#8217;s potential to reduce agitation in dementia due to AD. IGC-AD1 is currently in Phase 2B trials for treating agitation in dementia from AD, a condition that affects over 10-million individuals in North America and Europe, and</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:36pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>TGR-63</b>, a non-cannabinoid molecule, is an enzyme inhibitor shown in pre-clinical trials to reduce neurotoxicity in Alzheimer&#8217;s cell lines. Neurotoxicity causes cell dysfunction and death in Alzheimer&#8217;s disease. If shown to be efficacious, in AD cell lines, in halting this process, this inhibitor has the potential to treat Alzheimer&#8217;s disease by ameliorating A&#946;&#160;plaques.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i><span style="text-decoration:underline">Over-the-Counter Products</span></i>: We created a women&#8217;s wellness brand, Holief&#8482; available through online channels that is compliant with relevant federal, state, and local laws and regulations. Holief&#8482; is an all-natural, non-GMO, vegan, line of over-the-counter (OTC) products aimed at treating menstrual cramps (dysmenorrhea) and premenstrual symptoms (PMS). The products are available through Amazon and other online channels.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Alzheimer</b>&#8217;<b>s disease</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The National Institute on Aging (NIA) at the National Institutes of Health (NIH) defines Alzheimer&#8217;s as an irreversible, progressive brain disorder that destroys memory and thinking skills. According to the Alzheimer&#8217;s Association, approximately 11% of Americans over 65 have Alzheimer&#8217;s dementia, and many more could be undiagnosed. Some researchers suspect half of the 80 and over population will develop Alzheimer&#8217;s (Alzheimer&#8217;s Association, 2023). Alzheimer&#8217;s is the third leading cause of death, after heart disease and cancer. (NIA, 2019). The Alzheimer&#8217;s crisis is growing, and by 2030, World Health Organization (WHO, 2020) estimates that 55 million people worldwide will have dementia. With no approved cure, the global cost of dementia is expected to rise to about $2.8 trillion by 2030.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Dementia is a broader term used to describe the loss of cognitive functioning, including thinking, remembering, reasoning, and behavioral abilities. The WHO believes Alzheimer&#8217;s may be responsible for up to 70% of dementia. Alzheimer&#8217;s disease, and the dementia associated with it, is a progressive disease. Symptoms such as agitation, anxiety, depression, sleep disturbance (sundown syndrome), delusions, and hallucinations often begin to appear in patients in their mid-60s.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The NIA categorizes Alzheimer&#8217;s in three stages&#8211;- mild, moderate, and severe (NIA, 2019). Symptoms of mild Alzheimer&#8217;s can include wandering (getting lost, not remembering the way home), trouble handling money and paying bills, repeating questions, and personality or behavior changes. As the disease progresses to moderate, there is damage to the areas of the brain that control language, reasoning, sensory processing, and conscious thought. Patients can have difficulty with multi-step tasks such as getting dressed. Behavioral problems, including hallucinations, delusions, paranoia, and impulsive behavior, can also increase. When severe Alzheimer&#8217;s sets in, plaques and tangles spread throughout the patient&#8217;s brain, and the brain shrinks significantly. People with severe Alzheimer&#8217;s are completely dependent on others for care. They cannot communicate, and near the end of their life, they may be largely bedridden as the body shuts down (NIA, 2021).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Currently, there are limited options to help Alzheimer&#8217;s patients with the debilitating symptoms of the disease or relief for the burden placed on their caregivers (Cheng, 2017). Our Phase 1 trial for IGC-AD1 may provide hope for those patients suffering from mild to severe dementia due to Alzheimer&#8217;s disease.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">6</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Alzheimer</b>&#8217;<b>s Disease (AD) Pathology</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Alzheimer&#8217;s pathology can be divided into two categories, familial or inherited AD and sporadic AD. The histopathology of early-onset familial AD and late-onset sporadic AD are indistinguishable. Both forms of AD are characterized by extracellular amyloid-&#946; (A&#946;) plaques and intracellular tau-containing neurofibrillary tangles (G&#1255;tz, et al., 2011). Simplistically, in normal brain functioning, a large protein called Amyloid Precursor Protein (APP) is cleaved into smaller fragments called A&#946; proteins. In a normal brain, these are subsequently broken down further and cleared. However, in AD brains, these A&#946; proteins are not broken down and cleared; they instead stick to one another and deposit as inter-neuronal sticky plaque&#8212;that is, they deposit as plaque between neurons. In the brain, within a neuron, tau (&#964;) is a key protein that holds together the transport scaffold. As an analogy, it is the brick and mortar of the highway over which nutrients are transported within a neuron. In an AD brain, tau breaks down due to a process called hyperphosphorylation and is unable to hold the transport highway. The breakdown results in neurofibrillary tangles (NFTs) and eventually leads to neuronal death.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The misfolded structure of A&#946; proteins, along with NFTs, generates a characteristic tendency for their aggregation (Chiti &amp; Dobson, 2006) around damaged or dead neurons and within cerebral vasculature in the brain. It manifests by memory loss followed by progressive dementia. It has long been believed that A&#946;1&#8211;40 (A&#946;40) and A&#946;1&#8211;42 (A&#946;42) aggregates are the constituents of the insoluble plaques that are characteristic of AD. This disease is also associated with neuroinflammation, excitotoxicity, and oxidative stress (Campbell &amp; Gowran, 2007; Rich, et al., 1995). However, the continuous aggregation of A&#946; proteins along with hyperphosphorylation of tau protein inside the cell, causing NFT formation, are generally accepted as the major etiological factors of the neuronal cell death associated with the progression of Alzheimer&#8217;s disease (Octave, 1995; Reitz, et al., 2011; Pillay, et al., 2004).</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 50.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Figure 1: Hallmarks of Alzheimer</b>&#8217;<b>s</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-14pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Extracellular Plaque: &#946;-amyloid (A&#946;)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-14pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Tau Neurofibrillary Tangles (NTFs).</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-14pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Causes loss of neurons &amp; critical neuronal connections.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Also linked to Alzheimer&#8217;s:</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 77pt;text-indent:-18pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Metabolism disruption</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 77pt;text-indent:-18pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mitochondrial dysfunction</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 77pt;text-indent:-18pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neuroinflammation</p>
			</td>
			<td style="vertical-align: top; width: 50.5%;">
			<div><img alt="figure1.jpg" src="figure1.jpg"/></div>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>IGC-AD1 Studies on Alzheimer</b>&#8217;<b>s</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">While investigating cannabinoid-based combination therapies, researchers at the University of South Florida (USF) discovered the potential for cannabis to play a role in treating Alzheimer&#8217;s. The discovery was featured on Dr. Sanjay Gupta&#8217;s CNN show Weed 2. This work also led to several patent filings including one that was granted by the United States Patent and Trademark Office (USPTO). In fiscal year 2018, IGC acquired exclusive rights to the research data and patent filing. The research on the active ingredients of IGC-AD1 (IGC-AD1 Actives) showed that they, in combination, had potentially positive effects on Alzheimer&#8217;s disease. Specifically, the pre-clinical research on the IGC-AD1 Actives showed the following:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Impact on plaque levels: </b>Cao et al., (2014) reported a dose-dependent decrease in A&#946;40 levels in N2a/A&#946;PPswe cells (AD cell lines) in the presence of the IGC-AD1 Actives, after 24 hours of incubation. Furthermore, repeated exposure reduced A&#946;40 levels without changing APP levels, a novel non-obvious, and important finding as APP is a key protein associated with brain functioning. The mode of action is attributed to its direct interaction with A&#946; protein and inhibition of A&#946; aggregation (Cao et al., 2014).</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Impact on Tau Protein</b>: IGC-AD1 Actives lowered the level of phosphorylated Tau (pTau) expression in N2a/A&#946;PPswe cells in a dose-dependent manner. The mode of action was attributed to the direct interaction of IGC AD1 Actives with GSK3 protein kinase, which lowers pTau expression (Cao et al., 2014).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">7</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Impact on neurotoxicity</b>: Analysis of the neurotoxicity at various doses in N2a/A&#946;PPswe cells after incubation for up to 24 hours showed that the IGC-AD-1 Actives were non-toxic to cells at all doses (Cao et al., 2014).</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Impact on Mitochondria</b>: In a novel and non-obvious finding, it was discovered that THC in low doses has the unique property of enhancing mitochondrial functioning in isolated mitochondria obtained from N2a/A&#946;PPswe cells (Cao et al., 2014). This finding is contrary to what THC does at higher doses, alluding to a bi-phasic nature of THC.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Results with a mouse model:</b> Cao&#8217;s group extended their in vivo study to aged APP/PS1 mice to evaluate THC&#8217;s neuroprotective effects on behavioral models. They used a radial arm water maze (RAWM) to test spatial memory. RAWM tests revealed that treating aged APP/PS1 mice with low doses of THC for three months increased their spatial learning skills in a dose-dependent way (Wang et al., 2022).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Based on the evidence, we hypothesize that IGC-AD1 may have several AD modifying benefits, including:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Reduction in A&#946;&#160;expression without a reduction in APP.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Reduction in A&#946;&#160;aggregation and consequently plaques.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Enhanced mitochondrial functioning.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Reduction in the phosphorylation of tau and consequently a reduction in neurofibrillary tangles (NFTs).</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Research has shown that micro-dosing of THC could increase the functioning of mitochondria on AD cell lines (Cao et al., 2014) and potentially promote the growth of new pathways (neurogenesis) (Suliman, et al., 2018). Micro-dosing of THC affects the brain radically differently from the normal dosing in the FDA-approved prescription drug, Dronabinol. For example, there is a significant body of research showing that THC is neuro-toxic at normal levels, but micro-doses of THC have been shown to be non-toxic to neurons. With the exciting results of these pre-clinical studies, the Company developed an oral formulation, IGC-AD1, and completed a Phase 1 trial on AD patients.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>IGC-AD1 Clinical Trial Data</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">To the best of our knowledge, the Company&#8217;s Phase 1 clinical trial testing the safety and tolerability of IGC-AD1 is the first human clinical trial using low doses of THC, in combination with another molecule, to treat symptoms of dementia in Alzheimer&#8217;s patients. THC is a naturally occurring cannabinoid produced by the cannabis plant. It is known for being a psychoactive substance that can impact mental processes in a positive or negative way, depending on the dosage. THC is biphasic, meaning that low and high doses of the substance may affect mental and physiological processes in substantially different ways. For example, in some patients, low doses may relieve a symptom, whereas high doses may amplify a symptom. IGC&#8217;s trial is based on low dosing and controlled trials on patients suffering from Alzheimer&#8217;s disease.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">A double-blind, single-site, randomized, three cohort, multiple-ascending dose (MAD) clinical trial (FDA IND Number: 146069, NCT04749563) was conducted using the investigational new drug (IND) IGC-AD1. IGC received approval to proceed with the Phase 1 clinical trial from the FDA on July 30, 2020. The primary objective was safety and tolerability in elderly patients suffering from Alzheimer&#8217;s disease. The secondary objective was measuring changes in neuropsychiatric symptoms (NPS) using the neuropsychiatric inventory (NPI) as well as to assess the risk of suicide using the Columbia-Suicide Severity Rating Scale (C-SSRS). The exploratory objective was to measure the pharmacokinetics (PK) and the impact of polymorphisms of the gene CYP2C9 on PK. In all three cohorts, ten participants received IGC-AD1 and two received a placebo. There were at least four days of washout between the cohorts. In Cohort one, Cohort two, and Cohort three the doses were q.d. (once per day), b.i.d. (twice per day), and t.i.d. (three times per day), respectively. The trial concluded that all three dosing levels were safe with no serious or life-threatening events or deaths reported.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On December 1, 2021, IGC submitted the Clinical/Statistical Report (CSR) to the FDA on its Phase 1 trial titled &#8220;A Phase I Randomized Placebo-Controlled MAD Study to Evaluate Safety and Tolerability of IGC-AD1 In Subjects with Dementia Due to Alzheimer&#8217;s Disease.&#8221; Data that is relevant to the Phase 1 protocol and the design of the Phase 2 trial are presented here. The data presented here is not exhaustive.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">8</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Primary Endpoint: Safety &amp; Tolerability (S&amp;T)</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">S&amp;T was assessed by recording both solicited and non-solicited Adverse Events (AEs). The solicited AEs, assessed daily, were somnolence, falls, dizziness, asthenia, suicidal ideation, hypertension, psychiatric symptoms, and paradoxical nausea. All AEs were graded as mild, moderate, severe, life-threatening, and serious (SAE).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9679; In all three Cohorts, a) there were no SAEs, b) no life-threatening AEs, and c) no deaths.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9679; One AE, mild dizziness, reported in Cohort 1, was deemed to be related to IGC-AD1. All other AEs across all cohorts were deemed to be not related to IGC-AD1 or to the placebo.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9679; In Cohort 1, in the group that received IGC-AD1 (N=10), 50% reported hypertension, 40% reported asthenia, 30% reported somnolence and dizziness, 20% reported psychiatric symptoms, and 10% reported falls. One case of dizziness was deemed by the principal investigator (PI) to be related to IGC-AD1. In the placebo group (N=2) 100% reported hypertension, and 50% reported somnolence and falls.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9679; In Cohort 2 for the IGC-AD1 group, 60% reported psychiatric symptoms, 50% reported somnolence and asthenia, 30% reported hypertension, 20% reported nausea and dizziness, and 10% reported falls and suicidal ideation. In the placebo group 100% reported somnolence, 50% reported dizziness and hypertension.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9679; In Cohort 3 for the IGC-AD1 group, 70% reported somnolence, 60% reported psychiatric symptoms, 50% reported dizziness and asthenia, and 30% reported hypertension. In the placebo group 100% reported somnolence, and 50% reported hypertension and psychiatric symptoms.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div style="text-align: center;"><img alt="pe_img1.jpg" src="pe_img1.jpg"/></div><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Secondary Endpoints: Neuropsychiatric Inventory (NPI)</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Neuropsychiatric Symptoms (NPS) such as delusions, hallucinations, agitation/aggression, depression, anxiety, elation/euphoria, apathy, disinhibition, irritability, aberrant motor behavior, sleep disorders, and appetite/eating disorders are prevalent in patients who have Alzheimer&#8217;s disease (Phan et al., 2019). NPS in Alzheimer&#8217;s is a significant burden on patients and caregivers, and at some point, in the progression of Alzheimer&#8217;s disease, more than 97% of patients suffer from at least one symptom. The Neuropsychiatric Inventory (NPI) (Cummings et al., 1994) measures the severity of each symptom and establishes both individual symptom scores as well as an overall NPI score. Separately, the NPI also scores caregiver distress (NPI-D). The NPI is used by about 50% of neurologists to assess and treat Alzheimer&#8217;s patients (Fernandez et al., 2010).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">9</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the Phase 1 trial conducted on patients with Alzheimer&#8217;s disease, we measured changes in NPS as assessed by the NPI-12 as well as caregiver distress as assessed by the NPI-D. In the Phase 1 trial (N=10), seven received the active medication, and at baseline they had symptomatic Agitation with domain scores between two and twelve. In Cohorts two and three six Participants had symptomatic Agitation. We measured and analyzed the change in the mean NPI score for Agitation between Day 1 and Day 10 and between Day 1 and Day 15 for all three cohorts.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As shown in Table below, our analysis shows Cohort 2 had the largest absolute change in the mean Agitation score between Day one and Day ten (53% drop, p=.085) as well as between Day 1 and Day 15 (67% drop, p=.05).</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Table 1: NPI analysis for each of the three cohorts</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: middle; width: 8.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Domain</p>
			</td>
			<td colspan="3" style="vertical-align: middle; width: 12.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cohort 1 (n=7)</p>
			</td>
			<td colspan="3" style="vertical-align: middle; width: 12.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cohort 2 (n=6)</p>
			</td>
			<td colspan="3" style="vertical-align: middle; width: 12.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cohort 3 (n=5)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Agitation</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Baseline</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Baseline</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Baseline</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: auto; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">&#160;</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day 0</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day 0</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Day 0</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mean Score</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.7</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.3</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.3</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.1</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.5</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.2</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.2</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.4</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mean Change</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.4</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.7</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.2</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.8</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.8</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mean Change%</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">37%</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">48%</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">53%</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">67%</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">23%</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">67%</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">p-values</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">0.058</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">0.045</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">0.085</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">0.05</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">0.29</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-right: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">0.045</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">P(T&lt;=t) two-tail</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 5.2%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border-top: 1px solid black; border-bottom: 1px solid black; border-left: 1px solid black; border-image: initial;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 3.7%; border: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">According to the NPI Test, a reduction of 4 points or 30% in the score is considered clinically meaningful. In addition, we also used a paired 2-tailed t-test with 9 degrees of freedom to assess the statistical significance of the decrease both in the overall NPI and individual NPI domains.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9679; In Cohort 1 for those on IGC-AD1, the mean NPI decreased from a baseline 31.5 (SD 27.2) to 16.7 (SD 16.2) on day 10 (<i>p</i> = 0.0044) and 14.8 (SD 16.0) on day 15 (<i>p</i> = 0.0095).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">o Individual domains that showed improvement were in Agitation (<i>p</i> = .05), Dilutions (<i>p</i> = .05), Anxiety (<i>p</i> = .09), and Appetite and Eating Disorders (<i>p</i> = .01).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9679; In Cohort 2 for those on IGC-AD1, the mean NPI decreased from a baseline of 22.2 (SD 14.8) to 10.4 (SD 11.5) on day 10 (<i>p</i> = 0.0026) and 12.4 (SD14.7) on day 15 (<i>p</i> = 0.0127).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">o Individual domains that showed improvement were Agitation (<i>p</i> = .06), Irritability (<i>p</i> = .04), and Depression (<i>p</i> = .01).</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#9679; In Cohort 3 for those on IGC-AD1 the mean NPI decreased from a baseline of 16.0 (SD14.7) to 14.6 (SD10.9) on day 10 (<i>p</i> = 0.6751) and 7.9 (SD 9.0) on day 15 (<i>p</i> = 0.0113).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">o Individual domain&#160;that showed improvement was Agitation (<i>p</i> = .06).</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Figure 5: Results on Neuropsychiatric Symptoms (NPS) Measured by NPI Scores</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div style="text-align: center;"><img alt="figure5.jpg" src="figure5.jpg"/></div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">10</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">These results represent the intervention of IGC-AD1 in patients showed an overall improvement in NPS, and specifically in agitation, anxiety, and depression domains. Caregiver distress improved as well.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Figure 6: Results on Agitation Measured by NPI Scores</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div style="text-align: center;"><img alt="figure6.jpg" src="figure6.jpg"/></div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">These results represents that all three different doses, agitation improves both clinically and statistically (p&lt;.05).</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Phase 2 Clinical Trial Update</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Typically, a Phase 2 trial is divided into a Phase 2A and a Phase 2B trial with the former designed to assess dosing requirements and the latter to establish efficacy. In this document, we refer to the trial as Phase 2 and Phase 2B interchangeably. The Company has initiated a Phase 2B protocol titled &#8220;A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled, trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer&#8217;s disease&#8221;. The protocol is powered at 146 Alzheimer&#8217;s patients, with half receiving placebo, and is a superiority, parallel group study. While subject to changes, we expect to conduct the trial at about fifteen sites in USA, Canada, and Colombia. The primary end point is agitation in dementia due to Alzheimer&#8217;s disease as rated by the Cohen-Mansfield Agitation Inventory (CMAI) over a six-week period. The Phase 2 trial will also look at eleven exploratory objectives, including changes in anxiety, changes in cognitive processes such as attention, orientation, language, and visual spatial skills as well as memory, changes in depression, delusions, hallucinations, euphoria/elation, apathy, disinhibition, irritability, aberrant motor behavior, sleep disorder, appetite, quality of life, and caregiver burden. In addition, the trial will evaluate the impact of CYP450 polymorphisms and specifically CYP2C9 on each of the NPS and assess any reductions in psychotropic drugs, among others. CYP2C9 ranks amongst the most important drug metabolizing enzymes in humans, as it breaks down over 100 drugs, including nonsteroidal anti-inflammatory all drugs. We seek to understand how various versions of the enzyme act on IGC-AD1. Each participant will receive two doses of IGC-AD1 (b.i.d.) or two doses of placebo per day for six weeks.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Rationale For IGC-AD1 Phase 2</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The rationale for targeting agitation associated with dementia due to Alzheimer&#8217;s:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">About 76% of AD patients suffer from agitation as rated by the CMAI (Van der Mussele, et al., 2015). While there can be no guarantee, we expect the Phase 2 trial to take between 12 and 18 months to complete, barring a variety of unknown factors, such as a resurgence of COVID and the enforcement of lockdowns and travel restrictions. Agitation is a behavioral syndrome characterized by increased, often undirected, motor activity, restlessness, aggressiveness, and emotional distress.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Symptoms of AD depend on the stage of the disease: preclinical, mild, moderate, or severe. NPS like agitation, apathy, delusions, hallucinations, and sleep impairment are common accompaniments of dementia. Loss of functionality, including progressive difficulty in performing instrumental and basic activities of daily living, are also seen with disease progression (Tang et al., 2019). There is a spectrum of behavioral disorders that can affect patients with AD. These include agitation, anxiety, disturbance of the sleep cycle, depression, inappropriate sexual behavior, disinhibition, and irritability, among others (Lyketsos et al., 2011). These behavioral disturbances not only affect the patient&#8217;s quality of life but also cause extreme emotional distress for the caregivers. These disturbances can become very difficult to manage, so most of the time, combinational therapy is used (Matsunaga, et al., 2015). This can cause secondary undesirable effects, such as excessive sleepiness, which diminishes the capability of the patient to be active and alert during the day; dizziness, which can increase the risk for falls (Allan, et al., 2005); worsening of cognitive function, which in turn worsens functionality (Paterniti S, et al., 2002); and even death due to cardiovascular complications (Qiu, et. Al., 2006).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">11</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NMI Compounds </b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), in India conducted approximately 10 years of research and discovery work on naphthalene monoimide (NMI) compounds and the role of NMI compounds on neurotoxicity associated with Alzheimer&#8217;s. In Alzheimer&#8217;s patients, neurotoxicity is linked to beta amyloid (A&#946;) plaques and Neuro Fibrillary Tangles (NFT). JNCASR&#8217;s research based on Alzheimer&#8217;s cell lines identified one lead NMI molecule, TGR-63, from a family of NMI molecules, with the potential to reduce beta amyloid (A&#946;) plaques. Further, they demonstrated that the molecule reduces cognitive decline in a transgenic mouse model of Alzheimer&#8217;s. Their results were published in <i>Advanced Therapeutics</i> under the title &#8220;Naphthalene Monoimide Derivative Ameliorates Amyloid Burden and Cognitive Decline in a Transgenic Mouse Model of Alzheimer&#8217;s Disease&#8221; on January 28, 2021.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Figure 7: Shows the reduction of the amyloid burden by TGR63 in the APP/PS1 AD phenotypic mice model:</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div style="text-align: center;"><img alt="figure7.jpg" src="figure7.jpg"/></div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Figure 7 shows the Reduction of amyloid burden by TGR63 in APP/PS1 AD phenotypic mice model. A) Visualization of amyloid plaques in half hemisphere: Confocal microscopy images of coronal section of WT, AD mice, and TGR63 treated AD mice brain immunostained with amyloid fibrils specific OC primary antibody followed by fluorescently (&#955;<sub>ex</sub> = 633nm, &#955;<sub>em</sub> = 650nm) labeled secondary antibody (red) and DAPI (blue). B) Reduction of cortical and hippocampal amyloid burden by TGR63 treatment: Higher magnification images of vehicle and TGR63 treated mice (WT and AD) brain sections to visualize and compare the A&#946;<i> </i>plaques deposition in the cortex and hippocampus areas. The brain tissue sections were immunostained with amyloid fibrils specific primary antibody (OC) and red fluorescent-labeled (&#955;<sub>ex</sub> = 633nm and &#955;<sub>em</sub> = 650nm) secondary antibody. C, D) Quantification of A&#946;<i> </i>plaques: Amount of A&#946;<i> </i>plaques (%area) deposited in different regions (cortex and hippocampus) of vehicle and TGR63 treated mice (WT and AD) brain was analyzed. Data represent mean &#177; SEM, number of mice = 3 per group (*<i>p &lt; </i>0.05). Scale bar: 20 &#181;m.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On November 11, 2021, Hamsa Biopharma India Pvt. Ltd. (Hamsa Biopharma), a directly owned subsidiary of the Company, executed a Term Sheet with JNCASR, and on March 28, 2022, entered into an agreement for exclusive global rights corresponding to the molecules, technology, patent, and patent filings. The completion of outstanding items in the agreement occurred on May 10, 2022, and the agreement with JNCASR was filed on Form 8K on May 12, 2022. Pursuant to the agreement, IGC (through Hamsa Biopharma) acquired exclusive global rights to the molecule, which it intends to pursue as a drug development candidate, subject to further study, research, and development.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Rationale for the Acquisition of TGR-63</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As described above, IGC is currently engaged in human trials with IGC-AD1 that targets certain symptoms associated with dementia in Alzheimer&#8217;s. IGC-AD1 is currently being tested as a symptom modifying agent. Subject to further study, research, and development, TGR-63, on the other hand, could give the Company a potential disease modifying agent to expand the Company&#8217;s pursuit of a drug that can potentially treat or modify Alzheimer&#8217;s.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">12</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Contract Research Organization (CRO) and Clinical Trial Software</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The IGC-Pharma Electronic Data Capture system (IGC-EDC) is a secure and user-friendly data management software designed to collect clinical trial data in electronic format. The software incorporates rigorous security measures that help IGC to protect data and ensure compliance with regulatory requirements and industry standards. This format is designed for our clinical trials, especially our Phase 2 trial. The EDC system is designed to store and organize handwritten source documents, including medical history, concomitant medications, laboratory results, neuropsychiatric scales scores, adverse events, vital signs, safety calls, demographics, among others. The system allows users to generate data reports that will be used for data analysis and generate computational models to simulate the effects of our investigational drug IGC-AD1 on participants&#8217; outcomes. At IGC Pharma, we recognize the significance of operational excellence and cost management in clinical trials. One major cost driver in conducting trials is the expense associated with engaging CROs. These costs can significantly impact on the overall budget of a trial. To address this challenge and optimize trial costs, we have established an internal CRO, including proprietary software that we believe sets us apart from the traditional approach of outsourcing. We believe this strategic move will enable us to reduce the costs associated with clinical trials compared to relying on external CROs, although there can be no assurance. We have also begun working on overlaying machine learning technologies and Artificial Intelligence (AI) into the software framework for trial management with the expectation that this can lead to improved decision-making, contextual data entry, computational models, trial design (Phase 3), and data analysis, although there can be no assurance thereof.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Intellectual Property</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our goal is to use our intellectual property (IP) to develop products that we can bring to market in one or more of the following channels:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">1. Pharmaceutical products that are subject to FDA-approvals. We currently have one Alzheimer&#8217;s symptom modifying investigational drug candidate (IGC-AD1) in Phase 2 clinical trials under an INDA filed with the FDA, and a potential Alzheimer&#8217;s disease modifying drug development candidate (TGR-63) in a pre-clinical stage.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2. Branded wellness and lifestyle products to be sold in multiple retail and online channels, subject to applicable federal, state, and local laws and regulations.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3. Partnerships and licensing agreements with third parties who can accelerate bringing our IP to the market.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company holds all rights to the patents that it filed with the USPTO. In Fiscal 2017, the Company also acquired exclusive rights to the data and the patent filing from USF. Subsequent to Fiscal 2022, the Company acquired exclusive rights to the data and the patent filing from JNCASR.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company believes the registration of patents is an important part of its business strategy and future success. However, the Company cannot guarantee that these patent filings will lead to a successful registration with the USPTO. Please see Item 1A, Risk Factors- &#8220;We may not successfully register the provisional patents with the USPTO.&#8221;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Table below provides the status of our patent filings:</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="1" rowspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TARGET</b></p>
			</td>
			<td colspan="1" rowspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DESCRIPTION</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: middle; width: 11.8%; border-left: 1px solid black; border-top: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PATENT </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PENDING</b></p>
			</td>
			<td colspan="2" style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: middle; width: 22%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>GRANTED PATENTS</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; border-left: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>US</b></p>
			</td>
			<td style="vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FOREIGN</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Alzheimer&#8217;s Disease (IGC-AD1)&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Method &amp; Composition for Treating CNS Disorders&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Alzheimer&#8217;s Disease (TGR-63) &#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Manufactured molecule with ability to impact plaque build-up</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Alzheimer&#8217;s Disease (IGC-LMP)&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Composition, Synthesis, &amp; Medical use of Hybrid Cannabinoid&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Epilepsy&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Composition &amp; Method for Treating Seizures in Mammals</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Eating Disorders &#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Method &amp; Composition for Treating Cachexia &amp; Eating Disorders&#8203;&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stuttering &amp; Tourette Syndrome &#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Compositions &amp; Methods using Cannabinoids for Treating Stuttering &amp; Symptoms of Tourette Syndrome &#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">5</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fatigue &amp; Restoring Energy&#8203;&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cannabis-Based Method &amp; Compositions for Relieving Fatigue &amp; Restoring Energy&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">6</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 25.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pain&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 42.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cannabinoid Composition &amp; Method for Treating Pain&#8203;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">6</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 68.1%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TOTAL</b></p>
			</td>
			<td style="vertical-align: middle; width: 11.8%; border-left: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>41</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>8</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 13.1%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>1</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">13</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Products &amp; Services</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We market our brand, Holief&#8482;, and the formulations for the products, in accordance with applicable laws and regulations. Although there can be no assurance, we believe the brand and the formulations have significant potential in the growing natural products-based wellness and lifestyle market.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Holief</b>&#8482;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The word &#8220;Holief&#8221; was created by combining the words &#8220;holistic&#8221; and &#8220;relief.&#8221; The brand includes multiple hemp-based products for women. Holief&#8482; includes a patented formulation for treating the pain and symptoms of Premenstrual Syndrome (PMS) and period cramps. These products provide a natural alternative to pain medications such as opioids. The products are available online and through Amazon and other online channels.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Infrastructure segment</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s infrastructure business has been operating since 2008, it includes: (i) Execution of Construction Contracts and (ii) Rental of Heavy Construction Equipment.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>COVID-19 Update</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The ongoing COVID-19 pandemic and the resulting containment measures that have been in effect from time to time in various countries and territories since early 2020 have had a number of substantial negative impacts on businesses around the world and on global, regional, and national economies, including widespread disruptions in supply chains for a wide variety of products and resulting increases in the prices of many goods and services. Currently, our production facilities in all of our locations continue to operate as they had before the COVID-19 pandemic, with few changes other than for enhanced safety measures intended to prevent the spread of the virus.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Some of our ongoing clinical trials experienced short-term interruptions in the recruitment of patients due to the COVID-19 pandemic, as hospitals prioritized their resources towards the COVID-19 pandemic and government-imposed travel restrictions. Some clinical trials experienced increased expenses due to new protocols to protect participants from COVID-19. Additionally, certain suppliers had difficulties meeting their delivery commitments, and we are experiencing longer lead times for components. Future shutdowns could have an adverse impact on our operations. However, the extent of the impact of any future shutdown or delay is highly uncertain and difficult to predict.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">It is difficult at this time to estimate the complete impact that COVID-19 could have on our business, including our customers and suppliers, as the effects will depend on future developments, which are highly uncertain and cannot be predicted. Infections may resurge or become more widespread, including due to new variants and the limitation on our ability to travel and timely sell and distribute our products, as well as any closures or supply disruptions may be prolonged for extended periods, all of which would have a negative impact on our business, financial condition, and operating results.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Even after the COVID-19 pandemic has subsided, we may continue to experience an adverse impact on our business due to the continued global economic impact of the COVID-19 pandemic. We cannot anticipate all of the ways in which health epidemics such as COVID-19 could adversely impact our business. See Item 1A, &#8220;Risk Factors&#8221; for further discussion of the possible impact of the COVID-19 pandemic on our business.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Business Strategy</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Life Sciences business strategy includes:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:9.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Subject to FDA approval, developing IGC-AD1 as a drug for treating agitation in dementia due to Alzheimer&#8217;s and investigating and developing TGR-63 for the potential treatment of Alzheimer&#8217;s disease.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:9.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Marketing Holief&#8482;, and formulations.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">14</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We believe developing a drug for either symptoms or as a disease-modifying agent has less risk due to the need for multi-year trials and FDA approval. However, there is a considerable upside and significant value creation to the extent we obtain a first-to-market advantage, of which there can be no assurance. If we were to obtain a first-to-market advantage, such an advantage could result in significant growth if and when an approved drug launches. Our Holief&#8482; formulation strategy includes expanding the line of products and formulations, and developing online services that connect women with healthcare professionals who can help with PMS and dysmenorrhea. We believe that building an online community that brings women together can create brand equity, loyalty, generate revenue, and drive valuation.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We believe that additional investment in clinical trials, research, and development (R&amp;D), facilities, marketing, advertising, and acquisition of complementary products and businesses will be critical to the ongoing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative products that drive positive patient and customer experiences. We hope to leverage our R&amp;D and intellectual property to develop ground-breaking, science-based products that are proven effective through clinical trials, subject to FDA approval. Although there can be no assurance, we believe this strategy can improve our existing products and lead to the creation of new hemp-based products that can provide treatment options for multiple conditions, symptoms, and side effects.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Infrastructure strategy includes the following:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:9.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Executing existing construction contracts, and</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:9.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">leasing heavy construction equipment.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Markets and Distribution</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration:underline">Life Sciences segment</span></i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There is a growing awareness around PMS, dysmenorrhea, and menopause. Approximately 31.3 million (Statista, 2021) women in America suffer from dysmenorrhea and PMS. Our Life Sciences revenue is less than 1% of the relevant global market, which implies a tremendous opportunity for growth. In Fiscal 2023, our sales and suppliers were concentrated, which represents some risk. Two customers accounted for over 10% of sales.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration:underline">Infrastructure segment</span></i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In Fiscal 2023, our infrastructure business focused on projects in the state of Kerala. While executing this construction project, we took advantage of other opportunities to generate revenue from our infrastructure assets. We also lease our small fleet of heavy construction equipment, including graders, rollers, etc., to construction companies.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our infrastructure business revenue is less than 1% of the global revenue of the rental, construction, and commodities markets. We currently have one customer and one subcontractor/supplier of infrastructure materials. Our ability to grow is limited by the disruption to the Hong Kong economy and the impact of COVID-19. If and when the economy recovers, there is a potential opportunity for growth given the total size of the market.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Business Seasonality</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The infrastructure segment has historically experienced seasonality, with limited construction work available during the monsoon season. The hemp business also has seasonality, as most of the hemp harvest in America occurs in the fall. Pricing pressure is based on the volume of hemp biomass being harvested.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">15</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Competition</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Competition for the Company&#8217;s products and services varies by market:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>1. <span style="text-decoration:underline">Life Sciences segment</span>:</i> We are developing affordable medical products including products subject to FDA approval, which can help individuals suffering from debilitating diseases like Alzheimer&#8217;s. We face competition from well-funded pharmaceutical companies. With our existing research, patent filings, and experienced team, we have an early-mover advantage in cannabinoid-based products to treat the symptoms of Alzheimer&#8217;s. Our wellness and lifestyle products compete with multiple well-established companies, in the food, beverage, and skincare industries. We also face competition from companies with experience in wholesaling hemp crude extract and hemp isolate as well as companies that provide white labeling and tolling services. It is unclear how future FDA guidance and ruling on hemp-based food, beverage, and cosmetic products will impact the market.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>2. <span style="text-decoration:underline">Infrastructure segment:</span></i> The infrastructure industry in India and Hong Kong is highly competitive. Our differentiation is based primarily on price and local and industry knowledge of construction requirements in the regions where we operate.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Regulatory</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Despite the passage of the 2018 Farm Bill, the FDA has not established guidance or rules on the infusion of hemp-based derivatives into food and beverage products. This creates a complicated framework of local rules and regulations that we must navigate. When federal rules are clearly set, we expect the demand for hemp-based food and beverages will increase. We also believe competition will increase as major food and beverage manufacturers will enter the market.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Core business competencies and advantages</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our core competencies include:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:3.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:41.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">a network of doctors, scientists with Ph.D. degrees, and intellectual property legal experts with a sophisticated understanding of drug discovery, research, FDA filings, intellectual protection, and product formulation;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:41.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">knowledge of various cannabinoid strains, their phytocannabinoid profile, extraction methodology, and impact on various pathways;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:41.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">knowledge of plant and cannabinoid-based combination therapies;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:41.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">knowledge of research and development in the field;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:41.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">patents IGC-501, IGC-502, IGC-504, IGC-505, IGC-507, and IGC-514 for treatment of pain, treatment of seizures in humans and veterinary animals, treatment of cachexia and eating disorders in humans and veterinary animals, method and composition for treating seizure disorders, Alzheimer&#8217;s Disease and Self Assembly of Naphthalene Diimide Derivatives and Process Thereof, respectively;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:41.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">facilities and a team with experience in manufacturing, marketing, and selling products. These competencies have enabled us to make progress on our business goals, specifically completing the Phase 1 clinical trial of IGC-AD1, which has the potential to positively impact the lives of millions of patients suffering from the symptoms of Alzheimer&#8217;s disease, subject to FDA approval.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Licenses, Technology, and Cybersecurity</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have intellectual property attorneys that advise, counsel, and represent the Company regarding the filing of patents or provisional patent applications, copyrights applications, and trademark applications; trade secret laws of general applicability; employee confidentiality and invention assignment. Most of our data, including our accounting data, is stored in the cloud, which helps us mitigate the overall risk of losing data. We have a cybersecurity policy in place and are in the process of implementing tighter cybersecurity measures to safeguard against hackers. The Company holds all rights to the patents that have been filed by us with the USPTO.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">16</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The table below summarizes the nature of the activity, type of license required and held, and encumbrances in obtaining permits for each location where the Company operated through its subsidiaries in Fiscal 2023:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 6.8%; border-top: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Location</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 10.7%; border-top: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nature of Activity</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 10.7%; border-top: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Type of License Required</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 10.7%; border-top: 1px solid black; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Type of License held</b></p>
			</td>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Encumbrances in </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Obtaining Permit</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 6.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Life Sciences Products and General Management</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">General business</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">License to grow hemp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Industrial Alcohol User</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permit;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Clinical Trials;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Good Manufacturing Practices (GMP) certification.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">General business licenses; License to grow hemp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Industrial Alcohol User Permit; Clinical Trials</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">GMP Certificate.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None.</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 6.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Infrastructure Contract, Rental of heavy equipment and land</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">General business license</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Business registrations with tax authorities in various states in India</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None.</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 6.8%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Colombia</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Life Sciences Products and General Management</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">General business license;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) Permits;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fondo Nacional De Estupefacientes (FNE) Permits.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10.7%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">General business license;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) Permits;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fondo Nacional De Estupefacientes (FNE) Permits.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Governmental Regulations </i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the U.S., we are subject to oversight and regulations, for some or all of our activities, by the following agencies: SEC, state regulators, NYSE, FTC, and the FDA. The cannabis plant consists of several strains or varieties. Hemp and Marijuana are both cannabis plants. Under the 2018 Farm Bill, Hemp is classified as a cannabis plant that has 0.3% or less THC by dry weight. Marijuana is classified as a cannabis plant that has THC above 0.3% by dry weight.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Marijuana remains illegal under federal law, including in those states in which the use of marijuana has been legalized for medical and or recreational use. On the other hand, the 2018 Farm Bill, which was effective January 1, 2019, contains provisions that make industrial hemp legal. Although hemp is legal at the federal level, most states have created licensing and testing processes for the growing, processing, and sale of hemp and hemp-derived products.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For our business, we must apply for licenses in states where we desire to grow and process hemp. For example, in the state of Arizona, where we grew hemp, we were required to apply for licenses and register with the state the geo-location of all our operations, including the land on which hemp was grown and the facilities where hemp would be processed. These regulations are evolving, differ from jurisdiction to jurisdiction, and are subject to change.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>FDA Approval Process</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the U.S., pharmaceutical products are subject to extensive regulation by the FDA. The Federal Food, Drug, and Cosmetic Act, or the FDC Act, and other federal and state statutes and regulations, govern the research, development, testing, manufacturing, storage, recordkeeping, approval, labeling, promotion and marketing, distribution, post-approval monitoring, and reporting, sampling, and importing and exporting of pharmaceutical products, among other things. Failure to comply with applicable U.S. requirements may subject a company to a variety of administrative or judicial sanctions, such as the imposition of clinical holds, FDA refusal to approve pending New Drug Applications (NDA), warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement, civil penalties, and criminal prosecution.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pharmaceutical product development in the U.S. typically involves pre-clinical laboratory and animal tests and the submission to the FDA of an Investigational New Drug (IND), which must become effective before clinical testing may commence. For commercial approval, the sponsor must submit adequate tests by all methods reasonably applicable to show that the drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling. The sponsor must also submit substantial evidence, generally consisting of adequate, well-controlled clinical trials to establish that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling. In certain cases, the FDA may determine that a drug is effective based on one clinical study plus confirmatory evidence. Satisfaction of FDA premarket approval requirements typically takes many years and the actual time required may vary substantially based upon the type, complexity of the product, or disease.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">17</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pre-clinical tests include laboratory evaluation of product chemistry, formulation, and toxicity, as well as animal trials to assess the characteristics and potential safety and efficacy of the product. The conduct of the pre-clinical tests must comply with federal regulations and requirements, including the FDA&#8217;s good laboratory practices regulations and the U.S. Department of Agriculture&#8217;s (USDA&#8217;s) regulations implementing the Animal Welfare Act. The results of pre-clinical testing are submitted to the FDA as part of an IND along with other information, including information about product chemistry, manufacturing and controls, and a proposed clinical trial protocol. Long-term pre-clinical tests, such as animal tests of reproductive toxicity and carcinogenicity, may continue after the IND is submitted.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A 30-day waiting period after the submission of each IND is required prior to the commencement of clinical testing in humans. If the FDA has not imposed a clinical hold on the IND or otherwise commented or questioned the IND within this 30-day period, the clinical trial proposed in the IND may begin.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Clinical trials involve the administration of the investigational new drug to healthy volunteers or patients under the supervision of a qualified investigator. Clinical trials must be conducted: (i) in compliance with federal regulations; (ii) in compliance with Good Clinical Practice (GCP), an international standard meant to protect the rights and health of patients and to define the roles of clinical trial sponsors, administrators, and monitors; and (iii) under protocols detailing the objectives of the trial, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. Each protocol involving testing on U.S. patients and subsequent protocol amendments must be submitted to the FDA as part of the IND.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The FDA may order the temporary, or permanent, discontinuation of a clinical trial at any time or impose other sanctions if it believes that the clinical trial either is not being conducted in accordance with FDA requirements or presents an unacceptable risk to the clinical trial patients. The trial protocol and informed consent information for patients in clinical trials must also be submitted to an institutional review board, or IRB, for approval. An IRB may also require the clinical trial at the site to be halted, either temporarily or permanently, for failure to comply with the IRB&#8217;s requirements or may impose other conditions.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Clinical trials to support NDAs for marketing approval are typically conducted in three sequential phases, but the phases may overlap. In general, in Phase 1, the initial introduction of the drug into healthy human subjects or patients, the drug is tested to assess metabolism, pharmacokinetics, pharmacological actions, side effects associated with increasing doses and, if possible, early evidence on effectiveness. Phase 2 usually involves trials in a limited patient population to determine the effectiveness of the drug for a particular indication, dosage tolerance and optimum dosage, and to identify common adverse effects and safety risks. If a compound demonstrates evidence of effectiveness and an acceptable safety profile in Phase 2 evaluations, Phase 3 trials are undertaken to obtain the additional information about clinical efficacy and safety in a larger number of patients, typically at geographically dispersed clinical trial sites, to permit the FDA to evaluate the overall benefit-risk relationship of the drug and to provide adequate information for the labeling of the drug. In most cases, the FDA requires two adequate and well-controlled Phase 3 clinical trials to demonstrate the efficacy of the drug. The FDA may, however, determine that a drug is effective based on one clinical study plus confirmatory evidence. Only a small percentage of investigational drugs complete all three phases and obtain marketing approval. In some cases, the FDA may require post-market studies, known as Phase 4 studies, to be conducted as a condition of approval in order to gather additional information on the drug&#8217;s effect in various populations and any side effects associated with long-term use. Depending on the risks posed by the drugs, other post-market requirements may be imposed.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">After completion of the required clinical testing, an NDA is prepared and submitted to the FDA. The FDA approval of the NDA is required before marketing of the product may begin in the U.S. The NDA must include the results of all pre-clinical, clinical, and other testing and a compilation of data relating to the product&#8217;s pharmacology, chemistry, manufacture, and controls. The cost of preparing and submitting an NDA is substantial.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The FDA has 60 days from its receipt of an NDA to determine whether the application will be accepted for filing based on the agency&#8217;s threshold determination that it is sufficiently complete to permit substantive review. Once the submission is accepted for filing, the FDA begins an in-depth review. Under the statute and implementing regulations, the FDA has 180 days (the initial review cycle) from the date of filing to issue either an approval letter or a complete response letter, unless the review period is adjusted by mutual agreement between the FDA and the applicant or as a result of the applicant submitting a major amendment. In practice, the performance goals established pursuant to the Prescription Drug User Fee Act have effectively extended the initial review cycle beyond 180 days. The FDA&#8217;s current performance goals call for the FDA to complete review of 90 percent of standard (non-priority) NDAs within 10 months of receipt and within six months for priority NDAs, but two additional months are added to standard and priority NDAs for a new molecular entity (NME).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">18</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The FDA may also refer applications for novel drug products, or drug products that present difficult questions of safety or efficacy, to an advisory committee, which is typically a panel that includes clinicians and other experts, for review, evaluation, and a recommendation as to whether the application should be approved. The FDA is not bound by the recommendation of an advisory committee, but it generally follows such recommendations. Before approving an NDA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP. Additionally, the FDA will inspect the facility or the facilities at which the drug is manufactured. The FDA will not approve the product unless compliance with the current GMP is satisfactory, and the NDA contains data that provides substantial evidence that the drug is safe and effective in the indication studied.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">After the FDA evaluates the NDA and the manufacturing facilities, it issues either an approval letter or a complete response letter. A complete response letter generally outlines the deficiencies in the submission and may require substantial additional testing, or information, for the FDA to reconsider the application. If, or when, those deficiencies have been addressed to the FDA&#8217;s satisfaction in a resubmission of the NDA, the FDA will issue an approval letter. The FDA has committed to reviewing 90 percent of resubmissions within two to six months depending on the type of information included.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. As a condition of NDA approval, the FDA may require a risk evaluation and mitigation strategy (REMS) to help ensure that the benefits of the drug outweigh the potential risks. REMS can include medication guides, communication plans for health care professionals, and elements to assure safe use (ETASU). ETASU can include, but is not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patient registries. The requirement for a REMS can materially affect the potential market and profitability of the drug. Moreover, product approval may require substantial post-approval testing and surveillance to monitor the drug&#8217;s safety or efficacy. Once granted, product approvals may be withdrawn if compliance with regulatory standards is not maintained, or problems are identified following initial marketing.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Disclosure of Clinical Trial Information</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Sponsors of clinical trials of certain FDA-regulated products, including prescription drugs, are required to register and disclose certain clinical trial information on a public website maintained by the U.S. National Institutes of Health. Information related to the product, patient population, phase of the investigation, study sites, investigator and other aspects of the clinical trial is made public as part of the registration. Disclosure of the results of these trials can be delayed for up to two years if the sponsor certifies that it is seeking approval of an unapproved product or that it will file an application for approval of a new indication for an approved product within one year. Competitors may use this publicly available information to gain knowledge regarding the design and progress of our development programs.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>The Hatch-Waxman Act</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Orange Book Listing</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In seeking approval for a drug through an NDA, applicants are required to list with the FDA each patent the claims of which cover the applicant&#8217;s product. Upon approval of a drug, each of the patents listed in the application for the drug is then published in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Drugs listed in the Orange Book can, in turn, be cited by potential generic competitors in support of approval of an abbreviated new drug application (ANDA). An ANDA provides for the marketing of a drug product that has the same active ingredients in the same strengths and dosage form as the listed drug and has been shown through bioequivalence testing to be bioequivalent to the listed drug. Other than the requirement for bioequivalence testing, ANDA applicants are not required to conduct or submit results of pre-clinical or clinical tests to prove the safety or effectiveness of their drug product. Drugs approved in this way are considered to be therapeutically equivalent to the listed drug, are commonly referred to as &#8220;generic equivalents&#8221; to the listed drug and can often be substituted by pharmacists under prescriptions written for the original listed drug in accordance with state law.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The ANDA applicant is required to certify to the FDA concerning any patents listed for the approved product in the FDA&#8217;s Orange Book. Specifically, the applicant must certify that: (i) the required patent information has not been filed; (ii) the listed patent has expired; (iii) the listed patent has not expired but will expire on a particular date, and approval is sought after patent expiration; or (iv) the listed patent is invalid or will not be infringed by the new product. The ANDA applicant may also elect to submit a section viii statement, certifying that its proposed ANDA labeling does not contain (or carves out) any language regarding the patented method-of-use, rather than certify to a listed method-of-use patent. If the applicant does not challenge the listed patents, the ANDA application will not be approved until all the listed patents claiming the referenced product have expired.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">19</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A certification that the new product will not infringe the already approved product&#8217;s listed patents, or that such patents are invalid, is called a Paragraph IV certification. If the ANDA applicant has provided a Paragraph IV certification to the FDA, the applicant must also send notice of the Paragraph IV certification to the NDA and patent holders once the ANDA has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent infringement lawsuit in response to the notice of the Paragraph IV certification. The filing of a patent infringement lawsuit within 45 days of the receipt of a Paragraph IV certification automatically prevents the FDA from approving the ANDA until the earlier of 30 months, expiration of the patent, settlement of the lawsuit, or a decision in the infringement case that is favorable to the ANDA applicant. The ANDA application also will not be approved until any applicable non-patent exclusivity listed in the Orange Book for the referenced product has expired.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Exclusivity</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon NDA approval of a new chemical entity or NCE, which is a drug that contains no active component that has been approved by the FDA in any other NDA, that drug receives five years of marketing exclusivity during which time the FDA cannot receive any ANDA or 505(b)(2) application seeking approval of a drug that references a version of the NCE drug. Certain changes to a drug, such as the addition of a new indication to the package insert, are associated with a three-year period of exclusivity during which the FDA cannot approve an ANDA or 505(b)(2) application that includes the change.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">An ANDA or 505(b)(2) application may be submitted one year before NCE exclusivity expires if a Paragraph IV certification is filed. If there is no listed patent in the Orange Book, there may not be a Paragraph IV certification and thus no ANDA or 505(b)(2) application may be filed before the expiration of the exclusivity period.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For a botanical drug, the FDA may determine that the active moiety is one or more of the principal components or the complex mixture as a whole. This determination would affect the utility of any five-year exclusivity as well as the ability of any potential generic competitor to demonstrate that it is the same drug as the original botanical drug.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Five-year and three-year exclusivities do not preclude FDA approval of a 505(b)(1) application for a duplicate version of the drug during the period of exclusivity, provided that the 505(b)(1) applicant conducts or obtains a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Patent Term Extension</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">After NDA approval, owners of relevant drug patents may apply for up to a five-year patent extension. The allowable patent term extension is calculated as half of the drug&#8217;s testing phase &#8212; the time between IND submission and NDA submission &#8212; and all of the review phase &#8212; the time between NDA submission and approval up to a maximum of five years. The time can be shortened if the FDA determines that the applicant did not pursue approval with due diligence. The total patent term after the extension may not</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">exceed 14 years.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For patents that might expire during the application phase, the patent owner may request an interim patent extension. An interim patent extension increases the patent term by one year and may be renewed up to four times. For each interim patent extension granted, the post-approval patent extension is reduced by one year. The director of the PTO must determine that approval of the drug covered by the patent for which a patent extension is being sought is likely. Interim patent extensions are not available for a drug for which an NDA has not been submitted.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Orphan Drugs</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the Orphan Drug Act, the FDA may grant orphan drug designation to drugs intended to treat a rare disease or condition generally a disease or condition that affects fewer than 200,000 individuals in the U.S. (or affects more than 200,000 in the U.S. and for which there is no reasonable expectation that the cost of developing and making available in the U.S. a drug for such disease or condition will be recovered from sales in the U.S. of such drug). Orphan drug designation must be requested before submitting an NDA. After the FDA grants orphan drug designation, the generic identity of the drug and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. The first NDA applicant to receive FDA approval for a particular active ingredient to treat a particular disease with FDA orphan drug designation is entitled to a seven-year exclusive marketing period in the U.S. for that product, for that indication. During the seven-year exclusivity period, the FDA may not approve any other applications to market the same drug for the same disease, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity. If the FDA designates an orphan drug based on a finding of clinical superiority, the FDA must provide a written notification to the sponsor that states the basis for orphan designation, including &#8220;any plausible hypothesis&#8221; relied upon by the FDA. The FDA must also publish a summary of its clinical superiority findings upon granting orphan drug exclusivity based on clinical superiority. Orphan drug exclusivity does not prevent the FDA from approving a different drug for the same disease or condition, or the same drug for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the NDA application user fee.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">20</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Special Protocol Assessment</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A company may reach an agreement with the FDA under the Special Protocol Assessment (SPA), process as to the required design and size of clinical trials intended to form the primary basis of an efficacy claim. According to its performance goals, the FDA is supposed to evaluate the protocol within 45 days of the request to assess whether the proposed trial is adequate, and that evaluation may result in discussions and a request for additional information. A SPA request must be made before the proposed trial begins, and all open issues must be resolved before the trial begins. If a written agreement is reached, it will be documented and made part of the administrative record. Under the FDC Act and FDA guidance implementing the statutory requirement, an SPA is generally binding upon the FDA except in limited circumstances, such as if the FDA identifies a substantial scientific issue essential to determining safety or efficacy after the study begins, public health concerns emerge that were unrecognized at the time of the protocol assessment, the sponsor and the FDA agree to the change in writing, or if the study sponsor fails to follow the protocol that was agreed upon with the FDA.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>U.S. Coverage and Reimbursement</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Significant uncertainty exists as to the coverage and reimbursement status of our lead product candidates, such as IGC-AD1 or any other for which we may seek regulatory approval. Sales in the U.S. will depend in part on the availability of adequate financial coverage and reimbursement from third-party payors, which include government health programs such as Medicare, Medicaid, TRICARE, and the Veterans Administration, as well as managed care organizations and private health insurers. Prices at which we or our customers seek reimbursement for our product candidates can be subject to challenge, reduction, or denial by payors.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The process for determining whether a payor will provide coverage for a product is typically separate from the process for setting the reimbursement rate that the payor will pay for the product. Third-party payors may limit coverage to specific products on an approved list or formulary, which might not include all the FDA-approved products for a particular indication. Also, third-party payors may refuse to include a branded drug on their formularies or otherwise restrict patient access to a branded drug when a less costly generic equivalent or another alternative is available. Medicare Part D, Medicare&#8217;s outpatient prescription drug benefit, contains protections to ensure coverage and reimbursement for oral oncology products, and all Part D prescription drug plans are required to cover substantially all oral anti-cancer agents. However, a payor&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be available. Private payors often rely on the lead of the governmental payors in rendering coverage and reimbursement determinations. Sales of products such as IGC-AD1 or any other product candidates will therefore depend substantially on the extent to which the costs of our products will be paid by third-party payors. Achieving favorable coverage and reimbursement from the Centers for Medicare and Medicaid Services (CMS) and/or the Medicare Administrative Contractors is typically a significant gating issue for successful introduction of a new product.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Third-party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical products and services, in addition to their safety and efficacy. In order to obtain coverage and reimbursement for any product that might be approved for marketing, we may need to conduct studies in order to demonstrate the medical necessity and cost-effectiveness of any products, which would be in addition to the costs expended to obtain regulatory approvals. Third-party payors may not consider our product candidates to be medically necessary or cost-effective compared to other available therapies, or the rebate percentages required to secure favorable coverage may not yield an adequate margin over cost or may not enable us to maintain price levels sufficient to realize an appropriate return on our investment in drug development.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Human Capital Management and Environment, Health, and Safety</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Workplace Safety &amp; Employee Care During COVID-19</i>. Workplace safety is always a top priority for the Company. To create and sustain a safe and healthy workplace, we have implemented initiatives designed to address risk evaluation, education and training of employees, use of appropriate personal protective equipment, and compliance with relevant health and safety standards.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Environmental, Social, and Governance (ESG) Efforts</i>. During Fiscal 2023, we distributed $194 thousand worth of hand sanitizers and other wellness products in an effort to expand the Company&#8217;s ESG programs.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Employees.</i> As of March 31, 2023, we employed a team of approximately 61 full-time employees in our two segments. We also have contract workers and advisors in the U.S., India, Colombia, and Hong Kong.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Available Information</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Exchange Act are filed with the Securities and Exchange Commission (the SEC). The Company is subject to the informational requirements of the Exchange Act and files or furnishes reports, proxy statements, and other information with the SEC. Such reports and other information filed by the Company with the SEC are available free of charge on the Company&#8217;s website at www.igcinc.us when such reports are available on the SEC&#8217;s website. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov. The contents of these websites are not incorporated into this filing. Further, the Company&#8217;s references to the URLs for these websites are intended to be inactive textual references only.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">21</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i1a" title="i1a"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 1A. RISK FACTORS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>You should carefully consider the following risk factors, together with all other information included in this report, in evaluating the Company and our common stock. If any of the following risks and uncertainties develop into actual events, they could have a material adverse effect on our business, financial condition, or results of operations. In that case, the trading price of our common stock and other securities also could be adversely affected. We make various statements in this section, which constitute </i>&#8220;<i>forward-looking statements.</i>&#8221;<i> See </i>&#8220;<i>Forward-Looking Statements.</i>&#8221;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Risks Related to Our Business, Industry, and Operations:</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We have incurred significant losses and have an accumulated deficit. If we cannot achieve profitability, the market price of our common stock could decline significantly.</i></b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, we had cash and cash equivalents of $3.2 million and working capital of $4.6 million compared to cash and cash equivalents of $10.5 million and working capital of $12.7 million as of March 31, 2022, for continuing operations.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have had a history of operating losses. For Fiscal 2023 and Fiscal 2022, we had a net loss of approximately $11.5 million and $15 million, respectively. Our revenue increased from Fiscal 2022 to Fiscal 2023. Our short-term focus is to gain market share for our Life Sciences segment. Accordingly, there can be no guarantee that our efforts will be successful. If our revenues do not grow or if our operating expenses continue to increase, we may not be able to become profitable, and the market price of our common stock could decline. If we continue to have losses, we will be required to seek additional financing. No assurance can be given that we can raise any such financing, and such financing could be dilutive to our shareholders.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Our cannabinoid strategy makes it difficult to raise money as a public company.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Marijuana and hemp plants are both the same species, the dioecious plant Cannabis sativa L. Most countries differentiate hemp from marijuana by the amount of THC. Under the 2018 Farm Bill, hemp is classified as a cannabis plant that has 0.3% or less THC by dry weight. Marijuana is classified as a cannabis plant that has THC above 0.3% by dry weight. Both marijuana and hemp produce other cannabinoids, such as CBD.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">CBD, mentioned in the context of products, refers to hemp extracts naturally rich in cannabinoids like CBD, but with 0.3% or less THC by dry weight. Despite having no direct involvement in selling marijuana, the Company is often incorrectly classified as a &#8220;cannabis company&#8221; or a &#8220;marijuana company,&#8221; with all the nuances that accompany that label, including being blacklisted by banks, investment banks, and until recently by the largest stock clearing services company. The near-monopoly nature of some of these institutions, especially clearing houses, makes it difficult for the Company to raise money, deposit share certificates, or even have investment banking relationships. As we cannot control how others perceive us, there can be no assurance that we will be able to raise enough capital for our planned expansion.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The Drug Enforcement Administration (DEA) interim final rule related to statutory amendments to the Controlled Substances Act made by the Agriculture Improvement Act of 2018 (AIA) regarding the scope of regulatory controls over marijuana, tetrahydrocannabinols, and other related constituents may have an adverse impact on our Company.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Effective August 21, 2020, the interim rule to align DEA regulations in response to hemp legalization under the 2018 Farm Bill became effective. In order to meet the AIA&#8217;s definition of hemp and thus qualify for the exception in the definition of marijuana, a cannabis-derived product must itself contain 0.3% or less delta-9-Tetrahydrocannabinol (THC) on a dry weight basis. It is not enough that a product is labeled or advertised as &#8220;hemp.&#8221; Cannabis-derived products that exceed the 0.3% THC limit do not meet the statutory definition of &#8220;hemp&#8221; and are Schedule I controlled substances, regardless of claims made to the contrary in the labeling or advertising of the products. Further, a cannabis derivative, extract, or product that exceeds the 0.3% THC limit is a Schedule I controlled substance, even if the plant from which it was derived contained 0.3% or less THC on a dry weight basis. While&#8239;we strive to ensure compliance, further tightening of these definitions may have an adverse impact on our products.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">22</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>The Company depends on the performance of carriers, wholesalers, retailers, and other resellers.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company distributes its products through wholesalers, retailers, and resellers, many of whom may distribute products from competing manufacturers. The Company also intends to sell its products and resell third-party products in most of its major markets directly to consumers, small and mid-sized businesses, and other customers through its retail and online stores and its direct sales force. The Company intends to invest in programs to enhance reseller sales, including staffing selected resellers&#8217; stores with Company employees and contractors and improving product placement displays. These programs can require a substantial investment while not assuring return or incremental sales. The financial condition of these resellers could weaken, these resellers could stop distributing the Company&#8217;s products, or uncertainty regarding demand for some or all of the Company&#8217;s products could cause resellers to reduce their ordering and marketing of the Company&#8217;s products.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>We may engage in strategic transactions that could impact our liquidity, increase our expenses, and present significant distractions to our management, and which ultimately may not be successful. </i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">From time to time, we may consider strategic transactions, such as acquisitions of companies, asset purchases, and out-licensing or in-licensing of products, product candidates, or technologies, particularly those arrangements that seek to leverage other organizations&#8217; internal platforms or competencies for the benefit of our products or potential products. Additional potential transactions that we may consider may include a variety of different business arrangements, including spin-offs, strategic partnerships, joint ventures, restructurings, divestitures, business combinations, and investments. Any such transaction may require us to incur non-recurring or other charges that may increase our near and long-term expenditures and may pose significant integration challenges or disrupt our management or business, which could adversely affect our operations and financial results. For example, these transactions may entail numerous operational and financial risks, including:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">exposure to unknown or unanticipated liabilities, including foreign laws with which we are unfamiliar;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">disruption of our business and diversion of our management&#8217;s time and attention to develop acquired products, product candidates, or technologies;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the incurrence of substantial debt or dilutive issuances of equity securities to pay for acquisitions, which we may not be able to obtain on favorable terms, if at all;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">higher than expected acquisition and integration costs;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">write-downs of assets or goodwill or impairment charges;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">increased amortization expenses;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">difficulty and cost in combining the operations and personnel of any acquired businesses with our operations and personnel;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">entering a long-term relationship with a partner that proves to be unreliable or counterproductive;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">impairment of relationships with key suppliers or customers of any acquired businesses due to changes in management and ownership; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">inability to retain key employees of any acquired businesses.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There can be no assurance that we will undertake or successfully complete any transactions of the nature described above. Any transactions that we do complete could have a material adverse effect on our business, results of operations, financial condition, and prospects if we are unable to execute the planned objectives or capitalize on the relationship in the manner that was originally contemplated.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Global Operations</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We operate on a global scale and could be affected by currency fluctuations, capital, and exchange controls, global economic conditions including inflation, expropriation, and other restrictive government actions, changes in intellectual property legal protections and remedies, trade regulations, tax laws and regulations, and procedures and actions affecting approval, production, pricing, and marketing of, reimbursement for and access to our products, as well as impacts of political or civil unrest or military action, including but not limited to the current conflict between Russia and Ukraine, terrorist activity, unstable governments, and legal systems, inter-governmental disputes, public health outbreaks, epidemics, pandemics, natural disasters or disruptions related to climate change.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Some emerging market countries may be particularly vulnerable to periods of financial or political instability or significant currency fluctuations or may have limited resources for healthcare spending. As a result of these and other factors, our strategy to grow in emerging markets may not be successful, and growth rates in these markets may not be sustainable.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Government financing and economic pressures can lead to negative pricing pressure in various markets where governments take an active role in setting prices, access criteria (e.g., through health technology assessments) or other means of cost control.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">23</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We continue to monitor the global trade environment and potential trade conflicts and impediments that could impact our business. If trade restrictions or tariffs reduce global economic activity, potential impacts could include declining sales; increased costs; volatility in foreign exchange rates; a decline in the value of our financial assets and pension plan investments; required increases of our pension funding obligations; increased government cost control efforts; delays or failures in the performance of customers, suppliers and other third parties on whom we may depend for the performance of our business; and the risk that our allowance for doubtful accounts may not be adequate.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We may fail to expand our growing and manufacturing capability in time to meet market demand for our products and product candidates, and the FDA may refuse to accept our facilities or those of our contract manufactures as being suitable for the production of our products and product candidates. Any problems in our growing or manufacturing process could have a material adverse effect on our business, results of operations, and financial condition.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, before we can begin commercial manufacture of any medicinal product candidates for sale in the U.S., we must obtain FDA regulatory approval for the product, which requires a successful FDA inspection of the manufacturing facilities, which in turn includes the facilities of the processor(s) and quality systems in addition to other product-related approvals.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company established a Good Manufacturing Practice (GMP) certified processing facility in the State of Washington for processes such as: a) production of products such as lotions, creams, and oils, among others, to support our products and to support white labeling; b) extraction of hemp into crude oil; and c) distillation of crude oil into hemp extracts.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Due to the complexity of the processes used to manufacture our product candidates, we may be unable to initiate or continue to pass federal, state, or international regulatory inspections in a cost-effective manner. If we are unable to comply with manufacturing regulations, we may be subject to fines, unanticipated compliance expenses, recall or seizure of any approved products, total or partial suspension of production, and/or enforcement actions, including injunctions and criminal or civil prosecution. These possible sanctions would adversely affect our business, the results of operations, and financial condition.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Legal claims could be filed that may have a material adverse effect on our business, operating results, and financial condition. We may, in the future face risks of litigation and liability claims, the extent of such exposure can be difficult or impossible to estimate and which can negatively impact our financial condition and results of operations.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our operations are subject to numerous laws and regulations in the U.S., India, Colombia, and Hong Kong relating to the protection of the public and necessary disclosures regarding financial services. Liability under these laws involves inherent uncertainties. Violations of financial regulation laws are subject to civil, and, in some cases, criminal sanctions. We may not have been, or may not be, or may be alleged to have not been or to not be, at all times, in complete compliance with all requirements, and we may incur costs or liabilities in connection with such requirements or allegations. We may also incur unexpected interruptions to our operations, administrative injunctions requiring operation stoppages, fines judgments, settlements, or other financial obligations or penalties, which could negatively impact our financial condition and results of operations. See Item 3, Legal Proceedings of this report for further information on the current status of legal proceedings, if any. There can also be no assurance that any insurance coverage we have will be adequate or that we will prevail in any future cases. We can provide no assurance that we will be able to obtain liability insurance that would protect us from any such lawsuits. In the event that we are not covered by insurance, our management could spend significant time and resources addressing any such issues. And the legal fees necessary to defend against multiple lawsuits can be significant, impacting the Company&#8217;s overall bottom line when not covered by insurance or where the fees exceed the Company&#8217;s insurance policy limits.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our Company is in a highly regulated industry. Significant and unforeseen changes in policy may have material impacts on our business.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Continued development in the phytocannabinoids industry is dependent upon continued state legislative authorization of cannabinoids as well as legislation and regulatory policy at the federal level. The federal Controlled Substances Act currently makes cannabinoids use and possession illegal on a national level. While there may be ample public support for legislative authorization, numerous factors impact the legislative process. Any one of these factors could slow or halt the use and handling of cannabinoids in the U.S. or in other jurisdictions, which would negatively impact our development of phytocannabinoids-based therapies and our ability to test and productize these therapies.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">24</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Many U.S. state laws conflict with the federal Controlled Substances Act. While we do not and do not intend, to distribute or sell marijuana in the U.S., it is unclear whether regulatory authorities in the U.S. would object to the registration or public offering of securities in the U.S. by our Company, to the status of our Company as a reporting company, or even to investors investing in our Company, if we engage in legal cannabinoids cultivation and supply pursuant to the laws and authorization of the jurisdiction where the activity takes place. In addition, the status of cannabinoids under the Controlled Substances Act may have an adverse effect on federal agency approval of pharmaceutical use of phytocannabinoid products. Any such objection or interference could delay indefinitely or increase substantially the costs to access the equity capital markets, test our therapies, or create products from the Life Sciences segment.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our Company is inexperienced in conducting pre-clinical and clinical trials.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Company is inexperienced in conducting pre-clinical and clinical trials. Our attempt at demonstrating safety, efficacy, and ultimate useability may fail because of our lack of experience in designing, managing, and conducting clinical trials resulting in unanticipated or adverse outcomes. Such outcomes may have an adverse effect on our stock price.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Clinical trials are expensive, time-consuming, and difficult to design and implement, and involve an uncertain outcome.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process. Because the results of preclinical studies and early clinical trials are not necessarily predictive of future results, IGC-AD1 and our other compounds may not have favorable results in later preclinical and clinical studies or receive regulatory approval. We may experience delays in initiating and completing any clinical trials that we intend to conduct, and we do not know whether planned clinical trials will begin on time, need to be redesigned, enroll patients on time or be completed on schedule, or at all. Clinical trials can be delayed or terminated for a variety of reasons, including but not limited to:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation of our clinical studies;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">obtaining regulatory approval to commence a trial;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">reaching an agreement on acceptable terms with prospective contract research organizations (CROs), and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">obtaining Institutional Review Board (IRB) approval at each site, or Independent Ethics Committee (IEC) approval at sites outside the United States;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">recruiting suitable patients to participate in a trial in a timely manner and in sufficient numbers;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">having patients complete a trial or return for post-treatment follow-up;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">imposition of a clinical hold by regulatory authorities, including as a result of unforeseen safety issues or side effects or failure of trial sites to adhere to regulatory requirements or follow trial protocols;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">clinical sites deviating from trial protocol or dropping out of a trial;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">addressing patient safety concerns that arise during the course of a trial;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">adding a sufficient number of clinical trial sites; or</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">manufacturing sufficient quantities of the product candidate for use in clinical trials.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We could also encounter delays if a clinical trial is suspended or terminated by us, the IRBs or IECs of the institutions in which such trials are being conducted, the Data Safety Monitoring Board (DSMB), for such trial or the FDA or other regulatory authorities. Such authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. Furthermore, we rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials and, while we have agreements governing their committed activities, we have limited influence over their actual performance.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">25</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time-consuming, and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for IGC-AD1 or any other product candidates, our business will be substantially harmed.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The time required to obtain approval by the FDA and comparable foreign authorities is unpredictable but typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions. We have not obtained regulatory approval for any product candidate, and it is possible that we will never obtain regulatory approval for IGC-AD1 or any other product candidate. We are not permitted to market any of our pharmaceutical product candidates in the United States until we receive regulatory approval of an NDA from the FDA. The regulatory approval process can be affected by, among other things, the following:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe and effective for its proposed indication;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">serious and unexpected drug-related side effects experienced by participants in our clinical trials or by individuals using drugs similar to our product candidates, or other products containing the active ingredient in our product candidates;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">negative or ambiguous results from our clinical trials or results that may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">we may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the data collected from clinical trials of our product candidates may not be acceptable or sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the United States or elsewhere, and/or we may be required to conduct additional clinical trials;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the FDA or comparable foreign authorities may disagree regarding the formulation, labeling, and/or the specifications of our product candidates;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the FDA or comparable foreign regulatory authorities may fail to approve or find deficiencies with the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Prior to obtaining approval to commercialize a product candidate in the United States or abroad, we must demonstrate with substantial evidence from well-controlled clinical trials and to the satisfaction of the FDA or foreign regulatory agencies that such product candidates are safe and effective for their intended uses. Results from preclinical studies and clinical trials can be interpreted in different ways. Even if the preclinical or clinical data for our product candidates are promising, such data may not be sufficient to support approval by the FDA and other regulatory authorities. For diseases like Alzheimer&#8217;s, the FDA has stated that one single Phase 3 trial is adequate for approval if it demonstrates robust and unquestionable efficacy. However, the circumstances under which a single adequate and controlled study can be used as the sole basis for demonstrating the efficacy of a drug are exceptional.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The FDA or any foreign regulatory bodies can delay, limit, or deny approval of our product candidates or require us to conduct additional preclinical or clinical testing or abandon a program for many reasons, including:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the FDA or comparable foreign regulatory authorities may disagree with our safety interpretation of our drug;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the FDA or comparable foreign regulatory authorities may disagree with our efficacy interpretation of our drug;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the FDA or comparable foreign regulatory authorities may regard our Chemistry Manufacturing and Controls package as inadequate.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Of the large number of drugs in development, only a small percentage successfully complete the regulatory approval processes and are commercialized. This lengthy approval process, as well as the unpredictability of future clinical trial results, may result in us failing to obtain regulatory approval to market IGC-AD1 or another product candidate, which would significantly harm our business, results of operations, and prospects.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, the FDA or the applicable foreign regulatory agency also may approve a product candidate for a more limited indication or patient population than we originally requested, and the FDA or applicable foreign regulatory agency may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for our product candidates.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">26</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We have concentrated our research and development efforts on the treatment of Alzheimer</i></b>&#8217;<b><i>s Disease, which has seen limited success in drug development. Further, IGC-AD1 is based on a new approach to treating symptoms of Alzheimer</i></b>&#8217;<b><i>s Disease, which makes it difficult to predict the time and cost of development and subsequent obtaining of regulatory approval.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Efforts by biopharmaceutical and pharmaceutical companies in treating Alzheimer&#8217;s Disease have seen limited success in drug development, and there is no FDA-approved disease modifying therapeutic options available for patients with Alzheimer&#8217;s Disease. We cannot be certain that our approach will lead to the development of approvable or marketable products. The only drugs approved by the FDA to treat Alzheimer&#8217;s Disease to date address the disease&#8217;s symptoms. Alzheimer&#8217;s Disease drug candidates have the highest failure rate of approximately 99.6%. As a result, the FDA has a limited set of products to rely on in evaluating IGC-AD1. This could result in a longer than expected regulatory review process, increased expected development costs, or the delay or prevention of commercialization of IGC-AD1 for the treatment of Alzheimer&#8217;s Disease.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Enrollment and retention of patients in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside our control.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients who remain in the study until its conclusion. We may encounter delays in enrolling, or be unable to enroll, a sufficient number of patients to complete any of our clinical trials, and even once enrolled, we may be unable to retain a sufficient number of patients to complete any of our trials. Patient enrollment and retention in clinical trials depend on many factors, including:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the patient eligibility criteria defined in the protocol;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the size of the patient population required for analysis of the trial&#8217;s primary endpoints;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the nature of the trial protocol;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the existing body of safety and efficacy data with respect to the product candidate;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the proximity of patients to clinical sites;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">our ability to recruit clinical trial investigators with the appropriate competencies and experience;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">clinicians&#8217;&#160;and patients&#8217;&#160;perceptions as to the potential advantages of the product candidate being studied in relation to other available therapies, including any new drugs that may be approved for the indications we are investigating;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">competing clinical trials being conducted by other companies or institutions;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">our ability to maintain patient consents; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the risk that patients enrolled in clinical trials will drop out of the trials before completion.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our product candidates may cause serious adverse events or undesirable side effects, which may delay or prevent marketing approval, or, if approved, require them to be taken off the market, require them to include safety warnings or otherwise limit their sales.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Serious adverse events or undesirable side effects caused by IGC-AD1, or any other product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other comparable foreign authorities. Results of any clinical trial we conduct could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If unacceptable side effects arise in the development of our product candidates, we, the FDA, or the IRBs at the institutions in which our studies are conducted, or the DSMB, if constituted for our clinical trials, could recommend a suspension or termination of our clinical trials, or the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of a product candidate for any or all targeted indications. In addition, drug-related side effects could affect patient recruitment or the ability of enrolled patients to complete a trial or result in potential product liability claims. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff. We expect to have to train medical personnel using our product candidates to understand the side effect profiles for our clinical trials and upon any commercialization of any of our product candidates. Inadequate training in recognizing or managing the potential side effects of our product candidates could result in patient injury or death. Any of these occurrences may harm our business, financial condition, and prospects significantly.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">27</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Additionally, if one or more of our product candidates receives marketing approval, and we or others later identify undesirable side effects caused by such products, a number of potentially significant negative consequences could result, including:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">additional restrictions may be imposed on the marketing of the particular product or the manufacturing processes for the product or any component thereof;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">regulatory authorities may withdraw approvals of such product;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">regulatory authorities may require additional warnings on the label, such as a &#8220;black box&#8221;&#160;warning or contraindication;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">we may be required to implement a REMS or create a medication guide outlining the risks of such side effects for distribution to patients;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">we could be sued and held liable for harm caused to patients;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the product may become less competitive; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">our reputation may suffer.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Any of these events could prevent us from achieving or maintaining market acceptance of a product candidate, if approved, and could significantly harm our business, results of operations and prospects.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our product candidates may be unable to achieve the expected market acceptance, consequently, limiting our ability to generate revenue from new products. </i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Even when product development is successful and regulatory approval has been obtained, our ability to generate sufficient revenue depends on the acceptance of our products by customers. We cannot assure you that our products will achieve the expected level of market acceptance and revenue. The market acceptance of any product depends on several factors such as the price of the product, the effect of the product, the taste of the product, reputation of the Company, competition, and marketing and distribution support.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The success and acceptance of a product in one state may not be replicated in other states or may be negatively affected by our activities in another state. Any factors preventing or limiting the market acceptance of our products could have a material adverse effect on our business, results of operations and financial condition.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The nature of our products, customer base and sales channels cause us to lack visibility regarding future demand for our products, which makes it difficult for us to predict our revenues or operating results.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">It is important to the success of our business that we have the ability to accurately predict the future demand for our products. However, several factors contribute to a lack of visibility with respect to future orders, including:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the lengthy and unpredictable sales cycle for our products that can extend from 6 to 24 months or longer;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the project-driven nature of our customers&#8217;&#160;requirements;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the uncertainty of the extent and timing of market acceptance of our new products;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the requirement to obtain industry certifications or regulatory approval for some products; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the diversity of our product lines and geographic scope of our product distribution.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This lack of visibility impacts our ability to forecast inventory requirements. An overestimate of our customers&#8217; future requirements for products may lead to excess inventory, which would increase costs and potentially require us to write-off inventory that becomes obsolete. If we underestimate our customers&#8217; future requirements, we may have inadequate inventory, which could interrupt and delay the delivery of our products to our customers and could cause our revenues to decline. If any of these events occur, they could negatively impact our revenues, which could prevent us from achieving or sustaining profitability.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Some, but not all, of the factors that could affect our ability to achieve results are described in forward-looking statements. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Business interruptions could delay us in the process of developing our product candidates and could disrupt our product sales.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Loss of our manufacturing facilities, stored inventory or laboratory facilities through fire, theft, natural disasters or other causes, or loss of our botanical raw material due to pathogenic infection, waste, destruction, or other causes, could have an adverse effect on our ability to meet demand for our products or to continue product development activities and to conduct our business. Failure to supply our partners with commercial products may lead to adverse consequences.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">28</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Climate change concerns could disrupt our businesses, adversely affect client activity levels, adversely affect the creditworthiness&#160;of our counterparties and damage our reputation.</i></b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Climate change may cause extreme weather events that, among other things, could damage our facilities and equipment, injure our employees, disrupt operations at one or more of our primary locations, negatively affect our ability to service and interact with our clients, and adversely affect the value of our assets. Any of these events may increase our costs including our costs to insure against these events.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Climate change may also have a negative impact on the financial condition of our clients, which may decrease revenues from those clients and increase the credit exposures to those clients. Additionally, our reputation and client relationships may be damaged as a result of our involvement, or our clients&#8217; involvement, in certain industries associated with causing or exacerbating, or alleged to cause or exacerbate, climate change. We also may be negatively impacted by any decisions we make to continue to conduct or change our activities in response to considerations relating to climate change. New regulations or guidance relating to climate change, as well as the perspectives of shareholders, employees, and other stakeholders regarding climate change, may affect whether and on what terms and conditions we engage in certain activities or offer certain products.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Currency fluctuations may reduce our assets and profitability.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have assets located in foreign countries that are valued in foreign currencies. Fluctuation of the U.S. dollar relative to the foreign currency may adversely affect our assets and profit.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our business relies heavily on our management team, and any unexpected loss of key officers may adversely affect our operations.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The continued success of our business is largely dependent on the continued services of our key employees. The loss of the services of certain key personnel, without adequate replacement, could have an adverse effect on our performance. Our senior management, as well as the senior management of our subsidiaries, plays a significant role in developing and executing the overall business plan, maintaining client relationships, proprietary processes, and technology. While no one is irreplaceable, the loss of the services of any would be disruptive to our business.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Our quarterly revenue, operating results, and profitability will vary.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Factors that may contribute to the variability of quarterly revenue, operating results, or profitability include:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Fluctuations in revenue due to the seasonality of the marketplace, which results in uneven revenue and operating results over the year;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Additions and departures of key personnel;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Strategic decisions made by us and our competitors, such as acquisitions, divestitures, spin-offs, joint ventures, strategic investments, and changes in business strategy; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Economic conditions, including but not limited to the adverse impact on operating results due to the COVID-19 pandemic.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>We may not successfully register the provisional patents with the USPTO.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have filed forty-one (41) patent applications with the USPTO and also in other different countries, in the combination therapy space, for the indications of pain, Alzheimer&#8217;s, medical refractory epilepsy, eating disorders, and Tourette syndrome as part of our intellectual property strategy focused on the phytocannabinoid-based health care industry. Although nine patents have been issued, there is no guarantee that our remaining applications will result in a successful registration with the USPTO. If we are unsuccessful in registering patents, our ability to create a valuable line of products can be adversely affected. This in turn may have a material and adverse impact on the trading price of our common stock.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">29</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We may be unable to protect our intellectual property rights and/or intellectual property rights licensed to us and may be subject to intellectual property litigation and infringement claims by third parties.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We intend to protect our intellectual property through limited patents and our unpatented trade secrets and know-how through confidentiality or license agreements with third parties, employees, and consultants, and by controlling access to and distribution of our proprietary information. However, this method may not afford complete protection, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the U.S. and unauthorized parties may copy or otherwise obtain and use our products, processes, or technology. Additionally, there can be no assurance that others will not independently develop similar know-how and trade secrets. We are also dependent upon the owners of intellectual property rights licensed to us under various wholesale license agreements to protect and defend those rights against third party claims. If third parties take actions that affect our rights, the value of our intellectual property, similar proprietary rights or reputation or the licensors who have granted us certain rights under wholesale license agreements, or we are unable to protect the intellectual property from infringement or misappropriation, other companies may be able to offer competitive products at lower prices, and we may not be able to effectively compete against these companies. We also face the risk of claims that we have infringed third parties&#8217; intellectual property rights. Any claims of intellectual property infringement, even those without merit, may require us to:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">defend against infringement claims which are expensive and time consuming;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">cease making, licensing, or using, either temporarily or permanently, products that incorporate the challenged intellectual property;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">re-design, re-engineer, or re-brand our products or packaging; or</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">enter into royalty or licensing agreements to obtain the right to use a third party&#8217;s intellectual property.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event of claims by third parties for infringement of intellectual property rights we license from third parties under wholesale license agreements, we could be liable for costs of defending allegations of infringement, and there are no assurances the licensors will either adequately defend the licensed intellectual property rights or that they would prevail in the related litigation. In that event, we would incur additional costs and may be deprived from generating royalties from these agreements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>We may face risks relating to health care privacy and security laws. </i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may be subject to various privacy and security regulations, including but not limited to the Health Insurance Portability and Accountability Act of 1996 (HIPAA), as amended by The Health Information Technology for Economic and Clinical Health Act (HITECH), and their respective implementing regulations, including the related final published omnibus rule. HIPAA mandates, among other things, the adoption of uniform standards for the electronic exchange of information in common health care transactions, as well as standards relating to the privacy and security of individually identifiable health information. These obligations would require the Company to adopt administrative, physical, and technical safeguards to protect such information. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to &#8220;business associates&#8221; &#8212; independent contractors or agents of covered entities that receive or obtain protected health information in connection with providing a service on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates, and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. In addition, state laws govern the privacy and security of health information in certain circumstances, some of which are more stringent than HIPAA and many of which differ from each other in significant ways and may not have the same effect, thereby complicating compliance efforts. Failure to comply with these laws, where applicable, can result in the imposition of significant civil and criminal penalties.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Some of our lines of business will rely on third-party service providers to host and deliver services and data, and any interruptions or delays in these hosted services, security, or privacy breaches, including cybersecurity attacks, or failures in data collection could expose us to liability claims, increased costs, reduced revenue, and harm our business and reputation.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our lines of business and services, but especially our development of hemp-based cannabinoid combination therapies for products, including Hyalolex&#8482;, Drops of Clarity&#8482;, and our long-term use and/or development of blockchain technologies to solve critical issues facing the cannabinoids industry, rely on services hosted and controlled directly by our suppliers and distributors and their third-party service providers. We do not have redundancy for all our systems; many of our critical applications reside in only one of our data centers, and our disaster recovery planning may not account for all eventualities. These facts could cause reputational harm, loss of customers, or loss of future business, thereby reducing our revenue.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">30</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our suppliers and distributors and their third-party service providers hold customer data, some of which is hosted in third-party facilities. A security incident or cybersecurity attack at those facilities or ours may compromise the confidentiality, integrity, or availability of customer data. We have a cybersecurity policy in place, however, unauthorized access to customer data stored on our computers or networks may be obtained through break-ins, breaches of our secure network by an unauthorized party, employee theft or misuse, or other misconduct. It is also possible that unauthorized access to customer data may be obtained through inadequate use of security controls by customers. Accounts created with weak passwords could allow cyber-attackers to gain access to customer data. If there were an inadvertent disclosure of customer information, or if a third party were to gain unauthorized access to the information we possess on behalf of our customers, our operations could be disrupted, our reputation could be damaged, and we could be subject to claims or other liabilities. In addition, such perceived or actual unauthorized disclosure of the information we collect, or breach of our security could damage our reputation, result in the loss of customers, and harm our business.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Hardware or software failures or errors in our systems or those of our suppliers and distributors or their third-party service providers, could result in data loss or corruption, cause the information that we collect to be incomplete or contain inaccuracies that our customers regard as significant, or cause us to fail to meet committed service levels. Furthermore, our ability to collect and report data may be delayed or interrupted by several factors, including access to the internet, the failure of our network or software systems or security breaches. In addition, computer viruses or other malware may harm our systems, causing us to lose data, and the transmission of computer viruses or other malware could expose us to litigation. We may also find, on occasion, that we cannot deliver data and reports in near real time because of several factors, including failures of our network or software. If we supply inaccurate information or experience interruptions in our ability to capture, store and supply information in near real time or at all, our reputation could be harmed, we could lose customers, or we could be found liable for damages or incur other losses.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All our data is stored on the cloud on multiple servers which helps us mitigate the overall risk of losing data. We are in the process of implementing tighter cybersecurity measures to safeguard against hackers. Complying with these security measures and compliances would incur further costs.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The states in which we and our distributors and suppliers and their service providers operate require that we maintain certain information about our customers and transactions. If we fail to maintain such information, we could be in violation of state laws. Laws and regulations relating to the handling of personal data may impede the adoption of our services or result in increased costs, legal claims, fines against us, or reputational damage.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We face risks associated with the manufacture of our products which could adversely affect our business and financial results.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are subject to the risks inherent in manufacturing our products, including industrial accidents, environmental events, strikes and other labor disputes, disruptions in supply chain or information systems, loss or impairment of key manufacturing sites or suppliers, product quality control, safety, increase in commodity prices and energy costs, licensing requirements and other regulatory issues, as well as natural disasters and other external factors over which we have no control. If such an event were to occur, it could have an adverse effect on our business and financial results.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The Company is exposed to the risk of write-downs on the value of its inventory and other assets, in addition to purchase commitment cancellation risk.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company records a write-down for product and component inventories that become obsolete or exceed anticipated demand, or for which cost exceeds net realizable value. The Company may also accrue necessary cancellation fee reserves for orders of excess products and components. The Company reviews long-lived assets, including capital assets held at its suppliers&#8217; facilities and inventory prepayments, for impairment whenever events or circumstances indicate the assets may not be recoverable. If the Company determines that an impairment has occurred, it records a write-down equal to the amount by which the carrying value of the asset exceeds its fair value. Although the Company believes its inventory, capital assets, inventory prepayments, and other assets and purchase commitments are currently recoverable, no assurance can be given that the Company will not incur write-downs, fees, impairments, and other charges given the rapid and unpredictable pace of product obsolescence in the industries in which the Company competes.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company orders components for its products and builds inventory in advance of product announcements and shipments. Manufacturing purchase obligations cover the Company&#8217;s forecasted component and manufacturing requirements, typically for periods up to 150 days. Because the Company&#8217;s markets are volatile, competitive, and subject to rapid technology and price changes, there is a risk the Company will forecast incorrectly and order or produce excess or insufficient amounts of components or products, or not fully utilize firm purchase commitments.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">31</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our accounting personnel may make unintentional errors.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Given our small size and foreign operations, a small unrectified mistake in the preparation of financial statements and the maintenance of our books and records in accordance with U.S. GAAP and SEC rules and regulations may constitute a material weakness in our internal controls over financial reporting. For more information, please see Item 9A, &#8220;Controls and Procedures.&#8221;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The Company is subject to complex and changing laws and regulations worldwide related to climate change and ESG initiatives, which expose the Company to potential liabilities, increased costs, and other adverse effects on the Company</i></b>&#8217;<b><i>s business.</i></b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We&#160;are subject to transitional and physical risks related to climate change. Transitional risks include, for example, a disorderly global transition away from fossil fuels that may result in increased energy prices; customer preference for low or no-carbon products; stakeholder pressure to decarbonize assets; or new legal or regulatory requirements that result in new or expanded carbon pricing, taxes, restrictions on greenhouse gas emissions, and increased greenhouse gas disclosure and transparency. These risks could increase operating costs, including the cost of our electricity and energy use, or other compliance costs. Physical risks to our operations include water stress and drought; flooding and storm surge; wildfires; extreme temperatures and storms, which could impact pharmaceutical production, increase costs, or disrupt supply chains of medicines for patients. Our supply chain is likely subject to these same transitional and physical risks and would likely pass along any increased costs to us. We do not anticipate that these risks will have a material financial impact on the Company in the near term.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Governmental authorities, non-governmental organizations, customers, investors, employees, and other stakeholders are increasingly sensitive to ESG matters, such as equitable access to medicines and vaccines, product quality and safety, diversity, equity and inclusion, environmental stewardship, support for local communities, value chain environmental and social due diligence, corporate governance, and transparency, and addressing human capital factors in our operations. This focus on ESG matters may lead to new expectations or requirements that could result in increased costs associated with research, development, manufacture, or distribution of our products. Our ability to compete could also be affected by changing customer preferences and requirements, such as growing demand for companies to establish validated Net Zero targets or offer more sustainable products. While we strive to improve our ESG performance and meet our voluntary goals, if we do not meet, or are perceived not to meet, our goals or other stakeholder expectations in key ESG areas, we risk negative stakeholder reaction, including from proxy advisory services, as well as damage to our brand and reputation, reduced demand for our products or other negative impacts on our business and operations. While we monitor a broad range of ESG matters, we cannot be certain that we will manage such matters successfully, or that we will successfully meet the expectations of investors, employees, consumers, governments, and other stakeholders.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>A pandemic, epidemic, or outbreak of infectious disease, such as COVID-19, may materially and adversely affect our business and operations.</i></b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The COVID-19 pandemic is affecting the United States and global economies and has and may continue to affect our operations and those of third parties on which we rely, including by causing disruptions in the supply of our products candidates and the conduct of current and future clinical trials. As the end of the COVID-19 pandemic remains unknown, the full extent of the impact of COVID-19 on the Company remains unknown as well. The impact of COVID-19 on our operations is reflected in reduced revenue and increased expenses in both our Infrastructure and the Life Sciences segments.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, the COVID-19 pandemic may affect the operations of the FDA and other health authorities, which could result in delays of reviews and approvals, including with respect to our product candidates. The evolving COVID-19 pandemic is also likely to directly or indirectly impact the pace of enrollment in our clinical trial for IGC-AD1 for at least the next several months and possibly longer as patients may avoid or may not be able to travel to healthcare facilities and physicians&#8217; offices unless due to a health emergency. Such facilities and offices may also be required to focus limited resources on non-clinical trial matters, including treatment of COVID-19 patients, and may not be available, in whole or in part, for clinical trial services or our other product candidates. Additionally, while the potential economic impact brought by, and the duration of the COVID-19 pandemic is difficult to assess or predict, the impact of the COVID-19 pandemic on the global financial markets may reduce our ability to access capital, which could negatively impact our short-term and long-term liquidity. The ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. We do not yet know the full extent of potential delays or impacts on our business, financing, clinical trial activities or on healthcare systems, or the global economy as a whole. However, these effects could have a material impact on our liquidity, capital resources, operations, and business and those of the third parties on which we rely. The continued impact of the ongoing COVID-19 pandemic on the Company as well as on the regions in which we do business cannot be predicted.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">32</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Risks Related to ownership of our common stock:</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Future sales of common stock by us could cause our stock price to decline and dilute your ownership in our Company.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our certificate of incorporation authorizes the issuance of up to 150,000,000 shares of common stock, par value of $0.0001 per share, and 1,000,000 shares of preferred stock, par value of $0.0001 per share. We are not restricted from issuing additional shares of our common stock or preferred stock, including any securities that are convertible into or exchangeable for, or that represent the right to receive, common stock or preferred stock or any substantially similar securities. The market price of our common stock could decline as a result of sales of a large number of shares of our common stock by us in the market or the perception that such sales could occur. If we raise funds by issuing additional securities in the future or stock options to purchase our common stock are exercised, the newly issued shares will also dilute your percentage ownership in our Company.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our common stock price has fluctuated considerably and has recently reached our highest price levels, which may not be sustained.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The market price of shares of our common stock has fluctuated substantially in recent years and is likely to fluctuate significantly from its current level. Our common stock has also been volatile, with our 52-week closing price range being at a low of $0.31 and a high of $0.94 per share. Future announcements concerning the introduction of new products, services, or technologies or changes in product pricing policies by us or our competitors, or changes in earnings estimates by analysts, among other factors, could cause the market price of our common stock to fluctuate substantially. Also, stock markets have experienced extreme price and volume volatility in the last year. This volatility has had a substantial effect on the market prices of securities of many public companies for reasons frequently unrelated to the operating performance of the specific companies. These broad market fluctuations may also cause declines in the market price of our common stock. Investors seeking short-term liquidity should be aware that we cannot assure that the stock price will continue at these or any higher levels.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>A possible </i></b>&#8220;<b><i>short squeeze</i></b>&#8221;<b><i> due to a sudden increase in demand of our common stock that largely exceeds supply may lead to further price volatility in our common stock.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Investors may purchase shares of our common stock to hedge existing exposure in our common stock or to speculate on the price of our common stock. Speculation on the price of our common stock may involve long and short exposures. To the extent aggregate short exposure exceeds the number of shares of our common stock available for purchase in the open market, investors with short exposure may have to pay a premium to repurchase our common stock for delivery to lenders of our common stock. Those repurchases may in turn dramatically increase the price of our common stock until investors with short exposure are able to purchase additional shares of common stock to cover their short position. This is often referred to as a &#8220;short squeeze.&#8221; A short squeeze could lead to volatile price movements in shares of our common stock that are not directly correlated to the performance or prospects of our Company and once investors purchase the shares necessary to cover their short position the price of our common stock may decline. We believe that the recent volatility in our common stock may be due, in part, to short squeezes that may be temporarily increasing the price of our common stock, which could result in a loss of some or all of your investment in our common stock.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our management team will have broad discretion over the use of Company funds.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our management will use their discretion to direct the use of Company funds. We intend to use the net proceeds from the sale of IGC shares in ATM offerings, sales proceeds, sale of capital assets, and other funds to fund working capital and capital expenditure requirements. It may also be used for clinical trials, share repurchases, debt repayments, and investments, including but not limited to, mutual funds, treasury bonds, cryptocurrencies, and other asset classes. Management&#8217;s judgments may not result in positive returns on investor investment, and the investor will not have an opportunity to evaluate the economic, financial, or other information upon which the Management bases its decisions. The Company may invest the funds, pending their use, in a manner that does not produce income or that loses value. The failure by management to apply these funds effectively could result in financial losses, and these financial losses could have a material adverse effect on our business and cause the price of our common stock to decline.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our publicly filed reports are subject to review by the SEC, and any significant changes or amendments required as a result of any such review may result in material liability to us and may have a material adverse impact on the trading price of our common stock.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The reports of publicly traded companies are subject to review by the SEC from time to time for the purpose of assisting companies in complying with applicable disclosure requirements, and the SEC is required to undertake a comprehensive review of a company&#8217;s reports at least once every three years under the Sarbanes-Oxley Act of 2002. SEC reviews may be initiated at any time. We could be required to modify, amend, or reformulate information contained in prior filings as a result of an SEC review, as well as the state in filings that we have inadequate control or expertise over financial reporting. Any modification, amendment, or reformulation of information contained in such reports could be significant and result in material liability to us and have a material and adverse impact on the trading price of our common stock.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">33</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We do not anticipate declaring any cash dividends on our common stock.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have never declared or paid cash dividends on our common stock and do not plan to pay any cash dividends in the near future. Our current policy is to retain all funds and earnings for use in the operation and expansion of our business.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Maryland anti-takeover provisions and certain anti-takeover effects of our Charter and Bylaws may inhibit a takeover at a premium price that may be beneficial to our stockholders.</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Maryland anti-takeover provisions and certain anti-takeover effects of our charter and bylaws may be utilized, under some circumstances, as a method of discouraging, delaying, or preventing a change of control of our Company at a premium price that would be beneficial to our stockholders. For more detailed information about these provisions, please see &#8220;Anti-takeover Law, Limitations of Liability and Indemnification&#8221; as follows:</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Business Combinations</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the Maryland General Corporation Law, some business combinations, including a merger, consolidation, share exchange or, in some circumstances, an asset transfer or issuance or reclassification of equity securities, are prohibited for a period of time and require an extraordinary vote. These transactions include those between a Maryland corporation and the following persons (a Specified Person):</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">An interested stockholder, who is defined as any person (other than a subsidiary) who beneficially owns 10% or more of the corporation&#8217;s voting stock, or who is an affiliate or an associate of the corporation who, at any time within a two-year period prior to the transaction, was the beneficial owner of 10% or more of the voting power of the corporation&#8217;s voting stock; or an affiliate of an interested stockholder.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A person is not an interested stockholder if the board of directors approved in advance the transaction by which the person otherwise would have become an interested stockholder. The board of directors of a Maryland corporation also may exempt a person from these business combination restrictions prior to the time the person becomes a Specified Person and may provide that its exemption be subject to compliance with any terms and conditions determined by the board of directors. Transactions between a corporation and a Specified Person are prohibited for five years after the most recent date on which such stockholder becomes a Specified Person. After five years, any business combination must be recommended by the board of directors of the corporation and approved by at least 80% of the votes entitled to be cast by holders of voting stock of the corporation and two-thirds of the votes entitled to be cast by holders of shares other than voting stock held by the Specified Person with whom the business combination is to be effected, unless the corporation&#8217;s stockholders receive a minimum price as defined by Maryland law and other conditions under Maryland law are satisfied.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A Maryland corporation may elect not to be governed by these provisions by having its board of directors exempt various Specified Persons, by including a provision in its charter expressly electing not to be governed by the applicable provision of Maryland law or by amending its existing charter with the approval of at least 80% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation and two-thirds of the votes entitled to be cast by holders of shares other than those held by any Specified Person. Our Charter does not include any provision opting out of these business combination provisions.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Control Share Acquisitions</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Maryland General Corporation Law also prevents, subject to exceptions, an acquirer who acquires sufficient shares to exercise specified percentages of voting power of a corporation from having any voting rights except to the extent approved by two-thirds of the votes entitled to be cast on the matter not including shares of stock owned by the acquiring person, any directors who are employees of the corporation and any officers of the corporation. These provisions are referred to as the control share acquisition statute.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The control share acquisition statute does not apply to shares acquired in a merger, consolidation or share exchange if the corporation is a party to the transaction, or to acquisitions approved or exempted prior to the acquisition by a provision contained in the corporation&#8217;s charter or bylaws. Our Bylaws include a provision exempting us from the restrictions of the control share acquisition statute, but this provision could be amended or rescinded either before or after a person acquired control shares. As a result, the control share acquisition statute could discourage offers to acquire our common stock and could increase the difficulty of completing an offer.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">34</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Board of Directors</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Maryland General Corporation Law provides that a Maryland corporation which is subject to the Exchange Act and has at least three outside directors (who are not affiliated with an acquirer of the company) under certain circumstances may elect by resolution of the board of directors or by amendment of its charter or bylaws to be subject to statutory corporate governance provisions that may be inconsistent with the corporation&#8217;s charter and bylaws. Under these provisions, a board of directors may divide itself into three separate classes without the vote of stockholders such that only one-third of the directors are elected each year. A board of directors classified in this manner cannot be altered by amendment to the charter of the corporation. Further, the board of directors may, by electing to be covered by the applicable statutory provisions and notwithstanding the corporation&#8217;s charter or bylaws:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">provide that a special meeting of stockholders will be called only at the request of stockholders entitled to cast at least a majority of the votes entitled to be cast at the meeting,</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">reserve for itself the right to fix the number of directors,</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">provide that a director may be removed only by the vote of at least two-thirds of the votes entitled to be cast generally in the election of directors, and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:19.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">retain for itself sole authority to fill vacancies created by an increase in the size of the board or the death, removal, or resignation of a director.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, a director elected to fill a vacancy under these provisions serves for the balance of the unexpired term instead of until the next annual meeting of stockholders. A board of directors may implement all or any of these provisions without amending the charter or bylaws and without stockholder approval. Although a corporation may be prohibited by its charter or by resolution of its board of directors from electing any of the provisions of the statute, we have not adopted such a prohibition. We have adopted a staggered board of directors with three separate classes in our charter and given the board the right to fix the number of directors, but we have not prohibited the amendment of these provisions. The adoption of the staggered board may discourage offers to acquire our common stock and may increase the difficulty of completing an offer to acquire our stock. If our Board chose to implement the statutory provisions, it could further discourage offers to acquire our common stock and could further increase the difficulty of completing an offer to acquire our common stock.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Effect of Certain Provisions of our Charter and Bylaws</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition to the Charter and Bylaws provisions discussed above, certain other provisions of our Bylaws may have the effect of impeding the acquisition of control of our Company by means of a tender offer, proxy fight, open market purchases or otherwise in a transaction not approved by our Board of Directors. These provisions of Bylaws are intended to reduce our vulnerability to an unsolicited proposal for the restructuring or sale of all or substantially all of our assets or an unsolicited takeover attempt, which our Board believes is otherwise unfair to our stockholders. These provisions, however, also could have the effect of delaying, deterring, or preventing a change in control of our Company.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Bylaws provide that with respect to annual meetings of stockholders, (i) nominations of individuals for election to our Board of Directors and (ii) the proposal of business to be considered by stockholders may be made only pursuant to our notice of the meeting, by or at the direction of our Board of Directors, or by a stockholder who is entitled to vote at the meeting and has complied with the advance notice procedures set forth in our Bylaws.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Special meetings of stockholders may be called only by the chief executive officer, the board of directors or the secretary of our Company (upon the written request of the holders of a majority of the shares entitled to vote). At a special meeting of stockholders, the only business that may be conducted is the business specified in our notice of meeting. With respect to nominations of persons for election to our Board of Directors, nominations may be made at a special meeting of stockholders only pursuant to our notice of meeting, by or at the direction of our Board of Directors, or if our Board of Directors has determined that directors will be elected at the special meeting, by a stockholder who is entitled to vote at the meeting and has complied with the advance notice procedures set forth in our Bylaws.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">These procedures may limit the ability of stockholders to bring business before a stockholders meeting, including the nomination of directors and the consideration of any transaction that could result in a change in control and that may result in a premium to our stockholders.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i1b" title="i1b"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 1B. UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">35</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i2" title="i2"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 2. PROPERTIES</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our corporate headquarters is located in Potomac, Maryland. We own approximately 40,000 square feet of property used for general management and R&amp;D operations. In addition, we are leasing, through December 2025, approximately 16,000 square feet in Vancouver, Washington, for manufacturing, sales, and distribution of our Life Sciences segment products and services. In addition, we own and have short-term lease facilities in the U.S. and India that are used for sales, storage accounting, management, and R&amp;D. We own approximately 5 acres of land in India. The Company believes its existing facilities and equipment, which are used by all reportable segments, are in good operating condition and suitable for conducting its business.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div><a id="i3" title="i3"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 3. LEGAL PROCEEDINGS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company may be involved in legal proceedings, claims, and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. There are no such matters that are deemed material to the consolidated financial statements as of March 31, 2023.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, the Company and one of its officers are parties to the following litigation matters:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Apogee Financial Investments, Inc., et al. v. India Globalization Capital, Inc., et al., Civil Action No. 1:21-cv-03809 (U.S. District Court for the Southern District of New York). </b>On April 29, 2021, Apogee Financial Investments, Inc. (Apogee) and John R. Clarke (Clarke) filed a complaint against the Company and IGC&#8217;s President and Chief Executive Officer, Ram Mukunda (Mukunda) (the Apogee Litigation). The litigation was originally initiated by IGC on February 8, 2021 (India Globalization Capital, Inc. v. Apogee Financial Investments, Inc., Civil Action No. 1:21-cv-01131, U.S. District Court for the Southern District of New York), wherein IGC alleged that Apogee breached a purchase agreement dated December 18, 2014, related to IGC&#8217;s intended purchase of a business known as Midtown Partners &amp; Co., LLC (Midtown). In response to the original lawsuit filed by IGC, Apogee, and Clarke filed a counterclaim as well as the Apogee Litigation. On June 28, 2021, Apogee and Clarke filed an amended complaint. On July 23, 2021, IGC and Mukunda moved to partially dismiss the counterclaim and the Apogee Litigation. On March 7, 2022, the Court granted the motion to dismiss in substantial part, leaving only two claims: Apogee&#8217;s cross-claim against the Company for an alleged breach of the purchase agreement; and Clarke&#8217;s claim against the Company for an alleged breach of an alleged promise to issue him shares of the Company. On February 21, 2023, IGC and Mukunda filed a motion for summary judgment seeking judgment on both IGC&#8217;s underlying Complaint against Apogee and Apogee&#8217;s and Clarke&#8217;s claims against Apogee and Mukunda. On April 19, 2023, after the close of the Company&#8217;s fiscal year, Apogee and Clarke filed a response to the motion. Both Apogee and Clarke withdrew their claims against Mukunda at that time. The Company filed its reply in support of summary judgment on May 16, 2023. The court is expected to issue a decision sometime during fiscal year 2024 (on or before March 31, 2024). The Company considers the counterclaim and the Apogee Litigation to be ordinary, routine litigation incidental to the business. The Company and Mukunda deny any and all liability and, in particular, deny many of the factual allegations contained in the Apogee Litigation. Both the Company and Mukunda intend to vigorously defend the litigation and are represented by counsel for that purpose.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i4" title="i4"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 4. MINE SAFETY DISCLOSURES</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Not applicable.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">36</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PART II</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i5" title="i5"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 5. MARKET FOR REGISTRANT</b>&#8217;<b>S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our common stock is listed on the NYSE American under &#8220;IGC&#8221; symbol with CUSIP number 45408X308. The common stock of the Company is also quoted on the Frankfurt, Berlin, and Stuttgart (XETRA2) stock exchanges in Germany (ticker symbol: IGS1). We also have 91,472 units outstanding that can be separated into common stock. Ten units may be separated into one share of common stock. The unit holders are requested to contact the Company or our transfer agent, Continental Stock Transfer &amp; Trust, to separate their units into common stock.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Further information on the securities can be referred to in Note 13, &#8220;Securities&#8221; of Part II, Item 8.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Securities authorized for issuance under equity compensation plans</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table shows (in thousands), as of March 31, 2023, information regarding outstanding awards available under our compensation plans (including individual compensation arrangements) under which our equity securities may be delivered.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Plan category</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(a)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>securities to be</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>issued upon</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>exercise of</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>outstanding</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>options,</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>warrants and</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>rights </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(in thousands)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(b)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted-</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>average exercise</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>price of</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>outstanding</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>options,</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>warrants and</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>rights</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(c)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>securities</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>available for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>future</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>issuance</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(excluding</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>shares in</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>column (a)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(in thousands)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Equity compensation plans approved by security holders:</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2018 Omnibus Incentive Plan (1)</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">-</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align:bottom;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">-</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">-</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Special Grant (2)</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5,696</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align:bottom;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">0.98</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2,280</p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;text-indent:-18pt;">(1) Consists of our 2018 Omnibus Incentive Plans, as approved by our stockholders on November 8, 2017. See Note 14, &#8220;Stock-Based Compensation&#8221; of the Notes to the Consolidated Financial Statements included in this report.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;text-indent:-18pt;">(2) Consists of 2 million shares as a special grant of common stock, as approved by our stockholders on January 7, 2020, 2.5 million shares as a special grant of common stock, as approved by our stockholders on January 11, 2021, 3.5 million shares as a special grant of common stock, as approved by our stockholders on October 15, 2021, and 3 million shares as special grant of common stock, as approved by stockholders on September 9, 2022.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Holders of Record</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of July 6, 2023, we had approximately 37 registered shareholders of record of our common stock and 2 registered unit holders. The number of record holders does not include persons who held our common stock in nominee or &#8220;street name&#8221; accounts through brokers. Continental Stock Transfer &amp; Trust Company is the transfer agent and registrar for our common stock.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Dividend policy</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have not declared or paid any dividends on our common stock. We currently anticipate that we will retain future earnings, if any, for the development, operation, and expansion of our business and do not anticipate declaring or paying any dividends in the foreseeable future. Any future determinations related to the dividend policy will be made at the discretion of our Board of Directors.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Unregistered sales of equity securities</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">None.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Purchases of equity securities by the issuer and affiliated purchasers</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">None.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i6" title="i6"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 6. [RESERVED] </b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">37</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i7" title="i7"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 7. MANAGEMENT</b>&#8217;<b>S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following is a discussion and analysis of the consolidated statement of operations, liquidity, and capital resources, and a summary of cash flows, which apply to Fiscal 2023 ending on March 31, 2023, and Fiscal 2022, ending on March 31, 2022. These statements should be read in conjunction with our consolidated financial statements and the related notes that appear elsewhere in this Annual Report on Form 10-K.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition to historical information, this report contains forward-looking statements that involve risks and uncertainties that may cause our actual results to differ materially from the plans and results discussed in forward-looking statements. We encourage you to review the risks and uncertainties discussed in the sections entitled Item 1A. &#8220;Risk Factors&#8221; and &#8220;Forward-Looking Statements&#8221; are included at the beginning of this Annual Report on Form 10-K.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The risks and uncertainties can cause actual results to differ significantly from those in our forward-looking statements or implied in historical results and trends. We caution readers not to place undue reliance on any forward-looking statements made by us, which speak only as of the date they are made. We disclaim any obligation, except as specifically required by law and the rules of the SEC, to publicly update or revise any such statements to reflect any change in our expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Overview</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IGC Pharma, Inc. is a clinical-stage pharmaceutical company with a diversified revenue model that develops both prescription drugs and over-the-counter (OTC) products. Our focus is on developing innovative therapies for neurological disorders such as Alzheimer&#8217;s disease, epilepsy, Tourette syndrome, and sleep disorders. We also focus on formulations for eating disorders, chronic pain, premenstrual syndrome (PMS), and dysmenorrhea, in addition to health and wellness OTC formulations. The Company is developing its lead candidate, IGC-AD1, an investigational oral therapy for the treatment of agitation associated with Alzheimer&#8217;s disease. IGC-AD1 is currently in Phase 2 (Phase 2B) clinical trials after completing nearly a decade of research and realizing positive results from pre-clinical and a Phase 1 trial. This previous research into IGC-AD1 has demonstrated efficacy in reducing plaques and tangles, which are two important hallmarks of Alzheimer&#8217;s, as well as reducing neuropsychiatric symptoms associated with dementia in Alzheimer&#8217;s disease, such as agitation. We were formerly known as India Globalization Capital, Inc. and incorporated in Maryland on April 29, 2005. Our fiscal year is the 52- or 53-week period ending March 31.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Currently, most of our revenue comes from the Life Sciences segment and, in the future, we believe, from our investigational drugs for treating Alzheimer&#8217;s disease. We have also built a facility for a potential Phase 3 trial and have strategic relations for the procurement of Active Pharmaceutical Ingredients (APIs). In addition, we have acquired and initiated work on TGR-63, a pre-clinical molecule that exhibits an impressive affinity for reducing neurotoxicity in Alzheimer&#8217;s cell lines. The advancement of IGC-AD1 into Phase 2 trials represents a significant milestone for the company and positions us for multiple pathways to future success. Although there can be no assurance, we anticipate that the positive outcomes from these and other trials will drive further growth, valuation, and market potential for IGC-AD1.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC has two segments: Life Sciences and Infrastructure.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Life Sciences Segment</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration:underline">Pharmaceutical</span></i>:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Since 2014, we have focused a portion of our business on the application of phytocannabinoids such as THC and CBD, among others, in combination with other compounds, to address efficacy for various ailments and diseases such as Alzheimer&#8217;s disease. As previously disclosed, IGC submitted IGC-AD1, our investigational drug candidate for Alzheimer&#8217;s, to the FDA under Section 505(i) of the Federal Food, Drug, and Cosmetic Act and received approval on July 30, 2020, to proceed with the Phase 1 trial on Alzheimer&#8217;s patients and the Company completed all dose escalation studies, and as announced by the Company on December 2, 2021, the results of the clinical trial have been submitted in the Clinical/Statistical Report (CSR) filed with the FDA. The Company is motivated by the potential that, with future successful results from appropriate further trials, IGC-AD1 could contribute to relief for some of the 55 million people around the world expected to be impacted by Alzheimer&#8217;s disease by 2030 (WHO, 2021).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">38</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Currently, IGC-AD1 is in a Phase 2B safety and efficacy clinical trial for agitation in dementia from Alzheimer&#8217;s (clinicaltrials.gov, NCT05543681). The progress we are making in the clinic, gives us confidence in the potential of IGC-AD1 as a potentially groundbreaking therapy, with the potential to treat Alzheimer&#8217;s and also to manage devastating symptoms that separate families, increase admissions to nursing homes, and drive the cost of Alzheimer&#8217;s care, although there can be no assurance.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have a two-pronged approach for our Alzheimer&#8217;s investigational drug development strategy, the first prong is to investigate IGC-AD1 as an Alzheimer&#8217;s symptoms modifying agent, and the second is to investigate TGR-63 as a disease modifying agent. This involves conducting more trials on IGC-AD1 over the next few years, subject to FDA approval, with the anticipated goal of demonstrating safety and efficacy and potentially obtaining FDA approval for IGC-AD1 as a cannabinoid-based new drug that can help to manage agitation for patients suffering from Alzheimer&#8217;s disease. The second prong is to investigate the potential efficacy of TGR-63 on memory and/or decreasing or managing plaques and tangles, some of the hallmarks of Alzheimer&#8217;s disease.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our pipeline of investigational and development cannabinoid formulations also includes pain creams and tinctures for pain relief. We believe that the pharmaceutical component of our Life Sciences strategy will take several more years to mature and involves considerable risk; however, we also believe it may involve greater defensible growth potential and first-to-market advantage.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Although there can be no assurance, we believe that additional investment in clinical trials, research, and development (R&amp;D), facilities, marketing, advertising, and acquisition of complementary products and businesses supporting our Life Sciences segment will be critical to the development and delivery of innovative products and positive patient and customer experiences. We hope to leverage our R&amp;D and intellectual property to develop ground-breaking, science-based products that are proven effective through planned pre-clinical and clinical trials. Although there can be no assurance, we believe this strategy has the potential to improve existing products and lead to the creation of new products, which, based on scientific study and research, may offer positive results for the management of certain conditions, symptoms, and side effects.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">While the bulk of our medium and longer-term focus is on clinical trials and getting IGC-AD1 to be an FDA approved drug, our shorter-term strategy, is to use our resources to provide white label services and market Holief&#8482;. We believe this may provide us with several profit opportunities, although there can be no assurance of such profit opportunities.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration:underline">Over-the-Counter Products</span></i>:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have created a women&#8217;s wellness brand, Holief&#8482; available through online channels that are compliant with relevant federal, state, and local laws, and regulations. Holief&#8482; is an all-natural, non-GMO, vegan, line of over-the-counter (OTC) products aimed at treating menstrual cramps (dysmenorrhea) and premenstrual symptoms (PMS). The products are available online and through Amazon and other online channels. Holief&#8482; is compliant with relevant federal, state, and local laws, and regulations.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Infrastructure Segment</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s infrastructure business has been operating since 2008, it includes: (i) Execution of Construction Contracts and (ii) Rental of Heavy Construction Equipment.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>COVID-19 Update</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The ongoing COVID-19 pandemic and the resulting containment measures that have been in effect from time to time in various countries and territories since early 2020 have had a number of substantial negative impacts on businesses around the world and on global, regional, and national economies, including widespread disruptions in supply chains for a wide variety of products and resulting increases in the prices of many goods and services. Currently, our production facilities in all of our locations continue to operate as they had before the COVID-19 pandemic, with few changes other than for enhanced safety measures intended to prevent the spread of the virus.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Some of our ongoing clinical trials experienced short-term interruptions in the recruitment of patients due to the COVID-19 pandemic, as hospitals prioritized their resources towards the COVID-19 pandemic and government imposed travel restrictions. Some clinical trials experienced increased expenses due to new protocols to protect participants from COVID-19. Additionally, certain suppliers had difficulties meeting their delivery commitments, and we are experiencing longer lead times for components. Future shutdowns could have an adverse impact on our operations. However, the extent of the impact of any future shutdown or delay is highly uncertain and difficult to predict.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">39</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">It is not possible at this time to estimate the complete impact that COVID-19 could have on our business, including our customers and suppliers, as the effects will depend on future developments, which are highly uncertain and cannot be predicted. Infections may resurge or become more widespread, including due to new variants and the limitation on our ability to travel and timely sell and distribute our products, as well as any closures or supply disruptions may be prolonged for extended periods, all of which would have a negative impact on our business, financial condition, and operating results.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Even after the COVID-19 pandemic has subsided, we may continue to experience an adverse impact on our business due to the continued global economic impact of the COVID-19 pandemic. We cannot anticipate all of the ways in which health epidemics such as COVID-19 could adversely impact our business. See Item 1A, &#8220;Risk Factors&#8221; for further discussion of the possible impact of the COVID-19 pandemic on our business.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>The Global Economic Environment</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition to the industry-specific factors, such as regulations around cannabinoid research, we are exposed to economic cycles. Factors in the global economic environment that may impact our operations include, among other things, currency fluctuations, capital and exchange controls, global economic conditions including inflation, restrictive government actions, changes in intellectual property, legal protections and remedies, trade regulations, tax laws and regulations and procedures and actions affecting approval, production, pricing, and marketing of our products, as well as impacts of political or civil unrest or military action, including the current conflict between Russia and Ukraine, terrorist activity, unstable governments, and legal systems, inter-governmental disputes, public health outbreaks, epidemics, pandemics, natural disasters or disruptions related to climate change.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Operational Excellence</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We remain focused on continuing to build excellence broadly in three areas, cannabinoid-based investigations, drug development and product manufacturing, and online marketing. Although there can be no assurance, we believe these will give us a competitive advantage, including building an increasingly agile and adaptable commercialization engine with a strong customer-focused market expertise.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Workplace and Employees</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We support broad public health strategies designed to prevent the spread of COVID-19 and are focused on the health and welfare of our employees. We have mobilized to enable our employees to accomplish our most critical goals through a combination of remote work and in-person initiatives. In addition to rolling out new technologies and collaboration tools, we have implemented processes and resources to support our employees in the event an employee receives a positive COVID-19 diagnosis. We have developed plans regarding the opening of our sites to enable our employees to return to work in our global offices, the field, and our manufacturing facilities, which take into account applicable public health authority and local government guidelines, and which are designed to ensure community and employee safety. We are moving to a more flexible mix of virtual and in-person work to advance our culture, drive innovation and agility and enable greater balance and well-being for our workforce.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Research and Development</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">With respect to our clinical trial activities, we have taken measures to implement remote and virtual approaches, including remote data monitoring where possible, to maintain safety and trial continuity and to preserve study integrity. We have seen delays in initiating trial sites, due to COVID-19. We cannot guarantee that we will continue to perform our trials in a timely and satisfactory manner as a result of the evolving effects of the COVID-19 pandemic. Similarly, our ability to recruit and retain patients and principal investigators, and site staff who, as health care providers, may have heightened exposure to COVID-19 may adversely impact our clinical trial operations.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">40</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Fiscal 2023 Highlights</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On March 20, 2023, the Company announced the changing of its name to IGC Pharma, Inc. from India Globalization Capital, Inc., as a part of a rebranding strategy that better reflects IGC Pharma&#8217;s strategic focus and vision for the future.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On March 8, 2023, the Company filed in USPTO the provisional patent application titled &#8220;Composition, Synthesis, and Medical Use of Hybrid Cannabinoid&#8221;.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On January 4, 2023, the Company received a No-objection letter from Health Canada for approval to begin its trial in Canada &#8220;A, Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer&#8217;s Disease.&#8221;&#160;</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On December 1, 2022, the Company announced that it had begun its Phase 2 clinical trials &#8220;A, Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer&#8217;s Disease&#8221;&#160;at two U.S. sites with plan to add between three to five additional sites in the United States, Canada, and possibly South Africa, to increase population diversity.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On September 20, 2022, the USPTO granted a second patent (#11,446,276) for the treatment of Alzheimer&#8217;s disease titled &#8220;Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer&#8217;s disease.&#8221;&#160;The original patent application was initiated by the University of South Florida (USF) and filed on August 1, 2016. On May 25, 2017, the Company entered into an exclusive license agreement with USF with respect to the patent application and the associated research conducted on Alzheimer&#8217;s disease. IGC-AD1, described above, is based on some of this research.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On June 7, 2022, the USPTO issued a patent (#11,351,152) to the Company titled &#8220;Method and Composition for Treating Seizures Disorders.&#8221;&#160;The patent relates to compositions and methods for treating multiple types of seizure disorders and epilepsy in humans and animals using a combination of the CBD with other compounds. Subject to further research and study, the combination is intended to reduce side effects caused by hydantoin anticonvulsant drugs such as phenobarbital, by reducing the dosing of anticonvulsant drugs in humans, dogs, and cats.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">41</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Results of Operations</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Fiscal 2023 compared to Fiscal 2022</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The following table presents an overview of our results of operations for Fiscal 2023 and Fiscal 2022:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Statement of Operations (in thousands, audited)</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-0" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal</b></p>
			</td>
			<td id="new_id-1" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-4" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-5" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;"><b>&#160;</b></td>
			<td id="new_id-6" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-7" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-8" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-9" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-10" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-11" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-12" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-13" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-14" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-15" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-16" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-17" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p>
			<b>($)</b></td>
			<td id="new_id-18" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-19" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-20" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percent </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p>
			</td>
			<td id="new_id-21" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Revenue</p>
			</td>
			<td id="new_id-22" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-23" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-24" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">911</td>
			<td id="new_id-25" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-26" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-27" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-28" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">397</td>
			<td id="new_id-29" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-30" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-31" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-32" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">514</td>
			<td id="new_id-33" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-34" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-35" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-36" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">129</td>
			<td id="new_id-37" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cost of revenue</p>
			</td>
			<td id="new_id-38" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-39" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-40" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(469</td>
			<td id="new_id-41" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-42" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-43" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-44" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(203</td>
			<td id="new_id-45" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-46" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-47" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-48" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(266</td>
			<td id="new_id-49" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-50" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-51" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-52" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">131</td>
			<td id="new_id-53" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Gross profit</b></p>
			</td>
			<td id="new_id-54" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-55" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-56" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>442</b></td>
			<td id="new_id-57" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-58" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-59" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-60" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>194</b></td>
			<td id="new_id-61" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-62" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-63" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-64" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>248</b></td>
			<td id="new_id-65" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-66" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-67" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-68" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>128</b></td>
			<td id="new_id-69" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Selling, general and administrative expenses</p>
			</td>
			<td id="new_id-70" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-71" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-72" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(8,552</td>
			<td id="new_id-73" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-74" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-75" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-76" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(13,292</td>
			<td id="new_id-77" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-78" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-79" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-80" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">4,740</td>
			<td id="new_id-81" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-82" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-83" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-84" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(36</td>
			<td id="new_id-85" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Research and development expenses</p>
			</td>
			<td id="new_id-86" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-87" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-88" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(3,461</td>
			<td id="new_id-89" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-90" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-91" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-92" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(2,330</td>
			<td id="new_id-93" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-94" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-95" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-96" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(1,131</td>
			<td id="new_id-97" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-98" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-99" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-100" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">49</td>
			<td id="new_id-101" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Operating loss</b></p>
			</td>
			<td id="new_id-102" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-103" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-104" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(11,571</b></td>
			<td id="new_id-105" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-106" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-107" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-108" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(15,428</b></td>
			<td id="new_id-109" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-110" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-111" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-112" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>3,857</b></td>
			<td id="new_id-113" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-114" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-115" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-116" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(25</b></td>
			<td id="new_id-117" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Impairment</p>
			</td>
			<td id="new_id-118" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-119" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-120" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-121" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-122" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-123" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-124" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(49</td>
			<td id="new_id-125" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-126" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-127" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-128" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">49</td>
			<td id="new_id-129" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-130" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-131" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-132" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(100</td>
			<td id="new_id-133" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other income, net</p>
			</td>
			<td id="new_id-134" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-135" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-136" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">65</td>
			<td id="new_id-137" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-138" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-139" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-140" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">461</td>
			<td id="new_id-141" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-142" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-143" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-144" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(396</td>
			<td id="new_id-145" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-146" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-147" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-148" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(86</td>
			<td id="new_id-149" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Loss before income taxes</b></p>
			</td>
			<td id="new_id-150" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-151" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-152" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(11,506</b></td>
			<td id="new_id-153" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-154" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-155" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-156" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(15,016</b></td>
			<td id="new_id-157" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-158" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-159" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-160" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>3,510</b></td>
			<td id="new_id-161" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-162" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-163" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-164" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(23</b></td>
			<td id="new_id-165" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Income tax expense/benefit</p>
			</td>
			<td id="new_id-166" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-167" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-168" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-169" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-170" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-171" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-172" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-173" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-174" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-175" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-176" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-177" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-178" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-179" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-180" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-181" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net loss attributable to common stockholders</b></p>
			</td>
			<td id="new_id-182" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-183" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-184" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(11,506</b></td>
			<td id="new_id-185" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-186" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-187" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-188" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(15,016</b></td>
			<td id="new_id-189" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-190" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-191" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-192" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>3,510</b></td>
			<td id="new_id-193" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-194" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-195" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-196" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(23</b></td>
			<td id="new_id-197" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Revenue</i> &#8211; During Fiscal 2023, the Company generated approximately $911 thousand in revenue, representing a significant increase from the $397 thousand generated in Fiscal 2022. The primary source of revenue in both years was from the Life Sciences segment, encompassing the sale of our formulations as white labeled manufactured products and sales of branded holistic women&#8217;s health care products, among others. The growth can be attributed to higher sales volume driven by increased sales and marketing efforts. The Company implemented robust marketing and sales activities, which contributed to the successful expansion of its customer base and increased demand. Approximately 10%-12% of revenue in both years was derived from the Infrastructure segment. The Company remains committed to its current strategy of driving sales in formulated white labeled and wellness products. By continuing to focus on sales and marketing initiatives, the Company aims to further strengthen its position in the market and drive sustained revenue growth.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i style="font-size: 10pt; text-indent: 36pt;">Cost of revenue&#160;</i>&#8211; The cost of revenue amounted to approximately $469 thousand for Fiscal 2023, compared to $203 thousand in Fiscal 2022. This represents a gross margin of about 49% for both years. The cost of revenue is primarily attributable to the cost of raw materials, labor, and other direct overheads required to produce our products in the Life Science segment.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Selling, general and administrative expenses </i>&#8211; Selling, general, and administrative (SG&amp;A) expenses primarily encompass various costs such as employee-related expenses, sales commissions, professional fees, legal fees, marketing expenses, other corporate expenses, allocated general overhead, provisions, depreciation, and write-offs related to doubtful accounts and advances. For Fiscal 2023, the Company reported SG&amp;A expenses of approximately $8.5 million, representing a decrease of approximately $4.7 million, or 36%, compared to the $13.2 million recorded in Fiscal 2022. This decline in SG&amp;A expenses are attributable to a reduction in one-time expenses of approximately $4.2 million and a decrease of approximately $500 thousand in compensation, legal and marketing expenses, net realizable value (&#8220;NRV&#8221;) adjustments, and other SG&amp;A expenses. By effectively managing and reducing these expenses, the Company achieved cost savings during Fiscal 2023.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Research and Development (R&amp;D) expenses </i>&#8211; R&amp;D expenses were primarily associated with the Life Sciences segment, reflecting the Company&#8217;s investment in R&amp;D activities. In Fiscal 2023, the Company reported R&amp;D expenses of approximately $3.5 million, representing an increase of $1.2 million or 49% compared to approximately $2.3 million in Fiscal 2022. The increase in R&amp;D expenses is primarily attributed to the progression of Phase 2 trials on IGC-AD1 and pre-clinical studies on TGR-63, indicating the Company&#8217;s dedication to advancing its product pipeline. As the development of TGR-63 and the Phase 2B trial on Alzheimer&#8217;s gain momentum, the Company anticipates further increases in R&amp;D expenses. attributable to the progression of Phase 2 trials on IGC-AD1 and pre-clinical studies on TGR-63<i>. </i>We anticipate increased R&amp;D expenses as the development of TGR-63 and the Phase 2B trial on Alzheimer&#8217;s pick up more momentum.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Impairment loss</i> &#8211; During Fiscal 2023, there was no investment impairment. In Fiscal 2022, there was an impairment of approximately $49 thousand, which was attributed to the cancelation of 44 thousand shares of IGC common stock.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">42</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Other Income, net</i> &#8211; During Fiscal 2023, the Company reported approximately $65 thousand in other income, which represents a decrease compared to the $461 thousand recorded in Fiscal 2022. The decrease in other income for Fiscal 2023 can be primarily attributed to the absence of a one-time forgiveness of the PPP (Paycheck Protection Program) loan, which amounted to approximately $430 thousand in Fiscal 2022. The component of other income typically includes interest and rental income, dividend income, profits from the sale of assets, unrealized gains from non-debt investments, net income, and income from the sale of scraps. These sources contribute to the overall other income generated by the Company.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Liquidity and capital resources</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our sources of liquidity are cash and cash equivalents, funds raised through the ATM offering, cash flows from operations, short-term and long-term borrowings, and short-term liquidity arrangements. The Company continues to evaluate various financing sources and options to raise working capital to help fund current research and development programs and operations. The Company does not have any material long-term debt, capital lease obligations, or other long-term liabilities, except as disclosed in this report. Please refer to Note 12, &#8220;Commitments and contingencies&#8221;, Note 11, &#8220;Loans and Other Liabilities&#8221; and Note 9, &#8220;Leases&#8221; in Item 1 of this report for further information on Company commitments and contractual obligations.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $12 million and in addition sold 10,000,000 shares for $3,000,000. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#8217;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company expects to raise capital for its trials as and when it is able to do so, but there can be no assurance thereof. In addition, there can be no assurance of the terms thereof and any subsequent equity financing sought may have dilutive effects on our current shareholders. While there is no guarantee that we will be successful, we are applying to non-dilutive funding opportunities such as Small Business Research and Development programs. In addition, subject to limitations on the amount of capital that can be raised, the Company expects to utilize its shelf registration on statement on Form S-3 to raise capital through at-the-market offerings or otherwise.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Please refer to Item 1A. &#8220;Risk Factors&#8221; for further information on the risks related to the Company.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-198" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-199" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands, audited)</i></b></i></p>
			</td>
			<td id="new_id-200" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-201" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-202" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-203" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-204" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-205" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-206" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-207" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-208" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-209">&#160;</td>
			<td id="new_id-210">&#160;</td>
			<td id="new_id-211">&#160;</td>
			<td id="new_id-212">&#160;</td>
			<td id="new_id-213">&#160;</td>
			<td id="new_id-214">&#160;</td>
			<td id="new_id-215">&#160;</td>
			<td id="new_id-216">&#160;</td>
			<td id="new_id-217">&#160;</td>
			<td id="new_id-218">&#160;</td>
			<td id="new_id-219">&#160;</td>
			<td id="new_id-220">&#160;</td>
			<td id="new_id-221">&#160;</td>
			<td id="new_id-222">&#160;</td>
			<td id="new_id-223">&#160;</td>
			<td id="new_id-224">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-225" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-226" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-227" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-228" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-229" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-230" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-231" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-232" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-233" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-234" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-235" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percent </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p>
			</td>
			<td id="new_id-236" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Cash, cash equivalents</p>
			</td>
			<td id="new_id-237" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-238" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-239" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">3,196</td>
			<td id="new_id-240" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-241" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-242" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-243" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">10,460</td>
			<td id="new_id-244" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-245" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-246" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-247" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(7,264</td>
			<td id="new_id-248" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-249" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-250" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-251" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(69</td>
			<td id="new_id-252" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Working capital</p>
			</td>
			<td id="new_id-253" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-254" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-255" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">4,568</td>
			<td id="new_id-256" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-257" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-258" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-259" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">12,670</td>
			<td id="new_id-260" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-261" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-262" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-263" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(8,102</td>
			<td id="new_id-264" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-265" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-266" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-267" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(64</td>
			<td id="new_id-268" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)%</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Cash and cash equivalents </i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Cash and cash equivalents decreased by approximately $7.3 million to $3.2 million in Fiscal 2023&#160;from $10.5 million in Fiscal 2022, a decrease of approximately 69% is discussed in the summary of cash flows, as follows:</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-269" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-270" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands, audited)</i></b></i></p>
			</td>
			<td id="new_id-271" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-272" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-273" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-274" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-275" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-276" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-277" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-278" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-279" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-280">&#160;</td>
			<td id="new_id-281">&#160;</td>
			<td id="new_id-282">&#160;</td>
			<td id="new_id-283">&#160;</td>
			<td id="new_id-284">&#160;</td>
			<td id="new_id-285">&#160;</td>
			<td id="new_id-286">&#160;</td>
			<td id="new_id-287">&#160;</td>
			<td id="new_id-288">&#160;</td>
			<td id="new_id-289">&#160;</td>
			<td id="new_id-290">&#160;</td>
			<td id="new_id-291">&#160;</td>
			<td id="new_id-292">&#160;</td>
			<td id="new_id-293">&#160;</td>
			<td id="new_id-294">&#160;</td>
			<td id="new_id-295">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-296" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-297" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal</b></p>
			</td>
			<td id="new_id-298" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-299" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-300" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-301" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-302" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;"><b>&#160;</b></td>
			<td id="new_id-303" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-304" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-305" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-306" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-307" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-308" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-309" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-310" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-311" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-312" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-313" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-314" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p>
			<b>($)</b></td>
			<td id="new_id-315" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-316" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-317" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percent </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p>
			</td>
			<td id="new_id-318" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash used in operating activities</p>
			</td>
			<td id="new_id-319" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-320" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-321" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(7,047</td>
			<td id="new_id-322" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-323" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-324" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-325" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(7,462</td>
			<td id="new_id-326" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-327" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-328" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-329" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">415</td>
			<td id="new_id-330" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-331" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-332" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-333" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(6</td>
			<td id="new_id-334" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash used in investing activities</p>
			</td>
			<td id="new_id-335" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-336" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-337" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(235</td>
			<td id="new_id-338" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-339" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-340" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-341" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(742</td>
			<td id="new_id-342" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-343" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-344" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-345" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">507</td>
			<td id="new_id-346" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-347" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-348" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-349" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(68</td>
			<td id="new_id-350" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash provided by financing activities</p>
			</td>
			<td id="new_id-351" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-352" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-353" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">100</td>
			<td id="new_id-354" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-355" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-356" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-357" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">4,142</td>
			<td id="new_id-358" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-359" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-360" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-361" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(4,042</td>
			<td id="new_id-362" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-363" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-364" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-365" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(98</td>
			<td id="new_id-366" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Effects of exchange rate changes on cash and cash equivalents</p>
			</td>
			<td id="new_id-367" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-368" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-369" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(82</td>
			<td id="new_id-370" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-371" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-372" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-373" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(26</td>
			<td id="new_id-374" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-375" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-376" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-377" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(56</td>
			<td id="new_id-378" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-379" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-380" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-381" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">215</td>
			<td id="new_id-382" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net decrease in cash and cash equivalents</b></p>
			</td>
			<td id="new_id-383" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-384" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-385" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(7,264</b></td>
			<td id="new_id-386" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-387" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-388" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-389" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(4,088</b></td>
			<td id="new_id-390" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-391" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-392" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-393" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(3,176</b></td>
			<td id="new_id-394" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-395" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-396" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-397" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>78</b></td>
			<td id="new_id-398" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash and cash equivalents at the beginning of the period</p>
			</td>
			<td id="new_id-399" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-400" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-401" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,460</td>
			<td id="new_id-402" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-403" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-404" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-405" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">14,548</td>
			<td id="new_id-406" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-407" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-408" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-409" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(4,088</td>
			<td id="new_id-410" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-411" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-412" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-413" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(28</td>
			<td id="new_id-414" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cash and cash equivalents at the end of the period</b></p>
			</td>
			<td id="new_id-415" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-416" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-417" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>3,196</b></td>
			<td id="new_id-418" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-419" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-420" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-421" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>10,460</b></td>
			<td id="new_id-422" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-423" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-424" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-425" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(7,264</b></td>
			<td id="new_id-426" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-427" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-428" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-429" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(69</b></td>
			<td id="new_id-430" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)%</b></td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">43</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Operating Activities</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Net&#160;cash used in operating activities for Fiscal 2023 was approximately $7 million. It consists of a net loss of approximately $11.5 million, a positive impact on cash due to non-cash expenses of approximately $3.7 million, and changes in operating assets and liabilities of approximately $0.8 million. Non-cash expenses consist of an amortization and depreciation charge of approximately $0.7 million, stock-based expenses of approximately $2.8 million and other non-cash expenses of approximately $0.2 million. In addition, changes in operating assets and liabilities had a positive impact of approximately $0.8 million on cash, of which approximately $0.9 million is due to an adjustment in inventory and approximately $0.1 million decrease in other net current assets and liabilities.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Net cash used in operating activities for Fiscal 2022 was approximately $7.5 million. It consists of a net loss of approximately $15 million, a positive impact on cash due to non-cash expenses of approximately $5 million, and changes in operating assets and liabilities of approximately $2.5 million. Non-cash expenses consist of an amortization/depreciation charge of approximately $0.6 million, impairment of investment of $0.1 million, provision against debtor &amp; advances of $1.7 million, stock-based expenses of approximately $2.2 million, and a one-time impairment of PPE of $0.8 million and an offset of $0.4 million due to the forgiveness of a PPP Loan. In addition, changes in operating assets and liabilities had a positive impact of approximately $2.5 million in cash, of which approximately $1.9 million is due to an adjustment in inventory and an approximately $0.6 million increase in accounts payable.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Investing Activities</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Net cash used in investing activities for Fiscal 2023, was approximately $0.2 million, which comprises approximately $0.3 million for the acquisition and filing expenses related to intellectual property, approximately $0.2 million for the purchase of property, plant, and equipment and approximately $0.1 million of a short-term investment.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Net cash used in investing activities for Fiscal 2022, was approximately $0.7 million, which comprises approximately $0.5 million for the acquisition and filing expenses related to intellectual property, approximately $0.2 million for the purchase of property, plant, and equipment.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Financing Activities</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Net cash provided by financing activities was approximately $0.1 million for Fiscal 2023, which comprises net proceeds from issuance of equity stock through the ATM offering, net of all expenses related to the issuance of stock.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Net cash provided by financing activities was approximately $4.1 million for Fiscal 2022, which comprises net proceeds from issuance of equity stock through the ATM offering, net of all expenses related to the issuance of stock.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Critical Accounting Policies and Estimates</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements and related disclosures in conformity with U.S. GAAP and the Company&#8217;s discussion and analysis of its financial condition and operating results require the Company&#8217;s management to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and accompanying notes. We base our estimates on historical experience, as appropriate, and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates, and such differences may be material.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Management believes that the following accounting policies are the most critical to understanding and evaluating our consolidated financial condition and results of operations.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Revenue Recognition</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company recognizes revenue under ASC 606, <i>Revenue from Contracts with Customers</i> (ASC 606). The core principle of this standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">44</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">ASC 606 prescribes a 5-step process to achieve its core principle. The Company recognizes revenue from trading, rental, or product sales as follows:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">I. Identify the contract with the customer.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">II. Identify the contractual performance obligations.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">III. Determine the amount of consideration/price for the transaction.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IV. Allocate the determined amount of consideration/price to the performance obligations.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">V. Recognize revenue when or as the performing party satisfies performance obligations.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The consideration/price for the transaction (performance obligation(s)) is determined as per the agreement or invoice (contract) for the services and products in the Infrastructure and Life Sciences segment.</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Revenue in the Infrastructure segment is recognized for the renting business when the equipment is rented, and the terms of the agreement have been fulfilled during the period. Revenue from the execution of infrastructure contracts is recognized on the basis of the output method as and when part of the performance obligation has been completed and approval from the contracting agency has been obtained after survey of the performance completion as of that date. In the Life Sciences segment, the revenue from the wellness and lifestyle business is recognized once goods have been sold to the customer and the performance obligation has been completed. In retail sales, we offer consumer products through our online stores. Revenue is recognized when control of the goods is transferred to the customer. This generally occurs upon our delivery to a third-party carrier or to the customer directly. Revenue from white label services is recognized when the performance obligation has been completed and output material has been transferred to the customer.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Net sales disaggregated by significant products and services for Fiscal 2023 and 2022 are as follows:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-431" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-432" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year Ended March 31</i></b></i></p>
			</td>
			<td id="new_id-433" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-434" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-435" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-436" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-437" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-438" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-439" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 70%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Infrastructure segment</b></p>
			</td>
			<td id="new_id-440" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-441" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-442" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-443" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-444" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-445" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-446" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-447" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rental income (1)</p>
			</td>
			<td id="new_id-448" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-449" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-450" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">37</td>
			<td id="new_id-451" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-452" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-453" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-454" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">23</td>
			<td id="new_id-455" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction contracts (2)</p>
			</td>
			<td id="new_id-456" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-457" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-458" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">76</td>
			<td id="new_id-459" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-460" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-461" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-462" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">15</td>
			<td id="new_id-463" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-464">&#160;</td>
			<td id="new_id-465">&#160;</td>
			<td id="new_id-466">&#160;</td>
			<td id="new_id-467">&#160;</td>
			<td id="new_id-468">&#160;</td>
			<td id="new_id-469">&#160;</td>
			<td id="new_id-470">&#160;</td>
			<td id="new_id-471">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Life Sciences segment</b></p>
			</td>
			<td id="new_id-472" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-473" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-474" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-475" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-476" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-477" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-478" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-479" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Wellness and lifestyle (3)</p>
			</td>
			<td id="new_id-480" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-481" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-482" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">416</td>
			<td id="new_id-483" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-484" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-485" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-486" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">316</td>
			<td id="new_id-487" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">White label services (4)</p>
			</td>
			<td id="new_id-488" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-489" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-490" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">382</td>
			<td id="new_id-491" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-492" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-493" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-494" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">43</td>
			<td id="new_id-495" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-496" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-497" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-498" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>911</b></td>
			<td id="new_id-499" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-500" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-501" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-502" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>397</b></td>
			<td id="new_id-503" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1) Rental income consists of income from rental of heavy construction equipment.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2) Construction income consists of the execution of contracts directly or through subcontractors.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(3) Revenue from wellness and lifestyle consists of sale of products such as gummies, hand sanitizers, bath bombs, lotions, beverages, hemp crude extract, hemp isolate, and hemp distillate.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(4) Revenue from white label services consists of rebranding our formulations or the customer&#8217;s products as per customer&#8217;s requirement.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Accounts receivable</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We make estimates of the collectability of our accounts receivable by analyzing historical payment patterns, customer concentrations, customer creditworthiness, and current economic trends. If the financial condition of a customer deteriorates, additional allowances may be required. We had $107 thousand of accounts receivable, net of provision for the doubtful debt of $17 thousand as of March 31, 2023, as compared to $125 thousand of accounts receivable, net of provision for the doubtful debt of $93 thousand as of March 31, 2022.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Short-term and long-term investments</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our policy for short-term and long-term investments is to establish a high-quality portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations, and delivers an appropriate yield in relation to our investment guidelines and market conditions. Short-term and long-term investments consist of equity investment, mutual funds, corporate, various government securities, and municipal debt securities, as well as certificates of deposit. Certificates of deposit and commercial paper are carried at cost which approximates fair value. Available-for-sale securities: Investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the statement of financial position.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">45</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Investments are initially measured at cost, which is the fair value of the consideration given for them, including transaction costs. Where the Company&#8217;s ownership interest is in excess of 20% and the Company has a significant influence, the Company has accounted for the investment based on the equity method in accordance with ASC Topic 323, &#8220;Investments &#8211; Equity method and Joint Ventures.&#8221; Under the equity method, the Company&#8217;s share of the post-acquisition profits or losses of the equity investee is recognized in the consolidated statements of operations and its share of post-acquisition movements in accumulated other comprehensive income/(loss) is recognized in other comprehensive income/(loss). Where the Company does not have significant influence, the Company has accounted for the investment in accordance with ASC Topic 321, &#8220;Investments-Equity Securities.&#8221;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We consider all highly liquid interest-earning investments with a maturity of three months or less at the date of purchase to be cash equivalents. The fair values of these investments approximate their carrying values. In general, investments with original maturities of greater than three months and remaining maturities of less than one year are classified as short-term investments. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Debt investments are classified as available-for-sale and realized gains and losses are recorded using the specific identification method. Changes in fair value, excluding credit losses and impairments, are recorded in other comprehensive income. Fair value is calculated based on publicly available market information or other estimates determined by management. If the cost of an investment exceeds its fair value, we evaluate, among other factors, general market conditions, credit quality of debt instrument issuers, and the extent to which the fair value is less than the cost. To determine credit losses, we employ a systematic methodology that considers available quantitative and qualitative evidence. In addition, we consider specific adverse conditions related to the financial health of, and business outlook for, the investee. If we have plans to sell the security or it is more likely than not that we will be required to sell the security before recovery, then a decline in fair value below cost is recorded as an impairment charge in other income (expense), net and a new cost basis in the investment is established. If market, industry, and/or investee conditions deteriorate, we may incur future impairments.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Equity investments with readily determinable fair values are measured at fair value. Equity investments without readily determinable fair values are measured using the equity method or measured at cost with adjustments for observable changes in price or impairments (referred to as the measurement alternative). We perform a qualitative assessment on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value of the investment is less than the carrying value. Changes in value are recorded in other income (expense), net.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, the Company has approximately $154 thousand in short-term investments.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Impairment </i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company regularly reviews its investment portfolio to determine if any security is other-than-temporarily impaired, which would require the Company to record an impairment charge in the period any such determination is made. In making this determination, the Company evaluates, among other things, the duration and extent to which the fair value of a security is less than its cost; the financial condition of the issuer and any changes thereto; and the Company&#8217;s intent to sell, or whether it will more likely than not be required to sell, the security before recovery of its amortized cost basis. The Company&#8217;s assessment of whether a security is other-than-temporarily impaired could change in the future due to new developments or changes in assumptions related to any particular security, which would have an adverse impact on the Company&#8217;s financial condition and operating results. The estimated amount of liability is based on the information available to us with respect to bank debt and other borrowings. During Fiscal 2023, there was no impairment and Fiscal 2022, the Company impaired investments of approximately $49 thousand, respectively.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Inventory</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Inventory is valued at the lower of cost or net realizable value, which is defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Inventory consists of finished goods related to wellness products, hand sanitizers, finished hemp-based products, beverages. Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to primary cost. Inventory is primarily accounted for using the weighted average cost method. Primary costs include raw materials, packaging, direct labor, overhead, shipping, and the depreciation of manufacturing equipment. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">46</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We capitalize inventory costs related to our investigational drug, provided that management determines there is a potential alternative use for the inventory in future research and development projects or other purposes. As of March 31, 2023, and 2022, our consolidated balance sheet reported approximately $407 thousand and no clinical trial related inventory, respectively.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Abnormal amounts of idle facility expense, freight, handling costs, scrap, discontinued products and wasted material (spoilage) are expensed in the period they are incurred.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Please refer to Note 3, &#8220;Inventory,&#8221; for further information.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Stock-Based compensation</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company accounts for stock-based compensation to employees and non-employees in conformity with the provisions of ASC Topic 718, &#8220;<i>Stock-Based Compensation.</i>&#8221; The Company expenses stock-based compensation to employees over the requisite vesting period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards are recognized on a straight-line basis over the requisite vesting period. For stock-based employee compensation the cost recognized at any date will be at least equal to the amount attributable to the share-based compensation that is vested at that date.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For performance-based awards, stock-based compensation expense is recognized over the expected performance achievement period of individual performance milestones when the achievement of each individual performance milestone becomes probable by best of management estimate. For performance-based awards with a vesting schedule based entirely on the attainment of performance conditions, stock-based compensation expense associated with each tranche is recognized over the expected achievement period for the operational milestone, beginning at the point in time when the relevant operational milestone is considered probable to be achieved.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For market-based awards, stock-based compensation expense is recognized over the expected achievement period. The fair value of such awards is estimated on the grant date using binomial lattice model.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company estimates the fair value of stock option grants using the Black-Scholes option-pricing model. The assumptions used in calculating the fair value of stock-based awards represent Management&#8217;s best estimates. Generally, the closing share price of the Company&#8217;s common stock on the date of the grant is considered the fair value of the share. The volatility factor is determined based on the Company&#8217;s historical stock prices. The expected term represents the period that our stock-based awards are expected to be outstanding. The Company has never declared or paid any cash dividends. For further information, refer to Note 14, &#8220;Stock-Based Compensation&#8221; of Notes to Consolidated Financial Statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Income Taxes</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax base of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating loss for financial-reporting and tax-reporting purposes. Accordingly, for Federal and State income tax purposes, the benefit for income taxes has been offset entirely by a valuation allowance against the related federal, state, and foreign deferred tax assets.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Foreign currency translation</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IGC operates in India, U.S., Colombia, and Hong Kong, and a substantial portion of the Company&#8217;s financials are denominated in the Indian Rupee (&#8220;INR&#8221;), the Hong Kong Dollar (&#8220;HKD&#8221;), or the Colombian Peso (&#8220;COP&#8221;). As a result, changes in the relative values of the U.S. Dollar (&#8220;USD&#8221;), the INR, the HKD, or the COP affect financial statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">47</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The accompanying financial statements are reported in USD. The INR, HKD, and COP are the functional currencies for certain subsidiaries of the Company. The translation of the functional currencies into U.S. dollars is performed for assets and liabilities using the exchange rates in effect at the balance sheet date and for revenues and expenses using average exchange rates prevailing during the reporting periods. Adjustments resulting from the translation of functional currency financial statements to reporting currency are accumulated and reported as other comprehensive income/(loss), a separate component of shareholders&#8217; equity. Transactions in currencies other than the functional currency during the year are converted into the functional currency at the applicable rates of exchange prevailing when the transactions occurred. Transaction gains and losses are recognized in the consolidated statements of operations. The exchange rates used for translation purposes are as follows:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="5" style="vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Period End Average Rate</b></p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="5" style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Period End Rate</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Period</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="5" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(P&amp;L rate)</b></p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="5" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Balance sheet rate)</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Year ended March 31, 2023</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">INR</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">80.32</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">INR</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">82.18</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">HKD</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7.8</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">HKD</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7.8</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COP</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">4,465</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COP</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">4,645</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Year ended March 31, 2022</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">INR</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">74.50</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">INR</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">75.91</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">HKD</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7.78</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">HKD</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7.83</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:20.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COP</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,830</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COP</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:3.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,748</p>
			</td>
			<td style="vertical-align:bottom;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">USD</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Cybersecurity</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have a cybersecurity policy in place and have implemented tighter cybersecurity measures to safeguard against hackers. Complying with these security measures and compliances is expected to incur further expenses. In Fiscal 2023 and Fiscal 2022, there were no known or detected breaches in cybersecurity.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Recently issued and adopted accounting pronouncements</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Changes to U.S. GAAP are established by the Financial Accounting Standards Board (FASB) in the form of accounting standards updates (ASUs) to the FASB&#8217;s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Newly issued ASUs not listed are expected to have no impact on the Company&#8217;s consolidated financial position and results of operations, because either the ASU is not applicable, or the impact is expected to be immaterial. Recent accounting pronouncements which may be applicable to us are described in Note 2, &#8220;Significant Accounting Policies&#8221; in our Consolidated Financial Statements contained herein in Part II, Item 8.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Off-balance sheet arrangements</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We do not have any outstanding derivative financial instruments, off-balance sheet guarantees, interest rate swap transactions or foreign currency forward contracts. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity, or market risk support to such entity. We do not have any variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit support to us or that engages in leasing, hedging or research and development services with us.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i7a" title="i7a"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Item 7A does not apply to us because we are a smaller reporting company.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">48</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i8" title="i8"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:9.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Index to Consolidated Financial Statements</b></p>	</td>	<td style="border-bottom:solid 1px #000000;vertical-align:top;width:0.7%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Page</b></p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:9.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:top;width:0.7%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:9.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#report" style="-sec-extract:exhibit;">Report of Independent Registered Public Accounting Firms (PCAOB ID <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId">5341</ix:nonNumeric>)</a></p>	</td>	<td style="vertical-align:top;width:0.7%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">50</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:9.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#bs" style="-sec-extract:exhibit;">Consolidated Balance Sheets</a></p>	</td>	<td style="vertical-align:top;width:0.7%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">51</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:9.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#ops" style="-sec-extract:exhibit;">Consolidated Statements of Operations and Comprehensive Loss</a></p>	</td>	<td style="vertical-align:top;width:0.7%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">52</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:9.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#se" style="-sec-extract:exhibit;">Consolidated Statements of Stockholders&#8217;&#160;Equity</a></p>	</td>	<td style="vertical-align:top;width:0.7%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">53</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:9.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#cf" style="-sec-extract:exhibit;">Consolidated Statements of Cash Flows</a></p>	</td>	<td style="vertical-align:top;width:0.7%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>	</td>	</tr>	<tr>	<td style="vertical-align:top;width:9.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#notes" style="-sec-extract:exhibit;">Notes to Consolidated Financial Statements</a></p>	</td>	<td style="vertical-align:top;width:0.7%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">55</p>	</td>	</tr>
</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">49</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="report" title="report"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Report of Independent Registered Public Accounting Firm</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>To the shareholders and the board of directors of IGC Pharma, Inc.</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Opinion on the Consolidated Financial Statements </b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We have audited the accompanying consolidated balance sheets of IGC Pharma, Inc. (formerly known as &#8216;India Globalization Capital, Inc.&#8217;) and its subsidiaries (the &#8220;Company&#8221;) as of March 31, 2023 and 2022, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity and cash flows, for each of the two years in the period ended March 31, 2023, and the related notes (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as at March 31, 2023 and 2022, and the consolidated results of its operations and its cash flows for each of the two years in the period ended March 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Basis for Opinion</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Critical Audit Matters</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Critical audit matters are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical audit matters.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><span style="-sec-ix-hidden: hidden-fact-0">Manohar Chowdhry &amp; Associates</span></b>&#160; &#160; &#160; &#160; &#160;<b> </b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Chartered Accountants</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>We have served as the Company's auditor since 2018.</b></p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><span style="-sec-ix-hidden: hidden-fact-1">Chennai, India</span></b></p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>July 7, 2023</b></p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>UDIN: </b>&#160;<b>23237830BGZGZQ9446</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">50</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="bs" title="bs"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IGC Pharma, Inc.</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED BALANCE SHEETS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(In thousands, except share data)</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-504" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-505" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-506" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-507" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-508" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-509" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 70%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><span style="text-decoration:underline"><b>ASSETS</b></span></p>
			</td>
			<td id="new_id-510" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-511" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-512" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-513" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-514" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-515" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-516" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-517" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Current assets:</b></p>
			</td>
			<td id="new_id-518" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-519" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-520" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-521" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-522" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-523" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-524" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-525" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash and cash equivalents</p>
			</td>
			<td id="new_id-526" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-527" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-528" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">3,196</ix:nonFraction></td>
			<td id="new_id-529" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-530" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-531" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-532" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">10,460</ix:nonFraction></td>
			<td id="new_id-533" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounts receivable, net</p>
			</td>
			<td id="new_id-534" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-535" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-536" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd">107</ix:nonFraction></td>
			<td id="new_id-537" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-538" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-539" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-540" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd">125</ix:nonFraction></td>
			<td id="new_id-541" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Short term investments</p>
			</td>
			<td id="new_id-542" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-543" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-544" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" unitRef="usd">154</ix:nonFraction></td>
			<td id="new_id-545" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-546" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-547" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-548" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ShortTermInvestments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-549" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inventory</p>
			</td>
			<td id="new_id-550" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-551" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-552" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" unitRef="usd">2,651</ix:nonFraction></td>
			<td id="new_id-553" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-554" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-555" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-556" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" unitRef="usd">3,548</ix:nonFraction></td>
			<td id="new_id-557" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deposits and advances</p>
			</td>
			<td id="new_id-558" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-559" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-560" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd">358</ix:nonFraction></td>
			<td id="new_id-561" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-562" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-563" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-564" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd">978</ix:nonFraction></td>
			<td id="new_id-565" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total current assets</b></p>
			</td>
			<td id="new_id-566" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-567" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-568" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd">6,466</ix:nonFraction></b></td>
			<td id="new_id-569" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-570" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-571" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-572" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd">15,111</ix:nonFraction></b></td>
			<td id="new_id-573" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-574">&#160;</td>
			<td id="new_id-575">&#160;</td>
			<td id="new_id-576">&#160;</td>
			<td id="new_id-577">&#160;</td>
			<td id="new_id-578">&#160;</td>
			<td id="new_id-579">&#160;</td>
			<td id="new_id-580">&#160;</td>
			<td id="new_id-581">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-current assets:</b></p>
			</td>
			<td id="new_id-582" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-583" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-584" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-585" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-586" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-587" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-588" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-589" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intangible assets, net</p>
			</td>
			<td id="new_id-590" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-591" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-592" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">1,170</ix:nonFraction></td>
			<td id="new_id-593" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-594" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-595" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-596" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">917</ix:nonFraction></td>
			<td id="new_id-597" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property, plant and equipment, net</p>
			</td>
			<td id="new_id-598" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-599" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-600" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">8,213</ix:nonFraction></td>
			<td id="new_id-601" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-602" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-603" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-604" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">9,419</ix:nonFraction></td>
			<td id="new_id-605" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims and advances</p>
			</td>
			<td id="new_id-606" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-607" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-608" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">1,003</ix:nonFraction></td>
			<td id="new_id-609" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-610" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-611" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-612" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">937</ix:nonFraction></td>
			<td id="new_id-613" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-614" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-615" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-616" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">326</ix:nonFraction></td>
			<td id="new_id-617" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-618" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-619" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-620" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">450</ix:nonFraction></td>
			<td id="new_id-621" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total non-current assets</b></p>
			</td>
			<td id="new_id-622" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-623" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-624" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">10,712</ix:nonFraction></b></td>
			<td id="new_id-625" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-626" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-627" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-628" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">11,723</ix:nonFraction></b></td>
			<td id="new_id-629" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total assets</b></p>
			</td>
			<td id="new_id-630" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-631" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-632" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd">17,178</ix:nonFraction></b></td>
			<td id="new_id-633" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-634" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-635" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-636" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd">26,834</ix:nonFraction></b></td>
			<td id="new_id-637" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration:underline">LIABILITIES AND STOCKHOLDERS</span></b><span style="text-decoration:underline">&#8217;</span><b><span style="text-decoration:underline"> EQUITY</span></b></p>
			</td>
			<td id="new_id-638" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-639" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-640" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-641" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-642" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-643" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-644" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-645" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-646">&#160;</td>
			<td id="new_id-647">&#160;</td>
			<td id="new_id-648">&#160;</td>
			<td id="new_id-649">&#160;</td>
			<td id="new_id-650">&#160;</td>
			<td id="new_id-651">&#160;</td>
			<td id="new_id-652">&#160;</td>
			<td id="new_id-653">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Current liabilities:</b></p>
			</td>
			<td id="new_id-654" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-655" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-656" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-657" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-658" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-659" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-660" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-661" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounts payable</p>
			</td>
			<td id="new_id-662" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-663" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-664" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd">530</ix:nonFraction></td>
			<td id="new_id-665" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-666" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-667" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-668" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd">981</ix:nonFraction></td>
			<td id="new_id-669" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued liabilities and others</p>
			</td>
			<td id="new_id-670" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-671" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-672" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" unitRef="usd">1,368</ix:nonFraction></td>
			<td id="new_id-673" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-674" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-675" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-676" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" unitRef="usd">1,460</ix:nonFraction></td>
			<td id="new_id-677" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total current liabilities</b></p>
			</td>
			<td id="new_id-678" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-679" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-680" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd">1,898</ix:nonFraction></b></td>
			<td id="new_id-681" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-682" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-683" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-684" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd">2,441</ix:nonFraction></b></td>
			<td id="new_id-685" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-686">&#160;</td>
			<td id="new_id-687">&#160;</td>
			<td id="new_id-688">&#160;</td>
			<td id="new_id-689">&#160;</td>
			<td id="new_id-690">&#160;</td>
			<td id="new_id-691">&#160;</td>
			<td id="new_id-692">&#160;</td>
			<td id="new_id-693">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-current liabilities:</b></p>
			</td>
			<td id="new_id-694" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-695" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-696" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-697" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-698" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-699" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-700" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-701" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Long-term loans</p>
			</td>
			<td id="new_id-702" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-703" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-704" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" unitRef="usd">141</ix:nonFraction></td>
			<td id="new_id-705" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-706" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-707" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-708" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" unitRef="usd">144</ix:nonFraction></td>
			<td id="new_id-709" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other liabilities</p>
			</td>
			<td id="new_id-710" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-711" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-712" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" unitRef="usd">21</ix:nonFraction></td>
			<td id="new_id-713" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-714" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-715" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-716" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" unitRef="usd">16</ix:nonFraction></td>
			<td id="new_id-717" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease liability</p>
			</td>
			<td id="new_id-718" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-719" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-720" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd">207</ix:nonFraction></td>
			<td id="new_id-721" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-722" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-723" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-724" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd">341</ix:nonFraction></td>
			<td id="new_id-725" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total non-current liabilities</b></p>
			</td>
			<td id="new_id-726" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-727" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-728" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd">369</ix:nonFraction></b></td>
			<td id="new_id-729" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-730" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-731" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-732" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd">501</ix:nonFraction></b></td>
			<td id="new_id-733" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total liabilities</b></p>
			</td>
			<td id="new_id-734" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-735" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-736" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd">2,267</ix:nonFraction></b></td>
			<td id="new_id-737" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-738" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-739" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-740" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd">2,942</ix:nonFraction></b></td>
			<td id="new_id-741" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-742">&#160;</td>
			<td id="new_id-743">&#160;</td>
			<td id="new_id-744">&#160;</td>
			<td id="new_id-745">&#160;</td>
			<td id="new_id-746">&#160;</td>
			<td id="new_id-747">&#160;</td>
			<td id="new_id-748">&#160;</td>
			<td id="new_id-749">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Commitments and Contingencies </b>&#8211;<b> See Note 12</b></p>
			</td>
			<td id="new_id-750" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-751" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-752" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><div style="-sec-ix-hidden: hidden-fact-2"><b>&#160;</b></div></td>
			<td id="new_id-753" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-754" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-755" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-756" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><div style="-sec-ix-hidden: hidden-fact-3"><b>&#160;</b></div></td>
			<td id="new_id-757" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-758">&#160;</td>
			<td id="new_id-759">&#160;</td>
			<td id="new_id-760">&#160;</td>
			<td id="new_id-761">&#160;</td>
			<td id="new_id-762">&#160;</td>
			<td id="new_id-763">&#160;</td>
			<td id="new_id-764">&#160;</td>
			<td id="new_id-765">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Stockholders</b>&#8217;<b> equity:</b></p>
			</td>
			<td id="new_id-766" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-767" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-768" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-769" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-770" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-771" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-772" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-773" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Preferred stock, $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> par value: authorized <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">1,000,000</ix:nonFraction></ix:nonFraction> shares, <ix:nonFraction contextRef="c3" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding as of March 31, 2023, or March 31, 2022.</p>	</td>
			<td id="new_id-774" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-775" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-776" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" unitRef="usd">&#160;</ix:nonFraction></td>
			<td id="new_id-777" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-778" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-779" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-780" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" unitRef="usd">&#160;</ix:nonFraction></td>
			<td id="new_id-781" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common stock and additional paid-in capital, $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">150,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">53,077,436</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">51,054,017</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March 31, 2023, and March 31, 2022, respectively.</p>	</td>
			<td id="new_id-782" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-783" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-784" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="3" unitRef="usd">118,965</ix:nonFraction></td>
			<td id="new_id-785" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-786" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-787" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-788" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="3" unitRef="usd">116,019</ix:nonFraction></td>
			<td id="new_id-789" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated other comprehensive loss</p>
			</td>
			<td id="new_id-790" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-791" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-792" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" sign="-" unitRef="usd">3,389</ix:nonFraction></td>
			<td id="new_id-793" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-794" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-795" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-796" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" sign="-" unitRef="usd">2,968</ix:nonFraction></td>
			<td id="new_id-797" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated deficit</p>
			</td>
			<td id="new_id-798" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-799" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-800" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">100,665</ix:nonFraction></td>
			<td id="new_id-801" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-802" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-803" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-804" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">89,159</ix:nonFraction></td>
			<td id="new_id-805" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total stockholders</b>&#8217;<b> equity</b></p>
			</td>
			<td id="new_id-806" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-807" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-808" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">14,911</ix:nonFraction></b></td>
			<td id="new_id-809" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-810" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-811" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-812" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">23,892</ix:nonFraction></b></td>
			<td id="new_id-813" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total liabilities and stockholders</b>&#8217;<b> equity</b></p>
			</td>
			<td id="new_id-814" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-815" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-816" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd">17,178</ix:nonFraction></b></td>
			<td id="new_id-817" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-818" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-819" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-820" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd">26,834</ix:nonFraction></b></td>
			<td id="new_id-821" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The accompanying notes should be read in connection with these consolidated financial statements.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">51</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="ops" title="ops"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IGC Pharma, Inc.</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(in thousands, except loss per share and share data)</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-822" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-823" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Years Ended March 31,</b></p>
			</td>
			<td id="new_id-824" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-825" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-826" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-827" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-828" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-829" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-830" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 70%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Revenue</p>
			</td>
			<td id="new_id-831" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-832" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-833" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">911</ix:nonFraction></td>
			<td id="new_id-834" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-835" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-836" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-837" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">397</ix:nonFraction></td>
			<td id="new_id-838" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cost of revenue</p>
			</td>
			<td id="new_id-839" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-840" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-841" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">469</ix:nonFraction></td>
			<td id="new_id-842" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-843" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-844" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-845" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">203</ix:nonFraction></td>
			<td id="new_id-846" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Gross profit</b></p>
			</td>
			<td id="new_id-847" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-848" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-849" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">442</ix:nonFraction></b></td>
			<td id="new_id-850" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-851" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-852" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-853" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">194</ix:nonFraction></b></td>
			<td id="new_id-854" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Selling, general and administrative expenses</p>
			</td>
			<td id="new_id-855" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-856" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-857" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">8,552</ix:nonFraction></td>
			<td id="new_id-858" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-859" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-860" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-861" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">13,292</ix:nonFraction></td>
			<td id="new_id-862" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Research and development expenses</p>
			</td>
			<td id="new_id-863" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-864" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-865" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">3,461</ix:nonFraction></td>
			<td id="new_id-866" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-867" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-868" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-869" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">2,330</ix:nonFraction></td>
			<td id="new_id-870" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Operating loss</b></p>
			</td>
			<td id="new_id-871" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-872" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-873" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">11,571</ix:nonFraction></b></td>
			<td id="new_id-874" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-875" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-876" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-877" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">15,428</ix:nonFraction></b></td>
			<td id="new_id-878" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Impairment of investment</p>
			</td>
			<td id="new_id-879" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-880" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-881" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ImpairmentOfInvestments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-882" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-883" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-884" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-885" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfInvestments" scale="3" unitRef="usd">49</ix:nonFraction></td>
			<td id="new_id-886" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Other income, net</p>
			</td>
			<td id="new_id-887" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-888" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-889" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" unitRef="usd">65</ix:nonFraction></td>
			<td id="new_id-890" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-891" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-892" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-893" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" unitRef="usd">461</ix:nonFraction></td>
			<td id="new_id-894" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Loss before income taxes</b></p>
			</td>
			<td id="new_id-895" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-896" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-897" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">11,506</ix:nonFraction></b></td>
			<td id="new_id-898" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-899" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-900" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-901" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">15,016</ix:nonFraction></b></td>
			<td id="new_id-902" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Income tax expense/benefit</p>
			</td>
			<td id="new_id-903" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-904" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-905" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-906" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-907" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-908" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-909" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-910" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net loss attributable to common stockholders</b></p>
			</td>
			<td id="new_id-911" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-912" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-913" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd">11,506</ix:nonFraction></b></td>
			<td id="new_id-914" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-915" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-916" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-917" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd">15,016</ix:nonFraction></b></td>
			<td id="new_id-918" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Foreign currency translation adjustments</p>
			</td>
			<td id="new_id-919" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-920" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-921" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" sign="-" unitRef="usd">421</ix:nonFraction></td>
			<td id="new_id-922" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-923" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-924" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-925" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" sign="-" unitRef="usd">194</ix:nonFraction></td>
			<td id="new_id-926" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Comprehensive loss</b></p>
			</td>
			<td id="new_id-927" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-928" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-929" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd">11,927</ix:nonFraction></b></td>
			<td id="new_id-930" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-931" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-932" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-933" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd">15,210</ix:nonFraction></b></td>
			<td id="new_id-934" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-935">&#160;</td>
			<td id="new_id-936">&#160;</td>
			<td id="new_id-937">&#160;</td>
			<td id="new_id-938">&#160;</td>
			<td id="new_id-939">&#160;</td>
			<td id="new_id-940">&#160;</td>
			<td id="new_id-941">&#160;</td>
			<td id="new_id-942">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net loss per share attributable to common stockholders:</b></p>
			</td>
			<td id="new_id-943" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-944" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-945" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-946" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-947" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-948" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-949" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-950" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Basic and diluted</p>
			</td>
			<td id="new_id-951" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-952" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id="new_id-953" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="igc:EarningsPerShareBasicDiluted" scale="0" sign="-" unitRef="usdPershares">0.22</ix:nonFraction></td>
			<td id="new_id-954" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-955" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-956" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id="new_id-957" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="igc:EarningsPerShareBasicDiluted" scale="0" sign="-" unitRef="usdPershares">0.30</ix:nonFraction></td>
			<td id="new_id-958" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Weighted-average number of shares used in computing loss per share amounts:</p>
			</td>
			<td id="new_id-959" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-960" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-961" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="igc:WeightedAverageNumberOfShareOutstandingBasicDiluted" scale="0" unitRef="shares">52,576,258</ix:nonFraction></td>
			<td id="new_id-962" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-963" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-964" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-965" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="igc:WeightedAverageNumberOfShareOutstandingBasicDiluted" scale="0" unitRef="shares">49,991,631</ix:nonFraction></td>
			<td id="new_id-966" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The accompanying notes should be read in connection with these consolidated financial statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">52</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="se" title="se"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IGC Pharma, Inc.</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED STATEMENT OF STOCKHOLDERS</b>&#8217;<b> EQUITY</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(in thousands)</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-967" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-968" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Common Shares</b></p>
			</td>
			<td id="new_id-969" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-970" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-971" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Common Stock </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>and Additional </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Paid in Capital</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-972" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-973" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-974" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Accumulated </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Deficit</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-975" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-976" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-977" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Accumulated Other </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Comprehensive Loss</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-978" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-979" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-980" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Stockholders&#8217; </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Equity</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-981" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 35%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Balances as of April 1, 2021</b></p>
			</td>
			<td id="new_id-982" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-983" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-984" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" unitRef="shares">47,827</ix:nonFraction></b></td>
			<td id="new_id-985" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-986" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-987" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-988" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">109,720</ix:nonFraction></b></td>
			<td id="new_id-989" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-990" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-991" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-992" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">74,143</ix:nonFraction></b></td>
			<td id="new_id-993" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-994" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-995" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-996" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">2,774</ix:nonFraction></b></td>
			<td id="new_id-997" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>)</b></p>
			</td>
			<td id="new_id-998" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-999" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1000" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">32,803</ix:nonFraction></b></td>
			<td id="new_id-1001" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common stock-based compensation &amp; expenses, net</p>
			</td>
			<td id="new_id-1002" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1003" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1004" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" unitRef="shares">1,520</ix:nonFraction></td>
			<td id="new_id-1005" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1006" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1007" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1008" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd">2,197</ix:nonFraction></td>
			<td id="new_id-1009" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1010" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1011" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1012" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1013" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1014" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1015" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1016" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1017" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1018" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1019" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1020" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd">2,197</ix:nonFraction></td>
			<td id="new_id-1021" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net proceeds from issuance of common stock</p>
			</td>
			<td id="new_id-1022" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1023" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1024" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" unitRef="shares">1,750</ix:nonFraction></td>
			<td id="new_id-1025" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1026" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1027" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1028" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd">4,145</ix:nonFraction></td>
			<td id="new_id-1029" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1030" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1031" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1032" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1033" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1034" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1035" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1036" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1037" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1038" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1039" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1040" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd">4,145</ix:nonFraction></td>
			<td id="new_id-1041" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other adjustments</p>
			</td>
			<td id="new_id-1042" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1043" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1044" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" sign="-" unitRef="shares">43</ix:nonFraction></td>
			<td id="new_id-1045" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1046" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1047" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1048" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" sign="-" unitRef="usd">43</ix:nonFraction></td>
			<td id="new_id-1049" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1050" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1051" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1052" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1053" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1054" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1055" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1056" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1057" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1058" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1059" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1060" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" sign="-" unitRef="usd">43</ix:nonFraction></td>
			<td id="new_id-1061" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net loss</p>
			</td>
			<td id="new_id-1062" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1063" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1064" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1065" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1066" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1067" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1068" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1069" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1070" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1071" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1072" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">15,016</ix:nonFraction></td>
			<td id="new_id-1073" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1074" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1075" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1076" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1077" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1078" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1079" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1080" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">15,016</ix:nonFraction></td>
			<td id="new_id-1081" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Foreign currency translation adjustments</p>
			</td>
			<td id="new_id-1082" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1083" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1084" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-1085" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1086" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1087" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1088" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-1089" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1090" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1091" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1092" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-1093" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1094" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1095" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1096" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" sign="-" unitRef="usd">194</ix:nonFraction></td>
			<td id="new_id-1097" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1098" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1099" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1100" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" sign="-" unitRef="usd">194</ix:nonFraction></td>
			<td id="new_id-1101" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Balances as of March 31, 2022</b></p>
			</td>
			<td id="new_id-1102" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1103" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1104" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" unitRef="shares">51,054</ix:nonFraction></b></td>
			<td id="new_id-1105" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1106" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1107" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1108" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">116,019</ix:nonFraction></b></td>
			<td id="new_id-1109" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1110" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1111" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1112" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">89,159</ix:nonFraction></b></td>
			<td id="new_id-1113" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1114" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1115" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1116" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">2,968</ix:nonFraction></b></td>
			<td id="new_id-1117" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1118" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1119" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1120" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">23,892</ix:nonFraction></b></td>
			<td id="new_id-1121" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-1122">&#160;</td>
			<td id="new_id-1123">&#160;</td>
			<td id="new_id-1124">&#160;</td>
			<td id="new_id-1125">&#160;</td>
			<td id="new_id-1126">&#160;</td>
			<td id="new_id-1127">&#160;</td>
			<td id="new_id-1128">&#160;</td>
			<td id="new_id-1129">&#160;</td>
			<td id="new_id-1130">&#160;</td>
			<td id="new_id-1131">&#160;</td>
			<td id="new_id-1132">&#160;</td>
			<td id="new_id-1133">&#160;</td>
			<td id="new_id-1134">&#160;</td>
			<td id="new_id-1135">&#160;</td>
			<td id="new_id-1136">&#160;</td>
			<td id="new_id-1137">&#160;</td>
			<td id="new_id-1138">&#160;</td>
			<td id="new_id-1139">&#160;</td>
			<td id="new_id-1140">&#160;</td>
			<td id="new_id-1141">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-1142">&#160;</td>
			<td id="new_id-1143">&#160;</td>
			<td id="new_id-1144">&#160;</td>
			<td id="new_id-1145">&#160;</td>
			<td id="new_id-1146">&#160;</td>
			<td id="new_id-1147">&#160;</td>
			<td id="new_id-1148">&#160;</td>
			<td id="new_id-1149">&#160;</td>
			<td id="new_id-1150">&#160;</td>
			<td id="new_id-1151">&#160;</td>
			<td id="new_id-1152">&#160;</td>
			<td id="new_id-1153">&#160;</td>
			<td id="new_id-1154">&#160;</td>
			<td id="new_id-1155">&#160;</td>
			<td id="new_id-1156">&#160;</td>
			<td id="new_id-1157">&#160;</td>
			<td id="new_id-1158">&#160;</td>
			<td id="new_id-1159">&#160;</td>
			<td id="new_id-1160">&#160;</td>
			<td id="new_id-1161">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Balances as of April 1, 2022</b></p>
			</td>
			<td id="new_id-1162" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1163" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1164" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" unitRef="shares">51,054</ix:nonFraction></b></td>
			<td id="new_id-1165" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1166" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1167" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1168" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">116,019</ix:nonFraction></b></td>
			<td id="new_id-1169" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1170" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1171" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1172" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">89,159</ix:nonFraction></b></td>
			<td id="new_id-1173" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>)</b></p>
			</td>
			<td id="new_id-1174" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1175" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1176" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">2,968</ix:nonFraction></b></td>
			<td id="new_id-1177" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1178" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1179" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1180" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">23,892</ix:nonFraction></b></td>
			<td id="new_id-1181" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common stock-based compensation &amp; expenses, net</p>
			</td>
			<td id="new_id-1182" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1183" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1184" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" unitRef="shares">1,815</ix:nonFraction></td>
			<td id="new_id-1185" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1186" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1187" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1188" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd">2,843</ix:nonFraction></td>
			<td id="new_id-1189" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1190" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1191" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1192" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1193" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1194" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1195" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1196" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1197" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1198" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1199" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1200" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd">2,843</ix:nonFraction></td>
			<td id="new_id-1201" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net proceeds from issuance of common stock</p>
			</td>
			<td id="new_id-1202" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1203" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1204" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" unitRef="shares">208</ix:nonFraction></td>
			<td id="new_id-1205" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1206" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1207" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1208" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd">103</ix:nonFraction></td>
			<td id="new_id-1209" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1210" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1211" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1212" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1213" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1214" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1215" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1216" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1217" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1218" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1219" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1220" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd">103</ix:nonFraction></td>
			<td id="new_id-1221" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net loss</p>
			</td>
			<td id="new_id-1222" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1223" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1224" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1225" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1226" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1227" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1228" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1229" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1230" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1231" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1232" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">11,506</ix:nonFraction></td>
			<td id="new_id-1233" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1234" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1235" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1236" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1237" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1238" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1239" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1240" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">11,506</ix:nonFraction></td>
			<td id="new_id-1241" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Foreign currency translation adjustments</p>
			</td>
			<td id="new_id-1242" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1243" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1244" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-1245" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1246" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1247" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1248" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-1249" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1250" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1251" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1252" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-1253" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1254" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1255" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1256" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" sign="-" unitRef="usd">421</ix:nonFraction></td>
			<td id="new_id-1257" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1258" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1259" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1260" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" sign="-" unitRef="usd">421</ix:nonFraction></td>
			<td id="new_id-1261" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Balances as of March 31, 2023</b></p>
			</td>
			<td id="new_id-1262" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1263" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1264" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" unitRef="shares">53,077</ix:nonFraction></b></td>
			<td id="new_id-1265" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1266" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1267" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1268" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">118,965</ix:nonFraction></b></td>
			<td id="new_id-1269" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1270" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1271" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1272" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">100,665</ix:nonFraction></b></td>
			<td id="new_id-1273" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1274" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1275" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1276" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">3,389</ix:nonFraction></b></td>
			<td id="new_id-1277" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1278" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1279" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1280" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">14,911</ix:nonFraction></b></td>
			<td id="new_id-1281" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The accompanying notes should be read in connection with these consolidated financial statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">53</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="cf" title="cf"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IGC Pharma, Inc.</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(in thousands)</i></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1282" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1283" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Years Ended March 31,</b></p>
			</td>
			<td id="new_id-1284" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1285" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1286" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-1287" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1288" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1289" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-1290" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 70%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cash flows from operating activities:</b></p>
			</td>
			<td id="new_id-1291" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1292" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1293" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1294" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1295" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1296" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1297" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1298" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net loss</b></p>
			</td>
			<td id="new_id-1299" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1300" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1301" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd">11,506</ix:nonFraction></b></td>
			<td id="new_id-1302" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1303" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1304" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1305" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd">15,016</ix:nonFraction></b></td>
			<td id="new_id-1306" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>)</b></p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Adjustment to reconcile net loss to net cash:</i></p>
			</td>
			<td id="new_id-1307" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1308" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1309" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1310" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1311" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1312" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1313" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1314" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Depreciation and amortization</p>
			</td>
			<td id="new_id-1315" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1316" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1317" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" unitRef="usd">657</ix:nonFraction></td>
			<td id="new_id-1318" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1319" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1320" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1321" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" unitRef="usd">651</ix:nonFraction></td>
			<td id="new_id-1322" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Provision for bad debt</p>
			</td>
			<td id="new_id-1323" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1324" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1325" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" unitRef="usd">126</ix:nonFraction></td>
			<td id="new_id-1326" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1327" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1328" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1329" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" unitRef="usd">1,718</ix:nonFraction></td>
			<td id="new_id-1330" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permanent impairment of PPE</p>
			</td>
			<td id="new_id-1331" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1332" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1333" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetImpairmentCharges" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1334" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1335" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1336" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1337" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="3" unitRef="usd">833</ix:nonFraction></td>
			<td id="new_id-1338" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Impairment of non-marketable securities</p>
			</td>
			<td id="new_id-1339" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1340" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1341" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ImpairmentOfInvestments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1342" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1343" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1344" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1345" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfInvestments" scale="3" unitRef="usd">49</ix:nonFraction></td>
			<td id="new_id-1346" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common stock-based compensation and expenses, net</p>
			</td>
			<td id="new_id-1347" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1348" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1349" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd">2,843</ix:nonFraction></td>
			<td id="new_id-1350" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1351" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1352" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1353" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd">2,197</ix:nonFraction></td>
			<td id="new_id-1354" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net loss on sale of property, plant, and equipment</p>
			</td>
			<td id="new_id-1355" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1356" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1357" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" sign="-" unitRef="usd">39</ix:nonFraction></td>
			<td id="new_id-1358" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1359" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1360" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1361" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1362" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Forgiveness of PPP Loan</p>
			</td>
			<td id="new_id-1363" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1364" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1365" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1366" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1367" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1368" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1369" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" unitRef="usd">430</ix:nonFraction></td>
			<td id="new_id-1370" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-1371">&#160;</td>
			<td id="new_id-1372">&#160;</td>
			<td id="new_id-1373">&#160;</td>
			<td id="new_id-1374">&#160;</td>
			<td id="new_id-1375">&#160;</td>
			<td id="new_id-1376">&#160;</td>
			<td id="new_id-1377">&#160;</td>
			<td id="new_id-1378">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Changes in:</i></p>
			</td>
			<td id="new_id-1379" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1380" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1381" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1382" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1383" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1384" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1385" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-1386" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounts receivables, net</p>
			</td>
			<td id="new_id-1387" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1388" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1389" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd">5</ix:nonFraction></td>
			<td id="new_id-1390" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1391" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1392" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1393" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd">50</ix:nonFraction></td>
			<td id="new_id-1394" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inventory</p>
			</td>
			<td id="new_id-1395" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1396" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1397" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" sign="-" unitRef="usd">897</ix:nonFraction></td>
			<td id="new_id-1398" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1399" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1400" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1401" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" sign="-" unitRef="usd">1,930</ix:nonFraction></td>
			<td id="new_id-1402" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deposits and advances</p>
			</td>
			<td id="new_id-1403" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1404" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1405" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" sign="-" unitRef="usd">591</ix:nonFraction></td>
			<td id="new_id-1406" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1407" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1408" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1409" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" sign="-" unitRef="usd">541</ix:nonFraction></td>
			<td id="new_id-1410" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims and advances</p>
			</td>
			<td id="new_id-1411" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1412" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1413" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" unitRef="usd">150</ix:nonFraction></td>
			<td id="new_id-1414" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1415" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1416" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1417" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" unitRef="usd">334</ix:nonFraction></td>
			<td id="new_id-1418" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounts payable</p>
			</td>
			<td id="new_id-1419" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1420" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1421" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" sign="-" unitRef="usd">451</ix:nonFraction></td>
			<td id="new_id-1422" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1423" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1424" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1425" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd">504</ix:nonFraction></td>
			<td id="new_id-1426" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued and other liabilities</p>
			</td>
			<td id="new_id-1427" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1428" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1429" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd">88</ix:nonFraction></td>
			<td id="new_id-1430" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1431" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1432" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1433" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd">129</ix:nonFraction></td>
			<td id="new_id-1434" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-1435" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1436" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1437" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="igc:IncreaseDecreaseInOperatingLeaseAssets" scale="3" sign="-" unitRef="usd">124</ix:nonFraction></td>
			<td id="new_id-1438" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1439" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1440" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1441" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="igc:IncreaseDecreaseInOperatingLeaseAssets" scale="3" sign="-" unitRef="usd">38</ix:nonFraction></td>
			<td id="new_id-1442" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease liability</p>
			</td>
			<td id="new_id-1443" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1444" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1445" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" sign="-" unitRef="usd">134</ix:nonFraction></td>
			<td id="new_id-1446" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1447" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1448" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1449" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" sign="-" unitRef="usd">64</ix:nonFraction></td>
			<td id="new_id-1450" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net cash used in operating activities</b></p>
			</td>
			<td id="new_id-1451" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1452" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1453" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">7,047</ix:nonFraction></b></td>
			<td id="new_id-1454" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1455" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1456" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1457" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">7,462</ix:nonFraction></b></td>
			<td id="new_id-1458" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-1459">&#160;</td>
			<td id="new_id-1460">&#160;</td>
			<td id="new_id-1461">&#160;</td>
			<td id="new_id-1462">&#160;</td>
			<td id="new_id-1463">&#160;</td>
			<td id="new_id-1464">&#160;</td>
			<td id="new_id-1465">&#160;</td>
			<td id="new_id-1466">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cash flow from investing activities:</b></p>
			</td>
			<td id="new_id-1467" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1468" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1469" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1470" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1471" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1472" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1473" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1474" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Purchase of property, plant, and equipment</p>
			</td>
			<td id="new_id-1475" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1476" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1477" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">310</ix:nonFraction></td>
			<td id="new_id-1478" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1479" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1480" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1481" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">236</ix:nonFraction></td>
			<td id="new_id-1482" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sale of property, plant, and equipment</p>
			</td>
			<td id="new_id-1483" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1484" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1485" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" unitRef="usd">538</ix:nonFraction></td>
			<td id="new_id-1486" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1487" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1488" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1489" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" unitRef="usd">29</ix:nonFraction></td>
			<td id="new_id-1490" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment in short-term investments</p>
			</td>
			<td id="new_id-1491" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1492" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1493" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" unitRef="usd">154</ix:nonFraction></td>
			<td id="new_id-1494" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1495" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1496" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1497" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1498" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Acquisition and filing cost of patents and rights</p>
			</td>
			<td id="new_id-1499" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1500" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1501" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" unitRef="usd">309</ix:nonFraction></td>
			<td id="new_id-1502" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1503" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1504" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1505" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" unitRef="usd">535</ix:nonFraction></td>
			<td id="new_id-1506" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net cash used in investing activities</b></p>
			</td>
			<td id="new_id-1507" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1508" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1509" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">235</ix:nonFraction></b></td>
			<td id="new_id-1510" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1511" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1512" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1513" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">742</ix:nonFraction></b></td>
			<td id="new_id-1514" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-1515">&#160;</td>
			<td id="new_id-1516">&#160;</td>
			<td id="new_id-1517">&#160;</td>
			<td id="new_id-1518">&#160;</td>
			<td id="new_id-1519">&#160;</td>
			<td id="new_id-1520">&#160;</td>
			<td id="new_id-1521">&#160;</td>
			<td id="new_id-1522">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cash flows from financing activities:</b></p>
			</td>
			<td id="new_id-1523" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1524" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1525" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1526" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1527" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1528" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1529" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1530" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net proceeds from the issuance of common stock</p>
			</td>
			<td id="new_id-1531" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1532" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1533" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" unitRef="usd">103</ix:nonFraction></td>
			<td id="new_id-1534" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1535" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1536" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1537" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" unitRef="usd">4,145</ix:nonFraction></td>
			<td id="new_id-1538" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Repayment of long-term loan</p>
			</td>
			<td id="new_id-1539" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1540" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1541" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepaymentsOfDebt" scale="3" sign="-" unitRef="usd">3</ix:nonFraction></td>
			<td id="new_id-1542" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1543" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1544" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1545" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepaymentsOfDebt" scale="3" sign="-" unitRef="usd">3</ix:nonFraction></td>
			<td id="new_id-1546" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net cash provided by financing activities</b></p>
			</td>
			<td id="new_id-1547" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1548" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1549" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">100</ix:nonFraction></b></td>
			<td id="new_id-1550" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1551" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1552" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1553" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">4,142</ix:nonFraction></b></td>
			<td id="new_id-1554" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-1555">&#160;</td>
			<td id="new_id-1556">&#160;</td>
			<td id="new_id-1557">&#160;</td>
			<td id="new_id-1558">&#160;</td>
			<td id="new_id-1559">&#160;</td>
			<td id="new_id-1560">&#160;</td>
			<td id="new_id-1561">&#160;</td>
			<td id="new_id-1562">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Effects of exchange rate changes on cash and cash equivalents</p>
			</td>
			<td id="new_id-1563" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1564" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1565" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" sign="-" unitRef="usd">82</ix:nonFraction></td>
			<td id="new_id-1566" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-1567" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1568" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1569" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" sign="-" unitRef="usd">26</ix:nonFraction></td>
			<td id="new_id-1570" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net decrease in cash and cash equivalents</b></p>
			</td>
			<td id="new_id-1571" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1572" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1573" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd">7,264</ix:nonFraction></b></td>
			<td id="new_id-1574" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
			<td id="new_id-1575" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1576" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1577" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd">4,088</ix:nonFraction></b></td>
			<td id="new_id-1578" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"><b>)</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash and cash equivalents at the beginning of the period</p>
			</td>
			<td id="new_id-1579" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1580" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1581" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">10,460</ix:nonFraction></td>
			<td id="new_id-1582" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1583" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1584" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1585" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">14,548</ix:nonFraction></td>
			<td id="new_id-1586" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cash and cash equivalents at the end of the period</b></p>
			</td>
			<td id="new_id-1587" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1588" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1589" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">3,196</ix:nonFraction></b></td>
			<td id="new_id-1590" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1591" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1592" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1593" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">10,460</ix:nonFraction></b></td>
			<td id="new_id-1594" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-1595">&#160;</td>
			<td id="new_id-1596">&#160;</td>
			<td id="new_id-1597">&#160;</td>
			<td id="new_id-1598">&#160;</td>
			<td id="new_id-1599">&#160;</td>
			<td id="new_id-1600">&#160;</td>
			<td id="new_id-1601">&#160;</td>
			<td id="new_id-1602">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Supplementary information:</b></p>
			</td>
			<td id="new_id-1603" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1604" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1605" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1606" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1607" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1608" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1609" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1610" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-cash items:</b></p>
			</td>
			<td id="new_id-1611" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1612" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1613" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1614" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1615" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1616" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1617" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1618" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common stock issued/granted for stock-based compensation, including patent acquisition</p>
			</td>
			<td id="new_id-1619" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1620" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1621" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="3" unitRef="usd">2,842</ix:nonFraction></td>
			<td id="new_id-1622" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1623" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1624" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1625" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="3" unitRef="usd">2,197</ix:nonFraction></td>
			<td id="new_id-1626" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Forgiveness of PPP Loan</p>
			</td>
			<td id="new_id-1627" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1628" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1629" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:NotesReduction" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1630" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1631" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1632" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1633" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReduction" scale="3" unitRef="usd">430</ix:nonFraction></td>
			<td id="new_id-1634" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The accompanying notes should be read in connection with these consolidated financial statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">54</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="notes" title="notes"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IGC Pharma, Inc.</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>For Fiscal Years Ended March 31, 2023, and 2022</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless the context requires otherwise, all references in this report to &#8220;IGC,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refer to IGC Pharma, Inc., together with our subsidiaries.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_NatureOfOperations-c0_cont_1" escape="true" name="us-gaap:NatureOfOperations"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 1 </b>&#8211;<b> NATURE OF OPERATIONS AND MANAGEMENT</b>&#8217;<b>S PLANS </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Since 2014, our team has been committed to researching the application of cannabinoids such as THC and CBD in combination with other compounds to address various ailments, including Alzheimer&#8217;s disease. With our research, we have developed intellectual property, formulations, and wellness and lifestyle brands. IGC submitted IGC-AD1, our investigational drug candidate for Alzheimer&#8217;s, to the FDA under Section 505(i) of the Federal Food, Drug, and Cosmetic Act and received approval on July 30, 2020, to proceed with the Phase 1 trial on Alzheimer&#8217;s patients. The Company completed all dose escalation studies, and as announced by the Company on December 2, 2021, the results of the clinical trial have been submitted in the Clinical/Statistical Report (CSR) filed with the FDA. The Company is motivated by the potential that, with future successful results from appropriate further trials, IGC-AD1 could contribute to relief for some of the 55 million people around the world expected to be impacted by Alzheimer&#8217;s disease by 2030 (WHO, 2020). To the best of our knowledge, this is the first human clinical trial using ultra-low doses of THC, in combination with another molecule, to treat symptoms of dementia in Alzheimer&#8217;s patients. THC is a naturally occurring cannabinoid produced by the cannabis plant. It is known for being a psychoactive substance that can impact mental processes in a positive or negative way depending on the dosage. THC is biphasic, meaning that low and high doses of the substance may affect mental and physiological processes in substantially different ways. For example, in some patients, low doses may relieve a symptom, whereas high doses may amplify a symptom. Ultimately, the goal of IGC&#8217;s research is to discover and analyze whether, and at what level of dosing, IGC-AD1 provides relief of a given symptom. IGC&#8217;s trial is based on micro dosing on patients suffering from Alzheimer&#8217;s disease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has filed forty-one (41) patent applications to address various diseases such as Alzheimer&#8217;s, Central Nervous System (&#8220;CNS&#8221;) disorders, pain, stammering, seizures in cats and dogs, eating disorders, stress-relief, and calm-restoring beverage, and fatigue. As of March 31, 2023, our portfolio includes nine granted patents.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, we license a patent filing from the University of South Florida titled &#8220;Ultra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimer&#8217;s Disease.&#8221; The USPTO issued a patent (#11,065,225) for this filing on July 20, 2021.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, the Company had the following operating subsidiaries: Techni Bharathi Private Limited (TBL), IGCare LLC, Holi Hemp LLC, IGC Pharma LLC, SAN Holdings LLC, Sunday Seltzer, LLC, Hamsa Biopharma India Pvt. Ltd. And Colombia-based beneficially-owned subsidiary IGC Pharma SAS (formerly Hamsa Biopharma Colombia SAS) (Hamsa). The Company&#8217;s fiscal year is the 52- or 53-week period that ends on March 31. The Company&#8217; principal office is in Maryland established in 2005. Additionally, the Company have offices in Washington state, Colombia, South America, and India. The Company&#8217;s filings are available on www.sec.gov.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>IGC has two segments: Life Sciences and Infrastructure. </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Life Sciences Segment</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i><span style="text-decoration:underline">Pharmaceutical</span></i>: Since 2014, this part of our business has focused on the potential uses of phytocannabinoids, including THC and Cannabidiol (CBD), in combination with other compounds to treat multiple diseases, including Alzheimer&#8217;s. In addition, the Company has acquired and initiated work on TGR-63, a non-cannabinoid pre-clinical molecule, that exhibits an impressive affinity for reducing neurotoxicity in Alzheimer&#8217;s cell lines. Neurotoxicity causes cell dysfunction and death in Alzheimer&#8217;s disease. If shown to be efficacious, in AD cell lines, in halting this process, this inhibitor has the potential to treat Alzheimer&#8217;s disease by ameliorating A&#946; plaques.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i><span style="text-decoration:underline">Over the Counter Products</span></i>: We have created a women&#8217;s wellness brand, Holief&#8482; available through online channels that are compliant with relevant federal, state, and local laws, and regulations. Holief&#8482; is an all-natural, non-GMO, vegan, line of over the counter (OTC) products aimed at treating menstrual cramps (dysmenorrhea) and premenstrual symptoms (PMS). The products are available online and through Amazon and other online channels. Holief&#8482; is compliant with relevant federal, state, and local laws, and regulations.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">55</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation id="_NatureOfOperations-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Infrastructure Segment</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s infrastructure business has been operating since 2008, it includes: (i) Execution of Construction Contracts and (ii) Rental of Heavy Construction Equipment.</p></ix:continuation><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 2</b> &#8211;<b> SIGNIFICANT ACCOUNTING POLICIES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>a) <ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock">Principles of consolidation</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The consolidated financial statements include the accounts of the Company and all its subsidiaries. Intercompany accounts and transactions have been eliminated. In the opinion of the Company&#8217;s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Transactions between the Company and its subsidiaries are eliminated in the consolidated financial statements.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>b) <ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates">Use of estimates</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_UseOfEstimates-c0_cont_2" id="_UseOfEstimates-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_UseOfEstimates-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Management believes that the estimates and assumptions used in the preparation of the consolidated financial statements are prudent and reasonable. Significant estimates and assumptions are generally used for, but not limited to allowance for uncollectible accounts receivable; sales returns; normal loss during production; future obligations under employee benefit plans; the useful lives of property, plant, and equipment; intangible assets; valuations; impairment of goodwill and investments; recoverability of advances; the valuation of options granted, and warrants issued; and income tax and deferred tax valuation allowances, if any. Actual results could differ from those estimates. Appropriate changes in estimates are made as management becomes aware of changes in circumstances surrounding the estimates. Critical accounting estimates could change from period to period and could have a material impact on IGC&#8217;s results, operations, financial position, and cash flows. Changes in estimates are reflected in the financial statements in the period in which changes are made and, if material, their effects are disclosed in the notes to the consolidated financial statements.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>c) <ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock">Revenue recognition</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company recognizes revenue under ASC 606, <i>Revenue from Contracts with Customers </i>(&#8220;ASC 606&#8221;). The core principle of this standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">ASC 606 prescribes a 5-step process to achieve its core principle. The Company recognizes revenue from trading, rental, or product sales as follows:</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_4" id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">I. Identify the contract with the customer.</p></ix:continuation>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_5" id="_RevenueRecognitionPolicyTextBlock-c0_cont_4"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">II. Identify the contractual performance obligations.</p></ix:continuation>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_6" id="_RevenueRecognitionPolicyTextBlock-c0_cont_5"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">III. Determine the amount of consideration/price for the transaction.</p></ix:continuation>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_7" id="_RevenueRecognitionPolicyTextBlock-c0_cont_6"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IV. Allocate the determined amount of consideration/price to the contractual obligations.</p></ix:continuation>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_8" id="_RevenueRecognitionPolicyTextBlock-c0_cont_7"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">V. Recognize revenue when or as the performing party satisfies performance obligations.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_8"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The consideration/price for the transaction (performance obligation(s)) is determined as per the agreement or invoice (contract) for the services and products in the Infrastructure segment and Life Sciences segment. Refer to Note 17 &#8211; &#8220;Revenue Recognition.&#8221;</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>d) <ix:nonNumeric contextRef="c0" continuedAt="_CostOfSalesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock">Cost of Revenue</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_CostOfSalesPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our cost of revenue includes costs associated with in-house and outsourced distribution, labor expense, components, manufacturing overhead, and outbound freight for our products division. In our products division, cost of revenue also includes the cost of refurbishing or repackaging, if required, on products returned by customers that will be offered for resale.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">56</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>e) <ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock">Earnings/(Loss) per Share</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_2" id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The computation of basic loss per share for Fiscal 2023, excludes potentially dilutive securities of approximately shares which includes share options, unvested shares such as restricted shares and restricted share units, granted to employees, non-employees and advisors, and shares from the conversion of outstanding units, if any, because their inclusion would be anti-dilutive.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The weighted average number of shares outstanding for Fiscal 2023 and 2022, used for the computation of basic earnings per share (EPS) is <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">52,576,258</ix:nonFraction> and <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">49,991,631</ix:nonFraction>, respectively. Due to the loss incurred during Fiscal 2023 and 2022, all the potential equity shares are anti-dilutive, and accordingly, the fully diluted EPS is equal to the basic EPS.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>f) <ix:nonNumeric contextRef="c0" continuedAt="igc_GoingConcernPolicyPolicyTextblock-c0_cont_1" escape="true" name="igc:GoingConcernPolicyPolicyTextblock">Going Concern:</ix:nonNumeric></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="igc_GoingConcernPolicyPolicyTextblock-c0_cont_2" id="igc_GoingConcernPolicyPolicyTextblock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company assesses and determines its ability to continue as a going concern in accordance with the provisions of ASC Subtopic 205-40, "<i>Presentation of Financial Statements</i>&#8212;<i>Going Concern</i>", which requires the Company to evaluate whether there are conditions or events that raise substantial doubt about its ability to continue as a going concern.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="igc_GoingConcernPolicyPolicyTextblock-c0_cont_3" id="igc_GoingConcernPolicyPolicyTextblock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company is currently in a clinical trial stage and, thus, has not yet achieved profitability. The Company expects to continue to incur significant operating and net losses and negative cash flows from operations in the near future.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="igc_GoingConcernPolicyPolicyTextblock-c0_cont_4" id="igc_GoingConcernPolicyPolicyTextblock-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For the years ended March 31, 2023, and March 31, 2022, the Company incurred net losses of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" sign="-" unitRef="usd">11.5</ix:nonFraction> million and $<ix:nonFraction contextRef="c5" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" sign="-" unitRef="usd">15</ix:nonFraction> million, respectively. As of March 31, 2023, the Company&#8217;s cash and cash equivalents totaled $3.2 million. On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $<ix:nonFraction contextRef="c27" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" unitRef="usd">12</ix:nonFraction> million and, in addition, sold <ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">10,000,000</ix:nonFraction> shares for $<ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">3,000,000</ix:nonFraction>. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#8217;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions. Please refer to Note 19, &#8220;Subsequent Event,&#8221; for further information.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="igc_GoingConcernPolicyPolicyTextblock-c0_cont_4"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company estimates that its current cash and cash equivalents balance with working capital and equity investment is sufficient to support operations beyond the twelve months following the date these consolidated financial statements and footnotes were issued. These estimates are based on assumptions that may prove to be wrong, and the Company could use its available capital resources sooner than it currently expects.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>g) <ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock">Income taxes</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company accounts for income taxes under the asset and liability method, in accordance with ASC 740, Income Taxes, which requires an entity to recognize deferred tax liabilities and assets. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. A valuation allowance is established and recorded when management determines that some or all of the deferred tax assets are not likely to be realized and therefore, it is necessary to reduce deferred tax assets to the amount expected to be realized.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In evaluating a tax position for recognition, management evaluates whether it is more-likely-than-not that a position will be sustained upon examination, including resolution of related appeals or litigation processes, based on technical merits of the position. If the tax position meets the more-likely-than-not recognition threshold, the tax position is measured and recognized in the Company&#8217;s financial statements as the largest amount of tax benefit that, in management&#8217;s judgment, is greater than 50% likely of being realized upon settlement. As of March 31, 2023, and 2022, there was no significant liability for income tax associated with unrecognized tax benefits.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>h) <ix:nonNumeric contextRef="c0" continuedAt="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy">Accounts receivable</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:29pt;">We make estimates of the collectability of our accounts receivable by analyzing historical payment patterns, customer concentrations, customer creditworthiness, and current economic trends. If the financial condition of a customer deteriorates, additional allowances may be required. We had $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd">107</ix:nonFraction> thousand of accounts receivable, net of provision for doubtful debt of $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" unitRef="usd">17</ix:nonFraction> thousand as of March 31, 2023, as compared to $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd">125</ix:nonFraction> thousand of accounts receivable, net of provision for doubtful debt of $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" unitRef="usd">93</ix:nonFraction> thousand as of March 31, 2022.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">57</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>i) <ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock">Cash and cash equivalents</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For financial statement purposes, the Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents. The Company maintains its cash in bank accounts in the U.S., India, Colombia, and Hong Kong, which at times may exceed applicable insurance limits. The cash and cash equivalents in the Company on March 31, 2023, and 2022, were approximately $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">3,196</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">10,460</ix:nonFraction> thousand, respectively.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>j) <ix:nonNumeric contextRef="c0" continuedAt="_InvestmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentPolicyTextBlock">Short-term and long-term investments</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_2" id="_InvestmentPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our policy for short-term and long-term investments is to establish a high-quality portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations, and delivers an appropriate yield in relation to our investment guidelines and market conditions. Short-term and long-term investments consist of corporate, various government agencies and municipal debt securities, as well as certificates of deposit that have maturity dates that are greater than 90 days. Certificates of deposit and commercial paper are carried at a cost which approximates fair value. Available-for-sale securities: Investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the statement of financial position.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_3" id="_InvestmentPolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Investments are initially measured at cost, which is the fair value of the consideration given for them, including transaction costs. Where the Company&#8217;s ownership interest is in excess of 20% and the Company has a significant influence, the Company has accounted for the investment based on the equity method in accordance with ASC Topic 323, &#8220;<i>Investments </i>&#8211;<i> Equity method and Joint Ventures.</i>&#8221; Under the equity method, the Company&#8217;s share of the post-acquisition profits or losses of the equity investee is recognized in the consolidated statements of operations and its share of post-acquisition movements in accumulated other comprehensive income / (loss) is recognized in other comprehensive income / (loss). Where the Company does not have significant influence, the Company has accounted for the investment in accordance with ASC Topic 321, &#8220;<i>Investments-Equity Securities.</i>&#8221;</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_InvestmentPolicyTextBlock-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, investment in marketable securities is valued at fair value and investment in non-marketable securities with ownership less than 20% is valued at cost as per ASC Topic 321, &#8220;<i>Investments-Equity Securities.</i>&#8221;</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>k) <ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock">Property, plant, and equipment (PP&amp;E) </ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Property, plant, and equipment are recorded at cost net of accumulated depreciation and depreciated over their estimated useful lives using the straight-line method.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon retirement or disposition, cost and related accumulated depreciation of the Property, plant and equipment are de-recognized, and any gain or loss is reflected in the results of operation. Cost of additions and substantial improvements to property and equipment are capitalized. The cost of maintenance and repairs of the property and equipment are charged to operating expenses as incurred.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>l) <ix:nonNumeric contextRef="c0" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock">Fair value of financial instruments</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">ASC 820, &#8220;Fair Value Measurement&#8221; defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 1: Observable inputs such as quoted prices in active markets;</p></ix:continuation>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</p></ix:continuation>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The carrying amounts of the Company&#8217;s financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximately their fair values due to the nature of the items. Please refer to Note 15, &#8220;Fair value of financial instruments,&#8221; for further information.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">58</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>m) <ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk">Concentration of credit risk and significant customers</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Financial instruments, which potentially expose the Company to concentrations of credit risk, are primarily comprised of cash and cash equivalents, investments, accounts receivable and unbilled accounts receivable, if any. The Company places its cash investments in highly rated financial institutions. The Company adheres to a formal investment policy with the primary objective of preservation of principal, which contains credit rating minimums and diversification requirements. Management believes its credit policies reflect normal industry terms and business risk. The Company does not anticipate non-performance by the counterparties and, accordingly, does not require collateral. During Fiscal 2023, sales were spread across customers in Asia and U.S. and the credit concentration risk is low.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>n) <ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy">Stock </ix:nonNumeric></b><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1">&#8211;<b> Based Compensation</b></ix:continuation></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_3" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company accounts for stock-based compensation to employees and non-employees in conformity with the provisions of ASC Topic 718, &#8220;<i>Stock-Based Compensation.</i>&#8221; The Company expenses stock-based compensation to employees over the requisite vesting period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards are recognized on a straight-line basis over the requisite vesting period. For stock-based employee compensation the cost recognized at any date will be at least equal to the amount attributable to the share-based compensation that is vested at that date.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_4" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For performance-based awards, stock-based compensation expense is recognized over the expected performance achievement period of individual performance milestones when the achievement of each individual performance milestone becomes probable. For performance-based awards with a vesting schedule based entirely on the attainment of performance conditions, stock-based compensation expense associated with each tranche is recognized over the expected achievement period for the operational milestone, beginning at the point in time when the relevant operational milestone is considered probable to be achieved.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_5" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_4"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For market-based awards, stock-based compensation expense is recognized over the expected achievement period. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_5"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company estimates the fair value of stock option grants using the Black-Scholes option-pricing model. The assumptions used in calculating the fair value of stock-based awards represent Management&#8217;s best estimates. Generally, the closing share price of the Company&#8217;s common stock on the date of grant is considered the fair value of the share. The volatility factor is determined based on the Company&#8217;s historical stock prices. The expected term represents the period that our stock-based awards are expected to be outstanding. The Company has never declared or paid any cash dividends. For further information refer to Note 14, &#8220;Stock-Based Compensation&#8221; of Notes to Consolidated Financial Statements.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>o) <ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock">Commitments and contingencies</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Liabilities for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. We record associated legal fees as incurred. Information regarding our commitments and contingencies is incorporated by reference in Note 12, &#8220;Commitments and contingencies&#8221; of this Annual Report on Form 10-K.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>p) <ix:nonNumeric contextRef="c0" continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">Impairment of long </ix:nonNumeric></b><ix:continuation continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_2" id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1">&#8211;<b> lived assets</b></ix:continuation></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company reviews its long-lived assets, with finite lives, for impairment whenever events or changes in business circumstances indicate that the carrying amount of assets may not be fully recoverable. Such circumstances include, though are not limited to, significant or sustained declines in revenues or earnings, future anticipated cash flows, business plans, and material adverse changes in the economic climate, such as changes in the operating environment, competitive information, and impact of changes in government policies. For assets that the Company intends to hold for use, if the total of the expected future undiscounted cash flows produced by the assets or subsidiary company is less than the carrying amount of the assets, a loss is recognized for the difference between the fair value and carrying value of the assets. For assets, the Company intends to dispose of by sale, a loss is recognized for the amount by which the estimated fair value less cost to sell is less than the carrying value of the assets. Fair value is determined based on quoted market prices, if available, or other valuation techniques including discounted future net cash flows. Unlike goodwill, long-lived assets are assessed for impairment only where there are any specific indicators for impairment.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">59</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>q) <ix:nonNumeric contextRef="c0" continuedAt="_IntangibleAssetsFiniteLivedPolicy-c0_cont_1" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy">Intangible assets</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_IntangibleAssetsFiniteLivedPolicy-c0_cont_2" id="_IntangibleAssetsFiniteLivedPolicy-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s intangible assets are accounted for in accordance with ASC Topic 350, <i>Intangibles </i>&#8211;<i> Goodwill and Other. </i>Intangible assets having indefinite lives are not amortized, but instead are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We perform an impairment analysis on March 1 annually on the indefinite-lived intangible assets following the steps laid out in ASC 350-30-35-18. Our annual impairment analysis includes a qualitative assessment to determine if it is necessary to perform the quantitative impairment test. In performing a qualitative assessment, we review events and circumstances that could affect the significant inputs used to determine if the fair value is less than the carrying value of the intangible assets. If quantitative analysis is necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets will be tested on an interim basis if an event or circumstance indicates that it is more likely than not that an impairment loss has been incurred. The Company has analyzed a variety of factors in light of the known impact to date of the COVID-19 pandemic on its business to determine if a circumstance could trigger an impairment loss, and, at this time and based on the information presently known, does not believe it is more likely than not that an impairment loss has been incurred.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_IntangibleAssetsFiniteLivedPolicy-c0_cont_3" id="_IntangibleAssetsFiniteLivedPolicy-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Intangible assets with finite useful lives are amortized using the straight-line method over their estimated period of benefit. In accordance with ASC 360-10-35-21, definite lived intangibles are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_IntangibleAssetsFiniteLivedPolicy-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company intends to capitalize trademarks and related expenses exceeding $2,500 per trademark. Management may also capitalize trademarks and related expenses up to $2,500 per trademark based on its potential and benefit in coming years.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>r) <ix:nonNumeric contextRef="c0" continuedAt="_InventoryPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InventoryPolicyTextBlock">Inventory</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_2" id="_InventoryPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Inventory is valued at the lower of cost or net realizable value, which is defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_3" id="_InventoryPolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Inventory consists of finished goods related to wellness products, hand sanitizers, finished hemp-based products, beverages. Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to primary cost. Inventory is primarily accounted for using the weighted average cost method. Primary costs include raw materials, packaging, direct labor, overhead, shipping, and the depreciation of manufacturing equipment. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_4" id="_InventoryPolicyTextBlock-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We capitalize inventory costs related to our investigational drug, provided that management determines there is a potential alternative use for the inventory in future research and development projects or other purposes. As of March 31, 2023, and 2022, our consolidated balance sheet reported approximately $<ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" unitRef="usd">407</ix:nonFraction> thousand and <ix:nonFraction contextRef="c30" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InventoryNet" scale="3" unitRef="usd">no</ix:nonFraction> clinical trial-related inventory, respectively.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_5" id="_InventoryPolicyTextBlock-c0_cont_4"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Abnormal amounts of idle facility expense, freight, handling costs, scrap, discontinued products and wasted material (spoilage) are expensed in the period they are incurred.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_InventoryPolicyTextBlock-c0_cont_5"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Please refer to Note 3, &#8220;Inventory,&#8221; for further information.</p></ix:continuation>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>s) <ix:nonNumeric contextRef="c0" continuedAt="igc_CybersecurityPolicyPolicyTextBlock-c0_cont_1" escape="true" name="igc:CybersecurityPolicyPolicyTextBlock">Cybersecurity</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="igc_CybersecurityPolicyPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have a cybersecurity policy in place and tighter cybersecurity measures to safeguard against hackers. In Fiscal 2023, there were no impactful breaches in cybersecurity.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>t) <ix:nonNumeric contextRef="c0" continuedAt="_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">Research and Development Expenses</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During Fiscal 2023 and 2022, the Company recorded research and development expenses of approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitRef="usd">3.5</ix:nonFraction> million and $<ix:nonFraction contextRef="c5" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" unitRef="usd">2.3</ix:nonFraction> million, respectively. All research and development costs are expensed in the period in which they are incurred.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">60</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>u) <ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock">Leases</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_2" id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Lessor Accounting</i></p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_3" id="_LesseeLeasesPolicyTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the current ASU guidance, contract consideration will be allocated to its lease components and non-lease components (such as maintenance). For the Company as a lessor, any non-lease components will be accounted for under ASC Topic 606, &#8220;<i>Revenue from Contracts with Customers,</i>&#8221; unless the Company elects a lessor practical expedient to not separate the non-lease components from the associated lease component. The amendments in ASU 2018-11 also provide lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component if the non-lease components otherwise would be accounted for under the new revenue guidance (Topic 606). To elect the practical expedient, the timing and pattern of transfer of the lease and non-lease components must be the same and the lease component must meet the criteria to be classified as an operating lease if accounted for separately. If these criteria are met, the single component will be accounted for under either Topic 842 or Topic 606 depending on which component(s) are predominant. The lessor practical expedient to not separate non-lease components from the associated component must be elected for all existing and new leases.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_4" id="_LesseeLeasesPolicyTextBlock-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As a lessor, the Company expects that post-adoption substantially all existing leases will have no change in the timing of revenue recognition until their expiration or termination. The Company expects to elect the lessor practical expedient to not separate non-lease components such as maintenance from the associated lease for all existing and new leases and to account for the combined component as a single lease component. The timing of revenue recognition is expected to be the same for the majority of the Company&#8217;s new leases as compared to similar existing leases; however, certain categories of new leases could have different revenue recognition patterns as compared to similar existing leases.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_5" id="_LesseeLeasesPolicyTextBlock-c0_cont_4"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For leases that are accounted for as operating leases, income is recognized on a straight-line basis over the term of the lease contract. Generally, when a lease is more than 180 days delinquent (where more than three monthly payments are owed), the lease is classified as being nonaccrual and the Company stops recognizing leasing income on that date. Payments received on leases in nonaccrual status generally reduce the lease receivable. Leases on nonaccrual status remain classified as such until there is sustained payment performance that, in the Company&#8217;s judgment, would indicate that all contractual amounts will be collected in full.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_6" id="_LesseeLeasesPolicyTextBlock-c0_cont_5"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Lessee Accounting</i></p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_7" id="_LesseeLeasesPolicyTextBlock-c0_cont_6"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company adopted ASU 2016-02 effective April 1, 2019, using the modified retrospective approach. The standard establishes a right-of-use model (ROU) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. In connection with the adoption, the Company will elect to utilize the modified retrospective presentation whereby the Company will continue to present prior period financial statements and disclosures under ASC Topic 840. In addition, the Company will elect the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and initial direct costs. Further, the Company will adopt a short-term lease exception policy, permitting us to not apply the recognition requirements of this standard to short-term leases (i.e., leases with terms of 12 months or less), and an accounting policy to account for lease and non-lease components as a single component for certain classes of assets.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_8" id="_LesseeLeasesPolicyTextBlock-c0_cont_7"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under ASU 2016-02 (Topic 842), lessees are required to recognize the following for all leases (with the exception of short-term leases) on the commencement date: (i) lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and (ii) right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_9" id="_LesseeLeasesPolicyTextBlock-c0_cont_8"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At the commencement date, the Company recognizes the lease liability at the present value of the lease payments not yet paid, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate for the same term as the underlying lease. The right-of-use asset is recognized initially at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. There was no impairment for right-of-use lease assets as of March 31, 2023.</p></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_9"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company categorizes leases at their inception as either operating or finance leases. On certain lease agreements, the Company may receive rent holidays and other incentives. The Company recognizes lease costs on a straight-line basis without regard to deferred payment terms, such as rent holidays, that defer the commencement date of required payments. Please refer to Note 9, &#8220;Leases,&#8221; for further information.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">61</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>v) <ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock">Recently issued and adopted accounting pronouncements</ix:nonNumeric></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Changes to U.S. GAAP are established by the Financial Accounting Standards Board (&#8220;FASB&#8221;) in the form of accounting standards updates (ASUs) to the FASB&#8217;s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Newly issued ASUs not listed are expected to have no impact on the Company&#8217;s consolidated financial position and results of operations, because either the ASU is not applicable, or the impact is expected to be immaterial.</p></ix:continuation></ix:continuation><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 3 </b>&#8211;<b> INVENTORY</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1635" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1636" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1637" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1638" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1639" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1640" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1641" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1642" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1643" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Raw materials</p>
			</td>
			<td id="new_id-1644" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1645" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1646" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterials" scale="3" unitRef="usd">2,100</ix:nonFraction></td>
			<td id="new_id-1647" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1648" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1649" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1650" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterials" scale="3" unitRef="usd">2,247</ix:nonFraction></td>
			<td id="new_id-1651" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Work-in-progress</p>
			</td>
			<td id="new_id-1652" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1653" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1654" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcess" scale="3" unitRef="usd">18</ix:nonFraction></td>
			<td id="new_id-1655" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1656" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1657" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1658" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcess" scale="3" unitRef="usd">584</ix:nonFraction></td>
			<td id="new_id-1659" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Finished goods</p>
			</td>
			<td id="new_id-1660" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1661" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1662" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoods" scale="3" unitRef="usd">533</ix:nonFraction></td>
			<td id="new_id-1663" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1664" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1665" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1666" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoods" scale="3" unitRef="usd">717</ix:nonFraction></td>
			<td id="new_id-1667" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1668" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1669" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1670" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" unitRef="usd">2,651</ix:nonFraction></b></td>
			<td id="new_id-1671" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1672" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1673" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1674" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" unitRef="usd">3,548</ix:nonFraction></b></td>
			<td id="new_id-1675" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:nonNumeric>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to gummies, tincture, and hemp derivatives. Finished goods comprise, but is not limited to, hand sanitizers, gummies, lotions, and beverages, among others.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During Fiscal 2023, the Company charged $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWriteDown" scale="3" unitRef="usd">376</ix:nonFraction> thousand of inventory in selling, general and administration due to product expiration, handling costs, scrap, and wasted material (spoilage) as compared to approximately $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWriteDown" scale="3" unitRef="usd">252</ix:nonFraction> thousand for Fiscal 2022. This charge was recorded in Selling, general, and administrative expenses.</p></ix:nonNumeric><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="igc:DepositsAndAdvancesTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTE 4 </b>&#8211;<b> DEPOSITS AND ADVANCES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1676" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1677" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1678" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1679" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1680" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1681" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1682" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1683" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1684" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Advances to suppliers and consultants</p>
			</td>
			<td id="new_id-1685" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1686" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1687" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" unitRef="usd">72</ix:nonFraction></td>
			<td id="new_id-1688" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1689" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1690" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1691" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" unitRef="usd">170</ix:nonFraction></td>
			<td id="new_id-1692" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other receivables and deposits</p>
			</td>
			<td id="new_id-1693" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1694" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1695" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherInventoryNetOfReserves" scale="3" unitRef="usd">24</ix:nonFraction></td>
			<td id="new_id-1696" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1697" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1698" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1699" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherInventoryNetOfReserves" scale="3" unitRef="usd">472</ix:nonFraction></td>
			<td id="new_id-1700" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Prepaid expense and other current assets</p>
			</td>
			<td id="new_id-1701" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1702" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1703" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">262</ix:nonFraction></td>
			<td id="new_id-1704" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1705" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1706" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1707" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">336</ix:nonFraction></td>
			<td id="new_id-1708" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1709" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1710" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1711" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd">358</ix:nonFraction></b></td>
			<td id="new_id-1712" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1713" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1714" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1715" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd">978</ix:nonFraction></b></td>
			<td id="new_id-1716" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:nonNumeric>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Advances to suppliers and consultants primarily relate to advances to suppliers in our Life Sciences and Infrastructure segment. Prepaid and other current assets include approximately $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="igc:StatutoryAdvances" scale="3" unitRef="usd">25</ix:nonFraction> thousand in statutory advances for Fiscal 2023, as compared to $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="igc:StatutoryAdvances" scale="3" unitRef="usd">170</ix:nonFraction> thousand in Fiscal 2022. The Company decided to move advances paid to suppliers worth approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="igc:TransferFromDepositsAndAdvancesToClaimsAndAdvances" scale="3" unitRef="usd">164</ix:nonFraction> thousand to claims and advances, considering recovering might take more than 12 months.</p></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 5 </b>&#8211;<b> INTANGIBLE ASSETS </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Amortized intangible assets</i></b></p>
			</td>
			<td id="new_id-1717" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1718" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1719" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1720" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1721" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1722" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1723" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1724" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1725" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patents</p>
			</td>
			<td id="new_id-1726" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1727" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1728" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" unitRef="usd">709</ix:nonFraction></td>
			<td id="new_id-1729" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1730" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1731" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1732" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" unitRef="usd">290</ix:nonFraction></td>
			<td id="new_id-1733" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other intangibles</p>
			</td>
			<td id="new_id-1734" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1735" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1736" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" unitRef="usd">34</ix:nonFraction></td>
			<td id="new_id-1737" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1738" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1739" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1740" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" unitRef="usd">32</ix:nonFraction></td>
			<td id="new_id-1741" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated amortization</p>
			</td>
			<td id="new_id-1742" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1743" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1744" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" unitRef="usd">107</ix:nonFraction></td>
			<td id="new_id-1745" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1746" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1747" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1748" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" unitRef="usd">51</ix:nonFraction></td>
			<td id="new_id-1749" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total amortized intangible assets</b></p>
			</td>
			<td id="new_id-1750" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1751" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1752" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" unitRef="usd">636</ix:nonFraction></b></td>
			<td id="new_id-1753" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1754" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1755" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1756" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" unitRef="usd">271</ix:nonFraction></b></td>
			<td id="new_id-1757" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-1758">&#160;</td>
			<td id="new_id-1759">&#160;</td>
			<td id="new_id-1760">&#160;</td>
			<td id="new_id-1761">&#160;</td>
			<td id="new_id-1762">&#160;</td>
			<td id="new_id-1763">&#160;</td>
			<td id="new_id-1764">&#160;</td>
			<td id="new_id-1765">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Unamortized intangible assets</i></b></p>
			</td>
			<td id="new_id-1766" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1767" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1768" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1769" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1770" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1771" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1772" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1773" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i><b>&#160;</b></i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patents</p>
			</td>
			<td id="new_id-1774" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1775" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1776" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c35" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd">534</ix:nonFraction></td>
			<td id="new_id-1777" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1778" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1779" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1780" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c36" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd">646</ix:nonFraction></td>
			<td id="new_id-1781" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other intangibles</p>
			</td>
			<td id="new_id-1782" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1783" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1784" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c37" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1785" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1786" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1787" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1788" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c38" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1789" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total unamortized intangible assets</b></p>
			</td>
			<td id="new_id-1790" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1791" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1792" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd">534</ix:nonFraction></td>
			<td id="new_id-1793" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1794" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1795" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1796" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd">646</ix:nonFraction></td>
			<td id="new_id-1797" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total intangible assets</b></p>
			</td>
			<td id="new_id-1798" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1799" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1800" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">1,170</ix:nonFraction></b></td>
			<td id="new_id-1801" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1802" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1803" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1804" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">917</ix:nonFraction></b></td>
			<td id="new_id-1805" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric></ix:nonNumeric><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">62</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The value of intangible assets includes the cost of acquiring patent rights, supporting data, and the expense associated with filing of <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="igc:NumberOfPatents" scale="0" unitRef="pure">forty-one</ix:nonFraction> (41) patent applications in different countries along with <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="igc:NumberOfPatentsGranted" scale="0" unitRef="pure">nine</ix:nonFraction> (9) granted patents. It also includes acquisition costs related to domains, and licenses.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The amortization of patent and patent rights with finite life is up to <ix:nonNumeric contextRef="c31" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric> years, commencing from the date of grant or acquisition. The amortization expense in Fiscal 2023 and 2022 amounted to approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" unitRef="usd">57</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" unitRef="usd">24</ix:nonFraction> thousand, respectively.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company regularly reviews its intangible assets to determine if any intangible asset is other-than-temporarily impaired, which would require the Company to record an impairment charge in the period and concluded that, as of March 31, 2023, there was no impairment.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;">

		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Estimated amortization expense</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>(in thousands) </i></b></p>

			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>($)</i></b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2024</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" unitRef="usd">62</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2025</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" unitRef="usd">69</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2026</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" unitRef="usd">75</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2027</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" unitRef="usd">83</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2028</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" unitRef="usd">91</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>

</table></ix:nonNumeric></ix:continuation><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 6 </b>&#8211;<b> PROPERTY, PLANT, AND EQUIPMENT</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c41" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1806" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="9" id="new_id-1807" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands, except useful life)</i></b></i></p>
			</td>
			<td id="new_id-1808" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1809" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="1" id="new_id-1810" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; vertical-align: top;"><b>Useful Life (years)</b></p>
			</td>
			<td id="new_id-1811" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1812" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1813" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1814" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1815" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1816" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1817" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Land</p>
			</td>
			<td id="new_id-1818" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1819" style="width: 12%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; text-align: center;"><ix:nonNumeric contextRef="c42" name="igc:PropertyPlantAndEquipmentEstimatedUsefulLives1">N/A</ix:nonNumeric></td>
			<td id="new_id-1820" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1821" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1822" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1823" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">4,100</ix:nonFraction></td>
			<td id="new_id-1824" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1825" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1826" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1827" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">4,438</ix:nonFraction></td>
			<td id="new_id-1828" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Buildings and facilities</p>
			</td>
			<td id="new_id-1829" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1830" style="width: 12%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; text-align: center;"><ix:nonNumeric contextRef="c45" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">25</ix:nonNumeric></td>
			<td id="new_id-1831" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1832" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1833" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1834" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">2,298</ix:nonFraction></td>
			<td id="new_id-1835" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1836" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1837" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1838" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c46" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">2,810</ix:nonFraction></td>
			<td id="new_id-1839" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plant and machinery</p>
			</td>
			<td id="new_id-1840" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1841" style="width: 12%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; text-align: center;"><ix:nonNumeric contextRef="c47" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric>-<ix:nonNumeric contextRef="c48" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">20</ix:nonNumeric></td>
			<td id="new_id-1842" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1843" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1844" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1845" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">3,335</ix:nonFraction></td>
			<td id="new_id-1846" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1847" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1848" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1849" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">4,593</ix:nonFraction></td>
			<td id="new_id-1850" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Computer equipment&#8217;s</p>
			</td>
			<td id="new_id-1851" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1852" style="width: 12%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; text-align: center;"><ix:nonNumeric contextRef="c51" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></td>
			<td id="new_id-1853" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1854" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1855" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1856" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c51" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">138</ix:nonFraction></td>
			<td id="new_id-1857" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1858" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1859" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1860" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">241</ix:nonFraction></td>
			<td id="new_id-1861" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Office equipment&#8217;s</p>
			</td>
			<td id="new_id-1862" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1863" style="width: 12%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; text-align: center;"><ix:nonNumeric contextRef="c53" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c54" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></td>
			<td id="new_id-1864" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1865" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1866" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1867" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">84</ix:nonFraction></td>
			<td id="new_id-1868" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1869" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1870" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1871" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">145</ix:nonFraction></td>
			<td id="new_id-1872" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Furniture and fixtures</p>
			</td>
			<td id="new_id-1873" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1874" style="width: 12%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; text-align: center;"><ix:nonNumeric contextRef="c57" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></td>
			<td id="new_id-1875" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1876" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1877" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1878" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">92</ix:nonFraction></td>
			<td id="new_id-1879" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1880" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1881" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1882" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">141</ix:nonFraction></td>
			<td id="new_id-1883" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vehicles</p>
			</td>
			<td id="new_id-1884" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1885" style="width: 12%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; text-align: center;"><ix:nonNumeric contextRef="c59" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></td>
			<td id="new_id-1886" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1887" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1888" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1889" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">102</ix:nonFraction></td>
			<td id="new_id-1890" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1891" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1892" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1893" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">163</ix:nonFraction></td>
			<td id="new_id-1894" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction in progress</p>
			</td>
			<td id="new_id-1895" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1896" style="width: 12%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; text-align: center;"><ix:nonNumeric contextRef="c61" name="igc:PropertyPlantAndEquipmentEstimatedUsefulLives1">N/A</ix:nonNumeric></td>
			<td id="new_id-1897" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1898" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1899" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1900" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1901" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1902" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1903" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1904" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c62" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">108</ix:nonFraction></td>
			<td id="new_id-1905" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total gross value</b></p>
			</td>
			<td id="new_id-1906" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1907" style="text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1908" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1909" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1910" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1911" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">10,149</ix:nonFraction></b></td>
			<td id="new_id-1912" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1913" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1914" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1915" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">12,639</ix:nonFraction></b></td>
			<td id="new_id-1916" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: Accumulated depreciation</p>
			</td>
			<td id="new_id-1917" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1918" style="text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1919" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1920" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1921" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1922" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">1,936</ix:nonFraction></td>
			<td id="new_id-1923" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1924" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1925" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1926" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">3,220</ix:nonFraction></td>
			<td id="new_id-1927" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total property, plant and equipment, net</b></p>
			</td>
			<td id="new_id-1928" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1929" style="text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1930" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1931" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1932" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1933" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">8,213</ix:nonFraction></b></td>
			<td id="new_id-1934" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1935" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1936" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1937" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">9,419</ix:nonFraction></b></td>
			<td id="new_id-1938" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:nonNumeric>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The depreciation expense in Fiscal 2023 and 2022 amounted to approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd">600</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd">627</ix:nonFraction> thousand, respectively. The net decrease in total property, plant, and equipment (net) is primarily due to depreciation and foreign exchange translations because of a decrease in value of foreign currencies. In addition, Fiscal 2023, the Company disposed of fully depreciated assets in the amount of approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentDisposals" scale="6" unitRef="usd">1.6</ix:nonFraction> million from its subsidiaries. This resulted in a reduction in the value of total gross assets but did not affect the net value of assets as the disposed assets had previously been fully depreciated. The Company sold a property in Puerto Rico for net proceeds of approximately $<ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" unitRef="usd">485</ix:nonFraction> thousand (acquired for approximately $<ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentOwnedGross" scale="3" unitRef="usd">480</ix:nonFraction> thousand) and accounted for a profit of approximately $<ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" unitRef="usd">5</ix:nonFraction> thousand in other income. For more information, please refer to Note 18, &#8220;Segment Information&#8221; for the non-current assets other than financial instruments held in the country of domicile and foreign countries.</p></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 7 </b>&#8211;<b> LEFT BLANK INTENTIONALLY</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">63</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:OtherAssetsDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTE 8 </b>&#8211;<b> CLAIMS AND ADVANCES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfOtherAssetsNoncurrentTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1939" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1940" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1941" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1942" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1943" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1944" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1945" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1946" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1947" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims receivable (1)</p>
			</td>
			<td id="new_id-1948" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1949" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1950" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:OtherReceivables" scale="3" unitRef="usd">951</ix:nonFraction></td>
			<td id="new_id-1951" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1952" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1953" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1954" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:OtherReceivables" scale="3" unitRef="usd">368</ix:nonFraction></td>
			<td id="new_id-1955" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-current deposits</p>
			</td>
			<td id="new_id-1956" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1957" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1958" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositsAssetsNoncurrent" scale="3" unitRef="usd">27</ix:nonFraction></td>
			<td id="new_id-1959" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1960" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1961" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1962" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DepositsAssetsNoncurrent" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-1963" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-current advances</p>
			</td>
			<td id="new_id-1964" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1965" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1966" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="igc:OtherAdvances" scale="3" unitRef="usd">25</ix:nonFraction></td>
			<td id="new_id-1967" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1968" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1969" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1970" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="igc:OtherAdvances" scale="3" unitRef="usd">569</ix:nonFraction></td>
			<td id="new_id-1971" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1972" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1973" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1974" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">1,003</ix:nonFraction></b></td>
			<td id="new_id-1975" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1976" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1977" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1978" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">937</ix:nonFraction></b></td>
			<td id="new_id-1979" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:nonNumeric>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ScheduleOfOtherAssetsNoncurrentTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:2.3%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>	</td>	<td style="vertical-align:top;width:43.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:footnote id="ix_0_footnote" xml:lang="en-US">The claims receivable is due from different vendors. While the Company has initiated collection proceedings internally or with the appropriate authorities, it believes receiving the amount in the next 12 months will be challenging because of the time required for collection proceedings. The Company decided to move advances paid to some suppliers worth approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="igc:TransferFromDepositsAndAdvancesToClaimsAndAdvances" scale="3" unitRef="usd">164</ix:nonFraction> thousand to claims and advances, considering recovering might take more than 12 months. Includes $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForDeposits" scale="0" unitRef="usd">140</ix:nonFraction> thousand owed to one of our manufacturers for the equipment purchase.</ix:footnote></p>	</td>	</tr>
</table></ix:continuation></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 9 </b>&#8211;<b> LEASES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has short-term leases primarily consisting of spaces with the remaining lease term being less than or equal to 12 months. The total short- term lease expense and cash paid for Fiscal 2023 and 2022 are approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermLeaseCost" scale="3" unitRef="usd">178</ix:nonFraction> thousand. The Company also has four operating leases as of March 31, 2023.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>America</i></b>: In November 2019, the Company entered into a lease agreement with a lease term of less than 12 months. This lease was amended in March 2020, with a new lease term from March 1, 2020, to November 30, 2025. The annual lease expense is approximately $<ix:nonFraction contextRef="c63" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" unitRef="usd">123</ix:nonFraction> thousand. The lease contract does not contain any material residual value guarantees or material restrictive covenants. The remaining lease term for the operating lease is <ix:nonNumeric contextRef="c64" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.7</ix:nonNumeric> years with a discount rate of <ix:nonFraction contextRef="c64" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" unitRef="pure">7</ix:nonFraction>%. The lease does not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Asia</i></b>: The Company renewed three lease agreements for terms between three to four years, expiring between 2023 and 2024. The total annual lease expense is approximately $<ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" unitRef="usd">25</ix:nonFraction> thousand. The lease contracts do not contain any material residual value guarantees or material restrictive covenants. The remaining lease term for the operating leases is between <ix:nonNumeric contextRef="c66" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm">1</ix:nonNumeric> - <ix:nonNumeric contextRef="c67" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm">1.7</ix:nonNumeric> years with a discount rate of <ix:nonFraction contextRef="c68" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" unitRef="pure">7</ix:nonFraction>%. The lease does not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_LeaseCostTableTextBlock-c0_cont_1" escape="true" name="us-gaap:LeaseCostTableTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1980" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1981" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1982" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1983" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1984" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1985" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease costs</p>
			</td>
			<td id="new_id-1986" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1987" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1988" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" unitRef="usd">148</ix:nonFraction></td>
			<td id="new_id-1989" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1990" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1991" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1992" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" unitRef="usd">149</ix:nonFraction></td>
			<td id="new_id-1993" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Short term lease costs</p>
			</td>
			<td id="new_id-1994" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1995" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1996" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermLeaseCost" scale="3" unitRef="usd">178</ix:nonFraction></td>
			<td id="new_id-1997" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1998" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1999" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2000" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermLeaseCost" scale="3" unitRef="usd">178</ix:nonFraction></td>
			<td id="new_id-2001" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease costs</b></p>
			</td>
			<td id="new_id-2002" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2003" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2004" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd">326</ix:nonFraction></b></td>
			<td id="new_id-2005" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2006" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2007" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2008" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd">327</ix:nonFraction></b></td>
			<td id="new_id-2009" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric></ix:nonNumeric><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">64</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation id="_LesseeOperatingLeasesTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Right of use assets and lease liabilities for our operating leases were recorded in the consolidated balance sheet as follows:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_LeaseCostTableTextBlock-c0_cont_2" id="_LeaseCostTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2010" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2011" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2012" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2013" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2014" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2015" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2016" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2017" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2018" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2019" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2020" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2021" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Assets</b></p>
			</td>
			<td id="new_id-2022" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2023" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2024" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2025" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2026" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2027" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2028" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2029" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-2030" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2031" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2032" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">326</ix:nonFraction></td>
			<td id="new_id-2033" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2034" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2035" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2036" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">450</ix:nonFraction></td>
			<td id="new_id-2037" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease assets </b></p>
			</td>
			<td id="new_id-2038" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2039" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2040" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">326</ix:nonFraction></b></td>
			<td id="new_id-2041" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2042" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2043" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2044" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">450</ix:nonFraction></b></td>
			<td id="new_id-2045" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2046">&#160;</td>
			<td id="new_id-2047">&#160;</td>
			<td id="new_id-2048">&#160;</td>
			<td id="new_id-2049">&#160;</td>
			<td id="new_id-2050">&#160;</td>
			<td id="new_id-2051">&#160;</td>
			<td id="new_id-2052">&#160;</td>
			<td id="new_id-2053">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Liabilities</b></p>
			</td>
			<td id="new_id-2054" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2055" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2056" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2057" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2058" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2059" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2060" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2061" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Current liabilities:</p>
			</td>
			<td id="new_id-2062" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2063" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2064" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2065" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2066" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2067" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2068" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2069" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued liabilities and others (current portion &#8211; operating lease liability)</p>
			</td>
			<td id="new_id-2070" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2071" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2072" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd">133</ix:nonFraction></td>
			<td id="new_id-2073" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2074" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2075" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2076" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd">123</ix:nonFraction></td>
			<td id="new_id-2077" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Noncurrent liabilities:</p>
			</td>
			<td id="new_id-2078" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2079" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2080" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2081" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2082" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2083" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2084" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2085" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease liability (non-current portion &#8211; operating lease liability)</p>
			</td>
			<td id="new_id-2086" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2087" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2088" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd">207</ix:nonFraction></td>
			<td id="new_id-2089" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2090" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2091" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2092" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd">341</ix:nonFraction></td>
			<td id="new_id-2093" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease liability </b></p>
			</td>
			<td id="new_id-2094" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2095" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2096" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd">340</ix:nonFraction></b></td>
			<td id="new_id-2097" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2098" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2099" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2100" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd">464</ix:nonFraction></b></td>
			<td id="new_id-2101" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_LeaseCostTableTextBlock-c0_cont_2"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Supplemental cash flow and non-cash information related to leases is as follows:</p>
			</td>
			<td id="new_id-2102" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2103" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2104" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2105" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2106" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2107" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash paid for amounts included in the measurement of lease liabilities</p>
			</td>
			<td id="new_id-2108" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2109" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2110" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2111" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2112" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2113" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2114" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2115" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8211;Operating cash flows from operating leases</p>
			</td>
			<td id="new_id-2116" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2117" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2118" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd">118</ix:nonFraction></td>
			<td id="new_id-2119" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2120" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2121" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2122" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd">109</ix:nonFraction></td>
			<td id="new_id-2123" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Right-of-use assets obtained in exchange for operating lease obligations</p>
			</td>
			<td id="new_id-2124" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2125" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2126" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" unitRef="usd">326</ix:nonFraction></td>
			<td id="new_id-2127" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2128" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2129" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2130" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" unitRef="usd">450</ix:nonFraction></td>
			<td id="new_id-2131" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td colspan="4" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">As of March 31, 2023, the following table summarizes the maturity of our lease liabilities:</p>
			</td>
			<td id="new_id-2132" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2133">&#160;</td>
			<td id="new_id-2134">&#160;</td>
			<td id="new_id-2135">&#160;</td>
			<td id="new_id-2136">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 81%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-24</p>
			</td>
			<td id="new_id-2137" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2138" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2139" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd">151</ix:nonFraction></td>
			<td id="new_id-2140" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-25</p>
			</td>
			<td id="new_id-2141" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2142" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2143" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" unitRef="usd">133</ix:nonFraction></td>
			<td id="new_id-2144" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-26</p>
			</td>
			<td id="new_id-2145" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2146" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2147" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" unitRef="usd">87</ix:nonFraction></td>
			<td id="new_id-2148" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-27</p>
			</td>
			<td id="new_id-2149" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2150" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2151" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2152" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: Present value discount</p>
			</td>
			<td id="new_id-2153" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2154" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2155" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" unitRef="usd">31</ix:nonFraction></td>
			<td id="new_id-2156" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total Lease liabilities</b></p>
			</td>
			<td id="new_id-2157" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2158" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2159" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" unitRef="usd">340</ix:nonFraction></b></td>
			<td id="new_id-2160" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:nonNumeric></ix:continuation><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="igc:AccruedLiabilitiesDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 10 </b>&#8211;<b> ACCRUED LIABILITIES AND OTHERS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2161" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2162" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>
			</td>
			<td id="new_id-2163" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2164" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2165" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2166" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2167" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2168" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2169" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Compensation and other contributions</p>
			</td>
			<td id="new_id-2170" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2171" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2172" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd">619</ix:nonFraction></td>
			<td id="new_id-2173" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2174" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2175" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2176" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd">1,054</ix:nonFraction></td>
			<td id="new_id-2177" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Provision for expenses</p>
			</td>
			<td id="new_id-2178" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2179" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2180" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd">258</ix:nonFraction></td>
			<td id="new_id-2181" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2182" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2183" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2184" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd">103</ix:nonFraction></td>
			<td id="new_id-2185" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Short-term lease liability</p>
			</td>
			<td id="new_id-2186" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2187" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2188" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd">133</ix:nonFraction></td>
			<td id="new_id-2189" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2190" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2191" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2192" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd">123</ix:nonFraction></td>
			<td id="new_id-2193" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other current liability</p>
			</td>
			<td id="new_id-2194" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2195" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2196" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" unitRef="usd">358</ix:nonFraction></td>
			<td id="new_id-2197" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2198" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2199" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2200" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" unitRef="usd">180</ix:nonFraction></td>
			<td id="new_id-2201" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2202" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2203" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2204" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd">1,368</ix:nonFraction></b></td>
			<td id="new_id-2205" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2206" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2207" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2208" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd">1,460</ix:nonFraction></b></td>
			<td id="new_id-2209" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:nonNumeric>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Compensation and other contribution-related liabilities consist of accrued salaries to employees. In addition, provision for expenses includes provision for legal, professional, and marketing expenses. Other current liability also includes statutory payables of approximately $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrent" scale="3" unitRef="usd">31</ix:nonFraction> thousand and <ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrent" scale="3" unitRef="usd">55</ix:nonFraction> thousand as of March 31, 2023, and March 31, 2022, respectively, and approximately $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="3" unitRef="usd">3</ix:nonFraction> thousand of short-term loans as of March 31, 2023, and March 31, 2022, respectively.</p></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">65</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="igc:LoansAndOtherLiabilitiesTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 11 </b>&#8211;<b> LOANS AND OTHER LIABILITIES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Loan as of March 31, 2023:</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On June 11, 2020, the Company received an Economic Injury Disaster Loan (EIDL) for approximately $<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd">150</ix:nonFraction> thousand at an annual interest rate of <ix:nonFraction contextRef="c69" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure">3.75</ix:nonFraction>%. The Company must pay principal and interest payments of $<ix:nonFraction contextRef="c70" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentPeriodicPayment" scale="3" unitRef="usd">731</ix:nonFraction> every month beginning June 5, 2021. The SBA will apply each installment payment first to pay interest accrued to the day SBA receives the payment and will then apply any remaining balance to reduce principal. All remaining principal and accrued interest are due and payable <ix:nonNumeric contextRef="c70" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">30</ix:nonNumeric> years from the date of the loan. For Fiscal 2023, the interest expense and principal payment for the EIDL were approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" unitRef="usd">5</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="3" unitRef="usd">3</ix:nonFraction> thousand, respectively. As of March 31, 2023, approximately $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermLoansPayable" scale="3" unitRef="usd">141</ix:nonFraction> thousand of the loan is classified as Long-term loans and approximately $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LoansPayableCurrent" scale="3" unitRef="usd">3</ix:nonFraction> thousand as Short-term loans.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"><i>Other Liability:</i></ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2210" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2211" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands) </i></b></i></p>
			</td>
			<td id="new_id-2212" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2213" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2214" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of March 31,</b></p>
			</td>
			<td id="new_id-2215" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2216" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2217" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2218" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2219" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2220" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2221" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Statutory reserve</p>
			</td>
			<td id="new_id-2222" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2223" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2224" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="3" unitRef="usd">21</ix:nonFraction></td>
			<td id="new_id-2225" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2226" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2227" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2228" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="3" unitRef="usd">16</ix:nonFraction></td>
			<td id="new_id-2229" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Total</p>
			</td>
			<td id="new_id-2230" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2231" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2232" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" unitRef="usd">21</ix:nonFraction></b></td>
			<td id="new_id-2233" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2234" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2235" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2236" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" unitRef="usd">16</ix:nonFraction></td>
			<td id="new_id-2237" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The statutory reserve is a gratuity reserve for employees in our subsidiaries in India.</p></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 12 </b>&#8211;<b> COMMITMENTS AND CONTINGENCIES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company may be involved in legal proceedings, claims, and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. There are no such matters that are deemed material to the consolidated financial statements as of March 31, 2023, except as disclosed in Item 3 &#8211; Legal Proceedings, and Note 19 - Subsequent Events.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the U.S., we provide health insurance, life insurance, and a 401(k) plan wherein the Company matches up to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" unitRef="pure">6</ix:nonFraction>% of the employee&#8217;s pre-tax contribution up to a maximum annual amount determined by the IRS. In addition, under applicable Indian laws, the Company provides for gratuity, a defined benefit retirement plan (Gratuity Plan) covering certain categories of employees. The Gratuity Plan provides a lump sum payment to vested employees, at retirement or termination of employment, an amount based on the respective employee&#8217;s last drawn salary and the years of employment with the Company. In addition, employees receive benefits from a provident fund, a defined contribution plan. The employee and employer each make monthly contributions to the plan equal to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" unitRef="pure">12</ix:nonFraction>% of the covered employee&#8217;s salary. The contribution is made to the Indian Government&#8217;s provident fund.</p></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 13 </b>&#8211; <b>SECURITIES </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, the Company was authorized to issue up to <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">150,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction> per share, and <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares">53,077,436</ix:nonFraction> shares of common stock were issued and outstanding. The Company is also authorized to issue up to <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">1,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction> per share, and no preferred shares were issued and outstanding as of March 31, 2023. We have one security listed on the NYSE American: common stock, $0.0001 par value (ticker symbol: IGC). This security also trades on the Frankfurt, Stuttgart, and Berlin stock exchanges (ticker symbol: IGS1).</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company also has <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="igc:UnitsOutstanding" scale="0" unitRef="shares">91,472</ix:nonFraction> units outstanding that can be separated into common stock. <ix:nonNumeric contextRef="c0" name="igc:UnitDescription">Ten units may be separated into one share of common stock.</ix:nonNumeric> The unit holders are requested to contact the Company or our transfer agent, Continental Stock Transfer &amp; Trust, to separate their units into common stock.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On January 13, 2021, the Company entered into a Sales Agreement (the Agreement) with The Benchmark Company, LLC (Benchmark or the Sales Agent) pursuant to which the Sales Agent is acting as the Company&#8217;s sales agent with respect to the issuance and sale of up to $<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="igc:SalesAgreementMaximum" scale="0" unitRef="usd">75,000,000</ix:nonFraction> of the Company&#8217;s shares of common stock, par value $<ix:nonFraction contextRef="c71" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction> per share (the Shares), from time to time in an &#8220;at the market&#8221; (ATM) offering as defined in Rule 415(a)(4) of the Securities Act of 1933, as amended (the Offering). During Fiscal 2023, the Company raised approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" unitRef="usd">103</ix:nonFraction> thousand from the ATM, net of commission. The management may use these funds for working capital and capital expenditure requirements, along with clinical trials, share repurchases, debt repayments, investments, including but not limited to, mutual funds, treasury bonds, cryptocurrencies, and other asset classes.</p></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">66</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTE 14 </b>&#8211;<b> STOCK-BASED COMPENSATION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, under both the Company&#8217;s previous 2008 and current 2018 Omnibus Incentive Plans, a total of <ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">8,412,627</ix:nonFraction> shares of common stock have been issued to employees, non-employees, and advisors. In addition, <ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares" scale="6" unitRef="shares">5.5</ix:nonFraction> million restricted share units (RSUs) fair valued at $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" unitRef="usd">5.5</ix:nonFraction> million with a weighted average value of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="igc:WeightedAveragePricePerShare" scale="0" unitRef="usdPershares">1</ix:nonFraction> per share, have been granted but not yet issued from different Incentive Plans and Grants. This includes <ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="6" unitRef="shares">2.9</ix:nonFraction> million RSUs granted to employees and directors, which consists of a vesting schedule based entirely on the attainment either operational milestones (performance conditions) or market conditions, assuming continued employment either as an employee, or director with the Company. The performance based RSUs are accounted upon certification by the management confirming the probability of achievement of milestones. As of March 31, 2023, the management confirmed two milestones had been achieved, and the rest were probable to be achieved by March 31, 2027.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Additionally, options held by advisors and directors to purchase <ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" unitRef="shares">150</ix:nonFraction> thousand shares of common stock fair valued at $<ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">69</ix:nonFraction> thousand with a weighted average of $<ix:nonFraction contextRef="c72" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">0.46</ix:nonFraction> per share, which have been granted but are to be issued over a vesting period, between Fiscal 2022 and Fiscal 2026. Options granted and issued before the vesting period are expensed when issued.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">The options are fair valued using a Black-Scholes Pricing Model and market based RSU are valued based on lattice model with the following assumptions:</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2238" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2239" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Granted in </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>
			</td>
			<td id="new_id-2240" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2241" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2242" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Granted in </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>
			</td>
			<td id="new_id-2243" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected life of options</p>
			</td>
			<td id="new_id-2244" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2245" style="text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric> years</p>	</td>
			<td id="new_id-2246" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2247" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2248" style="text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric> years</p>	</td>
			<td id="new_id-2249" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested options</p>
			</td>
			<td id="new_id-2250" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2251" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2252" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure">100</ix:nonFraction></td>
			<td id="new_id-2253" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2254" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2255" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2256" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure">100</ix:nonFraction></td>
			<td id="new_id-2257" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk free interest rate</p>
			</td>
			<td id="new_id-2258" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2259" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2260" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">3.49</ix:nonFraction></td>
			<td id="new_id-2261" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2262" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2263" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2264" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">2.42</ix:nonFraction></td>
			<td id="new_id-2265" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected volatility</p>
			</td>
			<td id="new_id-2266" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2267" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2268" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">280</ix:nonFraction></td>
			<td id="new_id-2269" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2270" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2271" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2272" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">282</ix:nonFraction></td>
			<td id="new_id-2273" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected dividend yield</p>
			</td>
			<td id="new_id-2274" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2275" style="text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="-sec-ix-hidden: hidden-fact-4; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Nil</p>
			</td>
			<td id="new_id-2276" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2277" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2278" style="text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="-sec-ix-hidden: hidden-fact-5; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Nil</p>
			</td>
			<td id="new_id-2279" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The expense associated with share-based payments to employees, directors, advisors, and contractors is allocated over the vesting or service period and recognized in the Selling, general and administrative expenses (including research and development). For Fiscal 2023, the Company&#8217;s common stock-based compensation and expenses shown in Selling, general and administrative expenses (including research and development) was $<ix:nonFraction contextRef="c74" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">2.8</ix:nonFraction> million.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_NonvestedRestrictedStockSharesActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock">For Fiscal 2022, the Company&#8217;s common stock-based compensation and expenses shown in Selling, general and administrative expenses (including research and development) was $<ix:nonFraction contextRef="c75" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" unitRef="usd">2.2</ix:nonFraction> million.</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_NonvestedRestrictedStockSharesActivityTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-vested shares</b></p>
			</td>
			<td id="new_id-2280" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2281" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shares</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(in thousands)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(#)</b></p>
			</td>
			<td id="new_id-2282" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2283" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2284" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>grant date fair value</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2285" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-vested shares as of March 31, 2022</p>
			</td>
			<td id="new_id-2286" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2287" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2288" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" unitRef="shares">5,283</ix:nonFraction></b></td>
			<td id="new_id-2289" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2290" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2291" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2292" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">1.17</ix:nonFraction></td>
			<td id="new_id-2293" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p>
			</td>
			<td id="new_id-2294" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2295" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2296" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="3" unitRef="shares">1,615</ix:nonFraction></td>
			<td id="new_id-2297" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2298" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2299" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2300" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">0.43</ix:nonFraction></td>
			<td id="new_id-2301" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested</p>
			</td>
			<td id="new_id-2302" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2303" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2304" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" unitRef="shares">2,224</ix:nonFraction></td>
			<td id="new_id-2305" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2306" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2307" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2308" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">1.01</ix:nonFraction></td>
			<td id="new_id-2309" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cancelled/Forfeited</p>
			</td>
			<td id="new_id-2310" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2311" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2312" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" scale="3" unitRef="shares">245</ix:nonFraction></td>
			<td id="new_id-2313" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2314" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2315" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2316" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">0.77</ix:nonFraction></td>
			<td id="new_id-2317" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-vested shares as of March 31, 2023</b></p>
			</td>
			<td id="new_id-2318" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2319" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2320" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" unitRef="shares">4,429</ix:nonFraction></b></td>
			<td id="new_id-2321" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2322" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2323" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2324" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">1.01</ix:nonFraction></b></td>
			<td id="new_id-2325" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Options</b></p>
			</td>
			<td id="new_id-2326" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2327" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shares</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(in thousands)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(#)</b></p>
			</td>
			<td id="new_id-2328" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2329" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2330" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>grant date fair value</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2331" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2332" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2333" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>exercise price</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2334" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Options outstanding as of March 31, 2022</p>
			</td>
			<td id="new_id-2335" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2336" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2337" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" unitRef="shares">300</ix:nonFraction></b></td>
			<td id="new_id-2338" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2339" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2340" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2341" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">0.93</ix:nonFraction></b></td>
			<td id="new_id-2342" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2343" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2344" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2345" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">0.34</ix:nonFraction></b></td>
			<td id="new_id-2346" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p>
			</td>
			<td id="new_id-2347" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2348" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2349" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" unitRef="shares">-</ix:nonFraction></td>
			<td id="new_id-2350" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2351" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2352" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2353" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2354" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2355" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2356" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2357" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2358" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercised</p>
			</td>
			<td id="new_id-2359" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2360" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2361" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" unitRef="shares">-</ix:nonFraction></td>
			<td id="new_id-2362" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2363" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2364" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2365" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2366" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2367" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2368" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2369" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2370" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cancelled/forfeited</p>
			</td>
			<td id="new_id-2371" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2372" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2373" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" unitRef="shares">150</ix:nonFraction></td>
			<td id="new_id-2374" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2375" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2376" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2377" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">1.39</ix:nonFraction></td>
			<td id="new_id-2378" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2379" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2380" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2381" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">0.30</ix:nonFraction></td>
			<td id="new_id-2382" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Options outstanding as of March 31, 2023</b></p>
			</td>
			<td id="new_id-2383" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2384" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2385" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" unitRef="shares">150</ix:nonFraction></b></td>
			<td id="new_id-2386" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2387" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2388" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2389" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">1.39</ix:nonFraction></b></td>
			<td id="new_id-2390" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2391" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2392" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2393" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">0.30</ix:nonFraction></b></td>
			<td id="new_id-2394" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:nonNumeric>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There was a combined unrecognized expense of $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" unitRef="usd">2.7</ix:nonFraction> million related to non-vested shares and share options that the Company expects to be recognized over a life of <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">four years</ix:nonNumeric>.</p></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">67</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 15 </b>&#8211;<b> FAIR VALUE OF FINANCIAL INSTRUMENTS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, the Company&#8217;s marketable securities consist of liquid funds, which have been classified as Level 1 of the fair value hierarchy because they have been valued using quoted prices in active markets. The Company&#8217;s cash and cash equivalents have also been classified as Level 1 on the same principle. Financial instruments are classified as current if they are expected to be liquidated within the next twelve months. The Company&#8217;s remaining investments have been classified as Level 3 instruments as there is little or no market data. Level 3 investments are valued using the cost method. For further information refer Note 7, &#8220;Investments in Non-Marketable Securities.&#8221;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">The following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of March 31, 2023, and 2022, and indicates the fair value hierarchy of the valuation techniques the Company used to determine such fair value:</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock-c0_cont_2" id="_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2395" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2396" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 1</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2397" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2398" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2399" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 2</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2400" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2401" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2402" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 3</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2403" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2404" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2405" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2406" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>March 31, 2023</b></p>
			</td>
			<td id="new_id-2407" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2408" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2409" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2410" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2411" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2412" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2413" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2414" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2415" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2416" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2417" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2418" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2419" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2420" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2421" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2422" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2423">&#160;</td>
			<td id="new_id-2424">&#160;</td>
			<td id="new_id-2425">&#160;</td>
			<td id="new_id-2426">&#160;</td>
			<td id="new_id-2427">&#160;</td>
			<td id="new_id-2428">&#160;</td>
			<td id="new_id-2429">&#160;</td>
			<td id="new_id-2430">&#160;</td>
			<td id="new_id-2431">&#160;</td>
			<td id="new_id-2432">&#160;</td>
			<td id="new_id-2433">&#160;</td>
			<td id="new_id-2434">&#160;</td>
			<td id="new_id-2435">&#160;</td>
			<td id="new_id-2436">&#160;</td>
			<td id="new_id-2437">&#160;</td>
			<td id="new_id-2438">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Cash and cash equivalents:</i></p>
			</td>
			<td id="new_id-2439" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2440" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2441" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd">3,196</ix:nonFraction></td>
			<td id="new_id-2442" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2443" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2444" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2445" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c77" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2446" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2447" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2448" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2449" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c78" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2450" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2451" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2452" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2453" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd">3,196</ix:nonFraction></td>
			<td id="new_id-2454" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total cash and cash equivalents</b></p>
			</td>
			<td id="new_id-2455" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2456" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2457" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">3,196</ix:nonFraction></b></td>
			<td id="new_id-2458" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2459" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2460" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2461" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c77" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2462" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2463" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2464" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2465" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c78" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2466" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2467" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2468" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2469" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">3,196</ix:nonFraction></b></td>
			<td id="new_id-2470" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2471">&#160;</td>
			<td id="new_id-2472">&#160;</td>
			<td id="new_id-2473">&#160;</td>
			<td id="new_id-2474">&#160;</td>
			<td id="new_id-2475">&#160;</td>
			<td id="new_id-2476">&#160;</td>
			<td id="new_id-2477">&#160;</td>
			<td id="new_id-2478">&#160;</td>
			<td id="new_id-2479">&#160;</td>
			<td id="new_id-2480">&#160;</td>
			<td id="new_id-2481">&#160;</td>
			<td id="new_id-2482">&#160;</td>
			<td id="new_id-2483">&#160;</td>
			<td id="new_id-2484">&#160;</td>
			<td id="new_id-2485">&#160;</td>
			<td id="new_id-2486">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Investments:</i></p>
			</td>
			<td id="new_id-2487" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2488" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2489" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2490" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2491" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2492" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2493" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2494" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2495" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2496" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2497" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2498" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2499" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2500" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2501" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2502" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Marketable securities</p>
			</td>
			<td id="new_id-2503" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2504" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2505" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" unitRef="usd">154</ix:nonFraction></td>
			<td id="new_id-2506" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2507" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2508" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2509" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c77" decimals="-3" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesCurrent" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2510" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2511" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2512" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2513" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c78" decimals="-3" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesCurrent" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2514" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2515" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2516" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2517" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" unitRef="usd">154</ix:nonFraction></td>
			<td id="new_id-2518" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Non-marketable securities</p>
			</td>
			<td id="new_id-2519" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2520" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2521" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:fixed-zero" name="us-gaap:Investments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2522" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2523" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2524" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2525" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c77" decimals="-3" format="ixt:fixed-zero" name="us-gaap:Investments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2526" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2527" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2528" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2529" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c78" decimals="-3" format="ixt:fixed-zero" name="us-gaap:Investments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2530" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2531" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2532" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2533" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:fixed-zero" name="us-gaap:Investments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2534" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total investments</b></p>
			</td>
			<td id="new_id-2535" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2536" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2537" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd">154</ix:nonFraction></b></td>
			<td id="new_id-2538" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2539" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2540" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2541" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction contextRef="c77" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2542" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2543" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2544" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2545" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction contextRef="c78" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2546" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2547" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2548" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2549" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd">154</ix:nonFraction></b></td>
			<td id="new_id-2550" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock-c0_cont_2"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2551" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2552" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 1</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2553" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2554" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2555" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 2</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2556" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2557" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2558" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 3</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2559" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2560" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2561" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2562" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>March 31, 2022</b></p>
			</td>
			<td id="new_id-2563" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2564" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2565" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2566" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2567" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2568" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2569" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2570" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2571" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2572" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2573" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2574" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2575" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2576" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2577" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2578" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2579">&#160;</td>
			<td id="new_id-2580">&#160;</td>
			<td id="new_id-2581">&#160;</td>
			<td id="new_id-2582">&#160;</td>
			<td id="new_id-2583">&#160;</td>
			<td id="new_id-2584">&#160;</td>
			<td id="new_id-2585">&#160;</td>
			<td id="new_id-2586">&#160;</td>
			<td id="new_id-2587">&#160;</td>
			<td id="new_id-2588">&#160;</td>
			<td id="new_id-2589">&#160;</td>
			<td id="new_id-2590">&#160;</td>
			<td id="new_id-2591">&#160;</td>
			<td id="new_id-2592">&#160;</td>
			<td id="new_id-2593">&#160;</td>
			<td id="new_id-2594">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Cash and cash equivalents:</i></p>
			</td>
			<td id="new_id-2595" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2596" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2597" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd">10,460</ix:nonFraction></td>
			<td id="new_id-2598" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2599" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2600" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2601" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c80" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2602" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2603" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2604" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2605" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2606" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2607" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2608" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2609" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd">10,460</ix:nonFraction></td>
			<td id="new_id-2610" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total cash and cash equivalents</b></p>
			</td>
			<td id="new_id-2611" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2612" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2613" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">10,460</ix:nonFraction></b></td>
			<td id="new_id-2614" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2615" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2616" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2617" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c80" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2618" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2619" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2620" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2621" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2622" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2623" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2624" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2625" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">10,460</ix:nonFraction></b></td>
			<td id="new_id-2626" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2627">&#160;</td>
			<td id="new_id-2628">&#160;</td>
			<td id="new_id-2629">&#160;</td>
			<td id="new_id-2630">&#160;</td>
			<td id="new_id-2631">&#160;</td>
			<td id="new_id-2632">&#160;</td>
			<td id="new_id-2633">&#160;</td>
			<td id="new_id-2634">&#160;</td>
			<td id="new_id-2635">&#160;</td>
			<td id="new_id-2636">&#160;</td>
			<td id="new_id-2637">&#160;</td>
			<td id="new_id-2638">&#160;</td>
			<td id="new_id-2639">&#160;</td>
			<td id="new_id-2640">&#160;</td>
			<td id="new_id-2641">&#160;</td>
			<td id="new_id-2642">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Investments:</i></p>
			</td>
			<td id="new_id-2643" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2644" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2645" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2646" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2647" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2648" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2649" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2650" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2651" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2652" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2653" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2654" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2655" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2656" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2657" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2658" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Marketable securities</p>
			</td>
			<td id="new_id-2659" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2660" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2661" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesCurrent" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2662" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2663" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2664" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2665" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c80" decimals="-3" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesCurrent" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2666" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2667" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2668" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2669" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesCurrent" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2670" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2671" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2672" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2673" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesCurrent" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2674" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Non-marketable securities</p>
			</td>
			<td id="new_id-2675" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2676" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2677" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:fixed-zero" name="us-gaap:Investments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2678" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2679" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2680" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2681" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c80" decimals="-3" format="ixt:fixed-zero" name="us-gaap:Investments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2682" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2683" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2684" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2685" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:fixed-zero" name="us-gaap:Investments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2686" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2687" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2688" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2689" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:fixed-zero" name="us-gaap:Investments" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2690" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total investment </b></p>
			</td>
			<td id="new_id-2691" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2692" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2693" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2694" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2695" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2696" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2697" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction contextRef="c80" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2698" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2699" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2700" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2701" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2702" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2703" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2704" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2705" style="width: 9%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2706" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">68</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 16 </b>&#8211;<b> INCOME TAXES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company calculates its provision for foreign and U.S. federal income taxes based on the current tax law. As the Company maintains a full valuation allowance against its deferred tax assets, there is no income tax expense recorded related to this change other than the Federal AMT credit which are refundable due to the passage of tax reform.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Due to the Company&#8217;s history of losses and uncertainty of future taxable income, a valuation allowance sufficient to fully offset net operating losses and other deferred tax assets has been established. The valuation allowance will be maintained until sufficient positive evidence exists to support a conclusion that a valuation allowance is not necessary.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">Income tax expense/(benefit) for each of the years ended March 31 consists of the following:</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2707" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2708" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year Ended March 31,</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2709" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Income Tax Expense</b></p>
			</td>
			<td id="new_id-2710" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2711" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2712" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2713" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2714" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2715" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2716" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2717" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2718" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2719" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2720" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2721" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2722" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2723" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net income loss before tax</p>
			</td>
			<td id="new_id-2724" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2725" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2726" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">11,506</ix:nonFraction></td>
			<td id="new_id-2727" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2728" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2729" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2730" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">15,016</ix:nonFraction></td>
			<td id="new_id-2731" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax rate</p>
			</td>
			<td id="new_id-2732" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2733" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2734" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure">21</ix:nonFraction></td>
			<td id="new_id-2735" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2736" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2737" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2738" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure">21</ix:nonFraction></td>
			<td id="new_id-2739" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2740">&#160;</td>
			<td id="new_id-2741">&#160;</td>
			<td id="new_id-2742">&#160;</td>
			<td id="new_id-2743">&#160;</td>
			<td id="new_id-2744">&#160;</td>
			<td id="new_id-2745">&#160;</td>
			<td id="new_id-2746">&#160;</td>
			<td id="new_id-2747">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected income tax recovery</p>
			</td>
			<td id="new_id-2748" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2749" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2750" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" sign="-" unitRef="usd">2,416</ix:nonFraction></td>
			<td id="new_id-2751" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2752" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2753" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2754" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" sign="-" unitRef="usd">3,153</ix:nonFraction></td>
			<td id="new_id-2755" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Impact of tax rate differences in foreign jurisdictions</p>
			</td>
			<td id="new_id-2756" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2757" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2758" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" scale="3" unitRef="usd">7</ix:nonFraction></td>
			<td id="new_id-2759" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2760" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2761" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2762" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2763" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax rate changes and other adjustments</p>
			</td>
			<td id="new_id-2764" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2765" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2766" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" sign="-" unitRef="usd">667</ix:nonFraction></td>
			<td id="new_id-2767" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2768" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2769" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2770" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" sign="-" unitRef="usd">385</ix:nonFraction></td>
			<td id="new_id-2771" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permanent differences</p>
			</td>
			<td id="new_id-2772" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2773" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2774" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" unitRef="usd">88</ix:nonFraction></td>
			<td id="new_id-2775" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2776" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2777" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2778" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" unitRef="usd">50</ix:nonFraction></td>
			<td id="new_id-2779" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Change in valuation allowance</p>
			</td>
			<td id="new_id-2780" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2781" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2782" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" unitRef="usd">3,002</ix:nonFraction></td>
			<td id="new_id-2783" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2784" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2785" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2786" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" unitRef="usd">3,488</ix:nonFraction></td>
			<td id="new_id-2787" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2788" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2789" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2790" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2791" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2792" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2793" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2794" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-2795" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">The significant components of deferred income tax expense/(benefit) from operations before non-controlling interest for each of the years ended March 31 are approximated as following:</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2796" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2797" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year Ended March 31,</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2798" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Deferred income taxes</b></p>
			</td>
			<td id="new_id-2799" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2800" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2801" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2802" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2803" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2804" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2805" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2806" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2807" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2808" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2809" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2810" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2811" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2812" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2813">&#160;</td>
			<td id="new_id-2814">&#160;</td>
			<td id="new_id-2815">&#160;</td>
			<td id="new_id-2816">&#160;</td>
			<td id="new_id-2817">&#160;</td>
			<td id="new_id-2818">&#160;</td>
			<td id="new_id-2819">&#160;</td>
			<td id="new_id-2820">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net operating loss carry-forwards foreign</p>
			</td>
			<td id="new_id-2821" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2822" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2823" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" unitRef="usd">137</ix:nonFraction></td>
			<td id="new_id-2824" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2825" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2826" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2827" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" unitRef="usd">149</ix:nonFraction></td>
			<td id="new_id-2828" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-capital loss carry-forwards &#8211; U.S.</p>
			</td>
			<td id="new_id-2829" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2830" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2831" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="3" unitRef="usd">12,888</ix:nonFraction></td>
			<td id="new_id-2832" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2833" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2834" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2835" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="3" unitRef="usd">10,487</ix:nonFraction></td>
			<td id="new_id-2836" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Temporary differences</p>
			</td>
			<td id="new_id-2837" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2838" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2839" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" unitRef="usd">548</ix:nonFraction></td>
			<td id="new_id-2840" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2841" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2842" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2843" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" sign="-" unitRef="usd">66</ix:nonFraction></td>
			<td id="new_id-2844" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-2845">&#160;</td>
			<td id="new_id-2846">&#160;</td>
			<td id="new_id-2847">&#160;</td>
			<td id="new_id-2848">&#160;</td>
			<td id="new_id-2849">&#160;</td>
			<td id="new_id-2850">&#160;</td>
			<td id="new_id-2851">&#160;</td>
			<td id="new_id-2852">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net deferred tax asset</p>
			</td>
			<td id="new_id-2853" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2854" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2855" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd">13,573</ix:nonFraction></td>
			<td id="new_id-2856" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2857" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2858" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2859" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd">10,570</ix:nonFraction></td>
			<td id="new_id-2860" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Valuation allowance</p>
			</td>
			<td id="new_id-2861" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2862" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2863" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd">13,573</ix:nonFraction></td>
			<td id="new_id-2864" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2865" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2866" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2867" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd">10,570</ix:nonFraction></td>
			<td id="new_id-2868" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2869" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2870" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2871" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DeferredTaxAssetsNet" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2872" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2873" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2874" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2875" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DeferredTaxAssetsNet" scale="3" unitRef="usd">-</ix:nonFraction></b></td>
			<td id="new_id-2876" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">69</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_SummaryOfOperatingLossCarryforwardsTextBlock-c0_cont_1" escape="true" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock">The table below sets forth the details of expiration of the non-financial carried forward losses of the Company as of March 31, 2023, as under:</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation id="_SummaryOfOperatingLossCarryforwardsTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;">

		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>Amount</i></b></p>

			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>(in thousands)</i></b></p>

			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>($)</i></b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c82" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">47</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2024</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">309</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2025</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">3</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2026</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">12</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2027</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">30</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2028</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">14</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2029</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c88" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">25</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2030</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c89" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">141</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2031</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">3,081</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2032</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c91" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">4,141</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2033</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c92" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">627</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2034</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c93" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">1,269</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2035</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c94" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">1,735</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2036</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c95" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">1,176</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2037</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c96" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">819</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2038</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c97" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">1,256</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2039</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c98" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">4,132</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2040</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c99" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">7,932</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2041</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c100" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">8,841</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2042</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">14,966</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2043</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><ix:nonFraction contextRef="c102" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">11,359</ix:nonFraction></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Total</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 26%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">	<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd">61,915</ix:nonFraction></b></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;">
			<p style="font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Realization of deferred tax assets, including those related to net operating loss carryforwards, are dependent upon future earnings, if any, of which the timing and amount are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance. Based upon the Company&#8217;s current operating results management cannot conclude that it is more likely than not that such assets will be realized. The Company files income tax returns in India, Hong Kong, Colombia, and the U.S.</p></ix:continuation><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_RevenueFromContractWithCustomerTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueFromContractWithCustomerTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 17 </b>&#8211;<b> REVENUE RECOGNITION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Revenue in the Infrastructure segment is recognized for the renting business when the equipment is rented, and the terms of the agreement have been fulfilled during the period. Revenue from the execution of infrastructure contracts is recognized on the basis of the output method as and when part of the performance obligation has been completed and approval from the contracting agency has been obtained after survey of the performance completion as of that date. In the Life Sciences segment, the revenue from the wellness and lifestyle business is recognized once goods have been sold to the customer and the performance obligation has been completed. In retail sales, we offer consumer products through our online stores. Revenue is recognized when control of the goods is transferred to the customer. This generally occurs upon our delivery to a third-party carrier or to the customer directly. Revenue from white label services is recognized when the performance obligation has been completed and output material has been transferred to the customer.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">70</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation id="_RevenueFromContractWithCustomerTextBlock-c0_cont_1"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_DisaggregationOfRevenueTableTextBlock-c0_cont_1" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock">Net sales disaggregated by significant products and services for Fiscal 2023 and 2022 are as follows:</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_DisaggregationOfRevenueTableTextBlock-c0_cont_2" id="_DisaggregationOfRevenueTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2877" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2878" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year ended March 31,</i></b></i></p>
			</td>
			<td id="new_id-2879" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2880" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2881" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2882" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2883" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2884" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2885" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Infrastructure segment</b></p>
			</td>
			<td id="new_id-2886" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2887" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2888" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2889" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2890" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2891" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2892" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2893" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rental income (1)</p>
			</td>
			<td id="new_id-2894" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2895" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2896" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c103" decimals="-3" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:Revenues" scale="3" unitRef="usd">37</ix:nonFraction></td>
			<td id="new_id-2897" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2898" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2899" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2900" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c104" decimals="-3" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:Revenues" scale="3" unitRef="usd">23</ix:nonFraction></td>
			<td id="new_id-2901" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction contracts (2)</p>
			</td>
			<td id="new_id-2902" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2903" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2904" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c105" decimals="-3" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:Revenues" scale="3" unitRef="usd">76</ix:nonFraction></td>
			<td id="new_id-2905" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2906" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2907" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2908" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c106" decimals="-3" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:Revenues" scale="3" unitRef="usd">15</ix:nonFraction></td>
			<td id="new_id-2909" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2910">&#160;</td>
			<td id="new_id-2911">&#160;</td>
			<td id="new_id-2912">&#160;</td>
			<td id="new_id-2913">&#160;</td>
			<td id="new_id-2914">&#160;</td>
			<td id="new_id-2915">&#160;</td>
			<td id="new_id-2916">&#160;</td>
			<td id="new_id-2917">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-2918">&#160;</td>
			<td id="new_id-2919">&#160;</td>
			<td id="new_id-2920">&#160;</td>
			<td id="new_id-2921">&#160;</td>
			<td id="new_id-2922">&#160;</td>
			<td id="new_id-2923">&#160;</td>
			<td id="new_id-2924">&#160;</td>
			<td id="new_id-2925">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Life Sciences segment</b></p>
			</td>
			<td id="new_id-2926" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2927" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2928" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2929" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2930" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2931" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2932" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2933" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Wellness and lifestyle (3)</p>
			</td>
			<td id="new_id-2934" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2935" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2936" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:Revenues" scale="3" unitRef="usd">416</ix:nonFraction></td>
			<td id="new_id-2937" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2938" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2939" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2940" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c108" decimals="-3" format="ixt:num-dot-decimal" id="ix_7_fact" name="us-gaap:Revenues" scale="3" unitRef="usd">316</ix:nonFraction></td>
			<td id="new_id-2941" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">White labeling services (4)</p>
			</td>
			<td id="new_id-2942" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2943" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2944" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c109" decimals="-3" format="ixt:num-dot-decimal" id="ix_8_fact" name="us-gaap:Revenues" scale="3" unitRef="usd">382</ix:nonFraction></td>
			<td id="new_id-2945" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2946" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2947" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2948" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c110" decimals="-3" format="ixt:num-dot-decimal" id="ix_9_fact" name="us-gaap:Revenues" scale="3" unitRef="usd">43</ix:nonFraction></td>
			<td id="new_id-2949" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2950" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2951" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2952" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">911</ix:nonFraction></b></td>
			<td id="new_id-2953" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2954" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2955" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2956" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">397</ix:nonFraction></b></td>
			<td id="new_id-2957" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_DisaggregationOfRevenueTableTextBlock-c0_cont_3" id="_DisaggregationOfRevenueTableTextBlock-c0_cont_2"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1) <ix:footnote id="ix_1_footnote" xml:lang="en-US">Rental income consists of income from rental of heavy construction equipment.</ix:footnote></p></ix:continuation>

<ix:continuation continuedAt="_DisaggregationOfRevenueTableTextBlock-c0_cont_4" id="_DisaggregationOfRevenueTableTextBlock-c0_cont_3"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2) <ix:footnote id="ix_2_footnote" xml:lang="en-US">Construction income consists of the execution of contracts directly or through subcontractors.</ix:footnote></p></ix:continuation>

<ix:continuation continuedAt="_DisaggregationOfRevenueTableTextBlock-c0_cont_5" id="_DisaggregationOfRevenueTableTextBlock-c0_cont_4"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(3) <ix:footnote id="ix_3_footnote" xml:lang="en-US">Revenue from wellness and lifestyle consists of sale of products such as gummies, hand sanitizers, bath bombs, lotions, beverages, hemp crude extract, hemp isolate, and hemp distillate.</ix:footnote></p></ix:continuation>

<ix:continuation id="_DisaggregationOfRevenueTableTextBlock-c0_cont_5"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(4) <ix:footnote id="ix_4_footnote" xml:lang="en-US">Revenue from white label services consists of rebranding our formulations or the customer&#8217;s products as per customer&#8217;s requirement.</ix:footnote></p></ix:continuation></ix:continuation><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 18 </b>&#8211; <b>SEGMENT INFORMATION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">FASB ASC 280, &#8220;<i>Segment Reporting</i>&#8221; establishes standards for reporting information about reportable segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group (CODM), in deciding how to allocate resources and in assessing performance. The CODM evaluates revenues and gross profits based on product lines and routes to market. Based on our integration and Management strategies, we operate in <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" unitRef="pure">two</ix:nonFraction> reportable segments: (i) Infrastructure segment and (ii) Life Sciences segment.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s CODM is the Company&#8217;s Chief Executive Officer (CEO). The CEO reviews financial information presented on an operating segment basis for the purposes of making operating decisions and assessing financial performance. Therefore, and before our Life Sciences segment started, the Company had determined that it operated in a single operating and reportable segment. As of the date of this report and in preparation for the new and different source of revenue, the Company has determined that it operates in <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" unitRef="pure">two</ix:nonFraction> operating and reportable segments: (a) Infrastructure segment and (b) Life Sciences segment. The Company does not include intercompany transfers between segments for Management reporting purposes.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following provides information required by ASC 280-10-50-38 &#8220;Entity-wide Information&#8221;:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">1) The table below shows revenue reported by segment:</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Product &amp; Service</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock-c0_cont_2" id="_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2958" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2959" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2960" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td id="new_id-2961" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2962" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2963" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2964" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2965" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td id="new_id-2966" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2967">&#160;</td>
			<td id="new_id-2968">&#160;</td>
			<td id="new_id-2969">&#160;</td>
			<td id="new_id-2970">&#160;</td>
			<td id="new_id-2971">&#160;</td>
			<td id="new_id-2972">&#160;</td>
			<td id="new_id-2973">&#160;</td>
			<td id="new_id-2974">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Infrastructure segment</p>
			</td>
			<td id="new_id-2975" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2976" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2977" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c111" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">113</ix:nonFraction></td>
			<td id="new_id-2978" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2979" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2980" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2981" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c111" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">12</ix:nonFraction></td>
			<td id="new_id-2982" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Life Sciences segment</p>
			</td>
			<td id="new_id-2983" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2984" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2985" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c113" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">798</ix:nonFraction></td>
			<td id="new_id-2986" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2987" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2988" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2989" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c113" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">88</ix:nonFraction></td>
			<td id="new_id-2990" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2991" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2992" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2993" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">911</ix:nonFraction></b></td>
			<td id="new_id-2994" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2995" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2996" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2997" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">100</ix:nonFraction></b></td>
			<td id="new_id-2998" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">71</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation continuedAt="_SegmentReportingDisclosureTextBlock-c0_cont_2" id="_SegmentReportingDisclosureTextBlock-c0_cont_1"><ix:continuation id="_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock-c0_cont_2"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2999" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-3000" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-3001" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td id="new_id-3002" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3003" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3004" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3005" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3006" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td id="new_id-3007" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-3008">&#160;</td>
			<td id="new_id-3009">&#160;</td>
			<td id="new_id-3010">&#160;</td>
			<td id="new_id-3011">&#160;</td>
			<td id="new_id-3012">&#160;</td>
			<td id="new_id-3013">&#160;</td>
			<td id="new_id-3014">&#160;</td>
			<td id="new_id-3015">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Infrastructure segment</p>
			</td>
			<td id="new_id-3016" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3017" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3018" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c112" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">38</ix:nonFraction></td>
			<td id="new_id-3019" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3020" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3021" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3022" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c112" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">9</ix:nonFraction></td>
			<td id="new_id-3023" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Life Sciences segment</p>
			</td>
			<td id="new_id-3024" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3025" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3026" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c114" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">359</ix:nonFraction></td>
			<td id="new_id-3027" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3028" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3029" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3030" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c114" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">91</ix:nonFraction></td>
			<td id="new_id-3031" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-3032" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3033" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3034" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">397</ix:nonFraction></b></td>
			<td id="new_id-3035" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3036" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3037" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3038" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">100</ix:nonFraction></b></td>
			<td id="new_id-3039" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For information for revenue by product and service, refer Note 17, &#8220;Revenue Recognition.&#8221;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:continuation continuedAt="_RevenueFromExternalCustomersByGeographicAreasTableTextBlock-c0_cont_2" id="_RevenueFromExternalCustomersByGeographicAreasTableTextBlock-c0_cont_1">2) The table below shows the attributed to the country of domicile (U.S.) and foreign countries. Revenue is generally attributed to the geographic location of customers:</ix:continuation></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_RevenueFromExternalCustomersByGeographicAreasTableTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; width: 100%;">	<tr>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="6" style="vertical-align:bottom;width:11.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Country</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr style="background-color: rgb(204, 238, 255);">	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Asia</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c115" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">113</ix:nonFraction></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c115" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">12</ix:nonFraction></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>	</td>	</tr>	<tr style="background-color: rgb(255, 255, 255);">	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">America</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S.</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">777</ix:nonFraction></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c116" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">86</ix:nonFraction></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>	</td>	</tr>	<tr style="background-color: rgb(204, 238, 255);">	<td style="vertical-align:bottom;width:17.1%;">&#160;</td>	<td style="vertical-align:bottom;width:1.1%;">&#160;</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Colombia</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">21</ix:nonFraction></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c117" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">2</ix:nonFraction></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">%</td>	</tr>	<tr style="background-color: rgb(255, 255, 255);">	<td colspan="3" style="vertical-align:bottom;width:18.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">911</ix:nonFraction></b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">100</ix:nonFraction></b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>	</td>	</tr>
</table></ix:nonNumeric>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:continuation id="_RevenueFromExternalCustomersByGeographicAreasTableTextBlock-c0_cont_2"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="6" style="vertical-align:bottom;width:11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Country</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Asia</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">68</ix:nonFraction></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c118" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">17</ix:nonFraction></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">America</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S.</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">329</ix:nonFraction></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><ix:nonFraction contextRef="c119" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">83</ix:nonFraction></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="3" style="vertical-align:bottom;width:18.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">397</ix:nonFraction></b></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="igc:TotalRevenuePercentage" scale="-2" unitRef="pure">100</ix:nonFraction></b></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table></ix:continuation>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">3) The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries.</ix:nonNumeric></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<ix:continuation continuedAt="_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock-c0_cont_2" id="_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock-c0_cont_1"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3040" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="10" id="new_id-3041" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-3042" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nature of Assets</b></p>
			</td>
			<td id="new_id-3043" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3044" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>U.S. </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Country of Domicile)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3045" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3046" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3047" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Foreign Countries </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(India, Hong Kong, and Colombia)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3048" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3049" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3050" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total as of March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3051" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intangible assets, net</p>
			</td>
			<td id="new_id-3052" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3053" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3054" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">1,170</ix:nonFraction></td>
			<td id="new_id-3055" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3056" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3057" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3058" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">-</ix:nonFraction></td>
			<td id="new_id-3059" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3060" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3061" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3062" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">1,170</ix:nonFraction></td>
			<td id="new_id-3063" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property, plant and equipment, net</p>
			</td>
			<td id="new_id-3064" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3065" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3066" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">4,074</ix:nonFraction></td>
			<td id="new_id-3067" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3068" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3069" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3070" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">4,139</ix:nonFraction></td>
			<td id="new_id-3071" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3072" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3073" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3074" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">8,213</ix:nonFraction></td>
			<td id="new_id-3075" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims and advances</p>
			</td>
			<td id="new_id-3076" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3077" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3078" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">585</ix:nonFraction></td>
			<td id="new_id-3079" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3080" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3081" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3082" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">418</ix:nonFraction></td>
			<td id="new_id-3083" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3084" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3085" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3086" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">1,003</ix:nonFraction></td>
			<td id="new_id-3087" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-3088" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3089" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3090" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">298</ix:nonFraction></td>
			<td id="new_id-3091" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3092" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3093" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3094" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">28</ix:nonFraction></td>
			<td id="new_id-3095" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3096" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3097" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3098" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">326</ix:nonFraction></td>
			<td id="new_id-3099" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total non-current assets</b></p>
			</td>
			<td id="new_id-3100" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3101" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3102" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">6,127</ix:nonFraction></b></td>
			<td id="new_id-3103" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3104" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3105" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3106" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">4,585</ix:nonFraction></b></td>
			<td id="new_id-3107" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3108" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3109" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3110" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">10,712</ix:nonFraction></b></td>
			<td id="new_id-3111" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">72</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:continuation id="_SegmentReportingDisclosureTextBlock-c0_cont_2"><ix:continuation id="_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock-c0_cont_2"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3112" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="10" id="new_id-3113" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>
			</td>
			<td id="new_id-3114" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nature of Assets</b></p>
			</td>
			<td id="new_id-3115" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3116" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>U.S. </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Country of Domicile)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3117" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3118" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3119" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Foreign Countries </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(India Hong Kong and Colombia)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3120" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3121" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3122" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total as of March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3123" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intangible assets, net</p>
			</td>
			<td id="new_id-3124" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3125" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3126" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">436</ix:nonFraction></td>
			<td id="new_id-3127" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3128" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3129" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3130" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c123" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">481</ix:nonFraction></td>
			<td id="new_id-3131" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3132" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3133" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3134" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">917</ix:nonFraction></td>
			<td id="new_id-3135" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property, plant and equipment, net</p>
			</td>
			<td id="new_id-3136" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3137" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3138" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">4,978</ix:nonFraction></td>
			<td id="new_id-3139" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3140" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3141" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3142" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c123" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">4,441</ix:nonFraction></td>
			<td id="new_id-3143" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3144" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3145" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3146" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">9,419</ix:nonFraction></td>
			<td id="new_id-3147" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims and advances</p>
			</td>
			<td id="new_id-3148" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3149" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3150" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">550</ix:nonFraction></td>
			<td id="new_id-3151" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3152" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3153" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3154" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c123" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">387</ix:nonFraction></td>
			<td id="new_id-3155" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3156" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3157" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3158" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd">937</ix:nonFraction></td>
			<td id="new_id-3159" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-3160" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3161" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3162" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">396</ix:nonFraction></td>
			<td id="new_id-3163" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3164" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3165" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3166" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c123" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">54</ix:nonFraction></td>
			<td id="new_id-3167" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3168" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3169" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3170" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">450</ix:nonFraction></td>
			<td id="new_id-3171" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total non-current assets</b></p>
			</td>
			<td id="new_id-3172" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3173" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3174" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">6,360</ix:nonFraction></b></td>
			<td id="new_id-3175" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3176" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3177" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3178" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c123" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">5,363</ix:nonFraction></b></td>
			<td id="new_id-3179" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3180" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3181" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3182" style="width: 14%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">11,723</ix:nonFraction></b></td>
			<td id="new_id-3183" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table></ix:continuation></ix:continuation><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 19 </b>&#8211;<b> SUBSEQUENT EVENTS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $<ix:nonFraction contextRef="c124" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" unitRef="usd">12</ix:nonFraction> million and in addition sold <ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">10,000,000</ix:nonFraction> shares for $<ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">3,000,000</ix:nonFraction>. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#8217;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions.</p></ix:nonNumeric><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">73</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i9" title="i9"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 9 </b>&#8211;<b> CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">There were no changes in and disagreements with accountants on accounting and financial disclosures.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i9a" title="i9a"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9A. Controls and Procedures</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(a) Evaluation of disclosure controls and procedures</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Management maintains disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the Exchange Act) that are designed to provide reasonable assurance that information required to be disclosed in our reports filed or submitted under the Exchange Act is processed, recorded, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to Management, including our Chief Executive Officer and Principal Financial Officer (our principal executive officer and principal financial officer, respectively), as appropriate, to allow for timely decisions regarding required disclosure.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Management, including the Chief Executive Officer and Principal Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective to ensure that the information required to be disclosed in the reports filed or submitted by us under the Exchange Act was recorded, processed, summarized and reported within the requisite time periods specified in SEC rules and forms and that such information was accumulated and communicated to our Management, including our Chief Executive Officer and Principal Financial Officer, as appropriate to allow for timely decisions regarding required disclosure.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(b) Management</b>&#8217;<b>s annual report on internal control over financial reporting</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, we conducted an evaluation of the effectiveness, as of March 31, 2023, of our internal control over financial reporting based on the framework in 2013 Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was effective as of March 31, 2023.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(c) Changes in internal control over financial reporting</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Management, including our Chief Executive Officer and Principal Financial Officer, evaluated our &#8220;internal control over financial reporting&#8221; as defined in Exchange Act Rule 13a-15(f) to determine whether any changes in our internal control over financial reporting occurred during Fiscal 2023, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Based on that evaluation, there were no changes in our internal control over financial reporting during Fiscal 2023 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i9b" title="i9b"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9B. Other Information</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">None.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i9c" title="i9c"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Not Applicable.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">74</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PART III</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i10" title="i10"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Information about our executive officers and directors</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The names, ages, and positions of our executive officers and directors as of March 31, 2023, were as follows:</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 24%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%; background-color: rgb(255, 255, 255); border-bottom: 1px solid black;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;"><b>Class</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%; background-color: rgb(255, 255, 255); border-bottom: 1px solid black;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;"><b>Age</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 45%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Position</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director Since</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Term will Expire</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 24%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ram Mukunda</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;">C</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;">64</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 45%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President, Chief Executive Officer, and Director</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2005</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 24%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Richard Prins</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;">B</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;">66</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 45%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chairman of the Board of Directors</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2007</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2024</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 24%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">James Moran</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;">C</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;">78</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 45%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2022</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 24%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claudia Grimaldi</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;">A</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center; vertical-align: top;">52</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 45%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vice President, Principal Financial Officer, Chief Compliance Officer, and Director</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2022</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2023</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The principal occupations for the past five years (and, in some instances, for prior years) of each of our executive officers and directors are as follows:</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Ram Mukunda</b> has served as Director, CEO and President since April 29, 2005. He is responsible for general management and, over the past nine years, has been largely responsible for the Company&#8217;s strategy and positioning in the medical cannabinoids and pharmaceutical industry. He has been the chief inventor and architect of most of the Company&#8217;s patent filings, and the thrust into R&amp;D and medical trials, which support the Company&#8217;s desire to bring low-cost medications that address diseases and ailments that affect humankind. Prior to IGC, from January 1990 to May 2004, Mr. Mukunda served as Founder and CEO of Startec Global Communications, which he took public in 1997 on NASDAQ. Prior to Startec, he served as Strategic Planning Advisor at Intelsat, a communications satellite services provider and prior to that worked in the bond market for a boutique firm on Wall Street. Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering. From 2001 to 2003, he was a Council Member at Harvard&#8217;s Kennedy School of Government, Belfer Center of Science and International Affairs. Mr. Mukunda is the recipient of several awards including, among others, the 2013 University of Maryland&#8217;s International Alumnus of the year award, the 2001 Distinguished Engineering Alumnus Award, the 1998 Ernst &amp; Young, LLP&#8217;s Entrepreneur of the Year Award. He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland. Mr. Mukunda has traveled extensively, and managed companies in Europe and Asia. He has over 20 years of experience managing public companies and has acquired and integrated over 20 companies. His in-depth business experience in the medical cannabinoids industry, his knowledge of U.S. capital markets, capital structuring, international joint ventures, and broad science and engineering background make him qualified to serve as a director of our Company.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Richard Prins </b>has been our Chairman, Audit Committee and Compensation Committee Chairman since 2012 and has served as an Independent Director since May 2007. Mr. Prins has extensive experience in private equity investing and investment banking. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated (FBW). Mr. Prins served in a consulting role for RBC until January 2009. Mr. Prins currently serves on one other board, volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals, Inc. Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University. Mr. Prins has substantial knowledge and experience with U.S. capital markets, has served on and chaired audit and compensation committees of boards, has extensive experience in finance, accounting, and internal controls over financial reporting. His knowledge of the pharmaceutical industry and experience with U.S. capital markets make him qualified to serve as a director of our Company.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>James Moran (Congressman Moran) </b>has<b> </b>served on the Board as an Independent Director since January 2022. He served on Virginia&#8217;s 8th Congressional District for 24 years, where he was known as a &#8220;Problem Solver.&#8221; Throughout his tenure, he demonstrated bipartisan leadership and worked across the aisle to find common ground to resolve complex issues. He served on the Appropriation, Banking and Finance and Budget committees. He played a leadership role in the areas of defense, health, and the environment. During his 24 years in Congress, Congressman Moran was recognized as a champion of innovative research and development in areas including healthcare and national security, environmental protection and sustainability, and international trade and fiscal responsibility. He rose to senior leadership on the Appropriations Committee enabling him to bring billions of dollars into his Northern Virginia communities of Alexandria, Arlington, and Fairfax County. Having retired after 35 years in elected office, Congressman Moran is now with a major law firm and represents international and domestic clients in the defense, technology, entertainment, and international diplomacy sectors. He also serves in leadership roles for several non-profit foundations and is also a member of the Government Blockchain Association. Congressman Moran received a Master&#8217;s Degree in Public Administration from the University of Pittsburgh Graduate School of Public and International Affairs and a Bachelors in Economics from the College of the Holy Cross.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">75</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Congressman Moran introduced the AUTISM Educators Act in 2012, which funded partnerships between public schools and higher education and non-profit organizations to promote teaching skills for educators working with high functioning autism students. He understands that treatment and education for conditions such as Autism and Alzheimer&#8217;s disease have the potential to positively impact millions of lives. With his extensive experience in Congress and as a policy advisor on topics including health, technology, and education, we are confident Congressman Moran will be a great asset to IGC especially at a time when we pursue Phase 2/3 human trials on IGC- AD1 on individuals that have Alzheimer&#8217;s disease. Congressman Moran&#8217;s extensive experience makes him qualified to serve as a director of our Company.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On December 27, 2022, the Board of Directors appointed Mr. James Moran as a member of both the Company&#8217;s Audit and Compensation Committee, effective immediately.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Claudia Grimaldi</b>, Vice-president, PFO, Chief Compliance Officer, and Director is responsible for managing the accounting and finance teams in various countries and is responsible for ensuring timely and accurate statutory and regulatory compliance (SEC, FINRA, NYSE, IRS, XETRA 2, among others). In addition, she is responsible for building and managing an international team of doctors, scientists, and advisors that conduct and manage pre-clinical and FDA registered trials focused on Alzheimer&#8217;s disease. She is also responsible for relationships with partners that provide, among others, animal studies, cannabinoids, and software for AI. She has more than thirteen (13) years of experience with SEC filings, regulatory compliance, and disclosures, having held increasing responsibilities first as Manager of financial reporting and compliance from May 2011 to 2013 and then as General Manager financial reporting and compliance from 2013 to May 2018. She also serves as a Director/Manager for some of our subsidiaries. Ms. Grimaldi graduated summa cum laude from Javeriana University, a top five university in Colombia, with a Bachelor of Arts in Psychology. She holds an MBA in General Management, graduating with Highest Honors, from Meredith College, in North Carolina. She is a member of Delta Mu Delta International Honor Society. She has also completed Executive Education courses on SEC compliance, finance from UVA, and corporate governance from the Columbia Business School. In addition, she has attended the Darden School of Business Financial Management Executives program at the University of Virginia, and SEC reporting and compliance seminars. Currently she is pursuing her Directorship Certification with the National Association of Corporate Directors (NACD). She is also fluent in both English and Spanish.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On March 23, 2022, the Board of Directors of the Company appointed Ms. Claudia Grimaldi to serve on the Board as a non-independent director Class A until the Company&#8217;s 2023 annual meeting of stockholders upon the election and qualification of successor directors, her earlier death, resignation, or removal. Ms. Grimaldi brings a wealth of experience and qualifications that make her an excellent fit for the board. Ms. Grimaldi&#8217;s experience with SEC filing procedures is invaluable in ensuring regulatory compliance and transparency within our public company. Additionally, her in-depth understanding of Colombia, South America-where our company has invested in human capital provides valuable insights into the market dynamics, cultural nuances, and business opportunities within the region. Her SEC filing experience, understanding of Colombia, qualifications in business administration, and general business acumen makes her qualified to serve as a director of our Company.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Executive officers are appointed by our Board of Directors. Each executive officer holds his or her office until he or she resigns or is removed by the Board or his or her successor is elected and qualified. All directors hold office until the annual meeting of the stockholders in the year set forth above in the table and until their successors have been duly elected or qualified. There are no family relationships between any of our executive officers or directors. For information on legal proceedings against the Company or its officers and executive directors, please refer to Item 3. Legal Proceedings.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Board of directors and independence</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board of Directors is divided into three classes (Class A, Class B, and Class C) with only one class of directors being elected each year and each class serving a three-year term. The term of office of the Class A director, consisting of Claudia Grimaldi, will expire at the 2023 annual meeting of stockholders. The term of office of the Class B director, currently consisting of Richard Prins, will expire at the 2024 annual meeting of stockholders. The term of office of the Class C director, currently consisting of Ram Mukunda and James Moran, will expire at the 2025 annual meeting of stockholders. These individuals have played a key role in identifying and evaluating prospective acquisition candidates, selecting the target businesses, and structuring, negotiating and consummating acquisitions.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The NYSE American, upon which our shares are listed, requires the majority of our Board, or in the case of a smaller reporting Company at least 50% of our Board, to be &#8220;independent.&#8221; The NYSE American listing standards define an &#8220;independent director&#8221; generally as a person, other than an officer or an employee of the Company, who does not have a relationship with the Company that would interfere with the director&#8217;s exercise of independent judgment. Consistent with these standards, the Board of Directors has determined that Messrs. Prins and Moran are independent directors.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">76</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Board leadership structure</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Board believes its current leadership structure best serves the objectives of the Board&#8217;s oversight of management, the Board&#8217;s ability to carry out its roles and responsibilities on behalf of IGC&#8217;s shareholders, and IGC&#8217;s overall corporate governance. The Board also believes that the separation of the Chairman and CEO roles allows the CEO to focus his time and energy on operating and managing IGC, while leveraging the Chairman&#8217;s experience and perspectives. The Board periodically reviews its leadership structure to determine whether it continues to best serve IGC and its shareholders.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Board oversight of risk management</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Board is responsible for overseeing the major risks facing the Company, while management is responsible for assessing and mitigating the Company&#8217;s risks on a day-to-day basis. The Board has designated the Audit Committee with the responsibility for overseeing enterprise risk management. The Audit Committee discusses the steps management has taken to monitor and mitigate these risks, if any. In establishing and reviewing IGC&#8217;s executive compensation, the Compensation Committee considers whether the compensation program is focused on long-term shareholder value creation and whether it encourage short-term risk taking at the expense of long-term results. The Compensation Committee has also reviewed IGC&#8217;s compensation program and has concluded that these programs do not create risks that are reasonably likely to have a material adverse effect on IGC. Other Board committees also consider risks within their areas of responsibility and apprise the Board of significant risks and management&#8217;s response to those risks.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Audit committee</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board of Directors has established an Audit Committee, currently composed of two independent directors who report to the Board of Directors. Messrs. Prins and Moran, each of whom is an independent director under the NYSE American listing standards, serve as members of our Audit Committee. Mr. Prins is the Chairman of our Audit Committee. In addition, we have determined that Messrs. Prins and Moran are &#8220;audit committee financial experts,&#8221; as that term is defined under Item 407 of Regulation S-K. The Audit Committee is responsible for meeting with our independent accountants regarding, among other issues, audits and the adequacy of our accounting and control systems. The audit committee charter is followed by the committee.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Compensation committee</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board of Directors has established a Compensation Committee composed of two independent directors, Messrs. Moran, and Prins. Mr. Prins is the current Chairman of our Compensation Committee. The Compensation Committee&#8217;s purpose is to review and approve the compensation paid to our officers and directors and to administer our 2018 Omnibus Incentive Plan. As per the compensation committee charter, candidate experience, knowledge, and performance are used to evaluate the candidate. The compensation is accordingly decided for the candidate as per the industry standards.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Compensation committee interlocks and insider participation</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Compensation Committee is comprised of two independent members of the Board of Directors, Richard Prins, and James Moran. No executive officer of the Company served as a director or member of the Compensation Committee of any other entity. The Compensation Committee was responsible for determining executive compensation and the award of stock, and stock options to employees, advisors, and directors during Fiscal 2023. No consultants were used by the Compensation Committee during this fiscal year.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nominating and corporate governance committee</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the future, we intend to establish a nominating and corporate governance committee. The primary purpose of the nominating and corporate governance committee will be to identify individuals qualified to become directors, recommend to the Board of Directors the candidates for election by stockholders or appointment by the Board of Directors to fill a vacancy, recommend to the Board of Directors the composition and chairs of Board of Directors committees, develop and recommend to the Board of Directors guidelines for effective corporate governance, and lead an annual review of the performance of the Board of Directors and each of its committees. We do not have any formal process for stockholders to nominate a director for election to our Board of Directors. Currently, nominations are selected or recommended by a majority of the independent directors as stated in Section 804(a) of the NYSE American Company Guide. Since the Company is a small reporting company with limited officers and directors, the committee currently does not have a nomination committee charter. The Board of Director nominations occur by either selection or recommendation of a majority of the independent directors.</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">77</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Disclosure Committee</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The CEO and the PFO supervise and oversee the Disclosure Committee. The Board has appointed Mr. Richard Prins as the Chairperson of the Disclosure Committee. The Disclosure Committee&#8217;s responsibilities are to design, implement and regularly evaluate the Company&#8217;s internal controls and procedures, to ensure that the company provides the stakeholders, including the Securities and Exchange Commission (SEC), security holders, and the investment community, disclosures that comply with regulations and other compliance obligations. The Disclosure Committee will review all required material and relevant reports related to disclosure statements, including annual reports on Form 10-K, quarterly reports on Form 10-Q, press releases, and social media containing financial information and other related public documents. The Disclosure Committee meets not less than once per quarter and reviews and reassess the adequacy of the Disclosure Committee&#8217;s Charter at least annually.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Audit Committee Financial Expert</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Audit Committee will at all times be composed exclusively of &#8220;independent directors&#8221; who are &#8220;financially literate,&#8221; as defined under the NYSE American listing standards, who understand the audit committee functions. The NYSE American&#8217;s listing standards define &#8220;financially literate&#8221; as being able to read and understand fundamental financial statements, including a company&#8217;s balance sheet, income statement and cash flow statement. In addition, we must certify to the NYSE American that the Audit Committee has, and will continue to have, at least one member who has past employment experience in finance, accounting, or auditing, requisite professional certification in accounting, or other comparable experience or background that results in the individual&#8217;s financial sophistication, along with understanding of internal control over financial reporting. The Board of Directors has determined that Messrs. Prins and Moran satisfy the NYSE American&#8217;s definition of financial sophistication and qualify as &#8220;audit committee financial experts,&#8221; as defined under rules and regulations of the SEC.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Board and committee meetings</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During Fiscal 2023, there were five (5) Board meetings, five (5) meetings of the Audit Committee and two (2) Compensation Committee meetings, all of which were attended, either in person or telephonically, by all our directors of the Board and all of the members of the committees, respectively.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Communications with the Board</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Any matter intended for the Board, or any individual member of the Board, should be directed to Investor Relations at the Company&#8217;s principal executive office, with a request to forward the communication to the intended recipient. In general, any shareholder communication delivered to the Company for forwarding to Board members will be forwarded in accordance with the shareholder&#8217;s instructions. However, the Company reserves the right not to forward to Board members any abusive, threatening, or otherwise inappropriate materials.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Indemnification agreements</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are party to indemnification agreements with each of the executive officers and directors. Such indemnification agreements require us to indemnify these individuals to the fullest extent permitted by law. Under the terms of the indemnification agreements, we intend to agree to indemnify our officers and directors against expenses, judgments, fines, penalties, or other amounts actually and reasonably incurred by the independent director in connection with any proceeding if the officer or director acted in good faith and did not derive an improper personal benefit from the transaction or occurrence that is the basis of the proceeding.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Annual meeting attendance</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All directors, either in person or telephonically, attended the 2022 annual shareholders' meeting. We have a formal policy requiring the members of our Board of Directors to attend annual stockholder meetings in person or by telephone or video conference.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">78</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Corporate governance, code of conduct, and ethics</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A code of business conduct and ethics is a written standard designed to deter wrongdoing and to promote (a) honest and ethical conduct, (b) full, fair, accurate, timely, and understandable disclosure in regulatory filings and public statements, (c) compliance with applicable laws, rules, and regulations, (d) the prompt reporting violation of the code and (e) accountability for adherence to the code. The Company has adopted a written code of ethics (the &#8220;Code of Ethics&#8221;) that applies to the Company&#8217;s Chief Executive Officer and senior financial officers, including the Company&#8217;s Principal Accounting Officer, Controller, and persons performing similar functions (collectively, the &#8220;Senior Financial Officers&#8221;), in accordance with applicable federal securities laws and the rules of the NYSE American, and to all employees. Investors or any other person may view our Code of Ethics free of charge on the corporate governance subsection of the investor relations portion of our website at www.igcinc.us. The Company has established separate audit and compensation committees that are described elsewhere in this report. The Company does not have a separate nominating committee. Accordingly, Board of Director nominations occur by either selection or recommendation of a majority of the independent directors.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All our data, except accounting data, is stored in the cloud on multiple servers, which helps us mitigate the overall risk of losing data. As part of corporate governance, we also have a cybersecurity policy that employees are required to comply with to safeguard their systems from cyber-attacks.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Delinquent Section 16(a) reports</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 16(a) of the Securities and Exchange Act of 1934, as amended, requires our officers, directors, and beneficial owners of more than 10% of our equity securities to timely file certain reports regarding ownership of and transactions in our securities with the Securities and Exchange Commission. Copies of the required filings must also be furnished to us. Section 16(a) compliance was required during Fiscal 2023. Based solely on a review of Forms 3, 4, and 5 and amendments thereto furnished to us pursuant to Rule 16a-3(e) under the Exchange Act, we believe that Fiscal 2023&#8217;s filing requirements under Section 16(a) of the Exchange Act have been satisfied, except for (1) a Form 4 reporting four transactions by Ram Mukunda filed with the SEC on June 28, 2022, (2) a Form 4 reporting three transactions by Claudia Grimaldi filed with the SEC June 28, 2022, (3) a Form 4 reporting three transactions by John Lynch filed with the SEC on June 28, 2022 and (4) a Form 4 reporting three transactions by Richard K. Prins filed with the SEC on June 28, 2022.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i11" title="i11"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 11. EXECUTIVE COMPENSATION</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Compensation for executive officers of the Company</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth information concerning all cash and non-cash compensation awarded to, earned by, or paid to (i) all individuals serving as the smaller reporting company&#8217;s principal executive officer or acting in a similar capacity during the last completed fiscal year (PEO), regardless of compensation level; (ii) the smaller reporting company&#8217;s two most highly compensated executive officers other than the PEO who were serving as executive officers at the end of the last completed fiscal year and whose compensation exceeded $100,000 a year; and (iii) up to two additional individuals for whom disclosure would have been provided pursuant to paragraph (ii) but for the fact that the individual was not serving as an executive officer of the smaller reporting company at the end of the last completed fiscal year.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary Compensation Table</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 31%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Name and Principal Position</b></p>
			</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 4%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td id="new_id-3184" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" id="new_id-3185" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Salary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3186" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td id="new_id-3187" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" id="new_id-3188" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Bonus</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3189" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td id="new_id-3190" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" id="new_id-3191" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Stock Awards (2)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3192" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td id="new_id-3193" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" id="new_id-3194" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Other compensation (3)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3195" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td id="new_id-3196" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" id="new_id-3197" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3198" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; width: 0%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Ram Mukunda</p>
			</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td id="new_id-3199" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3200" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3201" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">360</td>
			<td id="new_id-3202" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3203" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3204" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3205" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">300</td>
			<td id="new_id-3206" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3207" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3208" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3209" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">301</td>
			<td id="new_id-3210" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3211" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3212" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3213" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">45</td>
			<td id="new_id-3214" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3215" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3216" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3217" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">1,006</td>
			<td id="new_id-3218" style="width: 0%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">President and CEO</p>
			</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td id="new_id-3219" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3220" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3221" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">320</td>
			<td id="new_id-3222" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3223" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3224" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3225" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">200</td>
			<td id="new_id-3226" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3227" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3228" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3229" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">4,974</td>
			<td id="new_id-3230" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3231" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3232" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3233" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">53</td>
			<td id="new_id-3234" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3235" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3236" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3237" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">5,547</td>
			<td id="new_id-3238" style="width: 0%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="width: 31%;">&#160;</td>
			<td style="width: 1%;">&#160;</td>
			<td style="width: 4%;">&#160;</td>
			<td id="new_id-3239" style="width: 1%;">&#160;</td>
			<td id="new_id-3240" style="width: 1%;">&#160;</td>
			<td id="new_id-3241" style="width: 10%;">&#160;</td>
			<td id="new_id-3242" style="width: 1%;">&#160;</td>
			<td id="new_id-3243" style="width: 1%;">&#160;</td>
			<td id="new_id-3244" style="width: 1%;">&#160;</td>
			<td id="new_id-3245" style="width: 10%;">&#160;</td>
			<td id="new_id-3246" style="width: 1%;">&#160;</td>
			<td id="new_id-3247" style="width: 1%;">&#160;</td>
			<td id="new_id-3248" style="width: 1%;">&#160;</td>
			<td id="new_id-3249" style="width: 10%;">&#160;</td>
			<td id="new_id-3250" style="width: 1%;">&#160;</td>
			<td id="new_id-3251" style="width: 1%;">&#160;</td>
			<td id="new_id-3252" style="width: 1%;">&#160;</td>
			<td id="new_id-3253" style="width: 10%;">&#160;</td>
			<td id="new_id-3254" style="width: 1%;">&#160;</td>
			<td id="new_id-3255" style="width: 1%;">&#160;</td>
			<td id="new_id-3256" style="width: 1%;">&#160;</td>
			<td id="new_id-3257" style="width: 10%;">&#160;</td>
			<td id="new_id-3258" style="width: 0%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Claudia Grimaldi</p>
			</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td id="new_id-3259" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3260" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3261" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">150</td>
			<td id="new_id-3262" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3263" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3264" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3265" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">75</td>
			<td id="new_id-3266" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3267" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3268" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3269" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">75</td>
			<td id="new_id-3270" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3271" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3272" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3273" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">20</td>
			<td id="new_id-3274" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3275" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3276" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3277" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">320</td>
			<td id="new_id-3278" style="width: 0%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: justify; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Vice President, CCO, and PFO</p>
			</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td id="new_id-3279" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3280" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3281" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">150</td>
			<td id="new_id-3282" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3283" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3284" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3285" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">75</td>
			<td id="new_id-3286" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3287" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3288" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3289" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">516</td>
			<td id="new_id-3290" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3291" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3292" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3293" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">20</td>
			<td id="new_id-3294" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3295" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3296" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3297" style="width: 10%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">761</td>
			<td id="new_id-3298" style="width: 0%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the fiscal year ended March 31, 2023, the Company owes approximately $92 thousand to Mr. Ram Mukunda and $135 thousand to Ms. Claudia Grimaldi.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Stock Awards represent the fair value of stock awards to the named executive officer as computed using the closing price at the day of grant. The Stock Awards include vested and unvested grants of stock awards as reflected in the table titled &#8220;Stock Awards at Fiscal Year End.&#8221;&#160;In Fiscal 2022, they also include two categories of Stock Awards that are set out in the tables titled &#8220;Performance Based Stock Awards&#8221;&#160;and &#8220;Market Price Based Stock Awards,&#8221;. As of March 31, 2023, 1 million Performance Stock Awards were issued.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(3)</p>
			</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Includes life insurance, 401 (k) contribution, and health insurance(s).</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">79</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation to Directors</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table shows, for fiscal 2023, the compensation awarded to, earned by, or paid to non-employee directors who served on the Board during the fiscal year.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td id="new_id-3299" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3300" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="text-indent: 0pt; margin: 0pt; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;"><b>Number of</b></p>

			<p style="text-indent: 0pt; margin: 0pt; font-family: &#34;Times New Roman&#34;, Times, serif; font-size: 10pt;"><b>Stock Awards </b></p>
			</td>
			<td id="new_id-3301" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3302" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3303" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3304" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Richard Prins</p>
			</td>
			<td id="new_id-3305" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3306" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3307" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">175</td>
			<td id="new_id-3308" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3309" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3310" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3311" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">75</td>
			<td id="new_id-3312" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">James Moran</p>
			</td>
			<td id="new_id-3313" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3314" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3315" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">100</td>
			<td id="new_id-3316" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3317" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3318" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3319" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">43</td>
			<td id="new_id-3320" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:2.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:top;width:43.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Total Compensation represents the fair value of stock awards to the named director as computed using the closing price at the day of grant. The Stock Awards include vested and unvested grants of stock awards as reflected in the table titled &#8220;Stock Awards at Fiscal Year End.&#8221;&#160;&#160;</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The following table shows, for fiscal 2022, the compensation awarded to, earned by, or paid to non-employee directors who served on the Board during the fiscal year.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td id="new_id-3321" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3322" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of Stock </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Awards </b></p>
			</td>
			<td id="new_id-3323" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3324" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3325" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3326" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Richard Prins</p>
			</td>
			<td id="new_id-3327" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3328" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3329" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">800</td>
			<td id="new_id-3330" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3331" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3332" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3333" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">977</td>
			<td id="new_id-3334" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">James Moran</p>
			</td>
			<td id="new_id-3335" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3336" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3337" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">150</td>
			<td id="new_id-3338" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3339" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3340" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3341" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">147</td>
			<td id="new_id-3342" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align: top; width: 94%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Total Compensation represents the fair value of stock awards to the named director as computed using the closing price at the day of grant. The Stock Awards include vested and unvested grants of stock awards. They also include two categories of Stock Awards that are set out in the tables titled &#8220;Performance Based Stock Awards&#8221;&#160;and &#8220;Market Price Based Stock Awards,&#8221;&#160;neither of these categories of Stock Awards vested as of March 31, 2022.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Stock Awards at Fiscal Year End</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:18.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>unvested Stock Awards (#)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Value of unvested</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Stock Awards ($)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Value of vested </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Stock Awards in Fiscal Year ($)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Value of</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Stock Awards ($)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ram Mukunda</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,200</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,352</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1,460</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">4,812</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claudia Grimaldi</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">312</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">292</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">182</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">474</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Richard Prins</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">592</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">609</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">304</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">913</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">James Moran</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">117</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">78</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">63</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">141</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Stock Awards reflect the grant date fair value, in accordance with Accounting Standards Codification (ASC) Topic 718, Compensation &#8212; Stock Compensation (formerly Statement of Financial Accounting Standards (SFAS) No. 123R) for awards pursuant to the Company&#8217;s equity incentive program.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Included in the tables above are two categories of Stock Awards: (i) performance-based stock awards that are based on achieving milestones in the area of drug development; and (ii) market price-based awards, based on advancing the IGC stock price. Both categories are set out in the two tables titled &#8220;Performance Based Stock Awards&#8221; and &#8220;Market Price Based Stock Awards.&#8221;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">80</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Performance Based Stock Awards</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="3" style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 28.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Performance based Stock Awards</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">These vest when milestones are met</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Milestones</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Stock Awards</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Comments</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Successful filing of IGC-AD1 protocol for Phase 2</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">750,000</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Including the removal of any initial clinical holds</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Commencement of IGC-AD1 Phase 2 trial</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">250,000</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Including selection of sites</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Completion of IGC-AD1 Phase 2 trial</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">300,782</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Completion of trial and closing of data</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filing of Clinical Research Report (CSR) on Phase 2</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">180,469</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Analysis of data and filing of CSR with the FDA</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Successful filing of IGC-AD1 protocol for Phase 3</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,203,125</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Including the removal of any initial clinical holds</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total performance-based Stock Awards</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2,684,376</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The total vests at the commencement of Phase 3, or commercialization of IGC-AD1 based on alternate FDA pathways, or the sale of IGC-AD1. All Stock Awards vest in the event of a change of control</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Market Based Stock Awards</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="3" style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 28.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Market based Stock Awards</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">These vest when a target is met</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Targets</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Stock Awards</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Comments</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC stock price at $2.5 or more</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">180,469</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Average closing price over five consecutive trading days</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC stock price of $3.5 or more</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">421,094</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Average closing price over five consecutive trading days</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC stock price of $5 or more</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">601,563</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Average closing price over five consecutive trading days</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.5%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total Market based Stock Awards for the advancement of IGC stock price</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9.3%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>1,203,126</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">All Stock Awards vest in the event of a change of control</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company believes that as of March 31, 2023, all Stock Awards are probable. As of March 31, 2023, 1 million Performance based Stock Awards were issued.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The assumptions used in calculating fair value and amortization schedule based on the probability of achieving milestones and targets are included in Note 14, &#8220;Stock-Based Compensation&#8221; to the Company&#8217;s audited financial statements for Fiscal 2023, included in this report. The Company cautions that the amounts reported in the Director Compensation Table for these awards may not represent the amounts that the directors will realize from the awards. Whether, and to what extent, an individual realizes value will depend on the Company&#8217;s actual operating performance and stock price fluctuations.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Employment contracts</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Ram Mukunda has served as President and Chief Executive Officer of our Company since its inception. On November 18, 2021, the Company, and Mr. Mukunda entered into the 2021 CEO Employment Agreement that expires on November 17, 2026. Pursuant to the 2021 CEO Employment Agreement we pay Mr. Mukunda a base salary of $360,000 per year. The Employment Agreement provides that the Board of Directors of our Company may review and update the targets and amounts for the net revenue and salary and contract bonuses on an annual basis. Mr. Mukunda is entitled to benefits, including insurance, participation in company-wide 401(k), reimbursement of business expenses, 20 days of annual paid vacation, sick leave, domestic help, driver, cook and a car (subject to partial reimbursement by Mr. Mukunda of rental payments for the car and reimbursement of business expenses). In the event of termination without cause, including a change of control, we would be required to pay Mr. Mukunda 1.5 times the average of the total compensation as disclosed in the previous two 10-K filings prior to termination. In addition, all unvested shares would be subject to immediate vesting.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Claudia Grimaldi has served as Vice President, Principal Financial Officer, Chief Compliance Officer, and Director of our subsidiaries since May 9, 2018. On May 5, 2023, the Company and Ms. Grimaldi entered into an Employment Agreement that expires on May 8, 2028 (the 2023 Employment Agreement). Pursuant to the Employment Agreement, we pay Ms. Grimaldi a base salary of $200,000 per year. The Employment Agreement provides that the Company may review and update performance targets and contract bonuses on an annual basis. Ms. Grimaldi is entitled to benefits, including insurance, participation in company-wide 401(k), reimbursement of business expenses, 20 days of annual paid vacation, sick leave, and a car (subject to partial reimbursement by Ms. Grimaldi of rental payments for the car). In the event of termination without cause, including a change of control, we would be required to pay Ms. Grimaldi 1.5 times her compensation. In addition, unvested shares that would otherwise vest in a 12-month period would be subject to immediate vesting.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">81</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For non-employee directors, the Company has a standard compensation arrangement such as fees for committee service, service as chairman of the board, or a committee, and meeting attendance.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Compensation risk assessment</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In setting compensation, the Compensation Committee considers the risks to our stockholders and to achievement of our goals that may be inherent in our compensation programs. The Compensation Committee reviewed and discussed its assessment with management and concluded that our compensation programs are within industry standards and are designed with the appropriate balance of risk and reward to align employees&#8217; interests with those of our Company and do not incent employees to take unnecessary or excessive risks. Although a portion of our executives&#8217; and employees&#8217; compensation is performance-based and &#8220;at risk,&#8221; we believe our compensation plans are appropriately structured and are not reasonably likely to result in a material adverse effect on our Company.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i12" title="i12"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth information regarding the beneficial ownership of our common stock as of July 6, 2023, by each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock, each of our executive officers and directors, and all our officers and directors as a group.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Beneficial ownership is determined in accordance with the rules of the SEC and does not necessarily indicate beneficial ownership for any other purpose. Under these rules, beneficial ownership includes those shares of common stock over which the stockholder has sole or shared voting or investment power. It also includes shares of common stock that the stockholder has a right to acquire within 60 days through the exercise of any option, or other right. The percentage ownership of the outstanding common stock, which is based upon shares of common stock outstanding as of July 6, 2023, is based on the assumption, expressly required by the rules of the SEC, that only the person or entity whose ownership is being reported has exercised options to purchase shares of our common stock.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially owned by them. Unless otherwise noted, the nature of the ownership set forth in the table below is common stock of the Company. The table below sets forth as of July 6, 2023, except as noted in the footnotes to the table, certain information with respect to the beneficial ownership of the Company&#8217;s common stock by (i) all persons or groups, according to the most recent Schedule 13D or Schedule 13G filed with the SEC or otherwise known to us, to be the beneficial owners of more than 5% of the outstanding common stock of the Company, (ii) each director of the Company, (iii) the executive officers named in the Summary Compensation Table, and (iv) all such executive officers and directors of the Company as a group.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3343" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-3344" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>Shares Owned</i></b></i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>
			</td>
			<td id="new_id-3345" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name and Address of Beneficial Owner/Named Executive Officers and Directors: (1)</b></p>
			</td>
			<td id="new_id-3346" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3347" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of Shares</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Beneficially Owned (3)</b></p>
			</td>
			<td id="new_id-3348" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3349" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3350" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>of Class*</b></p>
			</td>
			<td id="new_id-3351" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ram Mukunda (2)</p>
			</td>
			<td id="new_id-3352" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3353" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3354" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">8,110</td>
			<td id="new_id-3355" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3356" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3357" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3358" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">13</td>
			<td id="new_id-3359" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-3360">&#160;</td>
			<td id="new_id-3361">&#160;</td>
			<td id="new_id-3362">&#160;</td>
			<td id="new_id-3363">&#160;</td>
			<td id="new_id-3364">&#160;</td>
			<td id="new_id-3365">&#160;</td>
			<td id="new_id-3366">&#160;</td>
			<td id="new_id-3367">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claudia Grimaldi</p>
			</td>
			<td id="new_id-3368" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3369" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3370" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">1,518</td>
			<td id="new_id-3371" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3372" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3373" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3374" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">2</td>
			<td id="new_id-3375" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-3376">&#160;</td>
			<td id="new_id-3377">&#160;</td>
			<td id="new_id-3378">&#160;</td>
			<td id="new_id-3379">&#160;</td>
			<td id="new_id-3380">&#160;</td>
			<td id="new_id-3381">&#160;</td>
			<td id="new_id-3382">&#160;</td>
			<td id="new_id-3383">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Richard Prins</p>
			</td>
			<td id="new_id-3384" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3385" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3386" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">1,915</td>
			<td id="new_id-3387" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3388" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3389" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3390" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">3</td>
			<td id="new_id-3391" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-3392">&#160;</td>
			<td id="new_id-3393">&#160;</td>
			<td id="new_id-3394">&#160;</td>
			<td id="new_id-3395">&#160;</td>
			<td id="new_id-3396">&#160;</td>
			<td id="new_id-3397">&#160;</td>
			<td id="new_id-3398">&#160;</td>
			<td id="new_id-3399">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">James Moran</p>
			</td>
			<td id="new_id-3400" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3401" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3402" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">590</td>
			<td id="new_id-3403" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3404" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3405" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3406" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">1</td>
			<td id="new_id-3407" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-3408">&#160;</td>
			<td id="new_id-3409">&#160;</td>
			<td id="new_id-3410">&#160;</td>
			<td id="new_id-3411">&#160;</td>
			<td id="new_id-3412">&#160;</td>
			<td id="new_id-3413">&#160;</td>
			<td id="new_id-3414">&#160;</td>
			<td id="new_id-3415">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>All Executive Officers and Directors as a group (4 persons)</b></p>
			</td>
			<td id="new_id-3416" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3417" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-3418" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>12,133</b></td>
			<td id="new_id-3419" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3420" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3421" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-3422" style="width: 12%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;"><b>19</b></td>
			<td id="new_id-3423" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">*Based on fully diluted 63,082,750 shares of common stock outstanding as of July 6, 2023.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Unless otherwise indicated, the address of each of the individuals listed in the table is c/o IGC Pharma, Inc., 10224 Falls Road, Potomac, MD 20854.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The beneficial ownership table does not include 777,417 shares of common stock that is owned by Mr. Mukunda&#8217;s spouse for which Mr. Mukunda has no voting or financial rights.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(3)</p>
			</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The beneficial ownership table includes approximately 8.9 million shares granted but not vested/issued to individuals listed in the table as of July 6, 2023.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">82</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p><div>

</div><div><a id="i13" title="i13"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During the last two fiscal years, we have not entered into any material transactions or series of transactions that would be considered material in which any officer, director, or beneficial owner of 5% or more of any class of our capital stock, or any immediate family member of any of the preceding persons, had direct or indirect material interest, nor are there any such transactions presently proposed, other than the agreements with the affiliates of our CEO as described under &#8220;Executive Compensation &#8211; Compensation for Executive Officers of the Company.&#8221;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Review, approval, or ratification of related party transactions</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have a written policy for the review and approval of transactions with related persons. It is our policy for the disinterested members of our Board to review all related party transactions on a case-by-case basis. To receive approval, a related-party transaction must have a business purpose for us and be on terms that are fair and reasonable to us and as favorable to us as would be available from non-related entities in comparable transactions.</p><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i14" title="i14"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Manohar Chowdhry &amp; Associates (MCA) is our Principal Independent Registered Public Accounting Firm engaged to examine our financial statements for Fiscal 2023. During the Company&#8217;s two most recent fiscal years ended March 31, 2023, and 2022, and through July 6, 2023, the Company did not consult with MCA on (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that may be rendered on the Company&#8217;s financial statements, and MCA has not provided either a written report or oral advice to the Company that was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue; or (ii) the subject of any disagreement, as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions, or a reportable event within the meaning set forth in Item 304(a)(1)(v) of Regulation S-K.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Audit related and other fees</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The table below shows the fees that we paid or accrued for the audit and other services provided by Manohar Chowdhry &amp; Associates for Fiscal 2023 and Fiscal 2022.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Audit fees</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This category includes the audit of our annual financial statements, review of financial statements included in our annual and quarterly reports and services that are normally provided by the independent registered public accounting firms in connection with engagements for those fiscal years. This category also includes advice on audit and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Internal control audit fees</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This category includes the audit of the Company&#8217;s internal control over financial reporting based on criteria established in Internal Control&#8212;Integrated Framework: (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Audit-related fees</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This category consists of assurance and related services by the independent registered public accounting firms that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under &#8220;Audit Fees.&#8221; The services for the fees disclosed under this category include services relating to our registration statement and consultation regarding our correspondence with the SEC.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Tax fees</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This category consists of professional services rendered for tax compliance, tax planning, and tax advice. These services include tax return preparation and advice on state and local tax issues.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">83</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>All other fees</i></b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This category consists of fees for other miscellaneous items.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &#34;Times New Roman&#34;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3424" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-3425" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-3426" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3427" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-3428" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31,</b></p>
			</td>
			<td id="new_id-3429" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3430" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3431" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			</td>
			<td id="new_id-3432" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3433" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3434" style="text-align: center; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			</td>
			<td id="new_id-3435" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-3436">&#160;</td>
			<td id="new_id-3437">&#160;</td>
			<td id="new_id-3438">&#160;</td>
			<td id="new_id-3439">&#160;</td>
			<td id="new_id-3440">&#160;</td>
			<td id="new_id-3441">&#160;</td>
			<td id="new_id-3442">&#160;</td>
			<td id="new_id-3443">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Audit fees - Manohar Chowdhry &amp; Associates</p>
			</td>
			<td id="new_id-3444" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3445" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id="new_id-3446" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">66</td>
			<td id="new_id-3447" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3448" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3449" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id="new_id-3450" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">64</td>
			<td id="new_id-3451" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Audit-related fees - Manohar Chowdhry &amp; Associates</p>
			</td>
			<td id="new_id-3452" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3453" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3454" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-3455" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3456" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3457" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3458" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-3459" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax fees</p>
			</td>
			<td id="new_id-3460" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3461" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3462" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">11</td>
			<td id="new_id-3463" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3464" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3465" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3466" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">9</td>
			<td id="new_id-3467" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">All other fees</p>
			</td>
			<td id="new_id-3468" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3469" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3470" style="text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3471" style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3472" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3473" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3474" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-3475" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-3476" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3477" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td>
			<td id="new_id-3478" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>77</b></td>
			<td id="new_id-3479" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3480" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3481" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td>
			<td id="new_id-3482" style="width: 16%; text-align: right; font-family: &#34;Times New Roman&#34;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>73</b></td>
			<td id="new_id-3483" style="width: 1%; font-family: &#34;Times New Roman&#34;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Policy on pre-approval of audit and permissible non-audit services of independent auditors</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Consistent with SEC policies regarding auditor independence, the audit committee of our Board of Directors has responsibility for appointing, setting compensation, and overseeing the work of the independent auditor. In recognition of this responsibility, our Board of Directors has established a policy to pre-approve all audit and permissible non-audit services provided by the independent auditor. Prior to engagement of the independent auditor for the next year&#8217;s audit, management may submit, if necessary, an aggregate of services expected to be rendered during that year for each of the following four categories of services to our Board of Directors for approval.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Audit</i>&#160;services include audit work performed in the preparation of financial statements and audit of internal controls, as well as work that generally only the independent auditor can reasonably be expected to provide, including comfort letters, statutory audits, and attest services and consultation regarding financial accounting and/or reporting standards.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Audit-Related</i>&#160;services are for assurance and related services that are traditionally performed by the independent auditor, including due diligence related to mergers and acquisitions, employee benefit plan audits, and special procedures required to meet certain regulatory requirements.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Tax</i>&#160;services include all services performed by the independent auditor&#8217;s tax personnel except those services specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning, and tax advice.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:0.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Other</i>&#160;Fees are those associated with services not captured in the other categories.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Prior to engagement, our Board of Directors pre-approves these services by category of service. The fees are budgeted, and our Board of Directors requires the independent auditor and management to report actual fees versus the budget periodically throughout the year by category of service. During the year, circumstances may arise when it may become necessary to engage the independent auditor for additional services not contemplated in the original pre-approval. In those instances, our Board of Directors requires specific pre-approval before engaging the independent auditor.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our audit committee may delegate pre-approval authority to one or more of its members. The member to whom such authority is delegated must report, for informational purposes only, any pre-approval decisions to our Board of Directors at its next scheduled meeting.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">84</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Pre-approved services</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Audit Committee&#8217;s charter provides for pre-approval of audit, audit-related and tax services to be performed by the independent auditors. The Audit Committee approved the audit, audit-related and tax services to be performed by independent auditors and tax professionals in Fiscal 2023. The charter also authorizes the Audit Committee to delegate to one or more of its members pre-approval authority with respect to permitted services. The decisions of any Audit Committee member to whom pre-approval authority is delegated must be presented to the full Audit Committee at its next scheduled meeting. The Audit Committee has not delegated such authority to its members.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Audit committee report</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Audit Committee of the Board is composed of two directors, each of whom meets the current NYSE American test for independence. The Committee acts under a written charter adopted by the Board. The Audit Committee has prepared the following report on its activities with respect to the Company&#8217;s audited financial statements for Fiscal 2023 (the Audited Financial Statements):</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:6.4%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:200.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Audit Committee reviewed and discussed the Company&#8217;s Audited Financial Statements with management;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.4%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:200.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Audit Committee discussed with Manohar Chowdhry &amp; Associates, the Company&#8217;s independent auditors for Fiscal 2023, the matters required to be discussed by AS 1300, as adopted by the Public Company Accounting Oversight Board;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.4%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:200.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Audit Committee received from the independent auditors the written disclosures regarding auditor independence and the letter required by Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees), discussed with Manohar Chowdhry &amp; Associates, its independence from the Company and its management, and considered whether Manohar Chowdhry &amp; Associates&#8217;&#160;provision of non-audit services to the Company was compatible with the auditor&#8217;s independence; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.4%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;width:200.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on the review and discussion referred to above, and in reliance thereon, the Audit Committee recommended to the Board that the Audited Financial Statements be included in the Company&#8217;s Annual Report on Form 10-K for Fiscal 2023, for filing with the U.S. Securities and Exchange Commission.</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All members of the Audit Committee concur in this report.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AUDIT COMMITTEE:</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Richard Prins</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">James Moran</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">85</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PART IV</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i15" title="i15"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The exhibits listed in the accompanying index to exhibits are filed, furnished, or incorporated by reference as part of this Annual Report on Form 10-K.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(a) All Financial Statements</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:9.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Index to Consolidated Financial Statements</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Page</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#report" style="-sec-extract:exhibit;">Report of Independent Registered Public Accounting Firms</a></p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">50</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#bs" style="-sec-extract:exhibit;">Consolidated Balance Sheets</a></p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">51</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#ops" style="-sec-extract:exhibit;">Consolidated Statements of Operations and Comprehensive Loss</a></p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">52</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#se" style="-sec-extract:exhibit;">Consolidated Statements of Stockholders&#8217;&#160;Equity</a></p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">53</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#cf" style="-sec-extract:exhibit;">Consolidated Statements of Cash Flows</a></p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:9.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#notes" style="-sec-extract:exhibit;">Notes to Consolidated Financial Statements</a></p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">55</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(b) Exhibits required by Item 601 of Regulation S-K</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">3.1</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518512001643/ex3-1.htm" style="-sec-extract:exhibit;">Amended&#160;and Restated Articles of Incorporation of the Registrant, as amended on August 1, 2012. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on August 6, 2012).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">3.2</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518521000102/ex_222078.htm" style="-sec-extract:exhibit;">Amendment&#160;to the Amended and Restated Articles of Incorporation of the Registrant as amended on August 2, 2014. (incorporated by reference to Exhibit 3.3 to the Company&#8217;s Post-Effective Amendment No.1 to Form S-3 filed on January 22, 2021).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">3.3</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518523000238/ex_490458.htm" style="-sec-extract:exhibit;">Articles&#160;of Amendment to the Company&#8217;s Amended and Restated Articles of Incorporation filed with the State Department of Assessments and Taxation of Maryland on March 7, 2023 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on March 21, 2023).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">3.4</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518521000102/ex_222077.htm" style="-sec-extract:exhibit;">By-laws&#160;of the Registrant. (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Post-Effective Amendment No.1 to Form S-3 filed on January 22, 2021).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">3.5</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518523000238/ex_490459.htm" style="-sec-extract:exhibit;">Amendment&#160;to the Bylaws of the Company dated March 2, 2023 (incorporated by reference to Exhibit 3.2&#160;to the Company&#8217;s Current Report on Form 8-K filed on March 21, 2023).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">4.1</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518518001786/indiaglob20181002d_424b5.htm" style="-sec-extract:exhibit;">Description&#160;of Common Stock (incorporated by reference to prospectus supplement filed on Oct 2, 2018 to Prospectus effective May 11, 2018)</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">10.01**</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518517002130/ex10-1.htm" style="-sec-extract:exhibit;">2018&#160;Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Definitive Proxy Statement on Form DEF 14A dated October 10, 2017).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">10.02**</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518521001711/ex_309900.htm" style="-sec-extract:exhibit;">Employment&#160;Agreement, effective as of November 18, 2021, by and between India Globalization Capital Inc. and Mr. Ram Mukunda (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 19, 2021).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">10.03**</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518521001863/ex_318372.htm" style="-sec-extract:exhibit;">Restricted&#160;Stock Unit Agreement with CEO Mr. Ram Mukunda (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Registration Statement on Form S-8 filed on December 23, 2021).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">10.04**</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518519000890/ex_147646.htm" style="-sec-extract:exhibit;">Employment&#160;Agreement between India Globalization Capital, Inc. and Claudia Grimaldi dated June 14, 2019 (incorporated by reference to Exhibit 10.03 to the Company&#8217;s Annual Report on Form 10-K dated June 14, 2019).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">10.05</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518517001372/ex99-1.htm" style="-sec-extract:exhibit;">The&#160;definitive license agreement with the University of South Florida making IGC the exclusive licensee of the U.S. patent filing entitled &#8220;THC as a Potential Therapeutic Agent for Alzheimer&#8217;s Disease&#8221;&#160;(incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K dated June 12, 2017).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">10.06</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518521000077/ex_220700.htm" style="-sec-extract:exhibit;">Sales&#160;Agreement dated January 13, 2021, by and between India Globalization Capital, Inc. and The Benchmark Company, LLC (incorporated by reference to exhibit 10.01 to the Company's current report on Form 8-K filed on January 13, 2021).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">10.07</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1326205/000118518522000608/ex_374886.htm" style="-sec-extract:exhibit;">License&#160;Agreement entered into on May 10, 2022 by and between Jawaharlal Nehru Centre For Advanced Scientific Research, Bengaluru and Hamsa Biopharma India Private Limited, Delhi (incorporated by reference to exhibit 10.01 to the Company's current report on Form 8-K filed on May 12, 2022).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">21.1*</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;"><a href="ex_537644.htm" style="-sec-extract:exhibit;">Subsidiaries&#160;of India Globalization Capital, Inc.</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">23.1*</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;"><a href="ex_537645.htm" style="-sec-extract:exhibit;">Consent&#160;of Manohar Chowdhry &amp; Associates.</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">31.1*</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;"><a href="ex_537646.htm" style="-sec-extract:exhibit;">Certificate&#160;pursuant to 17 CFR 240.13a-14(a).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">31.2*</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;"><a href="ex_537647.htm" style="-sec-extract:exhibit;">Certificate&#160;pursuant to 17 CFR 240.13a-14(a).</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">32.1*</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;"><a href="ex_537648.htm" style="-sec-extract:exhibit;">Certificate&#160;pursuant to 18 USC. &#167;&#160;1350.</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">32.2*</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;"><a href="ex_537649.htm" style="-sec-extract:exhibit;">Certificate&#160;pursuant to 18 USC. &#167;&#160;1350.</a></p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">101.INS***</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">Inline XBRL Instance Document.</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">101.SCH***</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">Inline XBRL Taxonomy Extension Schema Document.</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">101.CAL***</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">101.DEF***</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">Inline XBRL Taxonomy Extension Definition Linkbase Document.</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">101.LAB***</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">Inline XBRL Taxonomy Extension Label Linkbase Document.</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">101.PRE***</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</p>
			</td>
		</tr>
		<tr style="font-size: 9pt;">
			<td style="vertical-align: top; width: 5.6%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">104</p>
			</td>
			<td style="vertical-align: top; width: 40.7%; font-size: 9pt;">
			<p style="font-family: &#34;Times New Roman&#34;; font-size: 9pt; font-variant: normal; margin: 0pt;">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">* Filed herewith.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">** Indicates management contract or compensatory plan or arrangement.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">*** Furnished herewith</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="i16" title="i16"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 16. FORM 10 - K SUMMARY</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">None.</p><div>

</div><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">86</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &#34;Times New Roman&#34;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div><div>

</div><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div><a id="sig" title="sig"></a></div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IGC PHARMA, INC.</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:4.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:4.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Ram Mukunda</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ram Mukunda</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:4.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President and Chief Executive Officer</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(Principal Executive Officer)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:4.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Claudia Grimaldi</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claudia Grimaldi</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:4.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vice-president &amp; Chief Compliance Officer</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(Principal Financial Officer)</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</p><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Ram Mukunda</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ram Mukunda</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President, Chief Executive Officer, and Director</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(Principal Executive Officer)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Claudia Grimaldi</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claudia Grimaldi</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vice-president &amp; Chief Compliance Officer, and Director</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(Principal Financial Officer)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#160;</td>
			<td style="vertical-align: top; width: 6%;">&#160;</td>
			<td style="vertical-align: top; width: 44%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Rohit Goel</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rohit Goel</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Principal Accounting Officer</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#160;</td>
			<td style="vertical-align: top; width: 6%;">&#160;</td>
			<td style="vertical-align: top; width: 44%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Richard Prins</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Richard Prins</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chairman of the Board of Directors</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#160;</td>
			<td style="vertical-align: top; width: 6%;">&#160;</td>
			<td style="vertical-align: top; width: 44%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ James Moran</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">James Moran</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p>
			</td>
		</tr>

</table><div>

</div><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><div>

</div><div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &#34;Times New Roman&#34;;">87</div>
</div>
</div>
</div><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:AuditorName">nter;margin:0pt;"&gt;CONSOLIDATED</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" id="hidden-fact-1" name="dei:AuditorLocation">nter;margin:0p</ix:nonNumeric>
<ix:nonFraction contextRef="c3" id="hidden-fact-2" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-3" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001326205</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="igc-20230331.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="ix_0_fact ix_1_fact" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_2_fact ix_3_fact" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_4_fact ix_5_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_6_fact ix_7_fact" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_8_fact ix_9_fact" toRefs="ix_4_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-07-06</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-30</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">igc:ClinicalTrialInventoryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">igc:ClinicalTrialInventoryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="igc:PropertyPlantAndEquipmentTableTypeAxis">igc:PropertyPlantAndEquipmentTableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y4QCn3wy0vWYacVKSOrI2x+HAoVIyehE0TJwp7ZEi22T/0R8HGCwjeAHX54t9rDaOwQnZlYSrrcHEk/vmnsJgrBykMl1kSBM4wydqoLLE94xz5efBgU/huurj9vXfCBprtkvwmaAETomP5VmpXCj02u] CSR-->
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-11</xbrli:startDate>
    <xbrli:endDate>2020-06-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-13</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">igc:ESOP2008OmnibusPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">igc:ESOP2008OmnibusPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2023Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2024Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2025Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2026Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2027Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2028Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2029Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2030Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2031Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2032Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2033Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2034Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2035Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2036Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2037Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2038Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2039Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2040Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2041Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2042Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2043Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:RentalIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:RentalIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ConstructionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ConstructionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:WellnessAndLifestyleMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:WellnessAndLifestyleMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:TollingWhiteLabelingServiceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:TollingWhiteLabelingServiceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:LegacyInfrastructureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:LegacyInfrastructureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:PlantAndCannabinoidMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:PlantAndCannabinoidMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CO</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326205</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-30</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>ex_537644.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html><head>
	<title>ex_537644.htm</title>
	<!-- Generated by ThunderDome Portal - 7/5/2023 12:45:36 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit 21.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The table below lists our subsidiaries.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Subsidiaries </b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Immediate</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>holding company</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Jurisdiction of</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Incorporation</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:6.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Percentage of holding</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>as of March 31, 2023</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:6.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Percentage of holding</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>as of March 31, 2023</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.5%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:6.9%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.5%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:7.5%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.5%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.5%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:5.9%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.5%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.5%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.5%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:5.9%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGCare, LLC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maryland, USA</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC Pharma, LLC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maryland, USA</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Holi Hemp, LLC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maryland, USA</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sunday Seltzer, LLC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maryland, USA</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SAN Holdings, LLC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maryland, USA</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC Pharma SAS (formerly Hamsa Biopharma Colombia SAS) (1)</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Colombia</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Techni Bharathi Private Limited</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(TBL)</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India Mining and Trading Private Limited</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(IGC-IMT) (2)</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC-M</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC Materials Private Limited</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(IGC-MPL) (2)</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC-M</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGC Enterprises Limited</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(IGC-ENT) (3)</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">TBL</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Hong Kong</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:23%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Hamsa Biopharma India Pvt. Ltd.</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IGCare</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">100</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:top;width:12.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Beneficially owned by IGC</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align:top;width:12.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">IGC-M, IGC-IMT, IGC-MPL are non-operating subsidiaries that we are in the process of closing and have&nbsp;not been consolidated. These subsidiaries did not have a material impact on the balance sheet or statement of operations.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(3)</p>
			</td>
			<td style="vertical-align:top;width:12.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Beneficially owned by Techni Bharathi Private Limited (TBL)</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex_537645.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html><head>
	<title>ex_537645.htm</title>
	<!-- Generated by ThunderDome Portal - 7/7/2023 4:46:15 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit 23.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To the Board of Directors</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">IGC Pharma, Inc.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We hereby consent to the incorporation by reference to the Registration Statement No. 333-261861, No. 333-226960, and No. 333-236615 on Form S-8 pertaining to the IGC Pharma, Inc. 2018 Omnibus Incentive Plan and Special Grants, and (ii) Registration Statement No. 333-251654 on Form S-3, of our report dated July 7, 2023, with respect to the consolidated financial statements of IGC Pharma Inc. included in this Annual Report (Form 10-K) for the fiscal year ended March 31, 2023.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>/s/ Manohar Chowdhry &amp; Associates</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Manohar Chowdhry &amp; Associates</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chennai, India</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">July 7, 2023</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>ex_537646.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html><head>
	<title>ex_537646.htm</title>
	<!-- Generated by ThunderDome Portal - 7/7/2023 4:46:06 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit 31.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 17 CFR 240.13(a)-14(a)</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(SECTION 302 CERTIFICATION)</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I, Ram Mukunda, certify that:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I have reviewed this annual report on Form 10-K of IGC Pharma, Inc.;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">a.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">b.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">c.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">d.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">a.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">b.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="3" style="vertical-align:top;width:9.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:8.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Ram Mukunda</p>
			</td>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:bottom;width:8.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ram Mukunda</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:8.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President and Chief Executive Officer</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(Principal Executive Officer)</p>
			</td>
			<td style="vertical-align:top;width:1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>ex_537647.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html><head>
	<title>ex_537647.htm</title>
	<!-- Generated by ThunderDome Portal - 7/7/2023 4:46:25 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit 31.2</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 17 CFR 240.13(a)-14(a)</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(SECTION 302 CERTIFICATION)</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I, Claudia Grimaldi, certify that:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I have reviewed this annual report on Form 10-K of IGC Pharma, Inc.;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">a.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">b.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">c.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">d.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">a.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">b.</p>
			</td>
			<td style="vertical-align:top;width:14.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:7.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Claudia Grimaldi</p>
			</td>
			<td style="vertical-align:bottom;width:3.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:bottom;width:7.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claudia Grimaldi</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vice-president &amp; Chief Compliance Officer</p>
			</td>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:bottom;width:7.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(Principal Financial Officer)</p>
			</td>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>ex_537648.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html><head>
	<title>ex_537648.htm</title>
	<!-- Generated by ThunderDome Portal - 7/7/2023 4:46:33 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit 32.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATION PURSUANT TO 18 USC. SECTION 1350</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In connection with the annual report on Form 10-K of IGC Pharma, Inc. (the &#8220;Company&#8221;) for the year ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Ram Mukunda, Chief Executive Officer, and President of the Company, certify, pursuant to 18 USC. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:14.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:14.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="3" style="vertical-align:top;width:8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:7.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/Ram Mukunda</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:bottom;width:7.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Ram Mukunda</p>
			</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:7.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">President and Chief Executive Officer</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(Principal Executive Officer)</p>
			</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>ex_537649.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html><head>
	<title>ex_537649.htm</title>
	<!-- Generated by ThunderDome Portal - 7/7/2023 4:47:11 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit 32.2</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATION PURSUANT TO 18 USC. SECTION 1350</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In connection with the annual report on Form 10-K of IGC Pharma, Inc. (the &#8220;Company&#8221;) for the year ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Claudia Grimaldi, Vice President, Principal Financial Officer of the Company, certify, pursuant to 18 USC. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:0.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:0.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:12.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:0.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:0.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:12.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:4.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="3" style="vertical-align:top;width:6.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: July 7, 2023</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:2.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Claudia Grimaldi</p>
			</td>
			<td style="vertical-align:bottom;width:3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:bottom;width:5.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claudia Grimaldi</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vice-president &amp; Chief Compliance Officer</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(Principal Financial Officer)</p>
			</td>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>igc-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Jul 07 17:41:02 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2023" targetNamespace="http://www.indiaglobalcap.com/20230331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:igc="http://www.indiaglobalcap.com/20230331" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20230331_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20230331_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20230331_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="igc-20230331_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet" id="igc_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals" id="igc_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement" id="igc_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3" id="igc_r_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ConsolidatedCashFlow" id="igc_r_ConsolidatedCashFlow">
        <link:definition>005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/NATUREOFOPERATIONSANDMANAGEMENTSPLANS" id="igc_r_NATUREOFOPERATIONSANDMANAGEMENTSPLANS">
        <link:definition>006 - Disclosure - NATURE OF OPERATIONS AND MANAGEMENT&#8217;S PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES" id="igc_r_SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/INVENTORY" id="igc_r_INVENTORY">
        <link:definition>008 - Disclosure - INVENTORY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES" id="igc_r_DEPOSITSANDADVANCES">
        <link:definition>009 - Disclosure - DEPOSITS AND ADVANCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETS" id="igc_r_INTANGIBLEASSETS">
        <link:definition>010 - Disclosure - INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT" id="igc_r_PROPERTYPLANTANDEQUIPMENT">
        <link:definition>011 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES" id="igc_r_CLAIMSANDADVANCES">
        <link:definition>012 - Disclosure - CLAIMS AND ADVANCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/LEASES" id="igc_r_LEASES">
        <link:definition>013 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS" id="igc_r_ACCRUEDLIABILITIESANDOTHERS">
        <link:definition>014 - Disclosure - ACCRUED LIABILITIES AND OTHERS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES" id="igc_r_LOANSANDOTHERLIABILITIES">
        <link:definition>015 - Disclosure - LOANS AND OTHER LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES" id="igc_r_COMMITMENTSANDCONTINGENCIES">
        <link:definition>016 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SECURITIES" id="igc_r_SECURITIES">
        <link:definition>017 - Disclosure - SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION" id="igc_r_STOCKBASEDCOMPENSATION">
        <link:definition>018 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS" id="igc_r_FAIRVALUEOFFINANCIALINSTRUMENTS">
        <link:definition>019 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/INCOMETAXES" id="igc_r_INCOMETAXES">
        <link:definition>020 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/REVENUERECOGNITION" id="igc_r_REVENUERECOGNITION">
        <link:definition>021 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATION" id="igc_r_SEGMENTINFORMATION">
        <link:definition>022 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS" id="igc_r_SUBSEQUENTEVENTS">
        <link:definition>023 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy" id="igc_r_AccountingPoliciesByPolicy">
        <link:definition>024 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/INVENTORYTables" id="igc_r_INVENTORYTables">
        <link:definition>025 - Disclosure - INVENTORY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables" id="igc_r_DEPOSITSANDADVANCESTables">
        <link:definition>026 - Disclosure - DEPOSITS AND ADVANCES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables" id="igc_r_INTANGIBLEASSETSTables">
        <link:definition>027 - Disclosure - INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables" id="igc_r_PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>028 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables" id="igc_r_CLAIMSANDADVANCESTables">
        <link:definition>029 - Disclosure - CLAIMS AND ADVANCES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/LEASESTables" id="igc_r_LEASESTables">
        <link:definition>030 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables" id="igc_r_ACCRUEDLIABILITIESANDOTHERSTables">
        <link:definition>031 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables" id="igc_r_LOANSANDOTHERLIABILITIESTables">
        <link:definition>032 - Disclosure - LOANS AND OTHER LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables" id="igc_r_STOCKBASEDCOMPENSATIONTables">
        <link:definition>033 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables" id="igc_r_FAIRVALUEOFFINANCIALINSTRUMENTSTables">
        <link:definition>034 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/INCOMETAXESTables" id="igc_r_INCOMETAXESTables">
        <link:definition>035 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables" id="igc_r_REVENUERECOGNITIONTables">
        <link:definition>036 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables" id="igc_r_SEGMENTINFORMATIONTables">
        <link:definition>037 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails" id="igc_r_SIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/INVENTORYDetails" id="igc_r_INVENTORYDetails">
        <link:definition>039 - Disclosure - INVENTORY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable" id="igc_r_ScheduleofInventoryCurrentTable">
        <link:definition>040 - Disclosure - INVENTORY (Details) - Schedule of Inventory, Current</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails" id="igc_r_DEPOSITSANDADVANCESDetails">
        <link:definition>041 - Disclosure - DEPOSITS AND ADVANCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable" id="igc_r_DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable">
        <link:definition>042 - Disclosure - DEPOSITS AND ADVANCES (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails" id="igc_r_INTANGIBLEASSETSDetails">
        <link:definition>043 - Disclosure - INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable" id="igc_r_ScheduleofIntangibleAssetsAndGoodwillTable">
        <link:definition>044 - Disclosure - INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" id="igc_r_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable">
        <link:definition>045 - Disclosure - INTANGIBLE ASSETS (Details) - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails" id="igc_r_PROPERTYPLANTANDEQUIPMENTDetails">
        <link:definition>046 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y4QCn3wy0vWYacVKSOrI2x+HAoVIyehE0TJwp7ZEi22T/0R8HGCwjeAHX54t9rDaOwQnZlYSrrcHEk/vmnsJgrBykMl1kSBM4wydqoLLE94xz5efBgU/huurj9vXfCBpruerVTKTt3qgJ6a1PPQlFZ2] CSR-->
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable" id="igc_r_PropertyPlantandEquipmentTable">
        <link:definition>047 - Disclosure -  PROPERTY, PLANT AND EQUIPMENT  (Details) - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails" id="igc_r_CLAIMSANDADVANCESDetails">
        <link:definition>048 - Disclosure - CLAIMS AND ADVANCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable" id="igc_r_ScheduleofOtherAssetsNoncurrentTable">
        <link:definition>049 - Disclosure - CLAIMS AND ADVANCES (Details) - Schedule of Other Assets, Noncurrent</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/LEASESDetails" id="igc_r_LEASESDetails">
        <link:definition>050 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/LeaseCostTable" id="igc_r_LeaseCostTable">
        <link:definition>051 - Disclosure - LEASES (Details) - Lease, Cost</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable" id="igc_r_LesseeOperatingLeaseLiabilityMaturityTable">
        <link:definition>052 - Disclosure - LEASES (Details) - Lessee, Operating Lease, Liability, Maturity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails" id="igc_r_ACCRUEDLIABILITIESANDOTHERSDetails">
        <link:definition>053 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" id="igc_r_ScheduleofAccountsPayableandAccruedLiabilitiesTable">
        <link:definition>054 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Details) - Schedule of Accounts Payable and Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails" id="igc_r_LOANSANDOTHERLIABILITIESDetails">
        <link:definition>055 - Disclosure - LOANS AND OTHER LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable" id="igc_r_ScheduleofLoansandOtherLiabilitiesTable">
        <link:definition>056 - Disclosure - LOANS AND OTHER LIABILITIES (Details) - Schedule of Loans and Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails" id="igc_r_COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>057 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SECURITIESDetails" id="igc_r_SECURITIESDetails">
        <link:definition>058 - Disclosure - SECURITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails" id="igc_r_STOCKBASEDCOMPENSATIONDetails">
        <link:definition>059 - Disclosure - STOCK-BASED COMPENSATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable" id="igc_r_ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable">
        <link:definition>060 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable" id="igc_r_NonvestedRestrictedStockSharesActivityTable">
        <link:definition>061 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Nonvested Restricted Stock Shares Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable" id="igc_r_SharebasedPaymentArrangementOptionActivityTable">
        <link:definition>062 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Share-based Payment Arrangement, Option, Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" id="igc_r_ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable">
        <link:definition>063 - Disclosure -  FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable" id="igc_r_ScheduleofEffectiveIncomeTaxRateReconciliationTable">
        <link:definition>064 - Disclosure - INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable" id="igc_r_ScheduleofComponentsofIncomeTaxExpenseBenefitTable">
        <link:definition>065 - Disclosure - INCOME TAXES (Details) - Schedule of Components of Income Tax Expense (Benefit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable" id="igc_r_SummaryofOperatingLossCarryforwardsTable">
        <link:definition>066 - Disclosure - INCOME TAXES (Details) - Summary of Operating Loss Carryforwards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable" id="igc_r_DisaggregationofRevenueTable">
        <link:definition>067 - Disclosure - REVENUE RECOGNITION (Details) - Disaggregation of Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails" id="igc_r_SEGMENTINFORMATIONDetails">
        <link:definition>068 - Disclosure - SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable" id="igc_r_RevenuefromExternalCustomersbyProductsandServicesTable">
        <link:definition>069 - Disclosure - SEGMENT INFORMATION (Details) - Revenue from External Customers by Products and Services</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable" id="igc_r_RevenuefromExternalCustomersbyGeographicAreasTable">
        <link:definition>070 - Disclosure - SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable" id="igc_r_ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable">
        <link:definition>071 - Disclosure - SEGMENT INFORMATION (Details) - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails" id="igc_r_SUBSEQUENTEVENTSDetails">
        <link:definition>072 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.indiaglobalcap.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:element name="ScheduleOfInventoryCurrentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfInventoryCurrentAbstract"/>
  <xs:element name="DepositsAndAdvancesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_DepositsAndAdvancesAbstract"/>
  <xs:element name="ScheduleOfIntangibleAssetsAndGoodwillAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfIntangibleAssetsAndGoodwillAbstract"/>
  <xs:element name="ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
  <xs:element name="ScheduleOfOtherAssetsNoncurrentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfOtherAssetsNoncurrentAbstract"/>
  <xs:element name="LesseeOperatingLeaseLiabilityMaturityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_LesseeOperatingLeaseLiabilityMaturityAbstract"/>
  <xs:element name="AccruedLiabilitiesDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_AccruedLiabilitiesDisclosureAbstract"/>
  <xs:element name="ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract"/>
  <xs:element name="LoansAndOtherLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_LoansAndOtherLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfLoansAndOtherLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfLoansAndOtherLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract"/>
  <xs:element name="NonvestedRestrictedStockSharesActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_NonvestedRestrictedStockSharesActivityAbstract"/>
  <xs:element name="ShareBasedPaymentArrangementOptionActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ShareBasedPaymentArrangementOptionActivityAbstract"/>
  <xs:element name="ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract"/>
  <xs:element name="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract"/>
  <xs:element name="ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract"/>
  <xs:element name="SummaryOfOperatingLossCarryforwardsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_SummaryOfOperatingLossCarryforwardsAbstract"/>
  <xs:element name="RevenueFromExternalCustomersByProductsAndServicesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_RevenueFromExternalCustomersByProductsAndServicesAbstract"/>
  <xs:element name="RevenueFromExternalCustomersByGeographicAreasAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_RevenueFromExternalCustomersByGeographicAreasAbstract"/>
  <xs:element name="ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract"/>
  <xs:element name="NonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_NonCurrentAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract1"/>
  <xs:element name="NonCurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_NonCurrentLiabilitiesAbstract"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract2"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract4"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract5"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract6"/>
  <xs:element name="AdjustmentToReconcileNetLossToNetCashAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_AdjustmentToReconcileNetLossToNetCashAbstract"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract7"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract8"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract9"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract10"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract11"/>
  <xs:element name="NonCashItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_NonCashItemsAbstract"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract12"/>
  <xs:element name="UnamortizedIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnamortizedIntangibleAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract13"/>
  <xs:element name="NoncurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_NoncurrentLiabilitiesAbstract"/>
  <xs:element name="CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract14"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract15"/>
  <xs:element name="InvestmentsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_InvestmentsAbstract0"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract16"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract17"/>
  <xs:element name="InfrastructureSegmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_InfrastructureSegmentAbstract"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract18"/>
  <xs:element name="UnlabeledAbstract19" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnlabeledAbstract19"/>
  <xs:element name="LifeSciencesSegmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_LifeSciencesSegmentAbstract"/>
  <xs:element name="EarningsPerShareBasicDiluted" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_EarningsPerShareBasicDiluted"/>
  <xs:element name="WeightedAverageNumberOfShareOutstandingBasicDiluted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted"/>
  <xs:element name="IncreaseDecreaseInOperatingLeaseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="igc_IncreaseDecreaseInOperatingLeaseAssets"/>
  <xs:element name="DepositsAndAdvancesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_DepositsAndAdvancesTextBlock"/>
  <xs:element name="AccruedLiabilitiesDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_AccruedLiabilitiesDisclosureTextBlock"/>
  <xs:element name="LoansAndOtherLiabilitiesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_LoansAndOtherLiabilitiesTextBlock"/>
  <xs:element name="GoingConcernPolicyPolicyTextblock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_GoingConcernPolicyPolicyTextblock"/>
  <xs:element name="CybersecurityPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_CybersecurityPolicyPolicyTextBlock"/>
  <xs:element name="PropertyPlantAndEquipmentTableTypeDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_PropertyPlantAndEquipmentTableTypeDomainDomain"/>
  <xs:element name="PROPERTYPLANTANDEQUIPMENTTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_PROPERTYPLANTANDEQUIPMENTTablesTable"/>
  <xs:element name="PROPERTYPLANTANDEQUIPMENTTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems"/>
  <xs:element name="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable"/>
  <xs:element name="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems"/>
  <xs:element name="PropertyPlantAndEquipmentEstimatedUsefulLives1" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1"/>
  <xs:element name="OtherAdvances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="igc_OtherAdvances"/>
  <xs:element name="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"/>
  <xs:element name="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems"/>
  <xs:element name="TotalRevenuePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_TotalRevenuePercentage"/>
  <xs:element name="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable"/>
  <xs:element name="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
  <xs:element name="StatutoryAdvances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="igc_StatutoryAdvances"/>
  <xs:element name="TransferFromDepositsAndAdvancesToClaimsAndAdvances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances"/>
  <xs:element name="INTANGIBLEASSETSDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_INTANGIBLEASSETSDetailsTable"/>
  <xs:element name="INTANGIBLEASSETSDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_INTANGIBLEASSETSDetailsLineItems"/>
  <xs:element name="NumberOfPatents" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_NumberOfPatents"/>
  <xs:element name="NumberOfPatentsGranted" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_NumberOfPatentsGranted"/>
  <xs:element name="PROPERTYPLANTANDEQUIPMENTDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_PROPERTYPLANTANDEQUIPMENTDetailsTable"/>
  <xs:element name="PROPERTYPLANTANDEQUIPMENTDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems"/>
  <xs:element name="LEASESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_LEASESDetailsTable"/>
  <xs:element name="LEASESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_LEASESDetailsLineItems"/>
  <xs:element name="UnitsOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnitsOutstanding"/>
  <xs:element name="UnitDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_UnitDescription"/>
  <xs:element name="SalesAgreementMaximum" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="igc_SalesAgreementMaximum"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_STOCKBASEDCOMPENSATIONDetailsTable"/>
  <xs:element name="STOCKBASEDCOMPENSATIONDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_STOCKBASEDCOMPENSATIONDetailsLineItems"/>
  <xs:element name="WeightedAveragePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_WeightedAveragePricePerShare"/>
  <xs:element name="SUBSEQUENTEVENTSDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="igc_SUBSEQUENTEVENTSDetailsTable"/>
  <xs:element name="SUBSEQUENTEVENTSDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_SUBSEQUENTEVENTSDetailsLineItems"/>
  <xs:element name="PropertyPlantAndEquipmentTableTypeAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="igc_PropertyPlantAndEquipmentTableTypeAxis"/>
  <xs:element name="ClinicalTrialInventoryMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ClinicalTrialInventoryMember"/>
  <xs:element name="ESOP2008OmnibusPlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_ESOP2008OmnibusPlanMember"/>
  <xs:element name="Expiring2023Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2023Member"/>
  <xs:element name="Expiring2024Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2024Member"/>
  <xs:element name="Expiring2025Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2025Member"/>
  <xs:element name="Expiring2026Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2026Member"/>
  <xs:element name="Expiring2027Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2027Member"/>
  <xs:element name="Expiring2028Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2028Member"/>
  <xs:element name="Expiring2029Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2029Member"/>
  <xs:element name="Expiring2030Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2030Member"/>
  <xs:element name="Expiring2031Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2031Member"/>
  <xs:element name="Expiring2032Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2032Member"/>
  <xs:element name="Expiring2033Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2033Member"/>
  <xs:element name="Expiring2034Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2034Member"/>
  <xs:element name="Expiring2035Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2035Member"/>
  <xs:element name="Expiring2036Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2036Member"/>
  <xs:element name="Expiring2037Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2037Member"/>
  <xs:element name="Expiring2038Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2038Member"/>
  <xs:element name="Expiring2039Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2039Member"/>
  <xs:element name="Expiring2040Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2040Member"/>
  <xs:element name="Expiring2041Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2041Member"/>
  <xs:element name="Expiring2042Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2042Member"/>
  <xs:element name="Expiring2043Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_Expiring2043Member"/>
  <xs:element name="LegacyInfrastructureMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_LegacyInfrastructureMember"/>
  <xs:element name="PlantAndCannabinoidMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_PlantAndCannabinoidMember"/>
  <xs:element name="PropertyPlantAndEquipmentTableMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_PropertyPlantAndEquipmentTableMember"/>
  <xs:element name="RentalIncomeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_RentalIncomeMember"/>
  <xs:element name="TollingWhiteLabelingServiceMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_TollingWhiteLabelingServiceMember"/>
  <xs:element name="WellnessAndLifestyleMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_WellnessAndLifestyleMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="igc_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>igc-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Jul 07 17:41:02 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedBalanceSheet" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedIncomeStatement" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedCashFlow" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofInventoryCurrentTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable" roleURI="http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofIntangibleAssetsAndGoodwillTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PropertyPlantandEquipmentTable" roleURI="http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofOtherAssetsNoncurrentTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LeaseCostTable" roleURI="http://www.indiaglobalcap.com/role/LeaseCostTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofAccountsPayableandAccruedLiabilitiesTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofLoansandOtherLiabilitiesTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofEffectiveIncomeTaxRateReconciliationTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofComponentsofIncomeTaxExpenseBenefitTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_ImpairmentOfInvestments" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AssetImpairmentCharges" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ImpairmentOfInvestments" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="igc_IncreaseDecreaseInOperatingLeaseAssets" xlink:href="igc-20230331.xsd#igc_IncreaseDecreaseInOperatingLeaseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="igc_IncreaseDecreaseInOperatingLeaseAssets" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1" weight="1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y4QCn3wy0vWYacVKSOrI2x+HAoVIyehE0TJwp7ZEi22T/0R8HGCwjeAHX54t9rDaOwQnZlYSrrcHEk/vmnsJgrBykMl1kSBM4wydqoLLE94xz5efBgU/huurj9vXfCBpruRMF7tZYd4gM2/7XTUhhsU] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterials" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcess" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoods" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventoryNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherInventoryNetOfReserves" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherReceivables" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="igc_OtherAdvances" xlink:href="igc-20230331.xsd#igc_OtherAdvances"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="igc_OtherAdvances" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LeaseCostTable">
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_ShortTermLeaseCost" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent" order="1" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable">
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_Investments" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" order="5" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>igc-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Jul 07 17:41:02 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedBalanceSheet" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedIncomeStatement" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ShareholdersEquityType2or3" roleURI="http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedCashFlow" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_NATUREOFOPERATIONSANDMANAGEMENTSPLANS" roleURI="http://www.indiaglobalcap.com/role/NATUREOFOPERATIONSANDMANAGEMENTSPLANS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INVENTORY" roleURI="http://www.indiaglobalcap.com/role/INVENTORY"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DEPOSITSANDADVANCES" roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INTANGIBLEASSETS" roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PROPERTYPLANTANDEQUIPMENT" roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_CLAIMSANDADVANCES" roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LEASES" roleURI="http://www.indiaglobalcap.com/role/LEASES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ACCRUEDLIABILITIESANDOTHERS" roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LOANSANDOTHERLIABILITIES" roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SECURITIES" roleURI="http://www.indiaglobalcap.com/role/SECURITIES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_STOCKBASEDCOMPENSATION" roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_FAIRVALUEOFFINANCIALINSTRUMENTS" roleURI="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INCOMETAXES" roleURI="http://www.indiaglobalcap.com/role/INCOMETAXES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_REVENUERECOGNITION" roleURI="http://www.indiaglobalcap.com/role/REVENUERECOGNITION"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SEGMENTINFORMATION" roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATION"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SUBSEQUENTEVENTS" roleURI="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_AccountingPoliciesByPolicy" roleURI="http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INVENTORYTables" roleURI="http://www.indiaglobalcap.com/role/INVENTORYTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DEPOSITSANDADVANCESTables" roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INTANGIBLEASSETSTables" roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_CLAIMSANDADVANCESTables" roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LEASESTables" roleURI="http://www.indiaglobalcap.com/role/LEASESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ACCRUEDLIABILITIESANDOTHERSTables" roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LOANSANDOTHERLIABILITIESTables" roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_STOCKBASEDCOMPENSATIONTables" roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_FAIRVALUEOFFINANCIALINSTRUMENTSTables" roleURI="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INCOMETAXESTables" roleURI="http://www.indiaglobalcap.com/role/INCOMETAXESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_REVENUERECOGNITIONTables" roleURI="http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SEGMENTINFORMATIONTables" roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofInventoryCurrentTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable" roleURI="http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofIntangibleAssetsAndGoodwillTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PropertyPlantandEquipmentTable" roleURI="http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofOtherAssetsNoncurrentTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LeaseCostTable" roleURI="http://www.indiaglobalcap.com/role/LeaseCostTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LesseeOperatingLeaseLiabilityMaturityTable" roleURI="http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofAccountsPayableandAccruedLiabilitiesTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofLoansandOtherLiabilitiesTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_NonvestedRestrictedStockSharesActivityTable" roleURI="http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SharebasedPaymentArrangementOptionActivityTable" roleURI="http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofEffectiveIncomeTaxRateReconciliationTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofComponentsofIncomeTaxExpenseBenefitTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SummaryofOperatingLossCarryforwardsTable" roleURI="http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DisaggregationofRevenueTable" roleURI="http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_RevenuefromExternalCustomersbyProductsandServicesTable" roleURI="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_RevenuefromExternalCustomersbyGeographicAreasTable" roleURI="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INVENTORYDetails" roleURI="http://www.indiaglobalcap.com/role/INVENTORYDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DEPOSITSANDADVANCESDetails" roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INTANGIBLEASSETSDetails" roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_CLAIMSANDADVANCESDetails" roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LEASESDetails" roleURI="http://www.indiaglobalcap.com/role/LEASESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ACCRUEDLIABILITIESANDOTHERSDetails" roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LOANSANDOTHERLIABILITIESDetails" roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SECURITIESDetails" roleURI="http://www.indiaglobalcap.com/role/SECURITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_STOCKBASEDCOMPENSATIONDetails" roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SEGMENTINFORMATIONDetails" roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SUBSEQUENTEVENTSDetails" roleURI="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#DocumentAndEntityInformation" roleURI="http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_NonCurrentAssetsAbstract" xlink:href="igc-20230331.xsd#igc_NonCurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="igc_NonCurrentAssetsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCurrentAssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCurrentAssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCurrentAssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCurrentAssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_NonCurrentLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_NonCurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="igc_NonCurrentLiabilitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_ImpairmentOfInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ProfitLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_EarningsPerShareBasicDiluted" xlink:href="igc-20230331.xsd#igc_EarningsPerShareBasicDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="igc_EarningsPerShareBasicDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted" xlink:href="igc-20230331.xsd#igc_WeightedAverageNumberOfShareOutstandingBasicDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:href="igc-20230331.xsd#igc_AdjustmentToReconcileNetLossToNetCashAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="igc_AdjustmentToReconcileNetLossToNetCashAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_ImpairmentOfInvestments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_IncreaseDecreaseInOperatingLeaseAssets" xlink:href="igc-20230331.xsd#igc_IncreaseDecreaseInOperatingLeaseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="igc_IncreaseDecreaseInOperatingLeaseAssets" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_NonCashItemsAbstract" xlink:href="igc-20230331.xsd#igc_NonCashItemsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="igc_NonCashItemsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCashItemsAbstract" xlink:to="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesReduction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReduction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonCashItemsAbstract" xlink:to="us-gaap_NotesReduction" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/NATUREOFOPERATIONSANDMANAGEMENTSPLANS">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INVENTORY">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES">
    <loc xlink:type="locator" xlink:label="igc_DepositsAndAdvancesAbstract" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesAbstract"/>
    <loc xlink:type="locator" xlink:label="igc_DepositsAndAdvancesTextBlock" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_DepositsAndAdvancesAbstract" xlink:to="igc_DepositsAndAdvancesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INTANGIBLEASSETS">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LEASES">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS">
    <loc xlink:type="locator" xlink:label="igc_AccruedLiabilitiesDisclosureAbstract" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="igc_AccruedLiabilitiesDisclosureTextBlock" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AccruedLiabilitiesDisclosureAbstract" xlink:to="igc_AccruedLiabilitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES">
    <loc xlink:type="locator" xlink:label="igc_LoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="igc_LoansAndOtherLiabilitiesTextBlock" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="igc_LoansAndOtherLiabilitiesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SECURITIES">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INCOMETAXES">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/REVENUERECOGNITION">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SEGMENTINFORMATION">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_GoingConcernPolicyPolicyTextblock" xlink:href="igc-20230331.xsd#igc_GoingConcernPolicyPolicyTextblock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="igc_GoingConcernPolicyPolicyTextblock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_CybersecurityPolicyPolicyTextBlock" xlink:href="igc-20230331.xsd#igc_CybersecurityPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="igc_CybersecurityPolicyPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INVENTORYTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables">
    <loc xlink:type="locator" xlink:label="igc_DepositsAndAdvancesAbstract" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_DepositsAndAdvancesAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables">
    <loc xlink:type="locator" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTTablesTable" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems" xlink:to="igc_PROPERTYPLANTANDEQUIPMENTTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentTableTypeAxis" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTTablesTable" xlink:to="igc_PropertyPlantAndEquipmentTableTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentTableTypeDomainDomain" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableTypeDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="igc_PropertyPlantAndEquipmentTableTypeAxis" xlink:to="igc_PropertyPlantAndEquipmentTableTypeDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentTableTypeDomainDomain_0" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableTypeDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="igc_PropertyPlantAndEquipmentTableTypeAxis" xlink:to="igc_PropertyPlantAndEquipmentTableTypeDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentTableMember" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_PropertyPlantAndEquipmentTableTypeDomainDomain" xlink:to="igc_PropertyPlantAndEquipmentTableMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LEASESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables">
    <loc xlink:type="locator" xlink:label="igc_AccruedLiabilitiesDisclosureAbstract" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AccruedLiabilitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables">
    <loc xlink:type="locator" xlink:label="igc_LoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INCOMETAXESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable">
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfInventoryCurrentAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfInventoryCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfInventoryCurrentAbstract" xlink:to="us-gaap_InventoryRawMaterials" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfInventoryCurrentAbstract" xlink:to="us-gaap_InventoryWorkInProcess" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfInventoryCurrentAbstract" xlink:to="us-gaap_InventoryFinishedGoods" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfInventoryCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventoryNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_OtherInventoryNetOfReserves" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable">
    <loc xlink:type="locator" xlink:label="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_OtherIntangibleAssetsMember" order="1" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_UnamortizedIntangibleAssetsAbstract" xlink:href="igc-20230331.xsd#igc_UnamortizedIntangibleAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="igc_UnamortizedIntangibleAssetsAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_UnamortizedIntangibleAssetsAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable">
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentEstimatedUsefulLives1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="3" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y4QCn3wy0vWYacVKSOrI2x+HAoVIyehE0TJwp7ZEi22T/0R8HGCwjeAHX54t9rDaOwQnZlYSrrcHEk/vmnsJgrBykMl1kSBM4wydqoLLE94xz5efBgU/huurj9vXfCBprskmI/1msx8wnSnG9zMO3P+] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable">
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfOtherAssetsNoncurrentAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfOtherAssetsNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_OtherReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_OtherAdvances" xlink:href="igc-20230331.xsd#igc_OtherAdvances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="igc_OtherAdvances" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LeaseCostTable">
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_ShortTermLeaseCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_AssetsAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable">
    <loc xlink:type="locator" xlink:label="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:href="igc-20230331.xsd#igc_LesseeOperatingLeaseLiabilityMaturityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfLoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfLoansAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfLoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfLoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable">
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable">
    <loc xlink:type="locator" xlink:label="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:href="igc-20230331.xsd#igc_NonvestedRestrictedStockSharesActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable">
    <loc xlink:type="locator" xlink:label="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:href="igc-20230331.xsd#igc_ShareBasedPaymentArrangementOptionActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable">
    <loc xlink:type="locator" xlink:label="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:href="igc-20230331.xsd#igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" xlink:href="igc-20230331.xsd#igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_Investments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable">
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable">
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2023Member" xlink:href="igc-20230331.xsd#igc_Expiring2023Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2023Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2024Member" xlink:href="igc-20230331.xsd#igc_Expiring2024Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2024Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2025Member" xlink:href="igc-20230331.xsd#igc_Expiring2025Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2025Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2026Member" xlink:href="igc-20230331.xsd#igc_Expiring2026Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2026Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2027Member" xlink:href="igc-20230331.xsd#igc_Expiring2027Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2027Member" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2028Member" xlink:href="igc-20230331.xsd#igc_Expiring2028Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2028Member" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2029Member" xlink:href="igc-20230331.xsd#igc_Expiring2029Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2029Member" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2030Member" xlink:href="igc-20230331.xsd#igc_Expiring2030Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2030Member" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2031Member" xlink:href="igc-20230331.xsd#igc_Expiring2031Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2031Member" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2032Member" xlink:href="igc-20230331.xsd#igc_Expiring2032Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2032Member" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2033Member" xlink:href="igc-20230331.xsd#igc_Expiring2033Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2033Member" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2034Member" xlink:href="igc-20230331.xsd#igc_Expiring2034Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2034Member" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2035Member" xlink:href="igc-20230331.xsd#igc_Expiring2035Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2035Member" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2036Member" xlink:href="igc-20230331.xsd#igc_Expiring2036Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2036Member" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2037Member" xlink:href="igc-20230331.xsd#igc_Expiring2037Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2037Member" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2038Member" xlink:href="igc-20230331.xsd#igc_Expiring2038Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2038Member" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2039Member" xlink:href="igc-20230331.xsd#igc_Expiring2039Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2039Member" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2040Member" xlink:href="igc-20230331.xsd#igc_Expiring2040Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2040Member" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2041Member" xlink:href="igc-20230331.xsd#igc_Expiring2041Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2041Member" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2042Member" xlink:href="igc-20230331.xsd#igc_Expiring2042Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2042Member" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2043Member" xlink:href="igc-20230331.xsd#igc_Expiring2043Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="igc_Expiring2043Member" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_RentalIncomeMember" xlink:href="igc-20230331.xsd#igc_RentalIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="igc_RentalIncomeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConstructionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ConstructionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_WellnessAndLifestyleMember" xlink:href="igc-20230331.xsd#igc_WellnessAndLifestyleMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="igc_WellnessAndLifestyleMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_TollingWhiteLabelingServiceMember" xlink:href="igc-20230331.xsd#igc_TollingWhiteLabelingServiceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="igc_TollingWhiteLabelingServiceMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_InfrastructureSegmentAbstract" xlink:href="igc-20230331.xsd#igc_InfrastructureSegmentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="igc_InfrastructureSegmentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_InfrastructureSegmentAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="srt_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_LegacyInfrastructureMember" xlink:href="igc-20230331.xsd#igc_LegacyInfrastructureMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="igc_LegacyInfrastructureMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_PlantAndCannabinoidMember" xlink:href="igc-20230331.xsd#igc_PlantAndCannabinoidMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="igc_PlantAndCannabinoidMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_Revenues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_TotalRevenuePercentage" xlink:href="igc-20230331.xsd#igc_TotalRevenuePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="igc_TotalRevenuePercentage" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable">
    <loc xlink:type="locator" xlink:label="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:href="igc-20230331.xsd#igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" xlink:href="igc-20230331.xsd#igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:to="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IN" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IN"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IN" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CO" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CO"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CO" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:to="us-gaap_Revenues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_TotalRevenuePercentage" xlink:href="igc-20230331.xsd#igc_TotalRevenuePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:to="igc_TotalRevenuePercentage" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_GeographicDistributionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_GeographicDistributionAxis" xlink:to="us-gaap_GeographicDistributionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_GeographicDistributionAxis" xlink:to="us-gaap_GeographicDistributionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GeographicDistributionDomain" xlink:to="us-gaap_GeographicDistributionDomesticMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GeographicDistributionDomain" xlink:to="us-gaap_GeographicDistributionForeignMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_AssetsNoncurrent" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="igc-20230331.xsd#igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="igc-20230331.xsd#igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_ClinicalTrialInventoryMember" xlink:href="igc-20230331.xsd#igc_ClinicalTrialInventoryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="igc_ClinicalTrialInventoryMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryNet" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INVENTORYDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryWriteDown" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails">
    <loc xlink:type="locator" xlink:label="igc_DepositsAndAdvancesAbstract" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesAbstract"/>
    <loc xlink:type="locator" xlink:label="igc_StatutoryAdvances" xlink:href="igc-20230331.xsd#igc_StatutoryAdvances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_DepositsAndAdvancesAbstract" xlink:to="igc_StatutoryAdvances" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances" xlink:href="igc-20230331.xsd#igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_DepositsAndAdvancesAbstract" xlink:to="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails">
    <loc xlink:type="locator" xlink:label="igc_INTANGIBLEASSETSDetailsLineItems" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_INTANGIBLEASSETSDetailsTable" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_INTANGIBLEASSETSDetailsLineItems" xlink:to="igc_INTANGIBLEASSETSDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_INTANGIBLEASSETSDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_NumberOfPatents" xlink:href="igc-20230331.xsd#igc_NumberOfPatents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsLineItems" xlink:to="igc_NumberOfPatents" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_NumberOfPatentsGranted" xlink:href="igc-20230331.xsd#igc_NumberOfPatentsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsLineItems" xlink:to="igc_NumberOfPatentsGranted" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_INTANGIBLEASSETSDetailsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
    <loc xlink:type="locator" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTDetailsTable" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="igc_PROPERTYPLANTANDEQUIPMENTDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_PR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_PR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_PR" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_Depreciation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOwnedGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOwnedGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentOwnedGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances" xlink:href="igc-20230331.xsd#igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_PaymentsForDeposits" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LEASESDetails">
    <loc xlink:type="locator" xlink:label="igc_LEASESDetailsLineItems" xlink:href="igc-20230331.xsd#igc_LEASESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_LEASESDetailsTable" xlink:href="igc-20230331.xsd#igc_LEASESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_LEASESDetailsLineItems" xlink:to="igc_LEASESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_LEASESDetailsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_LEASESDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_AsiaMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LEASESDetailsLineItems" xlink:to="us-gaap_ShortTermLeaseCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LEASESDetailsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LEASESDetailsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails">
    <loc xlink:type="locator" xlink:label="igc_AccruedLiabilitiesDisclosureAbstract" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AccruedLiabilitiesDisclosureAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_AccruedLiabilitiesDisclosureAbstract" xlink:to="us-gaap_ShortTermBorrowings" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails">
    <loc xlink:type="locator" xlink:label="igc_LoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DebtInstrumentPeriodicPayment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DebtInstrumentTerm" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_RepaymentsOfDebt" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermLoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLoansPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_LongTermLoansPayable" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_LoansPayableCurrent" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SECURITIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_UnitsOutstanding" xlink:href="igc-20230331.xsd#igc_UnitsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="igc_UnitsOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_UnitDescription" xlink:href="igc-20230331.xsd#igc_UnitDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="igc_UnitDescription" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_SalesAgreementMaximum" xlink:href="igc-20230331.xsd#igc_SalesAgreementMaximum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="igc_SalesAgreementMaximum" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails">
    <loc xlink:type="locator" xlink:label="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:href="igc-20230331.xsd#igc_STOCKBASEDCOMPENSATIONDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_STOCKBASEDCOMPENSATIONDetailsTable" xlink:href="igc-20230331.xsd#igc_STOCKBASEDCOMPENSATIONDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="igc_STOCKBASEDCOMPENSATIONDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsTable" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_ESOP2008OmnibusPlanMember" xlink:href="igc-20230331.xsd#igc_ESOP2008OmnibusPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:to="igc_ESOP2008OmnibusPlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="igc_WeightedAveragePricePerShare" xlink:href="igc-20230331.xsd#igc_WeightedAveragePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="igc_WeightedAveragePricePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails">
    <loc xlink:type="locator" xlink:label="igc_SUBSEQUENTEVENTSDetailsLineItems" xlink:href="igc-20230331.xsd#igc_SUBSEQUENTEVENTSDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="igc_SUBSEQUENTEVENTSDetailsTable" xlink:href="igc-20230331.xsd#igc_SUBSEQUENTEVENTSDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="igc_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="igc_SUBSEQUENTEVENTSDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="igc_SUBSEQUENTEVENTSDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="igc_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="38" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>igc-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Jul 07 17:41:02 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Total cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryNet_lbl1" xml:lang="en-US">Inventory, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Deposits and advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0" xml:lang="en-US">Total intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, plant and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Net Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Claims and advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl0" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued liabilities and others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Operating lease liability (non-current portion &#8211; operating lease liability)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies &#8211; See Note 12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStocksIncludingAdditionalPaidInCapital_lbl" xml:lang="en-US">Common stock and additional paid-in capital, $0.0001 par value: 150,000,000 shares authorized; 53,077,436 and 51,054,017 shares issued and outstanding as of March 31, 2023, and March 31, 2022, respectively.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="us-gaap_CommonStocksIncludingAdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Balances (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US">Balances (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl1" xml:lang="en-US">Total Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Net Income Loss before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss attributable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_EarningsPerShareBasicDiluted" xlink:href="igc-20230331.xsd#igc_EarningsPerShareBasicDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_EarningsPerShareBasicDiluted_lbl" xml:lang="en-US">Basic and diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_EarningsPerShareBasicDiluted" xlink:to="igc_EarningsPerShareBasicDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted" xlink:href="igc-20230331.xsd#igc_WeightedAverageNumberOfShareOutstandingBasicDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted_lbl" xml:lang="en-US">Weighted-average number of shares used in computing loss per share amounts: (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted" xlink:to="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Common stock-based compensation and expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivables, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Deposits and advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Claims and advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">Accrued and other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property, plant, and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Acquisition and filing cost of patents and rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Net proceeds from the issuance of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl0" xml:lang="en-US">Proceeds from Issuance or Sale of Equity (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xml:lang="en-US">Repayment of long-term loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Effects of exchange rate changes on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net decrease in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents at the beginning of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash and cash equivalents at the end of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_lbl" xml:lang="en-US">Common stock issued/granted for stock-based compensation, including patent acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expense and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total amortized intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentTableTypeAxis" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_PropertyPlantAndEquipmentTableTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Table Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentTableTypeAxis" xlink:to="igc_PropertyPlantAndEquipmentTableTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentEstimatedUsefulLives1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1_lbl" xml:lang="en-US">Property, plant and equipment, useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1" xlink:to="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property, plant and equipment, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, plant and equipment, useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Total lease costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Compensation and other contributions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Provision for expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Balance, non-vested shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl0" xml:lang="en-US">Balance, non-vested shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Balance, Weighted average grant date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Balance, Weighted average grant date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options outstanding, shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Options outstanding, shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Total Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Effective income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income tax expense/benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Net deferred tax asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xml:lang="en-US">Tax Credit Carryforward [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeographicDistributionAxis_lbl" xml:lang="en-US">Geographic Distribution [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicDistributionAxis" xlink:to="us-gaap_GeographicDistributionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_lbl" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract" xlink:to="igc_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_NonCurrentAssetsAbstract" xlink:href="igc-20230331.xsd#igc_NonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_NonCurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NonCurrentAssetsAbstract" xlink:to="igc_NonCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Total lease assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract0" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract0" xlink:to="igc_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract1" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract1" xlink:to="igc_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_NonCurrentLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_NonCurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_NonCurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NonCurrentLiabilitiesAbstract" xlink:to="igc_NonCurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract2" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract2" xlink:to="igc_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract3" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract3" xlink:to="igc_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value: authorized 1,000,000 shares, no shares issued or outstanding as of March 31, 2023, or March 31, 2022.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, authorized shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract4" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract4" xlink:to="igc_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net loss per share attributable to common stockholders:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Common stock-based compensation &amp; expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Common stock-based compensation &amp; expenses, net (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock through offering (net of expenses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of common stock through offering (net of expenses) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Other adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Other adjustments (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Gain on foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract5" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract5" xlink:to="igc_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract6" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract6" xlink:to="igc_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:href="igc-20230331.xsd#igc_AdjustmentToReconcileNetLossToNetCashAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_AdjustmentToReconcileNetLossToNetCashAbstract_lbl" xml:lang="en-US">Adjustment to reconcile net loss to net cash:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="igc_AdjustmentToReconcileNetLossToNetCashAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Provision for bad debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Permanent impairment of PPE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOfInvestments_lbl" xml:lang="en-US">Impairment of non-marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ImpairmentOfInvestments_lbl0" xml:lang="en-US">Impairment of investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract7" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract7" xlink:to="igc_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract8" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract8" xlink:to="igc_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flow from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Sale of property, plant, and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract9" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract9" xlink:to="igc_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract10" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract10" xlink:to="igc_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract11" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract11" xlink:to="igc_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplementary information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_NonCashItemsAbstract" xlink:href="igc-20230331.xsd#igc_NonCashItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_NonCashItemsAbstract_lbl" xml:lang="en-US">Non-cash items:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NonCashItemsAbstract" xlink:to="igc_NonCashItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Net loss on sale of property, plant, and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Forgiveness of PPP Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_IncreaseDecreaseInOperatingLeaseAssets" xlink:href="igc-20230331.xsd#igc_IncreaseDecreaseInOperatingLeaseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="igc_IncreaseDecreaseInOperatingLeaseAssets_lbl" xml:lang="en-US">Operating lease asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_IncreaseDecreaseInOperatingLeaseAssets" xlink:to="igc_IncreaseDecreaseInOperatingLeaseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xml:lang="en-US">Investment in short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesReduction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReduction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NotesReduction_lbl" xml:lang="en-US">Forgiveness of PPP Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReduction" xlink:to="us-gaap_NotesReduction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_DepositsAndAdvancesTextBlock" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_DepositsAndAdvancesTextBlock_lbl" xml:lang="en-US">Deposits and Advances [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_DepositsAndAdvancesTextBlock" xlink:to="igc_DepositsAndAdvancesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xml:lang="en-US">Advances to suppliers and consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventoryNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInventoryNetOfReserves_lbl" xml:lang="en-US">Other receivables and deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryNetOfReserves" xlink:to="us-gaap_OtherInventoryNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract12" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract12" xlink:to="igc_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnamortizedIntangibleAssetsAbstract" xlink:href="igc-20230331.xsd#igc_UnamortizedIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnamortizedIntangibleAssetsAbstract_lbl" xml:lang="en-US">Unamortized intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnamortizedIntangibleAssetsAbstract" xlink:to="igc_UnamortizedIntangibleAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Unamortized intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">For the year ended 2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">For the year ended 2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">For the year ended 2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">For the year ended 2027</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">For the year ended 2028</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Other Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Claims receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Non-current deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_OtherAdvances" xlink:href="igc-20230331.xsd#igc_OtherAdvances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_OtherAdvances_lbl" xml:lang="en-US">Other advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_OtherAdvances" xlink:to="igc_OtherAdvances_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">Short term lease costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShortTermLeaseCost_lbl0" xml:lang="en-US">Short-Term Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract13" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract13" xlink:to="igc_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Accrued liabilities and others (current portion &#8211; operating lease liability)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl0" xml:lang="en-US">Short-term lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_NoncurrentLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_NoncurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Noncurrent liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NoncurrentLiabilitiesAbstract" xlink:to="igc_NoncurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_lbl" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">&#8211; Operating cash flows from operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Mar-24</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Mar-25</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">Mar-26</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">Mar-27</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_AccruedLiabilitiesDisclosureTextBlock" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_AccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_AccruedLiabilitiesDisclosureTextBlock" xlink:to="igc_AccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_LoansAndOtherLiabilitiesTextBlock" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_LoansAndOtherLiabilitiesTextBlock_lbl" xml:lang="en-US">Loans and Other Liabilities [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LoansAndOtherLiabilitiesTextBlock" xlink:to="igc_LoansAndOtherLiabilitiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Assets and Other Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Statutory reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Vested options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Granted, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Granted, Weighted average grant date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Vested, Weighted average grant date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Cancelled/Forfeited, Weighted average grant date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Options outstanding, Weighted average grant date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options outstanding, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted, shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Cancelled/Forfeited, Weighted average grant date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled/Forfeited, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract14" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract14" xlink:to="igc_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsAbstract_lbl" xml:lang="en-US">Investments:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US">-Marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">-Non-marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract15" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract15" xlink:to="igc_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_InvestmentsAbstract0" xlink:href="igc-20230331.xsd#igc_InvestmentsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_InvestmentsAbstract0_lbl" xml:lang="en-US">Investments:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_InvestmentsAbstract0" xlink:to="igc_InvestmentsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract16" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract16_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract16" xlink:to="igc_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Expected income tax recovery</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Tax rate changes and other adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Permanent differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_lbl" xml:lang="en-US">Net operating loss carry-forwards foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl" xml:lang="en-US">Non-capital loss carry-forwards &#8211; USA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Temporary differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract17" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract17" xlink:to="igc_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_InfrastructureSegmentAbstract" xlink:href="igc-20230331.xsd#igc_InfrastructureSegmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_InfrastructureSegmentAbstract_lbl" xml:lang="en-US">Infrastructure segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_InfrastructureSegmentAbstract" xlink:to="igc_InfrastructureSegmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract18" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract18" xlink:to="igc_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnlabeledAbstract19" xlink:href="igc-20230331.xsd#igc_UnlabeledAbstract19"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnlabeledAbstract19_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract19" xlink:to="igc_UnlabeledAbstract19_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_LifeSciencesSegmentAbstract" xlink:href="igc-20230331.xsd#igc_LifeSciencesSegmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_LifeSciencesSegmentAbstract_lbl" xml:lang="en-US">Life Sciences segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LifeSciencesSegmentAbstract" xlink:to="igc_LifeSciencesSegmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_TotalRevenuePercentage" xlink:href="igc-20230331.xsd#igc_TotalRevenuePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_TotalRevenuePercentage_lbl" xml:lang="en-US">Percentage of Total Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TotalRevenuePercentage" xlink:to="igc_TotalRevenuePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: Present value discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Vested, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_lbl" xml:lang="en-US">Cancelled/Forfeited, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised, shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Cancelled/Forfeited, shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign_lbl" xml:lang="en-US">Impact of tax rate differences in foreign jurisdictions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIntangibleAssetsMember_lbl" xml:lang="en-US">Other Intangible Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_OtherIntangibleAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentTableMember" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_PropertyPlantAndEquipmentTableMember_lbl" xml:lang="en-US">Property Plant and Equipment Table [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentTableMember" xlink:to="igc_PropertyPlantAndEquipmentTableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US">Land [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xml:lang="en-US">Building and Building Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction in Progress [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2023Member" xlink:href="igc-20230331.xsd#igc_Expiring2023Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2023Member_lbl" xml:lang="en-US">Expiring 2023 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2023Member" xlink:to="igc_Expiring2023Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2024Member" xlink:href="igc-20230331.xsd#igc_Expiring2024Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2024Member_lbl" xml:lang="en-US">Expiring 2024 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2024Member" xlink:to="igc_Expiring2024Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2025Member" xlink:href="igc-20230331.xsd#igc_Expiring2025Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2025Member_lbl" xml:lang="en-US">Expiring 2025 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2025Member" xlink:to="igc_Expiring2025Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2026Member" xlink:href="igc-20230331.xsd#igc_Expiring2026Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2026Member_lbl" xml:lang="en-US">Expiring 2026 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2026Member" xlink:to="igc_Expiring2026Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2027Member" xlink:href="igc-20230331.xsd#igc_Expiring2027Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2027Member_lbl" xml:lang="en-US">Expiring 2027 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2027Member" xlink:to="igc_Expiring2027Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2028Member" xlink:href="igc-20230331.xsd#igc_Expiring2028Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2028Member_lbl" xml:lang="en-US">Expiring 2028 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2028Member" xlink:to="igc_Expiring2028Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2029Member" xlink:href="igc-20230331.xsd#igc_Expiring2029Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2029Member_lbl" xml:lang="en-US">Expiring 2029 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2029Member" xlink:to="igc_Expiring2029Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2030Member" xlink:href="igc-20230331.xsd#igc_Expiring2030Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2030Member_lbl" xml:lang="en-US">Expiring 2030 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2030Member" xlink:to="igc_Expiring2030Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2031Member" xlink:href="igc-20230331.xsd#igc_Expiring2031Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2031Member_lbl" xml:lang="en-US">Expiring 2031 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2031Member" xlink:to="igc_Expiring2031Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2032Member" xlink:href="igc-20230331.xsd#igc_Expiring2032Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2032Member_lbl" xml:lang="en-US">Expiring 2032 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2032Member" xlink:to="igc_Expiring2032Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2033Member" xlink:href="igc-20230331.xsd#igc_Expiring2033Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2033Member_lbl" xml:lang="en-US">Expiring 2033 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2033Member" xlink:to="igc_Expiring2033Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2034Member" xlink:href="igc-20230331.xsd#igc_Expiring2034Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2034Member_lbl" xml:lang="en-US">Expiring 2034 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2034Member" xlink:to="igc_Expiring2034Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2035Member" xlink:href="igc-20230331.xsd#igc_Expiring2035Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2035Member_lbl" xml:lang="en-US">Expiring 2035 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2035Member" xlink:to="igc_Expiring2035Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2036Member" xlink:href="igc-20230331.xsd#igc_Expiring2036Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2036Member_lbl" xml:lang="en-US">Expiring 2036 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2036Member" xlink:to="igc_Expiring2036Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2037Member" xlink:href="igc-20230331.xsd#igc_Expiring2037Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2037Member_lbl" xml:lang="en-US">Expiring 2037 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2037Member" xlink:to="igc_Expiring2037Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2038Member" xlink:href="igc-20230331.xsd#igc_Expiring2038Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2038Member_lbl" xml:lang="en-US">Expiring 2038 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2038Member" xlink:to="igc_Expiring2038Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2039Member" xlink:href="igc-20230331.xsd#igc_Expiring2039Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2039Member_lbl" xml:lang="en-US">Expiring 2039 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2039Member" xlink:to="igc_Expiring2039Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2040Member" xlink:href="igc-20230331.xsd#igc_Expiring2040Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2040Member_lbl" xml:lang="en-US">Expiring 2040 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2040Member" xlink:to="igc_Expiring2040Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2041Member" xlink:href="igc-20230331.xsd#igc_Expiring2041Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2041Member_lbl" xml:lang="en-US">Expiring 2041 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2041Member" xlink:to="igc_Expiring2041Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2042Member" xlink:href="igc-20230331.xsd#igc_Expiring2042Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2042Member_lbl" xml:lang="en-US">Expiring 2042 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2042Member" xlink:to="igc_Expiring2042Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_Expiring2043Member" xlink:href="igc-20230331.xsd#igc_Expiring2043Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_Expiring2043Member_lbl" xml:lang="en-US">Expiring 2043 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2043Member" xlink:to="igc_Expiring2043Member_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_RentalIncomeMember" xlink:href="igc-20230331.xsd#igc_RentalIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_RentalIncomeMember_lbl" xml:lang="en-US">Rental Income [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_RentalIncomeMember" xlink:to="igc_RentalIncomeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConstructionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConstructionMember_lbl" xml:lang="en-US">Construction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionMember" xlink:to="us-gaap_ConstructionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_WellnessAndLifestyleMember" xlink:href="igc-20230331.xsd#igc_WellnessAndLifestyleMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_WellnessAndLifestyleMember_lbl" xml:lang="en-US">Wellness and Lifestyle [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WellnessAndLifestyleMember" xlink:to="igc_WellnessAndLifestyleMember_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_TollingWhiteLabelingServiceMember" xlink:href="igc-20230331.xsd#igc_TollingWhiteLabelingServiceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_TollingWhiteLabelingServiceMember_lbl" xml:lang="en-US">Tolling/White labeling service [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TollingWhiteLabelingServiceMember" xlink:to="igc_TollingWhiteLabelingServiceMember_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_LegacyInfrastructureMember" xlink:href="igc-20230331.xsd#igc_LegacyInfrastructureMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_LegacyInfrastructureMember_lbl" xml:lang="en-US">Legacy Infrastructure [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LegacyInfrastructureMember" xlink:to="igc_LegacyInfrastructureMember_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PlantAndCannabinoidMember" xlink:href="igc-20230331.xsd#igc_PlantAndCannabinoidMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_PlantAndCannabinoidMember_lbl" xml:lang="en-US">Plant and Cannabinoid [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PlantAndCannabinoidMember" xlink:to="igc_PlantAndCannabinoidMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IN" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IN"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IN_lbl" xml:lang="en-US">INDIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IN" xlink:to="country_IN_lbl"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <loc xlink:type="locator" xlink:label="country_CO" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CO"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CO_lbl" xml:lang="en-US">COLOMBIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CO" xlink:to="country_CO_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeographicDistributionDomesticMember_lbl" xml:lang="en-US">Geographic Distribution, Domestic [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicDistributionDomesticMember" xlink:to="us-gaap_GeographicDistributionDomesticMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeographicDistributionForeignMember_lbl" xml:lang="en-US">Geographic Distribution, Foreign [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicDistributionForeignMember" xlink:to="us-gaap_GeographicDistributionForeignMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilitiesInventoryAxis_lbl" xml:lang="en-US">Inventory [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP) Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Inventory Write-down</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_StatutoryAdvances" xlink:href="igc-20230331.xsd#igc_StatutoryAdvances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_StatutoryAdvances_lbl" xml:lang="en-US">Statutory Advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_StatutoryAdvances" xlink:to="igc_StatutoryAdvances_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances" xlink:href="igc-20230331.xsd#igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances_lbl" xml:lang="en-US">Transfer from Deposits and Advances to Claims and Advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances" xlink:to="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_NumberOfPatents" xlink:href="igc-20230331.xsd#igc_NumberOfPatents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_NumberOfPatents_lbl" xml:lang="en-US">Number of Patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NumberOfPatents" xlink:to="igc_NumberOfPatents_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_NumberOfPatentsGranted" xlink:href="igc-20230331.xsd#igc_NumberOfPatentsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_NumberOfPatentsGranted_lbl" xml:lang="en-US">Number of Patents Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NumberOfPatentsGranted" xlink:to="igc_NumberOfPatentsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals_lbl" xml:lang="en-US">Property, Plant and Equipment, Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisposals" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOwnedGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOwnedGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentOwnedGross_lbl" xml:lang="en-US">Property, Plant, and Equipment, Owned, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOwnedGross" xlink:to="us-gaap_PropertyPlantAndEquipmentOwnedGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForDeposits_lbl" xml:lang="en-US">Payments for Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForDeposits" xlink:to="us-gaap_PaymentsForDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating Lease, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Accounts Payable, Other, Current</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y4QCn3wy0vWYacVKSOrI2x+HAoVIyehE0TJwp7ZEi22T/0R8HGCwjeAHX54t9rDaOwQnZlYSrrcHEk/vmnsJgrBykMl1kSBM4wydqoLLE94xz5efBgU/huurj9vXfCBprvPxWCT9SqZYBnBBQ6yXcQB] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Debt Instrument, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest Expense, Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Repayments of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermLoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLoansPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermLoansPayable_lbl" xml:lang="en-US">Loans Payable, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansPayableCurrent_lbl" xml:lang="en-US">Loans Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees&apos; Gross Pay</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnitsOutstanding" xlink:href="igc-20230331.xsd#igc_UnitsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnitsOutstanding_lbl" xml:lang="en-US">Units Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnitsOutstanding" xlink:to="igc_UnitsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_UnitDescription" xlink:href="igc-20230331.xsd#igc_UnitDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_UnitDescription_lbl" xml:lang="en-US">Unit, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnitDescription" xlink:to="igc_UnitDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_SalesAgreementMaximum" xlink:href="igc-20230331.xsd#igc_SalesAgreementMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_SalesAgreementMaximum_lbl" xml:lang="en-US">Sales Agreement, Offering, Maximum (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SalesAgreementMaximum" xlink:to="igc_SalesAgreementMaximum_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Number of Committed-to-be-Released Shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_WeightedAveragePricePerShare" xlink:href="igc-20230331.xsd#igc_WeightedAveragePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_WeightedAveragePricePerShare_lbl" xml:lang="en-US">Weighted Average Price per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WeightedAveragePricePerShare" xlink:to="igc_WeightedAveragePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of Operating Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_GoingConcernPolicyPolicyTextblock" xlink:href="igc-20230331.xsd#igc_GoingConcernPolicyPolicyTextblock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_GoingConcernPolicyPolicyTextblock_lbl" xml:lang="en-US">Going Concern, Policy [Policy Textblock}</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_GoingConcernPolicyPolicyTextblock" xlink:to="igc_GoingConcernPolicyPolicyTextblock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_CybersecurityPolicyPolicyTextBlock" xlink:href="igc-20230331.xsd#igc_CybersecurityPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_CybersecurityPolicyPolicyTextBlock_lbl" xml:lang="en-US">Cyber-security Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_CybersecurityPolicyPolicyTextBlock" xlink:to="igc_CybersecurityPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_ClinicalTrialInventoryMember" xlink:href="igc-20230331.xsd#igc_ClinicalTrialInventoryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_ClinicalTrialInventoryMember_lbl" xml:lang="en-US">Clinical Trial Inventory [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ClinicalTrialInventoryMember" xlink:to="igc_ClinicalTrialInventoryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_PR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_PR"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_PR_lbl" xml:lang="en-US">PUERTO RICO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_PR" xlink:to="country_PR_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_AsiaMember_lbl" xml:lang="en-US">Asia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_ESOP2008OmnibusPlanMember" xlink:href="igc-20230331.xsd#igc_ESOP2008OmnibusPlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="igc_ESOP2008OmnibusPlanMember_lbl" xml:lang="en-US">ESOP 2008 Omnibus Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ESOP2008OmnibusPlanMember" xlink:to="igc_ESOP2008OmnibusPlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PropertyPlantAndEquipmentTableTypeDomainDomain" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableTypeDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PropertyPlantAndEquipmentTableTypeDomainDomain_lbl" xml:lang="en-US">PropertyPlantAndEquipmentTableTypeDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentTableTypeDomainDomain" xlink:to="igc_PropertyPlantAndEquipmentTableTypeDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTTablesTable" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTTablesTable_lbl" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTTablesTable" xlink:to="igc_PROPERTYPLANTANDEQUIPMENTTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems_lbl" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT (Tables) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems" xlink:to="igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable_lbl" xml:lang="en-US">INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:to="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems_lbl" xml:lang="en-US">INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" xlink:href="igc-20230331.xsd#igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable_lbl" xml:lang="en-US">FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" xlink:to="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:href="igc-20230331.xsd#igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems_lbl" xml:lang="en-US">FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US">Product and Service [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xml:lang="en-US">Revenue from External Customer [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" xlink:href="igc-20230331.xsd#igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable_lbl" xml:lang="en-US">SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" xlink:to="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:href="igc-20230331.xsd#igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems_lbl" xml:lang="en-US">SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:to="igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeographicDistributionDomain_lbl" xml:lang="en-US">Geographic Distribution [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicDistributionDomain" xlink:to="us-gaap_GeographicDistributionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl" xml:lang="en-US">Inventory [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="igc-20230331.xsd#igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="igc-20230331.xsd#igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_INTANGIBLEASSETSDetailsTable" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_INTANGIBLEASSETSDetailsTable_lbl" xml:lang="en-US">INTANGIBLE ASSETS (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_INTANGIBLEASSETSDetailsTable" xlink:to="igc_INTANGIBLEASSETSDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_INTANGIBLEASSETSDetailsLineItems" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_INTANGIBLEASSETSDetailsLineItems_lbl" xml:lang="en-US">INTANGIBLE ASSETS (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_INTANGIBLEASSETSDetailsLineItems" xlink:to="igc_INTANGIBLEASSETSDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTDetailsTable" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTDetailsTable_lbl" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsTable" xlink:to="igc_PROPERTYPLANTANDEQUIPMENTDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems_lbl" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_LEASESDetailsTable" xlink:href="igc-20230331.xsd#igc_LEASESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_LEASESDetailsTable_lbl" xml:lang="en-US">LEASES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LEASESDetailsTable" xlink:to="igc_LEASESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_LEASESDetailsLineItems" xlink:href="igc-20230331.xsd#igc_LEASESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_LEASESDetailsLineItems_lbl" xml:lang="en-US">LEASES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LEASESDetailsLineItems" xlink:to="igc_LEASESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Plan [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_STOCKBASEDCOMPENSATIONDetailsTable" xlink:href="igc-20230331.xsd#igc_STOCKBASEDCOMPENSATIONDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_STOCKBASEDCOMPENSATIONDetailsTable_lbl" xml:lang="en-US">STOCK-BASED COMPENSATION (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsTable" xlink:to="igc_STOCKBASEDCOMPENSATIONDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:href="igc-20230331.xsd#igc_STOCKBASEDCOMPENSATIONDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_STOCKBASEDCOMPENSATIONDetailsLineItems_lbl" xml:lang="en-US">STOCK-BASED COMPENSATION (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="igc_STOCKBASEDCOMPENSATIONDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_SUBSEQUENTEVENTSDetailsTable" xlink:href="igc-20230331.xsd#igc_SUBSEQUENTEVENTSDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_SUBSEQUENTEVENTSDetailsTable_lbl" xml:lang="en-US">SUBSEQUENT EVENTS (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SUBSEQUENTEVENTSDetailsTable" xlink:to="igc_SUBSEQUENTEVENTSDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="igc_SUBSEQUENTEVENTSDetailsLineItems" xlink:href="igc-20230331.xsd#igc_SUBSEQUENTEVENTSDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_SUBSEQUENTEVENTSDetailsLineItems_lbl" xml:lang="en-US">SUBSEQUENT EVENTS (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SUBSEQUENTEVENTSDetailsLineItems" xlink:to="igc_SUBSEQUENTEVENTSDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_AccruedLiabilitiesDisclosureTextBlock_lbl0" xml:lang="en-US">Disclosure for accrued liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_AccruedLiabilitiesDisclosureTextBlock" xlink:to="igc_AccruedLiabilitiesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_CybersecurityPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy related to cyber-security.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_CybersecurityPolicyPolicyTextBlock" xlink:to="igc_CybersecurityPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_DepositsAndAdvancesTextBlock_lbl0" xml:lang="en-US">Disclosure of deposits and advances.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_DepositsAndAdvancesTextBlock" xlink:to="igc_DepositsAndAdvancesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_EarningsPerShareBasicDiluted_lbl0" xml:lang="en-US">The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_EarningsPerShareBasicDiluted" xlink:to="igc_EarningsPerShareBasicDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_GoingConcernPolicyPolicyTextblock_lbl0" xml:lang="en-US">Policy for going concern.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_GoingConcernPolicyPolicyTextblock" xlink:to="igc_GoingConcernPolicyPolicyTextblock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_IncreaseDecreaseInOperatingLeaseAssets_lbl0" xml:lang="en-US">Amount of increase (decrease) in operating lease assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_IncreaseDecreaseInOperatingLeaseAssets" xlink:to="igc_IncreaseDecreaseInOperatingLeaseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_LoansAndOtherLiabilitiesTextBlock_lbl0" xml:lang="en-US">Disclosure of loans and other liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LoansAndOtherLiabilitiesTextBlock" xlink:to="igc_LoansAndOtherLiabilitiesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_NumberOfPatents_lbl0" xml:lang="en-US">Number of patents.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NumberOfPatents" xlink:to="igc_NumberOfPatents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_NumberOfPatentsGranted_lbl0" xml:lang="en-US">Number of granted patents.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NumberOfPatentsGranted" xlink:to="igc_NumberOfPatentsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_OtherAdvances_lbl0" xml:lang="en-US">The amount of other noncurrent advances.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_OtherAdvances" xlink:to="igc_OtherAdvances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1_lbl0" xml:lang="en-US">Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1" xlink:to="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_SalesAgreementMaximum_lbl0" xml:lang="en-US">Maximum offering under sales agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SalesAgreementMaximum" xlink:to="igc_SalesAgreementMaximum_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_StatutoryAdvances_lbl0" xml:lang="en-US">Statutory advances.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_StatutoryAdvances" xlink:to="igc_StatutoryAdvances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_TotalRevenuePercentage_lbl0" xml:lang="en-US">Percentage of segment to total revenue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TotalRevenuePercentage" xlink:to="igc_TotalRevenuePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances_lbl0" xml:lang="en-US">Amount transferred from Deposits and Advances to Claims and Advances.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances" xlink:to="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_UnitDescription_lbl0" xml:lang="en-US">Description of unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnitDescription" xlink:to="igc_UnitDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_UnitsOutstanding_lbl0" xml:lang="en-US">Number of units outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnitsOutstanding" xlink:to="igc_UnitsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted_lbl0" xml:lang="en-US">Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted" xlink:to="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_WeightedAveragePricePerShare_lbl0" xml:lang="en-US">Weighted average price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WeightedAveragePricePerShare" xlink:to="igc_WeightedAveragePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_PropertyPlantAndEquipmentTableTypeAxis_lbl0" xml:lang="en-US">Information by property, plant and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentTableTypeAxis" xlink:to="igc_PropertyPlantAndEquipmentTableTypeAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_ESOP2008OmnibusPlanMember_lbl0" xml:lang="en-US">Name of the equity-based compensation arrangement plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ESOP2008OmnibusPlanMember" xlink:to="igc_ESOP2008OmnibusPlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_LegacyInfrastructureMember_lbl0" xml:lang="en-US">Product or service.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LegacyInfrastructureMember" xlink:to="igc_LegacyInfrastructureMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_PlantAndCannabinoidMember_lbl0" xml:lang="en-US">Represents of the Company&apos;s segments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PlantAndCannabinoidMember" xlink:to="igc_PlantAndCannabinoidMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_PropertyPlantAndEquipmentTableMember_lbl0" xml:lang="en-US">Description of property, plant and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentTableMember" xlink:to="igc_PropertyPlantAndEquipmentTableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_RentalIncomeMember_lbl0" xml:lang="en-US">Information about product and services.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_RentalIncomeMember" xlink:to="igc_RentalIncomeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_TollingWhiteLabelingServiceMember_lbl0" xml:lang="en-US">Type of product or service.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TollingWhiteLabelingServiceMember" xlink:to="igc_TollingWhiteLabelingServiceMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="igc_WellnessAndLifestyleMember_lbl0" xml:lang="en-US">Type of product or service.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WellnessAndLifestyleMember" xlink:to="igc_WellnessAndLifestyleMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:href="igc-20230331.xsd#igc_NonvestedRestrictedStockSharesActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_NonvestedRestrictedStockSharesActivityAbstract_lbl" xml:lang="en-US">Nonvested Restricted Stock Shares Activity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NonvestedRestrictedStockSharesActivityAbstract" xlink:to="igc_NonvestedRestrictedStockSharesActivityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl0" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2033Member_lbl0" xml:lang="en-US">Expiring2033 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2033Member" xlink:to="igc_Expiring2033Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfOtherAssetsNoncurrentAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfOtherAssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfOtherAssetsNoncurrentAbstract_lbl" xml:lang="en-US">Schedule Of Other Assets Noncurrent Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="igc_ScheduleOfOtherAssetsNoncurrentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl0" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_DepositsAndAdvancesTextBlock_lbl1" xml:lang="en-US">Deposits And Advances Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_DepositsAndAdvancesTextBlock" xlink:to="igc_DepositsAndAdvancesTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl0" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeographicDistributionForeignMember_lbl0" xml:lang="en-US">Geographic Distribution, Foreign [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicDistributionForeignMember" xlink:to="us-gaap_GeographicDistributionForeignMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_NonCurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Non Current Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NonCurrentLiabilitiesAbstract" xlink:to="igc_NonCurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressMember_lbl0" xml:lang="en-US">Construction in Progress [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl0" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentOwnedGross_lbl0" xml:lang="en-US">Property, Plant, and Equipment, Owned, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOwnedGross" xlink:to="us-gaap_PropertyPlantAndEquipmentOwnedGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_InvestmentsAbstract0_lbl0" xml:lang="en-US">Investments Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_InvestmentsAbstract0" xlink:to="igc_InvestmentsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_TollingWhiteLabelingServiceMember_lbl1" xml:lang="en-US">Tolling White Labeling Service Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TollingWhiteLabelingServiceMember" xlink:to="igc_TollingWhiteLabelingServiceMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl0" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl0" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract18" xlink:to="igc_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract19_lbl0" xml:lang="en-US">Unlabeled Abstract19</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract19" xlink:to="igc_UnlabeledAbstract19_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl0" xml:lang="en-US">Repayments of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract16" xlink:to="igc_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract17" xlink:to="igc_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_RevenueFromExternalCustomersByGeographicAreasAbstract" xlink:href="igc-20230331.xsd#igc_RevenueFromExternalCustomersByGeographicAreasAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_RevenueFromExternalCustomersByGeographicAreasAbstract_lbl" xml:lang="en-US">Revenue From External Customers By Geographic Areas Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_RevenueFromExternalCustomersByGeographicAreasAbstract" xlink:to="igc_RevenueFromExternalCustomersByGeographicAreasAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Disclosure Text Block Supplement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl0" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl0" xml:lang="en-US">Inventory, Finished Goods, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_LoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_LoansAndOtherLiabilitiesAbstract_lbl" xml:lang="en-US">Loans And Other Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LoansAndOtherLiabilitiesAbstract" xlink:to="igc_LoansAndOtherLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl0" xml:lang="en-US">Computer Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2027Member_lbl0" xml:lang="en-US">Expiring2027 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2027Member" xlink:to="igc_Expiring2027Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2025Member_lbl0" xml:lang="en-US">Expiring2025 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2025Member" xlink:to="igc_Expiring2025Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_SummaryOfOperatingLossCarryforwardsAbstract" xlink:href="igc-20230331.xsd#igc_SummaryOfOperatingLossCarryforwardsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_SummaryOfOperatingLossCarryforwardsAbstract_lbl" xml:lang="en-US">Summary Of Operating Loss Carryforwards Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SummaryOfOperatingLossCarryforwardsAbstract" xlink:to="igc_SummaryOfOperatingLossCarryforwardsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_PR_lbl0" xml:lang="en-US">PUERTO RICO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_PR" xlink:to="country_PR_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals_lbl0" xml:lang="en-US">Property, Plant and Equipment, Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisposals" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl0" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_WellnessAndLifestyleMember_lbl1" xml:lang="en-US">Wellness And Lifestyle Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WellnessAndLifestyleMember" xlink:to="igc_WellnessAndLifestyleMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnamortizedIntangibleAssetsAbstract_lbl0" xml:lang="en-US">Unamortized Intangible Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnamortizedIntangibleAssetsAbstract" xlink:to="igc_UnamortizedIntangibleAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl0" xml:lang="en-US">Asset Impairment Charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_TotalRevenuePercentage_lbl1" xml:lang="en-US">Total Revenue Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TotalRevenuePercentage" xlink:to="igc_TotalRevenuePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_IncreaseDecreaseInOperatingLeaseAssets_lbl1" xml:lang="en-US">Increase Decrease In Operating Lease Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_IncreaseDecreaseInOperatingLeaseAssets" xlink:to="igc_IncreaseDecreaseInOperatingLeaseAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2031Member_lbl0" xml:lang="en-US">Expiring2031 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2031Member" xlink:to="igc_Expiring2031Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl0" xml:lang="en-US">Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract10" xlink:to="igc_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract11" xlink:to="igc_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract14" xlink:to="igc_UnlabeledAbstract14_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract15" xlink:to="igc_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract12" xlink:to="igc_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract13" xlink:to="igc_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl0" xml:lang="en-US">Furniture and Fixtures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl0" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl0" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl0" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl0" xml:lang="en-US">Trademarks [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2043Member_lbl0" xml:lang="en-US">Expiring2043 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2043Member" xlink:to="igc_Expiring2043Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl0" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract2" xlink:to="igc_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract1" xlink:to="igc_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract4" xlink:to="igc_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract3" xlink:to="igc_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl1" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract0" xlink:to="igc_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl0" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract_lbl" xml:lang="en-US">Schedule Of Effective Income Tax Rate Reconciliation Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract9" xlink:to="igc_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl0" xml:lang="en-US">Office Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2036Member_lbl0" xml:lang="en-US">Expiring2036 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2036Member" xlink:to="igc_Expiring2036Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract6" xlink:to="igc_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract5" xlink:to="igc_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract8" xlink:to="igc_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract7" xlink:to="igc_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl0" xml:lang="en-US">Inventory Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2035Member_lbl0" xml:lang="en-US">Expiring2035 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2035Member" xlink:to="igc_Expiring2035Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_AccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US">Accrued Liabilities Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_AccruedLiabilitiesDisclosureTextBlock" xlink:to="igc_AccruedLiabilitiesDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2028Member_lbl0" xml:lang="en-US">Expiring2028 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2028Member" xlink:to="igc_Expiring2028Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl0" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReduction_lbl0" xml:lang="en-US">Notes Reduction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReduction" xlink:to="us-gaap_NotesReduction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnlabeledAbstract" xlink:to="igc_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLoansPayable_lbl0" xml:lang="en-US">Loans Payable, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2029Member_lbl0" xml:lang="en-US">Expiring2029 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2029Member" xlink:to="igc_Expiring2029Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl0" xml:lang="en-US">Accounts Payable, Other, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl0" xml:lang="en-US">Marketable Securities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl0" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees&apos; Gross Pay</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl0" xml:lang="en-US">Land [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfIntangibleAssetsAndGoodwillAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfIntangibleAssetsAndGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfIntangibleAssetsAndGoodwillAbstract_lbl" xml:lang="en-US">Schedule Of Intangible Assets And Goodwill Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfIntangibleAssetsAndGoodwillAbstract" xlink:to="igc_ScheduleOfIntangibleAssetsAndGoodwillAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl0" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl0" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1_lbl1" xml:lang="en-US">Property Plant And Equipment Estimated Useful Lives1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1" xlink:to="igc_PropertyPlantAndEquipmentEstimatedUsefulLives1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2041Member_lbl0" xml:lang="en-US">Expiring2041 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2041Member" xlink:to="igc_Expiring2041Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl0" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares_lbl0" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Number of Committed-to-be-Released Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeographicDistributionDomesticMember_lbl0" xml:lang="en-US">Geographic Distribution, Domestic [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicDistributionDomesticMember" xlink:to="us-gaap_GeographicDistributionDomesticMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_LifeSciencesSegmentAbstract_lbl0" xml:lang="en-US">Life Sciences Segment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LifeSciencesSegmentAbstract" xlink:to="igc_LifeSciencesSegmentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl0" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US">Lease, Cost [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2038Member_lbl0" xml:lang="en-US">Expiring2038 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2038Member" xlink:to="igc_Expiring2038Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnitsOutstanding_lbl1" xml:lang="en-US">Units Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnitsOutstanding" xlink:to="igc_UnitsOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl0" xml:lang="en-US">Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PropertyPlantAndEquipmentTableMember_lbl1" xml:lang="en-US">Property Plant And Equipment Table Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentTableMember" xlink:to="igc_PropertyPlantAndEquipmentTableMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_lbl0" xml:lang="en-US">Cash Paid For Amounts Included In The Measurement Of Lease Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="igc_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl0" xml:lang="en-US">Inventory Write-down</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2037Member_lbl0" xml:lang="en-US">Expiring2037 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2037Member" xlink:to="igc_Expiring2037Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2042Member_lbl0" xml:lang="en-US">Expiring2042 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2042Member" xlink:to="igc_Expiring2042Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl0" xml:lang="en-US">Operating Lease, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract_lbl" xml:lang="en-US">Schedule Of Revenue From External Customers And Long Lived Assets By Geographical Areas Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract" xlink:to="igc_ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_NonCashItemsAbstract_lbl0" xml:lang="en-US">Non Cash Items Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NonCashItemsAbstract" xlink:to="igc_NonCashItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_SalesAgreementMaximum_lbl1" xml:lang="en-US">Sales Agreement Maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_SalesAgreementMaximum" xlink:to="igc_SalesAgreementMaximum_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl0" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl1" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_StatutoryAdvances_lbl1" xml:lang="en-US">Statutory Advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_StatutoryAdvances" xlink:to="igc_StatutoryAdvances_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2040Member_lbl0" xml:lang="en-US">Expiring2040 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2040Member" xlink:to="igc_Expiring2040Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_RentalIncomeMember_lbl1" xml:lang="en-US">Rental Income Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_RentalIncomeMember" xlink:to="igc_RentalIncomeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xml:lang="en-US">Schedule Of Finite Lived Intangible Assets Future Amortization Expense Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2039Member_lbl0" xml:lang="en-US">Expiring2039 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2039Member" xlink:to="igc_Expiring2039Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_NumberOfPatents_lbl1" xml:lang="en-US">Number Of Patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NumberOfPatents" xlink:to="igc_NumberOfPatents_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueAbstract_lbl" xml:lang="en-US">Disaggregation of Revenue [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueAbstract" xlink:to="us-gaap_DisaggregationOfRevenueAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl0" xml:lang="en-US">Inventory, Raw Materials, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl1" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ClinicalTrialInventoryMember_lbl0" xml:lang="en-US">Clinical Trial Inventory Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ClinicalTrialInventoryMember" xlink:to="igc_ClinicalTrialInventoryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_CybersecurityPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Cybersecurity Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_CybersecurityPolicyPolicyTextBlock" xlink:to="igc_CybersecurityPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventoryNetOfReserves_lbl0" xml:lang="en-US">Other Inventory, Net of Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryNetOfReserves" xlink:to="us-gaap_OtherInventoryNetOfReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted_lbl1" xml:lang="en-US">Weighted Average Number Of Share Outstanding Basic Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted" xlink:to="igc_WeightedAverageNumberOfShareOutstandingBasicDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl0" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2034Member_lbl0" xml:lang="en-US">Expiring2034 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2034Member" xlink:to="igc_Expiring2034Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl0" xml:lang="en-US">Number of Operating Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaMember_lbl0" xml:lang="en-US">Asia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_lbl0" xml:lang="en-US">Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl0" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Schedule Of Components Of Income Tax Expense Benefit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl0" xml:lang="en-US">Machinery and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_LegacyInfrastructureMember_lbl1" xml:lang="en-US">Legacy Infrastructure Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LegacyInfrastructureMember" xlink:to="igc_LegacyInfrastructureMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl0" xml:lang="en-US">Investments, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsMember_lbl0" xml:lang="en-US">Other Intangible Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_OtherIntangibleAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForDeposits_lbl0" xml:lang="en-US">Payments for Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForDeposits" xlink:to="us-gaap_PaymentsForDeposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl0" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl0" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl0" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfInvestments_lbl1" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CO_lbl0" xml:lang="en-US">COLOMBIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CO" xlink:to="country_CO_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:href="igc-20230331.xsd#igc_LesseeOperatingLeaseLiabilityMaturityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_LesseeOperatingLeaseLiabilityMaturityAbstract_lbl" xml:lang="en-US">Lessee Operating Lease Liability Maturity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="igc_LesseeOperatingLeaseLiabilityMaturityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Accounts Payable And Accrued Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2032Member_lbl0" xml:lang="en-US">Expiring2032 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2032Member" xlink:to="igc_Expiring2032Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl0" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl0" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_RevenueFromExternalCustomersByProductsAndServicesAbstract" xlink:href="igc-20230331.xsd#igc_RevenueFromExternalCustomersByProductsAndServicesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_RevenueFromExternalCustomersByProductsAndServicesAbstract_lbl" xml:lang="en-US">Revenue From External Customers By Products And Services Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_RevenueFromExternalCustomersByProductsAndServicesAbstract" xlink:to="igc_RevenueFromExternalCustomersByProductsAndServicesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2024Member_lbl0" xml:lang="en-US">Expiring2024 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2024Member" xlink:to="igc_Expiring2024Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl0" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_WeightedAveragePricePerShare_lbl1" xml:lang="en-US">Weighted Average Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_WeightedAveragePricePerShare" xlink:to="igc_WeightedAveragePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_NonCurrentAssetsAbstract_lbl0" xml:lang="en-US">Non Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NonCurrentAssetsAbstract" xlink:to="igc_NonCurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl0" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl1" xml:lang="en-US">Short-Term Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:to="igc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2026Member_lbl0" xml:lang="en-US">Expiring2026 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2026Member" xlink:to="igc_Expiring2026Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfInventoryCurrentAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfInventoryCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfInventoryCurrentAbstract_lbl" xml:lang="en-US">Schedule Of Inventory Current Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfInventoryCurrentAbstract" xlink:to="igc_ScheduleOfInventoryCurrentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl0" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_GoingConcernPolicyPolicyTextblock_lbl1" xml:lang="en-US">Going Concern Policy Policy Textblock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_GoingConcernPolicyPolicyTextblock" xlink:to="igc_GoingConcernPolicyPolicyTextblock_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PropertyPlantAndEquipmentTableTypeAxis_lbl1" xml:lang="en-US">Property Plant And Equipment Table Type Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PropertyPlantAndEquipmentTableTypeAxis" xlink:to="igc_PropertyPlantAndEquipmentTableTypeAxis_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances_lbl1" xml:lang="en-US">Transfer From Deposits And Advances To Claims And Advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances" xlink:to="igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2030Member_lbl0" xml:lang="en-US">Expiring2030 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2030Member" xlink:to="igc_Expiring2030Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:href="igc-20230331.xsd#igc_ShareBasedPaymentArrangementOptionActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ShareBasedPaymentArrangementOptionActivityAbstract_lbl" xml:lang="en-US">Share Based Payment Arrangement Option Activity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="igc_ShareBasedPaymentArrangementOptionActivityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_AccruedLiabilitiesDisclosureAbstract" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_AccruedLiabilitiesDisclosureAbstract_lbl" xml:lang="en-US">Accrued Liabilities Disclosure Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_AccruedLiabilitiesDisclosureAbstract" xlink:to="igc_AccruedLiabilitiesDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_Expiring2023Member_lbl0" xml:lang="en-US">Expiring2023 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_Expiring2023Member" xlink:to="igc_Expiring2023Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl0" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_OtherAdvances_lbl1" xml:lang="en-US">Other Advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_OtherAdvances" xlink:to="igc_OtherAdvances_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_NumberOfPatentsGranted_lbl1" xml:lang="en-US">Number Of Patents Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NumberOfPatentsGranted" xlink:to="igc_NumberOfPatentsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Selling, General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl0" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl0" xml:lang="en-US">Operating Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl0" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_AdjustmentToReconcileNetLossToNetCashAbstract_lbl0" xml:lang="en-US">Adjustment To Reconcile Net Loss To Net Cash Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="igc_AdjustmentToReconcileNetLossToNetCashAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_DepositsAndAdvancesAbstract" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_DepositsAndAdvancesAbstract_lbl" xml:lang="en-US">Deposits And Advances Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_DepositsAndAdvancesAbstract" xlink:to="igc_DepositsAndAdvancesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl0" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ESOP2008OmnibusPlanMember_lbl1" xml:lang="en-US">ESOP2008 Omnibus Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ESOP2008OmnibusPlanMember" xlink:to="igc_ESOP2008OmnibusPlanMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_InfrastructureSegmentAbstract_lbl0" xml:lang="en-US">Infrastructure Segment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_InfrastructureSegmentAbstract" xlink:to="igc_InfrastructureSegmentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Other Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl0" xml:lang="en-US">Other Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl0" xml:lang="en-US">Debt Instrument, Periodic Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl0" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl0" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl0" xml:lang="en-US">Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_lbl0" xml:lang="en-US">Building and Building Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl0" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_NoncurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Noncurrent Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_NoncurrentLiabilitiesAbstract" xlink:to="igc_NoncurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfLoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfLoansAndOtherLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfLoansAndOtherLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Loans And Other Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfLoansAndOtherLiabilitiesAbstract" xlink:to="igc_ScheduleOfLoansAndOtherLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl0" xml:lang="en-US">Deposits Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl0" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl0" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsAbstract_lbl0" xml:lang="en-US">Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_LoansAndOtherLiabilitiesTextBlock_lbl1" xml:lang="en-US">Loans And Other Liabilities Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_LoansAndOtherLiabilitiesTextBlock" xlink:to="igc_LoansAndOtherLiabilitiesTextBlock_lbl1"/>
    <loc xlink:type="locator" xlink:label="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract_lbl" xml:lang="en-US">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl0" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl0" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_UnitDescription_lbl1" xml:lang="en-US">Unit Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_UnitDescription" xlink:to="igc_UnitDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="igc_PlantAndCannabinoidMember_lbl1" xml:lang="en-US">Plant And Cannabinoid Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="igc_PlantAndCannabinoidMember" xlink:to="igc_PlantAndCannabinoidMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_lbl0" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IN_lbl0" xml:lang="en-US">INDIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IN" xlink:to="country_IN_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl1" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0" xml:lang="en-US">Payments to Acquire Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionMember_lbl0" xml:lang="en-US">Construction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionMember" xlink:to="us-gaap_ConstructionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl0" xml:lang="en-US">Debt Instrument, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl0" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Other Assets and Other Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl0" xml:lang="en-US">Operating Lease, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl0" xml:lang="en-US">Interest Expense, Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableCurrent_lbl0" xml:lang="en-US">Loans Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl0" xml:lang="en-US">Deferred Tax Assets, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>igc-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Jul 07 17:41:02 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedBalanceSheet" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedIncomeStatement" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ShareholdersEquityType2or3" roleURI="http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ConsolidatedCashFlow" roleURI="http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_NATUREOFOPERATIONSANDMANAGEMENTSPLANS" roleURI="http://www.indiaglobalcap.com/role/NATUREOFOPERATIONSANDMANAGEMENTSPLANS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INVENTORY" roleURI="http://www.indiaglobalcap.com/role/INVENTORY"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DEPOSITSANDADVANCES" roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INTANGIBLEASSETS" roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PROPERTYPLANTANDEQUIPMENT" roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_CLAIMSANDADVANCES" roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LEASES" roleURI="http://www.indiaglobalcap.com/role/LEASES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ACCRUEDLIABILITIESANDOTHERS" roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LOANSANDOTHERLIABILITIES" roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SECURITIES" roleURI="http://www.indiaglobalcap.com/role/SECURITIES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_STOCKBASEDCOMPENSATION" roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_FAIRVALUEOFFINANCIALINSTRUMENTS" roleURI="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INCOMETAXES" roleURI="http://www.indiaglobalcap.com/role/INCOMETAXES"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_REVENUERECOGNITION" roleURI="http://www.indiaglobalcap.com/role/REVENUERECOGNITION"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SEGMENTINFORMATION" roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATION"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SUBSEQUENTEVENTS" roleURI="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_AccountingPoliciesByPolicy" roleURI="http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INVENTORYTables" roleURI="http://www.indiaglobalcap.com/role/INVENTORYTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DEPOSITSANDADVANCESTables" roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INTANGIBLEASSETSTables" roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_CLAIMSANDADVANCESTables" roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LEASESTables" roleURI="http://www.indiaglobalcap.com/role/LEASESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ACCRUEDLIABILITIESANDOTHERSTables" roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LOANSANDOTHERLIABILITIESTables" roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_STOCKBASEDCOMPENSATIONTables" roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_FAIRVALUEOFFINANCIALINSTRUMENTSTables" roleURI="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INCOMETAXESTables" roleURI="http://www.indiaglobalcap.com/role/INCOMETAXESTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_REVENUERECOGNITIONTables" roleURI="http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SEGMENTINFORMATIONTables" roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofInventoryCurrentTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable" roleURI="http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofIntangibleAssetsAndGoodwillTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PropertyPlantandEquipmentTable" roleURI="http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofOtherAssetsNoncurrentTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LeaseCostTable" roleURI="http://www.indiaglobalcap.com/role/LeaseCostTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LesseeOperatingLeaseLiabilityMaturityTable" roleURI="http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofAccountsPayableandAccruedLiabilitiesTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofLoansandOtherLiabilitiesTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_NonvestedRestrictedStockSharesActivityTable" roleURI="http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SharebasedPaymentArrangementOptionActivityTable" roleURI="http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofEffectiveIncomeTaxRateReconciliationTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofComponentsofIncomeTaxExpenseBenefitTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SummaryofOperatingLossCarryforwardsTable" roleURI="http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DisaggregationofRevenueTable" roleURI="http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_RevenuefromExternalCustomersbyProductsandServicesTable" roleURI="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_RevenuefromExternalCustomersbyGeographicAreasTable" roleURI="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable" roleURI="http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INVENTORYDetails" roleURI="http://www.indiaglobalcap.com/role/INVENTORYDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_DEPOSITSANDADVANCESDetails" roleURI="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_INTANGIBLEASSETSDetails" roleURI="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_CLAIMSANDADVANCESDetails" roleURI="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LEASESDetails" roleURI="http://www.indiaglobalcap.com/role/LEASESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_ACCRUEDLIABILITIESANDOTHERSDetails" roleURI="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_LOANSANDOTHERLIABILITIESDetails" roleURI="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SECURITIESDetails" roleURI="http://www.indiaglobalcap.com/role/SECURITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_STOCKBASEDCOMPENSATIONDetails" roleURI="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SEGMENTINFORMATIONDetails" roleURI="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#igc_r_SUBSEQUENTEVENTSDetails" roleURI="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails"/>
  <roleRef xlink:type="simple" xlink:href="igc-20230331.xsd#DocumentAndEntityInformation" roleURI="http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAssetsAbstract" xlink:href="igc-20230331.xsd#igc_NonCurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="NonCurrentAssetsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_NonCurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentLiabilitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_ImpairmentOfInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ProfitLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EarningsPerShareBasicDiluted" xlink:href="igc-20230331.xsd#igc_EarningsPerShareBasicDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="EarningsPerShareBasicDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageNumberOfShareOutstandingBasicDiluted" xlink:href="igc-20230331.xsd#igc_WeightedAverageNumberOfShareOutstandingBasicDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="WeightedAverageNumberOfShareOutstandingBasicDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentToReconcileNetLossToNetCashAbstract" xlink:href="igc-20230331.xsd#igc_AdjustmentToReconcileNetLossToNetCashAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentToReconcileNetLossToNetCashAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_ImpairmentOfInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentToReconcileNetLossToNetCashAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInOperatingLeaseAssets" xlink:href="igc-20230331.xsd#igc_IncreaseDecreaseInOperatingLeaseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOperatingLeaseAssets" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashItemsAbstract" xlink:href="igc-20230331.xsd#igc_NonCashItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="NonCashItemsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashItemsAbstract" xlink:to="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesReduction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReduction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashItemsAbstract" xlink:to="us-gaap_NotesReduction" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/NATUREOFOPERATIONSANDMANAGEMENTSPLANS">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NatureOfOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INVENTORY">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES">
    <loc xlink:type="locator" xlink:label="DepositsAndAdvancesAbstract" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesAbstract"/>
    <loc xlink:type="locator" xlink:label="DepositsAndAdvancesTextBlock" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepositsAndAdvancesAbstract" xlink:to="DepositsAndAdvancesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INTANGIBLEASSETS">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LEASES">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS">
    <loc xlink:type="locator" xlink:label="AccruedLiabilitiesDisclosureAbstract" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="AccruedLiabilitiesDisclosureTextBlock" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesDisclosureAbstract" xlink:to="AccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES">
    <loc xlink:type="locator" xlink:label="LoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="LoansAndOtherLiabilitiesTextBlock" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="LoansAndOtherLiabilitiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SECURITIES">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INCOMETAXES">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/REVENUERECOGNITION">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SEGMENTINFORMATION">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GoingConcernPolicyPolicyTextblock" xlink:href="igc-20230331.xsd#igc_GoingConcernPolicyPolicyTextblock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="GoingConcernPolicyPolicyTextblock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CybersecurityPolicyPolicyTextBlock" xlink:href="igc-20230331.xsd#igc_CybersecurityPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="CybersecurityPolicyPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INVENTORYTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables">
    <loc xlink:type="locator" xlink:label="DepositsAndAdvancesAbstract" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepositsAndAdvancesAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="PROPERTYPLANTANDEQUIPMENTTablesTable" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTTablesTable"/>
    <loc xlink:type="locator" xlink:label="PROPERTYPLANTANDEQUIPMENTTablesLineItems" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="PROPERTYPLANTANDEQUIPMENTTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentTableTypeAxis" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTTablesTable" xlink:to="PropertyPlantAndEquipmentTableTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentTableMember" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentTableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTableTypeAxis" xlink:to="PropertyPlantAndEquipmentTableMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTTablesTable" xlink:to="PROPERTYPLANTANDEQUIPMENTTablesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTTablesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LEASESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables">
    <loc xlink:type="locator" xlink:label="AccruedLiabilitiesDisclosureAbstract" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables">
    <loc xlink:type="locator" xlink:label="LoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INCOMETAXESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfInventoryCurrentAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfInventoryCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoryCurrentAbstract" xlink:to="us-gaap_InventoryRawMaterials" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoryCurrentAbstract" xlink:to="us-gaap_InventoryWorkInProcess" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoryCurrentAbstract" xlink:to="us-gaap_InventoryFinishedGoods" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoryCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventoryNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_OtherInventoryNetOfReserves" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIntangibleAssetsAndGoodwillAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfIntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable"/>
    <loc xlink:type="locator" xlink:label="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAndGoodwillAbstract" xlink:to="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_OtherIntangibleAssetsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_TrademarksMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable" xlink:to="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="UnamortizedIntangibleAssetsAbstract" xlink:href="igc-20230331.xsd#igc_UnamortizedIntangibleAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="UnamortizedIntangibleAssetsAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnamortizedIntangibleAssetsAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LandMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_MachineryAndEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_FurnitureAndFixturesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_VehiclesMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ConstructionInProgressMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentEstimatedUsefulLives1" xlink:href="igc-20230331.xsd#igc_PropertyPlantAndEquipmentEstimatedUsefulLives1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentEstimatedUsefulLives1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLALOm5tfIsNSqwD4AozZ/F944Y87fOfI0y4QCn3wy0vWYacVKSOrI2x+HAoVIyehE0TJwp7ZEi22T/0R8HGCwjeAHX54t9rDaOwQnZlYSrrcHEk/vmnsJgrBykMl1kSBM4wydqoLLE94xz5efBgU/huurj9vXfCBprv2MXXGbOl7kznaS6Lu4+Ah] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherAssetsNoncurrentAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfOtherAssetsNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_OtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherAdvances" xlink:href="igc-20230331.xsd#igc_OtherAdvances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="OtherAdvances" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LeaseCostTable">
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_ShortTermLeaseCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_AssetsAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable">
    <loc xlink:type="locator" xlink:label="LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:href="igc-20230331.xsd#igc_LesseeOperatingLeaseLiabilityMaturityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseLiabilityMaturityAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfLoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfLoansAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable">
    <loc xlink:type="locator" xlink:label="NonvestedRestrictedStockSharesActivityAbstract" xlink:href="igc-20230331.xsd#igc_NonvestedRestrictedStockSharesActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonvestedRestrictedStockSharesActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable">
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:href="igc-20230331.xsd#igc_ShareBasedPaymentArrangementOptionActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementOptionActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" xlink:href="igc-20230331.xsd#igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"/>
    <loc xlink:type="locator" xlink:label="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:href="igc-20230331.xsd#igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:to="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable" xlink:to="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_Investments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable">
    <loc xlink:type="locator" xlink:label="SummaryOfOperatingLossCarryforwardsAbstract" xlink:href="igc-20230331.xsd#igc_SummaryOfOperatingLossCarryforwardsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfOperatingLossCarryforwardsAbstract" xlink:to="us-gaap_OperatingLossCarryforwardsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="Expiring2023Member" xlink:href="igc-20230331.xsd#igc_Expiring2023Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2023Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2024Member" xlink:href="igc-20230331.xsd#igc_Expiring2024Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2024Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2025Member" xlink:href="igc-20230331.xsd#igc_Expiring2025Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2025Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2026Member" xlink:href="igc-20230331.xsd#igc_Expiring2026Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2026Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2027Member" xlink:href="igc-20230331.xsd#igc_Expiring2027Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2027Member" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2028Member" xlink:href="igc-20230331.xsd#igc_Expiring2028Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2028Member" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2029Member" xlink:href="igc-20230331.xsd#igc_Expiring2029Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2029Member" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2030Member" xlink:href="igc-20230331.xsd#igc_Expiring2030Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2030Member" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2031Member" xlink:href="igc-20230331.xsd#igc_Expiring2031Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2031Member" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2032Member" xlink:href="igc-20230331.xsd#igc_Expiring2032Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2032Member" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2033Member" xlink:href="igc-20230331.xsd#igc_Expiring2033Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2033Member" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2034Member" xlink:href="igc-20230331.xsd#igc_Expiring2034Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2034Member" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2035Member" xlink:href="igc-20230331.xsd#igc_Expiring2035Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2035Member" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2036Member" xlink:href="igc-20230331.xsd#igc_Expiring2036Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2036Member" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2037Member" xlink:href="igc-20230331.xsd#igc_Expiring2037Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2037Member" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2038Member" xlink:href="igc-20230331.xsd#igc_Expiring2038Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2038Member" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2039Member" xlink:href="igc-20230331.xsd#igc_Expiring2039Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2039Member" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2040Member" xlink:href="igc-20230331.xsd#igc_Expiring2040Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2040Member" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2041Member" xlink:href="igc-20230331.xsd#igc_Expiring2041Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2041Member" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2042Member" xlink:href="igc-20230331.xsd#igc_Expiring2042Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2042Member" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Expiring2043Member" xlink:href="igc-20230331.xsd#igc_Expiring2043Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="Expiring2043Member" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RentalIncomeMember" xlink:href="igc-20230331.xsd#igc_RentalIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="RentalIncomeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConstructionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="us-gaap_ConstructionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WellnessAndLifestyleMember" xlink:href="igc-20230331.xsd#igc_WellnessAndLifestyleMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="WellnessAndLifestyleMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TollingWhiteLabelingServiceMember" xlink:href="igc-20230331.xsd#igc_TollingWhiteLabelingServiceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="TollingWhiteLabelingServiceMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InfrastructureSegmentAbstract" xlink:href="igc-20230331.xsd#igc_InfrastructureSegmentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="InfrastructureSegmentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InfrastructureSegmentAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable">
    <loc xlink:type="locator" xlink:label="RevenueFromExternalCustomersByProductsAndServicesAbstract" xlink:href="igc-20230331.xsd#igc_RevenueFromExternalCustomersByProductsAndServicesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromExternalCustomersByProductsAndServicesAbstract" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="srt_ProductOrServiceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LegacyInfrastructureMember" xlink:href="igc-20230331.xsd#igc_LegacyInfrastructureMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="LegacyInfrastructureMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PlantAndCannabinoidMember" xlink:href="igc-20230331.xsd#igc_PlantAndCannabinoidMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="PlantAndCannabinoidMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TotalRevenuePercentage" xlink:href="igc-20230331.xsd#igc_TotalRevenuePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="TotalRevenuePercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable">
    <loc xlink:type="locator" xlink:label="RevenueFromExternalCustomersByGeographicAreasAbstract" xlink:href="igc-20230331.xsd#igc_RevenueFromExternalCustomersByGeographicAreasAbstract"/>
    <loc xlink:type="locator" xlink:label="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" xlink:href="igc-20230331.xsd#igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable"/>
    <loc xlink:type="locator" xlink:label="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:href="igc-20230331.xsd#igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromExternalCustomersByGeographicAreasAbstract" xlink:to="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IN" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IN"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IN" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_CO" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CO"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_CO" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable" xlink:to="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalRevenuePercentage" xlink:href="igc-20230331.xsd#igc_TotalRevenuePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems" xlink:to="TotalRevenuePercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract" xlink:href="igc-20230331.xsd#igc_ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_GeographicDistributionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GeographicDistributionAxis" xlink:to="us-gaap_GeographicDistributionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GeographicDistributionAxis" xlink:to="us-gaap_GeographicDistributionDomesticMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GeographicDistributionAxis" xlink:to="us-gaap_GeographicDistributionForeignMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_OtherAssetsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_AssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="igc-20230331.xsd#igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="igc-20230331.xsd#igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ClinicalTrialInventoryMember" xlink:href="igc-20230331.xsd#igc_ClinicalTrialInventoryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="ClinicalTrialInventoryMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryNet" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INVENTORYDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryWriteDown" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails">
    <loc xlink:type="locator" xlink:label="DepositsAndAdvancesAbstract" xlink:href="igc-20230331.xsd#igc_DepositsAndAdvancesAbstract"/>
    <loc xlink:type="locator" xlink:label="StatutoryAdvances" xlink:href="igc-20230331.xsd#igc_StatutoryAdvances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepositsAndAdvancesAbstract" xlink:to="StatutoryAdvances" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransferFromDepositsAndAdvancesToClaimsAndAdvances" xlink:href="igc-20230331.xsd#igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepositsAndAdvancesAbstract" xlink:to="TransferFromDepositsAndAdvancesToClaimsAndAdvances" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="INTANGIBLEASSETSDetailsTable" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsTable"/>
    <loc xlink:type="locator" xlink:label="INTANGIBLEASSETSDetailsLineItems" xlink:href="igc-20230331.xsd#igc_INTANGIBLEASSETSDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="INTANGIBLEASSETSDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsTable" xlink:to="INTANGIBLEASSETSDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NumberOfPatents" xlink:href="igc-20230331.xsd#igc_NumberOfPatents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsLineItems" xlink:to="NumberOfPatents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfPatentsGranted" xlink:href="igc-20230331.xsd#igc_NumberOfPatentsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsLineItems" xlink:to="NumberOfPatentsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INTANGIBLEASSETSDetailsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="PROPERTYPLANTANDEQUIPMENTDetailsTable" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTDetailsTable"/>
    <loc xlink:type="locator" xlink:label="PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:href="igc-20230331.xsd#igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="PROPERTYPLANTANDEQUIPMENTDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_PR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_PR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_PR" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTDetailsTable" xlink:to="PROPERTYPLANTANDEQUIPMENTDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOwnedGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOwnedGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentOwnedGross" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PROPERTYPLANTANDEQUIPMENTDetailsLineItems" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="TransferFromDepositsAndAdvancesToClaimsAndAdvances" xlink:href="igc-20230331.xsd#igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="TransferFromDepositsAndAdvancesToClaimsAndAdvances" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_PaymentsForDeposits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LEASESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="LEASESDetailsTable" xlink:href="igc-20230331.xsd#igc_LEASESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LEASESDetailsLineItems" xlink:href="igc-20230331.xsd#igc_LEASESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="LEASESDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_AsiaMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="LEASESDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_ShortTermLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails">
    <loc xlink:type="locator" xlink:label="AccruedLiabilitiesDisclosureAbstract" xlink:href="igc-20230331.xsd#igc_AccruedLiabilitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesDisclosureAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesDisclosureAbstract" xlink:to="us-gaap_ShortTermBorrowings" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails">
    <loc xlink:type="locator" xlink:label="LoansAndOtherLiabilitiesAbstract" xlink:href="igc-20230331.xsd#igc_LoansAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DebtInstrumentPeriodicPayment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DebtInstrumentTerm" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_RepaymentsOfDebt" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermLoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLoansPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_LongTermLoansPayable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansAndOtherLiabilitiesAbstract" xlink:to="us-gaap_LoansPayableCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SECURITIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="UnitsOutstanding" xlink:href="igc-20230331.xsd#igc_UnitsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="UnitsOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnitDescription" xlink:href="igc-20230331.xsd#igc_UnitDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="UnitDescription" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalesAgreementMaximum" xlink:href="igc-20230331.xsd#igc_SalesAgreementMaximum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="SalesAgreementMaximum" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsTable" xlink:href="igc-20230331.xsd#igc_STOCKBASEDCOMPENSATIONDetailsTable"/>
    <loc xlink:type="locator" xlink:label="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:href="igc-20230331.xsd#igc_STOCKBASEDCOMPENSATIONDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="STOCKBASEDCOMPENSATIONDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsTable" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ESOP2008OmnibusPlanMember" xlink:href="igc-20230331.xsd#igc_ESOP2008OmnibusPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="ESOP2008OmnibusPlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsTable" xlink:to="STOCKBASEDCOMPENSATIONDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAveragePricePerShare" xlink:href="igc-20230331.xsd#igc_WeightedAveragePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="WeightedAveragePricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="STOCKBASEDCOMPENSATIONDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SUBSEQUENTEVENTSDetailsTable" xlink:href="igc-20230331.xsd#igc_SUBSEQUENTEVENTSDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SUBSEQUENTEVENTSDetailsLineItems" xlink:href="igc-20230331.xsd#igc_SUBSEQUENTEVENTSDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SUBSEQUENTEVENTSDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsTable" xlink:to="SUBSEQUENTEVENTSDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUBSEQUENTEVENTSDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.indiaglobalcap.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="igc-20230331.xsd#igc_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>figure1.jpg
<TEXT>
begin 644 figure1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#@17AI9@  34T *@    @ ! $[  (
M   '   (2H=I  0    !   (4IR=  $    .   0RNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N9')E80
M  60 P "    %   $*"0!  "    %   $+22D0 "     S(R  "2D@ "
M S(R  #J'  '   (#   ")0     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M               R,#(S.C V.C(S(#$T.C$W.C4S #(P,C,Z,#8Z,C,@,30Z
M,3<Z-3,   !! &X 9 !R &4 80   /_A"QEH='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H
M:4AZ<F53>DY48WIK8SED)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E
M.FYS.FUE=&$O(CX\<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N
M;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S
M,V0W-3$X,F8Q8B(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M
M96YT<R\Q+C$O(B\^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z
M9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX
M;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E
M1&%T93XR,#(S+3 V+3(S5#$T.C$W.C4S+C(Q-3PO>&UP.D-R96%T941A=&4^
M/"]R9&8Z1&5S8W)I<'1I;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(G5U:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X
M;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD
M8SIC<F5A=&]R/CQR9&8Z4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO
M<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y!;F1R96$\
M+W)D9CIL:3X\+W)D9CI397$^#0H)"0D\+V1C.F-R96%T;W(^/"]R9&8Z1&5S
M8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" \/WAP86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&
M" <'" H1"PH)"0H5#Q ,$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@
M+S,O*C(G*BLJ_]L 0P$'" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@!(0$O P$B
M  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40
M  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$5
M4M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2U
MMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$
M !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'
M!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6
M)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#
MQ,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1
M #\ ^D:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***;)(
MD,;22NJ(HRS,< #U)H =134=)8U>-E=& *LIR"/4&G4 %%%% !1110 444Q)
M8Y"0CAL=<4 /HJ*.4B5HI/O#E3_>%.BD$L8<#')'ZT[ /HHHI %%%% !1110
M 4444 %%%% !1110 4A(526(  R2>U+5;48WFTNZBB&YWA=5'J2#0 ]+NVD\
MK9<1-YP)BPX.\#KCU_"IJ\9T[P=XUT_3_"DEO<&6ZL-.NHUBEB5%M)6A(0%A
M][YB!S4\4'CU/#JHQU:62290VZ8K+"1&<D'&64OCCH* /6UN(7G>%)8VEC +
MH&!90>F1VS1#<0W,9>WE25 Q4LC!AD'!''<&O')O#/BNZEAU2_@OA= Z8]R;
M:38\IC+^;TZD9!J>VT#Q/H=A=/%?WFFVTHU&>5GF'EPOYI>%@,<;N_UH ]<G
MGBMH6EN94BC7[SR,% _$U(#D9'2O,7L?$7B;X*WTM^LL^J:N/M$=KG'D(2-B
M+Z?*,_4TW3=-\8W&JVJ27.KP:0EZ[J)K@"<QB#A7;'W3)T]J /3)KB&VC#W$
MT<2%@H:1@H)/ '/>I*\>MK7Q]>/=+=07JPM);R+'/)YFQUG&_:2.FSTXXXKH
M_"=AXJL]=LI]7NKZ>"X@NOM<=Q*&2-Q*/)VCM\F: .^HHHH **** "@@$$'D
M=\U%/=06OE_:)5C\QPB;CC+'H*+J3RK.9R5&U"<L>.E,-CG+77].T.\?3KF\
MA-L\S>1*L@(CW'.Q_3DG!Z8..,5>N_%>FP;DMY?M<P.-D73/UZ5X;>WLL%A<
MR-&&#-@<=/QK8L;R[CC\V<&*UN'#++C 0[0"">W3K7J?4X*=FSS'B:SI>T22
M3;7W6_S/:M/ODU&S2>-2F[JI/2K58/A^,VNBVJJ<_+G/KDUN1N)%R/Q%>?4@
MHR=MCNIR<HJ^XZF2G$9RI8=P.M/JO/E.1(^YCA57O^%9K<U('EN#&R)$\BLO
MRN1M(_QIT,JR742J"A1#N4CI3UNGC4"ZC96]5&0:IWEXC3H]N2&3JV,9]JT2
MOH9MI:EK4 -D;%2Q#@8'<>E2A9I% (6%/1>3C^E9*Z@\TR.[!_+.=HXK12\D
MFCS#;L<\ DC%#BT@4DV68I/,4D#Y02![XI]44^UPQ*GEA5'WF4[CGZ59MRA3
MY'+GJ2>M0T6F2T445(PHHHH **** "BBB@"EK&KV6@Z1<:GJDWDVELA>63:6
MVCZ $FN'_P"%]?#O_H.2?^ ,_P#\16G\7/\ DD^O_P#7J?YU\6 %B H))X '
M>@#[ _X7U\._^@Y)_P" ,_\ \15NW^,O@J["&UU"ZEWG"[-.N#N/M\E?-&@>
M#HUM/[4U^>*TLXS\TD^=@/H!UD;_ &5_&M"\\;^47M/!T#V"[=K7LBAKJ4>Q
MZ1+].?>@#Z&OOC-X)TR;RM0U*XMI>\<NGSJP_ I4,7QQ\ SMMAU>>0^BV$Y_
M]DKYX\/>%/[766_U*9YM[')+$ECZDGD_C6HNA2:%J\5W8KYL$A$;HY_U>>XH
M ]W7XU>!WG,":E=-*!DH-.N,C\-E"_&'P-? P"]GG# YC_LV=L_ALKSF73XH
M8VN8503RH!\_1:X6WNI],\33K((Y1(-S,JXQSQQ0!]"S_&#P;:E5N+V[B+'"
MAM-N!D^GW*JR_'3P! ^R;6)HV]&L)Q_[)7GS-;W.DK?&)7=!UKDET6/Q%?W$
MU]$%AC3:B \?[Q/K0![]_P +6\*?88[T7-Z;67[DXTVX*-^.S%9\WQS\ 6TI
MCN-8FC<=5>PG!'_CE?.<+:MX/U&9M%N))=/<XEA9=\4G^RRGY6_G6FI\/^.8
M1;PA-,U11Q9SOM5C_P!,I&Z?[C?@: /=O^%]?#O_ *#DG_@#/_\ $4G_  OK
MX=_]!R3_ , I_P#XBOE/6M!O-$NGCNHV"JVW<5(P?0CL:RSTH ^^='U>RU_1
M[;5-*E,UG=)OBD*%=PSCH0".G>KM<;\(_P#DDOA[_KU_]F-=E0!7OK./4+":
MUF^Y*A4GT]ZQ+[5)[71;NSU-3#>+;/Y<JC<D^%^\OOW*GGKU'-='7G7Q8UHV
M<&G:<J'=<R%S(K%2H7C'XYK2GK-)]P<92BU'LW]RN>7ZLLXTM$)($LP &1@\
MUU)@6'26-_, GE,2N[)8?3UKE=0@9A8(A20-,"V&Z?7TKHM4^SV_AVZ9'\QO
M)P !A>?7->VW:<Y>GZGE1BI4*%)=7+\6E^AZ3X-O8]0\&Z;/"KJOE;,/U^4X
MK=1RC9%87@R#[/X*TJ,@#_1U;C'?FMNO(W6IZ=51C4DH;)NQ?1PZY6HI?DDW
M1H2Y'7:3^O:H(Y#&WMW%6RVZ,F/DXXK)KE8)W*XO<-LDB<2=U49K-OR)IF/E
M-&",'(QGWK8@A$,>.K'EF]34A&1@\BA22>@G%M'+VMELD(B+.SGH36Y!#=V\
M013$RCH#G^=<]H>L37/BNZLVBB6*/(4J#D<M[_[-=;6E7FB[,BE:2NBH999G
M,,BB'/J<D_2K8&!@4UT61=K#(_E3AP/6L6:A1112&%%%% !1110 4444 <;\
M7/\ DD^O_P#7J?YU\O>#M&M(-/N?$.MEDLK5<\?><YP%7_:8\#TY-?4?Q73S
M/A9KB#^*W(_45\Y^-$^R6WASPC;'RUV+=7!'=GX7/T7)_&@#-DM]1\<ZA%<S
MRK!8Q+MB@B&$MUS]Q1Z^I[UV5IX5TJWT_P"RJL1##OR2?4FKNC:78Z/;I#$Y
M" 8"MS^.:NW.BPW<Z2([1XYPO>@#+T2%=(D-E.VT;CM9NXKH/[-C>4&3YEZA
M:D;3[>2-%GC$I3HS#FK)8(@8X Z<F@#FO$*7,UP1"'"Q !-O<FN>TC?I\<W]
MIP/<S[B6V\Y]!FN_O%6>Q=41FW=#$PS^=<_H.F7EIJEPU[;2&!S\I8YS[T :
MFD7=MJFEMY<)B0'#1$=*JZA9K96'E6J;/..'8=A6POV:T?RXQ'$7.=N<$T^2
M,."KJ"IZ@T <PBV4-J(Y=H5>F:YOQ5H-C?61NH&6&=!E'Z9]N*[*\\.6<N?+
M8HYYR3FJD]G::;G,#7<O<GI0!R>AZY%XDMO^$=\6,B7PCV65[,,%QVBD/<'^
M%NHKA]?T2?0M2DM;A&4 D+N'(QV/N*Z#Q:KZC"VJQ1"W^RR"/8?O]>IKJO&%
MHGBCX7:=XDB3,ZQ>7<G')D3N?J* /=_A'_R27P]_UZ_^S&NRKC?A'_R27P]_
MUZ_^S&NRH *\=^+DRR^+]+MVD/[F!G*^F3_7'Z5[%7BGQ-CF/Q"66:W80_9%
M2-\</R>_U-;X=7JQ7F5S*%*I)_RO\5;]3*2VBELV:.<B2)5= 4X9AV-&N7=O
M-X>FBA@E\[*1NLGWDS[#^=6[3R%MI24F/*K]\8_&M.UT^;4=8C^Q+'%\NW:P
MX;# C)_ C\:]NLFX/T/ P=3V=:$FKV:?XGH^D0"VT2Q@5=@CMT&WT^45;JI9
M:E'?[UV-!<1X\VWD&&C)_F/0U;KQMCUV[NX5)%*8VY^Z>M1T4-7 T 01D<BB
MJD,NPX/W?Y5;ZBL)1LS5.YP?AW \>7FWIN;_ -GKO*X'PK^\\;7K(=ZX<DCL
M0[K7?5OB?C^2.?#?!\PHHHKF.D**** "BBB@ HHHH **** .6^)*>9\/M33^
M\BC_ ,>%?.&L3"Y^-5Z[+YT<:;%4\\!,"OI/XA?\B+J/./E7G_@0KY<NGG7X
MI7#PR*9')&]UZYXS@8H [M8))(@K1+:Q]S*P+"M:.\LX+<?O-X08SGKBN)OM
M%\3/'),T\7!RI"'D?G3+_3;^RT^VDOKM;BVD<))%LV%@3C.0<]>W>@#N[35;
M>_D:. G*<_44FHV9U"P> .5!Y)!Y/M5+1(UM[0; ,D87CH/2MG8?LY]=M 'D
M$T/B;PG?RII=Q<BU7YE+D%6]L'O]*O7WBKQI-:VZ)"UL9(]Q<0[6;G'&:[Z>
M$&)TD52K#G/(-5-,$[2.;J4SB([868#*KC[OO]: ,GPAX:NHKE-6U>:>XO&'
MS&5R0H/8"NU9@ 6<\#DFEMHR(\G)XXS5>3(=]^=I&,'TH SY/$>FK<&*16&.
M=^.*BO\ _2K=+G3@DZ'J0U<AXLTII+&:5;D[X0638V#CT-:^D0:CI^DP11E3
M&8Q^]!XSZ8H Q?$-B(=!U"YNL$S#@*,8QTK7\!EKSX3ZMI\JAD$8G4G^$YVG
M^=<[XUOKR>S:S\G@KEG7G.#TQ6W\*YA<Z)>V97/FV,\8^H^8?RH ]V^$@V_"
M?P^OI;8_\>:NQKD/A4-OPMT,>D!'_C[5U] !7EWQ;;R=0TR2.'S'*.&&[JN1
MV]:]#AOW_MB6PN(U5@GFPNI.'3.#GT(-><_$N>1O$]K''MQ'""2 2>IZUV8.
M-ZR./&RM19R\,_GV<5S96Z/,DVX*&)+ 'E2N.:['PA*U[JT4ZN#$J-@ =#@\
M8[?CTKFM-2ZBB1(PPW2-+Q'C&1ZGC%;/A:6.T\>1P-,/M%S:OYB+D[L<@D^O
M!KTZ[4:;/-PT.>HE%;:_([F\LYGU"VO;0QB6(&.19"0'C;J,@'D$ CZ8[U>H
MHKR3UPHHHH *;<7WV.QDD96< 855QDD\#K3JJZO:-<:'=?.T>(RRLF,Y'/>D
M[,>QSGPZ'VJ]O[XJRL>"&Z_,03G\5:N]KB?APOEPZ@NXN1)C<1UP\G^-=M1B
M;^T=Q8>WLU8****YS<**** "BBB@ HHHH **** .7^([;/A_J;#^&,'_ ,>%
M?*/B0SIXNM+BUR9G&01Z[C_C7U3\43M^&FLD<$0_U%?-MZ1#KNG2B-96D#1#
M<> 3@_XT =)937JM&Y^T*S@ E1N7\JT_$EA=7-K:R0)OEC((4# /^%4+>"\G
M="+N*WP1M7?_ $KI;S5H]-2VANG:2>7"_(.I]: *=E93V]K&;H)&P[$\*/<^
MM:,-_!*W[N5#VVA@3^58-Y;74\DB><+K!^8 ]/J*HWL$^C(MW%IX=U'3=MX[
MF@#L+F*&9"O0^@/2L7PS&B+=^??"Y=;EP2/X!V7\*V+9UEMU+K@L@()ZKD=Z
MQO"OA]O#[7WFW:W1N93)RF-O/_UZ -^YO8K:(/)(L<?8L<5D_P!JP7\FV&2,
ML#C:'^\/K5'7[A_M<44R*RR9$1)&TD=?QJ Z7.D8D(BMX^S9 H 76_#T]VH-
MM DZN!G<??O5C4#;6%A:V]Y;R*6'2/H#4$-V=.U*"&"8O$YS(<YW'O5^X\36
M1OWM?LYF$7);@XH Y6XL(KE9%C#1Q-]Z5DQ^ JI\/X([;7I+59&,"WP0.K8(
MR/6M[7VB;_29[I%AV[E3.-HKEM GCLK&;4X9"D"RO<;R,XV]/SH ^E_AO'Y7
MP^TR,X^02KQ[2N*ZBN1^%DQN?AAHL[_>FA:0_4NQ_K774 4]0TV._5&WO#/$
M28IXSAHS_4>H/!KQCQG-J-YXKED8YO+$")_+.T,!SQ]00?J:]OG<1VTCD[0J
M$Y].*^<=+9[R>ZN))][R2LQ9V.3SUKNP+_>6\CEQL/\ 9G4OLU^-_P#(Z6Q:
M2Y@B*S'RUC.=TGW?P]:M>#H!)\4IG $@M[(C>. ,\9_7%9,7V:#Q(ML\B[FM
M=SB,$ASG(Y]< UO?#E(Y?&VO741?"Q+& WU'_P 375BY)P27<G+J<H2J2:M[
ME_O:1Z71117 :A12@%C@#)JU%"$Y;EOY4G)(:5QD4'\3_@*?=1B6SEC(X9"/
MTJ6BL7)MW-;*UCAOA_,XOM0MY, [$.!Z\D_^AUW-<[IFD6NF>(9I[>1SYJLK
M ],EBQ_H/PKHJUKR4I\R,J$7&'*PHHHK V"BBB@ HHHH **** "BBB@#GO'F
MD7FO>!]4TW2U1KNXA*Q*[84MG.":\(UOX/\ CK5(X?(TR"&2.0.#]KC !QVP
M:^F** /GK2_AQX\LXT^U:):S3+_RT^VH<GUQFH=2^&/CZYO(;BUTR-'1MQ+W
MZ<^HQDU]%T4 >#P^!/'$-M)''HL0:0?,_P!MCS^>:H7?PY^(MVD,;V$/EQN&
M*_;$^8 ],YKZ'HH \A7PYXN#$_\ "/* >PO(O_BJ:GAKQ<I)/AX')_Y_(N/_
M !ZO8** /!O$/P]\7Z[#:Q#1?)$,_F,RWT0;'L<]:QKCX8_$_P M[>TM[<V^
M?E,UTA?'X'%?25% 'RO/\%_BA<R!Y%B##ILO47'Y&H(/@7\2;:?SH(XDDSDL
M+Y>?KSS7U?10!\KW_P %_B;J<?EW<-LR9SM%U&!_.KEM\'_B%9Z+%9P:=:ET
MDW-ONHRCKUP1GGFOIRB@#G_ FDWFA^!M,T[4XTBNX(B)4C8%5)8G ([<UT%%
M% &=X@G-MX;U&=55C';.P#' /RFOG[04B-FN]V4L>?D)[U[]XFLAJ'AC4;5G
M=!);N,H.>E>%:&(3;PC9(X)7)5L9[UZ. B^=R\CDQ]2*PRIK=RO\DG_F3V(B
M_P"$VO68>:D42J"!M!/'^->B>$_*TZ21IH5@74MK12X #LN04)]>A&>O->>:
M$\;^(-6FA@9_W@1?,^;;]?Q%>OZ=:)<>'8;>\B1UDC^=",@Y]?>M*C_=7[ME
M5+K$<O:$5^"9I4Y$+MA:K:/;7(TV&*\),D>4+$Y+ '@_EBM94"+A17!*5C11
MN-CB$8XZ]S3Z**QW-2.4-PRRB-1UR,YJE-.[LJ6\SG<=N[ "_G5K[)&TQDD+
M/DY"L<@?A3YH1)%M^Z5Y4CL:M-(EILK3VT<-@5&<K\P;N6J,7TX_<LB+* .6
M; -2QNDD(N+@D;?X3]T$=\4^"$.'EF0$R'.TC.!VIW[BMV)T;<HY!/?!IU,B
MACA!$2A<G)Q3ZS+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** ,WQ%*8?#>H2 $D0/T.#T]:\'L&6TO(I3$K0R2D.C#
M@9[CTYKZ!U"QAU.PEM+H$Q2KM;!P:YN#X?6%OMV3R';_ 'D4\5WX6O3I1:EN
M>?BJ%2I-.*T/.K"::VNI8PBPQ73ET<+@;NA4D].@Q7L6FVI6PMPY.%C4<C!/
M%5X_"^F16K0^1YP*D#S3NQ5W2X9[?2[>&[;=-&@5FSG..,U.(Q"J*T4:8?#N
MGK+<M@8&!112,=J$^@S7$=@M%<E!XZB86C7%M)"D@F:9RC;4$88_*<?-TJS_
M ,)QI@L?M)64(&VL-O3C.??BMG0J+H8JM3?4Z2BN1E\9S(]TJ68<1^<8W#<$
M(@89^N:N)XRL4MPU['+ ZA0X*<!BF\ 'W&<4.A470?MH=SHL#&,45@:KXG_L
MO4+"*2V8V]S"TLDAZP@8Y(].>:JVGCNPDCMQ<JR321AW6,%@F2<?7I0J-1JZ
M0.M!.S9U-%8+^+[!6A1(YY))TC:-$3)._.W^1IA\9:>$#-%< 2#,/R?ZT;PA
MQ_P(TO8U.P_:P[G0T54TW48M3M#/"K(%=HV5Q@JRG!%6ZS::=F6FFKH****0
MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ H(R"#T-%% %$Z+IQBBB-I&4A#B-3DA=V0WYY-0OX:TF2%(I+4NB A=T
MKDX(P1G.<>W2M2BKYY+J3R1[&:_A[2I!AK->K'AF&<KM/?N!BHKWPW97AB&P
M1QK*DLBA<^84&%&3TQ6LSJBEG8*HZDG %9/_  E>B?;EM%U*!IF;: K9&?3/
M3-+VLH]0]G&70OSZ?:W4PEN(%D=8VC!;^ZW4?C5:+P_I<+QM#:B,QH$ 5V *
MCH",X/7OFM$'(R.110I22LF'+%ZM&9;^'-*M9$D@LU5T*LI+L=N.F,GMD\4J
M^'=*1V86:98ACEB<$-NX&>.><"M*BG[2?<7)'L16UK#:1LEM&(U9RY [L3DF
MI:**C<O8**** "BBB@ HHHH **** "BBJ5SK&GV>J6FG75W%%>7@8V\+-AI=
MHRV![4 7:*S['7=.U&V>>UND:-)'C.3@[D.&&#[T[3=9L-6TU+^QN4DMW!(<
MG&,$CG/3D&@"]154:G9F[>V^T1^:D8D89X"DX!S4PN8&5BLT9"C+$..!0!)1
M5.]U:RTZU%Q=7"+&2H!!SG)P,8]S3KO4K2QT^XO;B91;VZ%Y74YV@=>E %JB
MJ\-]:W%M'<13QF*4 HVX<Y&:;-J5G;M$))T!FE$*8.<N>U %JBF1RQRY\J17
MQUVMG%/H **** "BBB@ I'=8T+NP55&22> *R/%6M'P_X=N=1159H@,!SQR<
M?C]*Q-)U75O$_A47&II;Z3;SHP:2099U_O!3P 1[U25R^27)SVTV.DM]<TRZ
MLY+JWOH7@B.UW#<*?2I;+4;34(]UI,LG&2H/S >XZBO-D?2M"N8O^$6LI-:E
ME8F6:9C)@C   '&#D\XKJ-(TO1?#NMM/)>F*^OT^6WFD&5W')'OSWK25-(5C
MJZ***Q).1^(YNT\*326G ! <J<,%/!_"O*$LK)K$-&;=8A:F4RF0B7SLGM^7
M'I7N%T)I/,CBM6F5SB2&8?(1Z@FN1;P/HL-ROVBSDADDG&$)RA7/0'U%<]7#
MRG*Z.JE448V9J^ M5O+KPY:?VD""PV1L1Z=/SKJ89Q,T@7_EFVW([\52U"U@
MMM#EB@011QKE0O&T^U/@2YDMU6-$M8B/J_\ A71&-H*YSR:;N7Z*YF7QWH5E
MK3:3<76R5&"!L$KGW;H*Z56#J&4@@C((I*2;LF)Q:W%HHHIB"BBB@ HHHH *
M*** "BBO(O&?Q[MO!_BZ^T*70I+EK0J#,+D*'RH;IM..M 'KM<)X@^']]KGB
M2;7%UEK:Z@\K^SXT12D>QMWSY&>6Z[2./6N!_P"&H+/_ *%J7_P,'_Q%'_#4
M%G_T+4O_ (&#_P"(H ['_A6=R=2L)Y_[,NHK2YGN=LD9#[Y'W+\V"2JY^[P"
M>M4Y?A!<?V:MO::C! WV=4F"1X6Z=9S(/,X.00=O(/T/2LC3_P!H@ZG(JVGA
M.=MQP#]KZ_0!,G\*WF^+D]NI.J:/9:85&2EYJ@1P/7;Y9/Z4 .@^%,JFV6>\
MADMT\GS+>0%U(21G91D ;?FP!@#V'2J\OP@F&DI:V>HPVSBV,4QCCP+@^?YB
MA_50OR\@X],<5E7O[1NDVF?+L8;H@XQ!=/S_ -]1"L]OVG[)6Q_PC<I_[>__
M +"@#O/#_P -H]*N3/=O!<'[";>-)%,@@<NS$J<# &<#&/;%)H?P_O=-\)ZW
MH\UY;_\ $PC\N'RTXC^4C<3@%LY[Y(Q]YJXC_AI:+8&_X12X*D9R+K/'_?%6
MK']H_3;ML3Z4ED<X!N+I\'_OF(T =#IWPLEAO;:>\EL1%#<>:+2&$F%2(#$&
M ./F)(8_3OUJMIOPJU6VD>2YU6W)DN8IV$:$*2@<$X  RV\?EU-6!\5[N>V%
MQI>AVFJ1$9)LM3#LH]U\L,/RKF[[]HT:>[+<^%)E"G!87?'_ *!Q^- 'H/@O
MP4?"4]PR2Q&.:TMH62)2H,D88,Y]VR.>O%=;7@W_  U!9_\ 0M2_^!@_^(H_
MX:@L_P#H6I?_  ,'_P 10![S17F7PZ^,L'Q!\12Z5#H[V1CMS-YK7&_."!C&
MT>M>FT %%-D<1QLY!(49PHR:RQ#>ZL2UVTMC:?PP1OMED]V8<K]%.?4]J8'D
M/QFU&Y/C*&S:25K-+=&,(DPI8LW./7@=:Q?[5>\LH&G=YD12"TLY<*<<8!Z5
M5\=Z1!I7CF[L[&61D5P5WL68$@$C)Z]>M07%M<H;1[KS'QM&-BXQGN!UX[FN
M^AHM4>K5@O9TU!WT_IGH'PYTN:[FN+U;AX1&R](R"WKC_/-=7 WAKQ?XH,FR
M<WMD,\G:DH5L?C@GV_&N;\(SP:%I=YK%S</+"L@CV1#.]CTZGIS746D5KJ^D
MG4?#T:6<MRV7D"!&?!Y#$5G4OS-GG2W+>DVOB:/Q1=2:G<1MIOS>6 1\V?NX
M'48]ZZ"X"B,O)*T:*,DJ<5%IJR1V$4<\OFRJ,,Q[U/*H9?N!R.5SV-<TG=D7
M*$,M]"2[0O-;MRJEAYB_AP/PZU0UO5$EL_(^SS1R,0P,B[=ON*NO?7UJP6:W
M24N<(BR?.?TQ_*J>LB^OX5C6P944[BQ8$U45K=C6YB/K%S=H(9+@R*ISM(Z_
M7UKH[+5;N_B/V>R7"_*7,N #^5<G#8;+LHD;"5VQM/!S76V.DW=E#MBO@NXY
M9?*!&:TJ<J14K'"7_P *;FXU=KUKQ#%)(9)D'+'GD#.!^9KT?3HX(;58;=9%
M5 !B0'/^?IQ5>62\#F*]:..!N/-B4\^QR?EK24!5 7H!@5RJG&%VEN$IRDDF
M+1113,PHHHH **** "BBB@ KXW^-W_)8M<_WX_\ T4E?9%?&_P ;O^2Q:Y_O
MQ_\ HI* .#56=@J LQ. !WKL]$\&1160U;Q%<)9V*'EY.=Q_NJO5V_2K/AS0
M;+1M$/B#Q "(@<11C[\SGI&@]3W/84Z\O+AYSJ>MIFYC4?9;)!F.U3MQTSZT
M 7)?$=P(VMO"\7]B6/W?/(W7EQ^/\/T%8>G:"=>O)X\LUQ&_[R2X8LV?3FNO
MT#0I#?Q:EYL5Y'*N2!_ 3SD>M:&F^'Y-.\67TI#.MV0\;XX'M0!Y[>Z%=66O
M1Z<HC=YL;)=N"@K3O]%NM$\N.01W#R\)N&"I[9]J]1N=)LEN?[5N(<SP)@'M
M7%^(&2XU*SE:0%S,"1F@#G;GPIJD5Q:&>??!(P#O&,;<U=\3:%9:'I/FO<,T
MS<1Q2'?D_0UV]A/(-16VD0/;2+U/.&K!\>:#)<>(=-FE&ZU=A&XQPM 'GEE-
M'!-%=P27%C.#GS8254'L0?\ (KL1XA-W L7BV);ZV9<#4X(QYT6?^>@_C'ZU
MI:QX-.H2+'YQ@M%0!8HD')]ZR4\*:AHL$LJ7"SQ*#MB8=O\ /:@#!\4>#9-+
MVW>GE9[25?,C>([E=?[RG^G45R5>C:5JT&BQK;WCFXT.[.9$7EK&0_QH/3U'
M<5B>,_#!TFZ^UVA66TF =9$'RNIZ.OL?T- ';_LU?\E$O/\ L'O_ .AK7U)7
MRW^S5_R42\_[![_^AK7U)0 5%<7,-I TUS(L<:C)9CBJ,DNHWL\D=HHLH$.W
MSY4RSG_97T]S^%.CT>TA;S[IGNI%!/F7+;L#Z=/TIV ^=_$=V/$'C+4]2A\Q
M8#)E?.X90,#GTZ=*2_!M('D2X0RQJ@ 7)R#UJSKTMN^O7H1O]?<M*[1KPP+'
M'Z<U#>QQ/9WBPI([G 4D8Z#TKT8)JF['L3<?:PBUHK77]?CYGK'@"SM;GP7Y
M<D"RP32$LDBY#<#\ZZR&&*V@6*"-8HD&%51@**\X\*^)[Q=/TO0]$L$N;QD\
MRZD9L1VZD\$X[XYQ7;_V*+CG5+N:\/\ <SY<?X*/\:XYN\F>96IRA+7J68=6
M@DU 6]H3.PR9'C&4C^K=,GT%;".'7(K.BBC@C$<$:QH.BHH J6-S&V1^(K-F
M)8CMPMQ),YW._ /]U?2IJ16#KE:6I&<IK5^]GXPL%2.,J^%8D<G.>?TKJZXK
MQ+_R.6G?0<^_-=K3NQB,H92K#(/4&A5"J%'0# I:*0@HHHH **** "BBB@ H
MHHH *^2OB;ICZQ^T!J5F@SOFBS]/*2OK6OG77(/*^.'BK5& Q:I&5)]?*7I0
M!R/B2ZA_X2)8XOWEKI$8CMXR<JTS'&<?7)K<\/:#Y$<ESJ$K3R7*X;?_ $KA
M;&Z:_P#$Q@E1F1KGS3MSVXY'Y_G7KU@ADMUW1,%!P..M %#0O#ITY72*</"7
M+(!D;,]L5TZ(0H3'([U"!;6F#+*JY/ )JVC8D!7D$<$=Z #;'(&C?:W]X$Y_
M2N&\9VD<*EA;1F$.!P"&^O\ ]<5QGCB;6-'\6,ZW<\(.6B:.0KCGVK0\._$[
M7C.MG?+#=@@[)&3#\#OCK0!W6@>'K11%>Q3S*< M%DLC?0G^E;\L$-UD.%D4
M=0><&O#-9^('B#6@R/=FU@/2*V^08]R.3^==O\+(]0GL9-0O)WDA.Y4#DDG\
M3[T =K<VX= (QC'4>U86IV][*GD6L21(1AYY,?*/85OSZA:V;(MY,D;2'"J?
MXJH:I;O<QE--O(UF(SY<AR&% 'C^LV]OHE\;6"X-W')GS8W[GTXKH?"<J^*?
M MWH,Y,LVGEGM-WWC$>63^H'M65K&D7UOJQ_MC3F2,DDR0#<K>^:K^ KJ.R\
M72B1W\L.LI:/[V W)'X&@#K_ -G2W>T^)^HP2?>CL74^_P Z\U]/UX9\-M-C
ML?CAJ$UMM,%SI[R1E>A!=2/T->YT %8GBN2\.BO;:: UQ<?( 2!A<?,>?:MN
MLGQ)&XT6XNH&59K:)W3>NY3\IR"/0BFE=V+IRY9)GSA#+NO7:>-68R\Y?'2M
M:&] 25[=(XQYC+NSDYQTW'K658?VA]HC^S*=QD)SM! _#O\ 2K-IIL=R+@7[
M 3"1F9VQN8'H1C\L>U>O/31'4K2E>?S/0/AA&^G^%9]2M4CG\R4_:4SB3"]U
M/0\$\''UKO)-7A\Z*&S22\ED4/LAQ\B'HS$D!1['D]A7F_PU\*0W:W5])<W4
M+6\Y@!MI]JS+CHQ7\.F*]/L;"UTVV$%C D,8.<*.I]2>Y]S7E=-2<:H^WE9W
M_K8L4444CC'Q2&-O;N*N AER.15"GK<>0C,WW "3B@#E-:5IO'-E$"=R[&P3
MTSN_PKN*\_T_4!K'C_=Y$L,L6,K,H!QMW*1@G_:KT 9P,]:DIA1110(****
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MQ8E@M/*MUV*B;44=N.*\OTSP;XLOTL[K4;HP^1=1S""ZNY)2Q25FWG^X=I
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>figure5.jpg
<TEXT>
begin 644 figure5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#@17AI9@  34T *@    @ ! $[  (
M   '   (2H=I  0    !   (4IR=  $    .   0RNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N9')E80
M  60 P "    %   $*"0!  "    %   $+22D0 "     S$P  "2D@ "
M S$P  #J'  '   (#   ")0     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MDCR7D96+\D!@RJH*D<@A1D$'%:E !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445SOBC7KG0Y(#'=:5
M;Q2@_P#'\\@8D=<!0>,=Z .BHK*T>;6;C][J9TUK:2,-"]C([;L\@Y(QC'<5
M/K%]/IVG-<6ML+EU8#RSYG0]\1QNQ_[Y_*@"]17-VOBN6ZGMF6PC^QRR0P23
M+=!F262(2 !0N&4;E!;<.O .*LS^()H=:^S"R5K-;E+22X\[#K*Z!QA-N"N&
M7)W#KT.* -NBBB@ HHJAKUS-9>&]2NK9]DT%I+)&V =K*A(.#QU%.*YFDA-V
M5R_17@?_  LKQ;_T%O\ R6B_^)H_X65XM_Z"W_DM%_\ $UZG]EUNZ_'_ "./
MZY3[,]\HK@?AAXEU;Q%_:G]L7?VCR/*\O]VB;=V_/W0,]!7?5Y]:E*C-PENC
MJIS52/,@HHHK(L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *X_P 4W@TKQ';WT>J:=9S-:&'R[ZVDERI?.1L(
MQTQ^%=A7-^*I/$S206WAZVS;R*3<7$<B+*O^RF\X'^]@T 4O E^#"=+CU?3K
M^*UBRB6MO)&Z MWW,1CG P!74WMC%J$ AG>=%#;LP7$D+9_WD8''MFL7PM9R
M6/G1OH+Z<7 :2ZENDGDN&_VF!))[\\>E=%0!DIX8TF*X2>*V>-HU"J$GD51A
M=@;:&QN"G ;&X>M2C0-.&I)?^5(;A-I!:>0J2%VABI;:S <;B"?>M&B@ HHH
MH *RO%'_ "*&L?\ 7A/_ .BVK5K*\4?\BAK'_7A/_P"BVK2G\:]29_"SYNHH
MHK[0^?/4_@M_S&O^V'_M2O4Z\L^"W_,:_P"V'_M2O4Z^5S#_ 'F7R_)'LX7^
M"OZZA1117"=(4444 %%%% !115'5-8M-'A6:_,ZQ'),D=M)*J <DN44A /5L
M"@#G7\.^+CHNJVX\6#[7<S[[6?[*!Y"=U]L^W3''6NKM8YHK.&.YG^T3)&JR
M3; OF,!RVT<#)YQ5:+6+.75GTT&=+I5+A9;:1%<#&2CLH5\;A]TGK1#K%I/J
MLFFJ9UNHU9]LMM)&KJI )5V4*X!9?ND]10!>HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "L/6KS6K!Y+BWET:"P0#,M_,\94^Y QUK<KGO%
MEWI<<-C!J5[#;2&\BDB$A4C(;.64D?+P03VXH 7P[K=QJMS-'/J&AW01 P73
M+HRL.>K ]!5GQ/!)<Z*\4&DQ:K(SJ%AF2-U3_;VNRAL=<9&>F1UK#\*16EOX
MENH+35;>_6.U B^R@$)&968"1@QRX+$#@<5V= '%VF@RV?B"QOK'2[U6A@2.
M5[P6C_NUA*A58$R"0G X(4\YXJ>;2+NX\6)>G2V60W44R:@SQYAA$6UH>&W<
MMNX *G?G/%=;10 4444 %97BC_D4-8_Z\)__ $6U:M97BC_D4-8_Z\)__1;5
MI3^->I,_A9\W4445]H?/GJ?P6_YC7_;#_P!J5ZG7EGP6_P"8U_VP_P#:E>H3
M31V\$DUQ(D44:EWD=@JJH&223T '>OE<P_WF7R_)'LX7^"OZZCZ*R!XKT$VE
MG<_VO9^3?/Y=NYE $C=Q[$< @]"0#R:UZX3I"BBB@ HHHH *Q_$.DWVKQ6\5
ME?06T4<F^:*XMFF2?'W58+(AP#R1G!Z'C(.Q6+K'B[0] O$M=6O?L\SQB15\
MEVRI)&<JI'4&JC"4W:*NQ.2BKMC4TC5EUVZU%M3LY?,B,5NDEDY-NN!\H(E
M(+#<W 9N!NPJ@26>DW\'B2ZU*ZO[>YAF79%$;5ED@3C"*_F%<9&3\@+'&3A5
M SO^%E>$O^@M_P"2TO\ \34MK\0?#%[>0VMMJ>^:>18XU^SRC<S' &2N.IK7
MZO67V']S(]K3_F7WG24445@:!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNW.03R*W=)L?[,T6QL#)YGV6WCAWG^+:H7/Z4 6Z*** "BBB@ HHHH ****
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MK#$D<8PB*%49Z 4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_!7]=2E6UX1_Y&JS_P"!_P#H#5BUM>$?^1JL_P#@?_H#5PG2>FT444 %%%%
M!7C'QA_Y&^U_Z\$_]&25[/7C'QA_Y&^U_P"O!/\ T9)7I9;_ +Q\F<F+_A'
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MCXP_\C?:_P#7@G_HR2O9Z\8^,/\ R-]K_P!>"?\ HR2O2RW_ 'CY,Y,7_".
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% ')ZD;__ (2P;?[2#+-
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MGW4_]IBYW3CYO)\G9MW;"<AOG"],@<@\U?U'3+V]\065Q&D26]LX<RM=.Q(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,
MEACF51-&D@5@X#J#A@<@_4'FGT44 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>figure6.jpg
<TEXT>
begin 644 figure6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#@17AI9@  34T *@    @ ! $[  (
M   '   (2H=I  0    !   (4IR=  $    .   0RNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N9')E80
M  60 P "    %   $*"0!  "    %   $+22D0 "     S(P  "2D@ "
M S(P  #J'  '   (#   ")0     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MFYNV@5+ZRMI+ 0H%'G0QEP21OR&<D<\8YSV[FBBI;N-!1112&%%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^RSZG>BU8D20#RB)$./D+%"V..H(;D\YQ5:"U-:BBBI&%%%% !1110 4444
M%%%% !117+:S-K9\8:4+>ROO[-BG57DMY$\N3<C;C(-X;"X7&1CKU.T4TKB9
MU-%<Q<W2W'B[3FMDU>%=HDDE,5T('!5@L93'EJ<D,S, 1@#J?EZ>AJP!1112
M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU_U_O_Z+CI_C<_\ $[A_Z]U_]":OC\;_ +Q/U/<P_P#"B9/]KZE_T$+K_O\
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M7UN7?[K'Y_FSP\5_&?\ 70=FC--S1FO0.8]O^#'_ ")MW_U_O_Z+CIWCT_\
M$^A_Z]E_]":F_!?_ )$R[_["#_\ HN.D\?G&O0?]>R_^A-7QN-_WB?J>]A_X
M43F\T9J/-&:Y#<DS7H'@+_D S?\ 7RW_ *"M>=YKT/P <Z#/_P!?+?\ H*T
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M>\?_ *"*N4 %%%% 'S/XJ/\ Q66M?]?\_P#Z,:LG-:GBL_\ %9:U_P!?\_\
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MBUKR_=7PU3XY>I]'#X429HS4>ZC=691)FO8J\9W5[-0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XG,XTE/(%T8_M$7
MVC[)O\T1;QNV[/F^NWG&<5L44(#D2;B;P2]K)<ZI:S"7?',;:YEF$/VAC&K;
M,2$F-0K ,& .3C/.YX=-R?#UF;Z-XYMG(=G+$9."?,)<$C!PQ)&<'I6E13;%
M8****0SR3XZ?\P+_ +>/_:=>25ZU\=?^8%_V\?\ M.O(\U];EW^ZQ^?YL\/%
M?QG_ %T'44W-&:] YCW3X*?\B7=_]A!__1<=1?$4X\10?]>J_P#H;U)\$_\
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M CS-_<3_ +[/^%&9O[B?]]G_  J2B@"/,W]Q/^^S_A7G7BKX43>)O$UUJ_\
M:T=M]HV?NO(+[=J*O7<,_=STKTFBMJ->I1ES4W9F=2G&HK2/'_\ A1<W_0?C
M_P# 0_\ Q='_  HN;_H/Q_\ @(?_ (NO8*K7VHV.EP"?4KRWLX2VT27$JQJ3
MZ9)Z\'\JZO[1Q7\WX+_(Q^J4>WYGE'_"BYO^@_'_ . A_P#BZ]%\*Z'-X9\,
MVND>:ES]GW_O>4W;G9NG./O8ZUK75S%9VDUS<MLAA1I)&P3M4#).!ST%2(P=
M%=3E6&0?:L:V+K5H\M1W7R-*="G3=XHX_6_ \VLZS/?_ &Z.'S=O[ORRV,*!
MUR/2L_\ X5G-_P!!./\ [\G_ !KOI)HH2@ED1#(VQ S ;FZX'J>#Q4$VJ6%O
M?165Q?6T5W,,Q0/,JR2#V4G)Z'I7,;'$?\*SF_Z"<?\ WY/^-'_"LYO^@G'_
M -^3_C7H-%("I86\UEIMM:X1_(B6/?N(W;0!G&..E3YF_N)_WV?\*DHH CS-
M_<3_ +[/^%&9O[B?]]G_  J2B@#RK5_@U-JFM7VH?VW'%]KN))_+^S%MFYBV
M,[AG&>M5/^%%S?\ 0?C_ / 0_P#Q=>P45W+,,2E92_!?Y',\+1;O;\SQ_P#X
M47-_T'X__ 0__%T?\*+F_P"@_'_X"'_XNO5[C4K&TNH;6ZO;>&XN#B&*255>
M0_[()R?PI]U=P6:(]R^Q9)$B4X)RS,%4<>I(JO[1Q7\WX+_(7U6CV_,K:193
M:7HMCI^4E^R6\<'F9*[]JA<XP<9QTKC?^%:3_P#043_OR?\ &O0:898Q,L)D
M42NI94+?,P& 2!Z#</S'K7 VV[LZ4K*QP/\ PK2?_H*)_P!^3_C1_P *TG_Z
M"B?]^3_C7;Q:G83:A)80WUM)>1+NDMDF4R(..2N<@<C\Q5JD,\^_X5I/_P!!
M1/\ OR?\:[W,W]Q/^^S_ (5)10 S,O=$_P"^S_A3Z** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S
M-=T^XO[:V:S\EI[6Y2X2.<E4D*Y^4D D=<@X."!Q6(GAK4)?$$.HW5OIL;^<
MLQGA=_-M@"Q:),J-ROGYFRN2[G;TKKJ*=VA6.%'@:ZMXT,$.G3!L-=VTK,L=
MZPE9E$AVG("MP2#R ,8Y#[OP(][I:6]REC,\6G-! LH++#*7W*%R#A5'R!NH
M';M7;T4^9BY4<_KFCW5[H=E;:?I^G+-;O"ZI)*42W"%25C(C)QA=O1>#^%;Z
M%BBF0!6Q\P4Y /U[TM%*Y04444@"BBB@ HHHH *Q]8L+Z74+._TR*TN);>.6
M$PW<C1J5DVG<&"M@@H!C'(8\BMBB@#BT\'7H^W 1:="\UM=PBY@+*UQYI^19
M%V_*J#"@;GX QCI45WX'G'G0V=IIDEFX<16\Q95@=XHE\Y0$/SAHW/8G>3N!
M)SW-%5S,GE1Q]_X+^U:BU]):V%].+R&56NQ\S1I"$92VUL$L-V.0<#\-;5;/
M4[S6;#RHK673(76657N&CD,@;@X",&"CD#*Y;&3@5M44N9CL%%%%(84444 %
M%%% !1110!S]_I&HOJ]Y-9+9O#J$<,<DEPS;[?RRW*J%(?[V0"5PW/.:RK3P
M7-_9SVUS::;!')+:&6W@9GCF$3[I';*#+.#@@@YVC)-=K15<S%9'$V?@R\MK
M^V9H[!XX9D>&XWL);2-)F<11C;C:RD*>5ZGAL"K6G>#UL-:L=1-CITLR-=FX
MG(Q)^\E#QN#LRS*H*\D8#'!QP>LHHYF%D8:Z9>OXM&HR)%%;QHZ@_:Y)FD!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% #)88IX]D\:2)D-M=01D'(.#Z$ _A3Z** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
,* "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>figure7.jpg
<TEXT>
begin 644 figure7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #T ?(# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#TGQ)\0(-
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M[,L:1M*(IRY),+2$8V]V 52I;/0\XKG_ .S8;&ZGC!R$=D#-R2,U6F4,V4!
MSP?2NW^SI*'-)Z]C/ZPF[(U]8T<V.F7,\5U>+)#=+$I>XW+(AW\C@<C: 1U'
M.0.*YE9[QF(^U3#'_30U86U=5QR>>PH2W8$G'MS6:P<M+HKVJZ$#37JX_P!)
MEY_Z:&F&YO5'-Q/_ -_#5MHB#QD9JNZ%2?NFIJ87E'&I<B^VW?\ S\S?]_#6
MWX-N[EO''A]6N)2#J5N""YY_>+6&5R>1CWS6OX-&/'?A\?\ 43MO_1JURN-C
M1,Z&\TBYUCQ1XJD-_+#Y5]/':KYH7S9R[E4&2,\*1@<Y*^M1W/AG_2(H$U.\
ML,SQ0F?4'(CDWQERR8 Z$8(Y^\O-9/B.$2^,-?8RLNS4I]JKG.3(W3WK'NA(
M4 DEFFV ;6)RH!["L^97L;JA-PY^AT=CI]O>6MIB[U%KB26X1C%.&63R45\1
MC:#E]V!G]>E:4'A>*6#S9;W4+<S &")[D,^/+9C@!?G;*\+\A-<0B&)$=B_!
MRNUL;3_CTI[3W!+2&9MY&2[/DG\^_'6G<SY>YV?_  BA%U% +_4) \;+YR,=
M@E"A@>GW3D =C_?&#7$BXO"RK]JE^;I^\- N9P?FEEY38,.?N^G7I[5&A&]6
M/;D@47!)$IFU!3S-<==OWSU]*8;N\4D-<3@CKES4QECW+\I.#PO3^5.;:'5Q
M*Q5Q]PC)'L<]:GF?4OV:Z,K?;;K_ )^9O^_AH^VW7_/S-_W\-2M SNBQH9"Q
MPH"\GZ8J"2$JN\'*@X/L:I-$.#1&6+,68DL3DD]Z*2BF2??]>*_M&NT?A_0G
M0X9;YF4^A"&O:J\4_:0_Y%O1/^OQO_0#36X,^?FU6^;I<%.=V(P$YSGMCOS^
M7I4]D;K4]1R\ISL*NX4<*1M('ID'%9E=3H%IY-@;@K^\F/&1T':O3P5%UZRB
M]EJSDQ%14J;:W-.WA"(L,.%5..#CBJ=S=H9#'!R1W[G_  %79CY,&!R3U'KZ
M#_/I5&*W&]V;.T'DCJQ/85]'4NDH1/(IV;<I%79(3DD+]!2?O$/)'XBK_P#9
M\KDE=HS_ +6 /:H9+65!TW#/4'(_.N=TI+6QLJD7H-202?*RX8^IZU!-#M4D
M'CUJ1E91D@\5([H\19V52!SGI2:NK,:=G='/ZA#LD\T'B0G(]#72Z+_R2?Q?
M_P!?EA_.2N8O;D7$@5/]6G3W]ZZ?1?\ DD_B_P#Z_+#^<E?.8KEYWR['K4K\
MJYCC5N9% VX!  W8YP.U,=RY&0J@# "C%,HKCLD=#J3DK-CG"JV%;</7&*;1
M2@D'(ZBF3U#!HHR:.?2@!>E)2G@]C10 E=IX"_Y!/C3_ + 4G_HV*N+XQ7:>
M O\ D$^-/^P%)_Z-BH$<\VNWA+E!%$T@^=D3!8XQGZXR/Q/K3_[7U"ZN(7:;
M_5.)-HX5FSNW$="2>:RJTK2(+'N/WNU=N&IRK5.6^AC/EBKV)TB"< #/\J5H
M@.97VCLHY-6 JV]OYC?ZQA\GL/7_  JDL3.O.26.!]:^@J05-*"C=]CE3YM;
MCPT"@D09]26IZ)'<#Y%P^?ND]:2.W'1AGVJQ' ,Y6,$^GK54J4Y6YDK>G^2%
M*26Q3E0I@%2I4XP1S563).:UK@))%DL1(G8]?_U5G2*@  R3U//%<>,H<KT>
MAI3G<IR#(^E=7\-O^1BOO^P1??\ HAZYF5<=\BNF^&W_ ",5]_V"+[_T0]>)
M7CRLZHNZ.46ZD11M"A@,!\<X]*VM&TY[H_:FB:)4_P!6T:G!/^/\JP(D,DJH
M.K' KN+-C;0K!%#'_H\8)9UY9O3()&>N._XUP5GRKW=ST<,Y5':;T1'K+BRF
M3>D<-U*OSI$FT+QPH'9CW-<[=SW$R?O" <\A,L3VY/I6EJ5R+VYGNDWYD;9&
MLGS$#V/?T_"B"&:.TFL(,..9+F4_=48]>W>HI^Y%7W+J_O)NVQA1J9I22KOD
MY;GK5B6T(8NF3GJK8SGVI6FCMSB./<5.#YB\?E_C1!+"27D>2(!?X%R-V>._
M3%;.^YRI1V9<TZ_^RR.I,P9DVHRL 0>.OX9_2M\:O#/YK;76-E&0F#G&, 9^
MG0URC[?-C.=R2$<CZXS]:TK6/[SR.J0@'@\$C''([_SK*=.+U9U4:TX^ZMAV
MJ17-WIJ3+;'R0F^,;2!&H.&P3U&2#[5H?"'_ )*KH/\ UU?_ -%O3[G4#ING
M2R3N&F:)H+?<OS8*X)/7L1]#3?A$<_%70O\ KJ__ *+>KHMM.^QABXI26NIQ
M4A.]AGN:V-&ML R2# ;H?3WK*50]T%/0OS72Q9"[5[U[F545*I[1]#R\5-J/
M*NI'-')(RQQ(=Q."*F'D6YVC]ZW1N@4?0U8NB(+0*O$D@!;GG!Z#\:IP6S3.
MO.0V<GMQ7ORCR3M'5_D<"ES1N]BQ%(DSM$(-QQS\W2G#3)@I*A''3:_!^H-6
MK=1%\D0VD\LW'/\ GTJVDJK#@G<V<]:[*>'C-?O-SFG6E%^X<U/:R12;)(V0
MCNPX_.J<L++]Y:[%T@GB8 G!&#D\BN8OH)K1]LQRAX20=#]?2O-QV#5*/-NO
MZW.O#8AU';9F6ZXZUJ>$5QXZ\/''!U.V&?\ MHM4955<@CG'0C%7/"#[O'GA
M_!.W^T[? _[:K7SF)BHZ'ITW<C\6DKXTU[!(_P")A<=/^NC5F0!L%F+!%YX_
MI6EXN_Y'37?^PC<?^C&J 1JPC5=^44$@#.T_XYKAD['1339%+*LD;,<!A@
M8X_QJKO;+8)Y&#[U)(<D#C/<^M&Q5AW,IW-TYH5D@DW)D)ZTHQGFE/W>,8ST
M[T?+R<=>G-40*.1P!^!IV\9!(SZ@&H:FA3S<JNT.!P#W^GO292NW9$OF$CY
M0!C..].1E,,SNI+;,$AL#T'&*A,<T;!C&X^H/-1R%L[&&"O&,4K)E<S6XRBB
MBJ,C[_KQ3]I#_D6]$_Z_&_\ 0#7M=>*?M(?\BWHG_7XW_H!IK<#YRKN;;;%9
MP1_Q* ,?05Q,(W3QKC.6 _6NSC/SC';->_E&CE+T/,Q^J2))B7G !X4D\>P%
M2B$QVL3D':P+,>G4]/QP/P!]: F^9#$?O$9JQ>MD>4#^[3Y0*]Y0WDSRG+51
M1"2\B_,  /NX'&/:JY&QQR1BE,VT@$$^E12/NY]/6LYR3U+C%@SAN&-8FMM/
MMC!"FW' *^OO6HQ!0D52OMO]GSF3IC"\]^U<&+7/2DKG7A_=FF<]78Z+_P D
MG\7_ /7Y8?SDKCJ['1?^23^+_P#K\L/YR5\S/8]A'#T445D4*.AY_"BDIQ]!
M^- PSQBC/.3244 %';C-%+@;AS\OK0 VNU\!?\@GQI_V I/_ $;%7%5VO@/_
M )!/C3_L!2?^C8J!''1J7<  G)K8AQ\HSC-8\7^L7ZUM6X!91@<=Z]K*E>3.
M:N]"6\/[_&.$&%Y]*5FV2F(<!% Z>O\ G]:GNHQ(K2IQ(N"?0^]01*-@<D\G
M.":]^<)*J_/7Y'%&2<21!CD#OS4B#8=R\$'BF^8NW /.>:9YGS%?6NA.,2+-
MDMRJW*XR4<<\5BGY6*L""#@@]16H[LI#53FVLQ<C)Z\GK7GX^*G[ZW-Z.FG0
MHW<A(3^\R#=_3\QBNF^&W_(Q7W_8(OO_ $0]<M*CR,\A/N2:ZGX;?\C%??\
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MV]P>_P!153SH_(6*0E'BD#1D<XSU'T[U[52\)MR^1PPM**2+KMFWX.WYOSJ
M7&WO^'K3%N5F4G>C*3D8I)5VJ'&0#T-7*IS+FB)0MI(M>8&&].G\JBDD$T;0
ME-^[^]VJFMQY3''*FF&Z (>-R'#<#TK*6)C:S^9:HN^@^>%?+;#8;TS_ #JK
MX.!;Q[H. 3C4[<G _P"FJU')?1EL.2,GG'0U)X,?_BNM QWU.W[_ /35:^=S
M.K3J2CR^9Z.'C**=R/Q7_P COKG_ &$9_P#T8U40P$AD;]X".588)]:O>+/^
M1VUS_L(W'_HQJSUC;RV/W0IQN[#\:\>1W0;Z$;'<<\C.>M3$)]IP!\C  ;CF
MJ_4$GIGC%2,25^\6 '4>E#0)D9&'VDG@\XI %*YW$'TQ4]Y;^0X&[<3][IUP
M#_6JM-.ZNA23B[,<>>:!U'K2'D9Q24R2[]HDAB*!V))ZEB1^ _K5:::29]TL
MC2-C&6.33=Q. 23@8'M33UJ5%(J4VU8****H@^_Z\4_:0_Y%O1/^OQO_ $ U
M[77F7QG\&ZUXST;3+;18(Y9;>Y:20/*$P"N.]-;@?+$#B*XC<]%8$_G79(X5
M_7*Y![&M+_A17CS_ *!]K_X%I_C5VV^$'Q'M8A&EC9L@^Z)+E&V_3FO5P.-A
M0;4MF<>)P\JJ3B95F5^TH!TSS]*ADU&UN-YBG1L,0><8_.MR?X1_$RXB:-[>
MV"-U5+F-<_E5#_A17CS_ *!]K_X%I_C7=/.HI<M-:>?],Y89<V^:;U,E[B$G
M<T\:Y'&7'-027$/\,R'U^85N_P#"BO'G_0/M?_ M/\:/^%%>//\ H'6O_@6G
M^-<KS5O[)NL"EU.?9]_\:XQ_>[5F:UYBO"A_U>W(]SWKL_\ A17CS_H'6O\
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MY4UT ,%N1[U6:<$D9.WTKUW_ (9O\3_]!?2/^^I?_B*/^&;_ !/_ -!?2/\
MOJ7_ .(KBGB9SW-HTTCQPL#T'YUM>#/^1Z\/?]A.V_\ 1JUZ3_PS?XG_ .@O
MI'_?4O\ \16CH'[/WB/2?$>EZE-JFE/%:7<4[JC2;B$<,0,IUXKGN6>1>+O^
M1TUW_L(W'_HQJK6KPF,@JVY.5<#/)]B<?SZUZMKWP(\8ZEXBU._@.G>3<W<L
MT>ZX(.UG)&?EZX-9_P#PSWXV_O:9_P"!)_\ B:35T5"7*[GFS"V,+JQ(F&-I
M[8YSGWZ5$K1AY-[<X^4J,@GM^%>G?\,]^-O[VF?^!)_^)H_X9[\;?WM,_P#
MD_\ Q-%AN=^AYC)*C;2,M@#*L>_?%0[<D_,!QFO5/^&>_&W][3/_  )/_P 3
M1_PSWXV_O:9_X$G_ .)HM8EN^YY4.O6D/6O5O^&>_&W][3/_  )/_P 31_PS
MWXV_O:9_X$G_ .)IB/*B0>@Q25ZM_P ,]^-O[VF?^!)_^)H_X9\\;8QG2_\
MP)/_ ,30!Y315O5-/GTC5KW3;G;]HLYWMY=AR-R,5.#Z9%% 'WI17E?BWPEK
MNH^-+S4;&Q:57^Q-;29B"@QN2^YRPDC&,?<'->J4 %%%% !14-U!]JLY[?>T
M?FQLF]#AER,9!]:X[3=)UZZOK<ZL)UM;E3-=I]H.(WC!C1!M/1P5<X[J<]:
M.WHKE;"RU;1_!T!LX))-3C(DEMY9MYF.<%=S$XX[Y[52>#QC<7S6T]P5MTGB
M_?0HBG:'C^8'W DRI!^G3(!V]%<7"?%:N/M"3!7 !:!8BSN%0#=DX53\^2N.
M?PS8\-_\)/'J"0:I@64=N% (#'(5-IWYR6SOSU_#C(!UE%%% !1110 4444
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M0#)8,&)/0CUX Z#PQ!JUOITBZO)*\QDRGFE2P&T9Y4GC=N(Y[]N@ -NBBB@
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M%>N5XE^TG_R+.B_]?C?^@&@#Q;_A9'C7_H:-5_\  EJ/^%D>-?\ H:-5_P#
MEJY>B@#J/^%D>-?^AHU7_P "6H_X61XU_P"AHU7_ ,"6KEZ* .H_X61XU_Z&
MC5?_  ):C_A9'C7_ *&C5?\ P):N7HH ZC_A9'C7_H:-5_\  EJ/^%D>-?\
MH:-5_P# EJY>B@#J/^%D>-?^AHU7_P "6H_X61XU_P"AHU7_ ,"6KEZ* .H_
MX61XU_Z&C5?_  ):NL^*NN:Q'K^BM'JE\@?1+667R[AEW,0<L<'J?6O*Z]#^
M+C,-9T)<_*=!LR1_P%J!JU]3C_\ A)-=_P"@UJ7_ (%/_C1_PDFN_P#0;U+_
M ,"G_P :S**!&G_PDFN_]!O4O_ I_P#&C_A)-=_Z#>I?^!3_ .-9E% &H?$F
MND_\AK41_P!O4G^-)_PDFN_]!O4O_ I_\:S** -/_A)-=_Z#>I?^!3_XTO\
MPD>O8_Y#>I?^!;_XUET4 :?_  DFN_\ 0;U+_P "G_QH_P"$DUW_ *#>I?\
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MGEE"R)E]IVH6!D[=,8_VNE>:_M)_\BSHO_7XW_H!H ^;J*** "BBB@ HHHH
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ML3:/]6G0=JVJ4U%77]?U^/39GHXO!1H4^=-[GHOE1_\ /-/^^11Y,7_/-/\
MOD4^BL3S1D<21;M@P&.2!ZT^BB@#X@\=_P#)0_$W_85NO_1K44>._P#DH?B;
M_L*W7_HUJ* /J+Q!:R3^-(DN98H4=8O(Q#,WGC<VY6VG:2/PX89R*X_]I/\
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MTG_R+.B_]?C?^@&@#RS_ (69;;=O_"!>$=N<X^Q-C_T*C_A9=K_T(/A#_P
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M<>+-::)PVV"U5L=C^\./UK0OX[Z8A+*06V&#-+A3OX(VX(/MS[4 2_VC:_\
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M OY5%0KVU'/EYGR;"]><\T#WI**9 H4L1@=3B@J5;:>HH!P?Z4K'<Q; &3G
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MR> .>M;'PLQ_PGL."O\ QY38Q(3QF/I_>'^T>3T[5C>+2!XTUW<5Q]L;=N;
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M#_[\3?\ QVBB@ _X:.\8?] W0_\ OQ-_\=H_X:.\8?\ 0-T/_OQ-_P#':**
M#_AH[QA_T#=#_P"_$W_QVC_AH[QA_P! W0_^_$W_ ,=HHH /^&CO&'_0-T/_
M +\3?_':/^&CO&'_ $#=#_[\3?\ QVBB@ _X:.\8?] W0_\ OQ-_\=H_X:.\
M8?\ 0-T/_OQ-_P#':** #_AH[QA_T#=#_P"_$W_QVC_AH[QA_P! W0_^_$W_
M ,=HHH /^&CO&'_0-T/_ +\3?_':/^&CO&'_ $#=#_[\3?\ QVBB@#RO5M2F
>UG6;[5+A8UGO;B2XD6,$*&=BQ R2<9/J:*** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>igcpharma_logo1.jpg
<TEXT>
begin 644 igcpharma_logo1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
M  $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!
M40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y
M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4
ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/D
MY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]Z**** "BBB@!K'F@CBAN
MM>._MX_M<:7^Q'^S'K_C[4(X[N\M0MII%@[[6U*^E.V*(=\9RS$=$1SVJ9SC
M"+E+9'9E^ KXW$PP>%CS5*DE%+S>B_KYG)_\% _^"F7@/_@G_P"$XUUACKWC
M+4H6DTGP[:/BXN ,CS9GP1!#G'SMRW.U6(X^8/\ @DY_P5Y\??ME_MC^(/!_
MCX:%9Z=K>C2W_AZRTVT,,=A-;NF^+S&9GD+Q.6+.>L7 4'%?DQ\4?BCXA^-W
MQ&UCQ9XJU2ZUKQ#K]RUS>7<[%BS$DA%!SMC4854'"JJ@  5]B_\ !OE\(-3\
M=_M\P^)X89ET;P+HMW<WMP%_=^=<+]GAASTW-OD;'I$:^9CFE:OBHQA\/;K\
MS^M,Q\'\CX>X,Q>(QUIXE4VW-[1FM8Q@NB;LN[N[V6B_<\=..G;CM3AP*:&S
MS^OK3A7U!_'XAI#\QI3UK\8?^#@#_@OYJ'PI\2:K\ O@/K7V7Q1$&LO%GBO3
MY\W.DR'Y6T^Q*\BY'(DE7YHCA5^<$I[&1Y%BLVQ2PN%6O5O:*[M_UV,ZE105
MV?IA^T[_ ,%&?@K^R"\EOX\^(?A?1]6C&3IKZA%]L'?YH\Y7_@7/H#7E/[&/
M_!6S0_V__CM<^&_A7I8\1>&M!0S>(->CM[A;/2E*MY,?GRK&LD\C !8XU?C<
MQ( S7X:?\$[/^" WQV_X*&>,H-:\1:5K7PV\"7D@N+[Q5XELI5O=14G+&TMY
MMLMP[9XE?;'WW-]T_P!(G[)?[('@/]AGX%:7\/?ASH4>@^'-+S*[/AKK4;A@
M!)=7,N 99WV@,[=@% "JH'TG$>3Y+E%+ZM1K.OB'H[64(^N]WV5_-F5*I4J.
M[5D>E*<TZJYU&V5]OVJVW>GG+DGZ9J9&WQ[E^9>S#D'\:^#Y6EJ=(ZBD#9I:
M "BBB@ HHHH **** "BBB@!KG%?C=_P<D_'JX\1_M!^"_AK;S-_9_A;2/[:N
MXQ]U[N[9T3/^[#$?PE-?LD?\_I7\_/\ P6]O9K[_ (*>?$8S,W[A--BCSV06
M$)&/^^C7CYY4<<-9=7;\_P#(_<OH]Y;2Q/%2JU%_"ISDO\6D4_DI,^5=/L)]
M5U"WL[2%KBZO)DMX(E^]+([!54?5B!^-?T6_\$ROV0-+_8O_ &3/#_A^VAB;
M7M4C&IZ_>@?->7<F203_ '$7$:CH GJ23^(O_!,WX?1_$/\ ;2\(+<1K-;Z"
MTNM,".KVZ$QD_27RS^ K^BGP4H7P=I>W[HM(L?\ ?(KAX?H+WJKWV/T+Z26?
M55##Y13=HWYY+N];)]TM7ZOR-,'M3N@KYF^,W_!7GX!?LX_M9-\&/B%XT_X0
MKQ>UI;7D,^KV<D.E3K< F-1=@&)#\I!,I1<Y )->]^,?BAX;^'GP[O/&&O:_
MH^D^%-/L_P"T;G6;J[2.QAML ^<92=OEX(.[.""*^PJ8+$4U"52FTIJ\6UI)
M>7?Y'\DJ2U29O!BK@J<%2#_3^M?EM_P4+_X*/_LL?\$8]7O/#_PS^$_@'Q%\
M:[IGNYM/TK3K>)=(E<^9YVHWF&D1F+%A$A:1NIV AC[-X^_X./OV./A]=M#_
M ,+<&N7$)Y71/#^HWR9]I%@\MOJ&_&OS.^-?AG_@E-^UO\2M2UNS^)GQ5^#V
MLZW=RW=W+;Z;>_V=<SRN6>1EN;6X";F)/#H.>W0?;<+</U88CVF:8>NJ5KM1
MA*TO*5K.WHF<]:LFK4VKGR[^TK_P7O\ VK?VGM7N)=0^*NJ>$=*E<F+2/",:
MZ/;P+TV^8F;B3ZR2M^%>'6?[<WQLL;_[7'\7OB4UQG.Z;Q#=3Y/^[([*?H17
MZV? '_@W^_85^,NF1ZAI'[27CKQM:,-V=/U?3K:,?[V+,LOT8BOJ7X-_\&Y/
M[$_A^>.:'1;WQU)&<C^UO%TMTI/H8X6C4_3%?I=3C3AK 0]E3PTE;HJ:C_Z5
M8XUAZTG=R_$_&#]GO_@L'^T3+XKT[PW:K8_%34]0D6"TTR?0_.U*X8G "-:!
M)&)]2&K]Z?\ @E%\+_CM'X=D\:_&K1]%^'LFJ6?E:?X.T^\FN[F$,0?/O69B
MD<F!\L*9*A\NP;Y!]%_ /]DWX9_LIZ&VG_#?P!X3\#6LJA93H^FQ6TEP!T\R
M0+OD^KL37?C\Z_+.*.+,'F"=/!8:-&/?[3^2]U?UJ=E'#RB[R=Q<\TM'4T5\
M.=04444 %%%% !1110 4444 -;K7X<_\'$'PEG\#_MX6OB;RBNG^./#MK.DN
M,*UQ;%K>5<^H00'Z-7[C-UKY$_X+/?L27/[8O[)\TWA^U^T^-O LIUC2(U^]
M>QXVW-J/4O'\RC^_&@[DUY^:8=UL.XK=:H_3O!_B:CDG$]#$8AVIU+TY/LI6
ML_12LWY7/S _X(OVT<_[5.LLWWX_#<XCR/[TT //TQ7[I?!G65UOX8Z7(#EX
M(S;/ST*,1_+!_&OP+_X)'>+X_#?[:&EVLN8_[=TV\T\!A@[]HE"^QS%CFOVX
M_9D\5K%J%]H\K8%POVF#ZC 8?D0?P->?D<K4N7S/U7Z0.7SJXQUH_9C"2\UK
M%_YGXO\ _!WS\ ;SP]^UC\,OB9';9T?Q;X7;P[<2A,J+RRN))0&/3+PW2X]H
M6^A^<?\ @E5_P7(\>?\ !/:>/P7XKCN/B7\#=1!M-0\*ZBZW#Z5 Y(D>Q,F0
M%PS%K=OW3Y( 0DM7]"'_  4^_8!T/_@I1^R#XB^&NJ21Z;JTFW4/#VJLNXZ1
MJ<63%(?6-@3'(.28Y'QSM(_DV^//P)\6?LQ_&+Q!X \=:/-H7BSPQ=-9W]G(
M. W\,D;='B=<,CJ2&5@17]3< XS+\[R7^R,8E*5+2SWY=U)=5:]KK;YG\C8B
M,J53VD=F?L/^U'_P;S_"?]O[X:Q_&3]C+QAH>DV^O0B]_P"$2O)2NDS,>66!
M^7LI <CRF5HPPP#&!7Y&_M+_ +)?Q,_8X\;-X?\ BCX'\1>"=0W,L1U&T*VM
MX <%H+A<Q3)GNC'K7T%_P2$_X*?ZU^P#\8H=/O-8NK3P'K\^+HJ-_P#8]PV
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MWX$\52:3-\7K;5)(9#'+=Z1I%[J%DI'I/%$4<>Z%A[U]'_LQ_MC_  M_;/\
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M3<X/^>**@#^??_@\./\ QF#\'?\ L3+G\/\ B8&NT_X.H_VSO$FE>$?@_P#
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MH"T@Z[&F^?T*VLN> 0?-O^#6A=/\.?$G]L**'['IVFZ7XRC553;%!:01S7X
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>pe_img1.jpg
<TEXT>
begin 644 pe_img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#@17AI9@  34T *@    @ ! $[  (
M   '   (2H=I  0    !   (4IR=  $    .   0RNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N9')E80
M  60 P "    %   $*"0!  "    %   $+22D0 "     SDQ  "2D@ "
M SDQ  #J'  '   (#   ")0     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M               R,#(S.C V.C(S(#$T.C Y.C P #(P,C,Z,#8Z,C,@,30Z
M,#DZ,#    !! &X 9 !R &4 80   /_A"QEH='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H
M:4AZ<F53>DY48WIK8SED)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E
M.FYS.FUE=&$O(CX\<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N
M;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S
M,V0W-3$X,F8Q8B(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M
M96YT<R\Q+C$O(B\^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z
M9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX
M;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E
M1&%T93XR,#(S+3 V+3(S5#$T.C Y.C P+CDP-SPO>&UP.D-R96%T941A=&4^
M/"]R9&8Z1&5S8W)I<'1I;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(G5U:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X
M;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD
M8SIC<F5A=&]R/CQR9&8Z4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO
M<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y!;F1R96$\
M+W)D9CIL:3X\+W)D9CI397$^#0H)"0D\+V1C.F-R96%T;W(^/"]R9&8Z1&5S
M8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" \/WAP86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&
M" <'" H1"PH)"0H5#Q ,$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@
M+S,O*C(G*BLJ_]L 0P$'" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@!-@*8 P$B
M  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40
M  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$5
M4M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2U
MMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$
M !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'
M!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6
M)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#
MQ,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1
M #\ ^D:*** "BBB@ HHHH **\?\ B[XZOK/4?^$>TB=[8+&&NI8SAF+#(0'L
M,$$^N?S\?9F=BSL68]23DFNF&'<E=LM1NC[ HKX^HJ_JOF/D/L&BOD&)!+,D
M9D6,.P4N^=JY/4XYQ767?AO2K>2>\1+N72+>T%PL\5VCF\W2"- I,8\L[B=P
M96(VD>E2\.EU%R'TE17SCJ/A#2[2RN8K:^:?4O-5;:$SQHS!VB\M#&1N8E)&
M8N#M!7%<Y-;V4>L16T3230(Z1S.D@_>G.'*''"GG:2#Q@GTH5!/9ARGUC17S
M/J_@35+/6KZWM(%:VAEG\IYKJ%6,<7)+ L,'85;& 2#D#%5;7P3KU]:QW%K:
MP21RE I%Y#G+J&52-^0Q!&%//M1["-K\P<J[GU%17RS:>#M=OD@:VL@WGL%1
M6GC5AD,5W*6!4-M."P ;C&<BK-QX'U2#3[.??:227,DJF)+N(B(1@$LS;\ ?
M>R>BX&3E@*/81_F#E7<^G:*^73X'\0"-W-BN$9T/^DQ9W*NXJ!NY.WY@!RR\
MC(YIB>%-4A19[RQS"]O).%6[B1B%CWGJ2<J"&*8W8[#J#V$?Y@Y5W/J6BOEN
MW\&:]=F);>R5WE*J$^T1AD+*64.I;*;@#C=C/;.:S]3TB]T>>.'4(EC>1-ZA
M9%?(W%3RI(!#*P(Z@@@T_JZ>G,/D\SZTHKX^HI_5?,.0^P:*^/J*/JOF'(?8
M-%?'U%'U7S#D/L&BOCZ@'!R.#1]5\PY#[!HKPCX6^/+^RUZVT34;B2YL;MA%
M$)#N,+G[N">Q/!'OGZ^[USU(.#LR&K!17E_C+Q#=7NK3V,4C1VMNYCV*<;V'
M!)]>:Y>A4[H\NIF$82<8QN>\45X/13]GYF?]I?W/Q_X![Q17CNBZ-_:,<T\N
MXQ1D(L:2*C32-T4,W _4]  <U9BT.U<QQ3/+!,8EN9&9@52(O@KT'S!2&S]1
MCO2Y%W-5C9M7Y/Q_X!ZS17CNH:=9VTLLD,[/;K&H4"17)E(^YO PP'4D#T'4
MYJM9:3>:A&\EHB,D;!7+2HFTGI]XCJ>/KQ1R>9+QTD^7D_'_ (![717C,?A[
M4Y2 ENN2^S#3(I#;BN#D\98$#U(.*9#HE].5$4<9W9Y\] !AMO))XR>!GKVS
M1R+N'UZ?_/M_U\CVFBO(+K09DL+:XMXF7,9,XEE7Y660H<=.,@9ZXSR:BET&
M]\V;R[81)$S*5EN(R1M +<Y&X#(R0,#-'(NXWC9K[']?<>R45Y!>^&+ZSDDP
MUN\4956E-Q&H#$ XY;C\>O6J\NBWF;EX[8I' SAE>9"PV?>QTW8[D#%'(NX/
M'36CI_U]Q[/17BMKH][>6_GV\2F/=MW-(J]P,\D<9(&>G-2Q>'M2FDECBAC9
MXF9743QY!7&[C=VR.:.1=Q+'3>U-_P!?(]EHKQS_ (1K51(D9MEWNVQ5\Y,D
MX)'?N <>N.*=_P (W?+9W$\WE((45U43(QDRV,#!]C[Y&,9HY%W']=J?\^W_
M %\CV&BO&T\.:I(^R.W5V^;.V9#@KC*G!X89^[U]J;)X?U*(H'MQEV55VRH?
MO D'@_=.#\W3@\T<B[A]>G_S[?\ 7R/9J*\-NK6:RN6@N4V2* 2-P/! (Y''
M0BHXY'B</$[(PZ,IP13]GYD?VC9V</Q_X![M17->"==GUC398[P[Y[8@&3NZ
MG."??@UI>(M7_L+P]>:EL#F!,JIZ%B0!G\2*CE=['ITYJK%2CU-.BOFO4M6O
MM8O'N=1N7GD8Y^8\#V Z 53KL6#?5G1[,^H**^7Z*?U/^]^ >S\SZ@HKP/3-
M&TW5X85MTO+=S<I"TTLJLKJ$9I&"!000%!QN/W@,]ZL6WA_19[$WT]Y+:6\\
M!>!)ITWQLN\/G@>9AE7"J 3O]JS>'2Z_A_P1<A[I17S7?6B62PPL6-UMW3J>
MD>?NI_O <GZXP"#5A?#>JM##,MLOES %7\Y, %-_S<_+\OS?-C P>XJOJJ_F
M'[/S/HRBOGI/"&MR9,=HC ,BAA<1X)<90@[L$-T!'!/ YXI@\*:P79?LT>4B
M\YLW$8VH&*L2=W&TC#?W>^*7U:/\_P#7WBY%W/HBBOG7_A&=7\R:/[(!)"S*
M8S*FYRHW,$&<O@8/RYZBK-WX:EGNX4T6)W22V@E*SSH#OD7<$!.W<>#@ 9.#
M1]6C_-_7WAR+N?0-%?.\OA768;6.X:T#1R;"ACF1RX<X4@*Q)!) SZT@\+ZL
MUPL*V\;%U#*XN8C&V6*@!]VTL6!&W.>#Q3^K1_G_ *^\.1=SZ)HKYA=&C=DD
M4JRG#*PP0?2FU7U/^]^ _9^9]045\OT4?4_[WX![/S/J"BOE^BCZG_>_ /9^
M9]045\OUJ:%XBU#P]?I<V$S!0?GA)^20=P1_6D\&[:,/9GT914%C=I?Z?;W<
M0PEQ$LJ@^C $?SJ>N$R"BBB@ HHHH **** "BBB@ HHHH ^;OBO_ ,E.U;_M
MC_Z)2J6F?V'H4,-WK5H=7O95$D=DLVR*)3R#(PR2QX.T<8Z]<"[\5_\ DIVK
M?]L?_1*5Q]>I!7@C=;'>?\+/V8A@\)Z EGC!A-KG([\YQ^E9M]=Z#XGXL=+7
M0]3/^K6*3-O<'^Z0<>6Q[$<9ZXZCE:V_%,FGR:E;'2M)?2HOL<):%Y-^\E=V
M\'T(*_EZYHY4GH%D8\)C6>,W".\08%U1PK,N>0"0<''?!^AK=C\201JUC]AF
M;1VMV@-JUR/-Y<2;_,V8W!P,?)C:,8Y)//UTT_@\V,B'4KWRH$L!>73QP^8T
M),IB$0&X!FW  Y(Q\W]WFI6ZAH4;SQ"]WJ.HWYMU2XO%\J,@_+!%MVE0,<G:
M N<]-W&2"+FN>+$UQ]*\ZQ:)+#&Y$GX880%(_E_=I\G"_-@L>M6;[P'-8Z/=
MWGVMIY()=L:0P%DD!:,*"V<J["4,$P<J"<USFHVB6-X;82^;)& LWRX"2?Q*
M#D[L'C/0XXXP3*Y7L&AV-MXK@U+5HGLK,6)&JR:I<276H1E"LF%E0 HN>.@!
M+8SP>RV6MV,7AJ?4IXDE>+6H[JVLEO8XG143"97!9D'RK@ <=",&N4;P]K27
M7V9]'OUG\OS?*-JX;9G&[&,XSQGI6LO@355TJ6YN;>YCN#;1W-K;K;%C.&F$
M97/9AN5L 'AAG%)Q@A:&C:_$F59["XO[>]N9;545XDU%H[>0I]UA%M(5N%R>
M0>2 "013TKQJFDV5O;065POV?[3&DL5YL<13 <!@G#J54AQQP1MYXP4T359$
ME>/3+QUAE$$I6W8A)"0H0\<-D@8/.2*GB\.ZFMPB7NF:E"C+(V4LF9L)PQ"G
M&0#@$YXS^%/E@.R.CMO']G!-!+)I=_<R0W#S^9/JGF.Y:$0G<QB)/"@_7H ,
M 5G\9Z=(;<2:-<.(;::W#M?AI LD7E;0YC)V@%R%.<%AC &T\U/I>H6MG%>7
M-C<PVT_^JGDA94DXS\K$8/X55I\D0LCMK/XA16FI_P!H#27-Q.T+7F+O"S&)
M<+M&P[,M@GENF!C-9=]J6BZEH$5NMO<V<^FV_E6N^Z$OG%IBYR!$!QO;^(=N
MO-<[11R);!9!1115C"BBB@ HHHH **** -CPA_R.^A_]A&W_ /1BU]4U\K>$
M/^1WT/\ ["-O_P"C%KZIKBQ.Z,YGBVN\^(]1Q_S]R_\ H9JY ^E:,0+NU.I7
MBGYT+[8HCZ?[1]>U4]=_Y&+4O^ON7_T,U0J>A\FY<LVT=*?%5BV0WAK3MGHJ
M '\\5G7B:=?1M/I<;VLJ#<]K(^X$=RC=3CJ0?Z50MFB2ZB:Y0R0AP9$4X++G
MD9^E3:I]G_M2X%G;O;0A\+#(<LF."#^.:+6'*I*4?>LR?3=56RA\J>!IT29;
MB,+)LVNOKP<@]Q[<$5)<:Z]Q:OOB/VN2+R'GW\&/=NQMQP>@SGH.G>H-,TT:
M@)V:1U6%<E8D5Y&Z]%++D  DXZ>E6;;0#<I OVC9<2HDIC9.%B9]N[=GKR#C
M'0]>U&@X^U<;+873]>&G7BR16[B%(A&D:3;6!W*Q;=@\DK@\=#CL*ETN:V_L
MC5GO$C*R/&PMTG6)FPQ)"@Y.!GTJK?Z+]@N9D><^7%$KDO'M<,P^5"N>&/IG
MH"?:J,%I<708VUO+,$QN\M"VW/3.*- YJD79^?\ D:\FMOJ4?DB$+=/*9$FD
MN%"1'>7RNX?)V!^;!P.,T7NLP27]_'+;^;:3E0%AD"%65L[E.",$ECT_BK,3
M3+^1(FCLKAEF.(BL3$/QGCCG@'\J#I>H!=QL;D#Y>?);^(X7MW/3UHL@YZC1
MJ)KUDEOY(TZ8+]F>WP+H<*S[SC*'H3CZ5,WBBW;[9C3Y$^U[_,V7 !8,H7!.
MSG')';GIWK%;3;Y)(XWLKA7E)6-3$P+D=0!CG%2C2I!8W4LOFQ7%O(B-;O%@
MG?G'?.>.F*5D-5*VR_)%W4=>MM1MWC>QE0RSI,Y%P.H7:0!LXR/K@^M,U#6K
M741(9K&0-YDLD1$XPADY.?E^;#9(Z>AS5/\ L?4]Y3^SKO<" 5\ALC/3M4)L
MKH6[SFVF$,;;7D\L[5/H3T!IV1,IU7>_Y%VVU)!I#:;]GWO*WRO),!&K$CYM
MI&%('&01UYR*N7&N)'?3>?#YY>S^SR&*8 %V4;WR 03GN.N/2L2XM;BSE\N[
M@E@?&=LJ%3CUP:T[CP[/%IL%S )KAI(UD9$AR I7.003D#@$D  GO1H.,JEK
M+H:NF:[9W6KQAK=K8/-'*TLUVNU=D90=5'4$]^N/I6>NOK:VS64-JPAC4"+,
MZN5=9"^XL%PPSV&.!U[UA44<J%[>=OZZG0+XDMT%RB6$BQ7/FM(OV@9WNNW(
M.S@ $\<]>O%">(K2(/Y=A< L(!G[9@CREVK@J@(X]^OY5S]%'*A>WJ=_P1I:
MC<V=^DETD9AN6D4>7NSN4+RQPH&2>XQU/'<YM%%,SE)R=V=Y\,_^8G_VR_\
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M5!(^5F'!)'!/2JM%%:(9]&>&/^11T?\ Z\8?_18K4K+\,?\ (HZ/_P!>,/\
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MMW6YDMO,076YBQC (!Q@A<L .IZ8S27PU=2QVK6L]M<-<3+ 8XG),3E=P#9
M'3.2"0,'/2IH/"-[=;VM;FUEBV*\,JLVV<D/A5RN0<QN/F"X(]Q4^YNV+0=J
M%UI%[X?6=@HU=F&X1^8-H#.-N#\@C"",#'S9'I6S9ZWIZZ.D*ZTENOE6GE6S
M0RC[/)&X,K JI'S$%L@Y.>>@KC9K22"V@FE*CSP61,_-M!QN/L3D#Z'VS-J>
MER:7) LLL4HN($G1HMV-K=.H!SQ3<(O2X61U]QK<"P7RV/BB./[5/,P0I/MC
MC+EP @CP68GYF/(7@9Z5+<>(8)?M,;>*5EA-I+# &%P6+EE82,=GWB0>!PH
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M/(%<*&8@*<C/':LTHZ"T+,?B>TCOM1N%\51&*2WN%TV%[67-GOV%4SY9V@;
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MVTRPV0Q74?W;5+V6=6;)4N-R8SC&P^F<CKCBGH1&$Y+1F5#J][!=&XCE42;
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MQGFJ*?LT%CH-0NM(O?#ZSL%&KLPW"/S!M 9QMP?D$801@8^;(]*WIO$EO!H
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M<0210Q>8I'GH65U7..GSXXS@=Q3;#0)6O;=-1B=(9\@&.5=RMLW $<X.,<$
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M[T^/Q5;(D"C39 L#[T1+@*JG85.!LX!R3ZY[US-%'*A_6*G?\$*VTL=@(7/
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MYN^*_P#R4[5O^V/_ *)2N>T..UF\0Z='J!46CW42SEC@!"XW9/;C-=#\5_\
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MZH:17C"?.QB)8@AF&,*"Q^7O5H_$- TXM[&]MEN(]LL\.H[;HD.&7]]Y>2%
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M>:Q<37D7E3DA9$]&4!3_ "I1-*\6HZMOU_X=E"BBBJ.,**** "BBB@ HHHH
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M,%%%1S3I;JK2G 9MN<4TKE1BY.R/0/AG_P Q/_ME_P"SUJ?$C_DGVI?]LO\
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MQ,ET_,?*BQOM25)1@'<@./IR :9115'.%%%% @HHHH **** "J&K_P#'FO\
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MHC'USQU(X:'3 8$Z>:?OM]!VKBI[J2=V9V)+')).2?J:L:TBQZ_J"(H55N9
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M%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]&>&/\
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M17>?\*S_ .HM_P"2W_V='_"L_P#J+?\ DM_]G1SQ#ZE7_E_%'!T5WG_"L_\
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M3_OH5B44>S0<YM_:(?\ GJG_ 'T*/M$/_/5/^^A6)11[-!SFW]HA_P">J?\
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MT0_\]4_[Z%8E%'LT'.;?VB'_ )ZI_P!]"C[1#_SU3_OH5B44>S0<YM_:(?\
MGJG_ 'T*/M$/_/5/^^A6)11[-!SFW]HA_P">J?\ ?0H^T0_\]4_[Z%8E%'LT
M'.;?VB'_ )ZI_P!]"C[1#_SU3_OH5B44>S0<YM_:(?\ GJG_ 'T*/M$/_/5/
M^^A6)11[-!SFW]HA_P">J?\ ?0H^T0_\]4_[Z%8E%'LT'.;?VB'_ )ZI_P!]
M"C[1#_SU3_OH5B44>S0<YO*P9<J01Z@TM5['_CS3\?YFK%9O1FB"BBBD 444
M4 %%%% !1110 5'/_P >TO\ N'^525'/_P >TO\ N'^5-;@8E%%%=!@%%%%
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MR(0,C.<\Y[FO9-:\(:/XBT.'1];AGN[*(*/+^U2Q^9MQ@OL8;^@/.>>:EO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPMBMP\(6T:4Y.Q_*+8S@ /YB@8^4X I:C+7B^U%UX3U',]U;O#;R31R6EU)
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M.X<KD^H%.\-^(KSQ)-K<,VG7.F+97CVD4S-$Q.%7/1F^8$D\KMP5'.#6;>>
MKZXOY_LVO_9+"75DU81QV2M.LH"Y7S&8J5)4D?N\@D<D @[6D:!<Z/>:S+#?
MQO%J%RUU#$UO_J9&4!MQW?.,J" -N!D<\$/46AY]I?C#58M2TV&/Q4VLZA)K
MLVGW>D2QVY9+59I$\XB*-70JBAR6.T^G(KIK/XM^&;^XNHK62:86]K)=HT!C
MG,\:8W;4C=G4\@[9%0XSQP<;'A3P_>Z!I=S9:CJ%O?K-<S7"M#:-!M,LC2.#
MF1\C<YQTP/7K6;9^#-5LO#<FA1>((WL8;:2VL0]D=\<; JHE(D EVH=HP$Z
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M*C,_LV;^\GYG_"C^S9O[R?F?\*TZ*.=ARHBMHS#;JC8)&>GUJ6BBH*"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
G **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564763872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jul. 06, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IGC PHARMA, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IGC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,077,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,812,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2760393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10224 Falls Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Potomac<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">983-0998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag', window );">Document Financial Statement Restatement Recovery Analysis [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">5341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">nter;margin:0pt;">CONSOLIDATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">nter;margin:0p<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtRestatementRecoveryAnalysisFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034560373104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,196<span></span>
</td>
<td class="nump">$ 10,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term investments</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">2,651<span></span>
</td>
<td class="nump">3,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Deposits and advances</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">978<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,466<span></span>
</td>
<td class="nump">15,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_NonCurrentAssetsAbstract', window );"><strong>Non-current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">8,213<span></span>
</td>
<td class="nump">9,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Claims and advances</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease asset</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">10,712<span></span>
</td>
<td class="nump">11,723<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">17,178<span></span>
</td>
<td class="nump">26,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accrued liabilities and others</a></td>
<td class="nump">1,368<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,898<span></span>
</td>
<td class="nump">2,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_NonCurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term loans</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,267<span></span>
</td>
<td class="nump">2,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies &#8211; See Note 12</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value: authorized 1,000,000 shares, no shares issued or outstanding as of March 31, 2023, or March 31, 2022.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock and additional paid-in capital, $0.0001 par value: 150,000,000 shares authorized; 53,077,436 and 51,054,017 shares issued and outstanding as of March 31, 2023, and March 31, 2022, respectively.</a></td>
<td class="nump">118,965<span></span>
</td>
<td class="nump">116,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(3,389)<span></span>
</td>
<td class="num">(2,968)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(100,665)<span></span>
</td>
<td class="num">(89,159)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">14,911<span></span>
</td>
<td class="nump">23,892<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 17,178<span></span>
</td>
<td class="nump">$ 26,834<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_NonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_NonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_NonCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_NonCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034565285728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">53,077,436<span></span>
</td>
<td class="nump">51,054,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">53,077,436<span></span>
</td>
<td class="nump">51,054,017<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034561574448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="num">(469)<span></span>
</td>
<td class="num">(203)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">442<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(8,552)<span></span>
</td>
<td class="num">(13,292)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(3,461)<span></span>
</td>
<td class="num">(2,330)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(11,571)<span></span>
</td>
<td class="num">(15,428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(11,506)<span></span>
</td>
<td class="num">(15,016)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense/benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">(11,506)<span></span>
</td>
<td class="num">(15,016)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(421)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (11,927)<span></span>
</td>
<td class="num">$ (15,210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_EarningsPerShareBasicDiluted', window );">Basic and diluted (in Dollars per share)</a></td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_WeightedAverageNumberOfShareOutstandingBasicDiluted', window );">Weighted-average number of shares used in computing loss per share amounts: (in Shares)</a></td>
<td class="nump">52,576,258<span></span>
</td>
<td class="nump">49,991,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_EarningsPerShareBasicDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_EarningsPerShareBasicDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_WeightedAverageNumberOfShareOutstandingBasicDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_WeightedAverageNumberOfShareOutstandingBasicDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-8A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564801744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Common Stock Including Additional Paid in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,720<span></span>
</td>
<td class="num">$ (74,143)<span></span>
</td>
<td class="num">$ (2,774)<span></span>
</td>
<td class="nump">$ 32,803<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in Shares) at Mar. 31, 2021</a></td>
<td class="nump">47,827,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Common stock-based compensation &amp; expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock-based compensation &amp; expenses, net (in Shares)</a></td>
<td class="nump">1,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock through offering (net of expenses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock through offering (net of expenses) (in Shares)</a></td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Other adjustments (in Shares)</a></td>
<td class="num">(43,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,016)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Gain on foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(194)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,019<span></span>
</td>
<td class="num">(89,159)<span></span>
</td>
<td class="num">(2,968)<span></span>
</td>
<td class="nump">$ 23,892<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in Shares) at Mar. 31, 2022</a></td>
<td class="nump">51,054,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,054,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Common stock-based compensation &amp; expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock-based compensation &amp; expenses, net (in Shares)</a></td>
<td class="nump">1,815,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock through offering (net of expenses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock through offering (net of expenses) (in Shares)</a></td>
<td class="nump">208,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,506)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,506)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Gain on foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(421)<span></span>
</td>
<td class="num">(421)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,965<span></span>
</td>
<td class="num">$ (100,665)<span></span>
</td>
<td class="num">$ (3,389)<span></span>
</td>
<td class="nump">$ 14,911<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in Shares) at Mar. 31, 2023</a></td>
<td class="nump">53,077,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,077,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034562276384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (11,506)<span></span>
</td>
<td class="num">$ (15,016)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_AdjustmentToReconcileNetLossToNetCashAbstract', window );"><strong>Adjustment to reconcile net loss to net cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for bad debt</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">1,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Permanent impairment of PPE</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of non-marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Common stock-based compensation and expenses, net</a></td>
<td class="nump">2,843<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Net loss on sale of property, plant, and equipment</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Forgiveness of PPP Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivables, net</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">897<span></span>
</td>
<td class="nump">1,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Deposits and advances</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Claims and advances</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(451)<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accrued and other liabilities</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_IncreaseDecreaseInOperatingLeaseAssets', window );">Operating lease asset</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(134)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(7,047)<span></span>
</td>
<td class="num">(7,462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flow from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant, and equipment</a></td>
<td class="num">(310)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Sale of property, plant, and equipment</a></td>
<td class="nump">538<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Investment in short-term investments</a></td>
<td class="num">(154)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition and filing cost of patents and rights</a></td>
<td class="num">(309)<span></span>
</td>
<td class="num">(535)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(235)<span></span>
</td>
<td class="num">(742)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from the issuance of common stock</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">4,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfDebt', window );">Repayment of long-term loan</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">4,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effects of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(82)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(7,264)<span></span>
</td>
<td class="num">(4,088)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the beginning of the period</a></td>
<td class="nump">10,460<span></span>
</td>
<td class="nump">14,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the end of the period</a></td>
<td class="nump">3,196<span></span>
</td>
<td class="nump">10,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_NonCashItemsAbstract', window );"><strong>Non-cash items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Common stock issued/granted for stock-based compensation, including patent acquisition</a></td>
<td class="nump">2,842<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReduction', window );">Forgiveness of PPP Loan</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (430)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_AdjustmentToReconcileNetLossToNetCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_AdjustmentToReconcileNetLossToNetCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_IncreaseDecreaseInOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating lease assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_IncreaseDecreaseInOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_NonCashItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_NonCashItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-8A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564764336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS AND MANAGEMENT&#8217;S PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 1 </b>&#8211;<b> NATURE OF OPERATIONS AND MANAGEMENT</b>&#8217;<b>S PLANS </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Since 2014, our team has been committed to researching the application of cannabinoids such as THC and CBD in combination with other compounds to address various ailments, including Alzheimer&#8217;s disease. With our research, we have developed intellectual property, formulations, and wellness and lifestyle brands. IGC submitted IGC-AD1, our investigational drug candidate for Alzheimer&#8217;s, to the FDA under Section 505(i) of the Federal Food, Drug, and Cosmetic Act and received approval on July 30, 2020, to proceed with the Phase 1 trial on Alzheimer&#8217;s patients. The Company completed all dose escalation studies, and as announced by the Company on December 2, 2021, the results of the clinical trial have been submitted in the Clinical/Statistical Report (CSR) filed with the FDA. The Company is motivated by the potential that, with future successful results from appropriate further trials, IGC-AD1 could contribute to relief for some of the 55 million people around the world expected to be impacted by Alzheimer&#8217;s disease by 2030 (WHO, 2020). To the best of our knowledge, this is the first human clinical trial using ultra-low doses of THC, in combination with another molecule, to treat symptoms of dementia in Alzheimer&#8217;s patients. THC is a naturally occurring cannabinoid produced by the cannabis plant. It is known for being a psychoactive substance that can impact mental processes in a positive or negative way depending on the dosage. THC is biphasic, meaning that low and high doses of the substance may affect mental and physiological processes in substantially different ways. For example, in some patients, low doses may relieve a symptom, whereas high doses may amplify a symptom. Ultimately, the goal of IGC&#8217;s research is to discover and analyze whether, and at what level of dosing, IGC-AD1 provides relief of a given symptom. IGC&#8217;s trial is based on micro dosing on patients suffering from Alzheimer&#8217;s disease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has filed forty-one (41) patent applications to address various diseases such as Alzheimer&#8217;s, Central Nervous System (&#8220;CNS&#8221;) disorders, pain, stammering, seizures in cats and dogs, eating disorders, stress-relief, and calm-restoring beverage, and fatigue. As of March 31, 2023, our portfolio includes nine granted patents.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, we license a patent filing from the University of South Florida titled &#8220;Ultra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimer&#8217;s Disease.&#8221; The USPTO issued a patent (#11,065,225) for this filing on July 20, 2021.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, the Company had the following operating subsidiaries: Techni Bharathi Private Limited (TBL), IGCare LLC, Holi Hemp LLC, IGC Pharma LLC, SAN Holdings LLC, Sunday Seltzer, LLC, Hamsa Biopharma India Pvt. Ltd. And Colombia-based beneficially-owned subsidiary IGC Pharma SAS (formerly Hamsa Biopharma Colombia SAS) (Hamsa). The Company&#8217;s fiscal year is the 52- or 53-week period that ends on March 31. The Company&#8217; principal office is in Maryland established in 2005. Additionally, the Company have offices in Washington state, Colombia, South America, and India. The Company&#8217;s filings are available on www.sec.gov.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>IGC has two segments: Life Sciences and Infrastructure. </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Life Sciences Segment</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i><span style="text-decoration:underline">Pharmaceutical</span></i>: Since 2014, this part of our business has focused on the potential uses of phytocannabinoids, including THC and Cannabidiol (CBD), in combination with other compounds to treat multiple diseases, including Alzheimer&#8217;s. In addition, the Company has acquired and initiated work on TGR-63, a non-cannabinoid pre-clinical molecule, that exhibits an impressive affinity for reducing neurotoxicity in Alzheimer&#8217;s cell lines. Neurotoxicity causes cell dysfunction and death in Alzheimer&#8217;s disease. If shown to be efficacious, in AD cell lines, in halting this process, this inhibitor has the potential to treat Alzheimer&#8217;s disease by ameliorating A&#946; plaques.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i><span style="text-decoration:underline">Over the Counter Products</span></i>: We have created a women&#8217;s wellness brand, Holief&#8482; available through online channels that are compliant with relevant federal, state, and local laws, and regulations. Holief&#8482; is an all-natural, non-GMO, vegan, line of over the counter (OTC) products aimed at treating menstrual cramps (dysmenorrhea) and premenstrual symptoms (PMS). The products are available online and through Amazon and other online channels. Holief&#8482; is compliant with relevant federal, state, and local laws, and regulations.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Infrastructure Segment</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s infrastructure business has been operating since 2008, it includes: (i) Execution of Construction Contracts and (ii) Rental of Heavy Construction Equipment.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034565236912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 2</b> &#8211;<b> SIGNIFICANT ACCOUNTING POLICIES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>a) Principles of consolidation</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The consolidated financial statements include the accounts of the Company and all its subsidiaries. Intercompany accounts and transactions have been eliminated. In the opinion of the Company&#8217;s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Transactions between the Company and its subsidiaries are eliminated in the consolidated financial statements.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>b) Use of estimates</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Management believes that the estimates and assumptions used in the preparation of the consolidated financial statements are prudent and reasonable. Significant estimates and assumptions are generally used for, but not limited to allowance for uncollectible accounts receivable; sales returns; normal loss during production; future obligations under employee benefit plans; the useful lives of property, plant, and equipment; intangible assets; valuations; impairment of goodwill and investments; recoverability of advances; the valuation of options granted, and warrants issued; and income tax and deferred tax valuation allowances, if any. Actual results could differ from those estimates. Appropriate changes in estimates are made as management becomes aware of changes in circumstances surrounding the estimates. Critical accounting estimates could change from period to period and could have a material impact on IGC&#8217;s results, operations, financial position, and cash flows. Changes in estimates are reflected in the financial statements in the period in which changes are made and, if material, their effects are disclosed in the notes to the consolidated financial statements.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>c) Revenue recognition</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company recognizes revenue under ASC 606, <i>Revenue from Contracts with Customers </i>(&#8220;ASC 606&#8221;). The core principle of this standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">ASC 606 prescribes a 5-step process to achieve its core principle. The Company recognizes revenue from trading, rental, or product sales as follows:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">I. Identify the contract with the customer.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">II. Identify the contractual performance obligations.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">III. Determine the amount of consideration/price for the transaction.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IV. Allocate the determined amount of consideration/price to the contractual obligations.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">V. Recognize revenue when or as the performing party satisfies performance obligations.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The consideration/price for the transaction (performance obligation(s)) is determined as per the agreement or invoice (contract) for the services and products in the Infrastructure segment and Life Sciences segment. Refer to Note 17 &#8211; &#8220;Revenue Recognition.&#8221;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>d) Cost of Revenue</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our cost of revenue includes costs associated with in-house and outsourced distribution, labor expense, components, manufacturing overhead, and outbound freight for our products division. In our products division, cost of revenue also includes the cost of refurbishing or repackaging, if required, on products returned by customers that will be offered for resale.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>e) Earnings/(Loss) per Share</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The computation of basic loss per share for Fiscal 2023, excludes potentially dilutive securities of approximately shares which includes share options, unvested shares such as restricted shares and restricted share units, granted to employees, non-employees and advisors, and shares from the conversion of outstanding units, if any, because their inclusion would be anti-dilutive.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The weighted average number of shares outstanding for Fiscal 2023 and 2022, used for the computation of basic earnings per share (EPS) is 52,576,258 and 49,991,631, respectively. Due to the loss incurred during Fiscal 2023 and 2022, all the potential equity shares are anti-dilutive, and accordingly, the fully diluted EPS is equal to the basic EPS.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>f) Going Concern:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company assesses and determines its ability to continue as a going concern in accordance with the provisions of ASC Subtopic 205-40, "<i>Presentation of Financial Statements</i>&#8212;<i>Going Concern</i>", which requires the Company to evaluate whether there are conditions or events that raise substantial doubt about its ability to continue as a going concern.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company is currently in a clinical trial stage and, thus, has not yet achieved profitability. The Company expects to continue to incur significant operating and net losses and negative cash flows from operations in the near future.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For the years ended March 31, 2023, and March 31, 2022, the Company incurred net losses of $11.5 million and $15 million, respectively. As of March 31, 2023, the Company&#8217;s cash and cash equivalents totaled $3.2 million. On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $12 million and, in addition, sold 10,000,000 shares for $3,000,000. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#8217;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions. Please refer to Note 19, &#8220;Subsequent Event,&#8221; for further information.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company estimates that its current cash and cash equivalents balance with working capital and equity investment is sufficient to support operations beyond the twelve months following the date these consolidated financial statements and footnotes were issued. These estimates are based on assumptions that may prove to be wrong, and the Company could use its available capital resources sooner than it currently expects.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>g) Income taxes</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company accounts for income taxes under the asset and liability method, in accordance with ASC 740, Income Taxes, which requires an entity to recognize deferred tax liabilities and assets. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. A valuation allowance is established and recorded when management determines that some or all of the deferred tax assets are not likely to be realized and therefore, it is necessary to reduce deferred tax assets to the amount expected to be realized.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In evaluating a tax position for recognition, management evaluates whether it is more-likely-than-not that a position will be sustained upon examination, including resolution of related appeals or litigation processes, based on technical merits of the position. If the tax position meets the more-likely-than-not recognition threshold, the tax position is measured and recognized in the Company&#8217;s financial statements as the largest amount of tax benefit that, in management&#8217;s judgment, is greater than 50% likely of being realized upon settlement. As of March 31, 2023, and 2022, there was no significant liability for income tax associated with unrecognized tax benefits.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>h) Accounts receivable</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:29pt;">We make estimates of the collectability of our accounts receivable by analyzing historical payment patterns, customer concentrations, customer creditworthiness, and current economic trends. If the financial condition of a customer deteriorates, additional allowances may be required. We had $107 thousand of accounts receivable, net of provision for doubtful debt of $17 thousand as of March 31, 2023, as compared to $125 thousand of accounts receivable, net of provision for doubtful debt of $93 thousand as of March 31, 2022.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>i) Cash and cash equivalents</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For financial statement purposes, the Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents. The Company maintains its cash in bank accounts in the U.S., India, Colombia, and Hong Kong, which at times may exceed applicable insurance limits. The cash and cash equivalents in the Company on March 31, 2023, and 2022, were approximately $3,196 thousand and $10,460 thousand, respectively.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>j) Short-term and long-term investments</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our policy for short-term and long-term investments is to establish a high-quality portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations, and delivers an appropriate yield in relation to our investment guidelines and market conditions. Short-term and long-term investments consist of corporate, various government agencies and municipal debt securities, as well as certificates of deposit that have maturity dates that are greater than 90 days. Certificates of deposit and commercial paper are carried at a cost which approximates fair value. Available-for-sale securities: Investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the statement of financial position.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Investments are initially measured at cost, which is the fair value of the consideration given for them, including transaction costs. Where the Company&#8217;s ownership interest is in excess of 20% and the Company has a significant influence, the Company has accounted for the investment based on the equity method in accordance with ASC Topic 323, &#8220;<i>Investments </i>&#8211;<i> Equity method and Joint Ventures.</i>&#8221; Under the equity method, the Company&#8217;s share of the post-acquisition profits or losses of the equity investee is recognized in the consolidated statements of operations and its share of post-acquisition movements in accumulated other comprehensive income / (loss) is recognized in other comprehensive income / (loss). Where the Company does not have significant influence, the Company has accounted for the investment in accordance with ASC Topic 321, &#8220;<i>Investments-Equity Securities.</i>&#8221;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, investment in marketable securities is valued at fair value and investment in non-marketable securities with ownership less than 20% is valued at cost as per ASC Topic 321, &#8220;<i>Investments-Equity Securities.</i>&#8221;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>k) Property, plant, and equipment (PP&amp;E) </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Property, plant, and equipment are recorded at cost net of accumulated depreciation and depreciated over their estimated useful lives using the straight-line method.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon retirement or disposition, cost and related accumulated depreciation of the Property, plant and equipment are de-recognized, and any gain or loss is reflected in the results of operation. Cost of additions and substantial improvements to property and equipment are capitalized. The cost of maintenance and repairs of the property and equipment are charged to operating expenses as incurred.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>l) Fair value of financial instruments</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">ASC 820, &#8220;Fair Value Measurement&#8221; defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 1: Observable inputs such as quoted prices in active markets;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The carrying amounts of the Company&#8217;s financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximately their fair values due to the nature of the items. Please refer to Note 15, &#8220;Fair value of financial instruments,&#8221; for further information.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>m) Concentration of credit risk and significant customers</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Financial instruments, which potentially expose the Company to concentrations of credit risk, are primarily comprised of cash and cash equivalents, investments, accounts receivable and unbilled accounts receivable, if any. The Company places its cash investments in highly rated financial institutions. The Company adheres to a formal investment policy with the primary objective of preservation of principal, which contains credit rating minimums and diversification requirements. Management believes its credit policies reflect normal industry terms and business risk. The Company does not anticipate non-performance by the counterparties and, accordingly, does not require collateral. During Fiscal 2023, sales were spread across customers in Asia and U.S. and the credit concentration risk is low.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>n) Stock </b>&#8211;<b> Based Compensation</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company accounts for stock-based compensation to employees and non-employees in conformity with the provisions of ASC Topic 718, &#8220;<i>Stock-Based Compensation.</i>&#8221; The Company expenses stock-based compensation to employees over the requisite vesting period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards are recognized on a straight-line basis over the requisite vesting period. For stock-based employee compensation the cost recognized at any date will be at least equal to the amount attributable to the share-based compensation that is vested at that date.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For performance-based awards, stock-based compensation expense is recognized over the expected performance achievement period of individual performance milestones when the achievement of each individual performance milestone becomes probable. For performance-based awards with a vesting schedule based entirely on the attainment of performance conditions, stock-based compensation expense associated with each tranche is recognized over the expected achievement period for the operational milestone, beginning at the point in time when the relevant operational milestone is considered probable to be achieved.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For market-based awards, stock-based compensation expense is recognized over the expected achievement period. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company estimates the fair value of stock option grants using the Black-Scholes option-pricing model. The assumptions used in calculating the fair value of stock-based awards represent Management&#8217;s best estimates. Generally, the closing share price of the Company&#8217;s common stock on the date of grant is considered the fair value of the share. The volatility factor is determined based on the Company&#8217;s historical stock prices. The expected term represents the period that our stock-based awards are expected to be outstanding. The Company has never declared or paid any cash dividends. For further information refer to Note 14, &#8220;Stock-Based Compensation&#8221; of Notes to Consolidated Financial Statements.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>o) Commitments and contingencies</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Liabilities for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. We record associated legal fees as incurred. Information regarding our commitments and contingencies is incorporated by reference in Note 12, &#8220;Commitments and contingencies&#8221; of this Annual Report on Form 10-K.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>p) Impairment of long </b>&#8211;<b> lived assets</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company reviews its long-lived assets, with finite lives, for impairment whenever events or changes in business circumstances indicate that the carrying amount of assets may not be fully recoverable. Such circumstances include, though are not limited to, significant or sustained declines in revenues or earnings, future anticipated cash flows, business plans, and material adverse changes in the economic climate, such as changes in the operating environment, competitive information, and impact of changes in government policies. For assets that the Company intends to hold for use, if the total of the expected future undiscounted cash flows produced by the assets or subsidiary company is less than the carrying amount of the assets, a loss is recognized for the difference between the fair value and carrying value of the assets. For assets, the Company intends to dispose of by sale, a loss is recognized for the amount by which the estimated fair value less cost to sell is less than the carrying value of the assets. Fair value is determined based on quoted market prices, if available, or other valuation techniques including discounted future net cash flows. Unlike goodwill, long-lived assets are assessed for impairment only where there are any specific indicators for impairment.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>q) Intangible assets</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s intangible assets are accounted for in accordance with ASC Topic 350, <i>Intangibles </i>&#8211;<i> Goodwill and Other. </i>Intangible assets having indefinite lives are not amortized, but instead are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We perform an impairment analysis on March 1 annually on the indefinite-lived intangible assets following the steps laid out in ASC 350-30-35-18. Our annual impairment analysis includes a qualitative assessment to determine if it is necessary to perform the quantitative impairment test. In performing a qualitative assessment, we review events and circumstances that could affect the significant inputs used to determine if the fair value is less than the carrying value of the intangible assets. If quantitative analysis is necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets will be tested on an interim basis if an event or circumstance indicates that it is more likely than not that an impairment loss has been incurred. The Company has analyzed a variety of factors in light of the known impact to date of the COVID-19 pandemic on its business to determine if a circumstance could trigger an impairment loss, and, at this time and based on the information presently known, does not believe it is more likely than not that an impairment loss has been incurred.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Intangible assets with finite useful lives are amortized using the straight-line method over their estimated period of benefit. In accordance with ASC 360-10-35-21, definite lived intangibles are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company intends to capitalize trademarks and related expenses exceeding $2,500 per trademark. Management may also capitalize trademarks and related expenses up to $2,500 per trademark based on its potential and benefit in coming years.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>r) Inventory</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Inventory is valued at the lower of cost or net realizable value, which is defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Inventory consists of finished goods related to wellness products, hand sanitizers, finished hemp-based products, beverages. Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to primary cost. Inventory is primarily accounted for using the weighted average cost method. Primary costs include raw materials, packaging, direct labor, overhead, shipping, and the depreciation of manufacturing equipment. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We capitalize inventory costs related to our investigational drug, provided that management determines there is a potential alternative use for the inventory in future research and development projects or other purposes. As of March 31, 2023, and 2022, our consolidated balance sheet reported approximately $407 thousand and no clinical trial-related inventory, respectively.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Abnormal amounts of idle facility expense, freight, handling costs, scrap, discontinued products and wasted material (spoilage) are expensed in the period they are incurred.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Please refer to Note 3, &#8220;Inventory,&#8221; for further information.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>s) Cybersecurity</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have a cybersecurity policy in place and tighter cybersecurity measures to safeguard against hackers. In Fiscal 2023, there were no impactful breaches in cybersecurity.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>t) Research and Development Expenses</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During Fiscal 2023 and 2022, the Company recorded research and development expenses of approximately $3.5 million and $2.3 million, respectively. All research and development costs are expensed in the period in which they are incurred.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>u) Leases</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Lessor Accounting</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the current ASU guidance, contract consideration will be allocated to its lease components and non-lease components (such as maintenance). For the Company as a lessor, any non-lease components will be accounted for under ASC Topic 606, &#8220;<i>Revenue from Contracts with Customers,</i>&#8221; unless the Company elects a lessor practical expedient to not separate the non-lease components from the associated lease component. The amendments in ASU 2018-11 also provide lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component if the non-lease components otherwise would be accounted for under the new revenue guidance (Topic 606). To elect the practical expedient, the timing and pattern of transfer of the lease and non-lease components must be the same and the lease component must meet the criteria to be classified as an operating lease if accounted for separately. If these criteria are met, the single component will be accounted for under either Topic 842 or Topic 606 depending on which component(s) are predominant. The lessor practical expedient to not separate non-lease components from the associated component must be elected for all existing and new leases.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As a lessor, the Company expects that post-adoption substantially all existing leases will have no change in the timing of revenue recognition until their expiration or termination. The Company expects to elect the lessor practical expedient to not separate non-lease components such as maintenance from the associated lease for all existing and new leases and to account for the combined component as a single lease component. The timing of revenue recognition is expected to be the same for the majority of the Company&#8217;s new leases as compared to similar existing leases; however, certain categories of new leases could have different revenue recognition patterns as compared to similar existing leases.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For leases that are accounted for as operating leases, income is recognized on a straight-line basis over the term of the lease contract. Generally, when a lease is more than 180 days delinquent (where more than three monthly payments are owed), the lease is classified as being nonaccrual and the Company stops recognizing leasing income on that date. Payments received on leases in nonaccrual status generally reduce the lease receivable. Leases on nonaccrual status remain classified as such until there is sustained payment performance that, in the Company&#8217;s judgment, would indicate that all contractual amounts will be collected in full.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Lessee Accounting</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company adopted ASU 2016-02 effective April 1, 2019, using the modified retrospective approach. The standard establishes a right-of-use model (ROU) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. In connection with the adoption, the Company will elect to utilize the modified retrospective presentation whereby the Company will continue to present prior period financial statements and disclosures under ASC Topic 840. In addition, the Company will elect the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and initial direct costs. Further, the Company will adopt a short-term lease exception policy, permitting us to not apply the recognition requirements of this standard to short-term leases (i.e., leases with terms of 12 months or less), and an accounting policy to account for lease and non-lease components as a single component for certain classes of assets.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under ASU 2016-02 (Topic 842), lessees are required to recognize the following for all leases (with the exception of short-term leases) on the commencement date: (i) lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and (ii) right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At the commencement date, the Company recognizes the lease liability at the present value of the lease payments not yet paid, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate for the same term as the underlying lease. The right-of-use asset is recognized initially at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. There was no impairment for right-of-use lease assets as of March 31, 2023.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company categorizes leases at their inception as either operating or finance leases. On certain lease agreements, the Company may receive rent holidays and other incentives. The Company recognizes lease costs on a straight-line basis without regard to deferred payment terms, such as rent holidays, that defer the commencement date of required payments. Please refer to Note 9, &#8220;Leases,&#8221; for further information.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>v) Recently issued and adopted accounting pronouncements</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Changes to U.S. GAAP are established by the Financial Accounting Standards Board (&#8220;FASB&#8221;) in the form of accounting standards updates (ASUs) to the FASB&#8217;s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Newly issued ASUs not listed are expected to have no impact on the Company&#8217;s consolidated financial position and results of operations, because either the ASU is not applicable, or the impact is expected to be immaterial.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563767408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory Disclosure [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 3 </b>&#8211;<b> INVENTORY</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1635" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1636" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1637" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1638" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1639" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1640" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1641" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1642" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1643" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Raw materials</p>
			</td>
			<td id="new_id-1644" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1645" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1646" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,100</td>
			<td id="new_id-1647" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1648" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1649" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1650" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,247</td>
			<td id="new_id-1651" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Work-in-progress</p>
			</td>
			<td id="new_id-1652" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1653" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1654" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">18</td>
			<td id="new_id-1655" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1656" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1657" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1658" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">584</td>
			<td id="new_id-1659" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Finished goods</p>
			</td>
			<td id="new_id-1660" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1661" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1662" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">533</td>
			<td id="new_id-1663" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1664" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1665" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1666" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">717</td>
			<td id="new_id-1667" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1668" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1669" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1670" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>2,651</b></td>
			<td id="new_id-1671" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1672" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1673" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1674" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>3,548</b></td>
			<td id="new_id-1675" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to gummies, tincture, and hemp derivatives. Finished goods comprise, but is not limited to, hand sanitizers, gummies, lotions, and beverages, among others.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During Fiscal 2023, the Company charged $376 thousand of inventory in selling, general and administration due to product expiration, handling costs, scrap, and wasted material (spoilage) as compared to approximately $252 thousand for Fiscal 2022. This charge was recorded in Selling, general, and administrative expenses.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034565168576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEPOSITS AND ADVANCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_DepositsAndAdvancesAbstract', window );"><strong>Deposits And Advances Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_DepositsAndAdvancesTextBlock', window );">Deposits and Advances [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTE 4 </b>&#8211;<b> DEPOSITS AND ADVANCES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1676" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1677" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1678" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1679" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1680" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1681" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1682" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1683" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1684" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Advances to suppliers and consultants</p>
			</td>
			<td id="new_id-1685" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1686" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1687" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">72</td>
			<td id="new_id-1688" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1689" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1690" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1691" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">170</td>
			<td id="new_id-1692" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other receivables and deposits</p>
			</td>
			<td id="new_id-1693" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1694" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1695" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">24</td>
			<td id="new_id-1696" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1697" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1698" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1699" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">472</td>
			<td id="new_id-1700" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Prepaid expense and other current assets</p>
			</td>
			<td id="new_id-1701" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1702" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1703" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">262</td>
			<td id="new_id-1704" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1705" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1706" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1707" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">336</td>
			<td id="new_id-1708" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1709" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1710" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1711" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>358</b></td>
			<td id="new_id-1712" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1713" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1714" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1715" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>978</b></td>
			<td id="new_id-1716" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Advances to suppliers and consultants primarily relate to advances to suppliers in our Life Sciences and Infrastructure segment. Prepaid and other current assets include approximately $25 thousand in statutory advances for Fiscal 2023, as compared to $170 thousand in Fiscal 2022. The Company decided to move advances paid to suppliers worth approximately $164 thousand to claims and advances, considering recovering might take more than 12 months.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_DepositsAndAdvancesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_DepositsAndAdvancesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_DepositsAndAdvancesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of deposits and advances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_DepositsAndAdvancesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034659527568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets Disclosure [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 5 </b>&#8211;<b> INTANGIBLE ASSETS </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Amortized intangible assets</i></b></p>
			</td>
			<td id="new_id-1717" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1718" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1719" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1720" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1721" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1722" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1723" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1724" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1725" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patents</p>
			</td>
			<td id="new_id-1726" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1727" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1728" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">709</td>
			<td id="new_id-1729" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1730" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1731" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1732" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">290</td>
			<td id="new_id-1733" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other intangibles</p>
			</td>
			<td id="new_id-1734" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1735" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1736" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">34</td>
			<td id="new_id-1737" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1738" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1739" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1740" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">32</td>
			<td id="new_id-1741" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated amortization</p>
			</td>
			<td id="new_id-1742" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1743" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1744" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(107</td>
			<td id="new_id-1745" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1746" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1747" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1748" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(51</td>
			<td id="new_id-1749" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total amortized intangible assets</b></p>
			</td>
			<td id="new_id-1750" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1751" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1752" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>636</b></td>
			<td id="new_id-1753" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1754" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1755" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1756" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>271</b></td>
			<td id="new_id-1757" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-1758">&#160;</td>
			<td id="new_id-1759">&#160;</td>
			<td id="new_id-1760">&#160;</td>
			<td id="new_id-1761">&#160;</td>
			<td id="new_id-1762">&#160;</td>
			<td id="new_id-1763">&#160;</td>
			<td id="new_id-1764">&#160;</td>
			<td id="new_id-1765">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Unamortized intangible assets</i></b></p>
			</td>
			<td id="new_id-1766" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1767" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1768" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1769" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1770" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1771" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1772" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1773" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patents</p>
			</td>
			<td id="new_id-1774" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1775" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1776" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">534</td>
			<td id="new_id-1777" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1778" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1779" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1780" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">646</td>
			<td id="new_id-1781" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other intangibles</p>
			</td>
			<td id="new_id-1782" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1783" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1784" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1785" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1786" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1787" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1788" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1789" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total unamortized intangible assets</b></p>
			</td>
			<td id="new_id-1790" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1791" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1792" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">534</td>
			<td id="new_id-1793" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1794" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1795" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1796" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">646</td>
			<td id="new_id-1797" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total intangible assets</b></p>
			</td>
			<td id="new_id-1798" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1799" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1800" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>1,170</b></td>
			<td id="new_id-1801" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1802" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1803" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1804" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>917</b></td>
			<td id="new_id-1805" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The value of intangible assets includes the cost of acquiring patent rights, supporting data, and the expense associated with filing of forty-one (41) patent applications in different countries along with nine (9) granted patents. It also includes acquisition costs related to domains, and licenses.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The amortization of patent and patent rights with finite life is up to 20 years, commencing from the date of grant or acquisition. The amortization expense in Fiscal 2023 and 2022 amounted to approximately $57 thousand and $24 thousand, respectively.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company regularly reviews its intangible assets to determine if any intangible asset is other-than-temporarily impaired, which would require the Company to record an impairment charge in the period and concluded that, as of March 31, 2023, there was no impairment.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Estimated amortization expense</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>(in thousands) </i></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>($)</i></b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2024</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">62</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2025</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">69</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2026</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">75</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2027</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">83</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2028</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">91</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563602880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment Disclosure [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 6 </b>&#8211;<b> PROPERTY, PLANT, AND EQUIPMENT</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1806" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="9" id="new_id-1807" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands, except useful life)</i></b></i></p>
			</td>
			<td id="new_id-1808" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1809" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="1" id="new_id-1810" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; vertical-align: top;"><b>Useful Life (years)</b></p>
			</td>
			<td id="new_id-1811" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1812" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1813" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1814" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1815" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1816" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1817" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Land</p>
			</td>
			<td id="new_id-1818" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1819" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">N/A</td>
			<td id="new_id-1820" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1821" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1822" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1823" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,100</td>
			<td id="new_id-1824" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1825" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1826" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1827" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,438</td>
			<td id="new_id-1828" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Buildings and facilities</p>
			</td>
			<td id="new_id-1829" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1830" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">25</td>
			<td id="new_id-1831" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1832" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1833" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1834" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,298</td>
			<td id="new_id-1835" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1836" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1837" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1838" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,810</td>
			<td id="new_id-1839" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plant and machinery</p>
			</td>
			<td id="new_id-1840" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1841" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">5-20</td>
			<td id="new_id-1842" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1843" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1844" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1845" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,335</td>
			<td id="new_id-1846" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1847" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1848" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1849" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,593</td>
			<td id="new_id-1850" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Computer equipment&#8217;s</p>
			</td>
			<td id="new_id-1851" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1852" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">3</td>
			<td id="new_id-1853" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1854" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1855" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1856" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">138</td>
			<td id="new_id-1857" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1858" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1859" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1860" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">241</td>
			<td id="new_id-1861" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Office equipment&#8217;s</p>
			</td>
			<td id="new_id-1862" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1863" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">3-5</td>
			<td id="new_id-1864" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1865" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1866" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1867" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">84</td>
			<td id="new_id-1868" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1869" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1870" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1871" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">145</td>
			<td id="new_id-1872" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Furniture and fixtures</p>
			</td>
			<td id="new_id-1873" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1874" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">5</td>
			<td id="new_id-1875" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1876" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1877" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1878" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">92</td>
			<td id="new_id-1879" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1880" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1881" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1882" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">141</td>
			<td id="new_id-1883" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vehicles</p>
			</td>
			<td id="new_id-1884" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1885" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">5</td>
			<td id="new_id-1886" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1887" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1888" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1889" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">102</td>
			<td id="new_id-1890" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1891" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1892" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1893" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">163</td>
			<td id="new_id-1894" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction in progress</p>
			</td>
			<td id="new_id-1895" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1896" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">N/A</td>
			<td id="new_id-1897" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1898" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1899" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1900" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1901" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1902" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1903" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1904" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">108</td>
			<td id="new_id-1905" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total gross value</b></p>
			</td>
			<td id="new_id-1906" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1907" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1908" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1909" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1910" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1911" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>10,149</b></td>
			<td id="new_id-1912" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1913" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1914" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1915" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>12,639</b></td>
			<td id="new_id-1916" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: Accumulated depreciation</p>
			</td>
			<td id="new_id-1917" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1918" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1919" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1920" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1921" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1922" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,936</td>
			<td id="new_id-1923" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1924" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1925" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1926" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,220</td>
			<td id="new_id-1927" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total property, plant and equipment, net</b></p>
			</td>
			<td id="new_id-1928" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1929" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1930" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1931" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1932" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1933" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>8,213</b></td>
			<td id="new_id-1934" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1935" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1936" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1937" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>9,419</b></td>
			<td id="new_id-1938" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The depreciation expense in Fiscal 2023 and 2022 amounted to approximately $600 thousand and $627 thousand, respectively. The net decrease in total property, plant, and equipment (net) is primarily due to depreciation and foreign exchange translations because of a decrease in value of foreign currencies. In addition, Fiscal 2023, the Company disposed of fully depreciated assets in the amount of approximately $1.6 million from its subsidiaries. This resulted in a reduction in the value of total gross assets but did not affect the net value of assets as the disposed assets had previously been fully depreciated. The Company sold a property in Puerto Rico for net proceeds of approximately $485 thousand (acquired for approximately $480 thousand) and accounted for a profit of approximately $5 thousand in other income. For more information, please refer to Note 18, &#8220;Segment Information&#8221; for the non-current assets other than financial instruments held in the country of domicile and foreign countries.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563606464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLAIMS AND ADVANCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Other Assets Disclosure [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTE 8 </b>&#8211;<b> CLAIMS AND ADVANCES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1939" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1940" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1941" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1942" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1943" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1944" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1945" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1946" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1947" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims receivable (1)</p>
			</td>
			<td id="new_id-1948" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1949" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1950" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">951</td>
			<td id="new_id-1951" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1952" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1953" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1954" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">368</td>
			<td id="new_id-1955" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-current deposits</p>
			</td>
			<td id="new_id-1956" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1957" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1958" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">27</td>
			<td id="new_id-1959" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1960" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1961" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1962" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1963" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-current advances</p>
			</td>
			<td id="new_id-1964" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1965" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1966" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25</td>
			<td id="new_id-1967" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1968" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1969" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1970" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">569</td>
			<td id="new_id-1971" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1972" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1973" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1974" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>1,003</b></td>
			<td id="new_id-1975" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1976" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1977" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1978" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>937</b></td>
			<td id="new_id-1979" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:2.3%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>	</td>	<td style="vertical-align:top;width:43.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The claims receivable is due from different vendors. While the Company has initiated collection proceedings internally or with the appropriate authorities, it believes receiving the amount in the next 12 months will be challenging because of the time required for collection proceedings. The Company decided to move advances paid to some suppliers worth approximately $164 thousand to claims and advances, considering recovering might take more than 12 months. Includes $140 thousand owed to one of our manufacturers for the equipment purchase.</p>	</td>	</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563561568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 9 </b>&#8211;<b> LEASES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has short-term leases primarily consisting of spaces with the remaining lease term being less than or equal to 12 months. The total short- term lease expense and cash paid for Fiscal 2023 and 2022 are approximately $178 thousand. The Company also has four operating leases as of March 31, 2023.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>America</i></b>: In November 2019, the Company entered into a lease agreement with a lease term of less than 12 months. This lease was amended in March 2020, with a new lease term from March 1, 2020, to November 30, 2025. The annual lease expense is approximately $123 thousand. The lease contract does not contain any material residual value guarantees or material restrictive covenants. The remaining lease term for the operating lease is 2.7 years with a discount rate of 7%. The lease does not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Asia</i></b>: The Company renewed three lease agreements for terms between three to four years, expiring between 2023 and 2024. The total annual lease expense is approximately $25 thousand. The lease contracts do not contain any material residual value guarantees or material restrictive covenants. The remaining lease term for the operating leases is between 1 - 1.7 years with a discount rate of 7%. The lease does not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1980" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1981" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1982" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1983" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1984" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1985" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease costs</p>
			</td>
			<td id="new_id-1986" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1987" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1988" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">148</td>
			<td id="new_id-1989" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1990" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1991" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1992" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">149</td>
			<td id="new_id-1993" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Short term lease costs</p>
			</td>
			<td id="new_id-1994" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1995" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1996" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">178</td>
			<td id="new_id-1997" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1998" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1999" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2000" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">178</td>
			<td id="new_id-2001" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease costs</b></p>
			</td>
			<td id="new_id-2002" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2003" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2004" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>326</b></td>
			<td id="new_id-2005" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2006" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2007" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2008" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>327</b></td>
			<td id="new_id-2009" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Right of use assets and lease liabilities for our operating leases were recorded in the consolidated balance sheet as follows:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2010" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2011" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2012" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2013" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2014" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2015" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2016" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2017" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2018" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2019" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2020" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2021" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Assets</b></p>
			</td>
			<td id="new_id-2022" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2023" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2024" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2025" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2026" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2027" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2028" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2029" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-2030" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2031" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2032" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">326</td>
			<td id="new_id-2033" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2034" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2035" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2036" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">450</td>
			<td id="new_id-2037" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease assets </b></p>
			</td>
			<td id="new_id-2038" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2039" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2040" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>326</b></td>
			<td id="new_id-2041" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2042" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2043" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2044" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>450</b></td>
			<td id="new_id-2045" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2046">&#160;</td>
			<td id="new_id-2047">&#160;</td>
			<td id="new_id-2048">&#160;</td>
			<td id="new_id-2049">&#160;</td>
			<td id="new_id-2050">&#160;</td>
			<td id="new_id-2051">&#160;</td>
			<td id="new_id-2052">&#160;</td>
			<td id="new_id-2053">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Liabilities</b></p>
			</td>
			<td id="new_id-2054" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2055" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2056" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2057" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2058" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2059" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2060" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2061" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Current liabilities:</p>
			</td>
			<td id="new_id-2062" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2063" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2064" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2065" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2066" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2067" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2068" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2069" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued liabilities and others (current portion &#8211; operating lease liability)</p>
			</td>
			<td id="new_id-2070" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2071" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2072" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">133</td>
			<td id="new_id-2073" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2074" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2075" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2076" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">123</td>
			<td id="new_id-2077" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Noncurrent liabilities:</p>
			</td>
			<td id="new_id-2078" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2079" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2080" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2081" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2082" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2083" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2084" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2085" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease liability (non-current portion &#8211; operating lease liability)</p>
			</td>
			<td id="new_id-2086" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2087" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2088" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">207</td>
			<td id="new_id-2089" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2090" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2091" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2092" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">341</td>
			<td id="new_id-2093" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease liability </b></p>
			</td>
			<td id="new_id-2094" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2095" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2096" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>340</b></td>
			<td id="new_id-2097" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2098" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2099" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2100" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>464</b></td>
			<td id="new_id-2101" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Supplemental cash flow and non-cash information related to leases is as follows:</p>
			</td>
			<td id="new_id-2102" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2103" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2104" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2105" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2106" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2107" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash paid for amounts included in the measurement of lease liabilities</p>
			</td>
			<td id="new_id-2108" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2109" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2110" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2111" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2112" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2113" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2114" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2115" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8211;Operating cash flows from operating leases</p>
			</td>
			<td id="new_id-2116" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2117" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2118" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">118</td>
			<td id="new_id-2119" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2120" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2121" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2122" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">109</td>
			<td id="new_id-2123" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Right-of-use assets obtained in exchange for operating lease obligations</p>
			</td>
			<td id="new_id-2124" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2125" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2126" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">326</td>
			<td id="new_id-2127" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2128" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2129" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2130" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">450</td>
			<td id="new_id-2131" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td colspan="4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">As of March 31, 2023, the following table summarizes the maturity of our lease liabilities:</p>
			</td>
			<td id="new_id-2132" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2133">&#160;</td>
			<td id="new_id-2134">&#160;</td>
			<td id="new_id-2135">&#160;</td>
			<td id="new_id-2136">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 81%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-24</p>
			</td>
			<td id="new_id-2137" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2138" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2139" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">151</td>
			<td id="new_id-2140" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-25</p>
			</td>
			<td id="new_id-2141" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2142" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2143" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">133</td>
			<td id="new_id-2144" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-26</p>
			</td>
			<td id="new_id-2145" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2146" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2147" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">87</td>
			<td id="new_id-2148" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-27</p>
			</td>
			<td id="new_id-2149" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2150" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2151" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2152" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: Present value discount</p>
			</td>
			<td id="new_id-2153" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2154" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2155" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(31</td>
			<td id="new_id-2156" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total Lease liabilities</b></p>
			</td>
			<td id="new_id-2157" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2158" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2159" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>340</b></td>
			<td id="new_id-2160" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563621248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED LIABILITIES AND OTHERS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_AccruedLiabilitiesDisclosureAbstract', window );"><strong>Accrued Liabilities Disclosure Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_AccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities Disclosure [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 10 </b>&#8211;<b> ACCRUED LIABILITIES AND OTHERS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2161" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2162" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>
			</td>
			<td id="new_id-2163" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2164" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2165" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2166" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2167" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2168" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2169" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Compensation and other contributions</p>
			</td>
			<td id="new_id-2170" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2171" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2172" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">619</td>
			<td id="new_id-2173" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2174" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2175" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2176" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,054</td>
			<td id="new_id-2177" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Provision for expenses</p>
			</td>
			<td id="new_id-2178" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2179" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2180" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">258</td>
			<td id="new_id-2181" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2182" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2183" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2184" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">103</td>
			<td id="new_id-2185" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Short-term lease liability</p>
			</td>
			<td id="new_id-2186" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2187" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2188" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">133</td>
			<td id="new_id-2189" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2190" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2191" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2192" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">123</td>
			<td id="new_id-2193" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other current liability</p>
			</td>
			<td id="new_id-2194" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2195" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2196" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">358</td>
			<td id="new_id-2197" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2198" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2199" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2200" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">180</td>
			<td id="new_id-2201" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2202" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2203" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2204" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>1,368</b></td>
			<td id="new_id-2205" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2206" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2207" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2208" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>1,460</b></td>
			<td id="new_id-2209" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Compensation and other contribution-related liabilities consist of accrued salaries to employees. In addition, provision for expenses includes provision for legal, professional, and marketing expenses. Other current liability also includes statutory payables of approximately $31 thousand and 55 thousand as of March 31, 2023, and March 31, 2022, respectively, and approximately $3 thousand of short-term loans as of March 31, 2023, and March 31, 2022, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_AccruedLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_AccruedLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_AccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure for accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_AccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563611056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS AND OTHER LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LoansAndOtherLiabilitiesAbstract', window );"><strong>Loans And Other Liabilities Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LoansAndOtherLiabilitiesTextBlock', window );">Loans and Other Liabilities [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 11 </b>&#8211;<b> LOANS AND OTHER LIABILITIES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Loan as of March 31, 2023:</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On June 11, 2020, the Company received an Economic Injury Disaster Loan (EIDL) for approximately $150 thousand at an annual interest rate of 3.75%. The Company must pay principal and interest payments of $731 every month beginning June 5, 2021. The SBA will apply each installment payment first to pay interest accrued to the day SBA receives the payment and will then apply any remaining balance to reduce principal. All remaining principal and accrued interest are due and payable 30 years from the date of the loan. For Fiscal 2023, the interest expense and principal payment for the EIDL were approximately $5 thousand and $3 thousand, respectively. As of March 31, 2023, approximately $141 thousand of the loan is classified as Long-term loans and approximately $3 thousand as Short-term loans.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Other Liability:</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2210" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2211" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands) </i></b></i></p>
			</td>
			<td id="new_id-2212" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2213" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2214" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of March 31,</b></p>
			</td>
			<td id="new_id-2215" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2216" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2217" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2218" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2219" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2220" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2221" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Statutory reserve</p>
			</td>
			<td id="new_id-2222" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2223" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2224" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">21</td>
			<td id="new_id-2225" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2226" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2227" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2228" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">16</td>
			<td id="new_id-2229" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Total</p>
			</td>
			<td id="new_id-2230" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2231" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2232" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>21</b></td>
			<td id="new_id-2233" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2234" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2235" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2236" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">16</td>
			<td id="new_id-2237" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The statutory reserve is a gratuity reserve for employees in our subsidiaries in India.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_LoansAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_LoansAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_LoansAndOtherLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of loans and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_LoansAndOtherLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563484272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 12 </b>&#8211;<b> COMMITMENTS AND CONTINGENCIES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company may be involved in legal proceedings, claims, and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. There are no such matters that are deemed material to the consolidated financial statements as of March 31, 2023, except as disclosed in Item 3 &#8211; Legal Proceedings, and Note 19 - Subsequent Events.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the U.S., we provide health insurance, life insurance, and a 401(k) plan wherein the Company matches up to 6% of the employee&#8217;s pre-tax contribution up to a maximum annual amount determined by the IRS. In addition, under applicable Indian laws, the Company provides for gratuity, a defined benefit retirement plan (Gratuity Plan) covering certain categories of employees. The Gratuity Plan provides a lump sum payment to vested employees, at retirement or termination of employment, an amount based on the respective employee&#8217;s last drawn salary and the years of employment with the Company. In addition, employees receive benefits from a provident fund, a defined contribution plan. The employee and employer each make monthly contributions to the plan equal to 12% of the covered employee&#8217;s salary. The contribution is made to the Indian Government&#8217;s provident fund.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563601648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SECURITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 13 </b>&#8211; <b>SECURITIES </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, the Company was authorized to issue up to 150,000,000 shares of common stock, par value $0.0001 per share, and 53,077,436 shares of common stock were issued and outstanding. The Company is also authorized to issue up to 1,000,000 shares of preferred stock, par value $0.0001 per share, and no preferred shares were issued and outstanding as of March 31, 2023. We have one security listed on the NYSE American: common stock, $0.0001 par value (ticker symbol: IGC). This security also trades on the Frankfurt, Stuttgart, and Berlin stock exchanges (ticker symbol: IGS1).</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company also has 91,472 units outstanding that can be separated into common stock. Ten units may be separated into one share of common stock. The unit holders are requested to contact the Company or our transfer agent, Continental Stock Transfer &amp; Trust, to separate their units into common stock.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On January 13, 2021, the Company entered into a Sales Agreement (the Agreement) with The Benchmark Company, LLC (Benchmark or the Sales Agent) pursuant to which the Sales Agent is acting as the Company&#8217;s sales agent with respect to the issuance and sale of up to $75,000,000 of the Company&#8217;s shares of common stock, par value $0.0001 per share (the Shares), from time to time in an &#8220;at the market&#8221; (ATM) offering as defined in Rule 415(a)(4) of the Securities Act of 1933, as amended (the Offering). During Fiscal 2023, the Company raised approximately $103 thousand from the ATM, net of commission. The management may use these funds for working capital and capital expenditure requirements, along with clinical trials, share repurchases, debt repayments, investments, including but not limited to, mutual funds, treasury bonds, cryptocurrencies, and other asset classes.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563611056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Payment Arrangement [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTE 14 </b>&#8211;<b> STOCK-BASED COMPENSATION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, under both the Company&#8217;s previous 2008 and current 2018 Omnibus Incentive Plans, a total of 8,412,627 shares of common stock have been issued to employees, non-employees, and advisors. In addition, 5.5 million restricted share units (RSUs) fair valued at $5.5 million with a weighted average value of $1 per share, have been granted but not yet issued from different Incentive Plans and Grants. This includes 2.9 million RSUs granted to employees and directors, which consists of a vesting schedule based entirely on the attainment either operational milestones (performance conditions) or market conditions, assuming continued employment either as an employee, or director with the Company. The performance based RSUs are accounted upon certification by the management confirming the probability of achievement of milestones. As of March 31, 2023, the management confirmed two milestones had been achieved, and the rest were probable to be achieved by March 31, 2027.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Additionally, options held by advisors and directors to purchase 150 thousand shares of common stock fair valued at $69 thousand with a weighted average of $0.46 per share, which have been granted but are to be issued over a vesting period, between Fiscal 2022 and Fiscal 2026. Options granted and issued before the vesting period are expensed when issued.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The options are fair valued using a Black-Scholes Pricing Model and market based RSU are valued based on lattice model with the following assumptions:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2238" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2239" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Granted in </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>
			</td>
			<td id="new_id-2240" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2241" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2242" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Granted in </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>
			</td>
			<td id="new_id-2243" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected life of options</p>
			</td>
			<td id="new_id-2244" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2245" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5 years</p>	</td>
			<td id="new_id-2246" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2247" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2248" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5 years</p>	</td>
			<td id="new_id-2249" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested options</p>
			</td>
			<td id="new_id-2250" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2251" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2252" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100</td>
			<td id="new_id-2253" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2254" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2255" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2256" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100</td>
			<td id="new_id-2257" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk free interest rate</p>
			</td>
			<td id="new_id-2258" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2259" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2260" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.49</td>
			<td id="new_id-2261" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2262" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2263" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2264" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.42</td>
			<td id="new_id-2265" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected volatility</p>
			</td>
			<td id="new_id-2266" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2267" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2268" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">280</td>
			<td id="new_id-2269" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2270" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2271" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2272" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">282</td>
			<td id="new_id-2273" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected dividend yield</p>
			</td>
			<td id="new_id-2274" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2275" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="-sec-ix-hidden: hidden-fact-4; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Nil</p>
			</td>
			<td id="new_id-2276" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2277" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2278" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="-sec-ix-hidden: hidden-fact-5; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Nil</p>
			</td>
			<td id="new_id-2279" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The expense associated with share-based payments to employees, directors, advisors, and contractors is allocated over the vesting or service period and recognized in the Selling, general and administrative expenses (including research and development). For Fiscal 2023, the Company&#8217;s common stock-based compensation and expenses shown in Selling, general and administrative expenses (including research and development) was $2.8 million.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For Fiscal 2022, the Company&#8217;s common stock-based compensation and expenses shown in Selling, general and administrative expenses (including research and development) was $2.2 million.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-vested shares</b></p>
			</td>
			<td id="new_id-2280" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2281" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shares</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(in thousands)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(#)</b></p>
			</td>
			<td id="new_id-2282" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2283" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2284" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>grant date fair value</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2285" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-vested shares as of March 31, 2022</p>
			</td>
			<td id="new_id-2286" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2287" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2288" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>5,283</b></td>
			<td id="new_id-2289" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2290" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2291" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2292" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.17</td>
			<td id="new_id-2293" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p>
			</td>
			<td id="new_id-2294" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2295" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2296" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,615</td>
			<td id="new_id-2297" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2298" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2299" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2300" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0.43</td>
			<td id="new_id-2301" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested</p>
			</td>
			<td id="new_id-2302" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2303" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2304" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(2,224</td>
			<td id="new_id-2305" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2306" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2307" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2308" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.01</td>
			<td id="new_id-2309" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cancelled/Forfeited</p>
			</td>
			<td id="new_id-2310" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2311" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2312" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(245</td>
			<td id="new_id-2313" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2314" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2315" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2316" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.77</td>
			<td id="new_id-2317" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-vested shares as of March 31, 2023</b></p>
			</td>
			<td id="new_id-2318" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2319" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2320" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>4,429</b></td>
			<td id="new_id-2321" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2322" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2323" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2324" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>1.01</b></td>
			<td id="new_id-2325" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Options</b></p>
			</td>
			<td id="new_id-2326" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2327" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shares</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(in thousands)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(#)</b></p>
			</td>
			<td id="new_id-2328" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2329" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2330" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>grant date fair value</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2331" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2332" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2333" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>exercise price</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2334" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Options outstanding as of March 31, 2022</p>
			</td>
			<td id="new_id-2335" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2336" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2337" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>300</b></td>
			<td id="new_id-2338" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2339" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2340" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2341" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>0.93</b></td>
			<td id="new_id-2342" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2343" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2344" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2345" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>0.34</b></td>
			<td id="new_id-2346" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p>
			</td>
			<td id="new_id-2347" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2348" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2349" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2350" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2351" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2352" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2353" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2354" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2355" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2356" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2357" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2358" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercised</p>
			</td>
			<td id="new_id-2359" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2360" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2361" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2362" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2363" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2364" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2365" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2366" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2367" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2368" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2369" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2370" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cancelled/forfeited</p>
			</td>
			<td id="new_id-2371" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2372" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2373" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(150</td>
			<td id="new_id-2374" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2375" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2376" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2377" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.39</td>
			<td id="new_id-2378" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2379" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2380" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2381" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.30</td>
			<td id="new_id-2382" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Options outstanding as of March 31, 2023</b></p>
			</td>
			<td id="new_id-2383" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2384" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2385" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>150</b></td>
			<td id="new_id-2386" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2387" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2388" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2389" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>1.39</b></td>
			<td id="new_id-2390" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2391" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2392" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2393" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>0.30</b></td>
			<td id="new_id-2394" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There was a combined unrecognized expense of $2.7 million related to non-vested shares and share options that the Company expects to be recognized over a life of four years.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563546480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 15 </b>&#8211;<b> FAIR VALUE OF FINANCIAL INSTRUMENTS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, the Company&#8217;s marketable securities consist of liquid funds, which have been classified as Level 1 of the fair value hierarchy because they have been valued using quoted prices in active markets. The Company&#8217;s cash and cash equivalents have also been classified as Level 1 on the same principle. Financial instruments are classified as current if they are expected to be liquidated within the next twelve months. The Company&#8217;s remaining investments have been classified as Level 3 instruments as there is little or no market data. Level 3 investments are valued using the cost method. For further information refer Note 7, &#8220;Investments in Non-Marketable Securities.&#8221;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of March 31, 2023, and 2022, and indicates the fair value hierarchy of the valuation techniques the Company used to determine such fair value:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2395" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2396" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 1</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2397" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2398" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2399" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 2</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2400" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2401" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2402" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 3</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2403" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2404" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2405" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2406" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>March 31, 2023</b></p>
			</td>
			<td id="new_id-2407" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2408" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2409" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2410" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2411" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2412" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2413" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2414" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2415" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2416" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2417" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2418" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2419" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2420" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2421" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2422" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2423">&#160;</td>
			<td id="new_id-2424">&#160;</td>
			<td id="new_id-2425">&#160;</td>
			<td id="new_id-2426">&#160;</td>
			<td id="new_id-2427">&#160;</td>
			<td id="new_id-2428">&#160;</td>
			<td id="new_id-2429">&#160;</td>
			<td id="new_id-2430">&#160;</td>
			<td id="new_id-2431">&#160;</td>
			<td id="new_id-2432">&#160;</td>
			<td id="new_id-2433">&#160;</td>
			<td id="new_id-2434">&#160;</td>
			<td id="new_id-2435">&#160;</td>
			<td id="new_id-2436">&#160;</td>
			<td id="new_id-2437">&#160;</td>
			<td id="new_id-2438">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Cash and cash equivalents:</i></p>
			</td>
			<td id="new_id-2439" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2440" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2441" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,196</td>
			<td id="new_id-2442" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2443" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2444" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2445" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2446" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2447" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2448" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2449" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2450" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2451" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2452" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2453" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,196</td>
			<td id="new_id-2454" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total cash and cash equivalents</b></p>
			</td>
			<td id="new_id-2455" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2456" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2457" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>3,196</b></td>
			<td id="new_id-2458" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2459" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2460" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2461" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2462" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2463" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2464" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2465" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2466" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2467" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2468" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2469" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>3,196</b></td>
			<td id="new_id-2470" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2471">&#160;</td>
			<td id="new_id-2472">&#160;</td>
			<td id="new_id-2473">&#160;</td>
			<td id="new_id-2474">&#160;</td>
			<td id="new_id-2475">&#160;</td>
			<td id="new_id-2476">&#160;</td>
			<td id="new_id-2477">&#160;</td>
			<td id="new_id-2478">&#160;</td>
			<td id="new_id-2479">&#160;</td>
			<td id="new_id-2480">&#160;</td>
			<td id="new_id-2481">&#160;</td>
			<td id="new_id-2482">&#160;</td>
			<td id="new_id-2483">&#160;</td>
			<td id="new_id-2484">&#160;</td>
			<td id="new_id-2485">&#160;</td>
			<td id="new_id-2486">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Investments:</i></p>
			</td>
			<td id="new_id-2487" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2488" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2489" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2490" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2491" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2492" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2493" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2494" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2495" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2496" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2497" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2498" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2499" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2500" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2501" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2502" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Marketable securities</p>
			</td>
			<td id="new_id-2503" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2504" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2505" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">154</td>
			<td id="new_id-2506" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2507" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2508" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2509" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2510" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2511" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2512" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2513" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2514" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2515" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2516" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2517" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">154</td>
			<td id="new_id-2518" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Non-marketable securities</p>
			</td>
			<td id="new_id-2519" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2520" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2521" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2522" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2523" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2524" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2525" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2526" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2527" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2528" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2529" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2530" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2531" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2532" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2533" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2534" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total investments</b></p>
			</td>
			<td id="new_id-2535" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2536" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2537" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>154</b></td>
			<td id="new_id-2538" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2539" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2540" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2541" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td>
			<td id="new_id-2542" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2543" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2544" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2545" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td>
			<td id="new_id-2546" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2547" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2548" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2549" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>154</b></td>
			<td id="new_id-2550" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2551" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2552" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 1</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2553" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2554" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2555" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 2</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2556" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2557" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2558" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 3</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2559" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2560" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2561" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2562" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>March 31, 2022</b></p>
			</td>
			<td id="new_id-2563" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2564" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2565" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2566" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2567" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2568" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2569" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2570" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2571" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2572" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2573" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2574" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2575" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2576" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2577" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2578" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2579">&#160;</td>
			<td id="new_id-2580">&#160;</td>
			<td id="new_id-2581">&#160;</td>
			<td id="new_id-2582">&#160;</td>
			<td id="new_id-2583">&#160;</td>
			<td id="new_id-2584">&#160;</td>
			<td id="new_id-2585">&#160;</td>
			<td id="new_id-2586">&#160;</td>
			<td id="new_id-2587">&#160;</td>
			<td id="new_id-2588">&#160;</td>
			<td id="new_id-2589">&#160;</td>
			<td id="new_id-2590">&#160;</td>
			<td id="new_id-2591">&#160;</td>
			<td id="new_id-2592">&#160;</td>
			<td id="new_id-2593">&#160;</td>
			<td id="new_id-2594">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Cash and cash equivalents:</i></p>
			</td>
			<td id="new_id-2595" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2596" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2597" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,460</td>
			<td id="new_id-2598" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2599" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2600" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2601" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2602" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2603" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2604" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2605" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2606" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2607" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2608" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2609" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,460</td>
			<td id="new_id-2610" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total cash and cash equivalents</b></p>
			</td>
			<td id="new_id-2611" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2612" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2613" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>10,460</b></td>
			<td id="new_id-2614" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2615" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2616" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2617" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2618" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2619" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2620" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2621" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2622" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2623" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2624" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2625" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>10,460</b></td>
			<td id="new_id-2626" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2627">&#160;</td>
			<td id="new_id-2628">&#160;</td>
			<td id="new_id-2629">&#160;</td>
			<td id="new_id-2630">&#160;</td>
			<td id="new_id-2631">&#160;</td>
			<td id="new_id-2632">&#160;</td>
			<td id="new_id-2633">&#160;</td>
			<td id="new_id-2634">&#160;</td>
			<td id="new_id-2635">&#160;</td>
			<td id="new_id-2636">&#160;</td>
			<td id="new_id-2637">&#160;</td>
			<td id="new_id-2638">&#160;</td>
			<td id="new_id-2639">&#160;</td>
			<td id="new_id-2640">&#160;</td>
			<td id="new_id-2641">&#160;</td>
			<td id="new_id-2642">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Investments:</i></p>
			</td>
			<td id="new_id-2643" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2644" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2645" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2646" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2647" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2648" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2649" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2650" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2651" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2652" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2653" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2654" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2655" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2656" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2657" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2658" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Marketable securities</p>
			</td>
			<td id="new_id-2659" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2660" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2661" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2662" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2663" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2664" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2665" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2666" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2667" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2668" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2669" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2670" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2671" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2672" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2673" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2674" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Non-marketable securities</p>
			</td>
			<td id="new_id-2675" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2676" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2677" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2678" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2679" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2680" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2681" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2682" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2683" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2684" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2685" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2686" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2687" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2688" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2689" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2690" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total investment </b></p>
			</td>
			<td id="new_id-2691" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2692" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2693" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2694" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2695" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2696" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2697" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td>
			<td id="new_id-2698" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2699" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2700" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2701" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2702" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2703" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2704" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2705" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2706" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563628608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 16 </b>&#8211;<b> INCOME TAXES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company calculates its provision for foreign and U.S. federal income taxes based on the current tax law. As the Company maintains a full valuation allowance against its deferred tax assets, there is no income tax expense recorded related to this change other than the Federal AMT credit which are refundable due to the passage of tax reform.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Due to the Company&#8217;s history of losses and uncertainty of future taxable income, a valuation allowance sufficient to fully offset net operating losses and other deferred tax assets has been established. The valuation allowance will be maintained until sufficient positive evidence exists to support a conclusion that a valuation allowance is not necessary.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Income tax expense/(benefit) for each of the years ended March 31 consists of the following:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2707" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2708" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year Ended March 31,</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2709" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Income Tax Expense</b></p>
			</td>
			<td id="new_id-2710" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2711" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2712" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2713" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2714" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2715" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2716" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2717" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2718" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2719" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2720" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2721" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2722" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2723" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net income loss before tax</p>
			</td>
			<td id="new_id-2724" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2725" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2726" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(11,506</td>
			<td id="new_id-2727" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2728" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2729" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2730" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(15,016</td>
			<td id="new_id-2731" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax rate</p>
			</td>
			<td id="new_id-2732" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2733" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2734" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">21</td>
			<td id="new_id-2735" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2736" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2737" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2738" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">21</td>
			<td id="new_id-2739" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2740">&#160;</td>
			<td id="new_id-2741">&#160;</td>
			<td id="new_id-2742">&#160;</td>
			<td id="new_id-2743">&#160;</td>
			<td id="new_id-2744">&#160;</td>
			<td id="new_id-2745">&#160;</td>
			<td id="new_id-2746">&#160;</td>
			<td id="new_id-2747">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected income tax recovery</p>
			</td>
			<td id="new_id-2748" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2749" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2750" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(2,416</td>
			<td id="new_id-2751" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2752" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2753" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2754" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(3,153</td>
			<td id="new_id-2755" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Impact of tax rate differences in foreign jurisdictions</p>
			</td>
			<td id="new_id-2756" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2757" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2758" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(7</td>
			<td id="new_id-2759" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2760" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2761" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2762" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2763" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax rate changes and other adjustments</p>
			</td>
			<td id="new_id-2764" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2765" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2766" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(667</td>
			<td id="new_id-2767" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2768" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2769" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2770" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(385</td>
			<td id="new_id-2771" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permanent differences</p>
			</td>
			<td id="new_id-2772" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2773" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2774" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">88</td>
			<td id="new_id-2775" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2776" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2777" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2778" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">50</td>
			<td id="new_id-2779" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Change in valuation allowance</p>
			</td>
			<td id="new_id-2780" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2781" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2782" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,002</td>
			<td id="new_id-2783" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2784" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2785" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2786" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,488</td>
			<td id="new_id-2787" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2788" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2789" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2790" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2791" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2792" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2793" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2794" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2795" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The significant components of deferred income tax expense/(benefit) from operations before non-controlling interest for each of the years ended March 31 are approximated as following:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2796" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2797" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year Ended March 31,</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2798" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Deferred income taxes</b></p>
			</td>
			<td id="new_id-2799" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2800" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2801" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2802" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2803" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2804" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2805" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2806" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2807" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2808" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2809" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2810" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2811" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2812" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2813">&#160;</td>
			<td id="new_id-2814">&#160;</td>
			<td id="new_id-2815">&#160;</td>
			<td id="new_id-2816">&#160;</td>
			<td id="new_id-2817">&#160;</td>
			<td id="new_id-2818">&#160;</td>
			<td id="new_id-2819">&#160;</td>
			<td id="new_id-2820">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net operating loss carry-forwards foreign</p>
			</td>
			<td id="new_id-2821" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2822" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2823" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">137</td>
			<td id="new_id-2824" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2825" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2826" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2827" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">149</td>
			<td id="new_id-2828" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-capital loss carry-forwards &#8211; U.S.</p>
			</td>
			<td id="new_id-2829" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2830" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2831" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">12,888</td>
			<td id="new_id-2832" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2833" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2834" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2835" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">10,487</td>
			<td id="new_id-2836" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Temporary differences</p>
			</td>
			<td id="new_id-2837" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2838" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2839" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">548</td>
			<td id="new_id-2840" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2841" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2842" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2843" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(66</td>
			<td id="new_id-2844" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-2845">&#160;</td>
			<td id="new_id-2846">&#160;</td>
			<td id="new_id-2847">&#160;</td>
			<td id="new_id-2848">&#160;</td>
			<td id="new_id-2849">&#160;</td>
			<td id="new_id-2850">&#160;</td>
			<td id="new_id-2851">&#160;</td>
			<td id="new_id-2852">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net deferred tax asset</p>
			</td>
			<td id="new_id-2853" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2854" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2855" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">13,573</td>
			<td id="new_id-2856" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2857" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2858" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2859" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">10,570</td>
			<td id="new_id-2860" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Valuation allowance</p>
			</td>
			<td id="new_id-2861" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2862" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2863" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(13,573</td>
			<td id="new_id-2864" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2865" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2866" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2867" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(10,570</td>
			<td id="new_id-2868" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2869" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2870" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2871" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2872" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2873" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2874" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2875" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2876" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The table below sets forth the details of expiration of the non-financial carried forward losses of the Company as of March 31, 2023, as under:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>Amount</i></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>(in thousands)</i></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>($)</i></b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">47</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2024</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">309</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2025</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">3</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2026</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">12</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2027</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">30</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2028</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">14</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2029</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">25</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2030</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">141</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2031</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">3,081</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2032</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">4,141</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2033</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">627</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2034</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1,269</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2035</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1,735</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2036</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1,176</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2037</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">819</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2038</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1,256</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2039</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">4,132</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2040</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">7,932</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2041</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">8,841</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2042</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">14,966</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2043</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">11,359</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Total</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>61,915</b></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Realization of deferred tax assets, including those related to net operating loss carryforwards, are dependent upon future earnings, if any, of which the timing and amount are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance. Based upon the Company&#8217;s current operating results management cannot conclude that it is more likely than not that such assets will be realized. The Company files income tax returns in India, Hong Kong, Colombia, and the U.S.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563606464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 17 </b>&#8211;<b> REVENUE RECOGNITION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Revenue in the Infrastructure segment is recognized for the renting business when the equipment is rented, and the terms of the agreement have been fulfilled during the period. Revenue from the execution of infrastructure contracts is recognized on the basis of the output method as and when part of the performance obligation has been completed and approval from the contracting agency has been obtained after survey of the performance completion as of that date. In the Life Sciences segment, the revenue from the wellness and lifestyle business is recognized once goods have been sold to the customer and the performance obligation has been completed. In retail sales, we offer consumer products through our online stores. Revenue is recognized when control of the goods is transferred to the customer. This generally occurs upon our delivery to a third-party carrier or to the customer directly. Revenue from white label services is recognized when the performance obligation has been completed and output material has been transferred to the customer.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Net sales disaggregated by significant products and services for Fiscal 2023 and 2022 are as follows:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2877" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2878" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year ended March 31,</i></b></i></p>
			</td>
			<td id="new_id-2879" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2880" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2881" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2882" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2883" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2884" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2885" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Infrastructure segment</b></p>
			</td>
			<td id="new_id-2886" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2887" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2888" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2889" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2890" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2891" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2892" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2893" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rental income (1)</p>
			</td>
			<td id="new_id-2894" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2895" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2896" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">37</td>
			<td id="new_id-2897" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2898" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2899" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2900" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">23</td>
			<td id="new_id-2901" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction contracts (2)</p>
			</td>
			<td id="new_id-2902" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2903" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2904" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">76</td>
			<td id="new_id-2905" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2906" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2907" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2908" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15</td>
			<td id="new_id-2909" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2910">&#160;</td>
			<td id="new_id-2911">&#160;</td>
			<td id="new_id-2912">&#160;</td>
			<td id="new_id-2913">&#160;</td>
			<td id="new_id-2914">&#160;</td>
			<td id="new_id-2915">&#160;</td>
			<td id="new_id-2916">&#160;</td>
			<td id="new_id-2917">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-2918">&#160;</td>
			<td id="new_id-2919">&#160;</td>
			<td id="new_id-2920">&#160;</td>
			<td id="new_id-2921">&#160;</td>
			<td id="new_id-2922">&#160;</td>
			<td id="new_id-2923">&#160;</td>
			<td id="new_id-2924">&#160;</td>
			<td id="new_id-2925">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Life Sciences segment</b></p>
			</td>
			<td id="new_id-2926" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2927" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2928" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2929" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2930" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2931" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2932" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2933" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Wellness and lifestyle (3)</p>
			</td>
			<td id="new_id-2934" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2935" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2936" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">416</td>
			<td id="new_id-2937" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2938" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2939" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2940" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">316</td>
			<td id="new_id-2941" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">White labeling services (4)</p>
			</td>
			<td id="new_id-2942" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2943" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2944" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">382</td>
			<td id="new_id-2945" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2946" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2947" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2948" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">43</td>
			<td id="new_id-2949" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2950" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2951" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2952" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>911</b></td>
			<td id="new_id-2953" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2954" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2955" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2956" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>397</b></td>
			<td id="new_id-2957" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1) Rental income consists of income from rental of heavy construction equipment.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2) Construction income consists of the execution of contracts directly or through subcontractors.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(3) Revenue from wellness and lifestyle consists of sale of products such as gummies, hand sanitizers, bath bombs, lotions, beverages, hemp crude extract, hemp isolate, and hemp distillate.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(4) Revenue from white label services consists of rebranding our formulations or the customer&#8217;s products as per customer&#8217;s requirement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563611056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 18 </b>&#8211; <b>SEGMENT INFORMATION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">FASB ASC 280, &#8220;<i>Segment Reporting</i>&#8221; establishes standards for reporting information about reportable segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group (CODM), in deciding how to allocate resources and in assessing performance. The CODM evaluates revenues and gross profits based on product lines and routes to market. Based on our integration and Management strategies, we operate in two reportable segments: (i) Infrastructure segment and (ii) Life Sciences segment.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s CODM is the Company&#8217;s Chief Executive Officer (CEO). The CEO reviews financial information presented on an operating segment basis for the purposes of making operating decisions and assessing financial performance. Therefore, and before our Life Sciences segment started, the Company had determined that it operated in a single operating and reportable segment. As of the date of this report and in preparation for the new and different source of revenue, the Company has determined that it operates in two operating and reportable segments: (a) Infrastructure segment and (b) Life Sciences segment. The Company does not include intercompany transfers between segments for Management reporting purposes.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following provides information required by ASC 280-10-50-38 &#8220;Entity-wide Information&#8221;:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">1) The table below shows revenue reported by segment:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Product &amp; Service</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2958" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2959" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2960" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td id="new_id-2961" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2962" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2963" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2964" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2965" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td id="new_id-2966" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2967">&#160;</td>
			<td id="new_id-2968">&#160;</td>
			<td id="new_id-2969">&#160;</td>
			<td id="new_id-2970">&#160;</td>
			<td id="new_id-2971">&#160;</td>
			<td id="new_id-2972">&#160;</td>
			<td id="new_id-2973">&#160;</td>
			<td id="new_id-2974">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Infrastructure segment</p>
			</td>
			<td id="new_id-2975" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2976" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2977" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">113</td>
			<td id="new_id-2978" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2979" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2980" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2981" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">12</td>
			<td id="new_id-2982" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Life Sciences segment</p>
			</td>
			<td id="new_id-2983" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2984" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2985" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">798</td>
			<td id="new_id-2986" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2987" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2988" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2989" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">88</td>
			<td id="new_id-2990" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2991" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2992" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2993" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>911</b></td>
			<td id="new_id-2994" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2995" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2996" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2997" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>100</b></td>
			<td id="new_id-2998" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2999" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-3000" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-3001" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td id="new_id-3002" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3003" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3004" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3005" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3006" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td id="new_id-3007" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-3008">&#160;</td>
			<td id="new_id-3009">&#160;</td>
			<td id="new_id-3010">&#160;</td>
			<td id="new_id-3011">&#160;</td>
			<td id="new_id-3012">&#160;</td>
			<td id="new_id-3013">&#160;</td>
			<td id="new_id-3014">&#160;</td>
			<td id="new_id-3015">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Infrastructure segment</p>
			</td>
			<td id="new_id-3016" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3017" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3018" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">38</td>
			<td id="new_id-3019" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3020" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3021" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3022" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9</td>
			<td id="new_id-3023" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Life Sciences segment</p>
			</td>
			<td id="new_id-3024" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3025" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3026" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">359</td>
			<td id="new_id-3027" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3028" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3029" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3030" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">91</td>
			<td id="new_id-3031" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-3032" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3033" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3034" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>397</b></td>
			<td id="new_id-3035" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3036" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3037" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3038" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>100</b></td>
			<td id="new_id-3039" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For information for revenue by product and service, refer Note 17, &#8220;Revenue Recognition.&#8221;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2) The table below shows the attributed to the country of domicile (U.S.) and foreign countries. Revenue is generally attributed to the geographic location of customers:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">	<tr>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="6" style="vertical-align:bottom;width:11.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Country</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr style="background-color: rgb(204, 238, 255);">	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Asia</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">113</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">12</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>	</td>	</tr>	<tr style="background-color: rgb(255, 255, 255);">	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">America</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S.</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">777</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">86</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>	</td>	</tr>	<tr style="background-color: rgb(204, 238, 255);">	<td style="vertical-align:bottom;width:17.1%;">&#160;</td>	<td style="vertical-align:bottom;width:1.1%;">&#160;</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Colombia</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">21</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">%</td>	</tr>	<tr style="background-color: rgb(255, 255, 255);">	<td colspan="3" style="vertical-align:bottom;width:18.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>911</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>100</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>	</td>	</tr>
</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="6" style="vertical-align:bottom;width:11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Country</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Asia</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">68</p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17</p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">America</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S.</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">329</p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">83</p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="3" style="vertical-align:bottom;width:18.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>397</b></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>100</b></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3) The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3040" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="10" id="new_id-3041" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-3042" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nature of Assets</b></p>
			</td>
			<td id="new_id-3043" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3044" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>U.S. </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Country of Domicile)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3045" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3046" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3047" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Foreign Countries </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(India, Hong Kong, and Colombia)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3048" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3049" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3050" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total as of March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3051" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intangible assets, net</p>
			</td>
			<td id="new_id-3052" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3053" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3054" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,170</td>
			<td id="new_id-3055" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3056" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3057" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3058" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-3059" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3060" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3061" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3062" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,170</td>
			<td id="new_id-3063" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property, plant and equipment, net</p>
			</td>
			<td id="new_id-3064" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3065" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3066" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,074</td>
			<td id="new_id-3067" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3068" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3069" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3070" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,139</td>
			<td id="new_id-3071" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3072" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3073" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3074" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">8,213</td>
			<td id="new_id-3075" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims and advances</p>
			</td>
			<td id="new_id-3076" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3077" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3078" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">585</td>
			<td id="new_id-3079" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3080" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3081" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3082" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">418</td>
			<td id="new_id-3083" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3084" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3085" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3086" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,003</td>
			<td id="new_id-3087" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-3088" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3089" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3090" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">298</td>
			<td id="new_id-3091" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3092" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3093" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3094" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">28</td>
			<td id="new_id-3095" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3096" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3097" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3098" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">326</td>
			<td id="new_id-3099" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total non-current assets</b></p>
			</td>
			<td id="new_id-3100" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3101" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3102" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>6,127</b></td>
			<td id="new_id-3103" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3104" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3105" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3106" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>4,585</b></td>
			<td id="new_id-3107" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3108" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3109" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3110" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>10,712</b></td>
			<td id="new_id-3111" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3112" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="10" id="new_id-3113" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>
			</td>
			<td id="new_id-3114" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nature of Assets</b></p>
			</td>
			<td id="new_id-3115" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3116" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>U.S. </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Country of Domicile)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3117" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3118" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3119" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Foreign Countries </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(India Hong Kong and Colombia)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3120" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3121" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3122" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total as of March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3123" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intangible assets, net</p>
			</td>
			<td id="new_id-3124" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3125" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3126" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">436</td>
			<td id="new_id-3127" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3128" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3129" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3130" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">481</td>
			<td id="new_id-3131" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3132" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3133" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3134" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">917</td>
			<td id="new_id-3135" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property, plant and equipment, net</p>
			</td>
			<td id="new_id-3136" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3137" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3138" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,978</td>
			<td id="new_id-3139" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3140" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3141" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3142" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,441</td>
			<td id="new_id-3143" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3144" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3145" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3146" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9,419</td>
			<td id="new_id-3147" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims and advances</p>
			</td>
			<td id="new_id-3148" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3149" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3150" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">550</td>
			<td id="new_id-3151" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3152" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3153" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3154" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">387</td>
			<td id="new_id-3155" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3156" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3157" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3158" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">937</td>
			<td id="new_id-3159" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-3160" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3161" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3162" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">396</td>
			<td id="new_id-3163" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3164" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3165" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3166" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">54</td>
			<td id="new_id-3167" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3168" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3169" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3170" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">450</td>
			<td id="new_id-3171" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total non-current assets</b></p>
			</td>
			<td id="new_id-3172" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3173" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3174" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>6,360</b></td>
			<td id="new_id-3175" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3176" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3177" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3178" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>5,363</b></td>
			<td id="new_id-3179" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3180" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3181" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3182" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>11,723</b></td>
			<td id="new_id-3183" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563638192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 19 </b>&#8211;<b> SUBSEQUENT EVENTS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $12 million and in addition sold 10,000,000 shares for $3,000,000. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#8217;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564839504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation, Policy [Policy Text Block]</a></td>
<td class="text">Principles of consolidation<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The consolidated financial statements include the accounts of the Company and all its subsidiaries. Intercompany accounts and transactions have been eliminated. In the opinion of the Company&#8217;s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Transactions between the Company and its subsidiaries are eliminated in the consolidated financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text">Use of estimates<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Management believes that the estimates and assumptions used in the preparation of the consolidated financial statements are prudent and reasonable. Significant estimates and assumptions are generally used for, but not limited to allowance for uncollectible accounts receivable; sales returns; normal loss during production; future obligations under employee benefit plans; the useful lives of property, plant, and equipment; intangible assets; valuations; impairment of goodwill and investments; recoverability of advances; the valuation of options granted, and warrants issued; and income tax and deferred tax valuation allowances, if any. Actual results could differ from those estimates. Appropriate changes in estimates are made as management becomes aware of changes in circumstances surrounding the estimates. Critical accounting estimates could change from period to period and could have a material impact on IGC&#8217;s results, operations, financial position, and cash flows. Changes in estimates are reflected in the financial statements in the period in which changes are made and, if material, their effects are disclosed in the notes to the consolidated financial statements.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue [Policy Text Block]</a></td>
<td class="text">Revenue recognition<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company recognizes revenue under ASC 606, <i>Revenue from Contracts with Customers </i>(&#8220;ASC 606&#8221;). The core principle of this standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">ASC 606 prescribes a 5-step process to achieve its core principle. The Company recognizes revenue from trading, rental, or product sales as follows:</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">I. Identify the contract with the customer.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">II. Identify the contractual performance obligations.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">III. Determine the amount of consideration/price for the transaction.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IV. Allocate the determined amount of consideration/price to the contractual obligations.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">V. Recognize revenue when or as the performing party satisfies performance obligations.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The consideration/price for the transaction (performance obligation(s)) is determined as per the agreement or invoice (contract) for the services and products in the Infrastructure segment and Life Sciences segment. Refer to Note 17 &#8211; &#8220;Revenue Recognition.&#8221;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Goods and Service [Policy Text Block]</a></td>
<td class="text">Cost of Revenue<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our cost of revenue includes costs associated with in-house and outsourced distribution, labor expense, components, manufacturing overhead, and outbound freight for our products division. In our products division, cost of revenue also includes the cost of refurbishing or repackaging, if required, on products returned by customers that will be offered for resale.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text">Earnings/(Loss) per Share<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The computation of basic loss per share for Fiscal 2023, excludes potentially dilutive securities of approximately shares which includes share options, unvested shares such as restricted shares and restricted share units, granted to employees, non-employees and advisors, and shares from the conversion of outstanding units, if any, because their inclusion would be anti-dilutive.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The weighted average number of shares outstanding for Fiscal 2023 and 2022, used for the computation of basic earnings per share (EPS) is 52,576,258 and 49,991,631, respectively. Due to the loss incurred during Fiscal 2023 and 2022, all the potential equity shares are anti-dilutive, and accordingly, the fully diluted EPS is equal to the basic EPS.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_GoingConcernPolicyPolicyTextblock', window );">Going Concern, Policy [Policy Textblock}</a></td>
<td class="text">Going Concern:<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company assesses and determines its ability to continue as a going concern in accordance with the provisions of ASC Subtopic 205-40, "<i>Presentation of Financial Statements</i>&#8212;<i>Going Concern</i>", which requires the Company to evaluate whether there are conditions or events that raise substantial doubt about its ability to continue as a going concern.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company is currently in a clinical trial stage and, thus, has not yet achieved profitability. The Company expects to continue to incur significant operating and net losses and negative cash flows from operations in the near future.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For the years ended March 31, 2023, and March 31, 2022, the Company incurred net losses of $11.5 million and $15 million, respectively. As of March 31, 2023, the Company&#8217;s cash and cash equivalents totaled $3.2 million. On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $12 million and, in addition, sold 10,000,000 shares for $3,000,000. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#8217;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions. Please refer to Note 19, &#8220;Subsequent Event,&#8221; for further information.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company estimates that its current cash and cash equivalents balance with working capital and equity investment is sufficient to support operations beyond the twelve months following the date these consolidated financial statements and footnotes were issued. These estimates are based on assumptions that may prove to be wrong, and the Company could use its available capital resources sooner than it currently expects.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text">Income taxes<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company accounts for income taxes under the asset and liability method, in accordance with ASC 740, Income Taxes, which requires an entity to recognize deferred tax liabilities and assets. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. A valuation allowance is established and recorded when management determines that some or all of the deferred tax assets are not likely to be realized and therefore, it is necessary to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In evaluating a tax position for recognition, management evaluates whether it is more-likely-than-not that a position will be sustained upon examination, including resolution of related appeals or litigation processes, based on technical merits of the position. If the tax position meets the more-likely-than-not recognition threshold, the tax position is measured and recognized in the Company&#8217;s financial statements as the largest amount of tax benefit that, in management&#8217;s judgment, is greater than 50% likely of being realized upon settlement. As of March 31, 2023, and 2022, there was no significant liability for income tax associated with unrecognized tax benefits.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable [Policy Text Block]</a></td>
<td class="text">Accounts receivable<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:29pt;">We make estimates of the collectability of our accounts receivable by analyzing historical payment patterns, customer concentrations, customer creditworthiness, and current economic trends. If the financial condition of a customer deteriorates, additional allowances may be required. We had $107 thousand of accounts receivable, net of provision for doubtful debt of $17 thousand as of March 31, 2023, as compared to $125 thousand of accounts receivable, net of provision for doubtful debt of $93 thousand as of March 31, 2022.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text">Cash and cash equivalents<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For financial statement purposes, the Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents. The Company maintains its cash in bank accounts in the U.S., India, Colombia, and Hong Kong, which at times may exceed applicable insurance limits. The cash and cash equivalents in the Company on March 31, 2023, and 2022, were approximately $3,196 thousand and $10,460 thousand, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text">Short-term and long-term investments<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our policy for short-term and long-term investments is to establish a high-quality portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations, and delivers an appropriate yield in relation to our investment guidelines and market conditions. Short-term and long-term investments consist of corporate, various government agencies and municipal debt securities, as well as certificates of deposit that have maturity dates that are greater than 90 days. Certificates of deposit and commercial paper are carried at a cost which approximates fair value. Available-for-sale securities: Investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the statement of financial position.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Investments are initially measured at cost, which is the fair value of the consideration given for them, including transaction costs. Where the Company&#8217;s ownership interest is in excess of 20% and the Company has a significant influence, the Company has accounted for the investment based on the equity method in accordance with ASC Topic 323, &#8220;<i>Investments </i>&#8211;<i> Equity method and Joint Ventures.</i>&#8221; Under the equity method, the Company&#8217;s share of the post-acquisition profits or losses of the equity investee is recognized in the consolidated statements of operations and its share of post-acquisition movements in accumulated other comprehensive income / (loss) is recognized in other comprehensive income / (loss). Where the Company does not have significant influence, the Company has accounted for the investment in accordance with ASC Topic 321, &#8220;<i>Investments-Equity Securities.</i>&#8221;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of March 31, 2023, investment in marketable securities is valued at fair value and investment in non-marketable securities with ownership less than 20% is valued at cost as per ASC Topic 321, &#8220;<i>Investments-Equity Securities.</i>&#8221;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text">Property, plant, and equipment (PP&amp;E) <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Property, plant, and equipment are recorded at cost net of accumulated depreciation and depreciated over their estimated useful lives using the straight-line method.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon retirement or disposition, cost and related accumulated depreciation of the Property, plant and equipment are de-recognized, and any gain or loss is reflected in the results of operation. Cost of additions and substantial improvements to property and equipment are capitalized. The cost of maintenance and repairs of the property and equipment are charged to operating expenses as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text">Fair value of financial instruments<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">ASC 820, &#8220;Fair Value Measurement&#8221; defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 1: Observable inputs such as quoted prices in active markets;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The carrying amounts of the Company&#8217;s financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximately their fair values due to the nature of the items. Please refer to Note 15, &#8220;Fair value of financial instruments,&#8221; for further information.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text">Concentration of credit risk and significant customers<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Financial instruments, which potentially expose the Company to concentrations of credit risk, are primarily comprised of cash and cash equivalents, investments, accounts receivable and unbilled accounts receivable, if any. The Company places its cash investments in highly rated financial institutions. The Company adheres to a formal investment policy with the primary objective of preservation of principal, which contains credit rating minimums and diversification requirements. Management believes its credit policies reflect normal industry terms and business risk. The Company does not anticipate non-performance by the counterparties and, accordingly, does not require collateral. During Fiscal 2023, sales were spread across customers in Asia and U.S. and the credit concentration risk is low.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Payment Arrangement [Policy Text Block]</a></td>
<td class="text">Stock &#8211;<b> Based Compensation</b><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company accounts for stock-based compensation to employees and non-employees in conformity with the provisions of ASC Topic 718, &#8220;<i>Stock-Based Compensation.</i>&#8221; The Company expenses stock-based compensation to employees over the requisite vesting period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards are recognized on a straight-line basis over the requisite vesting period. For stock-based employee compensation the cost recognized at any date will be at least equal to the amount attributable to the share-based compensation that is vested at that date.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For performance-based awards, stock-based compensation expense is recognized over the expected performance achievement period of individual performance milestones when the achievement of each individual performance milestone becomes probable. For performance-based awards with a vesting schedule based entirely on the attainment of performance conditions, stock-based compensation expense associated with each tranche is recognized over the expected achievement period for the operational milestone, beginning at the point in time when the relevant operational milestone is considered probable to be achieved.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For market-based awards, stock-based compensation expense is recognized over the expected achievement period. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company estimates the fair value of stock option grants using the Black-Scholes option-pricing model. The assumptions used in calculating the fair value of stock-based awards represent Management&#8217;s best estimates. Generally, the closing share price of the Company&#8217;s common stock on the date of grant is considered the fair value of the share. The volatility factor is determined based on the Company&#8217;s historical stock prices. The expected term represents the period that our stock-based awards are expected to be outstanding. The Company has never declared or paid any cash dividends. For further information refer to Note 14, &#8220;Stock-Based Compensation&#8221; of Notes to Consolidated Financial Statements.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies, Policy [Policy Text Block]</a></td>
<td class="text">Commitments and contingencies<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Liabilities for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. We record associated legal fees as incurred. Information regarding our commitments and contingencies is incorporated by reference in Note 12, &#8220;Commitments and contingencies&#8221; of this Annual Report on Form 10-K.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</a></td>
<td class="text">Impairment of long &#8211;<b> lived assets</b><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company reviews its long-lived assets, with finite lives, for impairment whenever events or changes in business circumstances indicate that the carrying amount of assets may not be fully recoverable. Such circumstances include, though are not limited to, significant or sustained declines in revenues or earnings, future anticipated cash flows, business plans, and material adverse changes in the economic climate, such as changes in the operating environment, competitive information, and impact of changes in government policies. For assets that the Company intends to hold for use, if the total of the expected future undiscounted cash flows produced by the assets or subsidiary company is less than the carrying amount of the assets, a loss is recognized for the difference between the fair value and carrying value of the assets. For assets, the Company intends to dispose of by sale, a loss is recognized for the amount by which the estimated fair value less cost to sell is less than the carrying value of the assets. Fair value is determined based on quoted market prices, if available, or other valuation techniques including discounted future net cash flows. Unlike goodwill, long-lived assets are assessed for impairment only where there are any specific indicators for impairment.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</a></td>
<td class="text">Intangible assets<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s intangible assets are accounted for in accordance with ASC Topic 350, <i>Intangibles </i>&#8211;<i> Goodwill and Other. </i>Intangible assets having indefinite lives are not amortized, but instead are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We perform an impairment analysis on March 1 annually on the indefinite-lived intangible assets following the steps laid out in ASC 350-30-35-18. Our annual impairment analysis includes a qualitative assessment to determine if it is necessary to perform the quantitative impairment test. In performing a qualitative assessment, we review events and circumstances that could affect the significant inputs used to determine if the fair value is less than the carrying value of the intangible assets. If quantitative analysis is necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets will be tested on an interim basis if an event or circumstance indicates that it is more likely than not that an impairment loss has been incurred. The Company has analyzed a variety of factors in light of the known impact to date of the COVID-19 pandemic on its business to determine if a circumstance could trigger an impairment loss, and, at this time and based on the information presently known, does not believe it is more likely than not that an impairment loss has been incurred.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Intangible assets with finite useful lives are amortized using the straight-line method over their estimated period of benefit. In accordance with ASC 360-10-35-21, definite lived intangibles are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company intends to capitalize trademarks and related expenses exceeding $2,500 per trademark. Management may also capitalize trademarks and related expenses up to $2,500 per trademark based on its potential and benefit in coming years.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Policy [Policy Text Block]</a></td>
<td class="text">Inventory<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Inventory is valued at the lower of cost or net realizable value, which is defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Inventory consists of finished goods related to wellness products, hand sanitizers, finished hemp-based products, beverages. Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to primary cost. Inventory is primarily accounted for using the weighted average cost method. Primary costs include raw materials, packaging, direct labor, overhead, shipping, and the depreciation of manufacturing equipment. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We capitalize inventory costs related to our investigational drug, provided that management determines there is a potential alternative use for the inventory in future research and development projects or other purposes. As of March 31, 2023, and 2022, our consolidated balance sheet reported approximately $407 thousand and no clinical trial-related inventory, respectively.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Abnormal amounts of idle facility expense, freight, handling costs, scrap, discontinued products and wasted material (spoilage) are expensed in the period they are incurred.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Please refer to Note 3, &#8220;Inventory,&#8221; for further information.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_CybersecurityPolicyPolicyTextBlock', window );">Cyber-security Policy [Policy Text Block]</a></td>
<td class="text">Cybersecurity<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have a cybersecurity policy in place and tighter cybersecurity measures to safeguard against hackers. In Fiscal 2023, there were no impactful breaches in cybersecurity.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Research, Development, and Computer Software, Policy [Policy Text Block]</a></td>
<td class="text">Research and Development Expenses<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During Fiscal 2023 and 2022, the Company recorded research and development expenses of approximately $3.5 million and $2.3 million, respectively. All research and development costs are expensed in the period in which they are incurred.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases [Policy Text Block]</a></td>
<td class="text">Leases<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Lessor Accounting</i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the current ASU guidance, contract consideration will be allocated to its lease components and non-lease components (such as maintenance). For the Company as a lessor, any non-lease components will be accounted for under ASC Topic 606, &#8220;<i>Revenue from Contracts with Customers,</i>&#8221; unless the Company elects a lessor practical expedient to not separate the non-lease components from the associated lease component. The amendments in ASU 2018-11 also provide lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component if the non-lease components otherwise would be accounted for under the new revenue guidance (Topic 606). To elect the practical expedient, the timing and pattern of transfer of the lease and non-lease components must be the same and the lease component must meet the criteria to be classified as an operating lease if accounted for separately. If these criteria are met, the single component will be accounted for under either Topic 842 or Topic 606 depending on which component(s) are predominant. The lessor practical expedient to not separate non-lease components from the associated component must be elected for all existing and new leases.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As a lessor, the Company expects that post-adoption substantially all existing leases will have no change in the timing of revenue recognition until their expiration or termination. The Company expects to elect the lessor practical expedient to not separate non-lease components such as maintenance from the associated lease for all existing and new leases and to account for the combined component as a single lease component. The timing of revenue recognition is expected to be the same for the majority of the Company&#8217;s new leases as compared to similar existing leases; however, certain categories of new leases could have different revenue recognition patterns as compared to similar existing leases.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For leases that are accounted for as operating leases, income is recognized on a straight-line basis over the term of the lease contract. Generally, when a lease is more than 180 days delinquent (where more than three monthly payments are owed), the lease is classified as being nonaccrual and the Company stops recognizing leasing income on that date. Payments received on leases in nonaccrual status generally reduce the lease receivable. Leases on nonaccrual status remain classified as such until there is sustained payment performance that, in the Company&#8217;s judgment, would indicate that all contractual amounts will be collected in full.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Lessee Accounting</i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company adopted ASU 2016-02 effective April 1, 2019, using the modified retrospective approach. The standard establishes a right-of-use model (ROU) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. In connection with the adoption, the Company will elect to utilize the modified retrospective presentation whereby the Company will continue to present prior period financial statements and disclosures under ASC Topic 840. In addition, the Company will elect the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and initial direct costs. Further, the Company will adopt a short-term lease exception policy, permitting us to not apply the recognition requirements of this standard to short-term leases (i.e., leases with terms of 12 months or less), and an accounting policy to account for lease and non-lease components as a single component for certain classes of assets.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under ASU 2016-02 (Topic 842), lessees are required to recognize the following for all leases (with the exception of short-term leases) on the commencement date: (i) lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and (ii) right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At the commencement date, the Company recognizes the lease liability at the present value of the lease payments not yet paid, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate for the same term as the underlying lease. The right-of-use asset is recognized initially at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. There was no impairment for right-of-use lease assets as of March 31, 2023.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company categorizes leases at their inception as either operating or finance leases. On certain lease agreements, the Company may receive rent holidays and other incentives. The Company recognizes lease costs on a straight-line basis without regard to deferred payment terms, such as rent holidays, that defer the commencement date of required payments. Please refer to Note 9, &#8220;Leases,&#8221; for further information.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text">Recently issued and adopted accounting pronouncements<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Changes to U.S. GAAP are established by the Financial Accounting Standards Board (&#8220;FASB&#8221;) in the form of accounting standards updates (ASUs) to the FASB&#8217;s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Newly issued ASUs not listed are expected to have no impact on the Company&#8217;s consolidated financial position and results of operations, because either the ASU is not applicable, or the impact is expected to be immaterial.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_CybersecurityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to cyber-security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_CybersecurityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_GoingConcernPolicyPolicyTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policy for going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_GoingConcernPolicyPolicyTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org//705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 4<br> -SubTopic 50<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482610/350-50-25-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -SubTopic 40<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482633/350-40-30-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563634768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1635" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1636" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1637" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1638" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1639" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1640" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1641" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1642" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1643" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Raw materials</p>
			</td>
			<td id="new_id-1644" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1645" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1646" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,100</td>
			<td id="new_id-1647" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1648" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1649" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1650" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,247</td>
			<td id="new_id-1651" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Work-in-progress</p>
			</td>
			<td id="new_id-1652" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1653" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1654" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">18</td>
			<td id="new_id-1655" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1656" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1657" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1658" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">584</td>
			<td id="new_id-1659" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Finished goods</p>
			</td>
			<td id="new_id-1660" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1661" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1662" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">533</td>
			<td id="new_id-1663" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1664" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1665" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1666" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">717</td>
			<td id="new_id-1667" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1668" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1669" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1670" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>2,651</b></td>
			<td id="new_id-1671" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1672" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1673" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1674" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>3,548</b></td>
			<td id="new_id-1675" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563855696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEPOSITS AND ADVANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_DepositsAndAdvancesAbstract', window );"><strong>Deposits And Advances Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1676" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1677" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1678" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1679" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1680" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1681" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1682" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1683" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1684" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Advances to suppliers and consultants</p>
			</td>
			<td id="new_id-1685" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1686" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1687" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">72</td>
			<td id="new_id-1688" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1689" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1690" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1691" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">170</td>
			<td id="new_id-1692" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other receivables and deposits</p>
			</td>
			<td id="new_id-1693" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1694" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1695" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">24</td>
			<td id="new_id-1696" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1697" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1698" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1699" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">472</td>
			<td id="new_id-1700" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Prepaid expense and other current assets</p>
			</td>
			<td id="new_id-1701" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1702" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1703" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">262</td>
			<td id="new_id-1704" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1705" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1706" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1707" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">336</td>
			<td id="new_id-1708" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1709" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1710" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1711" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>358</b></td>
			<td id="new_id-1712" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1713" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1714" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1715" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>978</b></td>
			<td id="new_id-1716" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_DepositsAndAdvancesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_DepositsAndAdvancesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563631632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Amortized intangible assets</i></b></p>
			</td>
			<td id="new_id-1717" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1718" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1719" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1720" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1721" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1722" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1723" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1724" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1725" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patents</p>
			</td>
			<td id="new_id-1726" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1727" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1728" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">709</td>
			<td id="new_id-1729" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1730" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1731" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1732" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">290</td>
			<td id="new_id-1733" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other intangibles</p>
			</td>
			<td id="new_id-1734" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1735" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1736" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">34</td>
			<td id="new_id-1737" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1738" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1739" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1740" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">32</td>
			<td id="new_id-1741" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated amortization</p>
			</td>
			<td id="new_id-1742" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1743" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1744" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(107</td>
			<td id="new_id-1745" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1746" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1747" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1748" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(51</td>
			<td id="new_id-1749" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total amortized intangible assets</b></p>
			</td>
			<td id="new_id-1750" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1751" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1752" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>636</b></td>
			<td id="new_id-1753" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1754" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1755" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1756" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>271</b></td>
			<td id="new_id-1757" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-1758">&#160;</td>
			<td id="new_id-1759">&#160;</td>
			<td id="new_id-1760">&#160;</td>
			<td id="new_id-1761">&#160;</td>
			<td id="new_id-1762">&#160;</td>
			<td id="new_id-1763">&#160;</td>
			<td id="new_id-1764">&#160;</td>
			<td id="new_id-1765">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Unamortized intangible assets</i></b></p>
			</td>
			<td id="new_id-1766" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1767" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1768" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1769" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1770" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1771" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1772" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
			<td id="new_id-1773" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i><b>&#160;</b></i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patents</p>
			</td>
			<td id="new_id-1774" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1775" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1776" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">534</td>
			<td id="new_id-1777" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1778" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1779" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1780" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">646</td>
			<td id="new_id-1781" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other intangibles</p>
			</td>
			<td id="new_id-1782" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1783" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1784" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1785" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1786" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1787" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1788" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1789" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total unamortized intangible assets</b></p>
			</td>
			<td id="new_id-1790" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1791" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1792" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">534</td>
			<td id="new_id-1793" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1794" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1795" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1796" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">646</td>
			<td id="new_id-1797" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total intangible assets</b></p>
			</td>
			<td id="new_id-1798" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1799" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1800" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>1,170</b></td>
			<td id="new_id-1801" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1802" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1803" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1804" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>917</b></td>
			<td id="new_id-1805" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Estimated amortization expense</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>(in thousands) </i></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>($)</i></b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2024</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">62</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2025</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">69</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2026</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">75</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2027</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">83</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the year ended 2028</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">91</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034567545120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_PropertyPlantAndEquipmentTableTypeAxis=igc_PropertyPlantAndEquipmentTableMember', window );">Property Plant and Equipment Table [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems', window );"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1806" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="9" id="new_id-1807" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands, except useful life)</i></b></i></p>
			</td>
			<td id="new_id-1808" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1809" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="1" id="new_id-1810" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; vertical-align: top;"><b>Useful Life (years)</b></p>
			</td>
			<td id="new_id-1811" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1812" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1813" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1814" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1815" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1816" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1817" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Land</p>
			</td>
			<td id="new_id-1818" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1819" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">N/A</td>
			<td id="new_id-1820" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1821" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1822" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1823" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,100</td>
			<td id="new_id-1824" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1825" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1826" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1827" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,438</td>
			<td id="new_id-1828" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Buildings and facilities</p>
			</td>
			<td id="new_id-1829" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1830" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">25</td>
			<td id="new_id-1831" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1832" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1833" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1834" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,298</td>
			<td id="new_id-1835" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1836" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1837" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1838" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,810</td>
			<td id="new_id-1839" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plant and machinery</p>
			</td>
			<td id="new_id-1840" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1841" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">5-20</td>
			<td id="new_id-1842" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1843" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1844" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1845" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,335</td>
			<td id="new_id-1846" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1847" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1848" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1849" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,593</td>
			<td id="new_id-1850" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Computer equipment&#8217;s</p>
			</td>
			<td id="new_id-1851" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1852" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">3</td>
			<td id="new_id-1853" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1854" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1855" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1856" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">138</td>
			<td id="new_id-1857" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1858" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1859" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1860" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">241</td>
			<td id="new_id-1861" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Office equipment&#8217;s</p>
			</td>
			<td id="new_id-1862" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1863" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">3-5</td>
			<td id="new_id-1864" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1865" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1866" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1867" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">84</td>
			<td id="new_id-1868" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1869" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1870" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1871" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">145</td>
			<td id="new_id-1872" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Furniture and fixtures</p>
			</td>
			<td id="new_id-1873" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1874" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">5</td>
			<td id="new_id-1875" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1876" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1877" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1878" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">92</td>
			<td id="new_id-1879" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1880" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1881" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1882" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">141</td>
			<td id="new_id-1883" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vehicles</p>
			</td>
			<td id="new_id-1884" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1885" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">5</td>
			<td id="new_id-1886" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1887" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1888" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1889" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">102</td>
			<td id="new_id-1890" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1891" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1892" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1893" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">163</td>
			<td id="new_id-1894" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction in progress</p>
			</td>
			<td id="new_id-1895" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1896" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">N/A</td>
			<td id="new_id-1897" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1898" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1899" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1900" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1901" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1902" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1903" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1904" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">108</td>
			<td id="new_id-1905" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total gross value</b></p>
			</td>
			<td id="new_id-1906" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1907" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1908" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1909" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1910" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1911" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>10,149</b></td>
			<td id="new_id-1912" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1913" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1914" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1915" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>12,639</b></td>
			<td id="new_id-1916" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: Accumulated depreciation</p>
			</td>
			<td id="new_id-1917" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1918" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1919" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1920" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1921" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1922" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,936</td>
			<td id="new_id-1923" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-1924" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1925" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1926" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,220</td>
			<td id="new_id-1927" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total property, plant and equipment, net</b></p>
			</td>
			<td id="new_id-1928" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1929" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1930" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-1931" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1932" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1933" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>8,213</b></td>
			<td id="new_id-1934" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1935" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1936" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1937" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>9,419</b></td>
			<td id="new_id-1938" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_PropertyPlantAndEquipmentTableTypeAxis=igc_PropertyPlantAndEquipmentTableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_PropertyPlantAndEquipmentTableTypeAxis=igc_PropertyPlantAndEquipmentTableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034659594800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLAIMS AND ADVANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1939" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-1940" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-1941" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1942" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1943" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1944" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1945" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1946" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1947" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims receivable (1)</p>
			</td>
			<td id="new_id-1948" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1949" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1950" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">951</td>
			<td id="new_id-1951" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1952" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1953" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1954" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">368</td>
			<td id="new_id-1955" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-current deposits</p>
			</td>
			<td id="new_id-1956" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1957" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1958" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">27</td>
			<td id="new_id-1959" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1960" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1961" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1962" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-1963" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-current advances</p>
			</td>
			<td id="new_id-1964" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1965" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1966" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25</td>
			<td id="new_id-1967" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1968" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1969" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1970" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">569</td>
			<td id="new_id-1971" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-1972" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1973" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1974" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>1,003</b></td>
			<td id="new_id-1975" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1976" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1977" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-1978" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>937</b></td>
			<td id="new_id-1979" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">	<tr>	<td style="vertical-align:top;width:2.3%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>	</td>	<td style="vertical-align:top;width:43.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The claims receivable is due from different vendors. While the Company has initiated collection proceedings internally or with the appropriate authorities, it believes receiving the amount in the next 12 months will be challenging because of the time required for collection proceedings. The Company decided to move advances paid to some suppliers worth approximately $164 thousand to claims and advances, considering recovering might take more than 12 months. Includes $140 thousand owed to one of our manufacturers for the equipment purchase.</p>	</td>	</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034658906976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1980" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1981" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1982" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-1983" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-1984" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-1985" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease costs</p>
			</td>
			<td id="new_id-1986" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1987" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1988" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">148</td>
			<td id="new_id-1989" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1990" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1991" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1992" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">149</td>
			<td id="new_id-1993" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Short term lease costs</p>
			</td>
			<td id="new_id-1994" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1995" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-1996" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">178</td>
			<td id="new_id-1997" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-1998" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-1999" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2000" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">178</td>
			<td id="new_id-2001" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease costs</b></p>
			</td>
			<td id="new_id-2002" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2003" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2004" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>326</b></td>
			<td id="new_id-2005" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2006" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2007" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2008" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>327</b></td>
			<td id="new_id-2009" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2010" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2011" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2012" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2013" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2014" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2015" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2016" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2017" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2018" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2019" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2020" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2021" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Assets</b></p>
			</td>
			<td id="new_id-2022" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2023" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2024" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2025" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2026" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2027" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2028" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2029" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-2030" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2031" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2032" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">326</td>
			<td id="new_id-2033" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2034" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2035" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2036" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">450</td>
			<td id="new_id-2037" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease assets </b></p>
			</td>
			<td id="new_id-2038" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2039" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2040" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>326</b></td>
			<td id="new_id-2041" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2042" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2043" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2044" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>450</b></td>
			<td id="new_id-2045" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2046">&#160;</td>
			<td id="new_id-2047">&#160;</td>
			<td id="new_id-2048">&#160;</td>
			<td id="new_id-2049">&#160;</td>
			<td id="new_id-2050">&#160;</td>
			<td id="new_id-2051">&#160;</td>
			<td id="new_id-2052">&#160;</td>
			<td id="new_id-2053">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Liabilities</b></p>
			</td>
			<td id="new_id-2054" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2055" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2056" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2057" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2058" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2059" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2060" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2061" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Current liabilities:</p>
			</td>
			<td id="new_id-2062" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2063" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2064" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2065" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2066" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2067" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2068" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2069" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued liabilities and others (current portion &#8211; operating lease liability)</p>
			</td>
			<td id="new_id-2070" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2071" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2072" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">133</td>
			<td id="new_id-2073" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2074" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2075" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2076" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">123</td>
			<td id="new_id-2077" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Noncurrent liabilities:</p>
			</td>
			<td id="new_id-2078" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2079" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2080" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2081" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2082" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2083" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2084" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2085" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease liability (non-current portion &#8211; operating lease liability)</p>
			</td>
			<td id="new_id-2086" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2087" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2088" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">207</td>
			<td id="new_id-2089" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2090" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2091" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2092" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">341</td>
			<td id="new_id-2093" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total lease liability </b></p>
			</td>
			<td id="new_id-2094" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2095" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2096" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>340</b></td>
			<td id="new_id-2097" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2098" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2099" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2100" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>464</b></td>
			<td id="new_id-2101" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Supplemental cash flow and non-cash information related to leases is as follows:</p>
			</td>
			<td id="new_id-2102" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2103" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2104" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2105" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2106" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2107" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash paid for amounts included in the measurement of lease liabilities</p>
			</td>
			<td id="new_id-2108" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2109" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2110" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2111" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2112" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2113" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2114" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2115" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8211;Operating cash flows from operating leases</p>
			</td>
			<td id="new_id-2116" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2117" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2118" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">118</td>
			<td id="new_id-2119" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2120" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2121" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2122" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">109</td>
			<td id="new_id-2123" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Right-of-use assets obtained in exchange for operating lease obligations</p>
			</td>
			<td id="new_id-2124" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2125" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2126" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">326</td>
			<td id="new_id-2127" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2128" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2129" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2130" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">450</td>
			<td id="new_id-2131" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td colspan="4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">As of March 31, 2023, the following table summarizes the maturity of our lease liabilities:</p>
			</td>
			<td id="new_id-2132" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2133">&#160;</td>
			<td id="new_id-2134">&#160;</td>
			<td id="new_id-2135">&#160;</td>
			<td id="new_id-2136">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 81%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-24</p>
			</td>
			<td id="new_id-2137" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2138" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2139" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">151</td>
			<td id="new_id-2140" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-25</p>
			</td>
			<td id="new_id-2141" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2142" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2143" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">133</td>
			<td id="new_id-2144" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-26</p>
			</td>
			<td id="new_id-2145" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2146" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2147" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">87</td>
			<td id="new_id-2148" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mar-27</p>
			</td>
			<td id="new_id-2149" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2150" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2151" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2152" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: Present value discount</p>
			</td>
			<td id="new_id-2153" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2154" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2155" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(31</td>
			<td id="new_id-2156" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total Lease liabilities</b></p>
			</td>
			<td id="new_id-2157" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2158" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2159" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>340</b></td>
			<td id="new_id-2160" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563835728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED LIABILITIES AND OTHERS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_AccruedLiabilitiesDisclosureAbstract', window );"><strong>Accrued Liabilities Disclosure Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2161" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2162" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>
			</td>
			<td id="new_id-2163" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2164" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2165" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2166" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2167" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2168" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2169" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Compensation and other contributions</p>
			</td>
			<td id="new_id-2170" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2171" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2172" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">619</td>
			<td id="new_id-2173" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2174" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2175" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2176" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,054</td>
			<td id="new_id-2177" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Provision for expenses</p>
			</td>
			<td id="new_id-2178" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2179" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2180" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">258</td>
			<td id="new_id-2181" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2182" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2183" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2184" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">103</td>
			<td id="new_id-2185" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Short-term lease liability</p>
			</td>
			<td id="new_id-2186" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2187" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2188" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">133</td>
			<td id="new_id-2189" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2190" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2191" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2192" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">123</td>
			<td id="new_id-2193" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other current liability</p>
			</td>
			<td id="new_id-2194" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2195" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2196" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">358</td>
			<td id="new_id-2197" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2198" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2199" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2200" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">180</td>
			<td id="new_id-2201" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2202" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2203" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2204" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>1,368</b></td>
			<td id="new_id-2205" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2206" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2207" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2208" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>1,460</b></td>
			<td id="new_id-2209" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_AccruedLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_AccruedLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034659604128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS AND OTHER LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LoansAndOtherLiabilitiesAbstract', window );"><strong>Loans And Other Liabilities Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock', window );">Schedule of Other Assets and Other Liabilities [Table Text Block]</a></td>
<td class="text"><i>Other Liability:</i><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2210" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2211" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands) </i></b></i></p>
			</td>
			<td id="new_id-2212" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2213" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2214" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of March 31,</b></p>
			</td>
			<td id="new_id-2215" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2216" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2217" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2218" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2219" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2220" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2221" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Statutory reserve</p>
			</td>
			<td id="new_id-2222" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2223" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2224" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">21</td>
			<td id="new_id-2225" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2226" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2227" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2228" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">16</td>
			<td id="new_id-2229" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Total</p>
			</td>
			<td id="new_id-2230" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2231" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2232" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>21</b></td>
			<td id="new_id-2233" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2234" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2235" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2236" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">16</td>
			<td id="new_id-2237" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_LoansAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_LoansAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564639088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text">The options are fair valued using a Black-Scholes Pricing Model and market based RSU are valued based on lattice model with the following assumptions:<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2238" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2239" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Granted in </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>
			</td>
			<td id="new_id-2240" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2241" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2242" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Granted in </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>
			</td>
			<td id="new_id-2243" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected life of options</p>
			</td>
			<td id="new_id-2244" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2245" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5 years</p>	</td>
			<td id="new_id-2246" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2247" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2248" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5 years</p>	</td>
			<td id="new_id-2249" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested options</p>
			</td>
			<td id="new_id-2250" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2251" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2252" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100</td>
			<td id="new_id-2253" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2254" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2255" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2256" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100</td>
			<td id="new_id-2257" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk free interest rate</p>
			</td>
			<td id="new_id-2258" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2259" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2260" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.49</td>
			<td id="new_id-2261" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2262" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2263" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2264" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.42</td>
			<td id="new_id-2265" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected volatility</p>
			</td>
			<td id="new_id-2266" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2267" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2268" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">280</td>
			<td id="new_id-2269" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2270" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2271" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2272" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">282</td>
			<td id="new_id-2273" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected dividend yield</p>
			</td>
			<td id="new_id-2274" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2275" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="-sec-ix-hidden: hidden-fact-4; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Nil</p>
			</td>
			<td id="new_id-2276" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2277" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2278" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="-sec-ix-hidden: hidden-fact-5; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Nil</p>
			</td>
			<td id="new_id-2279" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Nonvested Restricted Stock Shares Activity [Table Text Block]</a></td>
<td class="text">For Fiscal 2022, the Company&#8217;s common stock-based compensation and expenses shown in Selling, general and administrative expenses (including research and development) was $2.2 million.<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-vested shares</b></p>
			</td>
			<td id="new_id-2280" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2281" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shares</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(in thousands)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(#)</b></p>
			</td>
			<td id="new_id-2282" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2283" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2284" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>grant date fair value</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2285" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-vested shares as of March 31, 2022</p>
			</td>
			<td id="new_id-2286" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2287" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2288" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>5,283</b></td>
			<td id="new_id-2289" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2290" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2291" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2292" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.17</td>
			<td id="new_id-2293" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p>
			</td>
			<td id="new_id-2294" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2295" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2296" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,615</td>
			<td id="new_id-2297" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2298" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2299" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2300" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0.43</td>
			<td id="new_id-2301" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested</p>
			</td>
			<td id="new_id-2302" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2303" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2304" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(2,224</td>
			<td id="new_id-2305" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2306" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2307" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2308" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.01</td>
			<td id="new_id-2309" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cancelled/Forfeited</p>
			</td>
			<td id="new_id-2310" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2311" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2312" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(245</td>
			<td id="new_id-2313" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2314" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2315" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2316" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.77</td>
			<td id="new_id-2317" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-vested shares as of March 31, 2023</b></p>
			</td>
			<td id="new_id-2318" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2319" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2320" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>4,429</b></td>
			<td id="new_id-2321" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2322" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2323" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2324" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>1.01</b></td>
			<td id="new_id-2325" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Options</b></p>
			</td>
			<td id="new_id-2326" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2327" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shares</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(in thousands)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(#)</b></p>
			</td>
			<td id="new_id-2328" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2329" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2330" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>grant date fair value</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2331" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2332" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2333" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted average </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>exercise price</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2334" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Options outstanding as of March 31, 2022</p>
			</td>
			<td id="new_id-2335" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2336" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2337" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>300</b></td>
			<td id="new_id-2338" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2339" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2340" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2341" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>0.93</b></td>
			<td id="new_id-2342" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2343" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2344" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2345" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>0.34</b></td>
			<td id="new_id-2346" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Granted</p>
			</td>
			<td id="new_id-2347" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2348" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2349" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2350" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2351" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2352" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2353" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2354" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2355" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2356" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2357" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2358" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercised</p>
			</td>
			<td id="new_id-2359" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2360" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2361" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2362" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2363" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2364" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2365" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2366" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2367" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2368" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2369" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2370" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cancelled/forfeited</p>
			</td>
			<td id="new_id-2371" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2372" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2373" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(150</td>
			<td id="new_id-2374" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2375" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2376" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2377" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.39</td>
			<td id="new_id-2378" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2379" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2380" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2381" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.30</td>
			<td id="new_id-2382" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Options outstanding as of March 31, 2023</b></p>
			</td>
			<td id="new_id-2383" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2384" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2385" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>150</b></td>
			<td id="new_id-2386" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2387" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2388" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2389" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>1.39</b></td>
			<td id="new_id-2390" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2391" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2392" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2393" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>0.30</b></td>
			<td id="new_id-2394" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563880736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text">The following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of March 31, 2023, and 2022, and indicates the fair value hierarchy of the valuation techniques the Company used to determine such fair value:<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2395" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2396" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 1</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2397" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2398" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2399" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 2</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2400" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2401" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2402" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 3</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2403" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2404" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2405" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2406" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>March 31, 2023</b></p>
			</td>
			<td id="new_id-2407" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2408" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2409" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2410" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2411" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2412" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2413" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2414" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2415" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2416" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2417" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2418" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2419" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2420" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2421" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2422" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2423">&#160;</td>
			<td id="new_id-2424">&#160;</td>
			<td id="new_id-2425">&#160;</td>
			<td id="new_id-2426">&#160;</td>
			<td id="new_id-2427">&#160;</td>
			<td id="new_id-2428">&#160;</td>
			<td id="new_id-2429">&#160;</td>
			<td id="new_id-2430">&#160;</td>
			<td id="new_id-2431">&#160;</td>
			<td id="new_id-2432">&#160;</td>
			<td id="new_id-2433">&#160;</td>
			<td id="new_id-2434">&#160;</td>
			<td id="new_id-2435">&#160;</td>
			<td id="new_id-2436">&#160;</td>
			<td id="new_id-2437">&#160;</td>
			<td id="new_id-2438">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Cash and cash equivalents:</i></p>
			</td>
			<td id="new_id-2439" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2440" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2441" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,196</td>
			<td id="new_id-2442" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2443" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2444" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2445" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2446" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2447" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2448" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2449" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2450" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2451" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2452" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2453" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,196</td>
			<td id="new_id-2454" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total cash and cash equivalents</b></p>
			</td>
			<td id="new_id-2455" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2456" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2457" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>3,196</b></td>
			<td id="new_id-2458" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2459" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2460" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2461" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2462" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2463" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2464" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2465" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2466" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2467" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2468" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2469" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>3,196</b></td>
			<td id="new_id-2470" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2471">&#160;</td>
			<td id="new_id-2472">&#160;</td>
			<td id="new_id-2473">&#160;</td>
			<td id="new_id-2474">&#160;</td>
			<td id="new_id-2475">&#160;</td>
			<td id="new_id-2476">&#160;</td>
			<td id="new_id-2477">&#160;</td>
			<td id="new_id-2478">&#160;</td>
			<td id="new_id-2479">&#160;</td>
			<td id="new_id-2480">&#160;</td>
			<td id="new_id-2481">&#160;</td>
			<td id="new_id-2482">&#160;</td>
			<td id="new_id-2483">&#160;</td>
			<td id="new_id-2484">&#160;</td>
			<td id="new_id-2485">&#160;</td>
			<td id="new_id-2486">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Investments:</i></p>
			</td>
			<td id="new_id-2487" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2488" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2489" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2490" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2491" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2492" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2493" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2494" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2495" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2496" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2497" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2498" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2499" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2500" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2501" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2502" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Marketable securities</p>
			</td>
			<td id="new_id-2503" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2504" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2505" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">154</td>
			<td id="new_id-2506" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2507" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2508" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2509" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2510" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2511" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2512" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2513" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2514" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2515" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2516" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2517" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">154</td>
			<td id="new_id-2518" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Non-marketable securities</p>
			</td>
			<td id="new_id-2519" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2520" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2521" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2522" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2523" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2524" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2525" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2526" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2527" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2528" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2529" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2530" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2531" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2532" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2533" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2534" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total investments</b></p>
			</td>
			<td id="new_id-2535" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2536" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2537" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>154</b></td>
			<td id="new_id-2538" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2539" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2540" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2541" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td>
			<td id="new_id-2542" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2543" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2544" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2545" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td>
			<td id="new_id-2546" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2547" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2548" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2549" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>154</b></td>
			<td id="new_id-2550" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2551" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2552" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 1</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2553" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2554" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2555" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 2</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2556" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2557" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2558" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 3</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2559" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2560" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2561" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2562" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>March 31, 2022</b></p>
			</td>
			<td id="new_id-2563" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2564" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2565" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2566" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2567" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2568" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2569" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2570" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2571" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2572" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2573" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2574" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2575" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2576" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2577" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2578" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2579">&#160;</td>
			<td id="new_id-2580">&#160;</td>
			<td id="new_id-2581">&#160;</td>
			<td id="new_id-2582">&#160;</td>
			<td id="new_id-2583">&#160;</td>
			<td id="new_id-2584">&#160;</td>
			<td id="new_id-2585">&#160;</td>
			<td id="new_id-2586">&#160;</td>
			<td id="new_id-2587">&#160;</td>
			<td id="new_id-2588">&#160;</td>
			<td id="new_id-2589">&#160;</td>
			<td id="new_id-2590">&#160;</td>
			<td id="new_id-2591">&#160;</td>
			<td id="new_id-2592">&#160;</td>
			<td id="new_id-2593">&#160;</td>
			<td id="new_id-2594">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Cash and cash equivalents:</i></p>
			</td>
			<td id="new_id-2595" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2596" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2597" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,460</td>
			<td id="new_id-2598" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2599" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2600" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2601" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2602" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2603" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2604" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2605" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2606" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2607" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2608" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2609" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,460</td>
			<td id="new_id-2610" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total cash and cash equivalents</b></p>
			</td>
			<td id="new_id-2611" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2612" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2613" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>10,460</b></td>
			<td id="new_id-2614" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2615" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2616" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2617" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2618" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2619" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2620" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2621" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2622" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2623" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2624" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2625" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>10,460</b></td>
			<td id="new_id-2626" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2627">&#160;</td>
			<td id="new_id-2628">&#160;</td>
			<td id="new_id-2629">&#160;</td>
			<td id="new_id-2630">&#160;</td>
			<td id="new_id-2631">&#160;</td>
			<td id="new_id-2632">&#160;</td>
			<td id="new_id-2633">&#160;</td>
			<td id="new_id-2634">&#160;</td>
			<td id="new_id-2635">&#160;</td>
			<td id="new_id-2636">&#160;</td>
			<td id="new_id-2637">&#160;</td>
			<td id="new_id-2638">&#160;</td>
			<td id="new_id-2639">&#160;</td>
			<td id="new_id-2640">&#160;</td>
			<td id="new_id-2641">&#160;</td>
			<td id="new_id-2642">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Investments:</i></p>
			</td>
			<td id="new_id-2643" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2644" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2645" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2646" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2647" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2648" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2649" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2650" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2651" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2652" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2653" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2654" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2655" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2656" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2657" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
			<td id="new_id-2658" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Marketable securities</p>
			</td>
			<td id="new_id-2659" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2660" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2661" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2662" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2663" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2664" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2665" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2666" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2667" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2668" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2669" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2670" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2671" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2672" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2673" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2674" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">-Non-marketable securities</p>
			</td>
			<td id="new_id-2675" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2676" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2677" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2678" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2679" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2680" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2681" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2682" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2683" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2684" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2685" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2686" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2687" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2688" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2689" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2690" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total investment </b></p>
			</td>
			<td id="new_id-2691" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2692" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2693" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2694" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2695" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2696" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2697" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td>
			<td id="new_id-2698" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2699" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2700" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2701" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2702" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2703" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2704" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2705" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2706" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563604336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text">Income tax expense/(benefit) for each of the years ended March 31 consists of the following:<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2707" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2708" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year Ended March 31,</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2709" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Income Tax Expense</b></p>
			</td>
			<td id="new_id-2710" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2711" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2712" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2713" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2714" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2715" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2716" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2717" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2718" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2719" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2720" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2721" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2722" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2723" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net income loss before tax</p>
			</td>
			<td id="new_id-2724" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2725" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2726" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(11,506</td>
			<td id="new_id-2727" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2728" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2729" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2730" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(15,016</td>
			<td id="new_id-2731" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax rate</p>
			</td>
			<td id="new_id-2732" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2733" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2734" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">21</td>
			<td id="new_id-2735" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
			<td id="new_id-2736" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2737" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2738" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">21</td>
			<td id="new_id-2739" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2740">&#160;</td>
			<td id="new_id-2741">&#160;</td>
			<td id="new_id-2742">&#160;</td>
			<td id="new_id-2743">&#160;</td>
			<td id="new_id-2744">&#160;</td>
			<td id="new_id-2745">&#160;</td>
			<td id="new_id-2746">&#160;</td>
			<td id="new_id-2747">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected income tax recovery</p>
			</td>
			<td id="new_id-2748" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2749" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2750" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(2,416</td>
			<td id="new_id-2751" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2752" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2753" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2754" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(3,153</td>
			<td id="new_id-2755" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Impact of tax rate differences in foreign jurisdictions</p>
			</td>
			<td id="new_id-2756" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2757" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2758" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(7</td>
			<td id="new_id-2759" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2760" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2761" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2762" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-2763" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax rate changes and other adjustments</p>
			</td>
			<td id="new_id-2764" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2765" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2766" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(667</td>
			<td id="new_id-2767" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
			<td id="new_id-2768" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2769" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2770" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(385</td>
			<td id="new_id-2771" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Permanent differences</p>
			</td>
			<td id="new_id-2772" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2773" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2774" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">88</td>
			<td id="new_id-2775" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2776" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2777" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2778" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">50</td>
			<td id="new_id-2779" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Change in valuation allowance</p>
			</td>
			<td id="new_id-2780" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2781" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2782" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,002</td>
			<td id="new_id-2783" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2784" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2785" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2786" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,488</td>
			<td id="new_id-2787" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2788" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2789" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2790" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2791" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2792" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2793" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2794" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id="new_id-2795" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text">The significant components of deferred income tax expense/(benefit) from operations before non-controlling interest for each of the years ended March 31 are approximated as following:<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2796" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2797" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year Ended March 31,</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2798" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Deferred income taxes</b></p>
			</td>
			<td id="new_id-2799" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2800" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2801" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2802" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2803" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2804" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2805" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2806" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2807" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2808" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2809" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2810" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2811" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2812" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2813">&#160;</td>
			<td id="new_id-2814">&#160;</td>
			<td id="new_id-2815">&#160;</td>
			<td id="new_id-2816">&#160;</td>
			<td id="new_id-2817">&#160;</td>
			<td id="new_id-2818">&#160;</td>
			<td id="new_id-2819">&#160;</td>
			<td id="new_id-2820">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net operating loss carry-forwards foreign</p>
			</td>
			<td id="new_id-2821" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2822" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2823" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">137</td>
			<td id="new_id-2824" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2825" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2826" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2827" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">149</td>
			<td id="new_id-2828" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-capital loss carry-forwards &#8211; U.S.</p>
			</td>
			<td id="new_id-2829" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2830" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2831" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">12,888</td>
			<td id="new_id-2832" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2833" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2834" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2835" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">10,487</td>
			<td id="new_id-2836" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Temporary differences</p>
			</td>
			<td id="new_id-2837" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2838" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2839" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">548</td>
			<td id="new_id-2840" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2841" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2842" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2843" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(66</td>
			<td id="new_id-2844" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-2845">&#160;</td>
			<td id="new_id-2846">&#160;</td>
			<td id="new_id-2847">&#160;</td>
			<td id="new_id-2848">&#160;</td>
			<td id="new_id-2849">&#160;</td>
			<td id="new_id-2850">&#160;</td>
			<td id="new_id-2851">&#160;</td>
			<td id="new_id-2852">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net deferred tax asset</p>
			</td>
			<td id="new_id-2853" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2854" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2855" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">13,573</td>
			<td id="new_id-2856" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2857" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2858" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2859" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">10,570</td>
			<td id="new_id-2860" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Valuation allowance</p>
			</td>
			<td id="new_id-2861" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2862" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2863" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(13,573</td>
			<td id="new_id-2864" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
			<td id="new_id-2865" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2866" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2867" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(10,570</td>
			<td id="new_id-2868" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2869" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2870" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2871" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2872" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2873" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2874" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2875" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>-</b></td>
			<td id="new_id-2876" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Summary of Operating Loss Carryforwards [Table Text Block]</a></td>
<td class="text">The table below sets forth the details of expiration of the non-financial carried forward losses of the Company as of March 31, 2023, as under:<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>Amount</i></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>(in thousands)</i></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>($)</i></b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">47</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2024</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">309</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2025</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">3</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2026</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">12</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2027</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">30</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2028</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">14</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2029</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">25</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2030</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">141</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2031</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">3,081</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2032</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">4,141</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2033</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">627</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2034</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1,269</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2035</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1,735</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2036</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1,176</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2037</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">819</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2038</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1,256</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2039</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">4,132</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2040</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">7,932</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2041</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">8,841</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2042</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">14,966</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2043</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">11,359</p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 71%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Total</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 26%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">	<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>61,915</b></p>	</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
			</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034659601600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">Net sales disaggregated by significant products and services for Fiscal 2023 and 2022 are as follows:<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2877" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2878" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>Year ended March 31,</i></b></i></p>
			</td>
			<td id="new_id-2879" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2880" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2881" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			<b>($)</b></td>
			<td id="new_id-2882" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2883" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2884" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p>
			<b>($)</b></td>
			<td id="new_id-2885" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Infrastructure segment</b></p>
			</td>
			<td id="new_id-2886" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2887" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2888" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2889" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2890" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2891" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2892" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2893" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rental income (1)</p>
			</td>
			<td id="new_id-2894" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2895" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2896" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">37</td>
			<td id="new_id-2897" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2898" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2899" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2900" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">23</td>
			<td id="new_id-2901" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction contracts (2)</p>
			</td>
			<td id="new_id-2902" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2903" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2904" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">76</td>
			<td id="new_id-2905" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2906" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2907" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2908" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15</td>
			<td id="new_id-2909" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&#160;</td>
			<td id="new_id-2910">&#160;</td>
			<td id="new_id-2911">&#160;</td>
			<td id="new_id-2912">&#160;</td>
			<td id="new_id-2913">&#160;</td>
			<td id="new_id-2914">&#160;</td>
			<td id="new_id-2915">&#160;</td>
			<td id="new_id-2916">&#160;</td>
			<td id="new_id-2917">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&#160;</td>
			<td id="new_id-2918">&#160;</td>
			<td id="new_id-2919">&#160;</td>
			<td id="new_id-2920">&#160;</td>
			<td id="new_id-2921">&#160;</td>
			<td id="new_id-2922">&#160;</td>
			<td id="new_id-2923">&#160;</td>
			<td id="new_id-2924">&#160;</td>
			<td id="new_id-2925">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Life Sciences segment</b></p>
			</td>
			<td id="new_id-2926" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2927" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2928" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2929" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2930" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2931" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2932" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
			<td id="new_id-2933" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Wellness and lifestyle (3)</p>
			</td>
			<td id="new_id-2934" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2935" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2936" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">416</td>
			<td id="new_id-2937" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2938" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2939" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2940" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">316</td>
			<td id="new_id-2941" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">White labeling services (4)</p>
			</td>
			<td id="new_id-2942" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2943" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2944" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">382</td>
			<td id="new_id-2945" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2946" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2947" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2948" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">43</td>
			<td id="new_id-2949" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2950" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2951" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2952" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>911</b></td>
			<td id="new_id-2953" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2954" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2955" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2956" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>397</b></td>
			<td id="new_id-2957" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(1) Rental income consists of income from rental of heavy construction equipment.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2) Construction income consists of the execution of contracts directly or through subcontractors.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(3) Revenue from wellness and lifestyle consists of sale of products such as gummies, hand sanitizers, bath bombs, lotions, beverages, hemp crude extract, hemp isolate, and hemp distillate.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(4) Revenue from white label services consists of rebranding our formulations or the customer&#8217;s products as per customer&#8217;s requirement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563552048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue from External Customers by Products and Services [Table Text Block]</a></td>
<td class="text">1) The table below shows revenue reported by segment:<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2958" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-2959" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-2960" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td id="new_id-2961" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2962" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-2963" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-2964" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-2965" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td id="new_id-2966" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-2967">&#160;</td>
			<td id="new_id-2968">&#160;</td>
			<td id="new_id-2969">&#160;</td>
			<td id="new_id-2970">&#160;</td>
			<td id="new_id-2971">&#160;</td>
			<td id="new_id-2972">&#160;</td>
			<td id="new_id-2973">&#160;</td>
			<td id="new_id-2974">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Infrastructure segment</p>
			</td>
			<td id="new_id-2975" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2976" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2977" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">113</td>
			<td id="new_id-2978" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2979" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2980" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2981" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">12</td>
			<td id="new_id-2982" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Life Sciences segment</p>
			</td>
			<td id="new_id-2983" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2984" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2985" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">798</td>
			<td id="new_id-2986" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2987" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2988" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-2989" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">88</td>
			<td id="new_id-2990" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-2991" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2992" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2993" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>911</b></td>
			<td id="new_id-2994" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-2995" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2996" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-2997" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>100</b></td>
			<td id="new_id-2998" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-2999" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="6" id="new_id-3000" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-3001" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td id="new_id-3002" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3003" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3004" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3005" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3006" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td id="new_id-3007" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#160;</td>
			<td id="new_id-3008">&#160;</td>
			<td id="new_id-3009">&#160;</td>
			<td id="new_id-3010">&#160;</td>
			<td id="new_id-3011">&#160;</td>
			<td id="new_id-3012">&#160;</td>
			<td id="new_id-3013">&#160;</td>
			<td id="new_id-3014">&#160;</td>
			<td id="new_id-3015">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Infrastructure segment</p>
			</td>
			<td id="new_id-3016" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3017" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3018" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">38</td>
			<td id="new_id-3019" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3020" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3021" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3022" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9</td>
			<td id="new_id-3023" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Life Sciences segment</p>
			</td>
			<td id="new_id-3024" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3025" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3026" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">359</td>
			<td id="new_id-3027" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3028" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3029" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3030" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">91</td>
			<td id="new_id-3031" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td id="new_id-3032" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3033" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3034" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>397</b></td>
			<td id="new_id-3035" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3036" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3037" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3038" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>100</b></td>
			<td id="new_id-3039" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas [Table Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">	<tr>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="6" style="vertical-align:bottom;width:11.4%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Country</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	</tr>	<tr style="background-color: rgb(204, 238, 255);">	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Asia</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">113</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">12</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>	</td>	</tr>	<tr style="background-color: rgb(255, 255, 255);">	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">America</p>	</td>	<td style="vertical-align:bottom;width:1.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S.</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">777</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">86</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>	</td>	</tr>	<tr style="background-color: rgb(204, 238, 255);">	<td style="vertical-align:bottom;width:17.1%;">&#160;</td>	<td style="vertical-align:bottom;width:1.1%;">&#160;</td>	<td style="vertical-align:bottom;width:17.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Colombia</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">21</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>	<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">%</td>	</tr>	<tr style="background-color: rgb(255, 255, 255);">	<td colspan="3" style="vertical-align:bottom;width:18.2%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>911</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>	</td>	<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>100</b></p>	</td>	<td style="vertical-align:bottom;width:0.6%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>	</td>	</tr>
</table>2) The table below shows the attributed to the country of domicile (U.S.) and foreign countries. Revenue is generally attributed to the geographic location of customers:<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="6" style="vertical-align:bottom;width:11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>(in thousands)</i></b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Segments</b></p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Country</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenue</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(%)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Asia</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">India</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">68</p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17</p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">America</p>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:17.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S.</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">329</p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">83</p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="3" style="vertical-align:bottom;width:18.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>397</b></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#160;</b></p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;">	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>100</b></p>	</td>
			<td style="vertical-align:bottom;width:0.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>%</b></p>
			</td>
		</tr>

</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</a></td>
<td class="text">3) The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries.<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3040" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="10" id="new_id-3041" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i>(in thousands)</i></b></i></p>
			</td>
			<td id="new_id-3042" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nature of Assets</b></p>
			</td>
			<td id="new_id-3043" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3044" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>U.S. </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Country of Domicile)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3045" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3046" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3047" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Foreign Countries </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(India, Hong Kong, and Colombia)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3048" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3049" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3050" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total as of March 31, 2023</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3051" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intangible assets, net</p>
			</td>
			<td id="new_id-3052" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3053" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3054" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,170</td>
			<td id="new_id-3055" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3056" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3057" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3058" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id="new_id-3059" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3060" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3061" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3062" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,170</td>
			<td id="new_id-3063" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property, plant and equipment, net</p>
			</td>
			<td id="new_id-3064" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3065" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3066" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,074</td>
			<td id="new_id-3067" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3068" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3069" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3070" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,139</td>
			<td id="new_id-3071" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3072" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3073" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3074" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">8,213</td>
			<td id="new_id-3075" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims and advances</p>
			</td>
			<td id="new_id-3076" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3077" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3078" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">585</td>
			<td id="new_id-3079" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3080" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3081" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3082" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">418</td>
			<td id="new_id-3083" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3084" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3085" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3086" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,003</td>
			<td id="new_id-3087" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-3088" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3089" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3090" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">298</td>
			<td id="new_id-3091" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3092" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3093" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3094" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">28</td>
			<td id="new_id-3095" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3096" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3097" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3098" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">326</td>
			<td id="new_id-3099" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total non-current assets</b></p>
			</td>
			<td id="new_id-3100" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3101" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3102" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>6,127</b></td>
			<td id="new_id-3103" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3104" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3105" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3106" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>4,585</b></td>
			<td id="new_id-3107" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3108" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3109" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3110" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>10,712</b></td>
			<td id="new_id-3111" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3112" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="10" id="new_id-3113" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i><b><i><b><i>(in thousands)</i></b></i></b></i></p>
			</td>
			<td id="new_id-3114" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nature of Assets</b></p>
			</td>
			<td id="new_id-3115" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3116" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>U.S. </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Country of Domicile)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3117" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3118" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3119" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Foreign Countries </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(India Hong Kong and Colombia)</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3120" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td id="new_id-3121" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td colspan="2" id="new_id-3122" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total as of March 31, 2022</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td id="new_id-3123" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intangible assets, net</p>
			</td>
			<td id="new_id-3124" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3125" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3126" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">436</td>
			<td id="new_id-3127" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3128" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3129" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3130" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">481</td>
			<td id="new_id-3131" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3132" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3133" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3134" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">917</td>
			<td id="new_id-3135" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property, plant and equipment, net</p>
			</td>
			<td id="new_id-3136" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3137" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3138" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,978</td>
			<td id="new_id-3139" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3140" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3141" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3142" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,441</td>
			<td id="new_id-3143" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3144" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3145" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3146" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9,419</td>
			<td id="new_id-3147" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Claims and advances</p>
			</td>
			<td id="new_id-3148" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3149" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3150" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">550</td>
			<td id="new_id-3151" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3152" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3153" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3154" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">387</td>
			<td id="new_id-3155" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3156" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3157" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3158" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">937</td>
			<td id="new_id-3159" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease asset</p>
			</td>
			<td id="new_id-3160" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3161" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3162" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">396</td>
			<td id="new_id-3163" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3164" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3165" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3166" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">54</td>
			<td id="new_id-3167" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3168" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3169" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td id="new_id-3170" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">450</td>
			<td id="new_id-3171" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total non-current assets</b></p>
			</td>
			<td id="new_id-3172" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3173" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3174" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>6,360</b></td>
			<td id="new_id-3175" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3176" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3177" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3178" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>5,363</b></td>
			<td id="new_id-3179" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
			<td id="new_id-3180" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
			<td id="new_id-3181" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b>&#160;</b></td>
			<td id="new_id-3182" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>11,723</b></td>
			<td id="new_id-3183" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;">&#160;</td>
		</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034558149136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,576,258<span></span>
</td>
<td class="nump">49,991,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,506,000)<span></span>
</td>
<td class="num">$ (15,016,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of Credit Facility, Current Borrowing Capacity</a></td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in Shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="nump">4,145,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts Receivable, after Allowance for Credit Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">93,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,196,000<span></span>
</td>
<td class="nump">10,460,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,651,000<span></span>
</td>
<td class="nump">3,548,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,461,000<span></span>
</td>
<td class="nump">2,330,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=igc_ClinicalTrialInventoryMember', window );">Clinical Trial Inventory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 407,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=igc_ClinicalTrialInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=igc_ClinicalTrialInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034561624880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">$ 376<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564710576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORY (Details) - Schedule of Inventory, Current - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ScheduleOfInventoryCurrentAbstract', window );"><strong>Schedule Of Inventory Current Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">$ 2,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-progress</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 2,651<span></span>
</td>
<td class="nump">$ 3,548<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ScheduleOfInventoryCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ScheduleOfInventoryCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563932384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEPOSITS AND ADVANCES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_DepositsAndAdvancesAbstract', window );"><strong>Deposits And Advances Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_StatutoryAdvances', window );">Statutory Advances</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances', window );">Transfer from Deposits and Advances to Claims and Advances</a></td>
<td class="nump">$ 164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_DepositsAndAdvancesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_DepositsAndAdvancesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_StatutoryAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Statutory advances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_StatutoryAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount transferred from Deposits and Advances to Claims and Advances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034562359040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEPOSITS AND ADVANCES (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Advances to suppliers and consultants</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryNetOfReserves', window );">Other receivables and deposits</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expense and other current assets</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 358<span></span>
</td>
<td class="nump">$ 978<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after of valuation reserves and allowances, of inventory, classified as other, expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034558162672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_INTANGIBLEASSETSDetailsLineItems', window );"><strong>INTANGIBLE ASSETS (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_NumberOfPatents', window );">Number of Patents</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_NumberOfPatentsGranted', window );">Number of Patents Granted</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_INTANGIBLEASSETSDetailsLineItems', window );"><strong>INTANGIBLE ASSETS (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_INTANGIBLEASSETSDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_INTANGIBLEASSETSDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_NumberOfPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of patents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_NumberOfPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_NumberOfPatentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of granted patents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_NumberOfPatentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034562369712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems', window );"><strong>INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (107)<span></span>
</td>
<td class="num">$ (51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total amortized intangible assets</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_UnamortizedIntangibleAssetsAbstract', window );"><strong>Unamortized intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">646<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_UnamortizedIntangibleAssetsAbstract', window );"><strong>Unamortized intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">646<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_UnamortizedIntangibleAssetsAbstract', window );"><strong>Unamortized intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems', window );"><strong>INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangibles</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems', window );"><strong>INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangibles</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_UnamortizedIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_UnamortizedIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034561591680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Details) - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Schedule Of Finite Lived Intangible Assets Future Amortization Expense Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">For the year ended 2024</a></td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">For the year ended 2025</a></td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">For the year ended 2026</a></td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">For the year ended 2027</a></td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">For the year ended 2028</a></td>
<td class="nump">$ 91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034561583040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems', window );"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisposals', window );">Property, Plant and Equipment, Disposals</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from Sale of Property, Plant, and Equipment</a></td>
<td class="nump">538<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (Loss) on Disposition of Property Plant Equipment</a></td>
<td class="num">(39)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems', window );"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from Sale of Property, Plant, and Equipment</a></td>
<td class="nump">485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOwnedGross', window );">Property, Plant, and Equipment, Owned, Gross</a></td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (Loss) on Disposition of Property Plant Equipment</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOwnedGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation, of long-lived, depreciable flight asset owned. Excludes right-of-use asset from finance lease for flight asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOwnedGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034561786064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT  (Details) - Property, Plant and Equipment - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 10,149<span></span>
</td>
<td class="nump">$ 12,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(1,936)<span></span>
</td>
<td class="num">(3,220)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Assets</a></td>
<td class="nump">$ 8,213<span></span>
</td>
<td class="nump">9,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_PropertyPlantAndEquipmentEstimatedUsefulLives1', window );">Property, plant and equipment, useful life</a></td>
<td class="text">N/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="nump">4,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Building Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 2,298<span></span>
</td>
<td class="nump">2,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 3,335<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_PropertyPlantAndEquipmentEstimatedUsefulLives1', window );">Property, plant and equipment, useful life</a></td>
<td class="text">N/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_PropertyPlantAndEquipmentEstimatedUsefulLives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_PropertyPlantAndEquipmentEstimatedUsefulLives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564309616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLAIMS AND ADVANCES (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances', window );">Transfer from Deposits and Advances to Claims and Advances</a></td>
<td class="nump">$ 164,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDeposits', window );">Payments for Deposits</a></td>
<td class="nump">$ 140<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount transferred from Deposits and Advances to Claims and Advances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564763248">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CLAIMS AND ADVANCES (Details) - Schedule of Other Assets, Noncurrent - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ScheduleOfOtherAssetsNoncurrentAbstract', window );"><strong>Schedule Of Other Assets Noncurrent Abstract</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Claims receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 951<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Non-current deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_OtherAdvances', window );">Other advances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25<span></span>
</td>
<td class="nump">569<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,003<span></span>
</td>
<td class="nump">$ 937<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The claims receivable is due from different vendors. While the Company has initiated collection proceedings internally or with the appropriate authorities, it believes receiving the amount in the next 12 months will be challenging because of the time required for collection proceedings. The Company decided to move advances paid to some suppliers worth approximately $164 thousand to claims and advances, considering recovering might take more than 12 months. Includes $140 thousand owed to one of our manufacturers for the equipment purchase.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_OtherAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other noncurrent advances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_OtherAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ScheduleOfOtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ScheduleOfOtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034562445968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-Term Lease, Cost</a></td>
<td class="nump">$ 178<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Lessee, Operating Lease, Discount Rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Lessee, Operating Lease, Discount Rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Lessee, Operating Lease, Remaining Lease Term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Lessee, Operating Lease, Remaining Lease Term</a></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_LEASESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_LEASESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034565174720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - Lease, Cost - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short term lease costs</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease asset</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Total lease assets</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Accrued liabilities and others (current portion &#8211; operating lease liability)</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability (non-current portion &#8211; operating lease liability)</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">&#8211; Operating cash flows from operating leases</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease obligations</a></td>
<td class="nump">$ 326<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034566837696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details) - Lessee, Operating Lease, Liability, Maturity<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LesseeOperatingLeaseLiabilityMaturityAbstract', window );"><strong>Lessee Operating Lease Liability Maturity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Mar-24</a></td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Mar-25</a></td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Mar-26</a></td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Mar-27</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Present value discount</a></td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total Lease liabilities</a></td>
<td class="nump">$ 340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_LesseeOperatingLeaseLiabilityMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_LesseeOperatingLeaseLiabilityMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034560507792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED LIABILITIES AND OTHERS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_AccruedLiabilitiesDisclosureAbstract', window );"><strong>Accrued Liabilities Disclosure Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Accounts Payable, Other, Current</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-Term Debt</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_AccruedLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_AccruedLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034562354496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED LIABILITIES AND OTHERS (Details) - Schedule of Accounts Payable and Accrued Liabilities - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract', window );"><strong>Schedule Of Accounts Payable And Accrued Liabilities Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation and other contributions</a></td>
<td class="nump">$ 619<span></span>
</td>
<td class="nump">$ 1,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Provision for expenses</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term lease liability</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liability</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,368<span></span>
</td>
<td class="nump">$ 1,460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034558205136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS AND OTHER LIABILITIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 11, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_LoansAndOtherLiabilitiesAbstract', window );"><strong>Loans And Other Liabilities Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="nump">$ 731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt Instrument, Term</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Loans Payable, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans Payable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_LoansAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_LoansAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034560507664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LOANS AND OTHER LIABILITIES (Details) - Schedule of Loans and Other Liabilities - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ScheduleOfLoansAndOtherLiabilitiesAbstract', window );"><strong>Schedule Of Loans And Other Liabilities Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Statutory reserve</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ScheduleOfLoansAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ScheduleOfLoansAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034558207168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034557605440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SECURITIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">53,077,436<span></span>
</td>
<td class="nump">51,054,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_UnitsOutstanding', window );">Units Outstanding</a></td>
<td class="nump">91,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_UnitDescription', window );">Unit, description</a></td>
<td class="text">Ten units may be separated into one share of common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_SalesAgreementMaximum', window );">Sales Agreement, Offering, Maximum (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance or Sale of Equity (in Dollars)</a></td>
<td class="nump">$ 103,000<span></span>
</td>
<td class="nump">$ 4,145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_SalesAgreementMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum offering under sales agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_SalesAgreementMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_UnitDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_UnitDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_UnitsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of units outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_UnitsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034673314064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_STOCKBASEDCOMPENSATIONDetailsLineItems', window );"><strong>STOCK-BASED COMPENSATION (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in Shares)</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares', window );">Employee Stock Ownership Plan (ESOP), Number of Committed-to-be-Released Shares (in Shares)</a></td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-Based Payment Arrangement, Noncash Expense</a></td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_WeightedAveragePricePerShare', window );">Weighted Average Price per Share (in Dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=igc_ESOP2008OmnibusPlanMember', window );">ESOP 2008 Omnibus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_STOCKBASEDCOMPENSATIONDetailsLineItems', window );"><strong>STOCK-BASED COMPENSATION (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in Shares)</a></td>
<td class="nump">8,412,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-Based Payment Arrangement, Noncash Expense</a></td>
<td class="nump">$ 69,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_STOCKBASEDCOMPENSATIONDetailsLineItems', window );"><strong>STOCK-BASED COMPENSATION (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-Based Payment Arrangement, Noncash Expense</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_STOCKBASEDCOMPENSATIONDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_STOCKBASEDCOMPENSATIONDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_WeightedAveragePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_WeightedAveragePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The shares that, although not legally released, will be released by a future scheduled and committed debt service payment and will be allocated to employees for service rendered in the current accounting period. The ESOP documents typically define the period of service to which the shares relate. ESOP shares are released to compensate employees directly, to settle employer liabilities for other employee benefits, and to replace dividends on allocated shares that are used for debt service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=igc_ESOP2008OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=igc_ESOP2008OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034557613120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION  (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract', window );"><strong>Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of options</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vested options</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.49%<span></span>
</td>
<td class="nump">2.42%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">280.00%<span></span>
</td>
<td class="nump">282.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034558206544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION  (Details) - Nonvested Restricted Stock Shares Activity<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_NonvestedRestrictedStockSharesActivityAbstract', window );"><strong>Nonvested Restricted Stock Shares Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance, non-vested shares | shares</a></td>
<td class="nump">5,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance, Weighted average grant date fair value | $ / shares</a></td>
<td class="nump">$ 1.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted, shares | shares</a></td>
<td class="nump">1,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted average grant date fair value | $ / shares</a></td>
<td class="nump">$ 0.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, shares | shares</a></td>
<td class="num">(2,224)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted average grant date fair value | $ / shares</a></td>
<td class="nump">$ 1.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations', window );">Cancelled/Forfeited, shares | shares</a></td>
<td class="num">(245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled/Forfeited, Weighted average grant date fair value | $ / shares</a></td>
<td class="nump">$ 0.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance, non-vested shares | shares</a></td>
<td class="nump">4,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance, Weighted average grant date fair value | $ / shares</a></td>
<td class="nump">$ 1.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_NonvestedRestrictedStockSharesActivityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_NonvestedRestrictedStockSharesActivityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were either cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034557199808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION  (Details) - Share-based Payment Arrangement, Option, Activity - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ShareBasedPaymentArrangementOptionActivityAbstract', window );"><strong>Share Based Payment Arrangement Option Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Options outstanding, Weighted average grant date fair value</a></td>
<td class="nump">$ 1.39<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, Weighted average exercise price</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted, shares (in Shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised, shares (in Shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled/Forfeited, shares (in Shares)</a></td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Cancelled/Forfeited, Weighted average grant date fair value</a></td>
<td class="nump">$ 1.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled/Forfeited, Weighted average exercise price</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, shares (in Shares)</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ShareBasedPaymentArrangementOptionActivityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ShareBasedPaymentArrangementOptionActivityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034558234208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">$ 3,196<span></span>
</td>
<td class="nump">$ 10,460<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Total cash and cash equivalents</a></td>
<td class="nump">3,196<span></span>
</td>
<td class="nump">10,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">-Marketable securities</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">-Non-marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total Investment</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">3,196<span></span>
</td>
<td class="nump">10,460<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Total cash and cash equivalents</a></td>
<td class="nump">3,196<span></span>
</td>
<td class="nump">10,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">-Marketable securities</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">-Non-marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total Investment</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Total cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">-Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">-Non-marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Total cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">-Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">-Non-marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total Investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034557526432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract', window );"><strong>Schedule Of Effective Income Tax Rate Reconciliation Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Income Loss before tax</a></td>
<td class="num">$ (11,506)<span></span>
</td>
<td class="num">$ (15,016)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Expected income tax recovery</a></td>
<td class="num">$ (2,416)<span></span>
</td>
<td class="num">$ (3,153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign', window );">Impact of tax rate differences in foreign jurisdictions</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Tax rate changes and other adjustments</a></td>
<td class="num">(667)<span></span>
</td>
<td class="num">(385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Permanent differences</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Change in valuation allowance</a></td>
<td class="nump">3,002<span></span>
</td>
<td class="nump">3,488<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Effective income tax rate</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564149552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details) - Schedule of Components of Income Tax Expense (Benefit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract', window );"><strong>Schedule Of Components Of Income Tax Expense Benefit Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Net operating loss carry-forwards foreign</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Non-capital loss carry-forwards &#8211; USA</a></td>
<td class="nump">12,888<span></span>
</td>
<td class="nump">10,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Temporary differences</a></td>
<td class="nump">548<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax asset</a></td>
<td class="nump">13,573<span></span>
</td>
<td class="nump">10,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(13,573)<span></span>
</td>
<td class="num">(10,570)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034557692656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details) - Summary of Operating Loss Carryforwards<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 61,915<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2023Member', window );">Expiring 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2024Member', window );">Expiring 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2025Member', window );">Expiring 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2026Member', window );">Expiring 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2027Member', window );">Expiring 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2028Member', window );">Expiring 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2029Member', window );">Expiring 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2030Member', window );">Expiring 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2031Member', window );">Expiring 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">3,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2032Member', window );">Expiring 2032 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">4,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2033Member', window );">Expiring 2033 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2034Member', window );">Expiring 2034 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">1,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2035Member', window );">Expiring 2035 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">1,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2036Member', window );">Expiring 2036 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">1,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2037Member', window );">Expiring 2037 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2038Member', window );">Expiring 2038 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">1,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2039Member', window );">Expiring 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">4,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2040Member', window );">Expiring 2040 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">7,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2041Member', window );">Expiring 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">8,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2042Member', window );">Expiring 2042 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">14,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2043Member', window );">Expiring 2043 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 11,359<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=igc_Expiring2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034557969328">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details) - Disaggregation of Revenue - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_InfrastructureSegmentAbstract', window );"><strong>Infrastructure segment</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=igc_RentalIncomeMember', window );">Rental Income [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_InfrastructureSegmentAbstract', window );"><strong>Infrastructure segment</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">37<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ConstructionMember', window );">Construction [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_InfrastructureSegmentAbstract', window );"><strong>Infrastructure segment</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">76<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=igc_WellnessAndLifestyleMember', window );">Wellness and Lifestyle [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_InfrastructureSegmentAbstract', window );"><strong>Infrastructure segment</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">416<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=igc_TollingWhiteLabelingServiceMember', window );">Tolling/White labeling service [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_InfrastructureSegmentAbstract', window );"><strong>Infrastructure segment</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 382<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Rental income consists of income from rental of heavy construction equipment.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Construction income consists of the execution of contracts directly or through subcontractors.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Revenue from wellness and lifestyle consists of sale of products such as gummies, hand sanitizers, bath bombs, lotions, beverages, hemp crude extract, hemp isolate, and hemp distillate.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Revenue from white label services consists of rebranding our formulations or the customer&#8217;s products as per customer&#8217;s requirement.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_InfrastructureSegmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_InfrastructureSegmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=igc_RentalIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=igc_RentalIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ConstructionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ConstructionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=igc_WellnessAndLifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=igc_WellnessAndLifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=igc_TollingWhiteLabelingServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=igc_TollingWhiteLabelingServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563849360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034564923952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Details) - Revenue from External Customers by Products and Services - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TotalRevenuePercentage', window );">Percentage of Total Revenue</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=igc_LegacyInfrastructureMember', window );">Legacy Infrastructure [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TotalRevenuePercentage', window );">Percentage of Total Revenue</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=igc_PlantAndCannabinoidMember', window );">Plant and Cannabinoid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 798<span></span>
</td>
<td class="nump">$ 359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TotalRevenuePercentage', window );">Percentage of Total Revenue</a></td>
<td class="nump">88.00%<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_TotalRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of segment to total revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_TotalRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=igc_LegacyInfrastructureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=igc_LegacyInfrastructureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=igc_PlantAndCannabinoidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=igc_PlantAndCannabinoidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034558013664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems', window );"><strong>SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TotalRevenuePercentage', window );">Percentage of Total Revenue</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IN', window );">INDIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems', window );"><strong>SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TotalRevenuePercentage', window );">Percentage of Total Revenue</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems', window );"><strong>SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="nump">$ 777<span></span>
</td>
<td class="nump">$ 329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TotalRevenuePercentage', window );">Percentage of Total Revenue</a></td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">83.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CO', window );">COLOMBIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems', window );"><strong>SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_TotalRevenuePercentage', window );">Percentage of Total Revenue</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_TotalRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of segment to total revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_TotalRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034565124736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Details) - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">8,213<span></span>
</td>
<td class="nump">9,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Claims and advances</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease asset</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">10,712<span></span>
</td>
<td class="nump">11,723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Geographic Distribution, Domestic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,074<span></span>
</td>
<td class="nump">4,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Claims and advances</a></td>
<td class="nump">585<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease asset</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">6,127<span></span>
</td>
<td class="nump">6,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Geographic Distribution, Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,139<span></span>
</td>
<td class="nump">4,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Claims and advances</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease asset</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">$ 4,585<span></span>
</td>
<td class="nump">$ 5,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140034563858016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent Event [Member]<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_igc_SUBSEQUENTEVENTSDetailsLineItems', window );"><strong>SUBSEQUENT EVENTS (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of Credit Facility, Current Borrowing Capacity</a></td>
<td class="nump">$ 12,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in Shares) | shares</a></td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_igc_SUBSEQUENTEVENTSDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">igc_SUBSEQUENTEVENTSDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>igc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>igcpharma20230331_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:igc="http://www.indiaglobalcap.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="igc-20230331.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <instant>2023-07-06</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">igc:ClinicalTrialInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">igc:ClinicalTrialInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="igc:PropertyPlantAndEquipmentTableTypeAxis">igc:PropertyPlantAndEquipmentTableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <instant>2020-06-11</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <startDate>2020-06-11</startDate>
            <endDate>2020-06-11</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
        </entity>
        <period>
            <instant>2021-01-13</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">igc:ESOP2008OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">igc:ESOP2008OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2034Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">igc:Expiring2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:RentalIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:RentalIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:WellnessAndLifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:WellnessAndLifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:TollingWhiteLabelingServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:TollingWhiteLabelingServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:LegacyInfrastructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:LegacyInfrastructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:PlantAndCannabinoidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">igc:PlantAndCannabinoidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326205</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0">001-32830</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">IGC PHARMA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0">20-2760393</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">10224 Falls Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0">Potomac</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">20854</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">983-0998</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">IGC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c0">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0">true</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentFinStmtRestatementRecoveryAnalysisFlag contextRef="c0">true</dei:DocumentFinStmtRestatementRecoveryAnalysisFlag>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c1" decimals="0" unitRef="usd">20812750</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">53077436</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="c0">5341</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-3" unitRef="usd">3196000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="-3" unitRef="usd">10460000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c3" decimals="-3" unitRef="usd">107000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c4" decimals="-3" unitRef="usd">125000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ShortTermInvestments contextRef="c3" decimals="-3" unitRef="usd">154000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c4" decimals="-3" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" unitRef="usd">2651000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c4" decimals="-3" unitRef="usd">3548000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">358000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="-3" unitRef="usd">978000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">6466000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c4" decimals="-3" unitRef="usd">15111000</us-gaap:AssetsCurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="-3" unitRef="usd">1170000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c4" decimals="-3" unitRef="usd">917000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" unitRef="usd">8213000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="-3" unitRef="usd">9419000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">1003000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c4" decimals="-3" unitRef="usd">937000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="-3" unitRef="usd">326000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="-3" unitRef="usd">450000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">10712000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c4" decimals="-3" unitRef="usd">11723000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c3" decimals="-3" unitRef="usd">17178000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c4" decimals="-3" unitRef="usd">26834000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c3" decimals="-3" unitRef="usd">530000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c4" decimals="-3" unitRef="usd">981000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">1368000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c4" decimals="-3" unitRef="usd">1460000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">1898000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c4" decimals="-3" unitRef="usd">2441000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c3" decimals="-3" unitRef="usd">141000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c4" decimals="-3" unitRef="usd">144000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">21000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c4" decimals="-3" unitRef="usd">16000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c3" decimals="-3" unitRef="usd">207000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="-3" unitRef="usd">341000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">369000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c4" decimals="-3" unitRef="usd">501000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c3" decimals="-3" unitRef="usd">2267000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c4" decimals="-3" unitRef="usd">2942000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c4" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c4" decimals="0" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c3" decimals="0" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c4" decimals="0" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c3" decimals="0" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c4" decimals="0" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c3" decimals="-3" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c4" decimals="-3" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c4" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c4" decimals="0" unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="0" unitRef="shares">53077436</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="0" unitRef="shares">53077436</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c4" decimals="0" unitRef="shares">51054017</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c4" decimals="0" unitRef="shares">51054017</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital contextRef="c3" decimals="-3" unitRef="usd">118965000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital contextRef="c4" decimals="-3" unitRef="usd">116019000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c3" decimals="-3" unitRef="usd">-3389000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c4" decimals="-3" unitRef="usd">-2968000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-3" unitRef="usd">-100665000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="-3" unitRef="usd">-89159000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">14911000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-3" unitRef="usd">23892000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">17178000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c4" decimals="-3" unitRef="usd">26834000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">911000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c5" decimals="-3" unitRef="usd">397000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="-3" unitRef="usd">469000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c5" decimals="-3" unitRef="usd">203000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" unitRef="usd">442000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c5" decimals="-3" unitRef="usd">194000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="-3" unitRef="usd">8552000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c5" decimals="-3" unitRef="usd">13292000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" unitRef="usd">3461000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c5" decimals="-3" unitRef="usd">2330000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-11571000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">-15428000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ImpairmentOfInvestments contextRef="c0" decimals="-3" unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="c5" decimals="-3" unitRef="usd">49000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c0" decimals="-3" unitRef="usd">65000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c5" decimals="-3" unitRef="usd">461000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" unitRef="usd">-11506000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c5" decimals="-3" unitRef="usd">-15016000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c0" decimals="-3" unitRef="usd">-11506000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c5" decimals="-3" unitRef="usd">-15016000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c0" decimals="-3" unitRef="usd">-421000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c5" decimals="-3" unitRef="usd">-194000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="-3" unitRef="usd">-11927000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c5" decimals="-3" unitRef="usd">-15210000</us-gaap:ComprehensiveIncomeNetOfTax>
    <igc:EarningsPerShareBasicDiluted contextRef="c0" decimals="2" unitRef="usdPershares">-0.22</igc:EarningsPerShareBasicDiluted>
    <igc:EarningsPerShareBasicDiluted contextRef="c5" decimals="2" unitRef="usdPershares">-0.3</igc:EarningsPerShareBasicDiluted>
    <igc:WeightedAverageNumberOfShareOutstandingBasicDiluted contextRef="c0" decimals="0" unitRef="shares">52576258</igc:WeightedAverageNumberOfShareOutstandingBasicDiluted>
    <igc:WeightedAverageNumberOfShareOutstandingBasicDiluted contextRef="c5" decimals="0" unitRef="shares">49991631</igc:WeightedAverageNumberOfShareOutstandingBasicDiluted>
    <us-gaap:CommonStockSharesOutstanding contextRef="c6" decimals="-3" unitRef="shares">47827000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c7" decimals="-3" unitRef="usd">109720000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c8" decimals="-3" unitRef="usd">-74143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="-3" unitRef="usd">-2774000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="-3" unitRef="usd">32803000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c11" decimals="-3" unitRef="shares">1520000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c12" decimals="-3" unitRef="usd">2197000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c5" decimals="-3" unitRef="usd">2197000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c11" decimals="-3" unitRef="shares">1750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c12" decimals="-3" unitRef="usd">4145000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c5" decimals="-3" unitRef="usd">4145000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c11" decimals="-3" unitRef="shares">-43000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c12" decimals="-3" unitRef="usd">-43000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c5" decimals="-3" unitRef="usd">-43000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:NetIncomeLoss contextRef="c13" decimals="-3" unitRef="usd">-15016000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">-15016000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c14" decimals="-3" unitRef="usd">-194000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c5" decimals="-3" unitRef="usd">-194000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c15" decimals="-3" unitRef="shares">51054000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="-3" unitRef="usd">116019000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="-3" unitRef="usd">-89159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c18" decimals="-3" unitRef="usd">-2968000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-3" unitRef="usd">23892000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c15" decimals="-3" unitRef="shares">51054000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="-3" unitRef="usd">116019000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="-3" unitRef="usd">-89159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c18" decimals="-3" unitRef="usd">-2968000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-3" unitRef="usd">23892000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c19" decimals="-3" unitRef="shares">1815000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c20" decimals="-3" unitRef="usd">2843000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c0" decimals="-3" unitRef="usd">2843000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c19" decimals="-3" unitRef="shares">208000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20" decimals="-3" unitRef="usd">103000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="-3" unitRef="usd">103000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss contextRef="c21" decimals="-3" unitRef="usd">-11506000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-11506000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c22" decimals="-3" unitRef="usd">-421000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c0" decimals="-3" unitRef="usd">-421000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c23" decimals="-3" unitRef="shares">53077000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" unitRef="usd">118965000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="-3" unitRef="usd">-100665000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c26" decimals="-3" unitRef="usd">-3389000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">14911000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss contextRef="c0" decimals="-3" unitRef="usd">-11506000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c5" decimals="-3" unitRef="usd">-15016000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c0" decimals="-3" unitRef="usd">657000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c5" decimals="-3" unitRef="usd">651000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c0" decimals="-3" unitRef="usd">126000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c5" decimals="-3" unitRef="usd">1718000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AssetImpairmentCharges contextRef="c0" decimals="-3" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c5" decimals="-3" unitRef="usd">833000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ImpairmentOfInvestments contextRef="c0" decimals="-3" unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="c5" decimals="-3" unitRef="usd">49000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c0" decimals="-3" unitRef="usd">2843000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c5" decimals="-3" unitRef="usd">2197000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c0" decimals="-3" unitRef="usd">-39000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c5" decimals="-3" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c0" decimals="-3" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c5" decimals="-3" unitRef="usd">430000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c0" decimals="-3" unitRef="usd">-5000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c5" decimals="-3" unitRef="usd">-50000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="-3" unitRef="usd">-897000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c5" decimals="-3" unitRef="usd">-1930000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="-3" unitRef="usd">-591000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c5" decimals="-3" unitRef="usd">-541000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c0" decimals="-3" unitRef="usd">150000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c5" decimals="-3" unitRef="usd">334000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="-3" unitRef="usd">-451000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c5" decimals="-3" unitRef="usd">504000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c0" decimals="-3" unitRef="usd">-88000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c5" decimals="-3" unitRef="usd">-129000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <igc:IncreaseDecreaseInOperatingLeaseAssets contextRef="c0" decimals="-3" unitRef="usd">-124000</igc:IncreaseDecreaseInOperatingLeaseAssets>
    <igc:IncreaseDecreaseInOperatingLeaseAssets contextRef="c5" decimals="-3" unitRef="usd">-38000</igc:IncreaseDecreaseInOperatingLeaseAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c0" decimals="-3" unitRef="usd">-134000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c5" decimals="-3" unitRef="usd">-64000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" unitRef="usd">-7047000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c5" decimals="-3" unitRef="usd">-7462000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" unitRef="usd">310000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c5" decimals="-3" unitRef="usd">236000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c0" decimals="-3" unitRef="usd">538000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c5" decimals="-3" unitRef="usd">29000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c0" decimals="-3" unitRef="usd">154000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c5" decimals="-3" unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c0" decimals="-3" unitRef="usd">309000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c5" decimals="-3" unitRef="usd">535000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" unitRef="usd">-235000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c5" decimals="-3" unitRef="usd">-742000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c0" decimals="-3" unitRef="usd">103000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c5" decimals="-3" unitRef="usd">4145000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromRepaymentsOfDebt contextRef="c0" decimals="-3" unitRef="usd">-3000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfDebt contextRef="c5" decimals="-3" unitRef="usd">-3000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" unitRef="usd">100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c5" decimals="-3" unitRef="usd">4142000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c0" decimals="-3" unitRef="usd">-82000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c5" decimals="-3" unitRef="usd">-26000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-3" unitRef="usd">-7264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c5" decimals="-3" unitRef="usd">-4088000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="-3" unitRef="usd">10460000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c10" decimals="-3" unitRef="usd">14548000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-3" unitRef="usd">3196000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="-3" unitRef="usd">10460000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 contextRef="c0" decimals="-3" unitRef="usd">2842000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 contextRef="c5" decimals="-3" unitRef="usd">2197000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:NotesReduction contextRef="c0" decimals="-3" unitRef="usd">0</us-gaap:NotesReduction>
    <us-gaap:NotesReduction contextRef="c5" decimals="-3" unitRef="usd">430000</us-gaap:NotesReduction>
    <us-gaap:NatureOfOperations contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 1 &lt;/b&gt;&#x2013;&lt;b&gt; NATURE OF OPERATIONS AND MANAGEMENT&lt;/b&gt;&#x2019;&lt;b&gt;S PLANS &lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Since 2014, our team has been committed to researching the application of cannabinoids such as THC and CBD in combination with other compounds to address various ailments, including Alzheimer&#x2019;s disease. With our research, we have developed intellectual property, formulations, and wellness and lifestyle brands. IGC submitted IGC-AD1, our investigational drug candidate for Alzheimer&#x2019;s, to the FDA under Section 505(i) of the Federal Food, Drug, and Cosmetic Act and received approval on July 30, 2020, to proceed with the Phase 1 trial on Alzheimer&#x2019;s patients. The Company completed all dose escalation studies, and as announced by the Company on December 2, 2021, the results of the clinical trial have been submitted in the Clinical/Statistical Report (CSR) filed with the FDA. The Company is motivated by the potential that, with future successful results from appropriate further trials, IGC-AD1 could contribute to relief for some of the 55 million people around the world expected to be impacted by Alzheimer&#x2019;s disease by 2030 (WHO, 2020). To the best of our knowledge, this is the first human clinical trial using ultra-low doses of THC, in combination with another molecule, to treat symptoms of dementia in Alzheimer&#x2019;s patients. THC is a naturally occurring cannabinoid produced by the cannabis plant. It is known for being a psychoactive substance that can impact mental processes in a positive or negative way depending on the dosage. THC is biphasic, meaning that low and high doses of the substance may affect mental and physiological processes in substantially different ways. For example, in some patients, low doses may relieve a symptom, whereas high doses may amplify a symptom. Ultimately, the goal of IGC&#x2019;s research is to discover and analyze whether, and at what level of dosing, IGC-AD1 provides relief of a given symptom. IGC&#x2019;s trial is based on micro dosing on patients suffering from Alzheimer&#x2019;s disease.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company has filed forty-one (41) patent applications to address various diseases such as Alzheimer&#x2019;s, Central Nervous System (&#x201c;CNS&#x201d;) disorders, pain, stammering, seizures in cats and dogs, eating disorders, stress-relief, and calm-restoring beverage, and fatigue. As of March 31, 2023, our portfolio includes nine granted patents.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;In addition, we license a patent filing from the University of South Florida titled &#x201c;Ultra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimer&#x2019;s Disease.&#x201d; The USPTO issued a patent (#11,065,225) for this filing on July 20, 2021.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;As of March 31, 2023, the Company had the following operating subsidiaries: Techni Bharathi Private Limited (TBL), IGCare LLC, Holi Hemp LLC, IGC Pharma LLC, SAN Holdings LLC, Sunday Seltzer, LLC, Hamsa Biopharma India Pvt. Ltd. And Colombia-based beneficially-owned subsidiary IGC Pharma SAS (formerly Hamsa Biopharma Colombia SAS) (Hamsa). The Company&#x2019;s fiscal year is the 52- or 53-week period that ends on March 31. The Company&#x2019; principal office is in Maryland established in 2005. Additionally, the Company have offices in Washington state, Colombia, South America, and India. The Company&#x2019;s filings are available on www.sec.gov.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;IGC has two segments: Life Sciences and Infrastructure. &lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Life Sciences Segment&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Pharmaceutical&lt;/span&gt;&lt;/i&gt;: Since 2014, this part of our business has focused on the potential uses of phytocannabinoids, including THC and Cannabidiol (CBD), in combination with other compounds to treat multiple diseases, including Alzheimer&#x2019;s. In addition, the Company has acquired and initiated work on TGR-63, a non-cannabinoid pre-clinical molecule, that exhibits an impressive affinity for reducing neurotoxicity in Alzheimer&#x2019;s cell lines. Neurotoxicity causes cell dysfunction and death in Alzheimer&#x2019;s disease. If shown to be efficacious, in AD cell lines, in halting this process, this inhibitor has the potential to treat Alzheimer&#x2019;s disease by ameliorating A&#x3b2; plaques.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Over the Counter Products&lt;/span&gt;&lt;/i&gt;: We have created a women&#x2019;s wellness brand, Holief&#x2122; available through online channels that are compliant with relevant federal, state, and local laws, and regulations. Holief&#x2122; is an all-natural, non-GMO, vegan, line of over the counter (OTC) products aimed at treating menstrual cramps (dysmenorrhea) and premenstrual symptoms (PMS). The products are available online and through Amazon and other online channels. Holief&#x2122; is compliant with relevant federal, state, and local laws, and regulations.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Infrastructure Segment&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company&#x2019;s infrastructure business has been operating since 2008, it includes: (i) Execution of Construction Contracts and (ii) Rental of Heavy Construction Equipment.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 2&lt;/b&gt; &#x2013;&lt;b&gt; SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;a) Principles of consolidation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The consolidated financial statements include the accounts of the Company and all its subsidiaries. Intercompany accounts and transactions have been eliminated. In the opinion of the Company&#x2019;s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Transactions between the Company and its subsidiaries are eliminated in the consolidated financial statements.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;b) Use of estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Management believes that the estimates and assumptions used in the preparation of the consolidated financial statements are prudent and reasonable. Significant estimates and assumptions are generally used for, but not limited to allowance for uncollectible accounts receivable; sales returns; normal loss during production; future obligations under employee benefit plans; the useful lives of property, plant, and equipment; intangible assets; valuations; impairment of goodwill and investments; recoverability of advances; the valuation of options granted, and warrants issued; and income tax and deferred tax valuation allowances, if any. Actual results could differ from those estimates. Appropriate changes in estimates are made as management becomes aware of changes in circumstances surrounding the estimates. Critical accounting estimates could change from period to period and could have a material impact on IGC&#x2019;s results, operations, financial position, and cash flows. Changes in estimates are reflected in the financial statements in the period in which changes are made and, if material, their effects are disclosed in the notes to the consolidated financial statements.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;c) Revenue recognition&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company recognizes revenue under ASC 606, &lt;i&gt;Revenue from Contracts with Customers &lt;/i&gt;(&#x201c;ASC 606&#x201d;). The core principle of this standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;ASC 606 prescribes a 5-step process to achieve its core principle. The Company recognizes revenue from trading, rental, or product sales as follows:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;I. Identify the contract with the customer.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;II. Identify the contractual performance obligations.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;III. Determine the amount of consideration/price for the transaction.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;IV. Allocate the determined amount of consideration/price to the contractual obligations.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;V. Recognize revenue when or as the performing party satisfies performance obligations.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The consideration/price for the transaction (performance obligation(s)) is determined as per the agreement or invoice (contract) for the services and products in the Infrastructure segment and Life Sciences segment. Refer to Note 17 &#x2013; &#x201c;Revenue Recognition.&#x201d;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;d) Cost of Revenue&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Our cost of revenue includes costs associated with in-house and outsourced distribution, labor expense, components, manufacturing overhead, and outbound freight for our products division. In our products division, cost of revenue also includes the cost of refurbishing or repackaging, if required, on products returned by customers that will be offered for resale.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;e) Earnings/(Loss) per Share&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The computation of basic loss per share for Fiscal 2023, excludes potentially dilutive securities of approximately shares which includes share options, unvested shares such as restricted shares and restricted share units, granted to employees, non-employees and advisors, and shares from the conversion of outstanding units, if any, because their inclusion would be anti-dilutive.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The weighted average number of shares outstanding for Fiscal 2023 and 2022, used for the computation of basic earnings per share (EPS) is 52,576,258 and 49,991,631, respectively. Due to the loss incurred during Fiscal 2023 and 2022, all the potential equity shares are anti-dilutive, and accordingly, the fully diluted EPS is equal to the basic EPS.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;f) Going Concern:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company assesses and determines its ability to continue as a going concern in accordance with the provisions of ASC Subtopic 205-40, "&lt;i&gt;Presentation of Financial Statements&lt;/i&gt;&#x2014;&lt;i&gt;Going Concern&lt;/i&gt;", which requires the Company to evaluate whether there are conditions or events that raise substantial doubt about its ability to continue as a going concern.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company is currently in a clinical trial stage and, thus, has not yet achieved profitability. The Company expects to continue to incur significant operating and net losses and negative cash flows from operations in the near future.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For the years ended March 31, 2023, and March 31, 2022, the Company incurred net losses of $11.5 million and $15 million, respectively. As of March 31, 2023, the Company&#x2019;s cash and cash equivalents totaled $3.2 million. On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $12 million and, in addition, sold 10,000,000 shares for $3,000,000. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#x2019;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions. Please refer to Note 19, &#x201c;Subsequent Event,&#x201d; for further information.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company estimates that its current cash and cash equivalents balance with working capital and equity investment is sufficient to support operations beyond the twelve months following the date these consolidated financial statements and footnotes were issued. These estimates are based on assumptions that may prove to be wrong, and the Company could use its available capital resources sooner than it currently expects.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;g) Income taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company accounts for income taxes under the asset and liability method, in accordance with ASC 740, Income Taxes, which requires an entity to recognize deferred tax liabilities and assets. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. A valuation allowance is established and recorded when management determines that some or all of the deferred tax assets are not likely to be realized and therefore, it is necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;In evaluating a tax position for recognition, management evaluates whether it is more-likely-than-not that a position will be sustained upon examination, including resolution of related appeals or litigation processes, based on technical merits of the position. If the tax position meets the more-likely-than-not recognition threshold, the tax position is measured and recognized in the Company&#x2019;s financial statements as the largest amount of tax benefit that, in management&#x2019;s judgment, is greater than 50% likely of being realized upon settlement. As of March 31, 2023, and 2022, there was no significant liability for income tax associated with unrecognized tax benefits.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;h) Accounts receivable&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:29pt;"&gt;We make estimates of the collectability of our accounts receivable by analyzing historical payment patterns, customer concentrations, customer creditworthiness, and current economic trends. If the financial condition of a customer deteriorates, additional allowances may be required. We had $107 thousand of accounts receivable, net of provision for doubtful debt of $17 thousand as of March 31, 2023, as compared to $125 thousand of accounts receivable, net of provision for doubtful debt of $93 thousand as of March 31, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;i) Cash and cash equivalents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For financial statement purposes, the Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents. The Company maintains its cash in bank accounts in the U.S., India, Colombia, and Hong Kong, which at times may exceed applicable insurance limits. The cash and cash equivalents in the Company on March 31, 2023, and 2022, were approximately $3,196 thousand and $10,460 thousand, respectively.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;j) Short-term and long-term investments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Our policy for short-term and long-term investments is to establish a high-quality portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations, and delivers an appropriate yield in relation to our investment guidelines and market conditions. Short-term and long-term investments consist of corporate, various government agencies and municipal debt securities, as well as certificates of deposit that have maturity dates that are greater than 90 days. Certificates of deposit and commercial paper are carried at a cost which approximates fair value. Available-for-sale securities: Investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the statement of financial position.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Investments are initially measured at cost, which is the fair value of the consideration given for them, including transaction costs. Where the Company&#x2019;s ownership interest is in excess of 20% and the Company has a significant influence, the Company has accounted for the investment based on the equity method in accordance with ASC Topic 323, &#x201c;&lt;i&gt;Investments &lt;/i&gt;&#x2013;&lt;i&gt; Equity method and Joint Ventures.&lt;/i&gt;&#x201d; Under the equity method, the Company&#x2019;s share of the post-acquisition profits or losses of the equity investee is recognized in the consolidated statements of operations and its share of post-acquisition movements in accumulated other comprehensive income / (loss) is recognized in other comprehensive income / (loss). Where the Company does not have significant influence, the Company has accounted for the investment in accordance with ASC Topic 321, &#x201c;&lt;i&gt;Investments-Equity Securities.&lt;/i&gt;&#x201d;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;As of March 31, 2023, investment in marketable securities is valued at fair value and investment in non-marketable securities with ownership less than 20% is valued at cost as per ASC Topic 321, &#x201c;&lt;i&gt;Investments-Equity Securities.&lt;/i&gt;&#x201d;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;k) Property, plant, and equipment (PP&amp;amp;E) &lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Property, plant, and equipment are recorded at cost net of accumulated depreciation and depreciated over their estimated useful lives using the straight-line method.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Upon retirement or disposition, cost and related accumulated depreciation of the Property, plant and equipment are de-recognized, and any gain or loss is reflected in the results of operation. Cost of additions and substantial improvements to property and equipment are capitalized. The cost of maintenance and repairs of the property and equipment are charged to operating expenses as incurred.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;l) Fair value of financial instruments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;ASC 820, &#x201c;Fair Value Measurement&#x201d; defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Level 1: Observable inputs such as quoted prices in active markets;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The carrying amounts of the Company&#x2019;s financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximately their fair values due to the nature of the items. Please refer to Note 15, &#x201c;Fair value of financial instruments,&#x201d; for further information.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;m) Concentration of credit risk and significant customers&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Financial instruments, which potentially expose the Company to concentrations of credit risk, are primarily comprised of cash and cash equivalents, investments, accounts receivable and unbilled accounts receivable, if any. The Company places its cash investments in highly rated financial institutions. The Company adheres to a formal investment policy with the primary objective of preservation of principal, which contains credit rating minimums and diversification requirements. Management believes its credit policies reflect normal industry terms and business risk. The Company does not anticipate non-performance by the counterparties and, accordingly, does not require collateral. During Fiscal 2023, sales were spread across customers in Asia and U.S. and the credit concentration risk is low.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;n) Stock &lt;/b&gt;&#x2013;&lt;b&gt; Based Compensation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company accounts for stock-based compensation to employees and non-employees in conformity with the provisions of ASC Topic 718, &#x201c;&lt;i&gt;Stock-Based Compensation.&lt;/i&gt;&#x201d; The Company expenses stock-based compensation to employees over the requisite vesting period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards are recognized on a straight-line basis over the requisite vesting period. For stock-based employee compensation the cost recognized at any date will be at least equal to the amount attributable to the share-based compensation that is vested at that date.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For performance-based awards, stock-based compensation expense is recognized over the expected performance achievement period of individual performance milestones when the achievement of each individual performance milestone becomes probable. For performance-based awards with a vesting schedule based entirely on the attainment of performance conditions, stock-based compensation expense associated with each tranche is recognized over the expected achievement period for the operational milestone, beginning at the point in time when the relevant operational milestone is considered probable to be achieved.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For market-based awards, stock-based compensation expense is recognized over the expected achievement period. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company estimates the fair value of stock option grants using the Black-Scholes option-pricing model. The assumptions used in calculating the fair value of stock-based awards represent Management&#x2019;s best estimates. Generally, the closing share price of the Company&#x2019;s common stock on the date of grant is considered the fair value of the share. The volatility factor is determined based on the Company&#x2019;s historical stock prices. The expected term represents the period that our stock-based awards are expected to be outstanding. The Company has never declared or paid any cash dividends. For further information refer to Note 14, &#x201c;Stock-Based Compensation&#x201d; of Notes to Consolidated Financial Statements.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;o) Commitments and contingencies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Liabilities for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. We record associated legal fees as incurred. Information regarding our commitments and contingencies is incorporated by reference in Note 12, &#x201c;Commitments and contingencies&#x201d; of this Annual Report on Form 10-K.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;p) Impairment of long &lt;/b&gt;&#x2013;&lt;b&gt; lived assets&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company reviews its long-lived assets, with finite lives, for impairment whenever events or changes in business circumstances indicate that the carrying amount of assets may not be fully recoverable. Such circumstances include, though are not limited to, significant or sustained declines in revenues or earnings, future anticipated cash flows, business plans, and material adverse changes in the economic climate, such as changes in the operating environment, competitive information, and impact of changes in government policies. For assets that the Company intends to hold for use, if the total of the expected future undiscounted cash flows produced by the assets or subsidiary company is less than the carrying amount of the assets, a loss is recognized for the difference between the fair value and carrying value of the assets. For assets, the Company intends to dispose of by sale, a loss is recognized for the amount by which the estimated fair value less cost to sell is less than the carrying value of the assets. Fair value is determined based on quoted market prices, if available, or other valuation techniques including discounted future net cash flows. Unlike goodwill, long-lived assets are assessed for impairment only where there are any specific indicators for impairment.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;q) Intangible assets&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company&#x2019;s intangible assets are accounted for in accordance with ASC Topic 350, &lt;i&gt;Intangibles &lt;/i&gt;&#x2013;&lt;i&gt; Goodwill and Other. &lt;/i&gt;Intangible assets having indefinite lives are not amortized, but instead are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We perform an impairment analysis on March 1 annually on the indefinite-lived intangible assets following the steps laid out in ASC 350-30-35-18. Our annual impairment analysis includes a qualitative assessment to determine if it is necessary to perform the quantitative impairment test. In performing a qualitative assessment, we review events and circumstances that could affect the significant inputs used to determine if the fair value is less than the carrying value of the intangible assets. If quantitative analysis is necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets will be tested on an interim basis if an event or circumstance indicates that it is more likely than not that an impairment loss has been incurred. The Company has analyzed a variety of factors in light of the known impact to date of the COVID-19 pandemic on its business to determine if a circumstance could trigger an impairment loss, and, at this time and based on the information presently known, does not believe it is more likely than not that an impairment loss has been incurred.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Intangible assets with finite useful lives are amortized using the straight-line method over their estimated period of benefit. In accordance with ASC 360-10-35-21, definite lived intangibles are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company intends to capitalize trademarks and related expenses exceeding $2,500 per trademark. Management may also capitalize trademarks and related expenses up to $2,500 per trademark based on its potential and benefit in coming years.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;r) Inventory&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Inventory is valued at the lower of cost or net realizable value, which is defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Inventory consists of finished goods related to wellness products, hand sanitizers, finished hemp-based products, beverages. Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to primary cost. Inventory is primarily accounted for using the weighted average cost method. Primary costs include raw materials, packaging, direct labor, overhead, shipping, and the depreciation of manufacturing equipment. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;We capitalize inventory costs related to our investigational drug, provided that management determines there is a potential alternative use for the inventory in future research and development projects or other purposes. As of March 31, 2023, and 2022, our consolidated balance sheet reported approximately $407 thousand and no clinical trial-related inventory, respectively.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Abnormal amounts of idle facility expense, freight, handling costs, scrap, discontinued products and wasted material (spoilage) are expensed in the period they are incurred.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Please refer to Note 3, &#x201c;Inventory,&#x201d; for further information.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;s) Cybersecurity&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;We have a cybersecurity policy in place and tighter cybersecurity measures to safeguard against hackers. In Fiscal 2023, there were no impactful breaches in cybersecurity.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;t) Research and Development Expenses&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;During Fiscal 2023 and 2022, the Company recorded research and development expenses of approximately $3.5 million and $2.3 million, respectively. All research and development costs are expensed in the period in which they are incurred.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;u) Leases&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Lessor Accounting&lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Under the current ASU guidance, contract consideration will be allocated to its lease components and non-lease components (such as maintenance). For the Company as a lessor, any non-lease components will be accounted for under ASC Topic 606, &#x201c;&lt;i&gt;Revenue from Contracts with Customers,&lt;/i&gt;&#x201d; unless the Company elects a lessor practical expedient to not separate the non-lease components from the associated lease component. The amendments in ASU 2018-11 also provide lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component if the non-lease components otherwise would be accounted for under the new revenue guidance (Topic 606). To elect the practical expedient, the timing and pattern of transfer of the lease and non-lease components must be the same and the lease component must meet the criteria to be classified as an operating lease if accounted for separately. If these criteria are met, the single component will be accounted for under either Topic 842 or Topic 606 depending on which component(s) are predominant. The lessor practical expedient to not separate non-lease components from the associated component must be elected for all existing and new leases.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;As a lessor, the Company expects that post-adoption substantially all existing leases will have no change in the timing of revenue recognition until their expiration or termination. The Company expects to elect the lessor practical expedient to not separate non-lease components such as maintenance from the associated lease for all existing and new leases and to account for the combined component as a single lease component. The timing of revenue recognition is expected to be the same for the majority of the Company&#x2019;s new leases as compared to similar existing leases; however, certain categories of new leases could have different revenue recognition patterns as compared to similar existing leases.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For leases that are accounted for as operating leases, income is recognized on a straight-line basis over the term of the lease contract. Generally, when a lease is more than 180 days delinquent (where more than three monthly payments are owed), the lease is classified as being nonaccrual and the Company stops recognizing leasing income on that date. Payments received on leases in nonaccrual status generally reduce the lease receivable. Leases on nonaccrual status remain classified as such until there is sustained payment performance that, in the Company&#x2019;s judgment, would indicate that all contractual amounts will be collected in full.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Lessee Accounting&lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company adopted ASU 2016-02 effective April 1, 2019, using the modified retrospective approach. The standard establishes a right-of-use model (ROU) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. In connection with the adoption, the Company will elect to utilize the modified retrospective presentation whereby the Company will continue to present prior period financial statements and disclosures under ASC Topic 840. In addition, the Company will elect the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and initial direct costs. Further, the Company will adopt a short-term lease exception policy, permitting us to not apply the recognition requirements of this standard to short-term leases (i.e., leases with terms of 12 months or less), and an accounting policy to account for lease and non-lease components as a single component for certain classes of assets.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Under ASU 2016-02 (Topic 842), lessees are required to recognize the following for all leases (with the exception of short-term leases) on the commencement date: (i) lease liability, which is a lessee&#x2019;s obligation to make lease payments arising from a lease, measured on a discounted basis; and (ii) right-of-use asset, which is an asset that represents the lessee&#x2019;s right to use, or control the use of, a specified asset for the lease term.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;At the commencement date, the Company recognizes the lease liability at the present value of the lease payments not yet paid, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#x2019;s incremental borrowing rate for the same term as the underlying lease. The right-of-use asset is recognized initially at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. There was no impairment for right-of-use lease assets as of March 31, 2023.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company categorizes leases at their inception as either operating or finance leases. On certain lease agreements, the Company may receive rent holidays and other incentives. The Company recognizes lease costs on a straight-line basis without regard to deferred payment terms, such as rent holidays, that defer the commencement date of required payments. Please refer to Note 9, &#x201c;Leases,&#x201d; for further information.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;v) Recently issued and adopted accounting pronouncements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Changes to U.S. GAAP are established by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) in the form of accounting standards updates (ASUs) to the FASB&#x2019;s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Newly issued ASUs not listed are expected to have no impact on the Company&#x2019;s consolidated financial position and results of operations, because either the ASU is not applicable, or the impact is expected to be immaterial.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0">Principles of consolidation&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The consolidated financial statements include the accounts of the Company and all its subsidiaries. Intercompany accounts and transactions have been eliminated. In the opinion of the Company&#x2019;s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Transactions between the Company and its subsidiaries are eliminated in the consolidated financial statements.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0">Use of estimates&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Management believes that the estimates and assumptions used in the preparation of the consolidated financial statements are prudent and reasonable. Significant estimates and assumptions are generally used for, but not limited to allowance for uncollectible accounts receivable; sales returns; normal loss during production; future obligations under employee benefit plans; the useful lives of property, plant, and equipment; intangible assets; valuations; impairment of goodwill and investments; recoverability of advances; the valuation of options granted, and warrants issued; and income tax and deferred tax valuation allowances, if any. Actual results could differ from those estimates. Appropriate changes in estimates are made as management becomes aware of changes in circumstances surrounding the estimates. Critical accounting estimates could change from period to period and could have a material impact on IGC&#x2019;s results, operations, financial position, and cash flows. Changes in estimates are reflected in the financial statements in the period in which changes are made and, if material, their effects are disclosed in the notes to the consolidated financial statements.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0">Revenue recognition&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company recognizes revenue under ASC 606, &lt;i&gt;Revenue from Contracts with Customers &lt;/i&gt;(&#x201c;ASC 606&#x201d;). The core principle of this standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;ASC 606 prescribes a 5-step process to achieve its core principle. The Company recognizes revenue from trading, rental, or product sales as follows:&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;I. Identify the contract with the customer.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;II. Identify the contractual performance obligations.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;III. Determine the amount of consideration/price for the transaction.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;IV. Allocate the determined amount of consideration/price to the contractual obligations.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;V. Recognize revenue when or as the performing party satisfies performance obligations.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The consideration/price for the transaction (performance obligation(s)) is determined as per the agreement or invoice (contract) for the services and products in the Infrastructure segment and Life Sciences segment. Refer to Note 17 &#x2013; &#x201c;Revenue Recognition.&#x201d;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="c0">Cost of Revenue&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Our cost of revenue includes costs associated with in-house and outsourced distribution, labor expense, components, manufacturing overhead, and outbound freight for our products division. In our products division, cost of revenue also includes the cost of refurbishing or repackaging, if required, on products returned by customers that will be offered for resale.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">Earnings/(Loss) per Share&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The computation of basic loss per share for Fiscal 2023, excludes potentially dilutive securities of approximately shares which includes share options, unvested shares such as restricted shares and restricted share units, granted to employees, non-employees and advisors, and shares from the conversion of outstanding units, if any, because their inclusion would be anti-dilutive.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The weighted average number of shares outstanding for Fiscal 2023 and 2022, used for the computation of basic earnings per share (EPS) is 52,576,258 and 49,991,631, respectively. Due to the loss incurred during Fiscal 2023 and 2022, all the potential equity shares are anti-dilutive, and accordingly, the fully diluted EPS is equal to the basic EPS.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c0" decimals="0" unitRef="shares">52576258</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c5" decimals="0" unitRef="shares">49991631</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <igc:GoingConcernPolicyPolicyTextblock contextRef="c0">Going Concern:&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company assesses and determines its ability to continue as a going concern in accordance with the provisions of ASC Subtopic 205-40, "&lt;i&gt;Presentation of Financial Statements&lt;/i&gt;&#x2014;&lt;i&gt;Going Concern&lt;/i&gt;", which requires the Company to evaluate whether there are conditions or events that raise substantial doubt about its ability to continue as a going concern.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company is currently in a clinical trial stage and, thus, has not yet achieved profitability. The Company expects to continue to incur significant operating and net losses and negative cash flows from operations in the near future.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For the years ended March 31, 2023, and March 31, 2022, the Company incurred net losses of $11.5 million and $15 million, respectively. As of March 31, 2023, the Company&#x2019;s cash and cash equivalents totaled $3.2 million. On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $12 million and, in addition, sold 10,000,000 shares for $3,000,000. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#x2019;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions. Please refer to Note 19, &#x201c;Subsequent Event,&#x201d; for further information.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company estimates that its current cash and cash equivalents balance with working capital and equity investment is sufficient to support operations beyond the twelve months following the date these consolidated financial statements and footnotes were issued. These estimates are based on assumptions that may prove to be wrong, and the Company could use its available capital resources sooner than it currently expects.&lt;/p&gt;</igc:GoingConcernPolicyPolicyTextblock>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-5" unitRef="usd">-11500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-6" unitRef="usd">-15000000</us-gaap:NetIncomeLoss>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity contextRef="c27" decimals="-6" unitRef="usd">12000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c28" decimals="0" unitRef="shares">10000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c28" decimals="0" unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">Income taxes&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company accounts for income taxes under the asset and liability method, in accordance with ASC 740, Income Taxes, which requires an entity to recognize deferred tax liabilities and assets. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. A valuation allowance is established and recorded when management determines that some or all of the deferred tax assets are not likely to be realized and therefore, it is necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;In evaluating a tax position for recognition, management evaluates whether it is more-likely-than-not that a position will be sustained upon examination, including resolution of related appeals or litigation processes, based on technical merits of the position. If the tax position meets the more-likely-than-not recognition threshold, the tax position is measured and recognized in the Company&#x2019;s financial statements as the largest amount of tax benefit that, in management&#x2019;s judgment, is greater than 50% likely of being realized upon settlement. As of March 31, 2023, and 2022, there was no significant liability for income tax associated with unrecognized tax benefits.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c0">Accounts receivable&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:29pt;"&gt;We make estimates of the collectability of our accounts receivable by analyzing historical payment patterns, customer concentrations, customer creditworthiness, and current economic trends. If the financial condition of a customer deteriorates, additional allowances may be required. We had $107 thousand of accounts receivable, net of provision for doubtful debt of $17 thousand as of March 31, 2023, as compared to $125 thousand of accounts receivable, net of provision for doubtful debt of $93 thousand as of March 31, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AccountsReceivableNet contextRef="c3" decimals="-3" unitRef="usd">107000</us-gaap:AccountsReceivableNet>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c3" decimals="-3" unitRef="usd">17000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet contextRef="c4" decimals="-3" unitRef="usd">125000</us-gaap:AccountsReceivableNet>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c4" decimals="-3" unitRef="usd">93000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0">Cash and cash equivalents&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For financial statement purposes, the Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents. The Company maintains its cash in bank accounts in the U.S., India, Colombia, and Hong Kong, which at times may exceed applicable insurance limits. The cash and cash equivalents in the Company on March 31, 2023, and 2022, were approximately $3,196 thousand and $10,460 thousand, respectively.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-3" unitRef="usd">3196000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="-3" unitRef="usd">10460000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c0">Short-term and long-term investments&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Our policy for short-term and long-term investments is to establish a high-quality portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations, and delivers an appropriate yield in relation to our investment guidelines and market conditions. Short-term and long-term investments consist of corporate, various government agencies and municipal debt securities, as well as certificates of deposit that have maturity dates that are greater than 90 days. Certificates of deposit and commercial paper are carried at a cost which approximates fair value. Available-for-sale securities: Investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the statement of financial position.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Investments are initially measured at cost, which is the fair value of the consideration given for them, including transaction costs. Where the Company&#x2019;s ownership interest is in excess of 20% and the Company has a significant influence, the Company has accounted for the investment based on the equity method in accordance with ASC Topic 323, &#x201c;&lt;i&gt;Investments &lt;/i&gt;&#x2013;&lt;i&gt; Equity method and Joint Ventures.&lt;/i&gt;&#x201d; Under the equity method, the Company&#x2019;s share of the post-acquisition profits or losses of the equity investee is recognized in the consolidated statements of operations and its share of post-acquisition movements in accumulated other comprehensive income / (loss) is recognized in other comprehensive income / (loss). Where the Company does not have significant influence, the Company has accounted for the investment in accordance with ASC Topic 321, &#x201c;&lt;i&gt;Investments-Equity Securities.&lt;/i&gt;&#x201d;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;As of March 31, 2023, investment in marketable securities is valued at fair value and investment in non-marketable securities with ownership less than 20% is valued at cost as per ASC Topic 321, &#x201c;&lt;i&gt;Investments-Equity Securities.&lt;/i&gt;&#x201d;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0">Property, plant, and equipment (PP&amp;amp;E) &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Property, plant, and equipment are recorded at cost net of accumulated depreciation and depreciated over their estimated useful lives using the straight-line method.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Upon retirement or disposition, cost and related accumulated depreciation of the Property, plant and equipment are de-recognized, and any gain or loss is reflected in the results of operation. Cost of additions and substantial improvements to property and equipment are capitalized. The cost of maintenance and repairs of the property and equipment are charged to operating expenses as incurred.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0">Fair value of financial instruments&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;ASC 820, &#x201c;Fair Value Measurement&#x201d; defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Level 1: Observable inputs such as quoted prices in active markets;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The carrying amounts of the Company&#x2019;s financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximately their fair values due to the nature of the items. Please refer to Note 15, &#x201c;Fair value of financial instruments,&#x201d; for further information.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0">Concentration of credit risk and significant customers&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Financial instruments, which potentially expose the Company to concentrations of credit risk, are primarily comprised of cash and cash equivalents, investments, accounts receivable and unbilled accounts receivable, if any. The Company places its cash investments in highly rated financial institutions. The Company adheres to a formal investment policy with the primary objective of preservation of principal, which contains credit rating minimums and diversification requirements. Management believes its credit policies reflect normal industry terms and business risk. The Company does not anticipate non-performance by the counterparties and, accordingly, does not require collateral. During Fiscal 2023, sales were spread across customers in Asia and U.S. and the credit concentration risk is low.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0">Stock &#x2013;&lt;b&gt; Based Compensation&lt;/b&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company accounts for stock-based compensation to employees and non-employees in conformity with the provisions of ASC Topic 718, &#x201c;&lt;i&gt;Stock-Based Compensation.&lt;/i&gt;&#x201d; The Company expenses stock-based compensation to employees over the requisite vesting period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards are recognized on a straight-line basis over the requisite vesting period. For stock-based employee compensation the cost recognized at any date will be at least equal to the amount attributable to the share-based compensation that is vested at that date.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For performance-based awards, stock-based compensation expense is recognized over the expected performance achievement period of individual performance milestones when the achievement of each individual performance milestone becomes probable. For performance-based awards with a vesting schedule based entirely on the attainment of performance conditions, stock-based compensation expense associated with each tranche is recognized over the expected achievement period for the operational milestone, beginning at the point in time when the relevant operational milestone is considered probable to be achieved.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For market-based awards, stock-based compensation expense is recognized over the expected achievement period. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company estimates the fair value of stock option grants using the Black-Scholes option-pricing model. The assumptions used in calculating the fair value of stock-based awards represent Management&#x2019;s best estimates. Generally, the closing share price of the Company&#x2019;s common stock on the date of grant is considered the fair value of the share. The volatility factor is determined based on the Company&#x2019;s historical stock prices. The expected term represents the period that our stock-based awards are expected to be outstanding. The Company has never declared or paid any cash dividends. For further information refer to Note 14, &#x201c;Stock-Based Compensation&#x201d; of Notes to Consolidated Financial Statements.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c0">Commitments and contingencies&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Liabilities for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. We record associated legal fees as incurred. Information regarding our commitments and contingencies is incorporated by reference in Note 12, &#x201c;Commitments and contingencies&#x201d; of this Annual Report on Form 10-K.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c0">Impairment of long &#x2013;&lt;b&gt; lived assets&lt;/b&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company reviews its long-lived assets, with finite lives, for impairment whenever events or changes in business circumstances indicate that the carrying amount of assets may not be fully recoverable. Such circumstances include, though are not limited to, significant or sustained declines in revenues or earnings, future anticipated cash flows, business plans, and material adverse changes in the economic climate, such as changes in the operating environment, competitive information, and impact of changes in government policies. For assets that the Company intends to hold for use, if the total of the expected future undiscounted cash flows produced by the assets or subsidiary company is less than the carrying amount of the assets, a loss is recognized for the difference between the fair value and carrying value of the assets. For assets, the Company intends to dispose of by sale, a loss is recognized for the amount by which the estimated fair value less cost to sell is less than the carrying value of the assets. Fair value is determined based on quoted market prices, if available, or other valuation techniques including discounted future net cash flows. Unlike goodwill, long-lived assets are assessed for impairment only where there are any specific indicators for impairment.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c0">Intangible assets&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company&#x2019;s intangible assets are accounted for in accordance with ASC Topic 350, &lt;i&gt;Intangibles &lt;/i&gt;&#x2013;&lt;i&gt; Goodwill and Other. &lt;/i&gt;Intangible assets having indefinite lives are not amortized, but instead are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We perform an impairment analysis on March 1 annually on the indefinite-lived intangible assets following the steps laid out in ASC 350-30-35-18. Our annual impairment analysis includes a qualitative assessment to determine if it is necessary to perform the quantitative impairment test. In performing a qualitative assessment, we review events and circumstances that could affect the significant inputs used to determine if the fair value is less than the carrying value of the intangible assets. If quantitative analysis is necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets will be tested on an interim basis if an event or circumstance indicates that it is more likely than not that an impairment loss has been incurred. The Company has analyzed a variety of factors in light of the known impact to date of the COVID-19 pandemic on its business to determine if a circumstance could trigger an impairment loss, and, at this time and based on the information presently known, does not believe it is more likely than not that an impairment loss has been incurred.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Intangible assets with finite useful lives are amortized using the straight-line method over their estimated period of benefit. In accordance with ASC 360-10-35-21, definite lived intangibles are reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company intends to capitalize trademarks and related expenses exceeding $2,500 per trademark. Management may also capitalize trademarks and related expenses up to $2,500 per trademark based on its potential and benefit in coming years.&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="c0">Inventory&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Inventory is valued at the lower of cost or net realizable value, which is defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Inventory consists of finished goods related to wellness products, hand sanitizers, finished hemp-based products, beverages. Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to primary cost. Inventory is primarily accounted for using the weighted average cost method. Primary costs include raw materials, packaging, direct labor, overhead, shipping, and the depreciation of manufacturing equipment. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;We capitalize inventory costs related to our investigational drug, provided that management determines there is a potential alternative use for the inventory in future research and development projects or other purposes. As of March 31, 2023, and 2022, our consolidated balance sheet reported approximately $407 thousand and no clinical trial-related inventory, respectively.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Abnormal amounts of idle facility expense, freight, handling costs, scrap, discontinued products and wasted material (spoilage) are expensed in the period they are incurred.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Please refer to Note 3, &#x201c;Inventory,&#x201d; for further information.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryNet contextRef="c29" decimals="-3" unitRef="usd">407000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c30" decimals="-3" unitRef="usd">0</us-gaap:InventoryNet>
    <igc:CybersecurityPolicyPolicyTextBlock contextRef="c0">Cybersecurity&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;We have a cybersecurity policy in place and tighter cybersecurity measures to safeguard against hackers. In Fiscal 2023, there were no impactful breaches in cybersecurity.&lt;/p&gt;</igc:CybersecurityPolicyPolicyTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock contextRef="c0">Research and Development Expenses&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;During Fiscal 2023 and 2022, the Company recorded research and development expenses of approximately $3.5 million and $2.3 million, respectively. All research and development costs are expensed in the period in which they are incurred.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-5" unitRef="usd">3500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c5" decimals="-5" unitRef="usd">2300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0">Leases&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Lessor Accounting&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Under the current ASU guidance, contract consideration will be allocated to its lease components and non-lease components (such as maintenance). For the Company as a lessor, any non-lease components will be accounted for under ASC Topic 606, &#x201c;&lt;i&gt;Revenue from Contracts with Customers,&lt;/i&gt;&#x201d; unless the Company elects a lessor practical expedient to not separate the non-lease components from the associated lease component. The amendments in ASU 2018-11 also provide lessors with a practical expedient, by class of underlying asset, to not separate non-lease components from the associated lease component and, instead, to account for those components as a single component if the non-lease components otherwise would be accounted for under the new revenue guidance (Topic 606). To elect the practical expedient, the timing and pattern of transfer of the lease and non-lease components must be the same and the lease component must meet the criteria to be classified as an operating lease if accounted for separately. If these criteria are met, the single component will be accounted for under either Topic 842 or Topic 606 depending on which component(s) are predominant. The lessor practical expedient to not separate non-lease components from the associated component must be elected for all existing and new leases.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;As a lessor, the Company expects that post-adoption substantially all existing leases will have no change in the timing of revenue recognition until their expiration or termination. The Company expects to elect the lessor practical expedient to not separate non-lease components such as maintenance from the associated lease for all existing and new leases and to account for the combined component as a single lease component. The timing of revenue recognition is expected to be the same for the majority of the Company&#x2019;s new leases as compared to similar existing leases; however, certain categories of new leases could have different revenue recognition patterns as compared to similar existing leases.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For leases that are accounted for as operating leases, income is recognized on a straight-line basis over the term of the lease contract. Generally, when a lease is more than 180 days delinquent (where more than three monthly payments are owed), the lease is classified as being nonaccrual and the Company stops recognizing leasing income on that date. Payments received on leases in nonaccrual status generally reduce the lease receivable. Leases on nonaccrual status remain classified as such until there is sustained payment performance that, in the Company&#x2019;s judgment, would indicate that all contractual amounts will be collected in full.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Lessee Accounting&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company adopted ASU 2016-02 effective April 1, 2019, using the modified retrospective approach. The standard establishes a right-of-use model (ROU) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. In connection with the adoption, the Company will elect to utilize the modified retrospective presentation whereby the Company will continue to present prior period financial statements and disclosures under ASC Topic 840. In addition, the Company will elect the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and initial direct costs. Further, the Company will adopt a short-term lease exception policy, permitting us to not apply the recognition requirements of this standard to short-term leases (i.e., leases with terms of 12 months or less), and an accounting policy to account for lease and non-lease components as a single component for certain classes of assets.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Under ASU 2016-02 (Topic 842), lessees are required to recognize the following for all leases (with the exception of short-term leases) on the commencement date: (i) lease liability, which is a lessee&#x2019;s obligation to make lease payments arising from a lease, measured on a discounted basis; and (ii) right-of-use asset, which is an asset that represents the lessee&#x2019;s right to use, or control the use of, a specified asset for the lease term.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;At the commencement date, the Company recognizes the lease liability at the present value of the lease payments not yet paid, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#x2019;s incremental borrowing rate for the same term as the underlying lease. The right-of-use asset is recognized initially at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All right-of-use assets are reviewed for impairment. There was no impairment for right-of-use lease assets as of March 31, 2023.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company categorizes leases at their inception as either operating or finance leases. On certain lease agreements, the Company may receive rent holidays and other incentives. The Company recognizes lease costs on a straight-line basis without regard to deferred payment terms, such as rent holidays, that defer the commencement date of required payments. Please refer to Note 9, &#x201c;Leases,&#x201d; for further information.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0">Recently issued and adopted accounting pronouncements&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Changes to U.S. GAAP are established by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) in the form of accounting standards updates (ASUs) to the FASB&#x2019;s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Newly issued ASUs not listed are expected to have no impact on the Company&#x2019;s consolidated financial position and results of operations, because either the ASU is not applicable, or the impact is expected to be immaterial.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 3 &lt;/b&gt;&#x2013;&lt;b&gt; INVENTORY&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1635" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-1636" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1637" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1638" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1639" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1640" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1641" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1642" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1643" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Raw materials&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1644" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1645" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1646" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2,100&lt;/td&gt;
			&lt;td id="new_id-1647" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1648" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1649" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1650" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2,247&lt;/td&gt;
			&lt;td id="new_id-1651" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Work-in-progress&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1652" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1653" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1654" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;18&lt;/td&gt;
			&lt;td id="new_id-1655" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1656" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1657" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1658" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;584&lt;/td&gt;
			&lt;td id="new_id-1659" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Finished goods&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1660" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1661" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1662" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;533&lt;/td&gt;
			&lt;td id="new_id-1663" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1664" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1665" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1666" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;717&lt;/td&gt;
			&lt;td id="new_id-1667" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1668" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1669" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1670" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;2,651&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1671" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1672" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1673" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1674" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;3,548&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1675" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Work-and in-progress consist of products in the manufacturing process as on reporting date, including but not limited to gummies, tincture, and hemp derivatives. Finished goods comprise, but is not limited to, hand sanitizers, gummies, lotions, and beverages, among others.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;During Fiscal 2023, the Company charged $376 thousand of inventory in selling, general and administration due to product expiration, handling costs, scrap, and wasted material (spoilage) as compared to approximately $252 thousand for Fiscal 2022. This charge was recorded in Selling, general, and administrative expenses.&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1635" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-1636" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1637" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1638" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1639" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1640" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1641" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1642" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1643" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Raw materials&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1644" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1645" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1646" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2,100&lt;/td&gt;
			&lt;td id="new_id-1647" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1648" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1649" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1650" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2,247&lt;/td&gt;
			&lt;td id="new_id-1651" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Work-in-progress&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1652" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1653" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1654" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;18&lt;/td&gt;
			&lt;td id="new_id-1655" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1656" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1657" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1658" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;584&lt;/td&gt;
			&lt;td id="new_id-1659" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Finished goods&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1660" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1661" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1662" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;533&lt;/td&gt;
			&lt;td id="new_id-1663" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1664" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1665" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1666" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;717&lt;/td&gt;
			&lt;td id="new_id-1667" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1668" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1669" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1670" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;2,651&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1671" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1672" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1673" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1674" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;3,548&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1675" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials contextRef="c3" decimals="-3" unitRef="usd">2100000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="c4" decimals="-3" unitRef="usd">2247000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess contextRef="c3" decimals="-3" unitRef="usd">18000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="c4" decimals="-3" unitRef="usd">584000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods contextRef="c3" decimals="-3" unitRef="usd">533000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c4" decimals="-3" unitRef="usd">717000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" unitRef="usd">2651000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c4" decimals="-3" unitRef="usd">3548000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown contextRef="c0" decimals="-3" unitRef="usd">376000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c5" decimals="-3" unitRef="usd">252000</us-gaap:InventoryWriteDown>
    <igc:DepositsAndAdvancesTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;NOTE 4 &lt;/b&gt;&#x2013;&lt;b&gt; DEPOSITS AND ADVANCES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1676" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-1677" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1678" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1679" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1680" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1681" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1682" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1683" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1684" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Advances to suppliers and consultants&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1685" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1686" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1687" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;72&lt;/td&gt;
			&lt;td id="new_id-1688" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1689" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1690" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1691" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;170&lt;/td&gt;
			&lt;td id="new_id-1692" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Other receivables and deposits&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1693" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1694" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1695" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;24&lt;/td&gt;
			&lt;td id="new_id-1696" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1697" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1698" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1699" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;472&lt;/td&gt;
			&lt;td id="new_id-1700" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Prepaid expense and other current assets&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1701" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1702" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1703" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;262&lt;/td&gt;
			&lt;td id="new_id-1704" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1705" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1706" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1707" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;336&lt;/td&gt;
			&lt;td id="new_id-1708" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1709" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1710" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1711" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;358&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1712" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1713" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1714" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1715" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;978&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1716" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Advances to suppliers and consultants primarily relate to advances to suppliers in our Life Sciences and Infrastructure segment. Prepaid and other current assets include approximately $25 thousand in statutory advances for Fiscal 2023, as compared to $170 thousand in Fiscal 2022. The Company decided to move advances paid to suppliers worth approximately $164 thousand to claims and advances, considering recovering might take more than 12 months.&lt;/p&gt;</igc:DepositsAndAdvancesTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1676" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-1677" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1678" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1679" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1680" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1681" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1682" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1683" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1684" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Advances to suppliers and consultants&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1685" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1686" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1687" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;72&lt;/td&gt;
			&lt;td id="new_id-1688" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1689" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1690" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1691" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;170&lt;/td&gt;
			&lt;td id="new_id-1692" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Other receivables and deposits&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1693" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1694" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1695" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;24&lt;/td&gt;
			&lt;td id="new_id-1696" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1697" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1698" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1699" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;472&lt;/td&gt;
			&lt;td id="new_id-1700" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Prepaid expense and other current assets&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1701" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1702" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1703" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;262&lt;/td&gt;
			&lt;td id="new_id-1704" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1705" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1706" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1707" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;336&lt;/td&gt;
			&lt;td id="new_id-1708" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1709" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1710" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1711" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;358&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1712" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1713" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1714" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1715" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;978&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1716" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c3" decimals="-3" unitRef="usd">72000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c4" decimals="-3" unitRef="usd">170000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherInventoryNetOfReserves contextRef="c3" decimals="-3" unitRef="usd">24000</us-gaap:OtherInventoryNetOfReserves>
    <us-gaap:OtherInventoryNetOfReserves contextRef="c4" decimals="-3" unitRef="usd">472000</us-gaap:OtherInventoryNetOfReserves>
    <us-gaap:OtherAssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">262000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c4" decimals="-3" unitRef="usd">336000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">358000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="-3" unitRef="usd">978000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <igc:StatutoryAdvances contextRef="c3" decimals="-3" unitRef="usd">25000</igc:StatutoryAdvances>
    <igc:StatutoryAdvances contextRef="c4" decimals="-3" unitRef="usd">170000</igc:StatutoryAdvances>
    <igc:TransferFromDepositsAndAdvancesToClaimsAndAdvances contextRef="c0" decimals="-3" unitRef="usd">164000</igc:TransferFromDepositsAndAdvancesToClaimsAndAdvances>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 5 &lt;/b&gt;&#x2013;&lt;b&gt; INTANGIBLE ASSETS &lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;Amortized intangible assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1717" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-1718" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1719" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1720" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1721" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1722" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1723" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1724" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1725" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Patents&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1726" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1727" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1728" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;709&lt;/td&gt;
			&lt;td id="new_id-1729" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1730" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1731" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1732" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;290&lt;/td&gt;
			&lt;td id="new_id-1733" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Other intangibles&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1734" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1735" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1736" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;34&lt;/td&gt;
			&lt;td id="new_id-1737" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1738" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1739" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1740" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;32&lt;/td&gt;
			&lt;td id="new_id-1741" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Accumulated amortization&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1742" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1743" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1744" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(107&lt;/td&gt;
			&lt;td id="new_id-1745" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-1746" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1747" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1748" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(51&lt;/td&gt;
			&lt;td id="new_id-1749" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total amortized intangible assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1750" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1751" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1752" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;636&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1753" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1754" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1755" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1756" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;271&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1757" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1758"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1759"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1760"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1761"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1762"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1763"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1764"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1765"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;Unamortized intangible assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1766" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1767" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1768" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1769" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1770" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1771" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1772" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1773" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Patents&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1774" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1775" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1776" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;534&lt;/td&gt;
			&lt;td id="new_id-1777" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1778" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1779" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1780" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;646&lt;/td&gt;
			&lt;td id="new_id-1781" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Other intangibles&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1782" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1783" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1784" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-1785" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1786" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1787" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1788" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-1789" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total unamortized intangible assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1790" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1791" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1792" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;534&lt;/td&gt;
			&lt;td id="new_id-1793" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1794" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1795" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1796" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;646&lt;/td&gt;
			&lt;td id="new_id-1797" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total intangible assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1798" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1799" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1800" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;1,170&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1801" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1802" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1803" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1804" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;917&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1805" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The value of intangible assets includes the cost of acquiring patent rights, supporting data, and the expense associated with filing of forty-one (41) patent applications in different countries along with nine (9) granted patents. It also includes acquisition costs related to domains, and licenses.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The amortization of patent and patent rights with finite life is up to 20 years, commencing from the date of grant or acquisition. The amortization expense in Fiscal 2023 and 2022 amounted to approximately $57 thousand and $24 thousand, respectively.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company regularly reviews its intangible assets to determine if any intangible asset is other-than-temporarily impaired, which would require the Company to record an impairment charge in the period and concluded that, as of March 31, 2023, there was no impairment.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;"&gt;

		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Estimated amortization expense&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands) &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;($)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2024&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;62&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2025&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;69&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2026&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;75&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2027&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;83&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2028&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;91&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;Amortized intangible assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1717" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-1718" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1719" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1720" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1721" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1722" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1723" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1724" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1725" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Patents&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1726" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1727" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1728" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;709&lt;/td&gt;
			&lt;td id="new_id-1729" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1730" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1731" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1732" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;290&lt;/td&gt;
			&lt;td id="new_id-1733" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Other intangibles&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1734" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1735" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1736" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;34&lt;/td&gt;
			&lt;td id="new_id-1737" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1738" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1739" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1740" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;32&lt;/td&gt;
			&lt;td id="new_id-1741" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Accumulated amortization&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1742" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1743" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1744" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(107&lt;/td&gt;
			&lt;td id="new_id-1745" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-1746" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1747" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1748" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(51&lt;/td&gt;
			&lt;td id="new_id-1749" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total amortized intangible assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1750" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1751" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1752" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;636&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1753" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1754" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1755" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1756" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;271&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1757" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1758"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1759"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1760"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1761"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1762"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1763"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1764"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1765"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;Unamortized intangible assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1766" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1767" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1768" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1769" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1770" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1771" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1772" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-1773" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/i&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Patents&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1774" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1775" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1776" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;534&lt;/td&gt;
			&lt;td id="new_id-1777" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1778" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1779" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1780" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;646&lt;/td&gt;
			&lt;td id="new_id-1781" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Other intangibles&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1782" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1783" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1784" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-1785" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1786" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1787" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1788" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-1789" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total unamortized intangible assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1790" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1791" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1792" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;534&lt;/td&gt;
			&lt;td id="new_id-1793" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1794" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1795" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1796" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;646&lt;/td&gt;
			&lt;td id="new_id-1797" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total intangible assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1798" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1799" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1800" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;1,170&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1801" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1802" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1803" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1804" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;917&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1805" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c31" decimals="-3" unitRef="usd">709000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c32" decimals="-3" unitRef="usd">290000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c33" decimals="-3" unitRef="usd">34000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c34" decimals="-3" unitRef="usd">32000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c3" decimals="-3" unitRef="usd">107000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c4" decimals="-3" unitRef="usd">51000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c3" decimals="-3" unitRef="usd">636000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c4" decimals="-3" unitRef="usd">271000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c35" decimals="-3" unitRef="usd">534000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c36" decimals="-3" unitRef="usd">646000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c37" decimals="-3" unitRef="usd">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c38" decimals="-3" unitRef="usd">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c3" decimals="-3" unitRef="usd">534000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c4" decimals="-3" unitRef="usd">646000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="-3" unitRef="usd">1170000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c4" decimals="-3" unitRef="usd">917000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <igc:NumberOfPatents contextRef="c0" decimals="0" unitRef="pure">41</igc:NumberOfPatents>
    <igc:NumberOfPatentsGranted contextRef="c0" decimals="0" unitRef="pure">9</igc:NumberOfPatentsGranted>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c31">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c0" decimals="-3" unitRef="usd">57000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c5" decimals="-3" unitRef="usd">24000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;"&gt;

		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Estimated amortization expense&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands) &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;($)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2024&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;62&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2025&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;69&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2026&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;75&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2027&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;83&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;For the year ended 2028&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;91&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c3" decimals="-3" unitRef="usd">62000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c3" decimals="-3" unitRef="usd">69000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c3" decimals="-3" unitRef="usd">75000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c3" decimals="-3" unitRef="usd">83000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c3" decimals="-3" unitRef="usd">91000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 6 &lt;/b&gt;&#x2013;&lt;b&gt; PROPERTY, PLANT, AND EQUIPMENT&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1806" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="9" id="new_id-1807" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands, except useful life)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1808" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1809" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="1" id="new_id-1810" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; vertical-align: top;"&gt;&lt;b&gt;Useful Life (years)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1811" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1812" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1813" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1814" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1815" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1816" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1817" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Land&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1818" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1819" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;N/A&lt;/td&gt;
			&lt;td id="new_id-1820" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1821" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1822" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1823" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,100&lt;/td&gt;
			&lt;td id="new_id-1824" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1825" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1826" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1827" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,438&lt;/td&gt;
			&lt;td id="new_id-1828" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Buildings and facilities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1829" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1830" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;25&lt;/td&gt;
			&lt;td id="new_id-1831" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1832" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1833" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1834" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2,298&lt;/td&gt;
			&lt;td id="new_id-1835" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1836" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1837" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1838" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2,810&lt;/td&gt;
			&lt;td id="new_id-1839" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Plant and machinery&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1840" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1841" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;5-20&lt;/td&gt;
			&lt;td id="new_id-1842" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1843" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1844" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1845" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;3,335&lt;/td&gt;
			&lt;td id="new_id-1846" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1847" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1848" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1849" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,593&lt;/td&gt;
			&lt;td id="new_id-1850" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Computer equipment&#x2019;s&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1851" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1852" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;3&lt;/td&gt;
			&lt;td id="new_id-1853" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1854" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1855" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1856" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;138&lt;/td&gt;
			&lt;td id="new_id-1857" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1858" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1859" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1860" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;241&lt;/td&gt;
			&lt;td id="new_id-1861" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Office equipment&#x2019;s&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1862" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1863" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;3-5&lt;/td&gt;
			&lt;td id="new_id-1864" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1865" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1866" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1867" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;84&lt;/td&gt;
			&lt;td id="new_id-1868" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1869" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1870" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1871" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;145&lt;/td&gt;
			&lt;td id="new_id-1872" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Furniture and fixtures&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1873" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1874" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;5&lt;/td&gt;
			&lt;td id="new_id-1875" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1876" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1877" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1878" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;92&lt;/td&gt;
			&lt;td id="new_id-1879" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1880" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1881" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1882" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;141&lt;/td&gt;
			&lt;td id="new_id-1883" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Vehicles&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1884" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1885" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;5&lt;/td&gt;
			&lt;td id="new_id-1886" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1887" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1888" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1889" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;102&lt;/td&gt;
			&lt;td id="new_id-1890" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1891" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1892" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1893" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;163&lt;/td&gt;
			&lt;td id="new_id-1894" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Construction in progress&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1895" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1896" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;N/A&lt;/td&gt;
			&lt;td id="new_id-1897" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1898" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1899" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1900" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-1901" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1902" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1903" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1904" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;108&lt;/td&gt;
			&lt;td id="new_id-1905" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total gross value&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1906" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1907" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1908" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1909" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1910" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1911" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;10,149&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1912" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1913" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1914" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1915" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;12,639&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1916" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Less: Accumulated depreciation&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1917" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1918" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1919" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1920" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1921" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1922" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1,936&lt;/td&gt;
			&lt;td id="new_id-1923" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-1924" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1925" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1926" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(3,220&lt;/td&gt;
			&lt;td id="new_id-1927" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total property, plant and equipment, net&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1928" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1929" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1930" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1931" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1932" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1933" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;8,213&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1934" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1935" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1936" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1937" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;9,419&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1938" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The depreciation expense in Fiscal 2023 and 2022 amounted to approximately $600 thousand and $627 thousand, respectively. The net decrease in total property, plant, and equipment (net) is primarily due to depreciation and foreign exchange translations because of a decrease in value of foreign currencies. In addition, Fiscal 2023, the Company disposed of fully depreciated assets in the amount of approximately $1.6 million from its subsidiaries. This resulted in a reduction in the value of total gross assets but did not affect the net value of assets as the disposed assets had previously been fully depreciated. The Company sold a property in Puerto Rico for net proceeds of approximately $485 thousand (acquired for approximately $480 thousand) and accounted for a profit of approximately $5 thousand in other income. For more information, please refer to Note 18, &#x201c;Segment Information&#x201d; for the non-current assets other than financial instruments held in the country of domicile and foreign countries.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c41">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1806" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="9" id="new_id-1807" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands, except useful life)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1808" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1809" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="1" id="new_id-1810" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; vertical-align: top;"&gt;&lt;b&gt;Useful Life (years)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1811" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1812" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1813" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1814" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1815" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1816" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1817" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Land&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1818" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1819" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;N/A&lt;/td&gt;
			&lt;td id="new_id-1820" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1821" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1822" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1823" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,100&lt;/td&gt;
			&lt;td id="new_id-1824" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1825" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1826" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1827" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,438&lt;/td&gt;
			&lt;td id="new_id-1828" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Buildings and facilities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1829" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1830" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;25&lt;/td&gt;
			&lt;td id="new_id-1831" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1832" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1833" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1834" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2,298&lt;/td&gt;
			&lt;td id="new_id-1835" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1836" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1837" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1838" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2,810&lt;/td&gt;
			&lt;td id="new_id-1839" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Plant and machinery&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1840" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1841" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;5-20&lt;/td&gt;
			&lt;td id="new_id-1842" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1843" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1844" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1845" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;3,335&lt;/td&gt;
			&lt;td id="new_id-1846" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1847" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1848" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1849" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,593&lt;/td&gt;
			&lt;td id="new_id-1850" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Computer equipment&#x2019;s&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1851" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1852" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;3&lt;/td&gt;
			&lt;td id="new_id-1853" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1854" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1855" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1856" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;138&lt;/td&gt;
			&lt;td id="new_id-1857" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1858" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1859" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1860" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;241&lt;/td&gt;
			&lt;td id="new_id-1861" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Office equipment&#x2019;s&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1862" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1863" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;3-5&lt;/td&gt;
			&lt;td id="new_id-1864" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1865" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1866" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1867" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;84&lt;/td&gt;
			&lt;td id="new_id-1868" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1869" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1870" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1871" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;145&lt;/td&gt;
			&lt;td id="new_id-1872" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Furniture and fixtures&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1873" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1874" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;5&lt;/td&gt;
			&lt;td id="new_id-1875" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1876" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1877" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1878" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;92&lt;/td&gt;
			&lt;td id="new_id-1879" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1880" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1881" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1882" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;141&lt;/td&gt;
			&lt;td id="new_id-1883" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Vehicles&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1884" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1885" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;5&lt;/td&gt;
			&lt;td id="new_id-1886" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1887" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1888" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1889" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;102&lt;/td&gt;
			&lt;td id="new_id-1890" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1891" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1892" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1893" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;163&lt;/td&gt;
			&lt;td id="new_id-1894" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Construction in progress&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1895" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1896" style="width: 12%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; text-align: center;"&gt;N/A&lt;/td&gt;
			&lt;td id="new_id-1897" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1898" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1899" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1900" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-1901" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1902" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1903" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1904" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;108&lt;/td&gt;
			&lt;td id="new_id-1905" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total gross value&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1906" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1907" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1908" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1909" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1910" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1911" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;10,149&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1912" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1913" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1914" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1915" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;12,639&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1916" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Less: Accumulated depreciation&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1917" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1918" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1919" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1920" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1921" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1922" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1,936&lt;/td&gt;
			&lt;td id="new_id-1923" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-1924" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1925" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1926" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(3,220&lt;/td&gt;
			&lt;td id="new_id-1927" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total property, plant and equipment, net&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1928" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1929" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1930" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1931" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1932" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1933" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;8,213&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1934" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1935" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1936" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1937" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;9,419&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1938" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <igc:PropertyPlantAndEquipmentEstimatedUsefulLives1 contextRef="c42">N/A</igc:PropertyPlantAndEquipmentEstimatedUsefulLives1>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c43" decimals="-3" unitRef="usd">4100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c44" decimals="-3" unitRef="usd">4438000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c45">P25Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c45" decimals="-3" unitRef="usd">2298000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c46" decimals="-3" unitRef="usd">2810000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c47">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c48">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c49" decimals="-3" unitRef="usd">3335000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c50" decimals="-3" unitRef="usd">4593000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c51">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c51" decimals="-3" unitRef="usd">138000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c52" decimals="-3" unitRef="usd">241000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c53">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c54">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c55" decimals="-3" unitRef="usd">84000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c56" decimals="-3" unitRef="usd">145000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c57">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c57" decimals="-3" unitRef="usd">92000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c58" decimals="-3" unitRef="usd">141000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c59">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c59" decimals="-3" unitRef="usd">102000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c60" decimals="-3" unitRef="usd">163000</us-gaap:PropertyPlantAndEquipmentGross>
    <igc:PropertyPlantAndEquipmentEstimatedUsefulLives1 contextRef="c61">N/A</igc:PropertyPlantAndEquipmentEstimatedUsefulLives1>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c62" decimals="-3" unitRef="usd">108000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c3" decimals="-3" unitRef="usd">10149000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c4" decimals="-3" unitRef="usd">12639000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c3" decimals="-3" unitRef="usd">1936000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c4" decimals="-3" unitRef="usd">3220000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" unitRef="usd">8213000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="-3" unitRef="usd">9419000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" unitRef="usd">600000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c5" decimals="-3" unitRef="usd">627000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentDisposals contextRef="c0" decimals="-5" unitRef="usd">1600000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c39" decimals="-3" unitRef="usd">485000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentOwnedGross contextRef="c40" decimals="-3" unitRef="usd">480000</us-gaap:PropertyPlantAndEquipmentOwnedGross>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c39" decimals="-3" unitRef="usd">5000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;NOTE 8 &lt;/b&gt;&#x2013;&lt;b&gt; CLAIMS AND ADVANCES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1939" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-1940" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1941" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1942" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1943" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1944" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1945" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1946" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1947" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Claims receivable (1)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1948" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1949" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1950" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;951&lt;/td&gt;
			&lt;td id="new_id-1951" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1952" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1953" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1954" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;368&lt;/td&gt;
			&lt;td id="new_id-1955" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Non-current deposits&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1956" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1957" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1958" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;27&lt;/td&gt;
			&lt;td id="new_id-1959" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1960" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1961" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1962" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-1963" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Non-current advances&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1964" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1965" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1966" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;25&lt;/td&gt;
			&lt;td id="new_id-1967" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1968" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1969" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1970" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;569&lt;/td&gt;
			&lt;td id="new_id-1971" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1972" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1973" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1974" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;1,003&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1975" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1976" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1977" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1978" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;937&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1979" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"&gt;	&lt;tr&gt;	&lt;td style="vertical-align:top;width:2.3%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;(1)&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:top;width:43.4%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The claims receivable is due from different vendors. While the Company has initiated collection proceedings internally or with the appropriate authorities, it believes receiving the amount in the next 12 months will be challenging because of the time required for collection proceedings. The Company decided to move advances paid to some suppliers worth approximately $164 thousand to claims and advances, considering recovering might take more than 12 months. Includes $140 thousand owed to one of our manufacturers for the equipment purchase.&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;
&lt;/table&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1939" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-1940" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1941" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1942" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1943" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1944" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1945" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1946" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1947" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Claims receivable (1)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1948" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1949" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1950" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;951&lt;/td&gt;
			&lt;td id="new_id-1951" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1952" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1953" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1954" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;368&lt;/td&gt;
			&lt;td id="new_id-1955" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Non-current deposits&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1956" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1957" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1958" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;27&lt;/td&gt;
			&lt;td id="new_id-1959" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1960" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1961" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1962" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-1963" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Non-current advances&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1964" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1965" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1966" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;25&lt;/td&gt;
			&lt;td id="new_id-1967" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1968" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1969" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1970" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;569&lt;/td&gt;
			&lt;td id="new_id-1971" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1972" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1973" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1974" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;1,003&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1975" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1976" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1977" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1978" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;937&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-1979" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"&gt;	&lt;tr&gt;	&lt;td style="vertical-align:top;width:2.3%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;(1)&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:top;width:43.4%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The claims receivable is due from different vendors. While the Company has initiated collection proceedings internally or with the appropriate authorities, it believes receiving the amount in the next 12 months will be challenging because of the time required for collection proceedings. The Company decided to move advances paid to some suppliers worth approximately $164 thousand to claims and advances, considering recovering might take more than 12 months. Includes $140 thousand owed to one of our manufacturers for the equipment purchase.&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:OtherReceivables contextRef="c3" decimals="-3" id="ix_0_fact" unitRef="usd">951000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="c4" decimals="-3" id="ix_1_fact" unitRef="usd">368000</us-gaap:OtherReceivables>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">27000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c4" decimals="-3" unitRef="usd">0</us-gaap:DepositsAssetsNoncurrent>
    <igc:OtherAdvances contextRef="c3" decimals="-3" unitRef="usd">25000</igc:OtherAdvances>
    <igc:OtherAdvances contextRef="c4" decimals="-3" unitRef="usd">569000</igc:OtherAdvances>
    <us-gaap:OtherAssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">1003000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c4" decimals="-3" unitRef="usd">937000</us-gaap:OtherAssetsNoncurrent>
    <igc:TransferFromDepositsAndAdvancesToClaimsAndAdvances contextRef="c0" decimals="-3" unitRef="usd">164000</igc:TransferFromDepositsAndAdvancesToClaimsAndAdvances>
    <us-gaap:PaymentsForDeposits contextRef="c0" decimals="0" unitRef="usd">140</us-gaap:PaymentsForDeposits>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 9 &lt;/b&gt;&#x2013;&lt;b&gt; LEASES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company has short-term leases primarily consisting of spaces with the remaining lease term being less than or equal to 12 months. The total short- term lease expense and cash paid for Fiscal 2023 and 2022 are approximately $178 thousand. The Company also has four operating leases as of March 31, 2023.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;&lt;b&gt;&lt;i&gt;America&lt;/i&gt;&lt;/b&gt;: In November 2019, the Company entered into a lease agreement with a lease term of less than 12 months. This lease was amended in March 2020, with a new lease term from March 1, 2020, to November 30, 2025. The annual lease expense is approximately $123 thousand. The lease contract does not contain any material residual value guarantees or material restrictive covenants. The remaining lease term for the operating lease is 2.7 years with a discount rate of 7%. The lease does not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;&lt;b&gt;&lt;i&gt;Asia&lt;/i&gt;&lt;/b&gt;: The Company renewed three lease agreements for terms between three to four years, expiring between 2023 and 2024. The total annual lease expense is approximately $25 thousand. The lease contracts do not contain any material residual value guarantees or material restrictive covenants. The remaining lease term for the operating leases is between 1 - 1.7 years with a discount rate of 7%. The lease does not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1980" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1981" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1982" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1983" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1984" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1985" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease costs&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1986" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1987" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1988" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;148&lt;/td&gt;
			&lt;td id="new_id-1989" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1990" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1991" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1992" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;149&lt;/td&gt;
			&lt;td id="new_id-1993" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Short term lease costs&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1994" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1995" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1996" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;178&lt;/td&gt;
			&lt;td id="new_id-1997" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1998" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1999" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2000" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;178&lt;/td&gt;
			&lt;td id="new_id-2001" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total lease costs&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2002" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2003" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2004" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;326&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2005" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2006" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2007" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2008" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;327&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2009" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;Right of use assets and lease liabilities for our operating leases were recorded in the consolidated balance sheet as follows:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2010" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2011" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2012" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2013" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2014" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2015" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2016" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2017" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2018" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2019" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2020" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2021" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2022" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2023" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2024" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2025" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2026" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2027" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2028" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2029" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease asset&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2030" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2031" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2032" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;326&lt;/td&gt;
			&lt;td id="new_id-2033" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2034" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2035" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2036" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;450&lt;/td&gt;
			&lt;td id="new_id-2037" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total lease assets &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2038" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2039" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2040" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;326&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2041" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2042" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2043" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2044" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;450&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2045" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2046"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2047"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2048"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2049"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2050"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2051"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2052"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2053"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2054" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2055" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2056" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2057" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2058" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2059" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2060" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2061" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Current liabilities:&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2062" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2063" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2064" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2065" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2066" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2067" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2068" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2069" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Accrued liabilities and others (current portion &#x2013; operating lease liability)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2070" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2071" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2072" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;133&lt;/td&gt;
			&lt;td id="new_id-2073" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2074" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2075" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2076" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;123&lt;/td&gt;
			&lt;td id="new_id-2077" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Noncurrent liabilities:&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2078" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2079" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2080" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2081" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2082" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2083" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2084" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2085" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease liability (non-current portion &#x2013; operating lease liability)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2086" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2087" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2088" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;207&lt;/td&gt;
			&lt;td id="new_id-2089" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2090" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2091" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2092" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;341&lt;/td&gt;
			&lt;td id="new_id-2093" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total lease liability &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2094" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2095" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2096" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;340&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2097" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2098" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2099" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2100" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;464&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2101" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Supplemental cash flow and non-cash information related to leases is as follows:&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2102" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2103" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2104" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2105" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2106" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2107" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2108" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2109" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2110" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2111" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2112" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2113" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2114" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2115" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#x2013;Operating cash flows from operating leases&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2116" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2117" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2118" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;118&lt;/td&gt;
			&lt;td id="new_id-2119" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2120" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2121" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2122" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;109&lt;/td&gt;
			&lt;td id="new_id-2123" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Right-of-use assets obtained in exchange for operating lease obligations&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2124" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2125" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2126" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;326&lt;/td&gt;
			&lt;td id="new_id-2127" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2128" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2129" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2130" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;450&lt;/td&gt;
			&lt;td id="new_id-2131" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td colspan="4" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;As of March 31, 2023, the following table summarizes the maturity of our lease liabilities:&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2132" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2133"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2134"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2135"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2136"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 81%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Mar-24&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2137" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2138" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2139" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;151&lt;/td&gt;
			&lt;td id="new_id-2140" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Mar-25&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2141" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2142" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2143" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;133&lt;/td&gt;
			&lt;td id="new_id-2144" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Mar-26&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2145" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2146" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2147" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;87&lt;/td&gt;
			&lt;td id="new_id-2148" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Mar-27&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2149" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2150" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2151" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2152" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Less: Present value discount&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2153" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2154" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2155" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(31&lt;/td&gt;
			&lt;td id="new_id-2156" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total Lease liabilities&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2157" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2158" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2159" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;340&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2160" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:ShortTermLeaseCost contextRef="c0" decimals="-3" unitRef="usd">178000</us-gaap:ShortTermLeaseCost>
    <us-gaap:OperatingLeaseExpense contextRef="c63" decimals="-3" unitRef="usd">123000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c64">P2Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c64" decimals="2" unitRef="pure">0.07</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:OperatingLeaseExpense contextRef="c65" decimals="-3" unitRef="usd">25000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c66">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c67">P1Y8M12D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c68" decimals="2" unitRef="pure">0.07</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LeaseCostTableTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1980" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1981" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1982" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1983" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-1984" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1985" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease costs&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1986" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1987" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1988" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;148&lt;/td&gt;
			&lt;td id="new_id-1989" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1990" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1991" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1992" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;149&lt;/td&gt;
			&lt;td id="new_id-1993" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Short term lease costs&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-1994" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1995" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1996" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;178&lt;/td&gt;
			&lt;td id="new_id-1997" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1998" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-1999" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2000" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;178&lt;/td&gt;
			&lt;td id="new_id-2001" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total lease costs&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2002" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2003" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2004" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;326&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2005" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2006" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2007" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2008" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;327&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2009" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2010" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2011" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2012" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2013" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2014" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2015" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2016" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2017" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2018" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2019" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2020" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2021" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2022" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2023" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2024" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2025" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2026" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2027" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2028" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2029" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease asset&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2030" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2031" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2032" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;326&lt;/td&gt;
			&lt;td id="new_id-2033" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2034" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2035" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2036" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;450&lt;/td&gt;
			&lt;td id="new_id-2037" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total lease assets &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2038" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2039" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2040" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;326&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2041" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2042" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2043" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2044" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;450&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2045" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2046"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2047"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2048"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2049"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2050"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2051"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2052"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2053"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2054" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2055" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2056" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2057" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2058" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2059" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2060" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2061" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Current liabilities:&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2062" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2063" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2064" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2065" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2066" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2067" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2068" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2069" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Accrued liabilities and others (current portion &#x2013; operating lease liability)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2070" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2071" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2072" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;133&lt;/td&gt;
			&lt;td id="new_id-2073" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2074" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2075" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2076" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;123&lt;/td&gt;
			&lt;td id="new_id-2077" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Noncurrent liabilities:&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2078" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2079" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2080" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2081" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2082" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2083" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2084" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2085" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease liability (non-current portion &#x2013; operating lease liability)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2086" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2087" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2088" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;207&lt;/td&gt;
			&lt;td id="new_id-2089" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2090" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2091" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2092" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;341&lt;/td&gt;
			&lt;td id="new_id-2093" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total lease liability &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2094" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2095" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2096" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;340&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2097" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2098" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2099" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2100" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;464&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2101" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Supplemental cash flow and non-cash information related to leases is as follows:&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2102" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2103" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2104" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2105" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2106" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2107" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2108" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2109" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2110" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2111" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2112" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2113" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2114" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2115" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#x2013;Operating cash flows from operating leases&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2116" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2117" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2118" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;118&lt;/td&gt;
			&lt;td id="new_id-2119" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2120" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2121" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2122" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;109&lt;/td&gt;
			&lt;td id="new_id-2123" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Right-of-use assets obtained in exchange for operating lease obligations&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2124" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2125" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2126" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;326&lt;/td&gt;
			&lt;td id="new_id-2127" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2128" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2129" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2130" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;450&lt;/td&gt;
			&lt;td id="new_id-2131" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c0" decimals="-3" unitRef="usd">148000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c5" decimals="-3" unitRef="usd">149000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c0" decimals="-3" unitRef="usd">178000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c5" decimals="-3" unitRef="usd">178000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost contextRef="c0" decimals="-3" unitRef="usd">326000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c5" decimals="-3" unitRef="usd">327000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="-3" unitRef="usd">326000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="-3" unitRef="usd">450000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="-3" unitRef="usd">326000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="-3" unitRef="usd">450000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c3" decimals="-3" unitRef="usd">133000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="-3" unitRef="usd">123000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c3" decimals="-3" unitRef="usd">207000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="-3" unitRef="usd">341000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c3" decimals="-3" unitRef="usd">340000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c4" decimals="-3" unitRef="usd">464000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments contextRef="c0" decimals="-3" unitRef="usd">118000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c5" decimals="-3" unitRef="usd">109000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c0" decimals="-3" unitRef="usd">326000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c5" decimals="-3" unitRef="usd">450000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td colspan="4" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;As of March 31, 2023, the following table summarizes the maturity of our lease liabilities:&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2132" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2133"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2134"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2135"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2136"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 81%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Mar-24&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2137" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2138" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2139" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;151&lt;/td&gt;
			&lt;td id="new_id-2140" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Mar-25&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2141" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2142" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2143" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;133&lt;/td&gt;
			&lt;td id="new_id-2144" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Mar-26&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2145" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2146" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2147" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;87&lt;/td&gt;
			&lt;td id="new_id-2148" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Mar-27&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2149" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2150" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2151" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2152" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Less: Present value discount&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2153" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2154" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2155" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(31&lt;/td&gt;
			&lt;td id="new_id-2156" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total Lease liabilities&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2157" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2158" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2159" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;340&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2160" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c3" decimals="-3" unitRef="usd">151000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c3" decimals="-3" unitRef="usd">133000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c3" decimals="-3" unitRef="usd">87000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c3" decimals="-3" unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c3" decimals="-3" unitRef="usd">31000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c3" decimals="-3" unitRef="usd">340000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <igc:AccruedLiabilitiesDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 10 &lt;/b&gt;&#x2013;&lt;b&gt; ACCRUED LIABILITIES AND OTHERS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2161" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2162" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2163" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2164" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2165" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2166" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2167" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2168" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2169" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Compensation and other contributions&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2170" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2171" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2172" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;619&lt;/td&gt;
			&lt;td id="new_id-2173" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2174" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2175" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2176" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,054&lt;/td&gt;
			&lt;td id="new_id-2177" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Provision for expenses&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2178" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2179" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2180" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;258&lt;/td&gt;
			&lt;td id="new_id-2181" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2182" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2183" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2184" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;103&lt;/td&gt;
			&lt;td id="new_id-2185" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Short-term lease liability&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2186" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2187" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2188" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;133&lt;/td&gt;
			&lt;td id="new_id-2189" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2190" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2191" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2192" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;123&lt;/td&gt;
			&lt;td id="new_id-2193" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Other current liability&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2194" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2195" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2196" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;358&lt;/td&gt;
			&lt;td id="new_id-2197" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2198" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2199" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2200" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;180&lt;/td&gt;
			&lt;td id="new_id-2201" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2202" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2203" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2204" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;1,368&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2205" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2206" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2207" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2208" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;1,460&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2209" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Compensation and other contribution-related liabilities consist of accrued salaries to employees. In addition, provision for expenses includes provision for legal, professional, and marketing expenses. Other current liability also includes statutory payables of approximately $31 thousand and 55 thousand as of March 31, 2023, and March 31, 2022, respectively, and approximately $3 thousand of short-term loans as of March 31, 2023, and March 31, 2022, respectively.&lt;/p&gt;</igc:AccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2161" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2162" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2163" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2164" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2165" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2166" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2167" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2168" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2169" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Compensation and other contributions&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2170" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2171" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2172" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;619&lt;/td&gt;
			&lt;td id="new_id-2173" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2174" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2175" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2176" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,054&lt;/td&gt;
			&lt;td id="new_id-2177" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Provision for expenses&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2178" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2179" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2180" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;258&lt;/td&gt;
			&lt;td id="new_id-2181" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2182" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2183" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2184" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;103&lt;/td&gt;
			&lt;td id="new_id-2185" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Short-term lease liability&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2186" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2187" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2188" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;133&lt;/td&gt;
			&lt;td id="new_id-2189" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2190" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2191" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2192" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;123&lt;/td&gt;
			&lt;td id="new_id-2193" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Other current liability&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2194" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2195" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2196" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;358&lt;/td&gt;
			&lt;td id="new_id-2197" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2198" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2199" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2200" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;180&lt;/td&gt;
			&lt;td id="new_id-2201" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2202" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2203" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2204" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;1,368&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2205" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2206" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2207" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2208" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;1,460&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2209" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">619000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c4" decimals="-3" unitRef="usd">1054000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">258000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c4" decimals="-3" unitRef="usd">103000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c3" decimals="-3" unitRef="usd">133000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="-3" unitRef="usd">123000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">358000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c4" decimals="-3" unitRef="usd">180000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">1368000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c4" decimals="-3" unitRef="usd">1460000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c3" decimals="-3" unitRef="usd">31000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c4" decimals="-3" unitRef="usd">55000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:ShortTermBorrowings contextRef="c3" decimals="-3" unitRef="usd">3000</us-gaap:ShortTermBorrowings>
    <igc:LoansAndOtherLiabilitiesTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 11 &lt;/b&gt;&#x2013;&lt;b&gt; LOANS AND OTHER LIABILITIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Loan as of March 31, 2023:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;On June 11, 2020, the Company received an Economic Injury Disaster Loan (EIDL) for approximately $150 thousand at an annual interest rate of 3.75%. The Company must pay principal and interest payments of $731 every month beginning June 5, 2021. The SBA will apply each installment payment first to pay interest accrued to the day SBA receives the payment and will then apply any remaining balance to reduce principal. All remaining principal and accrued interest are due and payable 30 years from the date of the loan. For Fiscal 2023, the interest expense and principal payment for the EIDL were approximately $5 thousand and $3 thousand, respectively. As of March 31, 2023, approximately $141 thousand of the loan is classified as Long-term loans and approximately $3 thousand as Short-term loans.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Other Liability:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2210" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2211" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands) &lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2212" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2213" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2214" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of March 31,&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2215" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2216" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2217" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2218" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2219" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2220" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2221" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="text-align: justify; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Statutory reserve&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2222" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2223" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2224" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;21&lt;/td&gt;
			&lt;td id="new_id-2225" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2226" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2227" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2228" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;16&lt;/td&gt;
			&lt;td id="new_id-2229" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="text-align: justify; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Total&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2230" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2231" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2232" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;21&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2233" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2234" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2235" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2236" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;16&lt;/td&gt;
			&lt;td id="new_id-2237" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The statutory reserve is a gratuity reserve for employees in our subsidiaries in India.&lt;/p&gt;</igc:LoansAndOtherLiabilitiesTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c69" decimals="-3" unitRef="usd">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c69" decimals="4" unitRef="pure">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="c70" decimals="-3" unitRef="usd">731000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentTerm contextRef="c70">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:InterestExpenseDebt contextRef="c0" decimals="-3" unitRef="usd">5000</us-gaap:InterestExpenseDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c0" decimals="-3" unitRef="usd">3000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermLoansPayable contextRef="c3" decimals="-3" unitRef="usd">141000</us-gaap:LongTermLoansPayable>
    <us-gaap:LoansPayableCurrent contextRef="c3" decimals="-3" unitRef="usd">3000</us-gaap:LoansPayableCurrent>
    <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock contextRef="c0">&lt;i&gt;Other Liability:&lt;/i&gt;&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2210" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2211" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands) &lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2212" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2213" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2214" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;As of March 31,&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2215" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2216" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2217" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2218" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2219" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2220" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2221" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="text-align: justify; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Statutory reserve&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2222" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2223" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2224" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;21&lt;/td&gt;
			&lt;td id="new_id-2225" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2226" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2227" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2228" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;16&lt;/td&gt;
			&lt;td id="new_id-2229" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="text-align: justify; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Total&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2230" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2231" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2232" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;21&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2233" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2234" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2235" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2236" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;16&lt;/td&gt;
			&lt;td id="new_id-2237" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">21000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="c4" decimals="-3" unitRef="usd">16000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">21000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c4" decimals="-3" unitRef="usd">16000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 12 &lt;/b&gt;&#x2013;&lt;b&gt; COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company may be involved in legal proceedings, claims, and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. There are no such matters that are deemed material to the consolidated financial statements as of March 31, 2023, except as disclosed in Item 3 &#x2013; Legal Proceedings, and Note 19 - Subsequent Events.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;In the U.S., we provide health insurance, life insurance, and a 401(k) plan wherein the Company matches up to 6% of the employee&#x2019;s pre-tax contribution up to a maximum annual amount determined by the IRS. In addition, under applicable Indian laws, the Company provides for gratuity, a defined benefit retirement plan (Gratuity Plan) covering certain categories of employees. The Gratuity Plan provides a lump sum payment to vested employees, at retirement or termination of employment, an amount based on the respective employee&#x2019;s last drawn salary and the years of employment with the Company. In addition, employees receive benefits from a provident fund, a defined contribution plan. The employee and employer each make monthly contributions to the plan equal to 12% of the covered employee&#x2019;s salary. The contribution is made to the Indian Government&#x2019;s provident fund.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch contextRef="c0" decimals="2" unitRef="pure">0.06</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="c0" decimals="2" unitRef="pure">0.12</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 13 &lt;/b&gt;&#x2013; &lt;b&gt;SECURITIES &lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;As of March 31, 2023, the Company was authorized to issue up to 150,000,000 shares of common stock, par value $0.0001 per share, and 53,077,436 shares of common stock were issued and outstanding. The Company is also authorized to issue up to 1,000,000 shares of preferred stock, par value $0.0001 per share, and no preferred shares were issued and outstanding as of March 31, 2023. We have one security listed on the NYSE American: common stock, $0.0001 par value (ticker symbol: IGC). This security also trades on the Frankfurt, Stuttgart, and Berlin stock exchanges (ticker symbol: IGS1).&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company also has 91,472 units outstanding that can be separated into common stock. Ten units may be separated into one share of common stock. The unit holders are requested to contact the Company or our transfer agent, Continental Stock Transfer &amp;amp; Trust, to separate their units into common stock.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;On January 13, 2021, the Company entered into a Sales Agreement (the Agreement) with The Benchmark Company, LLC (Benchmark or the Sales Agent) pursuant to which the Sales Agent is acting as the Company&#x2019;s sales agent with respect to the issuance and sale of up to $75,000,000 of the Company&#x2019;s shares of common stock, par value $0.0001 per share (the Shares), from time to time in an &#x201c;at the market&#x201d; (ATM) offering as defined in Rule 415(a)(4) of the Securities Act of 1933, as amended (the Offering). During Fiscal 2023, the Company raised approximately $103 thousand from the ATM, net of commission. The management may use these funds for working capital and capital expenditure requirements, along with clinical trials, share repurchases, debt repayments, investments, including but not limited to, mutual funds, treasury bonds, cryptocurrencies, and other asset classes.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="0" unitRef="shares">53077436</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <igc:UnitsOutstanding contextRef="c0" decimals="0" unitRef="shares">91472</igc:UnitsOutstanding>
    <igc:UnitDescription contextRef="c0">Ten units may be separated into one share of common stock.</igc:UnitDescription>
    <igc:SalesAgreementMaximum contextRef="c71" decimals="0" unitRef="usd">75000000</igc:SalesAgreementMaximum>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c71" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c0" decimals="-3" unitRef="usd">103000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;NOTE 14 &lt;/b&gt;&#x2013;&lt;b&gt; STOCK-BASED COMPENSATION&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;As of March 31, 2023, under both the Company&#x2019;s previous 2008 and current 2018 Omnibus Incentive Plans, a total of 8,412,627 shares of common stock have been issued to employees, non-employees, and advisors. In addition, 5.5 million restricted share units (RSUs) fair valued at $5.5 million with a weighted average value of $1 per share, have been granted but not yet issued from different Incentive Plans and Grants. This includes 2.9 million RSUs granted to employees and directors, which consists of a vesting schedule based entirely on the attainment either operational milestones (performance conditions) or market conditions, assuming continued employment either as an employee, or director with the Company. The performance based RSUs are accounted upon certification by the management confirming the probability of achievement of milestones. As of March 31, 2023, the management confirmed two milestones had been achieved, and the rest were probable to be achieved by March 31, 2027.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Additionally, options held by advisors and directors to purchase 150 thousand shares of common stock fair valued at $69 thousand with a weighted average of $0.46 per share, which have been granted but are to be issued over a vesting period, between Fiscal 2022 and Fiscal 2026. Options granted and issued before the vesting period are expensed when issued.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The options are fair valued using a Black-Scholes Pricing Model and market based RSU are valued based on lattice model with the following assumptions:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2238" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2239" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Granted in &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2240" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2241" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2242" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Granted in &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2022&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2243" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Expected life of options&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2244" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2245" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;5 years&lt;/p&gt;	&lt;/td&gt;
			&lt;td id="new_id-2246" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2247" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2248" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;5 years&lt;/p&gt;	&lt;/td&gt;
			&lt;td id="new_id-2249" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Vested options&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2250" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2251" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2252" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;100&lt;/td&gt;
			&lt;td id="new_id-2253" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2254" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2255" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2256" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;100&lt;/td&gt;
			&lt;td id="new_id-2257" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Risk free interest rate&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2258" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2259" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2260" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;3.49&lt;/td&gt;
			&lt;td id="new_id-2261" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2262" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2263" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2264" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2.42&lt;/td&gt;
			&lt;td id="new_id-2265" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Expected volatility&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2266" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2267" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2268" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;280&lt;/td&gt;
			&lt;td id="new_id-2269" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2270" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2271" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2272" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;282&lt;/td&gt;
			&lt;td id="new_id-2273" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Expected dividend yield&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2274" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2275" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="-sec-ix-hidden: hidden-fact-4; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;Nil&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2276" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2277" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2278" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="-sec-ix-hidden: hidden-fact-5; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;Nil&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2279" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The expense associated with share-based payments to employees, directors, advisors, and contractors is allocated over the vesting or service period and recognized in the Selling, general and administrative expenses (including research and development). For Fiscal 2023, the Company&#x2019;s common stock-based compensation and expenses shown in Selling, general and administrative expenses (including research and development) was $2.8 million.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For Fiscal 2022, the Company&#x2019;s common stock-based compensation and expenses shown in Selling, general and administrative expenses (including research and development) was $2.2 million.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Non-vested shares&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2280" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2281" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(in thousands)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(#)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2282" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2283" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2284" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Weighted average &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;grant date fair value&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2285" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Non-vested shares as of March 31, 2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2286" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2287" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2288" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;b&gt;5,283&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2289" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2290" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2291" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2292" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1.17&lt;/td&gt;
			&lt;td id="new_id-2293" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Granted&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2294" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2295" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2296" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,615&lt;/td&gt;
			&lt;td id="new_id-2297" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2298" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2299" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2300" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;0.43&lt;/td&gt;
			&lt;td id="new_id-2301" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Vested&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2302" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2303" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2304" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(2,224&lt;/td&gt;
			&lt;td id="new_id-2305" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2306" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2307" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2308" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1.01&lt;/td&gt;
			&lt;td id="new_id-2309" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Cancelled/Forfeited&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2310" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2311" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2312" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(245&lt;/td&gt;
			&lt;td id="new_id-2313" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2314" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2315" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2316" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;0.77&lt;/td&gt;
			&lt;td id="new_id-2317" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Non-vested shares as of March 31, 2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2318" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2319" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2320" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;4,429&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2321" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2322" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2323" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2324" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;1.01&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2325" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2326" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2327" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(in thousands)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(#)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2328" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2329" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2330" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Weighted average &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;grant date fair value&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2331" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2332" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2333" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Weighted average &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;exercise price&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2334" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Options outstanding as of March 31, 2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2335" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2336" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2337" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;b&gt;300&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2338" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2339" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2340" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2341" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;b&gt;0.93&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2342" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2343" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2344" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2345" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;b&gt;0.34&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2346" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Granted&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2347" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2348" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2349" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2350" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2351" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2352" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2353" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2354" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2355" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2356" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2357" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2358" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Exercised&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2359" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2360" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2361" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2362" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2363" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2364" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2365" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2366" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2367" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2368" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2369" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2370" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Cancelled/forfeited&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2371" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2372" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2373" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(150&lt;/td&gt;
			&lt;td id="new_id-2374" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2375" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2376" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2377" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;1.39&lt;/td&gt;
			&lt;td id="new_id-2378" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2379" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2380" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2381" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;0.30&lt;/td&gt;
			&lt;td id="new_id-2382" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Options outstanding as of March 31, 2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2383" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2384" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2385" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;150&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2386" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2387" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2388" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2389" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;1.39&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2390" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2391" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2392" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2393" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;0.30&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2394" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;There was a combined unrecognized expense of $2.7 million related to non-vested shares and share options that the Company expects to be recognized over a life of four years.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c72" decimals="0" unitRef="shares">8412627</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares contextRef="c3" decimals="-5" unitRef="shares">5500000</us-gaap:EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-5" unitRef="usd">5500000</us-gaap:ShareBasedCompensation>
    <igc:WeightedAveragePricePerShare contextRef="c0" decimals="0" unitRef="usdPershares">1</igc:WeightedAveragePricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="c0" decimals="-5" unitRef="shares">2900000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c73" decimals="-3" unitRef="shares">150000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensation contextRef="c73" decimals="-3" unitRef="usd">69000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c72" decimals="2" unitRef="usdPershares">0.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0">The options are fair valued using a Black-Scholes Pricing Model and market based RSU are valued based on lattice model with the following assumptions:&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2238" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2239" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Granted in &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2240" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2241" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2242" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Granted in &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2022&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2243" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Expected life of options&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2244" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2245" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;5 years&lt;/p&gt;	&lt;/td&gt;
			&lt;td id="new_id-2246" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2247" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2248" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;5 years&lt;/p&gt;	&lt;/td&gt;
			&lt;td id="new_id-2249" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Vested options&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2250" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2251" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2252" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;100&lt;/td&gt;
			&lt;td id="new_id-2253" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2254" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2255" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2256" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;100&lt;/td&gt;
			&lt;td id="new_id-2257" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Risk free interest rate&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2258" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2259" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2260" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;3.49&lt;/td&gt;
			&lt;td id="new_id-2261" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2262" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2263" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2264" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;2.42&lt;/td&gt;
			&lt;td id="new_id-2265" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Expected volatility&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2266" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2267" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2268" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;280&lt;/td&gt;
			&lt;td id="new_id-2269" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2270" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2271" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2272" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;282&lt;/td&gt;
			&lt;td id="new_id-2273" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Expected dividend yield&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2274" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2275" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="-sec-ix-hidden: hidden-fact-4; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;Nil&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2276" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2277" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2278" style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="-sec-ix-hidden: hidden-fact-5; font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;Nil&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2279" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c0">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c5">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c0" decimals="2" unitRef="pure">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c5" decimals="2" unitRef="pure">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c0" decimals="4" unitRef="pure">0.0349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c5" decimals="4" unitRef="pure">0.0242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c0" decimals="2" unitRef="pure">2.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c5" decimals="2" unitRef="pure">2.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensation contextRef="c74" decimals="-2" unitRef="usd">2800</us-gaap:ShareBasedCompensation>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c0">For Fiscal 2022, the Company&#x2019;s common stock-based compensation and expenses shown in Selling, general and administrative expenses (including research and development) was $2.2 million.&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Non-vested shares&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2280" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2281" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(in thousands)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(#)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2282" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2283" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2284" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Weighted average &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;grant date fair value&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2285" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Non-vested shares as of March 31, 2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2286" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2287" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2288" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;b&gt;5,283&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2289" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2290" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2291" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2292" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1.17&lt;/td&gt;
			&lt;td id="new_id-2293" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Granted&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2294" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2295" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2296" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,615&lt;/td&gt;
			&lt;td id="new_id-2297" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2298" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2299" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2300" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;0.43&lt;/td&gt;
			&lt;td id="new_id-2301" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Vested&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2302" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2303" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2304" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(2,224&lt;/td&gt;
			&lt;td id="new_id-2305" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2306" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2307" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2308" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1.01&lt;/td&gt;
			&lt;td id="new_id-2309" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Cancelled/Forfeited&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2310" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2311" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2312" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(245&lt;/td&gt;
			&lt;td id="new_id-2313" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2314" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2315" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2316" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;0.77&lt;/td&gt;
			&lt;td id="new_id-2317" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Non-vested shares as of March 31, 2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2318" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2319" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2320" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;4,429&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2321" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2322" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2323" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2324" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;1.01&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2325" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensation contextRef="c75" decimals="-5" unitRef="usd">2200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c4" decimals="-3" unitRef="shares">5283000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="c4" decimals="2" unitRef="usdPershares">1.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="c0" decimals="-3" unitRef="shares">1615000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="c0" decimals="2" unitRef="usdPershares">0.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="c0" decimals="-3" unitRef="shares">2224000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="c0" decimals="2" unitRef="usdPershares">1.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations contextRef="c0" decimals="-3" unitRef="shares">245000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="c0" decimals="2" unitRef="usdPershares">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c3" decimals="-3" unitRef="shares">4429000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="c3" decimals="2" unitRef="usdPershares">1.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2326" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2327" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(in thousands)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(#)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2328" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2329" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2330" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Weighted average &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;grant date fair value&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2331" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2332" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2333" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Weighted average &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;exercise price&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2334" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Options outstanding as of March 31, 2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2335" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2336" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2337" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;b&gt;300&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2338" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2339" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2340" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2341" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;b&gt;0.93&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2342" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2343" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2344" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2345" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;b&gt;0.34&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2346" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Granted&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2347" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2348" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2349" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2350" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2351" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2352" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2353" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2354" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2355" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2356" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2357" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2358" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Exercised&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2359" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2360" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2361" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2362" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2363" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2364" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2365" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2366" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2367" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2368" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2369" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2370" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Cancelled/forfeited&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2371" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2372" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2373" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(150&lt;/td&gt;
			&lt;td id="new_id-2374" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2375" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2376" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2377" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;1.39&lt;/td&gt;
			&lt;td id="new_id-2378" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2379" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2380" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2381" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;0.30&lt;/td&gt;
			&lt;td id="new_id-2382" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Options outstanding as of March 31, 2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2383" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2384" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2385" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;150&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2386" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2387" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2388" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2389" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;1.39&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2390" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2391" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2392" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2393" style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;0.30&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2394" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c10" decimals="-3" unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="c5" decimals="2" unitRef="usdPershares">0.93</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c4" decimals="2" unitRef="usdPershares">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c0" decimals="-3" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c0" decimals="-3" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c0" decimals="-3" unitRef="shares">150000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="c0" decimals="2" unitRef="usdPershares">1.39</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="usdPershares">0.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c3" decimals="-3" unitRef="shares">150000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="c0" decimals="2" unitRef="usdPershares">1.39</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c3" decimals="2" unitRef="usdPershares">0.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c3" decimals="-5" unitRef="usd">2700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c0">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 15 &lt;/b&gt;&#x2013;&lt;b&gt; FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;As of March 31, 2023, the Company&#x2019;s marketable securities consist of liquid funds, which have been classified as Level 1 of the fair value hierarchy because they have been valued using quoted prices in active markets. The Company&#x2019;s cash and cash equivalents have also been classified as Level 1 on the same principle. Financial instruments are classified as current if they are expected to be liquidated within the next twelve months. The Company&#x2019;s remaining investments have been classified as Level 3 instruments as there is little or no market data. Level 3 investments are valued using the cost method. For further information refer Note 7, &#x201c;Investments in Non-Marketable Securities.&#x201d;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis as of March 31, 2023, and 2022, and indicates the fair value hierarchy of the valuation techniques the Company used to determine such fair value:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2395" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2396" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2397" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2398" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2399" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2400" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2401" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2402" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2403" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2404" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2405" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2406" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2407" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2408" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2409" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2410" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2411" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2412" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2413" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2414" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2415" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2416" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2417" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2418" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2419" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2420" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2421" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2422" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2423"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2424"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2425"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2426"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2427"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2428"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2429"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2430"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2431"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2432"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2433"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2434"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2435"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2436"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2437"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2438"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;Cash and cash equivalents:&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2439" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2440" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2441" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3,196&lt;/td&gt;
			&lt;td id="new_id-2442" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2443" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2444" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2445" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2446" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2447" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2448" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2449" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2450" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2451" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2452" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2453" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3,196&lt;/td&gt;
			&lt;td id="new_id-2454" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2455" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2456" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2457" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;3,196&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2458" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2459" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2460" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2461" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2462" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2463" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2464" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2465" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2466" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2467" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2468" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2469" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;3,196&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2470" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2471"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2472"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2473"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2474"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2475"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2476"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2477"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2478"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2479"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2480"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2481"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2482"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2483"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2484"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2485"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2486"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;Investments:&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2487" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2488" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2489" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2490" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2491" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2492" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2493" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2494" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2495" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2496" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2497" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2498" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2499" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2500" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2501" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2502" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;-Marketable securities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2503" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2504" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2505" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;154&lt;/td&gt;
			&lt;td id="new_id-2506" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2507" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2508" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2509" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2510" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2511" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2512" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2513" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2514" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2515" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2516" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2517" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;154&lt;/td&gt;
			&lt;td id="new_id-2518" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;-Non-marketable securities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2519" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2520" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2521" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2522" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2523" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2524" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2525" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2526" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2527" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2528" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2529" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2530" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2531" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2532" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2533" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2534" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total investments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2535" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2536" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2537" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;154&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2538" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2539" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2540" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2541" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2542" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2543" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2544" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2545" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2546" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2547" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2548" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2549" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;154&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2550" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2551" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2552" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2553" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2554" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2555" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2556" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2557" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2558" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2559" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2560" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2561" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2562" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2563" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2564" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2565" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2566" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2567" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2568" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2569" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2570" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2571" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2572" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2573" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2574" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2575" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2576" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2577" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2578" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2579"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2580"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2581"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2582"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2583"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2584"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2585"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2586"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2587"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2588"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2589"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2590"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2591"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2592"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2593"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2594"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;Cash and cash equivalents:&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2595" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2596" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2597" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;10,460&lt;/td&gt;
			&lt;td id="new_id-2598" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2599" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2600" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2601" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2602" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2603" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2604" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2605" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2606" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2607" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2608" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2609" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;10,460&lt;/td&gt;
			&lt;td id="new_id-2610" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2611" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2612" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2613" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;10,460&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2614" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2615" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2616" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2617" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2618" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2619" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2620" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2621" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2622" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2623" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2624" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2625" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;10,460&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2626" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2627"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2628"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2629"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2630"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2631"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2632"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2633"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2634"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2635"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2636"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2637"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2638"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2639"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2640"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2641"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2642"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;Investments:&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2643" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2644" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2645" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2646" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2647" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2648" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2649" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2650" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2651" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2652" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2653" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2654" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2655" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2656" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2657" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2658" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;-Marketable securities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2659" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2660" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2661" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2662" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2663" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2664" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2665" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2666" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2667" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2668" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2669" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2670" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2671" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2672" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2673" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2674" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;-Non-marketable securities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2675" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2676" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2677" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2678" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2679" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2680" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2681" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2682" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2683" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2684" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2685" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2686" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2687" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2688" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2689" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2690" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total investment &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2691" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2692" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2693" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2694" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2695" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2696" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2697" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2698" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2699" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2700" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2701" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2702" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2703" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2704" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2705" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2706" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c0">The following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis as of March 31, 2023, and 2022, and indicates the fair value hierarchy of the valuation techniques the Company used to determine such fair value:&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2395" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2396" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2397" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2398" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2399" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2400" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2401" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2402" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2403" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2404" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2405" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2406" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;March 31, 2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2407" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2408" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2409" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2410" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2411" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2412" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2413" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2414" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2415" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2416" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2417" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2418" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2419" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2420" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2421" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2422" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2423"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2424"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2425"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2426"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2427"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2428"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2429"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2430"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2431"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2432"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2433"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2434"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2435"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2436"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2437"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2438"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;Cash and cash equivalents:&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2439" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2440" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2441" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3,196&lt;/td&gt;
			&lt;td id="new_id-2442" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2443" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2444" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2445" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2446" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2447" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2448" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2449" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2450" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2451" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2452" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2453" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3,196&lt;/td&gt;
			&lt;td id="new_id-2454" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2455" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2456" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2457" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;3,196&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2458" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2459" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2460" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2461" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2462" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2463" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2464" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2465" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2466" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2467" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2468" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2469" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;3,196&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2470" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2471"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2472"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2473"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2474"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2475"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2476"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2477"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2478"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2479"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2480"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2481"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2482"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2483"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2484"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2485"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2486"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;Investments:&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2487" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2488" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2489" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2490" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2491" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2492" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2493" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2494" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2495" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2496" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2497" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2498" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2499" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2500" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2501" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2502" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;-Marketable securities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2503" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2504" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2505" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;154&lt;/td&gt;
			&lt;td id="new_id-2506" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2507" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2508" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2509" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2510" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2511" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2512" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2513" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2514" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2515" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2516" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2517" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;154&lt;/td&gt;
			&lt;td id="new_id-2518" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;-Non-marketable securities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2519" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2520" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2521" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2522" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2523" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2524" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2525" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2526" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2527" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2528" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2529" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2530" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2531" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2532" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2533" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2534" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total investments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2535" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2536" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2537" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;154&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2538" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2539" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2540" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2541" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2542" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2543" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2544" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2545" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2546" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2547" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2548" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2549" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;154&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2550" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2551" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2552" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2553" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2554" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2555" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2556" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2557" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2558" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2559" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2560" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2561" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2562" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;March 31, 2022&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2563" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2564" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2565" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2566" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2567" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2568" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2569" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2570" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2571" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2572" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2573" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2574" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2575" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2576" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2577" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2578" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2579"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2580"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2581"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2582"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2583"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2584"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2585"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2586"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2587"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2588"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2589"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2590"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2591"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2592"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2593"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2594"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;Cash and cash equivalents:&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2595" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2596" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2597" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;10,460&lt;/td&gt;
			&lt;td id="new_id-2598" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2599" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2600" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2601" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2602" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2603" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2604" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2605" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2606" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2607" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2608" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2609" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;10,460&lt;/td&gt;
			&lt;td id="new_id-2610" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2611" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2612" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2613" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;10,460&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2614" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2615" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2616" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2617" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2618" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2619" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2620" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2621" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2622" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2623" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2624" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2625" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;10,460&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2626" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2627"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2628"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2629"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2630"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2631"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2632"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2633"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2634"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2635"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2636"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2637"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2638"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2639"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2640"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2641"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2642"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;Investments:&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2643" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2644" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2645" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2646" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2647" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2648" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2649" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2650" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2651" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2652" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2653" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2654" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2655" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2656" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2657" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
			&lt;td id="new_id-2658" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;-Marketable securities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2659" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2660" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2661" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2662" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2663" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2664" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2665" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2666" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2667" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2668" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2669" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2670" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2671" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2672" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2673" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2674" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;-Non-marketable securities&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2675" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2676" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2677" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2678" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2679" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2680" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2681" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2682" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2683" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2684" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2685" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2686" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2687" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2688" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2689" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2690" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total investment &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2691" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2692" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2693" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2694" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2695" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2696" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2697" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2698" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2699" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2700" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2701" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2702" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2703" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2704" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2705" style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2706" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c76" decimals="-3" unitRef="usd">3196000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c77" decimals="-3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c78" decimals="-3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c3" decimals="-3" unitRef="usd">3196000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c76" decimals="-3" unitRef="usd">3196000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c77" decimals="-3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c78" decimals="-3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-3" unitRef="usd">3196000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c76" decimals="-3" unitRef="usd">154000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c77" decimals="-3" unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c78" decimals="-3" unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c3" decimals="-3" unitRef="usd">154000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:Investments contextRef="c76" decimals="-3" unitRef="usd">0</us-gaap:Investments>
    <us-gaap:Investments contextRef="c77" decimals="-3" unitRef="usd">0</us-gaap:Investments>
    <us-gaap:Investments contextRef="c78" decimals="-3" unitRef="usd">0</us-gaap:Investments>
    <us-gaap:Investments contextRef="c3" decimals="-3" unitRef="usd">0</us-gaap:Investments>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c76" decimals="-3" unitRef="usd">154000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c77" decimals="-3" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c78" decimals="-3" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c3" decimals="-3" unitRef="usd">154000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c79" decimals="-3" unitRef="usd">10460000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c80" decimals="-3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c81" decimals="-3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c4" decimals="-3" unitRef="usd">10460000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c79" decimals="-3" unitRef="usd">10460000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c80" decimals="-3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c81" decimals="-3" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="-3" unitRef="usd">10460000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c79" decimals="-3" unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c80" decimals="-3" unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c81" decimals="-3" unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c4" decimals="-3" unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:Investments contextRef="c79" decimals="-3" unitRef="usd">0</us-gaap:Investments>
    <us-gaap:Investments contextRef="c80" decimals="-3" unitRef="usd">0</us-gaap:Investments>
    <us-gaap:Investments contextRef="c81" decimals="-3" unitRef="usd">0</us-gaap:Investments>
    <us-gaap:Investments contextRef="c4" decimals="-3" unitRef="usd">0</us-gaap:Investments>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c79" decimals="-3" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c80" decimals="-3" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c81" decimals="-3" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c4" decimals="-3" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 16 &lt;/b&gt;&#x2013;&lt;b&gt; INCOME TAXES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company calculates its provision for foreign and U.S. federal income taxes based on the current tax law. As the Company maintains a full valuation allowance against its deferred tax assets, there is no income tax expense recorded related to this change other than the Federal AMT credit which are refundable due to the passage of tax reform.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Due to the Company&#x2019;s history of losses and uncertainty of future taxable income, a valuation allowance sufficient to fully offset net operating losses and other deferred tax assets has been established. The valuation allowance will be maintained until sufficient positive evidence exists to support a conclusion that a valuation allowance is not necessary.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Income tax expense/(benefit) for each of the years ended March 31 consists of the following:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2707" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2708" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;Year Ended March 31,&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2709" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Income Tax Expense&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2710" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2711" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2712" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2713" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2714" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2715" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2716" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2717" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2718" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2719" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2720" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2721" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2722" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2723" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Net income loss before tax&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2724" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2725" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2726" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(11,506&lt;/td&gt;
			&lt;td id="new_id-2727" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2728" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2729" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2730" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(15,016&lt;/td&gt;
			&lt;td id="new_id-2731" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Tax rate&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2732" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2733" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2734" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;21&lt;/td&gt;
			&lt;td id="new_id-2735" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2736" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2737" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2738" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;21&lt;/td&gt;
			&lt;td id="new_id-2739" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2740"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2741"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2742"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2743"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2744"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2745"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2746"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2747"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Expected income tax recovery&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2748" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2749" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2750" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(2,416&lt;/td&gt;
			&lt;td id="new_id-2751" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2752" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2753" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2754" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(3,153&lt;/td&gt;
			&lt;td id="new_id-2755" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Impact of tax rate differences in foreign jurisdictions&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2756" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2757" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2758" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(7&lt;/td&gt;
			&lt;td id="new_id-2759" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2760" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2761" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2762" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2763" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Tax rate changes and other adjustments&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2764" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2765" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2766" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(667&lt;/td&gt;
			&lt;td id="new_id-2767" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2768" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2769" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2770" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(385&lt;/td&gt;
			&lt;td id="new_id-2771" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Permanent differences&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2772" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2773" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2774" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;88&lt;/td&gt;
			&lt;td id="new_id-2775" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2776" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2777" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2778" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;50&lt;/td&gt;
			&lt;td id="new_id-2779" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Change in valuation allowance&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2780" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2781" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2782" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3,002&lt;/td&gt;
			&lt;td id="new_id-2783" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2784" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2785" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2786" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3,488&lt;/td&gt;
			&lt;td id="new_id-2787" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2788" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2789" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2790" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2791" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2792" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2793" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2794" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2795" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The significant components of deferred income tax expense/(benefit) from operations before non-controlling interest for each of the years ended March 31 are approximated as following:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2796" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2797" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;Year Ended March 31,&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2798" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Deferred income taxes&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2799" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2800" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2801" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2802" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2803" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2804" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2805" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2806" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2807" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2808" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2809" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2810" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2811" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2812" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2813"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2814"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2815"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2816"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2817"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2818"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2819"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2820"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Net operating loss carry-forwards foreign&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2821" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2822" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2823" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;137&lt;/td&gt;
			&lt;td id="new_id-2824" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2825" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2826" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2827" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;149&lt;/td&gt;
			&lt;td id="new_id-2828" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Non-capital loss carry-forwards &#x2013; U.S.&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2829" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2830" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2831" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;12,888&lt;/td&gt;
			&lt;td id="new_id-2832" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2833" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2834" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2835" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;10,487&lt;/td&gt;
			&lt;td id="new_id-2836" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Temporary differences&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2837" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2838" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2839" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;548&lt;/td&gt;
			&lt;td id="new_id-2840" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2841" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2842" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2843" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(66&lt;/td&gt;
			&lt;td id="new_id-2844" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2845"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2846"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2847"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2848"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2849"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2850"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2851"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2852"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Net deferred tax asset&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2853" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2854" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2855" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;13,573&lt;/td&gt;
			&lt;td id="new_id-2856" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2857" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2858" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2859" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;10,570&lt;/td&gt;
			&lt;td id="new_id-2860" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Valuation allowance&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2861" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2862" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2863" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(13,573&lt;/td&gt;
			&lt;td id="new_id-2864" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2865" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2866" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2867" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(10,570&lt;/td&gt;
			&lt;td id="new_id-2868" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2869" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2870" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2871" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2872" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2873" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2874" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2875" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2876" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The table below sets forth the details of expiration of the non-financial carried forward losses of the Company as of March 31, 2023, as under:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;"&gt;

		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;Amount&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;($)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2023&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;47&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2024&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;309&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2025&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;3&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2026&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;12&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2027&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;30&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2028&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;14&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2029&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;25&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2030&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;141&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2031&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;3,081&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2032&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;4,141&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2033&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;627&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2034&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;1,269&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2035&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;1,735&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2036&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;1,176&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2037&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;819&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2038&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;1,256&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2039&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;4,132&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2040&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;7,932&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2041&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;8,841&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2042&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;14,966&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2043&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;11,359&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;&lt;b&gt;61,915&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Realization of deferred tax assets, including those related to net operating loss carryforwards, are dependent upon future earnings, if any, of which the timing and amount are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance. Based upon the Company&#x2019;s current operating results management cannot conclude that it is more likely than not that such assets will be realized. The Company files income tax returns in India, Hong Kong, Colombia, and the U.S.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0">Income tax expense/(benefit) for each of the years ended March 31 consists of the following:&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2707" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2708" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;Year Ended March 31,&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2709" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Income Tax Expense&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2710" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2711" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2712" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2713" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2714" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2715" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2716" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2717" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2718" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2719" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2720" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2721" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2722" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2723" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Net income loss before tax&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2724" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2725" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2726" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(11,506&lt;/td&gt;
			&lt;td id="new_id-2727" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2728" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2729" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2730" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(15,016&lt;/td&gt;
			&lt;td id="new_id-2731" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Tax rate&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2732" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2733" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2734" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;21&lt;/td&gt;
			&lt;td id="new_id-2735" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2736" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2737" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2738" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;21&lt;/td&gt;
			&lt;td id="new_id-2739" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2740"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2741"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2742"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2743"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2744"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2745"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2746"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2747"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Expected income tax recovery&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2748" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2749" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2750" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(2,416&lt;/td&gt;
			&lt;td id="new_id-2751" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2752" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2753" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2754" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(3,153&lt;/td&gt;
			&lt;td id="new_id-2755" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Impact of tax rate differences in foreign jurisdictions&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2756" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2757" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2758" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(7&lt;/td&gt;
			&lt;td id="new_id-2759" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2760" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2761" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2762" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2763" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Tax rate changes and other adjustments&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2764" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2765" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2766" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(667&lt;/td&gt;
			&lt;td id="new_id-2767" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2768" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2769" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2770" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(385&lt;/td&gt;
			&lt;td id="new_id-2771" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Permanent differences&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2772" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2773" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2774" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;88&lt;/td&gt;
			&lt;td id="new_id-2775" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2776" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2777" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2778" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;50&lt;/td&gt;
			&lt;td id="new_id-2779" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Change in valuation allowance&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2780" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2781" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2782" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3,002&lt;/td&gt;
			&lt;td id="new_id-2783" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2784" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2785" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2786" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3,488&lt;/td&gt;
			&lt;td id="new_id-2787" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2788" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2789" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2790" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2791" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2792" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2793" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2794" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;
			&lt;td id="new_id-2795" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" unitRef="usd">-11506000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c5" decimals="-3" unitRef="usd">-15016000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c0" decimals="2" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c5" decimals="2" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="-3" unitRef="usd">-2416000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c5" decimals="-3" unitRef="usd">-3153000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign contextRef="c0" decimals="-3" unitRef="usd">7000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign contextRef="c5" decimals="-3" unitRef="usd">0</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c0" decimals="-3" unitRef="usd">-667000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c5" decimals="-3" unitRef="usd">-385000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c0" decimals="-3" unitRef="usd">88000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c5" decimals="-3" unitRef="usd">50000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c0" decimals="-3" unitRef="usd">3002000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c5" decimals="-3" unitRef="usd">3488000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c0">The significant components of deferred income tax expense/(benefit) from operations before non-controlling interest for each of the years ended March 31 are approximated as following:&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2796" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2797" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;Year Ended March 31,&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2798" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Deferred income taxes&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2799" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2800" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2801" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2802" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2803" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2804" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2805" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2806" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2807" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2808" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2809" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2810" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2811" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2812" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2813"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2814"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2815"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2816"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2817"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2818"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2819"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2820"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Net operating loss carry-forwards foreign&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2821" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2822" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2823" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;137&lt;/td&gt;
			&lt;td id="new_id-2824" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2825" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2826" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2827" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;149&lt;/td&gt;
			&lt;td id="new_id-2828" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Non-capital loss carry-forwards &#x2013; U.S.&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2829" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2830" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2831" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;12,888&lt;/td&gt;
			&lt;td id="new_id-2832" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2833" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2834" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2835" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;10,487&lt;/td&gt;
			&lt;td id="new_id-2836" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Temporary differences&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2837" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2838" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2839" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;548&lt;/td&gt;
			&lt;td id="new_id-2840" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2841" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2842" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2843" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;(66&lt;/td&gt;
			&lt;td id="new_id-2844" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2845"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2846"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2847"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2848"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2849"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2850"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2851"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2852"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Net deferred tax asset&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2853" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2854" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2855" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;13,573&lt;/td&gt;
			&lt;td id="new_id-2856" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2857" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2858" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2859" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;10,570&lt;/td&gt;
			&lt;td id="new_id-2860" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Valuation allowance&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2861" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2862" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2863" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(13,573&lt;/td&gt;
			&lt;td id="new_id-2864" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
			&lt;td id="new_id-2865" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2866" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2867" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(10,570&lt;/td&gt;
			&lt;td id="new_id-2868" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2869" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2870" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2871" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2872" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2873" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2874" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2875" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2876" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign contextRef="c3" decimals="-3" unitRef="usd">137000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign contextRef="c4" decimals="-3" unitRef="usd">149000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c3" decimals="-3" unitRef="usd">12888000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c4" decimals="-3" unitRef="usd">10487000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther contextRef="c3" decimals="-3" unitRef="usd">548000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c4" decimals="-3" unitRef="usd">-66000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c3" decimals="-3" unitRef="usd">13573000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c4" decimals="-3" unitRef="usd">10570000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c3" decimals="-3" unitRef="usd">13573000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c4" decimals="-3" unitRef="usd">10570000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c3" decimals="-3" unitRef="usd">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c4" decimals="-3" unitRef="usd">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="c0">The table below sets forth the details of expiration of the non-financial carried forward losses of the Company as of March 31, 2023, as under:&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 50%; margin-left: 25%; margin-right: 25%;"&gt;

		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;Amount&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;i&gt;($)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2023&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;47&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2024&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;309&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2025&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;3&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2026&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;12&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2027&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;30&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2028&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;14&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2029&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;25&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2030&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;141&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2031&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;3,081&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2032&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;4,141&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2033&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;627&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2034&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;1,269&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2035&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;1,735&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2036&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;1,176&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2037&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;819&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2038&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;1,256&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2039&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;4,132&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2040&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;7,932&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2041&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;8,841&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2042&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;14,966&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2043&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;11,359&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: 71%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 26%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;	&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"&gt;&lt;b&gt;61,915&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c82" decimals="-3" unitRef="usd">47000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c83" decimals="-3" unitRef="usd">309000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c84" decimals="-3" unitRef="usd">3000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c85" decimals="-3" unitRef="usd">12000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c86" decimals="-3" unitRef="usd">30000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c87" decimals="-3" unitRef="usd">14000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c88" decimals="-3" unitRef="usd">25000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c89" decimals="-3" unitRef="usd">141000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c90" decimals="-3" unitRef="usd">3081000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c91" decimals="-3" unitRef="usd">4141000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c92" decimals="-3" unitRef="usd">627000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c93" decimals="-3" unitRef="usd">1269000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c94" decimals="-3" unitRef="usd">1735000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c95" decimals="-3" unitRef="usd">1176000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c96" decimals="-3" unitRef="usd">819000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c97" decimals="-3" unitRef="usd">1256000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c98" decimals="-3" unitRef="usd">4132000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c99" decimals="-3" unitRef="usd">7932000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c100" decimals="-3" unitRef="usd">8841000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c101" decimals="-3" unitRef="usd">14966000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c102" decimals="-3" unitRef="usd">11359000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c3" decimals="-3" unitRef="usd">61915000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 17 &lt;/b&gt;&#x2013;&lt;b&gt; REVENUE RECOGNITION&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Revenue in the Infrastructure segment is recognized for the renting business when the equipment is rented, and the terms of the agreement have been fulfilled during the period. Revenue from the execution of infrastructure contracts is recognized on the basis of the output method as and when part of the performance obligation has been completed and approval from the contracting agency has been obtained after survey of the performance completion as of that date. In the Life Sciences segment, the revenue from the wellness and lifestyle business is recognized once goods have been sold to the customer and the performance obligation has been completed. In retail sales, we offer consumer products through our online stores. Revenue is recognized when control of the goods is transferred to the customer. This generally occurs upon our delivery to a third-party carrier or to the customer directly. Revenue from white label services is recognized when the performance obligation has been completed and output material has been transferred to the customer.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;Net sales disaggregated by significant products and services for Fiscal 2023 and 2022 are as follows:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2877" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2878" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;Year ended March 31,&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2879" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2880" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2881" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2882" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2883" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2884" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2885" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Infrastructure segment&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2886" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2887" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2888" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2889" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2890" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2891" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2892" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2893" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Rental income (1)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2894" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2895" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2896" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;37&lt;/td&gt;
			&lt;td id="new_id-2897" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2898" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2899" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2900" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;23&lt;/td&gt;
			&lt;td id="new_id-2901" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Construction contracts (2)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2902" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2903" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2904" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;76&lt;/td&gt;
			&lt;td id="new_id-2905" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2906" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2907" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2908" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;15&lt;/td&gt;
			&lt;td id="new_id-2909" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2910"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2911"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2912"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2913"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2914"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2915"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2916"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2917"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2918"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2919"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2920"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2921"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2922"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2923"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2924"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2925"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Life Sciences segment&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2926" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2927" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2928" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2929" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2930" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2931" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2932" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2933" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Wellness and lifestyle (3)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2934" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2935" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2936" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;416&lt;/td&gt;
			&lt;td id="new_id-2937" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2938" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2939" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2940" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;316&lt;/td&gt;
			&lt;td id="new_id-2941" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;White labeling services (4)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2942" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2943" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2944" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;382&lt;/td&gt;
			&lt;td id="new_id-2945" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2946" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2947" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2948" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;43&lt;/td&gt;
			&lt;td id="new_id-2949" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2950" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2951" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2952" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;911&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2953" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2954" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2955" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2956" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;397&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2957" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;(1) Rental income consists of income from rental of heavy construction equipment.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;(2) Construction income consists of the execution of contracts directly or through subcontractors.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;(3) Revenue from wellness and lifestyle consists of sale of products such as gummies, hand sanitizers, bath bombs, lotions, beverages, hemp crude extract, hemp isolate, and hemp distillate.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;(4) Revenue from white label services consists of rebranding our formulations or the customer&#x2019;s products as per customer&#x2019;s requirement.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c0">Net sales disaggregated by significant products and services for Fiscal 2023 and 2022 are as follows:&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2877" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2878" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;Year ended March 31,&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2879" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2880" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2881" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2882" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2883" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2884" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;
			&lt;b&gt;($)&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2885" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Infrastructure segment&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2886" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2887" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2888" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2889" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2890" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2891" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2892" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2893" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Rental income (1)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2894" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2895" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2896" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;37&lt;/td&gt;
			&lt;td id="new_id-2897" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2898" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2899" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2900" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;23&lt;/td&gt;
			&lt;td id="new_id-2901" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Construction contracts (2)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2902" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2903" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2904" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;76&lt;/td&gt;
			&lt;td id="new_id-2905" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2906" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2907" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2908" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;15&lt;/td&gt;
			&lt;td id="new_id-2909" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2910"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2911"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2912"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2913"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2914"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2915"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2916"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2917"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2918"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2919"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2920"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2921"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2922"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2923"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2924"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2925"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Life Sciences segment&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2926" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2927" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2928" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2929" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2930" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2931" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2932" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2933" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Wellness and lifestyle (3)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2934" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2935" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2936" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;416&lt;/td&gt;
			&lt;td id="new_id-2937" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2938" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2939" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2940" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;316&lt;/td&gt;
			&lt;td id="new_id-2941" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;White labeling services (4)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2942" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2943" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2944" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;382&lt;/td&gt;
			&lt;td id="new_id-2945" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2946" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2947" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2948" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;43&lt;/td&gt;
			&lt;td id="new_id-2949" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2950" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2951" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2952" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;911&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2953" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2954" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2955" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2956" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;397&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2957" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;(1) Rental income consists of income from rental of heavy construction equipment.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;(2) Construction income consists of the execution of contracts directly or through subcontractors.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;(3) Revenue from wellness and lifestyle consists of sale of products such as gummies, hand sanitizers, bath bombs, lotions, beverages, hemp crude extract, hemp isolate, and hemp distillate.&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;(4) Revenue from white label services consists of rebranding our formulations or the customer&#x2019;s products as per customer&#x2019;s requirement.&lt;/p&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="c103"
      decimals="-3"
      id="ix_2_fact"
      unitRef="usd">37000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c104"
      decimals="-3"
      id="ix_3_fact"
      unitRef="usd">23000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c105"
      decimals="-3"
      id="ix_4_fact"
      unitRef="usd">76000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c106"
      decimals="-3"
      id="ix_5_fact"
      unitRef="usd">15000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c107"
      decimals="-3"
      id="ix_6_fact"
      unitRef="usd">416000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c108"
      decimals="-3"
      id="ix_7_fact"
      unitRef="usd">316000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c109"
      decimals="-3"
      id="ix_8_fact"
      unitRef="usd">382000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c110"
      decimals="-3"
      id="ix_9_fact"
      unitRef="usd">43000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">911000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c5" decimals="-3" unitRef="usd">397000</us-gaap:Revenues>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 18 &lt;/b&gt;&#x2013; &lt;b&gt;SEGMENT INFORMATION&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;FASB ASC 280, &#x201c;&lt;i&gt;Segment Reporting&lt;/i&gt;&#x201d; establishes standards for reporting information about reportable segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group (CODM), in deciding how to allocate resources and in assessing performance. The CODM evaluates revenues and gross profits based on product lines and routes to market. Based on our integration and Management strategies, we operate in two reportable segments: (i) Infrastructure segment and (ii) Life Sciences segment.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The Company&#x2019;s CODM is the Company&#x2019;s Chief Executive Officer (CEO). The CEO reviews financial information presented on an operating segment basis for the purposes of making operating decisions and assessing financial performance. Therefore, and before our Life Sciences segment started, the Company had determined that it operated in a single operating and reportable segment. As of the date of this report and in preparation for the new and different source of revenue, the Company has determined that it operates in two operating and reportable segments: (a) Infrastructure segment and (b) Life Sciences segment. The Company does not include intercompany transfers between segments for Management reporting purposes.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The following provides information required by ASC 280-10-50-38 &#x201c;Entity-wide Information&#x201d;:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;1) The table below shows revenue reported by segment:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Product &amp;amp; Service&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2958" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2959" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2960" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Segments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2961" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2962" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2963" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2964" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2965" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Percentage of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenue&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(%)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2966" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2967"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2968"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2969"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2970"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2971"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2972"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2973"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2974"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Infrastructure segment&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2975" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2976" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2977" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;113&lt;/td&gt;
			&lt;td id="new_id-2978" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2979" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2980" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2981" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;12&lt;/td&gt;
			&lt;td id="new_id-2982" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Life Sciences segment&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2983" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2984" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2985" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;798&lt;/td&gt;
			&lt;td id="new_id-2986" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2987" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2988" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2989" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;88&lt;/td&gt;
			&lt;td id="new_id-2990" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2991" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2992" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2993" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;911&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2994" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2995" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2996" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2997" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;100&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2998" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2999" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-3000" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3001" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Segments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3002" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3003" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3004" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3005" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3006" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Percentage of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenue&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(%)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3007" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3008"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3009"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3010"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3011"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3012"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3013"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3014"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3015"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Infrastructure segment&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3016" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3017" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3018" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;38&lt;/td&gt;
			&lt;td id="new_id-3019" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3020" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3021" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3022" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;9&lt;/td&gt;
			&lt;td id="new_id-3023" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Life Sciences segment&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3024" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3025" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3026" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;359&lt;/td&gt;
			&lt;td id="new_id-3027" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3028" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3029" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3030" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;91&lt;/td&gt;
			&lt;td id="new_id-3031" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3032" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3033" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3034" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;397&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3035" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3036" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3037" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3038" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;100&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3039" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;For information for revenue by product and service, refer Note 17, &#x201c;Revenue Recognition.&#x201d;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;2) The table below shows the attributed to the country of domicile (U.S.) and foreign countries. Revenue is generally attributed to the geographic location of customers:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 100%;"&gt;	&lt;tr&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td colspan="6" style="vertical-align:bottom;width:11.4%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Segments&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Country&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2023&lt;/b&gt;&lt;/p&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Percentage of &lt;/b&gt;&lt;/p&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenue&lt;/b&gt;&lt;/p&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(%)&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr style="background-color: rgb(204, 238, 255);"&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Asia&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;India&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;113&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;12&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr style="background-color: rgb(255, 255, 255);"&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;America&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;U.S.&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;777&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;86&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr style="background-color: rgb(204, 238, 255);"&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;&#160;&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;&#160;&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Colombia&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;21&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;2&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;%&lt;/td&gt;	&lt;/tr&gt;	&lt;tr style="background-color: rgb(255, 255, 255);"&gt;	&lt;td colspan="3" style="vertical-align:bottom;width:18.2%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Total&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;911&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;100&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 100%;"&gt;

		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="6" style="vertical-align:bottom;width:11.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Segments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Country&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Percentage of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenue&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(%)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:9.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:9.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Asia&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;India&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;68&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;17&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;America&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;U.S.&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;329&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;83&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td colspan="3" style="vertical-align:bottom;width:18.2%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Total&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;397&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;100&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;3) The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries.&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3040" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="10" id="new_id-3041" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3042" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 49%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Nature of Assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3043" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3044" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;U.S. &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(Country of Domicile)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3045" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3046" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3047" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Foreign Countries &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(India, Hong Kong, and Colombia)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3048" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3049" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3050" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total as of March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3051" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Intangible assets, net&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3052" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3053" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3054" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,170&lt;/td&gt;
			&lt;td id="new_id-3055" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3056" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3057" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3058" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-3059" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3060" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3061" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3062" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,170&lt;/td&gt;
			&lt;td id="new_id-3063" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Property, plant and equipment, net&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3064" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3065" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3066" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,074&lt;/td&gt;
			&lt;td id="new_id-3067" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3068" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3069" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3070" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,139&lt;/td&gt;
			&lt;td id="new_id-3071" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3072" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3073" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3074" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;8,213&lt;/td&gt;
			&lt;td id="new_id-3075" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Claims and advances&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3076" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3077" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3078" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;585&lt;/td&gt;
			&lt;td id="new_id-3079" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3080" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3081" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3082" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;418&lt;/td&gt;
			&lt;td id="new_id-3083" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3084" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3085" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3086" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,003&lt;/td&gt;
			&lt;td id="new_id-3087" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease asset&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3088" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3089" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3090" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;298&lt;/td&gt;
			&lt;td id="new_id-3091" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3092" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3093" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3094" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;28&lt;/td&gt;
			&lt;td id="new_id-3095" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3096" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3097" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3098" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;326&lt;/td&gt;
			&lt;td id="new_id-3099" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total non-current assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3100" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3101" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3102" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;6,127&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3103" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3104" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3105" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3106" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;4,585&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3107" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3108" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3109" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3110" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;10,712&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3111" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3112" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="10" id="new_id-3113" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3114" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 49%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Nature of Assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3115" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3116" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;U.S. &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(Country of Domicile)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3117" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3118" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3119" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Foreign Countries &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(India Hong Kong and Colombia)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3120" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3121" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3122" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total as of March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3123" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Intangible assets, net&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3124" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3125" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3126" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;436&lt;/td&gt;
			&lt;td id="new_id-3127" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3128" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3129" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3130" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;481&lt;/td&gt;
			&lt;td id="new_id-3131" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3132" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3133" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3134" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;917&lt;/td&gt;
			&lt;td id="new_id-3135" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Property, plant and equipment, net&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3136" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3137" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3138" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,978&lt;/td&gt;
			&lt;td id="new_id-3139" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3140" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3141" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3142" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,441&lt;/td&gt;
			&lt;td id="new_id-3143" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3144" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3145" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3146" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;9,419&lt;/td&gt;
			&lt;td id="new_id-3147" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Claims and advances&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3148" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3149" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3150" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;550&lt;/td&gt;
			&lt;td id="new_id-3151" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3152" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3153" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3154" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;387&lt;/td&gt;
			&lt;td id="new_id-3155" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3156" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3157" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3158" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;937&lt;/td&gt;
			&lt;td id="new_id-3159" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease asset&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3160" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3161" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3162" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;396&lt;/td&gt;
			&lt;td id="new_id-3163" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3164" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3165" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3166" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;54&lt;/td&gt;
			&lt;td id="new_id-3167" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3168" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3169" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3170" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;450&lt;/td&gt;
			&lt;td id="new_id-3171" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total non-current assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3172" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3173" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3174" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;6,360&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3175" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3176" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3177" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3178" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;5,363&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3179" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3180" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3181" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3182" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;11,723&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3183" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments contextRef="c0" decimals="0" unitRef="pure">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments contextRef="c0" decimals="0" unitRef="pure">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock contextRef="c0">1) The table below shows revenue reported by segment:&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2958" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-2959" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2960" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Segments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2961" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2962" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2963" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2964" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-2965" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Percentage of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenue&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(%)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2966" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2967"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2968"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2969"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2970"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2971"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2972"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2973"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2974"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Infrastructure segment&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2975" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2976" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2977" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;113&lt;/td&gt;
			&lt;td id="new_id-2978" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2979" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2980" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2981" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;12&lt;/td&gt;
			&lt;td id="new_id-2982" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Life Sciences segment&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2983" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2984" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2985" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;798&lt;/td&gt;
			&lt;td id="new_id-2986" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2987" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2988" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2989" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;88&lt;/td&gt;
			&lt;td id="new_id-2990" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-2991" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2992" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2993" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;911&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2994" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2995" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2996" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2997" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;100&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-2998" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-2999" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="6" id="new_id-3000" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3001" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Segments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3002" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3003" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3004" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3005" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3006" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Percentage of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenue&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(%)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3007" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3008"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3009"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3010"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3011"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3012"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3013"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3014"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3015"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Infrastructure segment&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3016" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3017" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3018" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;38&lt;/td&gt;
			&lt;td id="new_id-3019" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3020" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3021" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3022" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;9&lt;/td&gt;
			&lt;td id="new_id-3023" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Life Sciences segment&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3024" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3025" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3026" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;359&lt;/td&gt;
			&lt;td id="new_id-3027" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3028" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3029" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3030" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;91&lt;/td&gt;
			&lt;td id="new_id-3031" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3032" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3033" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3034" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;397&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3035" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3036" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3037" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3038" style="width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;100&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3039" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues contextRef="c111" decimals="-3" unitRef="usd">113000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c111" decimals="2" unitRef="pure">0.12</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c113" decimals="-3" unitRef="usd">798000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c113" decimals="2" unitRef="pure">0.88</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">911000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c0" decimals="2" unitRef="pure">1</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c112" decimals="-3" unitRef="usd">38000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c112" decimals="2" unitRef="pure">0.09</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c114" decimals="-3" unitRef="usd">359000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c114" decimals="2" unitRef="pure">0.91</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c5" decimals="-3" unitRef="usd">397000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c5" decimals="2" unitRef="pure">1</igc:TotalRevenuePercentage>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c0">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 100%;"&gt;	&lt;tr&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td colspan="6" style="vertical-align:bottom;width:11.4%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Segments&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Country&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2023&lt;/b&gt;&lt;/p&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Percentage of &lt;/b&gt;&lt;/p&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenue&lt;/b&gt;&lt;/p&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(%)&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr style="background-color: rgb(204, 238, 255);"&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Asia&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;India&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;113&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;12&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr style="background-color: rgb(255, 255, 255);"&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;America&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;U.S.&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;777&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;86&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr style="background-color: rgb(204, 238, 255);"&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;&#160;&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:1.1%;"&gt;&#160;&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:17.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Colombia&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;21&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;	&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;2&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;%&lt;/td&gt;	&lt;/tr&gt;	&lt;tr style="background-color: rgb(255, 255, 255);"&gt;	&lt;td colspan="3" style="vertical-align:bottom;width:18.2%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Total&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;911&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;100&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;td style="vertical-align:bottom;width:0.6%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;
&lt;/table&gt;2) The table below shows the attributed to the country of domicile (U.S.) and foreign countries. Revenue is generally attributed to the geographic location of customers:&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 100%;"&gt;

		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="6" style="vertical-align:bottom;width:11.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Segments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Country&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fiscal 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Percentage of &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenue&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(%)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:9.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:9.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Asia&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;India&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;68&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;17&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;America&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:1.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:17.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;U.S.&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;329&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;83&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;%&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td colspan="3" style="vertical-align:bottom;width:18.2%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Total&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;397&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:double 3px #000000;vertical-align:bottom;width:9.1%;"&gt;	&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;100&lt;/b&gt;&lt;/p&gt;	&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:0.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues contextRef="c115" decimals="-3" unitRef="usd">113000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c115" decimals="2" unitRef="pure">0.12</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c116" decimals="-3" unitRef="usd">777000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c116" decimals="2" unitRef="pure">0.86</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c117" decimals="-3" unitRef="usd">21000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c117" decimals="2" unitRef="pure">0.02</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">911000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c0" decimals="2" unitRef="pure">1</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c118" decimals="-3" unitRef="usd">68000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c118" decimals="2" unitRef="pure">0.17</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c119" decimals="-3" unitRef="usd">329000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c119" decimals="2" unitRef="pure">0.83</igc:TotalRevenuePercentage>
    <us-gaap:Revenues contextRef="c5" decimals="-3" unitRef="usd">397000</us-gaap:Revenues>
    <igc:TotalRevenuePercentage contextRef="c5" decimals="2" unitRef="pure">1</igc:TotalRevenuePercentage>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="c0">3) The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries.&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3040" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="10" id="new_id-3041" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3042" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 49%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Nature of Assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3043" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3044" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;U.S. &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(Country of Domicile)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3045" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3046" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3047" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Foreign Countries &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(India, Hong Kong, and Colombia)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3048" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3049" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3050" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total as of March 31, 2023&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3051" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Intangible assets, net&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3052" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3053" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3054" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,170&lt;/td&gt;
			&lt;td id="new_id-3055" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3056" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3057" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3058" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;
			&lt;td id="new_id-3059" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3060" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3061" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3062" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,170&lt;/td&gt;
			&lt;td id="new_id-3063" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Property, plant and equipment, net&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3064" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3065" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3066" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,074&lt;/td&gt;
			&lt;td id="new_id-3067" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3068" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3069" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3070" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,139&lt;/td&gt;
			&lt;td id="new_id-3071" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3072" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3073" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3074" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;8,213&lt;/td&gt;
			&lt;td id="new_id-3075" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Claims and advances&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3076" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3077" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3078" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;585&lt;/td&gt;
			&lt;td id="new_id-3079" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3080" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3081" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3082" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;418&lt;/td&gt;
			&lt;td id="new_id-3083" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3084" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3085" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3086" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;1,003&lt;/td&gt;
			&lt;td id="new_id-3087" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease asset&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3088" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3089" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3090" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;298&lt;/td&gt;
			&lt;td id="new_id-3091" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3092" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3093" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3094" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;28&lt;/td&gt;
			&lt;td id="new_id-3095" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3096" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3097" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3098" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;326&lt;/td&gt;
			&lt;td id="new_id-3099" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total non-current assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3100" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3101" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3102" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;6,127&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3103" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3104" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3105" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3106" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;4,585&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3107" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3108" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3109" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3110" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;10,712&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3111" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;

		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3112" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="10" id="new_id-3113" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;&lt;b&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3114" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 49%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Nature of Assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3115" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3116" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;U.S. &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(Country of Domicile)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3117" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3118" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3119" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Foreign Countries &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;(India Hong Kong and Colombia)&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3120" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3121" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" id="new_id-3122" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total as of March 31, 2022&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3123" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Intangible assets, net&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3124" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3125" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3126" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;436&lt;/td&gt;
			&lt;td id="new_id-3127" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3128" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3129" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3130" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;481&lt;/td&gt;
			&lt;td id="new_id-3131" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3132" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3133" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3134" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;917&lt;/td&gt;
			&lt;td id="new_id-3135" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Property, plant and equipment, net&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3136" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3137" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3138" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,978&lt;/td&gt;
			&lt;td id="new_id-3139" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3140" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3141" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3142" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;4,441&lt;/td&gt;
			&lt;td id="new_id-3143" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3144" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3145" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3146" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;9,419&lt;/td&gt;
			&lt;td id="new_id-3147" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Claims and advances&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3148" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3149" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3150" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;550&lt;/td&gt;
			&lt;td id="new_id-3151" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3152" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3153" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3154" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;387&lt;/td&gt;
			&lt;td id="new_id-3155" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3156" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3157" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3158" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;937&lt;/td&gt;
			&lt;td id="new_id-3159" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Operating lease asset&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3160" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3161" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3162" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;396&lt;/td&gt;
			&lt;td id="new_id-3163" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3164" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3165" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3166" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;54&lt;/td&gt;
			&lt;td id="new_id-3167" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3168" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3169" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3170" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;450&lt;/td&gt;
			&lt;td id="new_id-3171" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Total non-current assets&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td id="new_id-3172" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3173" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3174" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;6,360&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3175" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3176" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3177" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3178" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;5,363&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3179" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3180" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;
			&lt;td id="new_id-3181" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3182" style="width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;11,723&lt;/b&gt;&lt;/td&gt;
			&lt;td id="new_id-3183" style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c120" decimals="-3" unitRef="usd">1170000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c121" decimals="-3" unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="-3" unitRef="usd">1170000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c120" decimals="-3" unitRef="usd">4074000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c121" decimals="-3" unitRef="usd">4139000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" unitRef="usd">8213000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c120" decimals="-3" unitRef="usd">585000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c121" decimals="-3" unitRef="usd">418000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">1003000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c120" decimals="-3" unitRef="usd">298000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c121" decimals="-3" unitRef="usd">28000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="-3" unitRef="usd">326000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent contextRef="c120" decimals="-3" unitRef="usd">6127000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c121" decimals="-3" unitRef="usd">4585000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">10712000</us-gaap:AssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c122" decimals="-3" unitRef="usd">436000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c123" decimals="-3" unitRef="usd">481000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c4" decimals="-3" unitRef="usd">917000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c122" decimals="-3" unitRef="usd">4978000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c123" decimals="-3" unitRef="usd">4441000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="-3" unitRef="usd">9419000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c122" decimals="-3" unitRef="usd">550000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c123" decimals="-3" unitRef="usd">387000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c4" decimals="-3" unitRef="usd">937000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c122" decimals="-3" unitRef="usd">396000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c123" decimals="-3" unitRef="usd">54000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="-3" unitRef="usd">450000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent contextRef="c122" decimals="-3" unitRef="usd">6360000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c123" decimals="-3" unitRef="usd">5363000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c4" decimals="-3" unitRef="usd">11723000</us-gaap:AssetsNoncurrent>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE 19 &lt;/b&gt;&#x2013;&lt;b&gt; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"&gt;On June 30, 2023, the Company successfully obtained a working capital credit facility totaling $12 million and in addition sold 10,000,000 shares for $3,000,000. The equity and the credit facility serve to minimize ongoing liquidity requirements and ensure the Company&#x2019;s ability to sustain its operations. Furthermore, the Company intends to raise additional funds through private placement and ATM offerings, subject to market conditions.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity contextRef="c124" decimals="-6" unitRef="usd">12000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c125" decimals="0" unitRef="shares">10000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c125" decimals="0" unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <dei:AuditorName contextRef="c0" id="hidden-fact-0">nter;margin:0pt;"&gt;CONSOLIDATED</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="hidden-fact-1">nter;margin:0p</dei:AuditorLocation>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c4"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c0"
      id="hidden-fact-4"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c5"
      id="hidden-fact-5"
      unitRef="pure"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="c0">2023</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001326205</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The claims receivable is due from different vendors. While the Company has initiated collection proceedings internally or with the appropriate authorities, it believes receiving the amount in the next 12 months will be challenging because of the time required for collection proceedings. The Company decided to move advances paid to some suppliers worth approximately $164 thousand to claims and advances, considering recovering might take more than 12 months. Includes $140 thousand owed to one of our manufacturers for the equipment purchase.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Rental income consists of income from rental of heavy construction equipment.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Construction income consists of the execution of contracts directly or through subcontractors.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Revenue from wellness and lifestyle consists of sale of products such as gummies, hand sanitizers, bath bombs, lotions, beverages, hemp crude extract, hemp isolate, and hemp distillate.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Revenue from white label services consists of rebranding our formulations or the customer&#x2019;s products as per customer&#x2019;s requirement.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>93
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #P@>=6G^XO0J<'  !*,P  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+6;_V^;.!C&_Q4K=YIV4M. G:3MUD9*DV;+;>VBIMNT.]T/+K@)&N"<,?WR
MWY\-"82=>0.2^TL;".\#?&+,\]AP_L3%SV3-F$3/41@G%YVUE)MWO5[BK5E$
MDV.^8;'ZYH&+B$JU*%:]9",8];.B*.QAQQGV(AK$G=%YMFXA1N<\E6$0LX5
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M$ AL[G><T-6SMZ;QBM4^"W5 Z.;'\LI(RVI L*56I54&!-(P($@F\B=0]:0
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M*5'4-4"]7W.EH\V-_JS2?D:;_PM02P,$%     @ \('G5DXI^,H  P  $@H
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M!%60$K$9NJ0I20-*8C1F@N8%]GTP%9*K,OO19+70;C=KZ[UW)C(20-]0FTL
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M&UM>,Z^%7PX[?#CQCFHN)??@;HIL!C?7#FQ]6U)GVYRF L4P4ZFXY2D-7EQ
MBHYD67Z&3YE4-X*\&:E+&W =H)[/&)//'7TMJ*Z!_A]02P,$%     @ \('G
M5D"C(4O4!   :1   !@   !X;"]W;W)K<VAE971S+W-H965T-"YX;6RMF&UO
MXC@0Q[^*Q:U.NU+;Q'F"] ") GN+U):J='=?G.Z%(8;DFL19VX'NM[]Q$@($
MD^M)^Z:)P\SD-Q/;_W'[.\9?14BI1&])G(I!)Y0RNS4,L0II0L0-RV@*OZP9
M3XB$(=\8(N.4!(53$AN6:7I&0J*T,^P7SY[XL,]R&4<I?>)(Y$E"^,\[&K/=
MH(,[^P?/T2:4ZH$Q[&=D0Q=4?LV>.(R,.DH0)305$4L1I^M!9X1OQ]A7#H7%
MMXCNQ-$]4JDL&7M5@UDPZ)B*B,9T)54( I<M'=,X5I& XT<5M%._4SD>W^^C
M?RZ2AV261- QB[]'@0P'G5X'!71-\E@^L]T76B7DJG@K%HOB+]I5MF8'K7(A
M65(Y T$2I>65O%6%.'+ W@4'JW*PF@[.!0>[<K"+1$NR(JT)D638YVR'N+*&
M:.JFJ$WA#=E$J?J,"\GAUPC\Y' \?US,[V>3T<MT@A8O<'F8/KXLT/PSFC]-
MGT<O,S! H\<)&L\?GIZG7Z:/B]FW*;J?+Q;H&GU=3-#'#Y_0!Q2EZ"5DN2!I
M(/J&!#3U F-58=R5&-8%#&RA!Y;*4*!I&M#@-( !.=6)6?O$[JS6B ^$WR ;
M7R'+M&P-T/C][E8+CEW7V2[BV1?BS=(52RA:2"(IK *)_AHMA>0PB__65:L,
MYNB#J:5]*S*RHH,.K%U!^99VAK__ACWS#UVFORC82=Y.G;?3%GWX3+<TS:DN
MQ]+1*QS5;K,=^ACWC>TQ^KF-[7=KFQ,BMR9R6XG&3$C$UK '720K [A';[UV
M/+^!IC&R3%O/YM5L7BO;GYP)@3+.UI'4@7EG[W0<J\%U;H-]1X_5K;&ZK5@+
MV&6C='.%-C2EG,0(%CDB 6Q'D9K#:B-&] V415#MVN^>EZKGNDUPC16V+=_2
ML_=J]MY_3$!!"5^%!7, WSQF6;$ VX![YRBVXS4GI\;*LFU3S^O7O'XK[SRC
MJJ+I!L4P%W1POJ9.V.TVZ71FKF/U]'C8/ B&V0HX2S(2\:*$L(JB=$N%5"/M
MIF^>09@-3(W)M>-?@#Q2-=Q>11E2#G!JT[U"*=73X;-7>VX3[]SF>"*<XED'
M/*L5[UXM\R6%+HQ6D$B2-_U<K$(UO[?I-4EU=JZ)O0NP!^7"K0*QERX W*\9
M8PG[P(4MJ@K6^LG;3$XA#S*#VW7F$3I>M6 0D9)'RUR290S,# %[ NTB-%*K
MUY#% >7Z*COOK++.KJ7*!U7"[;($32FTG"GT?)S3=/43P<::BIB4S6[P3UZN
M,CV\3K"LYH:@L[HH#?@@6;A=L\8L@;XA5)T]R,"E3:L*XIW6U[>Z34B=G6OA
M2Q/D(&&XV]J U1,$]E<D0@(K[QU3Y5:;2ZM:_M_N[%=%.ZW+01YQNS[>$1&M
M2G&,XES2 'V$5G["XICPHV)]TA:B#-T[_ECFC=44]LK,/S6[T"KA@U#B=J7\
M7AS1:'!-MB"9&XK2/%D"+ZA2@2Q0+B =R 8^;);7FGH\ Q*6PYJZ+7)>%$[Z
M1,_%U+7<KF>YO6:NYY:.[_O8LYNB81P=VA+*-\595@ K$)7'G/II?5X>%:?$
MQO,[=8XN#H.',.4A' XQFR@5**9K"&G>= &+E^?:<B!95AP-ETS"0;.X#2F!
MB:\,X/<U8W(_4"^H_[LP_!=02P,$%     @ \('G5JY.VPZ_!0  X"4  !@
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M%N!]9L"#[8ULL/VX=?%?4$L#!!0    ( /"!YU;L-<7 I"$  /QB   8
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M;Z0L8%2!,U/5/U]'(<CW^[.G$?GR*D_V5RDE!,E)Z+IRSO-DA]>J$&>2\O"
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MWFUI:YEIKO.#%%O!Z]&Q9N8=LW-GM8LIT?4!-RT1WTC*['_QC1W:BT6^&LO
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M]W -1\I_=L$EV%(UALG<?#I+#:@"J"!9V54$+LZ/"A(OF O&*T,MFR%?LZ5
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M=0;G 2C?@_F)D:7K>^;24!?EAAFUK:BL .TOI#0O$WM TPA/_@%02P,$%
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MA!Y6C #*2N@MZG)+<R:IUT:MN< '*5X*194U.7.!(-T!Y4K($O\A=.$<.]=
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MJ 7T?KYGFNX_#46\IH#A;]-D?#0DKZ2S3YSB"N$(9M$LF \C1#!<*D1ITT[
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MD6EFPF;C=!WGL)EVF.KBLL 8S28(X/>YQF#2;L(%W6 ^^1=02P,$%     @
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MGNXO( IA<+<N(;VA#&GS&#!2@ZV%<%O:^Y.T*3(4+"3>N^?GXR&[JWEH%)!
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MZY7*5T(:EE5V32&7%8FBHUX2B1:62)94>L4@0I\8BS>/%%N'O_UJD<3SUU9
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M@N\'Z XZNH-#Z,FC&;VL9@AB#1WU/ES44AH;7MQ)P1+?-<R92%_W"CC88K^
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MI74P]JT0^C2Q"=H7??XO4$L#!!0    ( /"!YU8BA,/?: ,  )@'   9
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MAF^GX=LYASZY1ZJR2[A5QL)GGY<]WB?9GL4[S;;-)=A<58;)A;F /Y'I.H%
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MPYP><*B= .TOE;+;B3/0/ DG_P!02P,$%     @ \('G5MY1(GK" @  W04
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M+RH;0/Z5E.9@V +U1N__!5!+ P04    " #P@>=6>(2-6W$"  !3!0  &0
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MY)RX"ER0::<]N Q UP]2O;%JZ1^!1%DBZ9?49!EJIT#G"Z7L=N,<[/X5C/\
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MLGS(EATM"OMX7 B-5<5^IOCVI](LP/FE$'K;,1OL_DV,_@-02P,$%     @
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M'1;ZSX#").CUG'.U"4R!_E\3_0902P,$%     @ \('G5O@,HXG, @  ; <
M !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULK95=;YLP%(;_BL6JJ96Z
M0B A79<@I:'5>K$V:MKN8MJ% R?!JL',QTFZ_?K9AJ)\T*C2=@,VG/?E.<?V
M8; 6\ADS $5><E[@T,F4*B]<%Y,,<HIGHH1"OYD+F5.EIW+A8BF!IE:4<]?W
MO-#-*2N<:&"?360T$$O%60$327"9YU3^O@0NUD.GX[P^N&>+3)D';C0HZ0*F
MH![+B=0SMW%)60X%,E$0"?.A,^I<C$,3;P.>&*QQ8TQ,)C,AGLWD)ATZG@$"
M#HDR#E3?5C &SHV1QOA5>SK-)XUP<_SJ?FUSU[G,*,)8\.\L5=G0.7=("G.Z
MY.I>K+]"G4_/^"6"H[V2=1WK.219HA)Y+=8$.2NJ.WVIZ[ AZ'3?$/BUP'^O
M(*@%@4VT(K-IQ531:"#%FD@3K=W,P-;&JG4VK#"K.%52OV5:IZ+X:G(WO7F8
MDM%M3$;QT^AV?#4EQS$HRCB>D$\DACE("2D9"U1X2L:T9(IR]@?24S*14%*F
M![1(R9W*0)(1(B@D,<.$"UQ*T!Z/TY@<'YV0(\(*\I"))>IX'+A*9V XW*2F
MO:QH_3=HOU%Y1H+.*?$]/VB1C]\O][?EKJY;4SR_*9YO_8*WBO?/I?DQFJ&2
M>B__;"M&]?5N^]?-^;[ DB8P=/0!1I K<**/'SJA]Z6M-/_);*M005.HX)![
M-$I7M$@ B1*Z7Y0E9R#1%B81!>H31PO5NATJV]#:FH:TBOIZX5:;>>V'=/I>
M$[.%VVUPNP=QJ]62D !;T1F'"C6%4B!KYZS\>AL0?G>'<S^DNY'+%F>OX>P=
MY*RW&($7W=01+*6P[,E2[\M"$6IW7!MQ;Y\XW"WM?DP0A.W(88,<'D1^$/J
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M%O2++!^!=,)6A<0^#T&/0+E +91DQYDZV$+Z6'4B]JU()\:CE<>C9?7S&H0
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MAV#G$!BA-3,CZQY)E$PXVP*NK16:?C"Q,=Y*#:%Z&1>2JZ]$^<GDX\-L\;
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MIN]=?ADZ()I9T@2*5[8=$ZYT<]MEKL<O"I.@SU><J]? ='@WT,,74$L#!!0
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MBT&: 'R^%$*_3TR[;V[W\!]02P,$%     @ \('G5CJ"VMM, P  D L  !D
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M&94=0._74IJGA@U0%^'1_U!+ P04    " #P@>=6BR8*S5<"  #*!0  &0
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M,+&PTXD/4C1L*!IV4G1/4L'1UU)P@4F<DE6;N\.]O1[:7N#L>-NYT+%WQHG
MMCBQK=>2QWJ7E9XL#GG$TD)5GZUE3C?&-R"HU.SF^!DM '$H,-.!EQ)!$250
M11BB2Q15F8JK,.VW7<C=BQW+[JG0MNG=J"CM3FKF.%-Y:,4 9(,@F?ZZE.=4
M!E\/W>*G-"_SS;/87F-VKG!LN7-2M+!&&VR<E\#?28[;S#FOS#GO9#0: <0<
M+1G-]4V&200ZITE.5235!>.[_#E[-MJ6NY_F6^0\V_/W\WRWX<>&E+G1K^3
M5KKOX_*8E$14C4$SV_26E[JCVIF_LB^F58?X"E,UK++L7Z6$HPR6$M+J!S*_
ML:H'K :"%KHK6E A>RS]FLB^&9@2D-^75!;E]4 MT'3BDY]02P,$%     @
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M@'DL[Q3._#9*Q@H0FDE!%.0C[ZQS,HZM?67PQ&"I5\;$9O(LY8N=7&4C+[!
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MM39KS-V6N;N;68JCE);,4.XDWO\2AYW.*1[F,Q=U';RW2A3&<;S![; *NO'
M3=YKR7L[R1\ SY["@DLREN>@0*3@O%V]K=U[W4W";9NC?M_-UV_Y^G\]#5A&
M02G(B,$[0;4&YP7H;\L3]0;1!J+#*N@- C?DH(4<[(1\HGQ.ZS;"L8]1U-!%
M.-B6QX7H,ON8,6X9XW\3$NKBX@*-MVY(L,&XRZ+&\U>:B&W@6$"G3&C"(4>?
MX'B ":JZ*=83(\NJKSQ+@UVJ&L[P.P*4-<#WN93F?6);5?MEDOP!4$L#!!0
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MAV8"#\UPH:'] M9(BZ&9M($?"?B1XX9FLAF:36:=7@-)9._43."I&2XTM%\
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M965T<R]S:&5E=#<P+GAM;+57;4_;,!#^*Z<,34S:R!OTA;65H,!6B4)%8?N
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M5$EIAE/UQX)<&ZCG8\;D<J)?4/P#=?X!4$L#!!0    ( /"!YU;NDY$@HP,
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M'P,@/C!E(-^O*!4O [5 \2'%_0]02P,$%     @ \('G5MOKBW91!   ]A(
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MW=BG&LJYT Z5*!LX]'Z%Y\+.=</)&IT)[5"C<A$!NU<1)[AN<WG0L-QFB!/
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M2NM@]C="Z&?#]G7[*L=_ 5!+ P04    " #P@>=6X!!PW34#  !*$P  #0
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M/(TX@CD #QB2).X]N/<^BM?OJ7CSW[/1;U!+ P04    " #P@>=6EXJ[',
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M4$L! A0#%     @ \('G5G1(S\WO    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ \('G5IE<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " #P@>=6G^XO0J<'  !*,P  &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ \('G5F4KXQ%&!@  4AL
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M965T-BYX;6Q02P$"% ,4    " #P@>=68;7)[<H(  #H$@  &
M    @('X*P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M\('G5NPUQ<"D(0  _&(  !@              ("!^#0  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( /"!YU9*_Y6)F ,  )@'   8
M          " @=)6  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " #P@>=6\/>FID\#  !8!P  &0              @(&@6@  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( /"!YU:*N<[2;00  #8*
M   9              " @29>  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ \('G5K(M_(<2!0  V@H  !D              ("!RF(
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #P@>=6MX3%
MF: #  "5!P  &0              @($3:   >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( /"!YU;5H=Y\A00  !0+   9
M  " @>IK  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M\('G5C+<<=9& P  G <  !D              ("!IG   'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " #P@>=6PT71BOL#  #2"   &0
M            @($C=   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( /"!YU:[O3-&F@0  !P*   9              " @55X  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ \('G5E7!ZFDT!0
MI L  !D              ("!)GT  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " #P@>=6,?>C4<P&  #D$   &0              @(&1
M@@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( /"!YU:5
M18N@3P0  /,*   9              " @92)  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ \('G5M*N*W&8!@  M X  !D
M     ("!&HX  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /"!YU8%<=1 A0(  &(%   9              "
M@8K'  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ \('G
M5FON1):T @  QP4  !D              ("!1LH  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " #P@>=6[ QD,R$#  #=!P  &0
M        @($QS0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( /"!YU8BA,/?: ,  )@'   9              " @8G0  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ \('G5HM3=A^E P  E@<
M !D              ("!*-0  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " #P@>=6P P43^T#   >"@  &0              @($$V
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( /"!YU;>42)Z
MP@(  -T%   9              " @2C<  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ \('G5GB$C5MQ @  4P4  !D
M ("!(=\  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #P
M@>=6J?FUP'P$  #U"@  &0              @(')X0  >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( /"!YU8\KD 18@,  "P(   9
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M  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ \('G5FS
M\'ZS!   ,!0  !D              ("!*O@  'AL+W=O<FMS:&5E=',O<VAE
M970S.2YX;6Q02P$"% ,4    " #P@>=6V$=>IE@"  "9!0  &0
M    @($4_0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M /"!YU;!B=BZC (  -P&   9              " @:/_  !X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ \('G5A)7+FV  @  =P8  !D
M             ("!9@(! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " #P@>=6^ RCB<P"  !L!P  &0              @($=!0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( /"!YU:Z\(RR\@(
M # *   9              " @2 ( 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ \('G5GEX)DBI P  $Q,  !D              ("!
M20L! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #P@>=6
MJFGE.7\"  ")!@  &0              @($I#P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( /"!YU:*B=Z 80,  ,H,   9
M      " @=\1 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ \('G5M49!T8P!@  'B\  !D              ("!=Q4! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #P@>=6L*.Z?V4"  !*!0
M&0              @('>&P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( /"!YU8V!6=N^@,  #P*   9              " @7H> 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ \('G5A3LT[#Q
M P  [!4  !D              ("!JR(! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    " #P@>=6Q9FTCKP#  #C#0  &0
M@('3)@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( /"!
MYU;BJZ[ @ (  (<&   9              " @<8J 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ \('G5K]2JD]@ @  W 4  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( /"!YU;GO0F^\P,  )4/   9
M  " @>4[ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M\('G5FQ6NG X!0  !QX  !D              ("!#T ! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    " #P@>=6M+)U' 0#   +"0  &0
M            @(%^10$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( /"!YU;,CL!/)P,  '$*   9              " @;E( 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ \('G5BC^W^YL P
M^@P  !D              ("!%TP! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    " #P@>=6 F/F4&<$   T&0  &0              @(&Z
M3P$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( /"!YU8E
M),AGB ,  *(*   9              " @5A4 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ \('G5B,>&OD$ P  I0@  !D
M     ("!%U@! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /"!YU;NDY$@HP,  %01   9              "
M@<EK 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ \('G
M5MOKBW91!   ]A(  !D              ("!HV\! 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    " #P@>=6^PU3"'("  "A!0  &0
M        @($K= $ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( /"!YU;@$'#=-0,  $H3   -              "  =1V 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ \('G5I>*NQS     $P(   L
M ( !-'H! %]R96QS+RYR96QS4$L! A0#%     @ \('G5EM+9(=\!0  !C
M  \              ( !'7L! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M /"!YU:WQP,P0@(  $(K   :              "  <:  0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /"!YU;XPP(=!@(  $\J   3
M              "  4"# 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !1
- %$ +A8  '>% 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>126</ContextCount>
  <ElementCount>306</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>60</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ConsolidatedCashFlow</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - NATURE OF OPERATIONS AND MANAGEMENT???S PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/NATUREOFOPERATIONSANDMANAGEMENTSPLANS</Role>
      <ShortName>NATURE OF OPERATIONS AND MANAGEMENT???S PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - INVENTORY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/INVENTORY</Role>
      <ShortName>INVENTORY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - DEPOSITS AND ADVANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES</Role>
      <ShortName>DEPOSITS AND ADVANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/INTANGIBLEASSETS</Role>
      <ShortName>INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - CLAIMS AND ADVANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES</Role>
      <ShortName>CLAIMS AND ADVANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - ACCRUED LIABILITIES AND OTHERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS</Role>
      <ShortName>ACCRUED LIABILITIES AND OTHERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - LOANS AND OTHER LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES</Role>
      <ShortName>LOANS AND OTHER LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SECURITIES</Role>
      <ShortName>SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - INVENTORY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/INVENTORYTables</Role>
      <ShortName>INVENTORY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INVENTORY</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - DEPOSITS AND ADVANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables</Role>
      <ShortName>DEPOSITS AND ADVANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables</Role>
      <ShortName>INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INTANGIBLEASSETS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - CLAIMS AND ADVANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables</Role>
      <ShortName>CLAIMS AND ADVANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/LEASES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables</Role>
      <ShortName>ACCRUED LIABILITIES AND OTHERS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - LOANS AND OTHER LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables</Role>
      <ShortName>LOANS AND OTHER LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INCOMETAXES</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/REVENUERECOGNITION</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - INVENTORY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/INVENTORYDetails</Role>
      <ShortName>INVENTORY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INVENTORYTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - INVENTORY (Details) - Schedule of Inventory, Current</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable</Role>
      <ShortName>INVENTORY (Details) - Schedule of Inventory, Current</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INVENTORYTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - DEPOSITS AND ADVANCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails</Role>
      <ShortName>DEPOSITS AND ADVANCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - DEPOSITS AND ADVANCES (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable</Role>
      <ShortName>DEPOSITS AND ADVANCES (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails</Role>
      <ShortName>INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable</Role>
      <ShortName>INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - INTANGIBLE ASSETS (Details) - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable</Role>
      <ShortName>INTANGIBLE ASSETS (Details) - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure -  PROPERTY, PLANT AND EQUIPMENT  (Details) - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT  (Details) - Property, Plant and Equipment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - CLAIMS AND ADVANCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails</Role>
      <ShortName>CLAIMS AND ADVANCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - CLAIMS AND ADVANCES (Details) - Schedule of Other Assets, Noncurrent</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable</Role>
      <ShortName>CLAIMS AND ADVANCES (Details) - Schedule of Other Assets, Noncurrent</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/LEASESDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/LEASESTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - LEASES (Details) - Lease, Cost</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/LeaseCostTable</Role>
      <ShortName>LEASES (Details) - Lease, Cost</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/LEASESTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - LEASES (Details) - Lessee, Operating Lease, Liability, Maturity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable</Role>
      <ShortName>LEASES (Details) - Lessee, Operating Lease, Liability, Maturity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/LEASESTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails</Role>
      <ShortName>ACCRUED LIABILITIES AND OTHERS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>054 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Details) - Schedule of Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable</Role>
      <ShortName>ACCRUED LIABILITIES AND OTHERS (Details) - Schedule of Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>055 - Disclosure - LOANS AND OTHER LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails</Role>
      <ShortName>LOANS AND OTHER LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>056 - Disclosure - LOANS AND OTHER LIABILITIES (Details) - Schedule of Loans and Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable</Role>
      <ShortName>LOANS AND OTHER LIABILITIES (Details) - Schedule of Loans and Other Liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>057 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>058 - Disclosure - SECURITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SECURITIESDetails</Role>
      <ShortName>SECURITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/SECURITIES</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>059 - Disclosure - STOCK-BASED COMPENSATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>060 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable</Role>
      <ShortName>STOCK-BASED COMPENSATION  (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>061 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Nonvested Restricted Stock Shares Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable</Role>
      <ShortName>STOCK-BASED COMPENSATION  (Details) - Nonvested Restricted Stock Shares Activity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>062 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Share-based Payment Arrangement, Option, Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable</Role>
      <ShortName>STOCK-BASED COMPENSATION  (Details) - Share-based Payment Arrangement, Option, Activity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>063 - Disclosure -  FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>064 - Disclosure - INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable</Role>
      <ShortName>INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INCOMETAXESTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>065 - Disclosure - INCOME TAXES (Details) - Schedule of Components of Income Tax Expense (Benefit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable</Role>
      <ShortName>INCOME TAXES (Details) - Schedule of Components of Income Tax Expense (Benefit)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INCOMETAXESTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>066 - Disclosure - INCOME TAXES (Details) - Summary of Operating Loss Carryforwards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable</Role>
      <ShortName>INCOME TAXES (Details) - Summary of Operating Loss Carryforwards</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/INCOMETAXESTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>067 - Disclosure - REVENUE RECOGNITION (Details) - Disaggregation of Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable</Role>
      <ShortName>REVENUE RECOGNITION (Details) - Disaggregation of Revenue</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>068 - Disclosure - SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails</Role>
      <ShortName>SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>069 - Disclosure - SEGMENT INFORMATION (Details) - Revenue from External Customers by Products and Services</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable</Role>
      <ShortName>SEGMENT INFORMATION (Details) - Revenue from External Customers by Products and Services</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>070 - Disclosure - SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable</Role>
      <ShortName>SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>071 - Disclosure - SEGMENT INFORMATION (Details) - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable</Role>
      <ShortName>SEGMENT INFORMATION (Details) - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="igcpharma20230331_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>072 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="igcpharma20230331_10k.htm">igcpharma20230331_10k.htm</File>
    <File>ex_537644.htm</File>
    <File>ex_537645.htm</File>
    <File>ex_537646.htm</File>
    <File>ex_537647.htm</File>
    <File>ex_537648.htm</File>
    <File>ex_537649.htm</File>
    <File>igc-20230331.xsd</File>
    <File>igc-20230331_cal.xml</File>
    <File>igc-20230331_def.xml</File>
    <File>igc-20230331_lab.xml</File>
    <File>igc-20230331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>figure1.jpg</File>
    <File>figure5.jpg</File>
    <File>figure6.jpg</File>
    <File>figure7.jpg</File>
    <File>igcpharma_logo1.jpg</File>
    <File>pe_img1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="614">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "igcpharma20230331_10k.htm": {
   "axisCustom": 1,
   "axisStandard": 14,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 614,
    "http://xbrl.sec.gov/dei/2023": 38
   },
   "contextCount": 126,
   "dts": {
    "calculationLink": {
     "local": [
      "igc-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "igc-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "igcpharma20230331_10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "igc-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "igc-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "igc-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    }
   },
   "elementCount": 486,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 4,
    "http://xbrl.sec.gov/dei/2023": 6,
    "total": 10
   },
   "keyCustom": 19,
   "keyStandard": 287,
   "memberCustom": 29,
   "memberStandard": 30,
   "nsprefix": "igc",
   "nsuri": "http://www.indiaglobalcap.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "igc:DepositsAndAdvancesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - DEPOSITS AND ADVANCES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES",
     "shortName": "DEPOSITS AND ADVANCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "igc:DepositsAndAdvancesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.indiaglobalcap.com/role/INTANGIBLEASSETS",
     "shortName": "INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - CLAIMS AND ADVANCES",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES",
     "shortName": "CLAIMS AND ADVANCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - LEASES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.indiaglobalcap.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "igc:AccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - ACCRUED LIABILITIES AND OTHERS",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS",
     "shortName": "ACCRUED LIABILITIES AND OTHERS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "igc:AccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "igc:LoansAndOtherLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - LOANS AND OTHER LIABILITIES",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES",
     "shortName": "LOANS AND OTHER LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "igc:LoansAndOtherLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - SECURITIES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.indiaglobalcap.com/role/SECURITIES",
     "shortName": "SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - STOCK-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.indiaglobalcap.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - REVENUE RECOGNITION",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.indiaglobalcap.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - SEGMENT INFORMATION",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.indiaglobalcap.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Accounting Policies, by Policy (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - INVENTORY (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.indiaglobalcap.com/role/INVENTORYTables",
     "shortName": "INVENTORY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "igc:DepositsAndAdvancesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - DEPOSITS AND ADVANCES (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables",
     "shortName": "DEPOSITS AND ADVANCES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "igc:DepositsAndAdvancesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables",
     "shortName": "INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c41",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c41",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - CLAIMS AND ADVANCES (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables",
     "shortName": "CLAIMS AND ADVANCES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - LEASES (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.indiaglobalcap.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "igc:AccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables",
     "shortName": "ACCRUED LIABILITIES AND OTHERS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "igc:AccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "igc:LoansAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - LOANS AND OTHER LIABILITIES (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables",
     "shortName": "LOANS AND OTHER LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "igc:LoansAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.indiaglobalcap.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - REVENUE RECOGNITION (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryWriteDown",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure - INVENTORY (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.indiaglobalcap.com/role/INVENTORYDetails",
     "shortName": "INVENTORY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryWriteDown",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure - INVENTORY (Details) - Schedule of Inventory, Current",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable",
     "shortName": "INVENTORY (Details) - Schedule of Inventory, Current",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "igc:DepositsAndAdvancesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "igc:StatutoryAdvances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - DEPOSITS AND ADVANCES (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails",
     "shortName": "DEPOSITS AND ADVANCES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "igc:DepositsAndAdvancesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "igc:StatutoryAdvances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "igc:DepositsAndAdvancesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - DEPOSITS AND ADVANCES (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable",
     "shortName": "DEPOSITS AND ADVANCES (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "igc:DepositsAndAdvancesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "igc:NumberOfPatents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - INTANGIBLE ASSETS (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails",
     "shortName": "INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "igc:NumberOfPatents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable",
     "shortName": "INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - INTANGIBLE ASSETS (Details) - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable",
     "shortName": "INTANGIBLE ASSETS (Details) - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "046 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "047 - Disclosure -  PROPERTY, PLANT AND EQUIPMENT  (Details) - Property, Plant and Equipment",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT  (Details) - Property, Plant and Equipment",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "igc:DepositsAndAdvancesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "igc:TransferFromDepositsAndAdvancesToClaimsAndAdvances",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "048 - Disclosure - CLAIMS AND ADVANCES (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails",
     "shortName": "CLAIMS AND ADVANCES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:PaymentsForDeposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3",
     "shortName": "CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "049 - Disclosure - CLAIMS AND ADVANCES (Details) - Schedule of Other Assets, Noncurrent",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable",
     "shortName": "CLAIMS AND ADVANCES (Details) - Schedule of Other Assets, Noncurrent",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShortTermLeaseCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "050 - Disclosure - LEASES (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.indiaglobalcap.com/role/LEASESDetails",
     "shortName": "LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c64",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "051 - Disclosure - LEASES (Details) - Lease, Cost",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.indiaglobalcap.com/role/LeaseCostTable",
     "shortName": "LEASES (Details) - Lease, Cost",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "052 - Disclosure - LEASES (Details) - Lessee, Operating Lease, Liability, Maturity",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable",
     "shortName": "LEASES (Details) - Lessee, Operating Lease, Liability, Maturity",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "igc:AccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableOtherCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "053 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails",
     "shortName": "ACCRUED LIABILITIES AND OTHERS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "igc:AccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableOtherCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "igc:AccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "054 - Disclosure - ACCRUED LIABILITIES AND OTHERS (Details) - Schedule of Accounts Payable and Accrued Liabilities",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable",
     "shortName": "ACCRUED LIABILITIES AND OTHERS (Details) - Schedule of Accounts Payable and Accrued Liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "igc:AccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "igc:LoansAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c69",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "055 - Disclosure - LOANS AND OTHER LIABILITIES (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails",
     "shortName": "LOANS AND OTHER LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "igc:LoansAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c69",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "igc:LoansAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherAccruedLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "056 - Disclosure - LOANS AND OTHER LIABILITIES (Details) - Schedule of Loans and Other Liabilities",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable",
     "shortName": "LOANS AND OTHER LIABILITIES (Details) - Schedule of Loans and Other Liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "igc:LoansAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherAccruedLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "057 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "058 - Disclosure - SECURITIES (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.indiaglobalcap.com/role/SECURITIESDetails",
     "shortName": "SECURITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c71",
      "decimals": "4",
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "059 - Disclosure - STOCK-BASED COMPENSATION (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails",
     "shortName": "STOCK-BASED COMPENSATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable",
     "shortName": "STOCK-BASED COMPENSATION  (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c4",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Nonvested Restricted Stock Shares Activity",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable",
     "shortName": "STOCK-BASED COMPENSATION  (Details) - Nonvested Restricted Stock Shares Activity",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c4",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c10",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "062 - Disclosure - STOCK-BASED COMPENSATION  (Details) - Share-based Payment Arrangement, Option, Activity",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable",
     "shortName": "STOCK-BASED COMPENSATION  (Details) - Share-based Payment Arrangement, Option, Activity",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "063 - Disclosure -  FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "064 - Disclosure - INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable",
     "shortName": "INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "065 - Disclosure - INCOME TAXES (Details) - Schedule of Components of Income Tax Expense (Benefit)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable",
     "shortName": "INCOME TAXES (Details) - Schedule of Components of Income Tax Expense (Benefit)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "066 - Disclosure - INCOME TAXES (Details) - Summary of Operating Loss Carryforwards",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable",
     "shortName": "INCOME TAXES (Details) - Summary of Operating Loss Carryforwards",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "067 - Disclosure - REVENUE RECOGNITION (Details) - Disaggregation of Revenue",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable",
     "shortName": "REVENUE RECOGNITION (Details) - Disaggregation of Revenue",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c103",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "068 - Disclosure - SEGMENT INFORMATION (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails",
     "shortName": "SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "006 - Disclosure - NATURE OF OPERATIONS AND MANAGEMENT\u2019S PLANS",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.indiaglobalcap.com/role/NATUREOFOPERATIONSANDMANAGEMENTSPLANS",
     "shortName": "NATURE OF OPERATIONS AND MANAGEMENT\u2019S PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "069 - Disclosure - SEGMENT INFORMATION (Details) - Revenue from External Customers by Products and Services",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable",
     "shortName": "SEGMENT INFORMATION (Details) - Revenue from External Customers by Products and Services",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c111",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070 - Disclosure - SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable",
     "shortName": "SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c115",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "071 - Disclosure - SEGMENT INFORMATION (Details) - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable",
     "shortName": "SEGMENT INFORMATION (Details) - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c120",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c124",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "072 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c124",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - INVENTORY",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.indiaglobalcap.com/role/INVENTORY",
     "shortName": "INVENTORY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "igcpharma20230331_10k.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 60,
   "tag": {
    "country_CO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COLOMBIA",
        "terseLabel": "COLOMBIA"
       }
      }
     },
     "localname": "CO",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INDIA",
        "terseLabel": "INDIA"
       }
      }
     },
     "localname": "IN",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO",
        "terseLabel": "PUERTO RICO"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails",
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "auth_ref": [
      "r620",
      "r621",
      "r622",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction.",
        "label": "Document Financial Statement Error Correction [Flag]",
        "terseLabel": "Document Financial Statement Error Correction [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "auth_ref": [
      "r620",
      "r621",
      "r622",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b).",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "terseLabel": "Document Financial Statement Restatement Recovery Analysis [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "igc_AccruedLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities Disclosure Abstract"
       }
      }
     },
     "localname": "AccruedLiabilitiesDisclosureAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_AccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for accrued liabilities.",
        "label": "Accrued Liabilities Disclosure Text Block",
        "terseLabel": "Accrued Liabilities Disclosure [Text Block]"
       }
      }
     },
     "localname": "AccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "igc_AdjustmentToReconcileNetLossToNetCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To Reconcile Net Loss To Net Cash Abstract",
        "terseLabel": "Adjustment to reconcile net loss to net cash:"
       }
      }
     },
     "localname": "AdjustmentToReconcileNetLossToNetCashAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_ClinicalTrialInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Clinical Trial Inventory Member",
        "terseLabel": "Clinical Trial Inventory [Member]"
       }
      }
     },
     "localname": "ClinicalTrialInventoryMember",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_CybersecurityPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to cyber-security.",
        "label": "Cybersecurity Policy Policy Text Block",
        "terseLabel": "Cyber-security Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CybersecurityPolicyPolicyTextBlock",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "igc_DepositsAndAdvancesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits And Advances Abstract"
       }
      }
     },
     "localname": "DepositsAndAdvancesAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_DepositsAndAdvancesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of deposits and advances.",
        "label": "Deposits And Advances Text Block",
        "terseLabel": "Deposits and Advances [Text Block]"
       }
      }
     },
     "localname": "DepositsAndAdvancesTextBlock",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "igc_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ESOP2008OmnibusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the equity-based compensation arrangement plan.",
        "label": "ESOP2008 Omnibus Plan Member",
        "terseLabel": "ESOP 2008 Omnibus Plan [Member]"
       }
      }
     },
     "localname": "ESOP2008OmnibusPlanMember",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_EarningsPerShareBasicDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicDiluted",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "igc_Expiring2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2023 Member",
        "terseLabel": "Expiring 2023 [Member]"
       }
      }
     },
     "localname": "Expiring2023Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2024 Member",
        "terseLabel": "Expiring 2024 [Member]"
       }
      }
     },
     "localname": "Expiring2024Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2025 Member",
        "terseLabel": "Expiring 2025 [Member]"
       }
      }
     },
     "localname": "Expiring2025Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2026 Member",
        "terseLabel": "Expiring 2026 [Member]"
       }
      }
     },
     "localname": "Expiring2026Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2027 Member",
        "terseLabel": "Expiring 2027 [Member]"
       }
      }
     },
     "localname": "Expiring2027Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2028 Member",
        "terseLabel": "Expiring 2028 [Member]"
       }
      }
     },
     "localname": "Expiring2028Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2029 Member",
        "terseLabel": "Expiring 2029 [Member]"
       }
      }
     },
     "localname": "Expiring2029Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2030 Member",
        "terseLabel": "Expiring 2030 [Member]"
       }
      }
     },
     "localname": "Expiring2030Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2031 Member",
        "terseLabel": "Expiring 2031 [Member]"
       }
      }
     },
     "localname": "Expiring2031Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2032 Member",
        "terseLabel": "Expiring 2032 [Member]"
       }
      }
     },
     "localname": "Expiring2032Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2033 Member",
        "terseLabel": "Expiring 2033 [Member]"
       }
      }
     },
     "localname": "Expiring2033Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2034Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2034 Member",
        "terseLabel": "Expiring 2034 [Member]"
       }
      }
     },
     "localname": "Expiring2034Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2035 Member",
        "terseLabel": "Expiring 2035 [Member]"
       }
      }
     },
     "localname": "Expiring2035Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2036 Member",
        "terseLabel": "Expiring 2036 [Member]"
       }
      }
     },
     "localname": "Expiring2036Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2037 Member",
        "terseLabel": "Expiring 2037 [Member]"
       }
      }
     },
     "localname": "Expiring2037Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2038 Member",
        "terseLabel": "Expiring 2038 [Member]"
       }
      }
     },
     "localname": "Expiring2038Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2039 Member",
        "terseLabel": "Expiring 2039 [Member]"
       }
      }
     },
     "localname": "Expiring2039Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2040 Member",
        "terseLabel": "Expiring 2040 [Member]"
       }
      }
     },
     "localname": "Expiring2040Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2041 Member",
        "terseLabel": "Expiring 2041 [Member]"
       }
      }
     },
     "localname": "Expiring2041Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2042 Member",
        "terseLabel": "Expiring 2042 [Member]"
       }
      }
     },
     "localname": "Expiring2042Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_Expiring2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring2043 Member",
        "terseLabel": "Expiring 2043 [Member]"
       }
      }
     },
     "localname": "Expiring2043Member",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]"
       }
      }
     },
     "localname": "FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table]"
       }
      }
     },
     "localname": "FAIRVALUEOFFINANCIALINSTRUMENTSDetailsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_GoingConcernPolicyPolicyTextblock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policy for going concern.",
        "label": "Going Concern Policy Policy Textblock",
        "terseLabel": "Going Concern, Policy [Policy Textblock}"
       }
      }
     },
     "localname": "GoingConcernPolicyPolicyTextblock",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "igc_INTANGIBLEASSETSDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INTANGIBLE ASSETS (Details) [Line Items]"
       }
      }
     },
     "localname": "INTANGIBLEASSETSDetailsLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Line Items]"
       }
      }
     },
     "localname": "INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Table]"
       }
      }
     },
     "localname": "INTANGIBLEASSETSDetailsScheduleofIntangibleAssetsAndGoodwillTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_INTANGIBLEASSETSDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INTANGIBLE ASSETS (Details) [Table]"
       }
      }
     },
     "localname": "INTANGIBLEASSETSDetailsTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_IncreaseDecreaseInOperatingLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating lease assets.",
        "label": "Increase Decrease In Operating Lease Assets",
        "negatedLabel": "Operating lease asset"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseAssets",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "igc_InfrastructureSegmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Infrastructure Segment Abstract",
        "terseLabel": "Infrastructure segment"
       }
      }
     },
     "localname": "InfrastructureSegmentAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_LEASESDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES (Details) [Line Items]"
       }
      }
     },
     "localname": "LEASESDetailsLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_LEASESDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES (Details) [Table]"
       }
      }
     },
     "localname": "LEASESDetailsTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_LegacyInfrastructureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service.",
        "label": "Legacy Infrastructure Member",
        "terseLabel": "Legacy Infrastructure [Member]"
       }
      }
     },
     "localname": "LegacyInfrastructureMember",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_LesseeOperatingLeaseLiabilityMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Operating Lease Liability Maturity Abstract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_LoansAndOtherLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Other Liabilities Abstract"
       }
      }
     },
     "localname": "LoansAndOtherLiabilitiesAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_LoansAndOtherLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of loans and other liabilities.",
        "label": "Loans And Other Liabilities Text Block",
        "terseLabel": "Loans and Other Liabilities [Text Block]"
       }
      }
     },
     "localname": "LoansAndOtherLiabilitiesTextBlock",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "igc_NonCashItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Items Abstract",
        "terseLabel": "Non-cash items:"
       }
      }
     },
     "localname": "NonCashItemsAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_NonCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Assets Abstract",
        "terseLabel": "Non-current assets:"
       }
      }
     },
     "localname": "NonCurrentAssetsAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_NonCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Liabilities Abstract",
        "terseLabel": "Non-current liabilities:"
       }
      }
     },
     "localname": "NonCurrentLiabilitiesAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_NonvestedRestrictedStockSharesActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonvested Restricted Stock Shares Activity Abstract"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_NumberOfPatents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of patents.",
        "label": "Number Of Patents",
        "terseLabel": "Number of Patents"
       }
      }
     },
     "localname": "NumberOfPatents",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "igc_NumberOfPatentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of granted patents.",
        "label": "Number Of Patents Granted",
        "terseLabel": "Number of Patents Granted"
       }
      }
     },
     "localname": "NumberOfPatentsGranted",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "igc_OtherAdvances": {
     "auth_ref": [],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of other noncurrent advances.",
        "label": "Other Advances",
        "terseLabel": "Other advances"
       }
      }
     },
     "localname": "OtherAdvances",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "igc_PROPERTYPLANTANDEQUIPMENTDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY, PLANT AND EQUIPMENT (Details) [Line Items]"
       }
      }
     },
     "localname": "PROPERTYPLANTANDEQUIPMENTDetailsLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_PROPERTYPLANTANDEQUIPMENTDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY, PLANT AND EQUIPMENT (Details) [Table]"
       }
      }
     },
     "localname": "PROPERTYPLANTANDEQUIPMENTDetailsTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_PROPERTYPLANTANDEQUIPMENTTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY, PLANT AND EQUIPMENT (Tables) [Line Items]"
       }
      }
     },
     "localname": "PROPERTYPLANTANDEQUIPMENTTablesLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_PROPERTYPLANTANDEQUIPMENTTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY, PLANT AND EQUIPMENT (Tables) [Table]"
       }
      }
     },
     "localname": "PROPERTYPLANTANDEQUIPMENTTablesTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_PlantAndCannabinoidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents of the Company's segments.",
        "label": "Plant And Cannabinoid Member",
        "terseLabel": "Plant and Cannabinoid [Member]"
       }
      }
     },
     "localname": "PlantAndCannabinoidMember",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_PropertyPlantAndEquipmentEstimatedUsefulLives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property Plant And Equipment Estimated Useful Lives1",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives1",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_PropertyPlantAndEquipmentTableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of property, plant and equipment.",
        "label": "Property Plant And Equipment Table Member",
        "terseLabel": "Property Plant and Equipment Table [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTableMember",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_PropertyPlantAndEquipmentTableTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by property, plant and equipment.",
        "label": "Property Plant And Equipment Table Type Axis",
        "terseLabel": "Property, Plant and Equipment, Table Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTableTypeAxis",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_RentalIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about product and services.",
        "label": "Rental Income Member",
        "terseLabel": "Rental Income [Member]"
       }
      }
     },
     "localname": "RentalIncomeMember",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_RevenueFromExternalCustomersByGeographicAreasAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue From External Customers By Geographic Areas Abstract"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_RevenueFromExternalCustomersByProductsAndServicesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue From External Customers By Products And Services Abstract"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByProductsAndServicesAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]"
       }
      }
     },
     "localname": "SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Table]"
       }
      }
     },
     "localname": "SEGMENTINFORMATIONDetailsRevenuefromExternalCustomersbyGeographicAreasTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) [Table]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_STOCKBASEDCOMPENSATIONDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCK-BASED COMPENSATION (Details) [Line Items]"
       }
      }
     },
     "localname": "STOCKBASEDCOMPENSATIONDetailsLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_STOCKBASEDCOMPENSATIONDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCK-BASED COMPENSATION (Details) [Table]"
       }
      }
     },
     "localname": "STOCKBASEDCOMPENSATIONDetailsTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_SUBSEQUENTEVENTSDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS (Details) [Line Items]"
       }
      }
     },
     "localname": "SUBSEQUENTEVENTSDetailsLineItems",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_SUBSEQUENTEVENTSDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS (Details) [Table]"
       }
      }
     },
     "localname": "SUBSEQUENTEVENTSDetailsTable",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_SalesAgreementMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum offering under sales agreement.",
        "label": "Sales Agreement Maximum",
        "terseLabel": "Sales Agreement, Offering, Maximum (in Dollars)"
       }
      }
     },
     "localname": "SalesAgreementMaximum",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "igc_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Accounts Payable And Accrued Liabilities Abstract"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Components Of Income Tax Expense Benefit Abstract"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Effective Income Tax Rate Reconciliation Abstract"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Abstract"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Finite Lived Intangible Assets Future Amortization Expense Abstract"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfIntangibleAssetsAndGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Intangible Assets And Goodwill Abstract"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfInventoryCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Inventory Current Abstract"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfLoansAndOtherLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Loans And Other Liabilities Abstract"
       }
      }
     },
     "localname": "ScheduleOfLoansAndOtherLiabilitiesAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfOtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Assets Noncurrent Abstract"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenue From External Customers And Long Lived Assets By Geographical Areas Abstract"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAndLongLivedAssetsByGeographicalAreasAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Abstract"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_ShareBasedPaymentArrangementOptionActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment Arrangement Option Activity Abstract"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionActivityAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_StatutoryAdvances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statutory advances.",
        "label": "Statutory Advances",
        "terseLabel": "Statutory Advances"
       }
      }
     },
     "localname": "StatutoryAdvances",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "igc_SummaryOfOperatingLossCarryforwardsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Operating Loss Carryforwards Abstract"
       }
      }
     },
     "localname": "SummaryOfOperatingLossCarryforwardsAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "xbrltype": "stringItemType"
    },
    "igc_TollingWhiteLabelingServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of product or service.",
        "label": "Tolling White Labeling Service Member",
        "terseLabel": "Tolling/White labeling service [Member]"
       }
      }
     },
     "localname": "TollingWhiteLabelingServiceMember",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"
     ],
     "xbrltype": "domainItemType"
    },
    "igc_TotalRevenuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of segment to total revenue.",
        "label": "Total Revenue Percentage",
        "terseLabel": "Percentage of Total Revenue"
       }
      }
     },
     "localname": "TotalRevenuePercentage",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable",
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "igc_TransferFromDepositsAndAdvancesToClaimsAndAdvances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount transferred from Deposits and Advances to Claims and Advances.",
        "label": "Transfer From Deposits And Advances To Claims And Advances",
        "terseLabel": "Transfer from Deposits and Advances to Claims and Advances"
       }
      }
     },
     "localname": "TransferFromDepositsAndAdvancesToClaimsAndAdvances",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails",
      "http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "igc_UnamortizedIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unamortized Intangible Assets Abstract",
        "terseLabel": "Unamortized intangible assets"
       }
      }
     },
     "localname": "UnamortizedIntangibleAssetsAbstract",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_UnitDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of unit.",
        "label": "Unit Description",
        "terseLabel": "Unit, description"
       }
      }
     },
     "localname": "UnitDescription",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "igc_UnitsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of units outstanding.",
        "label": "Units Outstanding",
        "terseLabel": "Units Outstanding"
       }
      }
     },
     "localname": "UnitsOutstanding",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "igc_WeightedAverageNumberOfShareOutstandingBasicDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic Diluted",
        "terseLabel": "Weighted-average number of shares used in computing loss per share amounts: (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicDiluted",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "igc_WeightedAveragePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price per share.",
        "label": "Weighted Average Price Per Share",
        "terseLabel": "Weighted Average Price per Share (in Dollars per share)"
       }
      }
     },
     "localname": "WeightedAveragePricePerShare",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "igc_WellnessAndLifestyleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of product or service.",
        "label": "Wellness And Lifestyle Member",
        "terseLabel": "Wellness and Lifestyle [Member]"
       }
      }
     },
     "localname": "WellnessAndLifestyleMember",
     "nsuri": "http://www.indiaglobalcap.com/20230331",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [
      "r692",
      "r693",
      "r694",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia [Member]",
        "terseLabel": "Asia [Member]"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r323",
      "r429",
      "r463",
      "r484",
      "r485",
      "r539",
      "r543",
      "r545",
      "r546",
      "r548",
      "r565",
      "r566",
      "r578",
      "r586",
      "r597",
      "r605",
      "r662",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails",
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r323",
      "r429",
      "r463",
      "r484",
      "r485",
      "r539",
      "r543",
      "r545",
      "r546",
      "r548",
      "r565",
      "r566",
      "r578",
      "r586",
      "r597",
      "r605",
      "r662",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails",
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r242",
      "r434",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r568",
      "r587",
      "r604",
      "r629",
      "r658",
      "r659",
      "r663",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable",
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r242",
      "r434",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r568",
      "r587",
      "r604",
      "r629",
      "r658",
      "r659",
      "r663",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable",
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r316",
      "r323",
      "r339",
      "r340",
      "r341",
      "r428",
      "r429",
      "r463",
      "r484",
      "r485",
      "r539",
      "r543",
      "r545",
      "r546",
      "r548",
      "r565",
      "r566",
      "r578",
      "r586",
      "r597",
      "r605",
      "r608",
      "r656",
      "r662",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails",
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r316",
      "r323",
      "r339",
      "r340",
      "r341",
      "r428",
      "r429",
      "r463",
      "r484",
      "r485",
      "r539",
      "r543",
      "r545",
      "r546",
      "r548",
      "r565",
      "r566",
      "r578",
      "r586",
      "r597",
      "r605",
      "r608",
      "r656",
      "r662",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails",
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r244",
      "r245",
      "r481",
      "r482",
      "r483",
      "r540",
      "r544",
      "r547",
      "r549",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r569",
      "r588",
      "r608",
      "r663",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails",
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r244",
      "r245",
      "r481",
      "r482",
      "r483",
      "r540",
      "r544",
      "r547",
      "r549",
      "r552",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r569",
      "r588",
      "r608",
      "r663",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails",
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accrued liabilities and others"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r22",
      "r603"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable, Other, Current",
        "terseLabel": "Accounts Payable, Other, Current"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r503",
      "r553",
      "r609",
      "r687"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r247",
      "r248"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r59",
      "r175",
      "r449"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r33",
      "r34",
      "r93",
      "r181",
      "r445",
      "r468",
      "r469"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.",
        "label": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r5",
      "r12",
      "r34",
      "r386",
      "r389",
      "r421",
      "r464",
      "r465",
      "r640",
      "r641",
      "r642",
      "r649",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Common stock-based compensation &amp; expenses, net"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r343",
      "r355"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Common stock-based compensation and expenses, net"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r182",
      "r251",
      "r256",
      "r257",
      "r259",
      "r687"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r10",
      "r51",
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r10",
      "r57"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Permanent impairment of PPE"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r125",
      "r178",
      "r203",
      "r225",
      "r233",
      "r238",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r379",
      "r383",
      "r397",
      "r442",
      "r508",
      "r603",
      "r616",
      "r660",
      "r661",
      "r677"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r170",
      "r186",
      "r203",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r379",
      "r383",
      "r397",
      "r603",
      "r660",
      "r661",
      "r677"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r203",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r379",
      "r383",
      "r397",
      "r660",
      "r661",
      "r677"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Total non-current assets",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Building Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r36",
      "r173",
      "r570"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents",
        "terseLabel": "Cash and Cash Equivalents, at Carrying Value",
        "totalLabel": "Total cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r36",
      "r106",
      "r200"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at the end of the period",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r4",
      "r106"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r31",
      "r74",
      "r443",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies \u2013 See Note 12"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r272",
      "r273",
      "r554",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies Disclosure [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock Including Additional Paid in Capital [Member]"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r606",
      "r607",
      "r608",
      "r610",
      "r611",
      "r612",
      "r613",
      "r649",
      "r650",
      "r670",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value (in Dollars per share)",
        "terseLabel": "Common Stock, Par or Stated Value Per Share (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r84",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r13",
      "r84",
      "r494",
      "r514",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding",
        "periodEndLabel": "Balances (in Shares)",
        "periodStartLabel": "Balances (in Shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r84",
      "r85",
      "r120"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common stock and additional paid-in capital, $0.0001 par value: 150,000,000 shares authorized; 53,077,436 and 51,054,017 shares issued and outstanding as of March 31, 2023, and March 31, 2022, respectively."
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r35",
      "r188",
      "r190",
      "r196",
      "r437",
      "r454"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r76",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration Risk, Credit Risk, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r71",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionMember": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Building or developing real estate. Includes, but is not limited to, improvement to land for drainage, utilities, grading and subdividing.",
        "label": "Construction [Member]",
        "terseLabel": "Construction [Member]"
       }
      }
     },
     "localname": "ConstructionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r100",
      "r203",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r397",
      "r660"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "negatedLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Goods and Service [Policy Text Block]"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r72",
      "r73",
      "r287",
      "r408",
      "r582",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r28",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r29",
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Debt Instrument, Periodic Payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt Instrument, Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DEPOSITSANDADVANCESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "auth_ref": [
      "r69",
      "r669"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "terseLabel": "Non-capital loss carry-forwards \u2013 USA"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r668"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r69",
      "r669"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Temporary differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "auth_ref": [
      "r68",
      "r69",
      "r669"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "terseLabel": "Net operating loss carry-forwards foreign"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r367"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofComponentsofIncomeTaxExpenseBenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r631"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Deposits Assets, Noncurrent",
        "terseLabel": "Non-current deposits"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r10",
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r10",
      "r228"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [
      "r314",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r314",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r324",
      "r325",
      "r344",
      "r345",
      "r347",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Payment Arrangement [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureTextBlockSupplementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block Supplement [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockSupplementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net loss per share attributable to common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r41",
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effects of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Compensation and other contributions"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of employee stock ownership plan.",
        "label": "Employee Stock Ownership Plan (ESOP) Name [Axis]"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The shares that, although not legally released, will be released by a future scheduled and committed debt service payment and will be allocated to employees for service rendered in the current accounting period. The ESOP documents typically define the period of service to which the shares relate. ESOP shares are released to compensate employees directly, to settle employer liabilities for other employee benefits, and to replace dividends on allocated shares that are used for debt service.",
        "label": "Employee Stock Ownership Plan (ESOP), Number of Committed-to-be-Released Shares",
        "terseLabel": "Employee Stock Ownership Plan (ESOP), Number of Committed-to-be-Released Shares (in Shares)"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entities identify multiple employee stock ownership plans by unique name.",
        "label": "Employee Stock Ownership Plan (ESOP), Plan [Domain]"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r13",
      "r168",
      "r192",
      "r193",
      "r194",
      "r205",
      "r206",
      "r207",
      "r209",
      "r214",
      "r216",
      "r220",
      "r254",
      "r255",
      "r305",
      "r348",
      "r349",
      "r350",
      "r371",
      "r372",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r421",
      "r464",
      "r465",
      "r466",
      "r479",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r289",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r396",
      "r425",
      "r426",
      "r427",
      "r582",
      "r583",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Disclosures [Text Block]"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r289",
      "r317",
      "r322",
      "r396",
      "r425",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r289",
      "r317",
      "r322",
      "r396",
      "r426",
      "r582",
      "r583",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r289",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r396",
      "r427",
      "r582",
      "r583",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r289",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r425",
      "r426",
      "r427",
      "r582",
      "r583",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r176",
      "r267"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "For the year ended 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "For the year ended 2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "For the year ended 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "For the year ended 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "For the year ended 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r264",
      "r266",
      "r267",
      "r269",
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails",
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r112",
      "r436"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r52",
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails",
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r112",
      "r435"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "verboseLabel": "Total amortized intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Net loss on sale of property, plant, and equipment",
        "terseLabel": "Gain (Loss) on Disposition of Property Plant Equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow",
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r10",
      "r61",
      "r62"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Forgiveness of PPP Loan"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionAxis": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r438",
      "r439",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Axis]"
       }
      }
     },
     "localname": "GeographicDistributionAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionDomain": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Domain]"
       }
      }
     },
     "localname": "GeographicDistributionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionDomesticMember": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic.",
        "label": "Geographic Distribution, Domestic [Member]",
        "terseLabel": "Geographic Distribution, Domestic [Member]"
       }
      }
     },
     "localname": "GeographicDistributionDomesticMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionForeignMember": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r438",
      "r439",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as foreign.",
        "label": "Geographic Distribution, Foreign [Member]",
        "terseLabel": "Geographic Distribution, Foreign [Member]"
       }
      }
     },
     "localname": "GeographicDistributionForeignMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r99",
      "r203",
      "r225",
      "r232",
      "r237",
      "r240",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r397",
      "r577",
      "r660"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Other than Temporary Impairment Losses, Investments",
        "negatedLabel": "Impairment of investment",
        "terseLabel": "Impairment of non-marketable securities"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow",
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r0",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r1",
      "r95",
      "r130",
      "r225",
      "r232",
      "r237",
      "r240",
      "r439",
      "r451",
      "r577"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Net Income Loss before tax",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement",
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r270",
      "r271",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r271",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r204",
      "r357",
      "r363",
      "r364",
      "r369",
      "r373",
      "r375",
      "r376",
      "r377",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax Disclosure [Text Block]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r147",
      "r215",
      "r216",
      "r229",
      "r361",
      "r374",
      "r456"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense/benefit",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement",
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r191",
      "r359",
      "r360",
      "r364",
      "r365",
      "r368",
      "r370",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Tax, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r358",
      "r362"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Tax rate changes and other adjustments"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r362"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Expected income tax recovery"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsForeign": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount",
        "negatedLabel": "Impact of tax rate differences in foreign jurisdictions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsForeign",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofEffectiveIncomeTaxRateReconciliationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accrued and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivables, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r628",
      "r647"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Claims and advances"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Deposits and advances"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r265",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Unamortized intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r53",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r55",
      "r431",
      "r432",
      "r433",
      "r435",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r50",
      "r54"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net",
        "totalLabel": "Total intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable",
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r102",
      "r290",
      "r291",
      "r584",
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory Disclosure [Text Block]"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INVENTORY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r184",
      "r571",
      "r603"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory",
        "terseLabel": "Inventory, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r137",
      "r172",
      "r183",
      "r260",
      "r261",
      "r263",
      "r430",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r635"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r634"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work-in-progress"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofInventoryCurrentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory Write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r455",
      "r470",
      "r471",
      "r472",
      "r473",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "-Non-marketable securities"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "totalLabel": "Total Investment"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land [Member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r414",
      "r602"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/LeaseCostTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases [Policy Text Block]"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Lessee, Operating Lease, Discount Rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total Lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Mar-24"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Mar-27"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Mar-26"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Mar-25"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: Present value discount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LesseeOperatingLeaseLiabilityMaturityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Lessee, Operating Lease, Remaining Lease Term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases [Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r25",
      "r203",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r380",
      "r383",
      "r384",
      "r397",
      "r492",
      "r576",
      "r616",
      "r660",
      "r677",
      "r678"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r89",
      "r127",
      "r447",
      "r603",
      "r648",
      "r653",
      "r671"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r27",
      "r171",
      "r203",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r380",
      "r383",
      "r384",
      "r397",
      "r603",
      "r660",
      "r677",
      "r678"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r20",
      "r78",
      "r79",
      "r80",
      "r82",
      "r203",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r380",
      "r383",
      "r384",
      "r397",
      "r660",
      "r677",
      "r678"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Current Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableCurrent": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.",
        "label": "Loans Payable, Current",
        "terseLabel": "Loans Payable, Current"
       }
      }
     },
     "localname": "LoansPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r179"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term loans"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLoansPayable": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Loans Payable, Noncurrent",
        "terseLabel": "Loans Payable, Noncurrent"
       }
      }
     },
     "localname": "LongTermLoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "-Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r138",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Operations [Text Block]"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NATUREOFOPERATIONSANDMANAGEMENTSPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flow from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r106",
      "r107",
      "r108"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r96",
      "r108",
      "r131",
      "r169",
      "r187",
      "r189",
      "r194",
      "r203",
      "r208",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r218",
      "r225",
      "r232",
      "r237",
      "r240",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r393",
      "r397",
      "r453",
      "r516",
      "r532",
      "r533",
      "r577",
      "r614",
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "verboseLabel": "Net Income (Loss) Attributable to Parent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Nonvested Restricted Stock Shares Activity [Table Text Block]"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NotesReduction": {
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.",
        "label": "Notes Reduction",
        "negatedLabel": "Forgiveness of PPP Loan"
       }
      }
     },
     "localname": "NotesReduction",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Operating Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office Equipment [Member]"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r225",
      "r232",
      "r237",
      "r240",
      "r577"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r415",
      "r602"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/LeaseCostTable": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating Lease, Expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/LeaseCostTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/LeaseCostTable": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Accrued liabilities and others (current portion \u2013 operating lease liability)",
        "verboseLabel": "Short-term lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LeaseCostTable",
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/LeaseCostTable": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liability",
        "verboseLabel": "Operating lease liability (non-current portion \u2013 operating lease liability)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r412",
      "r417"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "\u2013 Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r410"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease asset",
        "verboseLabel": "Total lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/LeaseCostTable",
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r419",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Provision for expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Statutory reserve"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r185",
      "r603"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Prepaid expense and other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Other Assets Disclosure [Text Block]",
        "terseLabel": "Other Assets Disclosure [Text Block]"
       }
      }
     },
     "localname": "OtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/CLAIMSANDADVANCES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r177"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Claims and advances",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable",
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r7",
      "r93",
      "r398",
      "r399",
      "r400"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Gain on foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInventoryNetOfReserves": {
     "auth_ref": [
      "r48",
      "r636"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after of valuation reserves and allowances, of inventory, classified as other, expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Other Inventory, Net of Reserves",
        "terseLabel": "Other receivables and deposits"
       }
      }
     },
     "localname": "OtherInventoryNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r26",
      "r603"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other current liability"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/ScheduleofLoansandOtherLiabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r637",
      "r654"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Advances to suppliers and consultants"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r180",
      "r502"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Claims receivable"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofOtherAssetsNoncurrentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": {
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Common stock issued/granted for stock-based compensation, including patent acquisition"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSDetails",
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForDeposits": {
     "auth_ref": [
      "r645",
      "r646"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.",
        "label": "Payments for Deposits",
        "terseLabel": "Payments for Deposits"
       }
      }
     },
     "localname": "PaymentsForDeposits",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r627",
      "r643"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Investment in short-term investments"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Acquisition and filing cost of patents and rights"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r83",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in Dollars per share)",
        "verboseLabel": "Preferred Stock, Par or Stated Value Per Share (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r83",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized shares",
        "verboseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r83",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r83",
      "r494",
      "r514",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r83",
      "r444",
      "r603"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value: authorized 1,000,000 shares, no shares issued or outstanding as of March 31, 2023, or March 31, 2022."
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r639"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Deposits and advances",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/DeferredCostsCapitalizedPrepaidandOtherAssetsDisclosureTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r8",
      "r475"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Net proceeds from the issuance of common stock",
        "terseLabel": "Proceeds from Issuance or Sale of Equity (in Dollars)"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow",
      "http://www.indiaglobalcap.com/role/SECURITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.",
        "label": "Repayment of long-term loan"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Sale of property, plant, and equipment",
        "verboseLabel": "Proceeds from Sale of Property, Plant, and Equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow",
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r169",
      "r187",
      "r189",
      "r198",
      "r203",
      "r208",
      "r215",
      "r216",
      "r225",
      "r232",
      "r237",
      "r240",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r378",
      "r381",
      "r382",
      "r393",
      "r397",
      "r439",
      "r452",
      "r478",
      "r516",
      "r532",
      "r533",
      "r577",
      "r599",
      "r600",
      "r615",
      "r642",
      "r660"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow",
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r142",
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment Disclosure [Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisposals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Disposals",
        "terseLabel": "Property, Plant and Equipment, Disposals"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisposals",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r116",
      "r174",
      "r450"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r440",
      "r450",
      "r603"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, plant and equipment, net",
        "totalLabel": "Net Assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable",
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOwnedGross": {
     "auth_ref": [
      "r655"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation, of long-lived, depreciable flight asset owned. Excludes right-of-use asset from finance lease for flight asset.",
        "label": "Property, Plant, and Equipment, Owned, Gross",
        "terseLabel": "Property, Plant, and Equipment, Owned, Gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOwnedGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r142",
      "r145",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r197",
      "r258"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for bad debt"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r77",
      "r356",
      "r685"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "negatedLabel": "Research and development expenses",
        "terseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement",
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r2",
      "r3",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "Research, Development, and Computer Software, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r86",
      "r120",
      "r446",
      "r467",
      "r469",
      "r476",
      "r495",
      "r603"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r168",
      "r205",
      "r206",
      "r207",
      "r209",
      "r214",
      "r216",
      "r254",
      "r255",
      "r348",
      "r349",
      "r350",
      "r371",
      "r372",
      "r385",
      "r387",
      "r388",
      "r390",
      "r392",
      "r464",
      "r466",
      "r479",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r149",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r517",
      "r567",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r195",
      "r203",
      "r226",
      "r227",
      "r231",
      "r235",
      "r236",
      "r242",
      "r244",
      "r246",
      "r253",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r397",
      "r439",
      "r660"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenue",
        "terseLabel": "Revenues",
        "verboseLabel": "Total Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement",
      "http://www.indiaglobalcap.com/role/DisaggregationofRevenueTable",
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyGeographicAreasTable",
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r418",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/RevenuefromExternalCustomersbyProductsandServicesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r21",
      "r90",
      "r91",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INVENTORYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, classified as other.",
        "label": "Schedule of Other Assets and Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Assets and Other Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LOANSANDOTHERLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/CLAIMSANDADVANCESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r47",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r47",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r16",
      "r17",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r230",
      "r234",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure [Text Block]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r9"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-Based Payment Arrangement, Noncash Expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancelled/Forfeited, Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balance, non-vested shares",
        "periodStartLabel": "Balance, non-vested shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance, Weighted average grant date fair value",
        "periodStartLabel": "Balance, Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested, shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations",
        "negatedLabel": "Cancelled/Forfeited, shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Granted, shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/NonvestedRestrictedStockSharesActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Cancelled/Forfeited, shares (in Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled/Forfeited, Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted, shares (in Shares)",
        "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, shares (in Shares)",
        "periodStartLabel": "Options outstanding, shares (in Shares)",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options outstanding, Weighted average exercise price",
        "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails",
      "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r324",
      "r326",
      "r336",
      "r337",
      "r338",
      "r339",
      "r342",
      "r351",
      "r352",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Payment Arrangement [Policy Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vested options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life of options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options forfeited.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancelled/Forfeited, Weighted average grant date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options outstanding, Weighted average grant date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r81",
      "r126",
      "r603",
      "r686"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-Term Debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ACCRUEDLIABILITIESANDOTHERSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r128",
      "r129",
      "r638"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r416",
      "r602"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/LeaseCostTable": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short term lease costs",
        "verboseLabel": "Short-Term Lease, Cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/LEASESDetails",
      "http://www.indiaglobalcap.com/role/LeaseCostTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r109",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r13",
      "r32",
      "r168",
      "r192",
      "r193",
      "r194",
      "r205",
      "r206",
      "r207",
      "r209",
      "r214",
      "r216",
      "r220",
      "r254",
      "r255",
      "r305",
      "r348",
      "r349",
      "r350",
      "r371",
      "r372",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r421",
      "r464",
      "r465",
      "r466",
      "r479",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r220",
      "r434",
      "r470",
      "r480",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r494",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504",
      "r505",
      "r506",
      "r507",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r534",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r220",
      "r434",
      "r470",
      "r480",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r494",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504",
      "r505",
      "r506",
      "r507",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r534",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r13",
      "r83",
      "r84",
      "r120",
      "r475",
      "r534",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock through offering (net of expenses) (in Shares)",
        "verboseLabel": "Stock Issued During Period, Shares, New Issues (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails",
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Other adjustments (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r13",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/STOCKBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r13",
      "r83",
      "r84",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Common stock-based compensation &amp; expenses, net (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r13",
      "r83",
      "r84",
      "r120",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised, shares (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SharebasedPaymentArrangementOptionActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r13",
      "r83",
      "r84",
      "r120",
      "r479",
      "r534",
      "r550",
      "r615"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock through offering (net of expenses)",
        "verboseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails",
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r84",
      "r87",
      "r88",
      "r110",
      "r496",
      "r514",
      "r535",
      "r536",
      "r603",
      "r616",
      "r648",
      "r653",
      "r671",
      "r690"
     ],
     "calculation": {
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Balances",
        "periodStartLabel": "Balances",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet",
      "http://www.indiaglobalcap.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r202",
      "r292",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r391",
      "r537",
      "r538",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity.",
        "label": "Equity [Text Block]",
        "terseLabel": "Equity [Text Block]"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SECURITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r407",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r407",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r422",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events [Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "terseLabel": "Summary of Operating Loss Carryforwards [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplementary information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SummaryofOperatingLossCarryforwardsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r249",
      "r250",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable [Policy Text Block]"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/ScheduleofIntangibleAssetsAndGoodwillTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r43",
      "r44",
      "r45",
      "r139",
      "r140",
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/PropertyPlantandEquipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r217",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Basic (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.indiaglobalcap.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org//350/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org//360/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org//505/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-8A",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org//275/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org//606/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "1402",
   "Subsection": "Instruction 5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org//280/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org//330/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//842-20/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org//855/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(15))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(i)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r618": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r619": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r621": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r622": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r623": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r624": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r625": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r626": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org//705/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0001185185-23-000693-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001185185-23-000693-xbrl.zip
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M)%Q'9+%!I@!%Y3ME*DK!=;;L_E^1W^\R?AG8VJ9$"DG%@5$J;^)4;6"?Y<4
MAEI+JJ5!:G[E3H?)+Q#8'?@H12$8KRY<S-DND1Y?IG][EIZ_#/\((^;7$&5,
MZZ/&^7"YLN;#<6@=+\+A6?6^?*2=CT]7BR>R-+&4O'DNC##+8#Z>74X?T,BB
M>@;_X$<L[.I93.>T?MM_!5!+ P04    " #P@>=65SM/M/ '  #C.P  #0
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MLA,,L"KDF.S(18J#D>DS)I;TM(SQ8)Z P3Y!0A1XZ]<B=#"^_NG%M1U:/9)
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MT,6NV=NG.2(CSW1-.=8KL_##>F&P(C6;E!WEVET29[\9<0QJ<*3X=OH&ZLC
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MJY#*G8B16,=>V'*G.Q@A8+:+]BM+"&A#.6TRNT*THJ?$VEN"ZW6>G@(.YQO
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M,X@0GQD$8B8J(B0F;"%TA_6[>3/3G]8=W9SO'MLV,Q4POVMN9V[OZ@)Z0TB
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ME4S=+_3< ]W"?J@";A_$@<AR \1H9WT$K;2:")(!;-MV\%D"!L#R1H=^:<
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MI>('\0B'/1!:K';CWP1)\C3(890+L.4A4)!D(6G & BOH1O)CJ@\8V._I98
MY2. ?M"_43'^-?@@99=Y3UV\IB<AXHBKWT&,[D\([ -=(!/R'9&UUV?;#TC
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M_)_@OX[.JNI I^%6/2,P=9S >$'+LT%W_H=I_[#L?\^P@/]?EOW'L/^R:Q'
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M("-P5,!R;4-G+Z>]S<MB&6-ABK\@&J X6&WP,(EYN40=+W:]X$T% V)*,F'
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M;*E-YEIG>GI*-A:,WQFC/*3#(<,ZKI"A!O,-B5-Q\B]23LE?,D+B=/H*5HM
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MJ4UT&^K== 2U '=2GG2]!2867%U./C;(%3>J.AK:CP@\3RI/HK,\B#1D5/L
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MH,\7+V6FC?HAF*U^8F1V81Z6$SNX0NV'&/@T OWD3TV. PPDS_2^W4\[@_I
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MDW>7;A;TB!.C::\M*O)+*,V$2P*PAHY82R#;5&4A<HHN#'/\R>C?](87%^:
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MP]4U),L9^AU*GK3"M52!^#%_HBF/4=K?(5CWF'*\[O00I-U6'G'? X<Y;K)
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M*WPWM6 ?S7G8(%*\3O*\20$KOF\D-.P\Z+F]<;AP%6NH;*0&ET&Z *7FUR?
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MJ39;->.6;TB)JJ!?S_0K?:3-UMIH-+^=K?79]6(^U4?ZI"'K[*&DK35]]I$
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M8!YCG7FZ(DQ'B9,!(1XS35RR2[1U\;D/#/(F3V39$VZ(,XJ/.K$%86HR^9(
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M@=95/;UV:=;E@\,OI4:D%4:RN>6=2QEI@&L_]Z315--O\J<CH5*0Q3F?0]5
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M D'Z -HC+-,WU6"BR1(9J&AR2/%$2]J)9H; RBO1H0<JAA 5W@95'1<78E>
M,:HJP,2[LJC""!:>@<KL:LE-BY43#AS3B4/8L69)GB.#D,*\"#EJD%YT+$!A
MGEF&%--KG9[9/>+32^^ R:*D-!4*2(Q5H )UT$PQ";@&LP04)SP""2X'(N<M
MC< #Y_0RSW(+(T$>BFH?;<J7*!?*M:<;I2$%=H&MIKDL]$28KS W1KYAV1X7
MT6F#LD-RZ(B5-6]#F[=F47L:0*>7TG)&4J6>E(B0 '/K0DA"^935=<@NCS?&
MGRX>V8;G%>LAM4^O;$ 9<(/EJJ$D;1%E^G$U@1[HS0"#AS,',V./RHHM0:I
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MR1N>[M9/2=7F-@BMYM (F+["PG,CK$>3*$PR9/Z\9:K6X7I&OT2#RR$^L(X
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M/VZ)@F5$G ZE"#\02N43FKG. ['!A#G*N[=V?<-._STM2C=S_4_(7R+3W3D
M^8QP? YNKP0466WJ1J=F+_S71S*+TWE =J4[J:Q],>&+4KG$JO.!';GH^AW.
M-7T_J<^NYLN;8LJ/F#9'&2!+=*"MO)T=U&.<*C*B3GX27S@58XLIR#Z:5M-1
MFW->([;TPF! !7,GEA",N*/7M<#"*2&D,!]70#1E2/'%3CNV0+>7J\FOM\0(
M33[2E]QM^AQ5C%6P\:Q<OKHA!"_[*L;E3C%D?=YI/R1>C$])A<R)=]LCZ;2>
M@CL/_160<2</M"0.^00@1::*"J ;QY<*PZ&*F5-0%5H@R8,EU$"R6JKIJ$YC
MJ='.&M$TZ*\B5S[2TU&8$E*8?R)#/GQ))1+D Y+*4$Y#X?FHSF8P9 *=I$ W
MQOEVA-'&H@4I:06>8UQ7YU1J=60<R-](?UK3B+2J($^#XX08I&#IF,P;F1EZ
M#/^JT^NN,U&%H6(!@?(BR5-$4J(DPW>W'0LR1U/9Y;\\*>91Y'N)WJT3.G;-
ML#@F[4_O^,1LZ,[6Q?LH;Z&I)[I!UA_)@*EQ*KS0TIYH9(A(A\@?SJI3.W#C
M[*>*$4N\TO9LIA_"=>.N\@J"*C$;B:Y?O5%N(D5<HEV85NGX,V/?3B:E RK8
M]IN*I1P(R7F E- :&_2><77<W[EV*ZBS(ZDPXDU!SLU=:GF7-"_T;"[%LH0#
M=>]RB-J4:-X\&7"-H8V/OE>69QKV)V3@B;,9L[LDU<-<.:B:DV53V*LQJ:^U
M+&:H"Y62*@NJ")EMYO##D D/3G*+,)^I+H([VS*O;-=@74/R"B,]6O]-4 D"
MTA.X*!V-,+0)^V[81CN5SXXTA.TS-_?:9"1!&T,(8,/6B8_S] MBA8NXS4IN
M1"4WT(*&) ]&?5458=L>[2:G^U?Z1"IHY\<Q!QZ"QK.1J<UU$1/$1]<.'-_
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MFV,_W):5SC>$GI?%U$BQXNWD;!SP\<!\3^\M[VA5IE:$3(D&O5\<GF#T$/;
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M)VU3$.!AC^SX=#C;5AJ/J23@OH*IQ*.2IL*[6*V@FR#=^8*NY\$:WJ+KSR+
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M!7#JNKO-SL?Z4J7DEZF4S][0LI$0VA?R//L1QO'WH#0)6)9FL9P"U;<\50J
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MLOB SH+!AF@P19F+A$Q#T(^;TF!)0S!94E<1S06V=%M5SAG<H(!T8^CQE&@
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MAL&W7@#.0]]WHAAL841%]HU5Z[8=Z_ER*"12[[<-A><2=?18[R8%$]-4, 0
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M,#B^IITG6@AGT^&OT99[Y5M-1<IZV652"G?:8&=RC!HG,6O?WWKQ;Y<1A/,
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MK*^\)W23(V\99;P<?_AM,R"B5E.A^UZ-0JBJ; N2PHEHV@,R;UI.<5+=F6B
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MAD]5#AH<^2F^!N1S@+^ORXX%P9&PK-*+4;!@[?-TZI+[K1>L;T)T9*/#>OJ
M3#_'37J6&L%$!D]'/A8<N2D&@&P$DIITC%7)D7.N+#R2A>N?7C^BN\%C I?3
M)Q@Y:WB]P[>$Q8JV3%WLDCAQ MS,X<R)/;=GF6HWMX5K9BL$N<_6% 9(@0 *
M!;?HI'! "= $$%"<KK4VQ%1+/LJ2VYZ&NM?3*R^ BQ7M^WGIX%Z@R7ZVBR+<
MYC:,HO 9S3)SMN@OR;YG26XUM?$:VVVPXSV;(A!89"D0D$&9@!0.R &!#)+M
M-A$ZXE!IHM26:ATBO5+U'M]"%WI/N$O7-1SH!*_-8=J!S,1"?'C'H/AX IP5
M[DJ2=UO%_8PSJ;P*X]BN[UC(1\9YSB"#_E&>T^0RC,[#W4.RVOG->?J6*K5)
M;805JJ'61O94I,Z*V+7B?$4.U6FD?4?)W8<_1EX"S\/G_CNZ-R:P(6]--*3>
M8?+EP1)]:E=O\5E4=7LP%Z@5Q(J=)SOB4UX^8?FK>3F8P4;-,2;9S,2 YZ[(
MO@/9A[:"BKATSH*)V$O2XNE]Y 3Q"D:7:/9SN UC+\&AKAG@^W#F.]ZF_"L%
MIFL -1EZUAX]?IMB @A@WH$,% E2RT:") 047.77E@Z?;AS/8USUZ*?7"#F[
M?*8]VQ6DKS["I&C5YN;(3>%.2+^S%^#,(6_&:M9Z>N'C9R1#"5RV9V<VT/0Q
MPD9#E<$@_7XTC*[1G\/O\BJU;<E++\#!\-X37,Z#!)')0^;I-(YA\C6&R';%
M:14]6Y=*4QKOLZ> %*_+ !EZ0,:"8C @HR> CB<)-I9[#;1@=:7I@"II.MRT
M-V&4>+^31[_%JC9+W^]UDLDLN,7%&/$NU*5!6)G5)<^VYT:)I96KLYP*NIYL
M9 A%T/4(Z)ZEJ0+:?%.4\O0<02E_8MFOPN)#600:J]%\^+^)PBV,DGV6V)'W
MH3WW8F02.W[OX77R"8V_4LAQXF7SI ,GH,CKR0=/0#[<=A">,I,KH7AJ5.GP
M]L"= 4=/+3]'86Q,^DHS6CC6%-!2D\!)700)@ D@(,8JA4UN*XEAC3;:H<7.
M'D.+L1LZ]0+T+72,&<SKN"82/)%*OR0O#=FWMI]4!5RJ" MGE1V4U ))GX/#
M7ZZ@$\.+ERT,XKXO>NPY3-_LF%APA"3_%I"/)R#]W+:<"+E5EA3^8O4O9U68
MM?"36[AQT/TP_>,]C#9'@TJ1PO0VGJK:(JDJ?XU@IQP6_0)@:%8R<;M*!U]J
M%:FG[?*Z@NA"":MSXCAV_$9[ZR1]:T'I=.8OC3*4N*4>\#!D?=6E-!L+\&#;
MNE*5O970)!6":-Y%6;";,FU Z!B3VE"5:JBU%4&Q7AR+'/+Y+I-&#H6ZQKG'
MR+3$ 2F+Y!%&:3!>W^Y6P4SF59\ &UG@4CH$"1\>E$=J5NZ??_V?!P?@YQ^_
M_/#NOW[^I[O=O?P4O/NT_/W#T_JG??#U?/?\^4/TZ</?CW_]>K^/_0]/[N^'
M_G\DGW9/M_%_W/_S"_P"GZ_V?_OTM[__^G[^?OOPY)Z__'HUO5ILWB6K>7Q]
M]Z_G\]-I^/M_OKW\='KZT\</J\5J?K@__<<L.'G>'S[]^)/C_O#WNT4T/W[Y
MWW^;AC_,]_#QXO#^/YZW'_[SPCL^OG][>/OQ;Y]GS[_"Z=_^^>XT^12=.XOG
M?P3_Z?]T%T7NWRY^>_NT">+_6$=G^]^^^$>_W9U].7W>+_\57EU=?#I]^?T=
M7)VMO[Y]W.VB7S\]_7,U.]M&3S<O/\[N/]W]ZS]_.@O.SO[Q?O]/]Q]G_P5F
M=[<'!W;,$@7Y9H4/\L1"-P'I,8P2O%GS -?>DX\8,QB_A3.0X,7QX"\/\*?H
M#OZ06/;="-A3233B+*_#]1LO?DXJ&.*+_:7CPND&"V#OCQ.<:8R+" \3[IO%
M0P**[R<X0!X".L3J=4?&N.IKAF#-O0G//$#$AS&Q4TD&Y?(&(NX%";H[#2I.
MPHEMO(2I(J<J<QD,<JV9T%S;)2C@V,QV:R\#?,F4TDKS]*O.@F!ZX=)S4V?F
MH*)9G\NRNJNAHRI_V3"0CAN1XN,PDR]C+!+TI@('N$ S)K!Q66ZBH2H\M0NP
M?9'AW78Y2^R0'4&U6>K\QN![E@W6#,8U# ,);G9$>HREGTZJIK>5[ @NBZKI
M$>PE=M ;MW";OJ4M5@-(1@.\Z<>N.@+<5@#99SAR; 0W,1Y?RN+ 7)O^L]95
M&*RQMKD*G2"[]_?MA65-82$0@X4'S\&*/RE<7=>(=4TWEQ5WJH!=%><I;ZW:
M6? E0,-X2%DSF,]I;R*A)B)U-Z@5V>"RJ"H:["5VLD-77@"7LS#(RP.2TEBT
M:%;TQ4G<1YS67OX[O5LM5N2/O9NM7?&QH)XZ(\VUB0E<4!Y( LHF((,-,N"5
MCR;9)1^?CN0+V]JO-SFK6MY]T%T_)EMW]M'L&4M70EUT!]TF69W ^,_.-HS_
M0F,S\2EA]Q6VNY3ULV/TDX"_!EY2KNM3E7YF5EYCB-D>(O7I>77I\6?E8DT6
M\VYY1,Y2[YA+TF@-@N&<P]B-O&TS%X7+R_((DPFSM;D%?)R 9?&=O3Q*#GG+
M7*RO1R]A]L[Q83Q=1Y#4J_SBO'B;W4:!F^QQ9K<G$P?>>RW^%N0?3\!BM8(1
M*:R6#B2EU<Y#WW<B:[75I!S):S-PEZ[YQ"&NCILE[,["S<9+$KB\#\_@+?1Q
M",^2%FSKV9;ICH\%^[\STAT*-D]*Y0/S&0Z2\. !'F239'4%644$1U?8N87,
MJ9=Y5N6![EV @#C#P- ,V-D[1*8F9Q+S+]5L1+@1,^CC _)U]@X(IE&$/DDU
M,G;1.?'C6%(5Q*RLAM5PR:!A6=6BQF\BSX7(]B:3*!S,PN%&VS6*,%$MB4H&
M@2U2:V18^8PFOXWQ;VV>UBK<*II\2@C2P7]'U-T\CG=P>;[#=@U]IZ8J[1;B
MIA\NFII\-GUVHD'2-S61,!_FIX4GMZ(7/I,I-$#!I0$/D_20Q4'=&<ST""=0
MT[S/L1S'W42HHA#UZ=MA"^0G/VV$RM;*Z)!Y0@B@38CGC>_#Q/'+?Y^%<7(=
M)C_!Y!:ZX3KP?J^7#^K/M.T=3^,;:;"E=+ AZ%S9#L/ T6\3L(<)*.!/&B&8
M=HR,P666:1H/PJTNAQ<3DQ)CS_;%)RG?"7KD__V VZAE.J;OI,U>43,=1-$G
M\@H[LCQ)>5N"ASU@[ERZ1<E_0#I;>G3:];4/(8_R"T,'ON@'CV07XCQ)ZPZN
M-\T2B)WW$7\>"WX:+C+20GM%NEXVQ*ZD2ME7%COQLG5='AG46[@-HP2') PL
M0HR)3"M6/BI2"2J&L$3(JA#Q.<B2(L[:]571+ SBT/>61!F29C;[>_B2G*%1
MO_4L2L*I;+R%BQ#B-54N#YG0)D9[\'/Z7SP:D.&V.ZBIL+4L7U)2: =4?XWA
M8G6!#L^-D_3^8%$#;OPJ5IV?]\(9DUXM^6>*8F-!:MB\*LL)8\&=XJF?8+"#
MZ9UF> TDG\^&&I)BQ0W#)N-DVL=.0+8B8ZL1VBITT%9$^ Z]6)$WW*'/.>Y$
MIDTF/BK<\RTF\5B?PW!)R]JG?@NAE%DYX&3<K!YO0CKHFT\73H3+:L39B\*P
MDB6;S;1X2?#A/:RGH[#7@;HHU$Y$&YY"-?96_'T*--&+&OH<TN! %T:I9BQ@
M/S2EC?E0*8=A]+52B@Y'A,@XD YD2@\9_7\MOE$J<RM[J%2C10=KB[9)OG=>
MAE52W&DL)#FR,1$WQ4;?CU8?R5C8[(K-67T',;J/G"6<!DM2Y:;9G(S.UK-,
MJ<UI/A9'"2_UEG9C,[):L;HL>^ITT8R<G#GQ(X*/_X-K'S\ARP[77QK6KE>:
MT[P0*N'%L_=Q[!<V\\D/I>&JOBTKMG\;YE>N <J4TA3+.7G&)14K!CYC>?-8
M>-CA(B/HMTB_'Z\G3,K(>B-&/@&T:[#S:KP/*UK*TXZI)8":X$DZ4XS4YFLK
M!TI] OH4U$O'BWYP_!W\ IUX%\$"_K"2JCZO\79@JICQ>H*A\8   "4(2A)J
M04!;\[_2'JP5J3J]<^)$RH@\<-UZ\6^T733^J?]G3NY,%HQ#/C;\)\YB!, ?
M3K+>VO0?XY1"!0;7'CR%=-$NV<H*,EJ0A$&D?^=D4N\)8H4<#W)5UL%@'"%R
M0ASU8E-'=YAWD ]Y+)N<@%WT)\[=(A$G^ 85!CB4"0:N-_QKFO+$-K2K*G)<
M99L#H-?P,HA1QY>T%8>J\FU%-MW+^&:+C O2%2O*VK,M5KC"$^E&2AM##GQ/
MUT'!O!CKH,F[W.>@ .Z4E0+#3\H87-KFE@(<\>V_@^14' .Z=-5V/U6[GI9Z
M[PYB:\CGLQ%/(\6*7^FRV@)W LK-F4?K(%#F>JTZI@*1.I11?4)2'T8#NP"X
MTUAX:V1C(O"!DL_'>IV2,;#N_^2N7>.E$;^&S_8/F.3N+O*2O8(WB1GMH #$
MH!=3#2.>H8@''F0C1R8T[1B6!3PHTD+7+7D+8XAP?SR'3] /B=>3&)N;[0ZQ
MZ"Y<)<^#!VSIX6 G"%4#4VY@*H6%2T7GT";I_88"!!G$,;\S=I*@:F2K+G$[
MMBDD[;X&ON.(9K+5G)")C:0I'!TS%I7:@H_-YF_\Y6M>+*[A<QK%@7,@HS!
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M;&X,(GSL.8Q':+"PX,5@Y-\"\G%3D&P$6HA850FEX*ZT0U;HOW9>LL?^G3!
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MUZXHQ8$\U%$GG<YH_*$,F_:BQ3K@+%GNJIQ5D+/&\=;M8?<B2+QD_Z.WA/,
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M$$T[O#@9*3D04$!)$[LI') ! ADDBV$76JS-PS':T\M@E>,Y00YO"\7TAV+
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M&C7ZV+VT+\,(>FM)G#.GK3A2''0T^)F.M^LN4U@@BWG*=#'*+<&YAZ1-RV!
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M T?.:ER:+7Z$R\]AN!2TLD^_GH#L>T &C"27GKT:H8W"6+=)%3+#B\*5=K"
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M?G>6W"P27R1> -H_LK6NCL?7%Z\KT529T0X![;5I,D6T"YLS-PQ?EQBPF^H
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MHK@XB<3(YW,-)D#?J+LV#H_HGH[PJ>IK!UY14/IOS[;;_"41?"+QY$T4_:B
M^YJDQ"JVPN]COTC#>,5.CC%2HMM9GW-QCRZ![R)3:6Y-LMN]\5I@]X_LR'1/
MD^UG)?O)SM%\MX-L=;=5H!PFELX$S-!40<-(V%8H+?? LY50"1LHD!/!_(_[
M-CU:;/#8'$>\14.# UM46C T_4( D3!F1R^%+O[L.)E1W@5U0)'"G_NB(0S0
MJ@!UC)4&[WL'K7^*ZVQ&QH]-@I/-'^$)(C1-I7/V=%)Q-6UX"K5F8&W)9Y:_
M3N@17B%B-._5<) 'B<R5-$-2V3;-H'[4=\@$^1_U*3)Y_FDO!P<TS_!QHMU:
M=8_8.J.#$>^Y@O%,(_XFM&(IED21;*^R-7_];SY4*D&W9K(Y$^VC59I#1X]'
MCZ L4D5+.O/D5-R0^-[9:^H$;3*]==&CLU;1(QW")4@PH!'1FA?&9%<='R,:
M(G.JK$>XX06$@YDR-!)O^1D>=>5=OMPFZ<[^E6OF#"65?&=H*2@AW97=Y4S1
M:_TZ9K'-\?QW)W6J!(E#*2P?"V)90>MM-ST6M7%I+G7'W.Q@%] 0\X0IKQ;^
MT<_!R$X_S\E_8<;M]E^T.9OBR>YI>(W^IY0\G0LP!MIR E&B0WC\R%R&82#$
MW*C3^D5BJ"&F8FI+\>2)KBW'TV3W@\17R?_\R4M0GA7:T"\G?+3*_V/Z<QJ*
MZD=]CB*2.^ISTSDS[;LD^,CK P\.V5#10RZ(#%G83<AH'$<9!C]IF3UC(U&.
MF2YS5 5+@SZ4XF-P*,7'.:DB9MR>4(J/T2 8VI54K0(8R@?C#A[J%)1=,+LZ
M2!@&99R@H@&.\<"B(#&-APJN#WBHAJ9*&4!RZ>4V?W%$.A[LD_)^BCIRWC,6
ME_)HND#NG<P[EKW0)U\,32!@(ELW^Y $)I<TAY)H+^D6ZE)UE^_)_9[CODVK
MY8X:FV,1&AK2*]*OK>UW?$8I;C9E,;2*G(V6&I4E5V'9#)C]-.(/8LHCU@I:
MH^TJ! @KM$'$JFK9B (U5NFW5M&9^=SV;I[PBWY(!@?<\?P!#OI;_@1P?=G#
MJ>YWUV=(BP\Z!N&ZU%5S5K>?R[DY-&>MJ]S',[%BU50@;%4?K'^MH< ^\8QO
MTNJLNN1KJ&$)VL@>PAI;%0R=[ZW0"I!)Q?0'6/V%;I\%P'WNLTCQH">1F_>
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M//]0T,9,H>P1V?N"LX%;9-P,:\U*\_)%=-6ZK_B-^ >D5T.+?P-02P,$%
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M1^2\!9Z.K411=$BM,^A"&4!AF '"@$(!(M='9"_9!*:$FBHYXDIF,ZOV\D#
M/NOIN.3;3%O?+2?SZ_EBLM36^GRVTF;C6VVFW4QN)[/U:C'59JN7XM4#HJQG
M6J72M2U3WDU1#2-1>S?\ ),Y*"U&5<) =8"[65V9B5""$-P.IJ"_KWXSTZ_U
MD39;:Z/1_&ZVUF<WB_E4'^D3.@>^L F0VJ"*Q-<$Y2OR_6?H4S@;TV%-%%8D
MASQY]-DGLE_,E[\+3I3DI>R)!H=MUPN*+<?!'BY4<VKQ"J- 5-84J66E>F(P
MJ#'[P*(.-MBZD1U/B/%D,5_I:WJ>TL:?M-F(>P\9HX/K6;Y'*_!MCC0C@,=-
MKON:<T<H(55AW*R2Y RV<W-E@):::?W A[U<K[79C7XUG6BKU60='?&%J@6Y
M[N;1LFT"43Y]4?I*SL>[13$L%CZREGM.YBIO3H1L(5,OB1-HX'A9QW-PL:1>
M]_IWZF.3V3B>_'*G+ZC7+5ISO?*-@:3YU\RO12RRDKC\*<?%6FGDF5GCN00T
M#F2AYIB"=@933;_-G;\$C;$$F4O07]+L8N,I[+&DBLW(GU$-S!0GE7!IMQ#(
M[V!_ZG[NT'/A1/Q46()&=[.D_=R8(J)3E'WK+RWDU<"L?W.C;D8T(3?<&:&-
M1LN[R7BJ:U?Z5%_K$[JSS-<_398"^XIFFC@@ X_K1UBHT5DJ[TC!0D:@<48-
M61['GXV.DE8)'/B''3'8$!FN=4_GVNQLT"D;YPQ935W#\9)*=BFT.&RZD01G
M\*J*'H\A-]-0$\9BA9N:, ,.0PYHC>:WM_HZO+,F9CR:AY=WDUE\=2=X#J -
MWZRH$#]!;A3FK.^08S*LU^VS%KEXBP>WF/C(.OMP,E>:%BQB"_GN@3Q #SNX
MM9J,[I;)%B)V_UQHF4DS;Z3U$*QEUK+-?8&P_)G%SE?EI&+3<7TCU4H\!SZ!
MUO/1SU?$"R>;V>UB0DYG-#T+(H1%\PHOS4:6R [[?;J>[X7M2.YI.Y*D-H5T
MKUU(&&''GIGO59JOK#G:5AK5E_TP)I7I0-=6/X-.&;C6].4G;7HWF5]?ZS.-
M'%ZUJ3Y;K9=WX;E6.!IW;5@XS"B^P"MK8M>R:G$;5$97UK2LYZ7TOH=%D^GY
MU #;<.,5^HSLBI.U]EN+(+7N$')H;3QUD')6S:E-X=\\47DI9S6L5.]"#&K,
MU?2M@6W0^\=R\FDRNYLL)Z/YS4R_'!>%S&N)CL@)$*U20GU5"N>OEO\P"CR?
MX(<ES116KJ)/I!OHRYI S&P5W_9P*CT]K]B1'7*8<36YH6<Q?78]7]YJ+:?8
M"NWH^76)#K2_LK.3%=NH8B,ZB?($.XAF,'!479FB09F9( 8+@(.>)G=7J\DO
M=V2FT"VIA>NR"NX]]%= ))P<)<8C*MD(3Y$<06D3HY*/ZNG0H+CL*_5*L(8\
M"8IO?:Y.X9].PM-AP,_)Z%MF0FH3@AS!(.]6J8:5:G>%[^E8/6J@LX-;HW<>
M+4[I^=;>\,'+ N:(*XVZ\*DL#PM8>?=6'@_M7[QS+/F3KYG?L&8@ WY@K3X$
M%U;/GV]IJ5A/]K):R4CE'2+O@EJ-5HMRVZT[+T\,[) AT )BX06'7%4V<1N.
M/AMQ@ZJ6S:/4&Y?V%W,=$^%XM;B(=<^8<]9,0VUE,C8U,2 !V .Q71Q=[I2K
M9#.@HTTU5.*E6T$..6$[S7,'Y4*#]=CK@E4H&\\A3%).%)6V.HQK&.;+;LH]
M^##Q')*F&5$4+P8)H.FH(PJ-D\I>F*OX* ZA\:[-E7!!%7<479TK'YS*52PS
MVT'IF1W,)/  D=XAGK!SBPQZL7&14*[2V?D.Q\?AP#+1N9IF@N%!G][]ACE[
MEO=Y1)A;/OT3?(BWDM.@-N(ZQ!)E*@HL71(MTZF8\T,()JW0026WCHBN1)Z4
M([:(!,.9UD+X)C;1.D@%_5A(=NR1F?&PIC\[GHGFV_=]$SN.[P]D&PIKC^.D
MH<M\.W6=W938Z":J@B#YI"XBPI#,00SCQ#  (FAB?EJV4M.UY5@^"@66LBDT
M\QO6!1,#?HF&5877SF4:Y7OBI6P&%2*M@BI18ONX&:<61Z=[^KT98,L_,?A@
MI=<1#$2&,>U8T$A4I2;PM23(D5$_C-$1V6Y4SLL)SX@!H;YRM_ZC] M",1F&
M80$M<4Z, R*<)EZ<**JL(]<(ZC@-Z5A5BUB2O*$HB6J&'E.#P:Y#_FB&$1ZO
MBW 9-_MA37%^=!-S $K74E6%?4TO[#S1T@L#+\:^,A_0)J"ML\_D1P&FEA7"
M(BT7FY6MXOL&SAKM[&@.]SEI2;%VL1G4FYKMB?;&L1K"I_,CXV#YAFW]35Q+
MC Z&M3G?]G=4"+2U.$I<0<9R\7"8@R5VJZ\L?YE'7PO,LVQ863:$<R)$9WL7
MJP2#+C4O!+GJ_HR)T.XV%20LQ \#VI9+V].GA7^'.ID\T=LEU(D!@8CV+"P+
M1DF KT<4; :5+0Y2NP)H1M&0.ATT@!/^/\.AD8D,_][40);8" I;9;:7\$)J
M.+T4V'0G/GEMT:VB<A31PD*^U)XL)J6Q$5(3!^29.J&Z&%$!6VWA5':+]O<(
MMU983$91Z('/*ILUEH "Z2?UW(*9EV/QUXAV-G8)MRMWGN&K.%[ NW<RY?<^
MF\JFA;X\Z1!!R[*>SZ8]S\4_3<6*:*/X./0J/0[0P+9_;4G86O:PXSK<:';4
MO*=MX&WP/7P,#]$(K-2P1Q47U=>DW&U[*L""K8<HF.N0;2>4]*XXW=+^\^2_
MDA7,+X'*\!5 OZ9&@"&]I/YT<1(^A?2[F5-QXTM>]BZ,$QTRO=0JL.[HLD%
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M$W(EJ3@'(TP= L%"!.G5)3L@.6IFX:CZR32\VIEP'O#1*QUVJ2\2QY\/Q52
M3C :TTR/U]/(5W4<(]^P;(\#H.81M.?1Y:BF' 6P8/BHVC>$+)4N$P!& U)!
M2RBQN+IVW]7IUOC3Q2/;\+QB,:WV><8<G%69!-ARD&ESR ,Y3&DU8,NX"#DS
M]FCL[@W+Z<XZ2KDKSKGFGT6,%E$.=<I_%(Q?+PR?)@R655UK?TC,T%;M!K34
M30XHU8F3L9.9,Q(96JSC-.C95@LA8%JD6(1[@[;*MF1>[FK,0,JFS T\B-LO
MP40ZV)M%)% 9W!6<5!SFP;)+B\9XTOO/'V^D;]5#UE(!*ZC=6D1Q:VQLT-[
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M2EA'!1)_?;#\B 3Y2RP\LRZ::?1WZ6(8/WP]IAX?4]@/Y=TW>M"=+3:BQ2O
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MN-A?([P/*^*/7 _:;RYAH.H,7>_\9BI9E: "V2.W?3L(.<4TRGDHGT:UNJK
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M*2FF<4,\""6<:0WB%%@ (%$%U#.,\HH3_WQ-I:"M7.G?_C]02P,$%     @
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M1FM3#8DO 9\\DGM!CE1E;.MI<P$]LXI@#\DT5![]2GHN+AW'VM6L];;:BI.
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MJ) 61NESO&N$".R.<S4+FDJEGC,I^O(F4\R*,)%40."'A:-5):7#3F*\^YD
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MA[]F?Y[%O-@3EO??^*@2IZ_32<$2X%2J<@)1EG-''-1W:\>R0C6[]PW[ ".
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ML'+HX&C[:2'6[G!<FV8.%=^U,=/8=RW^TLHDB%EP=4;.5]OKC"WC*?BMQJQ
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M3*-[F"#'_@ <J[6O?IE;-39EF5@3Y&^/NL[BZ!_QO<K^C\5466[56]OCTDP
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MAH?$:*\=7FYGI /HSX@T= Q0/K)[V 0:[+X.R_NZ+/;UF??U>>&^D*==BM$
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M<O)T8(#Y>0QNE4[@8%UE?>J,I,0@DEK.E+O\&<%1@M78P(K4J7-NTV-L>OP
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M*PW1OG=D6_^; 6_Y&;! S0FE=,;F1*UH*\LE'OM 2R,"B8VHL%A:,ZP]'S'
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M"7(AU:?U-]0Y_2*^8 U7,I.1>'HCN>PZ"C*I8Y&5^ 3V! 62;&_*2[2W#(5
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MI+BSV_C%=[&;9N^-!.EPC5W2,>?IC"3"2):2E\5B.@8]C:?,M1H_);/XYBJ
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M>'J&)O_J/\]G\9L^Y:ZW6A7ZJMIMG+_AL<(338++^6]1A718>"_/6I!!.1"
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M\#*RUVE=I4W#Y1+:U5&FAYZ:, DCZ,C(1,P!2VW[RKVE2+=JN"[X,A[=98O
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ME>W!Y!+3$X=N85@E%0@.].B)C &]PT7/$8\<_QBPFU&3!"HQTC,X2P%(.4"
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M7S9K(8H'"2W-E=);)519YB3+.]H ZPTB@.SIE_"],V*$=;;$<)6-E_9(FNA
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MB2L=Q[;=^K3;W95$]3>HB51KC+&MM158(FXT2!<VQ]+S ^_SJ.]Z2IU0JU5
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MN6?%AW1$U[;L5E@MNIZ=/[Z>>YR3:W!L)D.$5(J0/??#]1X7*M]N0=*OW8M
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MHMB)3%7*VKJ4? ]?:YA>(7*#D?L^>0@/T>^DL)3=.S)<;6 @[%]Z<0PA0VG
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MX?!#?'(2QA[AC^*MQ$_A0@[U(FP#\>IM7A*/$^"<H&0)TSC[./6V5SN!-P"
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M28?P_L7MS8$<9ZQ/ :YAQL[$@<KW:B@]2VTE5E&0-_CMO%8P2/V\.4:W 58
M88(4WBS6M:6*$W1]EV()D==/$\&N/=!+!SSL&BUJ>01'6=[V1(2HH=@4>:<_
M@M;FN[G9RJ"/@$9F.W(3<Q$?_]AI=5O6_I^_?^8;.-B8GZV$*SW;#(W378;&
M+D/C&6MCBXUYPV^&CD%ES;VQ8GL@>"QZ)M\+W)],:>VL\X+, T1\=Y;5[:L/
M,/MM#L/[AO7IXJYU=-3K'I^VY>1X8-=#4BS0=*/0SU=VUQHBJ&$-0=22M0A<
M>X!IOXY0CV12PC!6J;I&_P6$,I-C/Q+\>>F3;&02R1 V(7L>2O;$D^3C$)^!
M^T*OMRON;0R64-!$><O(\-03+>FR23*#LA<1_[?=L4<I&63I!FD4X_NC<*SD
M-YN?;#BS!Z;$<+?1J6(O-8N?@F39>!:^C1;M(6!C,%1*G0WJJZK-F#W]4C74
M2*-77J4IZU8#+X)[I.^3&S(T/B!R>%NF$FK,&H<N[(DRZGG$JM(18X&!QI)/
MLT^)*4*I'X6O2!^U3)H@(L. "OY]'*)CF?TB0/<*3HS$T+(!G*@U@!M"_RKR
MYK3_;PI-AJ1J*^78(+3,/^-:PY#)-G-]$QF5<"-V&V7T'/8Q>HY/F\N8_A?>
ML6$.'5(@%2!^X+O2TW1'PI\8%)UQN0'5+TAE/$XQB(HKSF%XVJBYRZYCWGWG
M.8[>)1R%O"Y8?0R'$M'.?P$XP*!&UB&K*@C4N2$!4X-=' ;00&\116X=B\ H
MPL2;"%27\!2+E$_\VB!\ ^?R 3X2'3*A)J: GH67.I;7!W]!VR:6>$>1'[1*
MR,LM'>>&3W,VW!H&*G,/("ZXY24S8N=F8G]%%+TG4Y=(G,B7B8#L*_9/9_P@
M]M N1GT+DUA _PT?\'7VN)+O7<+G<8:"2L :HB05B+X# 1_!#[ OU4!_7(O8
MXV$2'DJ7*CFA,:R\P\Q%]9FKN<1SN*."$I1GAXA,.(NHF ^5-G2HLC&#X?LW
M5.OX]J"A8BVDWO#= 5MJX/UA^X.8?T"U"2,?[/:7Q<=@3>/',%M41?#I2>7E
M(@_2A%Q@-")X!J5EI$D5?CE8[>)(!2Y?TB8W0 -]ITS".AL@M[8.%$BVS\FN
M<!? 43G+)^+5.?(43LAYX LY%PV!E$<C*2@!.TQP2@XZ)N!,* %6PB;5TD.E
MEP+KYMU)6:5AXYN+"-I[$:#$$(Y,9N "5<Q(#.B50CRZ<*TKQU$RI/$,]D&N
M_Z*ZC%$H  O.!WT_*)7,,Z6$ 7DG#H7T& 50$*L'91B[P<E.*/WH(!*,)Y%C
M:ZJ2+25&(H\)*:MI-BPO(TXLSE482^;;Y=*QE%8ELS6 Q<F#?39%@8]7AT>>
MS^I)/_6_*EDR%JZ7CODV44&.#K$R,Y=J,Y-H <\.14+HH#0R]I !OF4ZFW!)
M&6//;CP"8E<?S]1G5I]4GJY..9?N5:P"1>P!K<JW 6G1/7#OJ3"4%">_ARA(
M0>OIG79>%>2IQYEVZE-IS+JJ$H_P^P$(M9 X$5:GLX]U*1'AV9$'O.P#SS4>
MMGHHZ+/*Y;J0N5S7DA7LHD*944KLDB)!#R"  JVUZ^2M?D1Y%CGTMK*Q:THX
MA.3JHYS50/B&."$QC* RSH.^*5#O HN.PB -S@-M2,I'\O;M!\DO(S',<L;R
M$'ADQH+E<1B@.HD?"L+@\/W'SPWK7@SMH&$I97I)3I]EPW%S\KG*!LGRWYP(
M1&UL[9LY;P<LQ_-I<M)XIC0Y[7:2WT=E5Q^8/"@VJOGLSL?V7[)TAN-BA<,L
MV7M5I_I,F43_=3XYX#NBYL^.XHU8F.%ARIV2COZB#D9Q.%F@A2X3&49NG3;0
M E,VYJ\6AC8OOPDG55K7!3E:4HY]HN,\LI6BMN_!PS?<V@2>_%W8]]/\\SAL
MC13JYXN:%Y__>?7VL'UF?:&B@)>.DZ#MA8A@^E@ 0UTQ!JT\*XQ#M1N?D=59
MI'&/A1V3+X-$318Z]I3M(C.P8!MD&^!_X6\JH8"$0>0IQY:(P+8+Z6?&=$[:
MQ2@[?YLZ$AF=@N*TCR469* $8LB6'H=F25LU;,R9@*[,)1U2'FJ#^O2@M<SL
M.5!.'_3OA6/EU><1FQBO$_&$*@Y=+XY2GM&,&T-+UJ>J$5F^AC(=U4W<,7H[
M,7_#M)JR8U5! ]TVA:9?DS]OC*'S81BZ_([2?)N6$?1!G5E^F7R:VEZG&)#O
M*QT?!1&#B_?H8:(G7 RS&&&QV3>E@^Z+ 7F%D645T4)%Z0$QN4(F5KEU\!-G
MN <CF[(2I)M78PH:RX'+@?0)Y9JRHTL>J/1GWGM1NKF:E*?@%+J5WE^\5$6^
M1>LL\V2X;'6QS857$)EHRP3N1*FG,_:U0]QE#)F#!H PHS"FY&W,\?%"],[\
M)8C0O+P5AX5'<?EWV(Q$'9'9"J:WHX, I-:]H-0/3%.7.BAM?-%.%25QTD:
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M\MDX"CM7M$L]:\8X7X@:27#FX2%/PU!=)K" )M>4@JH>0]]G_T5"QC^H*Z.
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MV#Y?-^M??GFU9FUV.[5F;78[&\G:/&FT>B?S8=I,XN;<K(]NI]8\P&ZGUCS
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M)^[)D.P+"VW!,""_?@I(P$J.XT5..@:@T9AOHE!'/4D=\-B>PFTAAV&N!&\
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M*-L=58$D2S"A788)AQ(#;K6&H:[\A1@[Y=:_XB(T8@&U<V!%K&UK#G H["A
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M" *M N__U]]/.^V35W'Y0A>AZPU X.#D^Z9U!^\@%=K!%$@LB#T7T)R^9$^
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MC.6Y+G3:,I6PTD#0H%S RD/YHP[ E?OSAR00A(+\H?<:@W8:JOJN?2X7&N$
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M/;J,QT<<:JEV\.XG ?^<A@\*;7'19L.+XH0_OU8%(LK6Z=)D/;?X"U*=0'I
MU"VMU0\2WD'K3^"XQ,XGZ-5Y ]& ===_6CC7[?FWLWLT2/?.=&^[ V(1\]YC
M<0:U<O1%;CO'ZU?(M+<KK'3GFQ@(U;!-$/^ ;H3G3$1QNDEUW6?@,7L\'^*L
M?,]9N=@6/34]WJ!.,3[+&%/?+Z5+&KR:WN:Y8WB7U0PU'H6G,<8[9X8(V<+]
MQM2P/G.IV(Z8FKH8 SZ>FD^F1TGB:SO]+XV--S(L+];]R+5N<,5LY8Y-ZOO1
MJ#A^:4Q^-1[)LS)G09(+5H=]N<&3>+B=MX)'WCXY^!3+'E-;$7,%(C8X@D
M<DM?M]4L;19-_8X*77O'0M=CH6LM"ET/J@<,0KV%RPC+*YYE!=7^E>$BZ 2.
M%+^?&R[;4_=GW.;=A^""'TZ^.)YW2K8B75DK4V"_O0G((/]>5F[]+Y8K/\S)
MCA%_A*>B\5@\7#OI0X&$QUNOV7>AEL.>+<(0L58<+P5+RG@I!R: ,9_Z76!\
M\!MZ(F@>:G?^&)$/;F@K2BECMS._.@!\<,/Y>L%?>&X_^2GAZ<)= JP$\ *"
M3+G'^W_"7WG6?_J$6 ZB[T7<.(03@%,B. &1L@;3";,2A'_#'\,SS0W,_V)[
MG<A/TJO1MYX#8%@$6SD+-JEVU2/Y";QB@N5Z#KU,CJFAV2M"F7)FP=G%#VF-
M=$.TQD98TB%..84+F-B2&"><7-W=D[>;'[R\60@E^I_B[4;\Y6[HW< 9H3>[
MC5[L(ZXP!)%NQD"D^2: 8:4WNOU>0^]NCHFF7<@/=%W5&W2&C>&PU>BU6QMO
M@!D4#[-LP$K6R[EVN0IC<R2[@/U65"$BZFG220 K9).=I^@Y^*&4HIZ\.-<*
M="'0ZRZ^0H!-,%N%\@\>"22"% *W$JVLB+=%! 5_J3:[I[#<8%;,^# ?)__^
M[,">@N$X8:Z(ED5":)S' H&;O,^\R;L/=(DFKGE?U.A0F7 MMBO"]BBZE34I
M.,"R,P(GXQ5>(ICH4:XUJ"?#1+W8'P[5\TA'.>$O2JE[XDT*4889.@+[\JC4
M#&0[IGKO5V/?60)-ZLWN6:?9T-[]9'ZXBU6SXX6?PEJA^[!6"$L9*)2H_PC?
M2! 2_NE=4&0?UMG&ZP+0$.'5:B%<&2$,,=$";7/8 :H&P""(+\(3KF%Z+ [8
MIDT=> '8%=!T!?:GQI4%Q6BVO0^A5VZXQ& H23G9OO7" 0/7X!7AF!]%Y9L_
M1VP%[.[#FM,7Y@<E"!0DGYF^./ED^4&L "4D!]_A2E'S8N6O4;<@,IW-?-*>
M@@=#Z,*H[(^;Q5&I8%APAWA!O$[US1!99Q\BJ[16X9,P9E\(K9QM12M/?*8G
M44Y"PRE&#" +_U1@6$^WV%@4YE]3=2_& D)S$*=FP8O#W38&IK?.NYL&;0"@
MBJ^W>ZW)$2Z]<M>Z?:7K!FPFQ%D$[X+<&%;CLFC(/+"X;V"AV9_:YWKPG'/M
M%B'D;!;@!:\!IT48MXBA.O8-GL C2!L.IKHT?8*X8*"=M)DQ"30-?(H7[-YM
MG)RU]W9_@;7<SB[HR9_$@R^XY/SHN"[AO%T82P.Q;>*GL78(FZ,'X^1".#41
MXH_G6!FN$0[GVM<WNL<QF]=4V'Y)CLD=U3]SWPB$ _W)V^D4M9J-9I/^M_E:
M0>P"Y$#&L<A_!QJFM_L5Z#C:6Y?/=9CPP(+>GG6ZPSPQ*3,P#LT%EA4X-C=R
M+!.^.<5KA/$5-0DQFYJ/TK@I9CEY(&2!_,F@BE3<N?:)0SPO')>MRTJ?":PI
M;J(9(6H=*$/ZB\!N60J0P:5E3%B8NQX]_,)33AAD:*"!]Q_JL,)^+/=7D+^1
M27BNW5F$>^0F$]O#1I#1!I/6@_?&>U^A[1C.1J .3H%2;=K\H'<6!56AIXMK
MVDI+VQ+&5MC]0,8ZE89R(;5#5(\-*_)1UF5MT)I# %]!<PV:C0@MC'D$WK3G
MK98$?AXSQ\;LQ1&,XS\S"SAE :\[#VI*@X:3J:A[RC./BB/6.H[/FRJ>T5WA
MK3G$KQY;:_\( 9(W&@@1 !I=,28*HY]=QQ:P]W&NXMTK&$DESR:$1 IV!R0<
M):]A.QS')A<*@=/\F%$M[-_?3:SEL6"BAQLQ#\;W/3,\V[Z/:+U!HU:MNX8S
M-R!(X^38J9J(H;#1<$:%5M$QB+8-*L;"SKY$N^V+MF#^W!%6T%KL!",E?8R.
MB%-]P-MM1#B ^:C%X86/. BJ_1(]>NL=P;S%$ M;8Q=MZP9V673;*&(ONB+Q
MBRC#2/7!P@V?U[-PV#D>? W [5%FQ'$)TB -)H;KTEB_6"\Q^X[C)O"S[3W.
M/.N#JQD;@0,=>=<4DZ;+<+G<I*$GX>L\&^ZTP%XLP Y8X75\"@,U$-I\' 1^
MTT79'I\7@;#J=#;P5]H501S"=>?.8MB QYM28#- M2#^0WSO"*HA.8E"]'NB
MQ,<.%A\;780=Q]O%@?6F.5Z,\/=%;PPN3+P(#:.('3Y:9XG5Q]&(139Q&FT)
MG2BJ-O"OTOI$*4P?@Q\6>!A88C+E9:JQ_LY82)(>QT=XN)1$$'W)J6]*<!O8
M+_PKX^? 9T1:]$*"=,"J(^O2)#4?H6\01^$ B]1;"_(6%<L;)\,?\1J*97.(
MXRJKQ>T@;,MG@^ )!'VQHE0L+")MQ"DF"/9Z8;27GR]Z$F><'L[0>#E#^A -
M;N&-@YHTX94@OR\=FX9R".#;.) M&D56".CE,HO#=2Z70 443T8^X_6ZT1B0
M1F2L^82*3N"TP%$1!$ZP',)^);,R_O(+QD177.HKQ?8%/2'FS<&Y;FS>!K<D
M$&H!"T8,G^:UI1NJ?"D6'"9.MXD*^4DJBQ9Y/N7'C'-V>-?_K*:/'&C'Q*9T
MA#P5UF6W^>> @3$[S/B6"QZF<^&RCQ<?I\=RHK0CC_D_4U W$8Z-M')2B6^4
M<Z[LV![%7N_WTLL\+VCP/KC&E(WLZ2UNO2C+\KZ&B Q<[.2U?G/=[-V'T2;R
M0ZTL8I*\13>F"C&L#^EE_LG686I"-!""VXAA3F"%<0KP!H%&T[@@Y-^Y2=-9
M:#"2\<+QK,!Z9"Y6( 4%PCQUALT*HC0I^@-9<>"Z^W."8!0("<+S!^ZTG070
MI>\R/FAN'<<FC.T(VR>X+YD9!&M-8]:BB%*$;D&>-*EX7N=\SG&:LR+?[0.&
MEV^2Q@WSM\\P;S7[F]%)'RO0R2Z>I9U.@U(.O%&;IVM)"E*J$Z%,IFSL9Z<B
M#GK)8(<_.>ZE>.SFB^]XZUTO;:0K!0[2;+C<;MO];AV%!ZBGI"Z4'.!!+WG@
M 0[;Q0Y0W]$>(+5L.;U!(/G)&VX1Z!];!(XM J^_1:"]7XN .N>7;&NS:+.@
MX<W!@L0?5U&&8]^^P3PW>_?A8EMBI7X6=M'MJ;A^)!7F=>4N'8H7)/,TO&W8
MHP@8#OH$[Y@G8;FJ-PDEG/OF'+T24;RP,^"%F^XN"_-3&*$0&"MCMG&JR>JF
MA8%@=:;-2P/I6O#GQP:(T- JB>%?-OC,K_A<,*2<GQWP ?Y.&2B!B^MK/FTR
M6M?L.XU3%B,I>=346[D4-"3D/[&F[1F^9.0B/B5M,R! 2;5DGT1Y5FXZ08[\
M"Q'YID3^=ANIW6@->[O,I,P*G$,LO ,7WVHV.KV4PHE@]6M5.6\B?[@NW_]3
M.%D8I*#WSA9NN<&[#_=S\)_/,*XN9M#8C_RW&*ADK41ZT:V)\HC9FUAQ1_F2
M%L:GD^<X%C&+.4R?@'1''7"&70\HX:,)MA39)JAP%\%(PWF0#1$_C@IW;)"Y
M&/1XPF%P\+#XH/7U0 RO$K=HUBL!ML6N?3&91;%C"H2;'*<-@T*Q<HI'>":C
M265TJY2*FSS$R;6@)_!BW"7%;1KAR.)'3([9O.#GD=F3(%NX +'$9V*2IHP:
MYB@B@%.U*#+ 7)_L1!'LFC(*F?,-)7C/4)].HP(4 JZ-!Z^'3?@S#O6^V'(_
MCAF*LX\YYJ>!_4Y4D@Y2U>13KPS>?2]49:2J/(X.CYD.S+(%U1IG0$9GV$ ?
M>[?WVG6<?.SU=X]- T/'"%;*H42B$A"B3;KIW.#9D3!OX(7E3PB#[<=6%6CB
MR)Y) &Z'&8X:->05E3+MW%*FXD1:=/QXS,*UM%YBZ1^?Z"RPR<0(VMAAQA"@
M(Q1&/KA=5 8LXGFQ.'X-(6.<:_^D[$M:5@DG[+K>W%Q291^VE8I9M6@->L0R
M>O//&P5+-!@RD<<Q[9E%Y0AI$R3Y?+FHD"$FDZ)T7%0(R>LSMI5G/% 72QO-
M25$'B"->8_L<-JRT\"\TK2>Z*;[)_SKPLMH_X&*<=WX>7(^5@]_"PI'$6M++
MDD4+;Y@V!-+ 89DBQ<>;%;B='Q:5Q^[,-X&QS7S_!H1O+.-'&-)A\5LX7B)8
MR<8J%B".0^D#V[E:K'BB-)H>ZK(YLVG^IDB__:"=6-2EOK&R'%]*H39MZC#>
MS4$27 ;99-!&:PMMG EBN \E</ST:R0.<\JV2GLOTG.^R4/B-@9ILIC6 [HB
MT39=4UM);'6:SN+89^GWX"-P0_'%76G4_2BO$@\@+2[PN5XUD93E'OU:T#VZ
M$\#Z=PBK#ZYI. ]M3V\I[_UP7M0N2'_MY.[N+\9B^>/5J59C%ZKP]@4>U1[[
M7J%XR#BKH,:1"L\"+A79M+B> HL=+C-%&9L=^P"5F)A@B^CX(D<^3<Z!B"H&
M/3",,!=P1B-DN5Y_#95B>Y!+A:?^#2N#7.:+9A2T?C"/$\Y4X,*8*IY$P=:V
MLQ;6TAH9I5#1E)U%5HJ *P ;XA$;6X3QQ2V9M2$-P8",N$D%'J- 7 O*$+B1
M%>]$QH'EH56%8RC$"E.6)@KXJ2A1P+[SNU- E]EDO?#=P&$C40W:CEO.L=B+
M4N=1L6TX[L>(<"!^)W515D'E]0GVF4*FOW '+.*D/;57[AN^^_ IX=1%#GDL
M;5!CO55\YP+%M<^>5XR,/]";H7E(QT;KUV(O$+B,4S:CD%K<CN4^?#CZ0  I
M$^YB (W$BTB$=V/8HE$!P?$-D[@['.1@Q(HD3[#UX#O./<);GD8#HT2 $6^P
M(!&+,XBPJ1YC<B+2%_A1X:.B^_()$%1%@!7;L1!"T#T@[H%XQ13'(V>4/WT1
M;8HH/;_V.99E5&F.\0)*?YV!0>W&-VL.OZ,/\1)$0)98"P:R]S>!)6':RY4?
M#<CB3R.@H\2.O\89 L49H[TW2U5J%GQA3\S26N^UVS'&Q$5ZD<XU0#K[[\KQ
M">.!,)')P2<H!DYXWG;'2_86=_;>XDK=<;[%.H:<<5\;(EA#/C&R4<;^-J)8
MM!.=$3/I)E,PYR889J8:[> W&E2F[%BZ>Q]+I7VS_%C:[[5OMK-!^[$>)-YD
MBDT+OD5--G;8$PTRU5CK01,&;##0,>I&F^+CG"7OZ'Y.M*2^!F=G'[*H&DTR
MI7UN=P-'O$HD&,:\M:JBD5YW&GZX-%Z(H@1*FXM!KUB;66.MR(([RY'FQ/&+
M8=<@GX4<O(#IL\76+OQNTCK:;=3F:\RO!G+Z=U-1.CA6E!XK2E]_16EGOXI2
M=:891246A<=/Q$H]OIK>KQP""/^5?_[$UEO@ (K8'ZER@W=DN_!7'N"*)>7"
M40&U"D:(.15Y]JG*@M)4_1=XMC'H:/9]Z7C)-"G'KHN5_*P=5$/,> 9=[L+[
M\#PLS7?$Z[8;$+'BG51K@KZVLL%DL'A =M/<"&8+QXM2"=DG49&:*'41Y;'N
M&LP*;HOIKT3!40+.88I&,!\ZR LDK7@V4!1KQ2 N<1\0P>L_O'J1]^%0S55(
MYK'**S%MUQ&%M,&^\@ J02NM%L'P=H*_IK(AD\+9$;C2N98VWYOV@-]P*410
M$&\.1ET#F0 !88,[<\5SQIB<P+PE'FYR+\*,.<:<\05\1KG0^#RB<3!B#K/D
M+@5F>*U5(PG7&]XK\!VP>Q!KI0P+4837P8(;8BPC5>AZL*$&TH2+4?3$Q-"1
M9QKT&EAQO Y>E:!C+F70N7&>?R=1:;N@_"<XM(]8"X,4P&R/MN66'+>1/;VF
MW02RQ"205ZQW=X];O_M B&?I2=0,;7[ BX3S) [:C+#V9_Q!HYMH\;MP%;;I
M"=0BPG[(B[<E;%YM\&(3R#X>TN(9+Q2;Q-XI,>6 P[<F!AV8M+TT:,]_V06-
MS M"^JU!O""$..!LDX 2Y6+K"+24@\NWWB!US:6R!\ZVAJJ.9@)RA)=D:5R8
MWJ89#V>$9[99)&@(9)VMFPG_FS&3"M]$F@(TZ&2R<L^U^]BZ^7W6@8@P [^6
M1T>4]QPO<ZY]6CO)8"?6MBC(D<:>BE%)F]?[AA A\!F&)?PDY+S OT@#1*(*
MN=1#(1P=3Q/C-PQ1:TQYC(H#9BE,HDB8="0(D\IQ@6.V4H*J&]LY5/#P6N%C
M2-TAWE#<#!/HU-Q&Y9P+S(A1\B=SNC[W%S8 Z,RQ.4 .I_?X#1!ZRZ Q,;N_
MCJ-7G 6U%CACI'/.8-M>.6A&"YC2F\S9=&4%T(5XB"XAO8@5^6@C!PN*+R!J
M%LBQB^L0+O1FF%N<S+.W.&5;@_QE6*V!V#W!CN T&B (FR*QOBC)-7D5(3:Y
M1?L-;\J>8E#@R?L05KDHM>:0X^- CHS#LZJTN*(\MN]*8/M*DRW( SQI(IOC
M-\F1*]FD"N:Y3,YR'&A-*&W!6*2[N2;CA6F_H%>@71BNA;!(5 >E)E53,.YR
M&%75Q*J,P]9NG!PY/'P<%S^F>.W@1\L \KF?S!WTC/E59YA)I=B!,V46IX8X
M &Q0KP!^]83.5=PKY;E)6>VR)1_+$0LUA%FD,;9HA"]RKGUF-CKRP5B>B>70
MHGE# *\[V9*/PO8G1/'B+VY'*+EP/:?3I"1,[TJA!_&7?W+P+3F6ES'Q,56<
M&)&<L&?75Q.#)N(KXGEJ :P8XOQA+UJX/^$P[1 /$1O>4G8T!<4Q-C K:2W3
MX GV1+!$$\L0.(]4E$,MX!CI(MW,08X^I6>TUM-EG0BT>HM?$;@4L*\W!#L,
MW[V(-X&DS6;YG413G,+1] 7X?+1#V#E-?Q.]B'L/=\Y[1XRUA]>*/L/8U74,
MJ>^Q65465,0P5&=!?6]BCX'?39*"-+H%F-A<4)<I#EL24? (&Q)^F84ML<"-
MAA4"W/("F@!Z.U&P3L8DA[:,+$0.9QD5U:$H&6/M7#AA)(B2QH :13T>7QE>
M\ /!:R[85-1!3PQ;@)MZ8*F.K4B/<10TOJ:XL6VQ1X3C9VOUP#A3/B:?'@V*
M$)/,G.PB6=X1&+;ZTC1I$F^$/@P:CHLX/11Q.QD@)N=\$/K:R+;1R_G*.+"[
MC1)UH;6:9W__G0BW95%P@@66BN/NWKJ75%IO6+>S+X[]^ 7K24<$E+LO;L$>
M]W[W(?H6GBHVC>\3.3[HO4+0@<,V)QX[MJ@ZE^,.URQJ?/BKUB;2Z[(GDSWS
M#!K!#<2WO<'C!C,LGV"\H:?!<6(CBD-)3.::&!\'?^55UQ0 #E-L$].=K!9H
M\O'JQREA G"9[6]6<5$'"(><1FP<S)Z-@Z&7 @"<1UWNT>-;OSF5=#4(8N5Q
M'H/#!JE(!F@C.9',C2$>H]')9P"BC(97PA(M'(XG!K,V A3X*#$XC4TK:T1O
MC.TR C0"E06-63.FF-ED\1TB+W<BH#OAV0M"<PB*<M<NC'6<V$^FZ]@<.Y@\
M:M_T>3MPJ&3XP_&L)APM(KI9#"4B2)AR6SK ^0[.)67P#$(J$Q6 AT69:4)7
MQN%,88=U8.N+O5K!<7M!-W%LM!NH;D0:GP:I5/%P.I Q^#TFYI<GT0R[J,ET
M"\E$-VF@)1!V'FU ^4<8\TEX_F0O;/B$9(Q?3!*(MFOKC![>>D7?A%?$O&[&
MNL2KP,5A76HLBA%;'FT%1>IQ+ NB=VS?G_35Q] JTMU$4; <-!Z0/\@K$0)T
MC 8>%;?2(JA[CNO]WU7(B;B$V/D+FL!6PX@4SK5O-J)= V$Z4TPR-#:E$9^-
MRT=V3M?%D&-;N&>B\UW,MZ1I8T"*R.F!S'%<;^V[Q^I'!=6/PV/UX['Z\?57
M/W;WJWZ4&91?]U_^6QA<#>RD1Q-.D)NHG\BZ(YNU6&%+YHT0?B>X)#3D:Q1^
MV7=?(H2U_#M9#W,_#/>:ZP?#]64"\F4WQDNWV= (MR.XT0;PSV>ARLF4(K3_
M<[ID@R@0E@:-!%QVW-<(+7>PBER?=Y>/5QSEDZKB*"*$_@N%=C".P5ND<#2(
M-G-#<"ZP65*]DRRG)/! 4.2B_\%M!EP&UDB2)1*?JIUH[!!XGI[X0](8H\"1
MR.MBXV?,D*%I 533$<!WMF+O9HN.S&"CA(&T>9S)Z7NP7TLP#S&(3O.[;3I)
M.,.S-ORW>]8:G&L(R,<?E+H<X55A'RG'V^.#FF.Q,^I^$F8D;GG*9*'@E7D_
M'+I0XC:Q)_I@[V*L++B83\!)?R;BF H2"$Z8[/;$N=)Q\A%_!I\015N20$&*
M.ES7WV+-+<AI96\<"(UC2+QRM+.Q3:(7XCW*?&P$"X']#(]/V(Y/X!'^*<59
M\;&!\]G8R/UO6U1\$.TF%07E/CXOSB$$$(Y49BY$Z1%5)O/-)^Z*;7W(4>&<
MRF 443B:"G<Q&D648 3RDC9"N)O)(K%/.$$8MXIQJ%^> 2,NMXA]Q<'\:F-7
MGO")\:Q%QHT<N-M_7%^>M88:W'O*T!]W^&C6T*=?)PXC^;Z<R'PPMQ^9F_(Z
M#5$=[//0*Y5%4"%R/#,7SV*)1!OL%*T[5DLL2I_E[&F]&Q/W5=/MPFJZ8JC"
M3>Z+@F\)4!W2U8%.S(#82<?HB0JEQ!@G+@I2U'V[USQKD9) P*Z$@H[K'>\U
M:^-ZTW]!(JZT[N\A/0X6X?!@_1G(5L/]U4O $(75N_R@:,R[WN@VFP0;%WXI
MT?Z!D6&"N2AP^]62AMZDW#J2PBCRPU8A+J#%*#<J:2:+A&98OH4,V;H[Z>Z!
MU6V#JMT7OF?;]SEV*_VEUDYCQMO'T;@SMJEBF%Q:71*Y$:4N>!' )80U[9&%
MAX%;/HB0HD!T=0P\E\/Q$(IRI&XP0$W%Z"'X!64S, '.0_PK5T3)0P.6K.Q8
MTGV)C4T37E-.L+I\38NEQ;CU.A4Y.#'>&R%T,*4=:W"OK80O2%/MO#15.?0R
MIZD)!RSW!#X!'WR+@7XOE,\@DQ&"G"?.*"N$694Y=<8:-H$1N;Q2A'][SA9+
M46,673[&/"0H!T1<=MQ?SSB<Z1E<\.CR=$D(G!Y\*2!%V(05N@R\&T^,*Z7Y
M6W8,YF-*N;G( <-@1#*S&'9%(HF>:PF^BAI'DW&6R'[CP5UD'OXBG.<$5*)V
M%[MU!%SA&L]A?A'V /R:7PTXE<>& (T!KW_LN TR ^?, &L)\5J7=$50#K..
M^Y?<C1#_CI1O[ _!+=,U;;! 8$ETRS"9C&?3B#I/@@FB#6WEAW 9,60^OL 0
MBX]&BU<[(.- QNWD9=Q*;;A_QG$3J0,X8&//3W!L--Y U'+A< %W!81%/5Y\
M+K;A;YUH+2!WC+BQ9>$T3!X@ 9<G 3TM&,D.,HCH&U. C*.2$NX.SVB[SG\H
M5!)F)X-Q0MF#<GDU5JSL<PSDBPX1B!U2?"@+^)B>W*-S].$!XV="6MDY/+&S
M<_HE_F_W<)_FKA7.S.]L>@82V-EO<;:SN3:LLJ!J8Q\%UUE 5>$Y'S06I^;Z
MNYM7#%3:RS$:B\[Y&*Z2.<61&,:$UU<*4=] YQX5%U?89.B1K !5,W&-98-G
M_\461:H7J?+9\'B-@2B0.0&;S;1 6IR&1>.V%T'&AK7F[$6,<]@K@E6R5LAW
MN)6V9:2"2D43'<+%YT..>NWSJG)4B7K%W&+S<?+OBY<Q%GL1B/W+7A"W<)?W
MV7=Y]R%Q3:V\962%PGM1K>U#,S(,;1)?<0!^ F*(4%>XY4S&NKMVI0!CI;"7
M9\S8X\K ZG!$P_9P ,?D5[B8HJT)S ]N#1'FA^V(_ 0&?,<N=FV* &G\06\A
M]I2#[_R"X:BOPBB\C.Q!ZJI8+%=P5O?.S'\&Q;%GK&JOF[_[\#5NJ,:^JUT)
M7ZEV+'OP-E;(PIN(.C'S/EZG&3:3;'4D0E\6JY$+&/Q):[I;R-X/=AZV.[;Y
M@E)"&[NW,2/S/&5Z.NRY98JQ#;M7W%6_8OT\9?2Y6/&:]:^-+&O[*7&_=(>Y
M&$=Y3;,;CZ6?999^XO#38^GGL?3SM9=^]O8K_93IYJT;1ZN"QM$7+)UG7]#U
MV[=#;<<M$&O;J)LU4WP#@HQ=OLU2B&IJ?L E@1\>D1V64]8(JJ+X9K<+;':U
M<Y7"P91D.8#9,;K_1A-]>:8"5XA6S-J8T! ORX)7">+FU&M'\1?,7X*>"^H6
M$3]MXP\G02]8+#-RRKN/XM8L302UB$ :U/B2>K-P/<D,%+U<5-S;:_;B4&Q?
M>9TA+S.\$"\JRI,N DC*1AR7;66+(LD8^(=%(?E@C=J2;#XTT=%JFYJB@A33
M:1Y;&BXO_6'IKQ$6/":ZKA,7"4 0L!"G(20J'IG>; W.6BU>."+R%&)-(4Q3
MRMH:V)-%*A^5'VV8Q9O/L!RGL;'T?9?-*P1%A3.O;.)')5(ASAK5\#FP]J,5
MOX<H6TU= R5$GDV/1:-PTHB!O@\<)6I,0TK73D(2 2)\</BY"F"_E%VCWD"3
M%_%B,L_P,<%#%9?!?!U1?<E7NI4-%D!H5(J*=6Z&*)R,OA>]/%V(8[X%'JI)
MH64!.[(VYMF.=53R^YBSM>T(3A3=D&M:J1>[*SH3"R;><^,<=G&;F.S!=W/0
MT3%9%6XM9F29S>$![! Y5]SVQ#L50,1LBL5(1D#L!3@K-WFN[2N\#!-3W&AN
MDH4/,3FH&1T=D S=M^[3+HJKJDX!557U7-A($R1$\'=>04Y)63ZI>"H0EV+S
M]; ^(7ZL_#@Y+5-LU'9$U6;@9@O^!CX.I(7H;*5;HZ5B!06HWY=F@('N:CP5
M+.;^K4-Y3OAPOTB\'$K=*6ITAT#.H&XN?=:%,SUO3.5/,8$>$]&I.FKW]B&,
M61(Z*92 P4,7QG\<BCUO09J*+]OC_=0NOYL'C[8,=_VPP=5VGK&8!NP:YF)G
MO(;&RZ.#=1SXE-@=><T[$4;05.VGOH@0_7G7\.;D1[> _*@<Q$\<;CB2*JG!
ML"XJJ3<)Y9[FD*\!^64BUA*D6,($"$SI!+@: ?X8@9(6'0_4ZM :-+6I\8*5
MAW!_*C+73G@G>'01C;Z#WVT?,?&7QHM Q\%I.\]L>MJ(/1]AUQ)FPICA>X)0
MH?D^HB0X+EC!!%Y&KQUL"F]IHTT)<&[Y=+Z[X/'A#$+XN]AQ/G,[>! .GE]Y
MVF.P#_ -!$R(+38:$G"N<9K"FVW>PF4+8N/$BY%(#.4SK\:)H##$+B7P1_$M
M&H'<7Y<S_UE-'T57%@F%9 D_2M/@:%>QLH+ 2$)4_' ^+")]O#D)T"L@ =15
M!X21!6 0Q9$%Q?O?+[#_O;IT49")!DPA?-?>65/7&+4Q8HW<:.D"\U(=6VO8
MB)62+IPI9W.7^:X3Y%)X%LN8S+GE00B,F)Y.S@FEG,&9,SO#"CQ"U]1.OMY^
M.^5\+*98!$8F(VC>4.3#IW"I&'&*<I*+J0B4372Y)<OJ FLKM#7)#2?5@# @
MP1C%ELY%N!?*NE!X).0:GW9"4_Q"/26PC((+Q6@1WA :;%K@G5(/:?)"!(86
M4+4)ZRSHV2,Q[P7 D)3?!SJRV42$@40+9F!P)PUS>@MAZ3J\&/8WMNL815^@
MB#&AZ!8(.HD[!AS"ZY(YI"D-=PT!G4-(RW#EP006#Y%,J8YA/3@TZ#37^D:W
MO<J<<2<_L/^P,EDT6Z(V3K'D/5S9PO2#ME6QO0&=!FT&# NN[1!)-CX?AA.C
MZ ;C+PO;,+%6?.* ,<;^9Z'GD>7"$VX$UL<:@5 -.251@H)JRC>>:Y]X-53*
MZ],AH]TS=US_C%,QW1M[F[B_Q>M)&L'K(@&NO,"/ 2;EDP(3I)9XRP"]+^1@
M-*37'N=I)^8Y.V\DN(I/OX&OA[Q$@XAAMTZ#T>V!L4>5\+SN9<W3R0C5I >E
M\(NA-V'1"44H7V].UP\*Z)I^]8'MN'8Y"6-2IPTAXH/N3J+ :5+@4X-\B#:P
M)LE/0LD7T3ZB+J^3ZFF@%Q )$V&YPF'6[X&*3]>U2*S?*-!"H17J@")[# =^
M+(Q? U,Y9O7'X$F%3]$("K>$SQ(#K"*'A6;MPE)@+0GU*,*_T7*"2>)"5R:@
MDM=62C<BB>]Q*"TRCQTRQJGZW9DA7)A L IPL$*WG[\5;F*=X,J+L\JP *L,
M*@VL^>DDNEE61)SAQ4XILG^"V0A"'R=0(];H%'7!"\U\-Z>-.$5&9AYA,2 D
M.<6]S,42T]!^8);P^V$8D#("AKAL8M@"4!&'BV%#4@3_EGB7&%S,A&L>T()C
MQW4YK]/- FJDB!1Q-!]K$\^1T#JXR;G)/&L1 Z%L+=HI5+6QL?1K<_>"\?1<
M.R=1 #<$QM)"# UJ2][4YF%!4"-H$B-@>5!5%D75QJ[S:]"1M5B8GL>!BRG)
MA?<4!D6 PA]Y]J)T:>.EU]KEUP#I<*>P&A2AT)TX?@->E[B9T,3BEBF]+357
MK+D9?U@7?RP(A")_!T%57X2WD0"XCL/N5Y[@B0)E6$$O'!,1XM1N[= D$B?Y
M"):QP,B."Q5L=1<TI5&$=4X-2B]QH.R(_)+1])A "DPU:L;<%II#E8U6,H>H
MYI@G,T;XV4%(B*S("*4TL2(QR'[*6PO2Y"4/=0M;(I!V6P9=#\-$-*>/XRCK
M&E3TM8X5?<>*OEI4].U3D:<NM$=%>D\%B_3@^;&W<!T;_LF%I[=7$U%0N5?T
MOMBW,!&(/9ZW$M,3@G!D/$:0N%>MJO^(/ [8T IMC@L!C 2*D ;\?AZ-[GB1
M>QBK#7&SH]$TT8OBE!H*#7G:1P?U^(G0HY]&]Q^%$CT-' 4"Y7-F\5/UPJ^O
MEE,*M9V,[K^!HRX&.@:W(?\@];$7%+N<I.3W@QHY;L!CN LN"_RC!&0YAA+P
ML>>XVQ$EXD<">8%/C5P;,!34*00W2L]7)?J\HUCHTA$12PYKX*TL'G +Q]41
MU,3$0/M;&'EX=PRAF%X8P,,W$@C9Y*7PE6QF\\U%T/RZQ53/,BW*MG76Y>\.
M098+Y^<RC"W'1(U*@7QS^W"EM3443+%Q$]<W_[BZ>;C]^B_5 FO/_;P7(R1O
M9^'.7O#*5%+H\;WEH#G<#/O;.U0X8-8L,7YO/X:_>T"?X>_<$ *6H'N%1DO2
M FUMF*GTB3"3!H?8F%I<((*I^QWV[0]_^)__^<D/[<TG\)LP>1!86V/']YT%
M7O<_>-TT[>AV/7%]J=%!^=/PGJA/;/;\;W-ZUNJUN^]*>0@8NW 8-K5,)1_8
MVVG=[[N(35=#;&()/"G6NIY^_@FGTWPX(6W$,2N\4YZ!IKDOG!]Q2=L/HR_]
M,."G^Z%V1#<HF>CT=:(;*B(Z(:#.^)["9<OO&JEGS7T<GS0;&O[W5#5MCC]P
MQ)A(*ZA]>C*:5]4J3OYT&CYZ)QMVF@>3IR8T4YP0<C!&IZ68,3KZD3'JPAAZ
M_1FCK88Q\BNME/@:TI/>[,"6M@?P?]WNJ3S5ED+7PE+LZ7^63;R)8_H:1\C+
M<5*=C8C?G_=GYQR"JZOX>;V-Y_7^G(Q<DH$OUZ#<#3\F Q\-COF7X)2W8Y'I
MC5:SN8$[L&.W^C)/)XT)YCC& ;TOAB'R9]=8YCG$@6*B&:I]7K=9.R+MJ"12
MO;.)Y[=CMUHU(-+#-4^W2TJG?,U3IK8AY-D8ZFRVPNGJBGFKK?AYFPJU:EZ6
MHG#PI*_M.XX5O)V96X,BG"S5&)"F;KJ;-D.Y)"-5Z^9XWJ8ZK9I$I:B;G"3:
M'72*T*A46Z R;:/,SRE3VWQ*P*EGZYK>IEU5*F/UY%HF>2,AF<O:5+FE\WON
MQ9>ON0*JP0E]N\1">Q.A;<>>2C4K4H,=TO193[&/WY.KUJ6Q006A #EL($4[
MYF2#?JN(+]:3&S"0R 9'!RV(VC[@L/I\<=N>XD!+3ZYQM<9L;6"VJ;/"<H!U
M;AN'2QOOH.Y^!7&90B]1OO+<.>I ;_2ZK11IL7-/Y=I(ZQ*C+5-Q]A7'*OIR
MC0KI[%!!:$,>.TA1HCO9H=WH=M+"'SOW5*ZM))$=N +] _S JJ@/ZY6N;PAZ
M/0T9OZJ)6O^?O;?M;A/)UH:_W[^"Y9X^G:PENP5( J7G9"W%<3*^.[%SVT[/
M,Y]Z8:ED,2V!!B0[GE__[%V ! )!(8JB9#/KG$XB(>IMO]?>UWY8+Q:T,Q3\
M %\7MH7"#F! OI[]:(4U+TE?>%,E%O8,]W?>F]%=;#/2W W3/(/>CV%7L0Z6
MF&$=#Z9\!A7++ZK/!1.6>K(L:3R#GY,B</'<YD+,H2R$W/OH/CDYTL88Y#1!
MPO8U\2Y284_"3H2N$Z:W+Y"*5B%(V20"3Z"T'8,OV]OJIJBI31+[J@RH?%_0
M+FI]+6<7L>QJ2PX:YG4C7A*E UJPN$'5ARV^W=GB3FJ/'S>@[3$(@'CU0,/%
M)B63<[%ART="$\C]D3,931YI,^,Z$ITSLYI[NUG-'R^^7=]>WMTJHZN/RNCC
M'Z.K\XO;(\EP_AA6'9XC@YUO.M)-OH'ZL.P)[.\U2N*@'W)V5GF;^5R/5;Z-
M&]63:[>;^6QL@RIMYO/N8?#/")8R\]D8UDQTNPF>9E<0T;4)GB\@\]FLGG]\
M8.:SJ8EF#+UE#%D80_[,9[,GAC&.*"- 5.9SY']0=+@U%J5BS2U%-W0=K&NU
M:,%VX0D*SE V!6<;F>DKNZ:S?ZK<5%"O*'22PBYL865HSAUGVN?/V2^N=V+<
M[B9,P3G*0\&Y-,/T/5'39%KE!N$0,E6-,KG[0ZZ75>VM>Q551$\[AE8>XLR&
ML;)B'304G+0\%)PA-$SKV*:9N[(.BM\17D^Q3:CW2/+*'LIDH0ZY&@G<E-!0
M<.;R4'!^RC"M9)NFT\I*J"R=]LI82T:7JYG0IDM7T4*AN;&!<M^")T9=_0(H
MS4)]9'2Y)NT4\IW1Y6O+<,H@-;IIM7PD&:25M5MP[U1HLFJ#4L*"J]E1:Q*U
MT14;%C"Z?#4^-Q9H('K0?!)U&1;0]71>1LY^\HTNM G4C290&UVQ41E#Y6MN
M<<X8-=0&@CAR)% G0SW)[(UB$=(OF49JJ'P-ICJSJ@U5;'##4/E:&=QYI(%8
MB!Q9U95X9&B4YA&^%E6;:LVOW0#3U5VL)X9'YK33HJM8F;^T'<5=>\H7>TJ4
MV[%-Z!/XNDMGZEG^REO3W&K%)P]!"XK(5=[G(H=)VZ14#NLA^@-S*F^QB25&
M:*)MR4M?S<E>Q;3?Z%7;C4KFM.J=W2S=_#4=PN\EUY1U[9%8U$Y&[C9!&\>=
M!*M8N-C_+UHS/=L$A3RY'G;=*W&:A^1UX\KOPL[OGSQWD94MZY[/+7L1_RAG
M:P;IH/%V:V"!8_JN,/$X>%MG T!-N]B0,3:CI0U?@H9,V#(JUE]VTW3PP 1E
M?D*I3'IR$E0>2URQ-QWLZ:4#LN/!!K&Z-W.6%5*^W%L;0'GNIU&>[T97GR\_
M?+E01K>W%W>WRI$D0\?AGI,[#9L?G4.+_'S<^3I!,O!H@<5102^LZ*@W<>DH
M,[C([5;YXR'GIF@;ZC9LTZ9H[QX&_]1E&5.T#:TZ^F^I3%1#4P4179N)>OPI
MVH96/5'ZL!1M0ZN._EN2,7HM8\C"&-*G:!M:]4X6+RU%N]8L!"OLLU9X+F(3
MH0U-;/*2H<D'NZBK%<*WB$"P(E^P\>NNE_;9<_,0&(WNL,05J28# F-Z6KK8
MA&A#%YR#HS> &EA$KEHCY*H-2^1A&SI?$)_V\KYR'O8VL,"@A72QJ="&+CBO
M2)>P(4*5B_;#V5HOD8!MZ%)V1C!TL0G1ABXXOZ4G7V<$O<J5=P5J+9-8V7L9
M+1)>A/\S&H_7B_6<MEVU@F W!54J5D4]L?"#1H^OY<(KY32C19$\*:=O:LL@
MRQ$5,9(:Q2@JY]ZX6P+4U^#;HREC<S.S5+-%RMN<:0J.%W!NCL2-/1H(*W!B
MCYHT:6GVR 2QW;O?=8<C#N&.UM]+)&M'BC;[5IDE2)S1DJM6X<*YJ15SQ01;
MCFI&TR9Y9$R=:=PY4B87"GB06022N\7'TU#"R.AQ52]S---0@I4YI.XK46/^
M]J',H1DE0>,-OAVRY*J2VN/D%C.%R< XP^)G!EV&9U2&9S2&9W2&9WH,S_3;
M@'=.3MUW)]?^8<VJ&]0$?)H<A$?J7I"W%A?6=HXT&?# $"TY)(^<N')#&C6E
MIR4'X=&'ON2Z> ! EAR21T)3WI!MJ+1<JDA&)Y):#5"^73H8QI/PDJX:(O^$
M3/=;BQ<_PHX846I_3JBFU*V=(>>MG2'XULX0?&MG2GAK-Y""? >],N 0YLNX
MQGL1EO4!J22FX/L[DVL(B6$\"5N=&WEL/K5_D,GI?XGGUL?AIV7X6\K^YX9@
M1&(C Y&XWO$D3,0UCXIN9<C(;7VFY)77.C_HPQ+P$8SQ;&1@/,MPHYZ!I"Q1
M0+^^EJ_-^&A\L8[KO?@2C)-L9. D2\$@4M]XU=<$MADOD"_(LER77R_"-=RH
MX$/5KN!P4 :JM42 :&8&A/01 :)54\&I6_024D7M9#>,R-WKX^G&;O(%A688
M3^IN[&8&>/(1L4DU15R%389J5BYT[DX?38_VNA&Y=N' <N'!=O\1P2U]^_SA
M]]2&=E,@2W$*#)&8X"/0X\EW77W_F@O^D!@@=1:,AP@FFQ8L!!8TVQ@[WT:?
M+TX_W%R,?C\=?;J[N'FG6/,GZ]F/^ 3/S2$[<YB18#$:'GMH"_W4I?_+,I/"
MKTY^W5WX/S[>9"X<=R\QY,Z6S::GGONT\^'=]?D7V_E+@2\1)"O[>":VOYQ;
ML%&V,[<=<GJ/N%M)B4,'!^ZWE)F''/?3RATG[\Z?PN6C(6T#J85G@D_L?A@1
MY>ZSI<^OH]!/.XH/9#J%^5&X+X3,.$>91*^<K??A 6?]T71C[A#>+FC3CK+I
M<(@[4;!T>Y ^'ZWYF@3=Z7=LY0ABTU=6\!SVF<?'K/%_UC:%*US2Y(! I^%1
MKI=+#'?!-Q-K907-UO&7FVX7ON^.;5IV]62O9LK4I@WL$2>%&>:QF]!+ISX9
MHVYZ N;VB1,'>00)>$^\ZVF8P;#1/MV8]EG"B9R\A_>MGD]!+*2!'-_TU+?1
M,BT$JAS3 Z=PIA-[.B44D'0,TF'EV0AH.G=A071Q]2_ILP='3R8Y*W/LS$4-
MWRH/P6_#M?EGRB4L<.Z[VR.GQ^S;X=Q]H(8 XI6"6DZ (FW'#XX8=@6/-\"G
M%(9;*Q-8;KR($,DYHAAGDN21B.PQ8@';-B6*[2OK)>YH'C0CXDSL4LAD[3T3
MRV-/ /[ND^EZCOB[)^^U[JZ=H.#+*##I8D$<A&-4IIZ[H.P[06!?6!6E&<7U
MXJ01H+TFUA]Q>P(65J>;@6!$^/#:">FH;K37:%OB14=I!,N<N&G:,-V"N^+_
MYT^Y2H+.H5/.:&*VF7('>-A?$OCT$?;[]?)KA$[LD8?UW/(H?/6C39Y KE.M
MMZL'4>(1L%T7($\5&U0@_';W*61EBE-]BJB]IRNR &488&/;,)KM$=A^\"#&
M,^7)7<\G,"3J44)9+)H0#(1PP!X25_BS!=4P,U@392E\>@DLZTXB,&XJKU'1
M6BN*' V<FL3%Z^"/8* G^-)Q8Z_E30!UXLZZTYS:AD]KQ Z/<TR(8+\'D+8(
MA;94K'/'E$U;Q*'%WD_Y4UK_YUU_"C]* <[RF4<JE,L6OE?VQ8_#91GLGC?C
M##/)L<+^)SV7D%;#?=^D MR_OP#IL4AA D3J;&_<N"#*7CH\(?$FQ5AZ=Q?B
M0)!<R>M(-RXK[I&BN!2JKY*H!)%QNG][FUNL\NJ9(>/^C=.<#LN8>17"^Q/X
M)&@7H0^C$ >M(;![>BV%[A77[2ZP[X(VX+@-30CT\,YI1YXW 9*3-M"O8,R[
M)S)_)%]=['&2DZ&1A;:U?-_2=;/ZIR!=Y!7KGWXK>5O]T^H?N?7/OX!E[Y[<
M'+63A8O=JIVFU4[K]NQ3.X-6X+9JIU4[1Z!V9AXA.1T9TGU$6\73O.)I_9U]
MBL=H16ZK>%K%([_B^>2NO?UZQ]1;O2.AWFD=GGUZQVPE;JMW6KUS!'H'GLTK
M FKU#JO>V987997_Q$L36.HD=I; LTKBP*2_;YZ[A"-^_C:',4?.Y.(_:WN)
M&8L9A13"RB=H#LS5]=V%,J!]7?_G)U-3U=_@0^7;S?6WBYN[?W64;U]&5W<=
M973U4;GX?]\OOWV]N+K;)O0TFVF)+8@.VO5T F60V[7)G<S+I0S+F::V0Y,Q
ML^N8LCF$H90OGN +C/,CG3S9>%=RLUL3:.\FYVYXLC.@D5M_=^@D:B_A+^HH
M;&<ES744\F-,EBME30L<:%E%+$G-+J[V-[L\T(</Q6$028@\((_S"%'=(42U
M*X@0&:%(2@7U2BK]@]1\*OMUY2X#11.4ZRA8KZ.\H<4Y;+VT3;4Z_O-A3>9-
ME0<,=(DF\Z:JRT5>K[G)O"Y[DWE3[37&&-7;VY=DC$'+&+(PAB8_8U3O]\#$
M&$<$#[FIV0K*L6K#J?H"%BS# 8E%HS+5-!J5QA=--$,JG>0&#+#QZK80?J^G
MNJGABJJ='XFOGKR_^G64CI3L6[W&%7*3&]:2QA47BF$\P=A.6AK;26L8 KA7
M)3ZZET8+NDKW.FHW"S-L[[YQ!<#D1ZYB^W.8FEB$;%-+0T V3JY5$+P.)]>>
M;I8A5ZZZK$7)K&)]?%C;<[3:? HE,+7&]MQ>V0Q]%$Q-;/L24T_KY,8MDCXS
M*,M>WDI@LO39311=ABXD&=,2;#+H8KMKF'I:U38N\ZM S!PJ\[6.-BPC\W4I
MFVJ8NF"301?;5,/4TZJV<7*MTO/I<'(UU3(6M=[VTI#&1*%G3<V3A36>V0[Q
MGHNMDY[8IAEF+ZV.&[=.#+[62<HX.<T=W>1L&Z7PZG(.@ZL1PDW9] 3;*CVQ
M?3',7EK'-ZYLA@TH&[VCZUF5.WOWC:L1PH]<!=LJ/<$A[EYVB+M)<NU7 ;@\
M/'S3'V8E_._;M[X,P?$V?$/?C*"1:S %%!(=-DU)-'YC".#T!=\F]--:N6D3
MJ<^.JLMDI.CL-DJ?;Q\+7D*_+]AFZ N^(^BG=6WC0E]M0.BKI2+V?2D[=IM]
MP19#7W#(>Y =\FZ46+4FHC>]K,*0O;LF0V2\C=W0-U]/I_:8'&*=# 1?) RR
M<P\:M4[TFJV3W  .6@*UAH]RSD+.?(:!8%ME(/AR8B!?/D._B;LMLT2C7',@
M0S)#QK0$FRJ&X'B[D1UO;Y16F[C84GME(HV&#('Q-G1#W_QI[<%)KCT29-X
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M?;0^&6O_0XJR'CQ"J"BGQ&O%"19V=DNM"0H%^REX[@D. ,C F01US\%!P"&
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M0M0AT:N".^(M/KB>1S'0<C"&TF&X[6)AI7[LVL&U'/_ #3BC%2Z[!3?-E=?
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MC/(^(F[2SGKI<L*<G>>+$2@A-[4.=S(^^^C.@1XQ/8Q![@@&B!YPM2L9QFL
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M![, ^./4$P?@WU=*P2]'GDL74*GSW_O]VO/?KR.H3!8S3:NIQ'1?<J^N;?V
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MG'[UY/W477O*,[$\?Y?G:$?+5-^^B?U(^13_K!O#(#D8_">""/CV^</OV?
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M?2P>FHAUK)H\UN0@/-"_61?$0T2PCB504J@U 44G!M$$B@B-AXA@':LV27&
MUBX^!9WAI'H,S_09GADP/&,P/&,R/#,L?D;O,CRC,CRC,3S#L,\ZPS[K#/NL
M,^RSSK#/>FJ?V_J2\*;K_?F^N]MWP8U D74I& RUQQ<,E5<Y7"\-ECJ4)P\W
M+XD02WH/KB-!XADY$_SC8DLY&=DJF?4A-"M0[ZC# 7O-6H\S#FJ=N>H]P>"H
M/;[@J/QX(U5F=2R\81R&F<2!+4K@)/4XPZ'6RQ)BJZ5Z?%% ^;%$2FL>"TN8
M1\$2G&%":V4)P=BA/;[8H=Q8(@TQ>B0L4:40MP$#BC-RJE1%_R\"6BNZY-F?
M5LL6]Q>,1=OCBT6[RYLZ\.;$76-VU4&EDKTT=*UP^9*[!M%>VFAU;GG>,_!N
MLK*86<#D;G:]@#XZ5_TK.(+!%XN6.Y^DH6N/B4^X>FS,+))EFN;N<;U!#*[L
M(1CNML<7[I8_>S0?S*C 'ER]M_K8H]Z !E_V$!S0X(L"S)\]F@]L',X>_#VY
M6HTLSGC('-FDMNNU0O8P&*XY#89K3H/AFM-@N.8T&*XY#89K3H/AFM-@N$XV
M&*Z338;K9)-AGTV&?389]MEDV&>389_-U#ZW$8?H&CA6&,IX\6N*2"LTN20+
MV9MQ[!QQ:G))*V0;:\@E9XAQ+!%IA4,NR4*,"^*25L@X%I>T0L:Q1*05#KFD
M%3(NB$M:(>-8 B7%4$!:89]#H1'K@OI<2HM8QZI-4K1)7?3-<42'+;!(H4+O
M=\4&>OI=L7V-^EWQD9LZ<Z^VI[R%[3@/H%#VNYEJ/ZO7[MX=D[+Q4K\K-N32
M[XIMO-3OBH^AU)0(=1"-ELCSZ*LRM(3*F);8E(Z^*K8=;%\5GZM14UY2_10J
M9:/:OBHV.:"OBFU4VU?%W_;7F"8D0->K+Z.1[HN(QYTB+ELF/&"Q%:^*S6;H
M:U+68_2UYK,8ZJC'V*_(8@%</HI+.YY"B[XFV'75I"RTZ&O-YR:(+;3@3_3'
M4TK1UP2[P9J4I11]K?F, [&E%-R)7C^>8HF^+MBSUJ4LENCK+[)80B3-O^ J
MB!=QB[&I@HBA83/5/?1UP:$-7>JZA[[^:NL>8D*C5$55=N D=X^/I]RA+QBP
MH5\O8,-^TBJ<5_,1@AR^J-E;JJOPME\S/ -73A ,S]"O%YZA B<T'S8XE!.J
MNU#U<<+Q%#'T!:,R].M%9:AL,DF SM!,$8,XBZEF@(;*M0O)'ICQ1A7-=,?
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M&6#B1\( 56_R:F$ OH8*=U65@S#ZLF'W#D2R0E U%Z.;_O5T#^%4!;(J/42
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MOC%4CHS0^G"1?YL/.I,XSG[:7*Q55O3YFEN,\"?,$89^VH@0+C-R%Y$K-ZH
MZ!:+B:&:!82;NYM\3:1=6:'S5)I]P>&+/E^#@CLC-!#MX,<(53I<,UB.PZR\
MK-S=Y&LA<60$.0!T>);QZ0>5\6D"84#>J&\57/+4=5>."QYO:+^I?T:?G"@_
M%O-W<PO+!8ES^OUV-T$4T0AL?^4'F!/T(UJ][P5/P:<S8CT^T^<V*3X;5(PS
M>LS18.^SD60X'TOOH&/111Z+EGTL6MZQ)'*H,@XGA1"RS;.* !@H.$.()>&O
M[Z,'7,]OXISZ!YU33^0YZ=GGI.>S3QSC(ON:(WYN6#*-?V[JHD-P)^5AO5C8
M6'$_HY72%A;P_Y=X\,&]M9J!"EO<P]_G+NX:?@CC>M8#_0%9+)6QAW!2L$(\
MXO S&SQ$:T4"A!KZR02F8<_QPT-)X( S[(L\PU[V&?;8SS +IR1^@AZY]V!#
M,9"(&"EH :SG="-\)000BE!&-MA@VRIX'\%-T@]X*$,]PBQ$7Q) UVV0D'!#
MEJZ'^$% 7>.YZZ^]\M@%#*]J I;+C,-R*?#Q[<7GKQ=7=\KEU:?KFZ^CUP/+
M]6ET^T$9W9XKF@DV-^Z(!I.RWX<'IVQ.#FNOZ=>P82!&0;+8_@RS5U; >X@A
MB(P';!,^C@!9U!2GV%'W[GH5?D<1%,*4%_],V8!I;CX+H0BG 4"53[&%7(=^
MXR( H4+++)>>[9/PQ0$8H4^6%KP*I(;M6,[8IC;4=@XVO/C1LN=T_ #ESU=(
M@"L( X'L!*'A@9*^?PY$QLPFTQAV(#H1/KYH8?U%O Y*ENBC4_@('\% TU)Y
M<W[]\>M;A&.D#U"Y-'.?*&33' @>I^@1'T05"C+4!+9#P01]'Q^-02V%4(+P
MNLU$_0A4*_@EC.A383:U87ON*1XB3#&4;@I"W 0/PLSPQS '((>_R"H"3PQQ
MI6S8T@<O/"P'*^\W (E@],"X#W:$D44WA,*XL4<HN@F_[-0G8_3-GL )](FS
M*S) 1MT3[WJZH8R0%+=^6C?FIRU!E)R\7SVY*4<MB][>*6_LM_NPYW#A;VSX
M/C,]ZTPHI\HB'NXR<#4I02*06=9WE&LN COXD2C7TRGH:P^8XN+Z;4C/%]=(
MQ#9Y\O>PZA+8@T+Y*90<8TP8'56 IQ?! P(-+%W@'Y0/(2NF^3;@@RV?;8?>
MY3B/P#]#(^V>_IWR2"95H/CS*.A@;#? 8IS N @_2(58A"D:\D[ \ K.8DYB
M,Z5\FJ+9,V6T\2\0>"_X.\5IPT<C 0)[1L4?[E^T+PZ0!GX]L1'8CLZ62IW
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MKD([K,!X?&T%7J2O-]"(I1;2KU7E9J5Y[-W1NENUM+EF$BOB,KEF0"M"N\'
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M\R$':H!Y6G+.2L[-ZIX-1,\JGJ3'LG'J68_O%(L3"G)2Y63?X%\#!DYR<=)
M#B)6&+N*$K\;)-R,#+AC87>Y=_4\L 6.@VIW,KTX;##W%1R$2]=0EJ#TARWG
MK(Z?!+.3 AM/"&PH&5!N@LO4U$=H0K;VML1$=LRS&K8GV,ZJI:N:U<_&TF&[
MVY9$_HY\VVI5%6..^.20O9*3=^6<%7>)$C-S@^O2G7K.W.RB>J_SLU%-7\8Y
MMK-Z$30O'#%5KA/]^0 UOYM++HGN&M%+O5;3LTT+;WIE(\96Z-4G] ;UHK4:
M67E[+^,<VUF]")JO%:9U(#WU'Z+HJ_KSL?S4DKKXD%_6JR_/85\6]Q6<XSU+
MXG!I5,.;Y>)CHU;=I675O? ]Y)8\A)%'G6*>HSOW,P>7:W,%K;,E1YEG6HT"
M,BP(DDOKL:?DA$4 >E/W];M7T_$""NZS%\V_DN)7'P^MRCFKEH.DY*!FBI'D
M(MMX<5#<ZTF6!<4 H1MIH<ZM_.,@_-F,U58H!PB!8W<+FEE<MOIJQ&*[OUNB
MS.Z,2CL]R;<OY/!&IG=@X8!@,,+<VH$CVO(8+,+N;'DDOC>+J7L<@D+Z?=ZI
M,3@BZJXQW[O%)SXB$I!\>B^"0ENDXBVGY" 5RTN*.:; ,=NR$FCX8]Z^5FQ7
MF=ZP/=QV>BWM2;1[&3B A^']-2O4H\J(5B-6J94X(KI](=.3*__ K/7Z<I"%
MU1]=:KR<(VVG]T(9HM;;R+RL8YE.EP5(^##D_H8-B&W-16M#5*C".%*1)%M\
M4>#TY9*XPWI1F;6L_@@RRMFC5_(M1\G(4;76CN252,M$O!5LF'U!D ,SF.M;
MXR:)^46(C\,R,NN;?RHILY9E2)::V53#!!E%R M3SRU_R<9?S:8^RT3+,G1'
MR ?=EPGIGQD4_G8\(Y/UG%Q/(]F<F;<]<B9?7.?AB_T(O_-]LDID<EOS"ICQ
M]<T M$E>"P'8H]/QVO-@ZQ2+OE%QX7,/OK0<96H[EC.VK;EB.]ADF.94*C,R
MGR@TPS6[X4!VIX'=W'RA%%*0LB^<'*(N$4(H[X J@O$<B '.Q';H6U.=9[ Z
M(%T[$#_"O**#.+\J7=H^_?\D78X]_=>X=58K;K/4JUY+D3G(QCM2NR<[(VZ[
M[\6[)86)9%P; G/54$5);W9!4KS-T&VNIW$_C0Q'MVZJR^HY%C!4;UB[X7!E
MT0[Q(*@#"<+6YJ^GU\P&VBX7] 1Q 7,K3Z',<D]O#QK+D7USOM7G'T-]_E;&
MK/(DS?2KU[UEM29ET!(#T>QAO'+V^!0:EN>18=D<K]!<H8[R#[#,E-_A/QUJ
M^4:8,D? -F9C;#,4S#;][BMGFZ#XP?)1L'^UO/%,T=5.HE.)M&3:5\60*;M!
M^*+;0%\Z*\MYL-%A# ("'<4A*X9C$MP0NL^U(33#>.D.S[VZ&]L676AJ54!6
MM@<=. 179'7Q8SQ?(Z-\=MW)DSV?YZ! =U0C*W2Z=_OXMG3.\*0.ZM[<%]R]
MN<^U>S/#>.EVS,U3K9I'M5/[!YF<_I=X+E^"/2U#K'7W6CZ,6 ==L<0S4 6/
MEU8A31.K?C0"=L!5'QY(L]5MJ(+,V..PH;YY[A*6_=Q1EG/+"?IRD_^L[25>
MH##:4X.TO5$O\W%5T SCI35OT\Q>S9Z*#OT;'OG(F5Q$!PY\OY_->YVNT2O#
MYEP-"'ZJ*6UGU$L]7#5T\7A&6O4V3ZVY=E1-U*KJ66G#>[>-JP7!C5H-P;ZJ
M(=A7->3S5:L84H?1JMG1,CL5[=TT&3S4-@A%WWP^M^R%3^TF:_)H.6/B%UM,
MAF!?WA#LRQLR^O)5+*9KS#0*?2/7"=.0]C-TW^R786<Y?7A3L ]O"O;A3?E\
M^&J&4DDB[:E9I=U[=TL&ISUC6H)]3U.P[VG*YWM6L8]*DJC:Z7;+&$:F#"YG
M&UFB;[X&0]A:V<Z#,B>6'U[1%9M&IF#WW.2K?%DOU8NF-6S BV>>?)V&5D0U
M7Y!H;G")U]/O?A"7SFFB,RRCRX9\??VL*WMN"FXH.  PY*OGN?%# W$"7OQ0
MR:8[D!]*L0/?<$*]["#8<Q[RM2BXL4,##C8?=JAD/1[&#+J6U1]Q[];R-0@X
M<D,;<4OF"*8KPIC2]-2NV,"&VN5K;NRP(=;-AB6TNWR8K,?=.[T&XB"E%E&C
MN<GNB@XZJK:OUGWOSO*UI79%B<Y1L:I=L8$4M<O7Z.#.% W$77@R116;LT0(
ML9,=Z<[=6;X65;U,(388H79K#4949@I5@J#$X4Q1Q?(L$;+L=@PUJU-K[L;6
M&Y"HP!.[> TU Y^D\2 R/IG8CW1*^&?J'U%!^+?/'W[/+@9/;T3X":5=^A&8
MK\EW77W_FEN6PZ7:_.2]H04+@07--C;^M]'GB],/-Q>CWT]'G^XN;MXIUOS)
M>O8CUL"S<\C.'&8D6(R&1Q^Z !&Z2H9W$'YU\NONPO_Q\29SX;A[B2%WMFPV
M/?7<IYT/[Z[/O]C.7PI\B67\V<<SL?WEW(*-LIVY[9#3>\0(2 H9.C@PO*7,
M/&2\GU;N.%EY\Q0NWP;>M('<PC/!)W8_C AS]]G2Y]=1Z*<=Q2>>/44T+XIE
MX$Z5<Q1#M,>7]3X\X*P_DK2<R6F_[ S\2Q5>2PR7V1LR;$YV0Y:NAW[W1]L?
MSUU_[>WI 9G]$A$@%2URQ 'FALH?JR ?.4)5]5PQ*FT @A4YHA@_@A%'0E5[
MW,^FQ9%@B0ZIU4OT2U7\JNI $$_(6O';XDAL)L-8::RJ1F4B/:P@GJ+KBV6/
MX2MG#]EP)+8P$L>%(D$CQ<TPC58=&* <TVC:*V>:O2@24G:>39Y==2"K%D6B
M=A0)51-\8:*)S3Q5-?DR3ZE8:ZC(N:>72")0-1D243.F)?@^0Q-;^ZCJ,M8^
M-E>8WS/5$C2K2UD!J>IB$R!576P%I*K+5P'9:XQBAYDMU?9NW<NH@WP1Z?X<
M@"1476QRIZJ++8M4=1G+(JN85(>6Y@^-$OG)JBYE?:3:$YQ&V!-;'ZGV9*R/
M%%^<W^OT>F7,J![?I#]NU"K87>T)=E=[\KFK5<RHPVAUV.FI)4!/U)X,;FH;
MAUH>"B2A]@0[]#W!#GU?1H>^BL54%DBB7P)83^W+Z<$+QMM5!>/MJE+B[0JL
MTM?-,DZ[G/"ZJF!X754PO*XJ(;QN%?NH)(D.]5(D*H/#V<:5EH?#2*B" 8A5
MO@#$O.J$U29PBGF5S5<RLPZL%!Z6N>3CC&-<9]V\*ABC5^6+T<N/'R0HZSN4
M'QJHG.^7P/M5.>/]ULL.@OUFOB# W-BA":Q@/NQ0R78\C!EZI7QQSGC"+8R$
M=# 2@J&95;[0S-R+@YM <N99,5_%W"P#(Z$/]O5QW[NS]>(S<:V8%XQLK/)%
M-N;/%!+@-%5A"C$U\WU@BBR8S]R=K1>FB2M3"$925ODB*7-GBB: E_DQ117+
MLP2,A-HQM+(\P1FCN488B=(P#W7C3NS6PL.F7ZT7Q+/'R=,'3B9P9DLLK/'6
M9/> ;]?W/OG/&H[VXA$K_C>EZB?\EA#CDW^O_94]?4Y7OE[?72CJD!:*_<]/
MIJ:JO\&GRNWW#[<7_^_[Q=6=<O$'_/=V6PLC;';;/=\W:"D:34Q!"><0$FE(
MGW&Y$DTI69ZO#X)0LZ/\W[5#%+T;])OM**L9^?_;>]/FQHUD7?CSF5^!M^_X
M7&DNI>8F4;3G= 1%4=VR6\N1U/;XW+@Q402+(MP@0&.11/_Z-S-K00$$%RW<
M&3'3%DF@4*C*RCV?M)I^?\"\H17&MLW#L!N[[M#RVQ%S/-ZQF/7D!]_1/0U$
MX: Y80>\XT16E]F.ZT1#*T(C R_X^Q19FV8LQR]B+%]A,M?=)CWZ7#ZY*7C,
MJ1\$_A-,H,D0_" ::J9S/,)T1G%K+-@2%R>+>0D._ =8 DT>3/:.->6-CLPW
M*K[HA>XB.#0781CSSED<P.QOX"SZG;L>"W@(5$$_A?I5BL:KA'0-(?$4B_3_
MT;<2U^"$IF[+^[_$K\R-^>1W$-[HL?,_M.Z!,C&]%@@,=P8)-4MX(0\>.9 ?
M;*'G].',6+[WX%,DQ8$[.WA-@&,$'!.+1.H)]Q#=PR1\XA^UG^#GMB)H. LA
MTK_EP%V^\*;X7GAHG<<!QN7Z?L#3A\=! )1.B/<&S,$PCJ0C.##=F'[I!7[\
MT+,&@?/((HY9Q#;-BZ;5N+^T_&Z7XR(BPDK<_H/;$;T<"[[S"#=-#!@>:ARA
MA(<O4YBL/29198=)M,,D6@HF$?W#2,=UP-R+G B?#7]^2F:]2+7JXKYU:8UH
M5<TOC:O/K3OKXLIJ7)U99Q=WC<^WK=8E*EC6;Q?W7ZQ&LWG][>J^@5]<7ZF/
M%U>?Z8;SBZO&5?.B\15O;7Z]OOMVVU**V1+YUEP>!F(+I,L3_N/YEMUCW@.,
MYPCU DX9>PBXE$9/3M2SF&TCZ@'#+U )$1\="3W0=3SFV7 ^\%8)3"7Y_\J0
M+3/HELV%<$>H-.)]J]XXI",>^*X0[#>!;_,.+M"FTA;6V+-]J_4(ZI6 'P,V
MEQ &Z75Z.0:;N!R369AI\BB+)PZL2^:Q!Z%I]4&G0[TNG&'9$%NAP[MD!,'Y
MO8U!K)0J[*!TM,?WZ=K244=^ J'. ]('[[@-BG"$(":M9W'\K08H<K!3I7JE
M:NWA1>8O^W ; QT0)M+A(;P9/ ZT/IC'H]/A%F+"@1(IB_?C -.FQ1V.)Q1U
MI .IY=*=;:Y>3DS<AR4("-\.S ''A2_!)@#]LN]$$7Q(IIZ:KQ.*I0AAE +<
M;Z/6TT'%M \K#IO4H240 \,'9&8$"@:S@WVU!F0(A%8X ,NAZXBIT *UFEKA
M#F!-Q;+CJX 0%YH^O!S8HKW4&\)\@#?&_=AED7RV[??[8$_8] 6\>++/!;A5
M5F32ZS=[#N_"^\'>1 Z8#-?=KF/#6PNV =<Z V"QYYK9JM_W\.:!OH#K 7QC
M@.3WA%O+WW'A< 'P'G>X7T"28@-85[@'9EW 63/7]9_(3L-U \L;3:T0]7RX
M^8$%]!)Z?Q.RG54*S-7#L9*GW-Q],M%>M_L%,KEB6Y";Q5-<%\?E8*[1UGIP
M2O!+I);9^(H: 7Z0?XKS O<\<MSG-EBA/2>4Y^O0.F5XFGU/?)O,I? F^H89
MXD)Q>>AFG#\I-_KED8:U30V#X,O,RIKPV@FL"18A#L<QJ"<6&FS)X%4S<"B:
M4^A$DW@5\*DL?YK GG VT_B3/Y9*W["'69ZRHBQEN4I3>]]8>&W<U-"XP4WU
M8EA/02=XQ-"5@\"MZ@!8>"8-YAXHL-AM5ZSZB6)%K"H< (D1SA#2'@\Q%.*$
M/67,*.6+/G> _)!<9UYL(G0Z=W!#'Q^84<Y"I9UU4]I9=W\,!SFTONGOPQAX
MP".=$;J73#-BRPSSAN#H*<;OI]X[>XB3@_J*@_S$7R1Q"GG@7Y6"FN3,"VNU
M$]D".Q>P/D>//RYKN5BJ6!=J(&EM60?TU4- ?.T\N9[<P$)RD5^4N#BY8NZ0
M,'QT;5K7P0/SG+^$/U6]USUHN9TG-A1WA;@-ALC#MS'60NTF4(">;"&S+WF2
M;?8%06:>R+>\5=Y83FGO@R#2/HL=)WR3\ODFL2XI'H\ #(,"JUS\:>8-H>M+
M/V5LV)0"91JTP"1!;^AP9*UPL?74XQCFL#"R8?BP7G:,?)N2 $##H- 0O"3&
M@73@D:$Y#F/!3:"B,#IOJ+^!Z$!C6!N^0\MUOJ,60[&0S V%E\TII4C#!$Q%
M.AKGN7O96X^^K'A4C\'NY[SPR][WA:^[Y#.9\A.V#3]A>X%^PM-#BVKI0&II
M?7V#^-5DYG3E>TM7ZU-48!M48"^0"IJ'5M+;P;K59I#"'OX9CFW8<6RAE]")
MO0FPFT,$="-\./##!M'-B^7<E1]9C<' !8,65/S%$%7.-#8V"EW=1:%W4>BE
MA/,6!Q%]T[B]MRXN+E: CYI2";NX**D$?R]$*F&DO50$J71QVVK>7]_>%:S6
MOUK-;_<7O[:LZ_/SBV8+O\/X>?/Z]N;ZMG'?LCY?_]JZQ6#ZQL;/<6D,ORIK
M^[%0>D>"+Z$,J0<@F_U@DT3S9 &(B7&8A8<.H <N@V8#/W2T2V66Y1KC/"+S
MAV'>(/J0PQ^7GFKPXJ97+]\"(8)( IGZ 8LC_Z>4>D#?Z"Y7V:+ ;(EAY ^T
ME"QC^O_8LM"V"T)YWJ6 5T R8\O^9GB%T@_Y=1DSW'KTPXP('F]9HGDF52M5
M+^\E:7&;J.3L5G=.J]MX6!;E5H^6?FYO)&=?T@J<+'T!SJ3(LNX<SUX6(2Q_
M&>XQZH78XE;K>0!+DK<0.87OKRMPGR;+YOFNMZQO7<;?8<9L.=QT-?E@<[<8
MR6(<5Y<D#.8+,,]#IT,QI#%1(Z'K*X:X'#8XSQ4H%XM'F_A6Y9&WFIU33\&X
M6RJG=NP>"T0<,Q_*=TO9T^EN,0Q>?;R!O+K98PY\JS-S3GT\"-AA-?%';1X?
M*]8V\:W*(\K$1NC1/Z./T+KT ^;MV-%.C\Y=#.Q2LW&\>9/U8^SNNH%OM9GZ
M<=-E,;:3_AP@=D+'V7&>A/,T=HN1+,;1,D[UO-GPKX[-+<.G,3';53@\$$S#
M=:C$<6L\'AO*T2OY'#T!R%K_,/V+,^@P<I]4BV)Z]$#605"M%I6;A)'518_?
MD+,@M/: ^C&CW K]/M;*A!&U32K0#3 4_$L7[J/IR9G=FSW\_ZHX_S84D_ZS
MG0Y!M#]9/2P]0K"A#JZ9XD; M5K7,I%?<CDKQ!B5U8"M<:UR';,JBD>'UA>>
M5R#UP#T> "$892NTW93-K:G!PWQ\VN0"S:/-N6>Y\ :8(IX=,@_5*(RP4N=A
MF,H3P=1760S9YQUD$Y;-/(^U'<]W.K+DL\=@!6T>$QN!RSNP?L&07D?/A'"9
MB'D['F;+^J*T =-*G(B+PO>^'T;*49*='9P ?/&NXPK@(X7U%/4">!JFNOO6
M[7^R_N"G,U%$)F<;85H\7/_4<X#JPWA U7MY3\"J^H#J(MN4F0_T#@HDC"V&
M,A)^6:<38"EOQPD1-UNV*G-< =<A+A%9^+T8-NT[K,@ABC5<>-^Z^-R$<QGX
M?>MGYL4L&%JE>KTH"M.'2 C5@G49'"K",@CJW!<U3?@X)"FLF(I8 ,MG?7;]
M-I5>J5)2G*UZ:UPFW_]N#>*VZ]BXG_#$&A8W7#7NSAK_;4Q.CE? >Y('WPG2
M@'NQ"Q\11:/SZ(2XB1%5>;DA ]'-C%I66B[XEKLN%M#B8,!?0@58H&OBQ7-I
MT;!"*RGX;?M4"TB@5DBSS,(<+^?/&$C8"?HX_=^8Z^+D.(\.1]>,<I>89[40
M^2J*0]C(?AL>+"O8M"ON5RSQ)5XG"..;!_PP"!'A2V0^#5TZ;W=VS\<BBJ[5
M\H O<,+@.K3.<2MAVTKX'O#?"BT>%?K"?L3 Q5WK4CP9'O"%!<!X.IKJ?N&>
MQSM#8_#/>*X]42-TRMTNW-<DK9#VVW8X<@Y</%EP)\'#&MTN<X(PO0Y.*.N8
M090X>'Y@B) _$CMA3S"/,"E#@NWK^UB.@T40H4 MH\*^_/70;Y"9AAOWO5A7
M["%#$D]2 \(ZG3DA5IW$3MB#[3864]_=2.X 4CVQ6@&(-(N.M_4[K"E,]NO7
M&SV%E@<T, B 3\:!>O+O^&0:1S BWT5V99T>WAW"44=T':IT<N&8!L0IC'D4
MQ(7&=9<,QL1<0UOR'F9=XD@XA#%_.M;C:2B].<@;X6 ]<BQH!_G"@4$C_D-!
M5L$BMZ?J<&!3CB@Q:L78#5, P84.TRR61$&Y*+4!E/'/6*Q.I$(#X>3D\4\&
MQ&%Z5) N2[P%M*&NV52CZCO@>0[.XZ##!U'/:L<@QI 1&D^;)"R49( # L-\
M]_PG>/,'2G_^AHNI@"/%H8>%5E_ 3;$=Q6)KG!2]_>'#9PLE"F(.B*5K!SX#
M]=8X*MS8H\0_  _Z#NOG]*T_8Y#\5-&/F'X$%TCG5^E!2EV2,F/YR$I+U7K,
M<!YA@&DI+RH91<BC8#5BA&%,*GQ);L$* J&+K-WD)QTG$8H1\)VR)L]$#L'O
M%S ;&("4*)WQ(VZ2XK,F3IF8'=ZOCU:&3A7 HD2/1+TDU(A:XA,I6VT2X8K3
MBTQ8X$K'DM^?:'Z/A']F4,Q%,L:I& ,EP#D/ @<H]12(+P 1%B&E7WBV'X!J
M0N=N[_STMWWS+>0*(#H8UO*%L4OS#'RISMV>-BU$ W.U2@'SJILC2)AE=ZA$
M(]9+@\)(S!X$*[';1]^%43@: 0CN*D O!/H8]88 T=V%#?6-TNP"*@)HI,-T
MKA@9$I>B,%N>1<3CT2LM%M6'65&.%BQ%.U#3%6(SH22E!$@AW>B#F@EF36#=
MI-1-L7:I+=><OJ$Y/?'EIN\^X"P,WDR<'+C[(5U,5UVC;+SU05R#+I=<FB6J
M,&ZCD875( 8G(UZ3$!FM73YK,PA;8@G8> 20SNG42&"0Y*S8ZJP0?Z=UD<.,
MHV]1Z,D+!EA<0;-XLRXTG% '^R7+J<G@R-?X9W[]N3/>C7,) -LUXG367A,T
M-;1!D&725_N*$2,0(_Z9$%>B[$YEH0G[*)=)N4A&^=7!^3E,*UTGL+EJ&D(6
MHUX'NI10U\M598T^4<&TY)%(2Y[88UFK?A/X8);VK3O?!2H\5!7I]P(&%\LZ
M4%L $H\12[>'\&>@IPIK%62]0] ;(;R7RQG8%6'/&0AL#F%-,#OP0\&;F1.Z
M9. !I0O8'7@OJ0H@'B\/<0IT[%S^+( JPLPRX#@-#:-#'%#S=AA&N"P%(SB-
MX<A$QL&EH;!PC>"RC>D2(Y>:$\,";P+LXUTXUO3*S(UZB<G+O4<G\,E".+0$
MG#(MD5IQ'$EM3,$:H12-B/3@"? CW M@/OV!1!!Q/,]_%+P<;N0D[\@I!(:#
MZP\$CHLG)YJ@&(AIVN0P@JNUAA8*I#O0^HR)P_>PAI$HEZ7K)9*RQ%9.,2HY
M$.QXATNX2RJ:UUX-NH56%_::"U;BH65IK''>WH6&!L*QIEXL93]Q K0%Z+?8
M$-]UQ?+"S[C@5SZ!/"=G0YF_!.N'0@O(".8+3P,Y&>#H$1(,$0HP^RY[)@N1
MYLX>!=I2)(1 %PV^RE&RH]R5, #DI\O;5Y@1'"XEL/OL#UP ]B2L90EQA1N*
M3HKTRM+N^GU4?\ ^<!UY"2V8)D/8K)[GN_X#[23<CMLES-31O>HX Q>8H8WZ
M!CD2:7= 7/M* 7&\[ D0[DUEGAH*1Q=/J-PPI5/@2$Q;]$(L)9:S1:T&4*)Z
M8"B%OBWV^S!GU> D<(?T2U#M0G@'S>#.M/5W(RRG1@<!Q(GS(-6.,?9N@)["
M=AP\]*S/0+&$7I18]W*HL?:[-"Y/F=V#PR:VO@5RVN^#Z9D\$G09ER<"^8L/
MFET3&=VR)>3:EU<?[<JK=^75VV73YX@2M LZL<V%QM'X=G]Q=VFUX!M&GE)"
M?B7<K[)R,F/S K@<M3%/,'6TY*(G-.:DYRDD+BC]3D =P+DY#:ET@#%&9BB!
M;OL^XA9B^ I%9?@=9+.0&5Q/3/4@(2&(S\!YV2J2P<!@"?NPS#&^OI!)Y%)'
M4ZXC7?<1Z#61[K>03! ?E#17$!!SH  UQ)CDDG/_@D/?-T2(C! (4!^RG'PD
M0[2Q\)4HR((N/\L!\P;6M&^H&R[\ E/\3;S)>#-/[9Z0'&1N^[#:8(U)%SUJ
M/OX Q4=664L+]=3K$LP<$^B>71&SRM$DL<RH#=>!%LV9;!HI8QP6(=I*3"+X
M27H3>D .,/(@#D"Y1EL>5J?\L2(B)3):@S.&$0ZLQEE) "W"^7! DKJA@9$T
M=K5SI+R^)'<1T1H-=W[ %_&,:P_T(UNH7^4:E867"V-2G!%W%-VTL*SH1#$-
M65K=1(MK^Q)/,1N<:VBG2+X#L6  \3E]]#YCY&F>_H)UC%>/)IJU/Q4L3, Y
M&!@)..?7LR;:Y(6K=;R!K-F\/@7$Q/NDVN)+^7%HT56!"DKDH80B=#"-*J!J
MB=DA<!RJU\"^HQBF,Y1FS@.BZ^)'.YG_WEVK6< 6$[>-@G7U^UVK8%T@<,:_
M6O>W#:N<CG[M'X)VKEOS@#[1RXW,MV/'[22PI?*]F9<U7.%MA0%)QZ$@0A,@
M-B(53!*<6G(W">YI1(% ^/$#L,L\<K>1^7C6P/=TT&!!;B7X9M>W8PE;-X$[
MWHF7(1,J^T8!=X7()?E-4E1)=#$Y&;[-!@M!5O<I4 /TQ2ERD\1]Q#N&?C=Z
M0H&"CVE<B&F@^Q)[).'8A%D=1*@O[)4J^[FQ+)H0(B[K/(#<S2ZH+AJJ%08Z
M2A^%W'/15+71=R'L;<.%@.0'QG*(@DQ"-1)7RH/O4_Y925U=$1I SUE)!H)+
M%>6Q(3;W669QJ'%G'90&TLD!I1.Q<*8E33Q4G<B/>GRTI3$;2(HL=%@[</@#
MBN-=PO\5%P#A+<S4CL#$MNRX;R&GX"I-X1'!!3UF&+H8(06E0N0@Q8G]2_H(
M6/YM='E(3X2R9<DC$@C/PDTX!&40]0Y)",)I#^+ZM(&_IU=+>!GD-+5Z]P55
M2-BL+V =(PV*/>#4_*NG+&3*BB)'C=5D 2A&'DM.@"%YSK@;,>LREG^D;7-Z
M@G7GP[&-A@GETB8(;R$N7E*&V=)*(_"U(!3A%B1;DT05+Z1I?_NU49#;+\-
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MDU,F!N0" ,)7]+B"=N@"I88XZ7J#=BKM+%YS*H-5G$MTQ<YPS+3WM3_PB;F
M<O?DYWM#R!TDF[W+&')>('",EZ6@499@&&)HE!68D^&0-!V?XA@K).%=D;:D
M>SAE7M4L598 ("8,<>X=J?2A)YFP_A*/DO35L33U&EENI+E&8<'H."S87Z9+
MNU@/BJE5BS5RCXND!&2E=P>_Y,O#O#Q4Z1D7,1%JAYLLO\Q+95CH%J@FGZFD
M1EG^61#UV*&NOA0=Z6WM0\UDN*I6N^$0A')?RI#LJF#D(:)'2&"M)/BK+]JB
MX&$SM\Y]FY7C6=G<>%UK!@Y7T =:LBS5:SS,X2#*:9#E)/D3F*0Z)9!><8"3
MI"<H/4IK%;XLF$EK4LRA/!<_5ID5HWAUHI9;)=.@US\.*''6NNY[3CM&P"+T
M\J+NBFA6AU8C1'MY]&DCY[601+U2^3X:'Z&@C')*/R C'5@CZ;$P)]6I749:
MY$ABJ5(/1FD!7(5X$HBK#K<I'JP2P)))L&3F&H-!RXOM5J/R>8H(TZ #6N4G
M"+67, 00;G'^3;]7>^W&\*(Q;,81E@Z: +FLQM!3\O6G0C8,GPE_'UI7?DZ:
M52;OU  (,O+>@DQU^)AW\+LBO8AD/O(%S/">8/@)](2TJJ$4)9$(F&<9)^K#
MD[*2,%JO0N/PI^4/=*VC"E'B@LC2D$*&SW5$PN:Y0$+ K E:*XD.1'H-]>@D
MYB-UBS%O)(>*T&DID14PWV-SBMM&6ESZF(=NJ&PY*?<[-00F="&R KIQ1-@K
M3X)_"@FK]1!*WW[!@HK3-< D(!!72@F0A_1%(^GZ4YB.2F%)9;RDDF/;W,9R
M&$/]01"4?E^^SYC(>DK@RFICE43>'J8S)]'')I)'!6[8<.R@"$$#4V?6(X/!
M[>$+YD*:G:-Y"J%&$8?-N2%Q\Q04>HOTZ4U_V$,,2XH!6_G2NKPR;T\$=\+@
M@D4Q$DI-DAJ=PHPRM**Q\B#)0\,4B<A\@T/K-ZZ<8\+CY9$7M:]2.T.)'V+N
M2.0KBN*F;$CMHM0G\XQ[7:92T(1)&"0!ESE/(J=5+Z=@M2R59R.5LQP' R*
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M!XVS$AJ.0"F^2];G30]8FC4QR+F)AZ9V5"P4)Z=%;_X1$=:Q,B(#WO<?@8T
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MZIG)K&?CP.:TUX(%OY3-FB\XF<\NCH&:<THX*'9!-9EEAM-EN1R1AWB&C];
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M#)Q!7505#OPX% "[HL[2!"/L4;F746V:  ,3 PC7ERPJ&T,6NLZ7P">>G;X
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M[R+_?O[O5[3[# LSRYG_9Z%V %PL@!?PD9[N G"*BXZ>BX[: T!HMC+2_8<
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M)64IIKZB* $EFA>BGK:O7^KFNM%P/PS%(F4R^4@^?L=M@Z@)ZT&S4 '/=+X
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M(+E714,ZF_N?UTGI?]C*:5:L[RN_P_/:71H[.B0Z_M-H6N"BR98ASZW!4+^
M44[JW/\ 4$L#!!0    ( /"!YU:Y_+>>-ID   ?%   +    <&5?:6UG,2YJ
M<&?LNP547<^R-WAP@KM;X.#N[AXLN+L'=P\6(-@!#@&"NP5W#1[<W8.[N_.1
M>]^][[XW[\WZYIM9,[/6]R]6K5-]=N^N75W=5;^NLWF=?UT#H'V0DI4"0$!
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M 9<B#I5?2X-E!=DF,:K!M!7/HR8A8\C4]7JA 4.<;F,(.7J>-=<LG'.5W;P
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M_VQZ)*CU-ZM9[32/0U>F<GMLIXGB0@4>XU'P%&\DC5."!A5@DG?,J;;3^O7
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M0#T:"S+:_C'B$H[<K%J&O@T?F=,ZPI!S-2E:QA-<A9!C\Y&,YQ!5(>U%V Z
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MC306PE$9%>P.X&E)DZ+B''W:HGB_F2,EC6V(>*25'I.N(4W+;S-PG.BRKXP
MCE&2GHIO4P47IXPH?G#,C2=EZVN"NDS_O0@/[P!U@0RI3M4/3]#&IH9/Y#L=
M'NY$22MEER9'#XC893.7#-JJNT\[,BMM$_8"3;[%$$SNQ(^P,BIP@C5I+E$J
MS*'EJ2^Z2P$"*SV)7?>VV#475_>!8R*\/)WYV1IE)JTI.]ET4M$,QB9QYB*Q
MY,=&+/ =5U"@--7VAFNBW9&8]T,Q5YXO*DYIOJU0()&URXR"0B&\GS@F>ZWD
MQ!T.E$''S+5"1W:]7H=ONM3EGNE\$(N,?#]<9GD^U1EI88BL!_#V7Q5F,R])
MZB]_OXM1H3LP^Q)F84EJ'HFDBT^]O<M#&EN0B?9)(FHX#&;@N<MWZ>5,F'D8
M-;M_?U]'ISS2!B69*/:[L=4&!GNB^R4/PE!< G.[8T<'5$6=$JHUK9\7=-)G
MI8445=PDBDJV]*;W[K=0<&!^MWTY.;T&@N4#HM_A6 ;DT^M]21RF-J>&5YZC
M4]&MOJU&CG#&O]1:FW4;HA.QON89$YK\.!$<Q8+X/95%E%'G+8A\ JR+TM/N
MFA(#);-A/$:ZW2O"+SI[?@3L_F0@>!>'HS;-H.\[$P5IULU.!!';#H+H)_EV
M];ZW-"$Y1M)N9+TD#BD)4;" E>*K<EH]VGH M/NM<#3O$T51K_1W4]%0!FT]
MF#?HG;![BOK=W).:!WK"E=E4M2I$TFK%ZF)1JVQJ6;>:'2V0"'QGTF3 T@WJ
M [%'18P66-(T[G5%T&3%M]Y9O@)8A?]@_YK9PIZ8>^K%I#]U^HEB;7^D5\ .
M]9^W/VZ\I^_B7@' 1Y4_1XD'3GJ>5P"V=^X^BW!GS/7TV2./I8>779R9C>NE
MMK:X;U94>F$0K-?-P!ZRZVY?Y'.\]=O9&/XFFJ$R:=6B!@;%*>@'_*(BBI^C
M4'!"77/*X %_I#8!;:Y=_X$7;'.D ^8>]Z?<'@/\(&MI1L'4[W*9*C]$QC;O
M- LY_72:]JM_]D6?Y$^=V#&ZII-WZ$N9),KQ*S$.9N3R<@9SYLV>=0,'*A7S
M-Z$O-'E68L1'47T)]D\$%-9;1'[/"^%\D9'&^"TS!2-\@B%]J/=K>[LWV_V6
M&UQ;(^,\^GLW\%@"U]Q(6J'0ADM'H2T=^A:GX;/ZA#_7[$I<=O1X7FIR@AR)
M&JC=!7]??4DM"*_TJM]-%B:]KJ5L.''5!+%L6*L7 K )S:0%,7W5Z_6#]I$#
MAP]9[%#FY]G#:*=4^3 W_%-G+:Q3 ]P6^A?TP)A4BLF&@G/*5@) :+=>M&5#
M=;T6.L4W$S/;IFW6?KR!!]=RV$RDR:7A>-W^\P]ASGRL&JH'\/NR4_*\2N(-
M,_K7@AKT]/=E[_WXY'K96N*0)JMY>? IK(S88$6AKXN4(FQ)$!."'E9I\RQT
MPPLB?%<^;V..J$<%O#,W@7)NZN_L+Z<25'S!;;1RL*>P2;O?-C<R']-??EI1
M,M0I43W25';."'/;6))UN%9F*K_%49&U W[<T*\F?P641='J0:Y<!K@,Y#>=
MR[,M?7J'TF0)TQ/W]7@W@CXMX=(#<G@]U9'P/*:ET8ZZ(7U"NNJK<^Z$O:]X
M_GU\67D=EA/G7F/,8(0Y!7L8?W68@$O"HC/@/NQ#1<7^^0!M_<Q'W9H5KYLN
M7C6]VB@=7M&E&0]J:J0VPZ$,]BYEI3^H>N4N5W/J>HEW7<%YI7T*1PLZ3AXR
M*Q+Y%<#PD/AT^"4GHE%25!N9'@9+68/E'[_1[HTA^??GYKX"YJ*$'Q@T\LWO
M3%\DB4E?6HW?UKE)'7UW4L^H9>,;SB;_Q[GY'RQD?U?Q"J#DUWA;]\(/E+0<
MAMA6*9IA1@VM9R.A^=[@?A+94+SL3M4TH@LM/T#^?^A,#XZ@I4XF#R20!1H5
M?64;5@( ^%*N-N*#FIKGCU\!ZX+C_GOBD^VG%2^]54^F%=J>08<*C5-'N94R
MME^8;="Z)+JT4>"@>)%0-_6.A:PH&[[]<L+\10;XYD8G)24--[]3+$:[ A,[
M[M@1"P^7?:I;<U=N$ZTC-S=E*Z;PJ3Y^,?!]A-4TC=[V$"07%4+E-L3U*#*V
M A7[AUW]UI;F]J9OA8O,HY0)HC"JS<P\")^5#T.@>("$!'WA)]?=EL_9#K9=
M\R=&V6$9/>15_JF-T=)#M=X06K7*@P%'<#V1YT[ [@]3+L @#>7= ,.AB\L8
M[LS8S0PXY> 132'>Y"R6=-P/K-^-OY0P#"-(+,6BF9%=S@GZS#%+*@$ES6P^
M-5]^.LCQ0=1Z*E*!1[*C9<FI(6+:Y1T]<DD# 'KIJ2+HP)5OL:D 0A+KXW]F
MV/^9@IN3B8>4BX"N_BL@+O(M8E4T^5^QRT]=VQS3B3WX#77I%A$%7\,%*_W+
MVZFS*9[VO4N*H7Z6FKJTY1\%/GZ5BRW,MG4944R<OC?0;H[N*^SWS1"<(V&,
M9&#-/"T5%ZX@S3?27]4SU,,_I?+*MR_=%0Z;+-/?#U-L##^!;ZR):],^GL>.
M]>@\\HLF.$E+46QP,2>L#4?'LR!*"_ O0UB!45$W^WE;N40LK]7-X&_:D#FZ
MGJ)_WZ??3H_"\V0]>8@Y8F$W[$1+OYVL+F-*LK'$M\:D9)P!&.7)_5 5=,WL
M>QMG@&B9PA)@%'>@=/=9W7U)HBZ.#.25![((8<J/=YROPNW$ZW7&"AWUD^*?
MR-KXP;.G5C>[6]MRF1N* 2V'T2,.\Q&/94_TL5O0:U?0JF8VOT:[LR'(Q8E\
M\)C&=EMQ_58+I8[J_^Q_=))S]R<,4L/M4]%T>XD3+&46JCL]&:]'G>91\I3S
M@V\C]!H8AC92D]4#:^M4%CH-V;<IGX8#V_%7QA27SV5>J,!24G9\0ZS]D[20
M(NK)P1@H3\$)1#&%BK3M\Q;T)2'-TEJMQ8L8E&*=N?KSCNS!46:.7GG-XUM>
MZ+7SZ9M<YX-=LIIDU2=DKJ, ZL!QE?&"0WA?:<<I28'$^FH]B4>PA9@6\N/Y
M'-X8,3OHFFAQ:_*WCCX0[1=C\2#VZE*;R6^N'=ZMS-'TK'VY'WJ*E!AXZU_Z
MW1M%%*5AOI(YQ4_5H:X_#C 3T-/,JI$)6([*5V->Q(]!@YQF,[Z\W"@WO^.\
M!]9P99K4ZOK]FF0IE[ 7A0G5>KCB)4*A3;%OX/H>40S3NDYY:7KY+3TZ"H-%
M6AG4M$>C_P;:R;Y_+*<P#=_$U^113;L5?/3(L\.Y"L^3\XN3.LJ39;,'L*AX
M1P7(P 3T34;#/"[]-FQ,\PQIK6!^Y!MS ),=TO!#C+*1"L2/E5$_ >%NM:88
MI,%+N1VQ,/RW&+!/*-*&BGQJ]3I02D7+TD[0<>*XW_.\]K3U-7GV+S>CUCRP
MEI A-7XV*$A1RUCVP_)J.M>/=*"/HK!V B;'VW_S^RVA.& I=L14+J(FJFT.
M[[\?\B<M$UN\Y)QHM!,:&C%M6J8/M>SGKR:D<Q;^ BJHMBHT,SL8N>8XJ1LX
M*=UIL&+<Q!S8D3DO@>QSLD_N^]PXRL*N_4U9/EQVR/$M!@-/A?Z[]TH-NX7O
MPU\!2\S/&75"0/\!H>GVXZ27Z ^CPK\,BA[D4<],G]T$Z&CR,LPBL*R!SMC*
ML'*8\RC7>;ZL9>7YR,'[28@N0O)6 ]$=;KP"1AY7Q4^D/Y;VVFCJ6UOQHL69
MGILNAF@AJHXSASBS"SVG-"<<F"<O'N2F@$Q?7QP35,2$-%733/>?Z:>^%?I(
MDJ2VBS-KGY57967%J]0NH)-Y?5V?)A4377OVHR=I:!6LUO6SEUO*TWKIV,JK
M&)[$X'+TCIWG?040=/Z(]&$1E;22R[)!HZM]4+CZ=(0NM\2#U+,&$3>=,2,E
MLXIO0!N7&X=7DHN$35%$4?5#03"4*X+.NHS);B-"-]++!&2^@MF,C8&J3EWT
M\!&:0UF2Y>\YJ.1=X:JL"W:K>WSM)8WGAM: I0H;/-X M$N*B&9.*56F#_6B
M0(OLTE'3Y4U/W^ KP"<F*?MP7Z(>-Y8!F;/TO*QCF'*3[(.@YES1_J'D./9>
M(9^ "H<S/44QW6 W-/HTNL(_PRS<1 ;>6\24EGZ+F'C^5UIE'X;^XXN#FF',
MX6EC;]ZDD\!2E@3\*_NN_&O=2(T$T#YEYZM>*%ULC>A]ZD$:QS9X"%2Q)X2'
M"*I$#@X2)ID1_N5_3[O8\%SUEH%I]7K3G8C+BVV<^%HDD?I/JIHTZ/ P(*#1
M_#HK%.FN)B^X=8D3BXON5*5GF#@>3\,.DG!.J[H.G2O'IA%V6Y4K?FT02ZW:
MZ L)\JTN+C!F!P*9Z]3 ;#U(&?X)[K<-!C@S)R=N-*WO2@PE+EBY8P5^@->>
M7WCP>Y4.1YQ)6*>O_%0VY1U0=3GS2W'(<1I,9*.?%MY!9_Y,[]C]/4?^C7OA
M%6#(2I&>4V[-YYK25F59*-)IUIQLHF$?V;C).=ZW7L:LE:I2>7;?@OO@?:K9
MDBS0DJ\!OX6<.[@5Q#;,FA8W6^LLY[2\550V% -[6)\DY^!B$=??*^*A]ZM>
M,%#.P6Y>'E;U$CU]")137!Y23&RBS[!DVQ+F\1UT\"-02@Z7VDK/I86GS]MW
MJ/'$<D+7Q5-<MP&TO5,K@=,9%; L#<96_UZTD@2A+4L?-R)PQVR@&Q)2NJEA
MNYYR0):,A!;]6!_<>-SKD@;*FMR)<=+'XU!?LB._.7BPD0A7L?&]7_6-Q/@5
MA'5B2<8\++)U3>;&V8[ZQ:1RW*'B28HJ5(:::PB)&RTL^H8521FD9^DPR/(!
MW!$G#A9UB<]I%J3NJEZUXEX,F58@R&\>LJ%>-!61_29]6;Q%.V0,FD@0R!A.
M[7PH4?">O;&&UB@C _.>KC$%"3B<M 3T;R&Y2+,AYF;F-,.=V9=]BF%<J64F
MD.0W(1:#7(AV7H8%'O-0BHRR\1S@NZW]_#PJ _:A7&$()X!NC+[0EZ.]UUJ7
MT>"/&;K(\.1PD6[4QU/3F/*4UI4Y 7(9]3F@):]81I50=3W&AO8$6P&/1_FG
M<5](IFN;RC;;0WD4NK]%1YTG,.3!P@0;.RJBR'2.>A/\F5P+9=UX3V&=P(@1
MF&:[Y"QG!^,NOF)GO-.N=;6T-!1:I6#.F61R+NN?MXY,)OP?C@>K5BX:1C/I
MC9ZZ(_0F3NAS$2(2#Q9U^9O*[%7-QOLG^IO@;*"">&ZQL3_^.6<AQ_SGPHDA
MO:?XB[0?ZDL7URO@@=7F(&6CYR1JQ[/^/[[^ES]]C><FY^-ESD:YA5;*P!4$
MAAC?+>(19(V(_ _X1C(QQLNW?$*43#(\#\64QQ9IC515=?R>>WB;ICR7P6%Q
MO-:9.MV&&:.C+Y0D=R+,5/4NXH58R:"QM7YE6ZXVNAO:-PO]/B*0(_4F3EQ;
MGP8(Z1O*\\0JWUZ5JM">.+D%P2"-7+M%PH:Z936Y8?\)QP?'-;6N&G0ARTC5
M*/N>I4;J4<*XY2U$]6$S+'XYWW?*JP=+<]1OP#0ZB[6^K[F(<MMCC^_87RT<
M=_WN1HBOLX.#T,!2N B['F+B@;3K4,BSR5GWG( URU7P*)?"%4J+L" %VLKD
M@ IL9%W;/?48HXA0*$F=*E3Y.''U[(?T/]A[ZZ"XNFU?M GN$MP)$-S=+30T
M! CN[BZ-2[#@C;L'A^#>. 1W#>X:W((3N-GGV??M=U[5/??LNO7^V'^,JCEK
MC%4]U^JUQOB-.8>@BQD0NVT/X[6%JU 1 Q/MC3R8\->"AYF"!Z5BOI>OZ,O@
M59XD+LD-NPM_O13MDVHQA&4$CU03'3XLR#CF+16^=SR9V:)=+18_O8JXC=OE
MG2 0HY]<H\F96ZDD8G78S[!G[V?2U_LBM4\/I9*B%!"9V!G@"H[4E/9A;-)Y
M!2CM6HYNZVJ'DBAE,5:,A#?+X?/$2R8K[UT 2#%50!/6P7V\>7+1HD#5-Y+*
M9U),=BH(>TO!<^1]V#UXY0AA%I?=_K5KNPF>.%:]H*?HS7/$K$U 20YP*T$&
M;WA]:=S<95H!-_YYC&!,I2V QO)7<<5PZ;&$?E?O"XS/Q_E4Q:8/O&=74F*Y
M;PO;@.X[:.P>;,V(B9,\P@:4C9&WMH$E0Q_Z"""KSX7^3E5K11P!,$3D'1PA
MTD+4\!K6-.E34MOR;DVR>S7Q6=*XY@F;]'WV+4XH63Y7-HW[U>:?5ZJX'_B8
M6B2; <;:45B?#629^\@%(<$Q+O3Y0PX-R_7/\=/-$:>[[==[LX6T9LD[J"X(
M<%&AB+L'+60<YTJQ_1I#<?2S9JBPYQ_D [Z5&*L&U@>X*%7Y+'!)DY;Z:Y5M
M7$@VS0P:48&[Z6@P*VEQ5=G_9:>4B&4&ZU:G.]D[YI$J/:0QA!!+BH^1=IQI
M%B \Y<BLK3G.W%)AXE\<57]T^7=LZS*EK6Q.K0*H)Q&J/<D0H@N;B//0[7,'
M:'A@7J9X+58T9MW:.$5KQS*&F8@(Z![<3;<B;'EXK*RI"]YA\N)^:K.GZTW1
MP-'[/@WBE@(C3:Z3(1:YJ&VOK&GA35Q_:LT$\;HS%:VACDLI-C6Q,)&5D+C@
MB[37"%O2P?TJ;S; #3J]B:BN, >9M4"36=5DQ[[*"<;@ 5?CV/L#Z1@!52+M
M=!6TWR6G),FF^%\!\E$DBF\2/(PLG0:\;R?0:?Z1L]OP)+6TQYOZ?01RC][8
M*>[AM$K.?QXYF&QM_=9\]3"Q=UY&I25F1SP#VX[V2=CY(2'SAS:6(XJ9BE-E
M5CD '">JPBB_)J:4^B$2H=Z\KI$@K\H\[JS6:*4 N-POCZ/NGI48#P'KM7K*
MZR0HD[K7MOD^K("Q 5_AD[(7T6"&52>$G%7T/*64PT[RZ1K3JRBO,^WG=$U'
MDP%-)^ !3$E%!-G\/R@$RW?4@&;ZU/48D<'$GEPH#Z]BW=C8!T;%=QT$!V&@
M=1+S@CCK"OJ'59!OR&-^;9Q<7I[BSF-UP1LPMW#ZX#? FQCCPHDA<"K4RSEL
M6:90VLLL9A&D&8OS+?LRBS1O%&^2)!3!<\*S!+OLF/ACXK(U[S<B?"*+@'B:
M;YG\5Z,[1%</ZJ2;'CV.ZK:0^>9I[N.T>9D9.(U3VCZ/A(J$_=Y1PT0!NS?>
M?RS\5]@BPUE?MA)]?:*B:?^I(A_>D+LQW(K:SQ>P;5]=!$X4D4_U,CS%=.-O
M!ZUBW.M]FSFPK[+8A^S,S,S<R([V4[_>!P,7F,],9C<3MBQ6<%TF,K5':O6V
M>G89* \022V+&%BX4V_NHO;5+LD@^/%:@HN\F6!N!XMZDP=QTA#3KCC9%VV
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MN^H:02Q\;:=JCNLR>S6K@36CB:$D-4 ERA_$.;<C?J*GIU53-*4PE.S&07]
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M)SF7CU5[S$W(U\[=6#264C02]-M^Z'R08I58SP1-R Y)'[RIMS:8Q\[J9&T
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MR2GM;,7\X^W\C..-,E,K-8ZX$%"<+G>^!.)9[/,%&FYSI>#P$?G=0U$!=5#
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MD0'%Q6*6YD47:!^:YHP@+!69%M$6) 3C"FU19KL.=O:$>EEN6UV2QB3E9:\
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MLT!CVWZ??6Z?I@MO%-#. $VG1PA!L/=  %*R+E9QH@$NF796&_P?8L?[AJ^
M+R:8C6G ?-E%,J3@]Q*)(P$;_-T3FAX&V<[R'Z:!-3-L.=.XC CO5@4F561A
MBSF&1<(0$E]P1)3&-@Z*73"$PR^0:,X&5AV&Z41L.F+*O4K>L-"HPP=O;6OV
MH@4 -YV\1.CG].:\4C+\#2Q*GM\=,V-GRF]P6E.'2I#TUL!0VQ,)B&!^Y4&H
M1:_P5DR;A]!HX 2S)5!;]@+X8'+W/9^_46^+?(0@YQLFJ]DU1\NBN$"_7P8/
M]6MV_'"X09IFS>'5&F;$P?WX=OCIJYOPM.4<+:->I;2_Y@W#M#2>#+NRM SW
MH<.WF2P$^Y9^[BHUD]V36/'_[WUF0S0MP:./A5B^%=BO -A*P[_U1?@/;!@%
M6_0?V)#J(@W$LU'/5>'HYLC3KL+1+>.YI'E-1Q%ML;ZX9KV@8._G2-L^Y 4B
M0#P^$SF"\@N0V=;6WF=7+RW3MN?/_Z+\WC%FGDGQJ5=,U:"P);'=383O<X@8
MQF%];Z'-<N,,MX:\*0T#-039S#]9S?OZN3RCLAK+LU[]DHERSEP9S9(!3KX1
M]]>$4"XXIS%*D>&<4O/H#Q#4^OZ?=$?Z6Z>D?UT1H2K1-LR_;5-!'V^LGY'6
M[/ZQCG%#-/VBL,B&E9:JSF%< @::1-\-1M@4"GJZ^'B(1]4(&Y$NJOV'IG+4
MB05-N([O:V++E&9]QGARU:-#ZG& MCK>:P,/;,C'4*=Q_*UV*IC(@ZRWZVTM
MRW/+2ML*HB326A7M*T(R]5](K-$.W^*C?)4C\!@9PUPGV@4GS706UH/[1*D:
M&B[A;I<[RP\<,NB:U"-6#RMO+0SY@P!T/@5;(#'6SQ=OZAR$#6H]=6Y)_+&Y
MCM;U4!SRKN.KM/6'G?IAAJ+C^7@)3R@O(</;\N6H3^6_&?<9HI_@T\_V(0J[
M5-ARX_L<U[CO(K" _$)AGYE2YAM\HNP5)T^;<I=N/>!-@ZVB"[$#VEO_./?:
MC<EI'(@LBZ;8A/U%SC0Q$Z^  1V[1)N$GF_+JR3I:VEZO:[K]FT?\$Q04,H8
M/;8,]Q ^AI+.BT7R=/"I7/SHP]=IE0T]0SYE)B;"J\S72D?S6FDP:A9?W(QS
M40"N ^JO&^$-L:1(W3TP+=ZWQO#CE7P"47"WK'R'! S2/$.)&"AZ[]G,9!LZ
MC$;Y$AW![Y2L][Z$FJ]EA=G5[9I[@WN.Z/6B2JULY+=';1W1*CNSM^EWH$VS
M]@GK_-OILE 0K,!D:O!5= L=Z4X>C\."CA>/GP69F JTMCE1+N7WV,2>48XE
M"/G[;G1> -P;";@81=OLAHO*)$'0)7IGEX>C+9J)55',&'(OLF\=.^WWK"3*
M4 '$+),F!U]VZGD>WMEG!7"QCBQ5Z+9M>HJ8J&:4CU=($4G2 <V5RRX\I47B
M)W3$7,+#.EW]RLX">[2K-MJQ.ZS5_>L[[)*L<FP49#<+F %-]ZW@>,7.R\:D
MQ]"&NN,$O44%EL(:B8@F>6+_JO#_HTS!TNX\[C)M4^IFI0'1.L,-DD)A JQ=
M2_.UJ!U-"VV@"M>4F7-.HZ[2A8Z-H'[TJF!^:HL)K7I :S? W4CK;2A*^G(/
M.!X"B7LPAFJ3*1Q *@_J?U W7>)%-_:54C?FT#O<V5\'OQG;2N,L\S7]LG:5
M\UGEO)]8+-.IZ3-E*+WA)P)E+W;%+Q:[LA[F2&)L OJ5R:C7:*8("]VM;O,I
M/!Q5(RF*I=-M6L^[#:&<11^RL'KG@C# \J\ )/2X#&D_MV0JW3SF_*%DS>9%
M/<Q<&M]G4C<RH6DK#W1TY';YHH'K3 43L3JA=;_B,6G&J*;D]/PDLFQ-%[0F
M(M_J5&&+P? ;5"4BFE;[F Y'9^[F6I!-+'HW2A0,AN*['687T FG$E[@GY^2
MKC.4@5MN S:#91S-]A=$3=L9**\!_G&?;Q" 9Z"=-]6@+<)&PQJ>\?ZF1+RF
M=,1E<V2<?6#*![B]>-#W*P^SG19N'53=T!#'L-;UW/QQY_=YI;^3A"\22;SR
M:"".JTHIA;5$6\@HX,0V@,;U?0'03Q!5048_Z&4>59?;Q_\]^ "$VU/X- W9
M([!B]MD)S#C([7;F9B!+J4G5K+9AU: )NS-#?D[IRZP!GJD%#B%2>8[HWK,I
MMK:WQ*#[8&NEZ YFK%%Q\*5AF?H&R@IGG2'"%LOB+@=[0'^1[*"K;"C/N X-
MM&;TKS4TD]MUJH6/5767/<RY$PYX;F( JH#-#5WH@Z6>H=<*MB>#-J1145I]
MHY2:J&VTR>I.'@X6L+!DLH@&Y]V\\TVJ7;>C/'VVGAH4=49\2Q&8UXZ;I,X#
M7H?KE7(<4][4D?EMZ(XR#3.^!"RM\F3]IU65MSX1G\>PX_LLO1%W6Q%(W\9(
M;#HI46AD=]^^ MY8.1\+OMG7#+6B#,R/]_^2+-(%H__!>[[LZU"-[53ZZ75(
M:VSNY,(O,9W1>^57 *7F*Z#:Q_\W?'E[ G<*+TA9G]"H'"W8D$,N>F<2T=+C
M^L=9C%IK07]C!+Z]RZ/5A&G"MHP4Q R?AK@2OF]^!IFE*(& C)B7T9_#(*K2
MDY@DQ-JU#KOU@?6SZB^1KDFYS6K7T2B2T$BK)3+O @R9^P4[#KWJA+KZ\^GG
M5\#8)=,6HZ2B\ISY0)&?%Z%\VTK$%&E(BH;Q8T:E--ZR$^_*W$]?D=)>4^NP
M+GE-OEK9S8*$Z5*A ,:2*O'C2<H+KT;RTH_N"5)@NJSF]Q.\FD;$9$>;,3F]
M.8O/ G)9ZVOX(=%C_5\!'WQ[T[H/FV<OBD8<B4]EDH[/W,I]_.2VF=J@^U!M
M!^'TR"'\13*HI!H"A5O8:)9EIP*/KSRN![%/-$@=OB\:3-8J6QXZR$^=/+&S
M('Q M.D\J\#2-\[2%\L</2I4:_*Y<);!)7^=T6/JI*+Q6,NT$3A')4%2EIUN
M:>F!8Y[E_A#J1>W!+SJ2,1Z70$2A'CZ$+[O6WB*!9(Z6I[@.((.!]\&.W*$O
M2$8]YFJL_.UWH.(FI K MEG7GVZZVFEAHK2JY1*=D=PUU\),I=ZC+F;<L4WA
M2E8NE4%O$QG,1(Y12A.$)\.]T&4&^@3/.?<KRS#B] V[/@^.1)&<@E24 SPH
M^1]=8(J5I94G_EC0-__W'DQ>^2M@,.,5L"#Q'&WXC;CKV:OZMRO%T'S2"[?;
MYBM@G>K(F_D%?=Z7R8WV%1#D,!;/QZDU 8:B7>;\]HMMJ7@%X'CNK^A<&!04
M&^K*EQP5C*([OLOBP&'@%X'";;XT'JG'5]V;REWBDO P&4T@X)@]F"GEO82]
MJXU66P8;<ATFI:H>V##57K+U1JM*:;/:O0)F3U)I6MDF@G\7O13\JA+LX)_@
MTHRHLS[YG\$?_SLQR& ODX2PRU?)Z1HC,M@RRH-DRB"1\)ZJ8)7$/F^,//33
MQUZ'ZP\7A=:D+!C=3I=I2;B$)B#) O1AHOTZ[J#C"AU""$S?-PGHTEZ,?Y3_
M:&REM\C"K=_S.J5MRR^&0FC.A6Z=2 86FE?(V)?=!-F!5=(SUL$B2SZ+]\Z"
MV7^T+7F1<RGN.U !00+SM!"7X$/$2()<S0/T :2\!F1<]XQ2[4H8/V?%MZBG
M[.W$/>*%-%,("!'0UBD*C'LHD)6VM%B?-?B$9]BS/[@<?3J)DX:1082'HHF+
M,9#W6;2($>B*\UBSVAETKVSS,-A<HD-4:>R!5.%GPU<'3UVN],-\I8F4A@2V
M3&"PV/([3OV/K+1KMMCD5G#(>');AHG7](B=ME):EY!]6]PIUH-05'D?\]7;
MZ7YJ$(H]7%T*<T>WB?@PX0[/R+3F*/82"9=GO6;.\O8ZZ.L5JRDV"&=9LKR!
MPS$)_GOVH( >CI,/BO?]H*XV6JYU2'H*N_RRY!)'$':,YGF <]>YSP431J2
MZ2)S=%0LWC&!CN[A'1_'J.,[&L?6=<ZSLCL8O[88(1S/X9NBX/[6M<J.!MZ%
M3KGE.L(,_GC=O8DI+?2Q K!O8?RDW$!^C/JB.Q_U94P]3NL@R[>!+1B(ED0-
MG,G(FY-NF @[F+G$]2)'TN.Q!(:<N0CA\5? )5OS0_N85_J#6!2L*!1O4EF&
MV0=E:#UQ(..D8NSNT_,*TIL9+.QX]X)2Y"M^4@0]7@#1I@G/I7M-[2!%ML.T
M#* )FR>).9K0J)LSJ=<($N0B03<WSX+K,EBC33+CN:"?3&9PA&/VI7N">0NS
MIFF;[\NJJ&F;P(37\3A/NVFE\"2UDL/'P+YO=GE+K-M%455C K1J>X'";A6"
M]'NQ1G7<E<\293H;:P8RG-P+Z=?/B]3QAOOH=T1ROS>1=B#..CB>YWUO<<R@
MC28:T@*SIP\X_A4OF-OGQWJGN"[]OU"I394O-6J_+9*(2.X+Y%EJD_!>AEDJ
M-W XM4690A(3!.=%<%5!+*%^B!<%+^+5?[ZS/_;F$573T</+T10FX\P\DF,M
MUK"DTLLQF&=_NH'_71"/3]10Y7:8CY'# .".IF:[35X)3<&+O_V2K*<EM?0+
M1;Q?UV-O;*5O/W'=WFYQU=EO_(I=I7R.FTDRV:V\69A 0:^2\^8I]RI&GS(Z
M=TL3>=($1=!C1FWEN\'J(Z1(/(U]\6\( ))8/&!;V9:*[PT%US-!OC ID+$(
MN%/W1\NU8?SS&?C_B_X?S??C\:\JT5II1\8 \_<V><G4S9AGXF"K3)C'=\-3
MCZC!I2TQUU= @S?;]6V5@XAMGR&6P_NFZ6S7:$YA9',Z3G:!0>H%Q,!8L(IG
M9D^K4N@+^1&;+4&F6WBSWNAH[GJQ\T_1W$I38F<5.9];T60:ITZJRYSJ;1DF
M#[YD^]R4958L/S^E^1KZ_ [9?FEM,A)X7&6U_ZQ:T3_3?ZO$QO&E^XRM?_A=
MO5R(RCY_(22^%X:X[+?: K:A\GUUSZ-AU D^.HC(+/8]2?B]Y_"+Z9QF+E^W
M.K.[)R3D!#U%Z052=>2VF9_(HZ(A[!YY2W'_J>N&TW_WCR*V*WC!9?O],?>!
M^A6PPJ3DJ 1]B-^9TZQY!7P/>064);X":/R?S"DN\OR/S%X!PQ0O2S+-):L"
M_Y;Y+\O ;K()W\?&/EZ^ DZ3?+S]>M-)"8+A]\MW*A$H)_GBW=["'V%3&PW&
MK++X">DU!S_#%'D*D,OK+_#5L2ZT)J'M3,M<Q![H*SBK)YF=XN5E9?B0<VP3
M+HOAV##NP*T.;02:R/RT%>RP[2-_6[^0]7%B_H[2=%PBNW<JYB;X%8 R^9*_
M\<#R"EA29RBG$-.$U\V^*B\(SF^;O-?PO\'_LW+'EXG8OXQSA3^^%!D^^.,Z
MN6IZ_?7ZZ;]-)K$>D_WWGI5[IO4/GIG$'J/\=YM? 98R?QT+2QVIOP)2+V40
MI3UR+_[@DJ,_ER9L_,ZF^.N$]!*S3//%L)^4#&_=_WO]*Z"T^47>_];UK^,_
M[OW_C]>T$$W3'2\%+P!X7/#[ZX)F"^ZM GM2U2P,MHQZQ&)V9 2)>[;?MAI&
M8H;&UT0I)U)0$\Y1.+>)C6E4]_'G. *.; E7)0NP1. BE7ZB.U@_^C6EFJ4T
M.9]$B.$HE8DV&D^;12=(HT&0S(WC9(K,QZVOR=?),XL4I'^)&N5W@%7NI4S!
MGE>'RU%+P$%15>E]^%M$)_[GH]QGANK'6/_=W#^W;Y#1-W/F >Z[>F2:$]M2
M\)_S^?.*O@*>!/\V$:V5A_Y;YK\L,S?5B7?XJ/^H;[C6]'4Z>Y@HRL2REIJ.
M.^=]A@X'N._H6>1MSU8T*P-P(68"S\@'*X!X.C_R:J6M)4!9&C?@;["7!@#B
MARWC5@/_L7H-76<4>^*(RU2O@)RR5X ?BN@TYO.-TM-/#5J\ZGJ@[_[&?\;"
M]>$F_3?GWYQ_<_XW<ZYJS$?B9$JY&PT&7X1G+U\L*C0<@59!D?2%?\.%RI.O
M /*95P#4/QGTES$/E#!)6=J5\)];7_U/D9=,C#!5Z>#V<2S!/1X^F8]\)(-9
M4S1[*\3.T)N?<+6/_J#L<,&:O%K[=IDVN[@6_$W2H?.':Y[Y-1NMYP4&D-J"
M'GH+6W;#G0&=#X/9RK894$+)Q?*4G" CM$FUFV7T_.PS3ZOVIJ)I3[;7\2$6
MD8[,MF#J[. 2JZUV89D,.)U/\C6W5U.#?O6.#VWD%7 6F',SH[VH8SW,J-4=
M1U/7,%'*CEH[RBL"VGV:K6:A[JQ/6+9(-XTSAKP55A2-^<+^C)3? _[N:ONT
MQG<K VHX2&#0 4840N)&8MW5:V04D2FB/0S@7@$1_GU=I%:\6$5-\2:W*CHK
M'S)-0PH#")8186G>R%0I@?7)DS=C,:W6*7*E:FL<3]H"-.1!9[09PJ2[,-1D
M+30Y'),B-DTE%Z\ 8-=%]DLP*2WE'!GY-F@_Q9J&<43"DJTC'.G-7C@A*19O
MLH50UL'@L:Y7)]81USB<BH(CS7LB,ABKX6081F](D Q9>=2EX9=J>U<V@F,.
M*^NM4P3]=X2S"A;A#W<H/S^\Z'T<^H(&.1 ^:*DVFV^G*KB/D@J3F=_*.1NA
M+!A]4JM]R'0.>B)T_(DI<)"1\@KH%30HVVJ:<B,L@<ZF2PH[>C!X '81$MVO
M9UOVPTB"W(47E.^CR^^-73-MQ4[:R@F-9@N@@2HR.3SI3MH;+A5FIP]JB#2^
M@X#((YG(QE/#;?S*/$\O[J'37[P-3UJ=.%ZI;SYIC]F5H#8"$=3K_."U6NXU
M-Y^:W:&SM.[Q5#)BCE"2]CC\=\YTS%^-^/0L<Q2L5^_Y)-L60NMY,OVZ1K0,
MU*#Q<$,E5&;J1G48N;[DP3-1[%.[O_S#O4.[=D@J!45H2V;>JN;*IZM\M^2
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M;'GEGGPT.;ARU,D%XA;$3>I=CQH=0:C"<B,<N9>) 11N2J;I98_*!L3NC 9
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MU19OYA>"'\^4=:2]=BG<F3I]$C):2<-=ID'!$LZQ3L#8\9Y+*TXKUH&Y<=D
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M+-6@O;^L9$=.[6.7;J'W>]&?8"_@JSEK:/;(&UMS:D%5X%DT7-*6^1P2#D%
MZM(/A 96Q3[1$.!4CJ<+[#\C&!;-(J18Y'\\/ G1=&D8UX M=&?IPA4%I:OT
M.%PI6]1K39X4L.*X7+]]7*0[V$(WFO\RFT1]$4&Z!@I;)4$D-(?.GP&6.A@
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M>%\U,S<V-#4N:'1M4$L! A0#%     @ \('G5E<[3[3P!P  XSL   T
M         ( !!PD  &5X7S4S-S8T-BYH=&U02P$"% ,4    " #P@>=6:JL$
M[N@'  !6.0  #0              @ $B$0  97A?-3,W-C0W+FAT;5!+ 0(4
M Q0    ( /"!YU:/G7#FM00  (<>   -              "  349  !E>%\U
M,S<V-#@N:'1M4$L! A0#%     @ \('G5J>R'/W(!   ]!P   T
M     ( !%1X  &5X7S4S-S8T.2YH=&U02P$"% ,4    " #P@>=61KL:!LTV
M  #94@  "P              @ $((P  9FEG=7)E,2YJ<&=02P$"% ,4
M" #P@>=6K7CV5.X@  #H0@  "P              @ '^60  9FEG=7)E-2YJ
M<&=02P$"% ,4    " #P@>=6]D?/1"0F   ]1P  "P              @ $5
M>P  9FEG=7)E-BYJ<&=02P$"% ,4    " #P@>=6=[T(V412  "760  "P
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M              "  9#] 0!I9V,M,C R,S S,S%?<')E+GAM;%!+ 0(4 Q0
M   ( /"!YU93*..2Q:4" $=E&0 9              "  2E# @!I9V-P:&%R
M;6$R,#(S,#,S,5\Q,&LN:'1M4$L! A0#%     @ \('G5LX];KTX(   /"$
M !,              ( !)>D$ &EG8W!H87)M85]L;V=O,2YJ<&=02P$"% ,4
M    " #P@>=6N?RWGC:9   'Q0  "P              @ &."04 <&5?:6UG
;,2YJ<&=02P4&     !( $@!-!   [:(%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
